data_2m9q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m9q _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.18 -4.68 1.69 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.251 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -174.84 90.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.344 0.592 . . . . 0.0 109.632 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 118' ' ' VAL . 4.7 mp -133.69 95.05 3.39 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.149 1.78 . . . . 0.0 108.502 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.632 ' HB3' HG11 ' A' ' 64' ' ' VAL . 3.7 tp10 -97.53 140.67 31.62 Favored 'General case' 0 C--O 1.26 1.622 0 CA-C-O 121.76 0.79 . . . . 0.0 112.639 -170.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 86' ' ' ILE . 57.0 mt -86.28 149.16 25.25 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.409 175.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -147.47 111.06 4.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.621 -0.674 . . . . 0.0 109.757 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.453 ' N ' ' HB3' ' A' ' 67' ' ' ASP . 55.7 ttp180 -62.78 137.17 58.2 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.629 1.104 . . . . 0.0 110.363 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.43 -28.8 3.58 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.281 0.632 . . . . 0.0 110.477 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.06 -169.67 2.44 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.077 0.951 . . . . 0.0 109.583 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 18.7 t70 -109.5 151.14 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.545 0.738 . . . . 0.0 109.524 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.448 HG21 HG13 ' A' ' 101' ' ' VAL . 44.8 t -75.29 98.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.708 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.94 160.22 4.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -172.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.0 t90 -64.05 126.07 26.52 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 11.0 tp10 -95.62 143.96 26.46 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.523 0.729 . . . . 0.0 109.039 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.03 -3.85 11.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.971 0.908 . . . . 0.0 113.278 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.442 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 14.3 mm100 -82.61 36.06 0.48 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.452 0.701 . . . . 0.0 110.867 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -61.69 112.59 2.32 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 125.125 1.37 . . . . 0.0 111.769 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -124.1 119.41 29.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.013 0.925 . . . . 0.0 110.096 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.86 114.24 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -144.62 -24.37 0.52 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.352 0.661 . . . . 0.0 111.683 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.14 -145.39 0.06 OUTLIER Glycine 0 C--N 1.359 1.858 0 N-CA-C 114.351 0.501 . . . . 0.0 114.351 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m 64.57 18.4 11.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 9.9 m -65.54 120.21 66.31 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.386 0.674 . . . . 0.0 109.61 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 15.3 Cg_exo -65.67 -96.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.384 2.723 . . . . 0.0 114.549 -161.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.2 mm -113.37 119.51 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.447 HD21 HG22 ' A' ' 223' ' ' VAL . 7.2 mp -110.92 164.07 13.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.245 0.618 . . . . 0.0 110.687 172.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 p -115.23 110.88 20.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.58 HG21 ' HE1' ' A' ' 39' ' ' MET . 44.0 mt -114.09 143.43 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.307 1.043 . . . . 0.0 108.33 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 p -90.99 108.08 19.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.69 0.757 . . . . 0.0 108.971 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.551 HG13 HG21 ' A' ' 179' ' ' THR . 27.2 mm -79.18 127.68 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.951 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 19.7 m -100.79 95.51 6.69 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.098 0.559 . . . . 0.0 110.07 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 58.23 27.78 15.65 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.228 1.411 . . . . 0.0 111.84 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 75.95 -42.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.523 1.529 . . . . 0.0 113.586 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.06 -42.48 98.13 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 49.2 m -106.33 161.4 14.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.59 0.356 . . . . 0.0 110.732 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.58 ' HE1' HG21 ' A' ' 31' ' ' ILE . 4.3 ppp? -150.41 136.7 18.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.04 0.936 . . . . 0.0 108.948 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 p -163.52 177.27 8.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.968 0.414 . . . . 0.0 111.026 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.436 ' H ' HG21 ' A' ' 215' ' ' VAL . 2.8 tp -102.13 146.6 9.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.92 70.69 6.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.078 0.942 . . . . 0.0 109.729 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.94 114.86 3.49 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.794 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.98 103.93 1.61 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.698 0.624 . . . . 0.0 110.276 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HG3' ' NH2' ' B' ' 254' ' ' ARG . 2.2 pt-20 . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 124.378 1.071 . . . . 0.0 109.961 170.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 7' ' ' GLU . 3.4 t . . . . . 0 CA--C 1.557 1.247 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -179.68 142.41 0.17 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.671 1.588 . . . . 0.0 107.385 -166.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.573 ' CD1' ' HE3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -147.32 178.12 8.67 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.453 ' HB3' ' N ' ' A' ' 10' ' ' ARG . 59.1 t0 179.73 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 111.267 -2.697 . . . . 0.0 105.318 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 CA--C 1.566 1.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.471 -174.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 126.47 -151.41 18.03 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.253 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.88 120.21 32.99 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 124.795 1.238 . . . . 0.0 109.295 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 11.3 m-85 -105.56 144.4 32.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 123.609 0.764 . . . . 0.0 110.473 -171.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.38 131.82 35.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 153.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.497 HG12 ' O ' ' A' ' 98' ' ' GLY . 7.1 pt -132.58 142.84 41.44 Favored 'Isoleucine or valine' 0 C--O 1.254 1.322 0 O-C-N 121.083 -1.011 . . . . 0.0 109.283 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 94' ' ' TYR . 48.8 tttm -148.98 134.67 18.77 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.59 1.156 . . . . 0.0 110.17 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -110.02 157.93 18.79 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -99.69 92.16 5.2 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 155.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.48 175.16 42.57 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 118.962 -0.91 . . . . 0.0 111.352 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' HG2' ' B' ' 253' ' ' LYS . 78.0 mt 59.07 -80.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 124.921 1.288 . . . . 0.0 112.052 173.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 tp -127.09 29.77 5.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.962 0.905 . . . . 0.0 109.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.02 -143.78 16.33 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.638 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 87' ' ' LYS . 11.9 m-85 -86.84 95.57 9.91 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.919 0.888 . . . . 0.0 109.234 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.416 ' HB2' ' HD3' ' B' ' 253' ' ' LYS . 7.8 m -140.42 146.98 39.01 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.854 1.206 . . . . 0.0 111.646 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -102.46 130.97 49.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.143 1.777 . . . . 0.0 113.48 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.646 HD12 ' N ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -90.36 -30.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.626 0.77 . . . . 0.0 110.13 174.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 86' ' ' ILE . . . 100.83 -86.41 0.63 Allowed Glycine 0 C--O 1.2 -2.002 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.633 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -99.44 119.58 38.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.568 2.684 . . . . 0.0 111.127 -149.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.05 122.36 5.3 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.303 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 199' ' ' PRO . 60.0 t -108.58 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 110.096 -165.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.635 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 24.4 t80 -123.09 117.27 25.03 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -123.53 127.21 48.01 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.67 1.188 . . . . 0.0 108.646 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 65.73 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.955 1.302 . . . . 0.0 111.391 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.86 -0.44 1.27 Allowed Glycine 0 N--CA 1.472 1.038 0 CA-C-O 120.052 -0.304 . . . . 0.0 113.254 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -116.57 126.84 53.86 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.279 0.632 . . . . 0.0 110.87 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.803 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 70.1 t80 -99.64 110.98 23.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.634 ' NE2' HD23 ' A' ' 137' ' ' LEU . 29.2 t60 -130.23 114.57 15.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.693 0.397 . . . . 0.0 110.752 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.61 -171.49 2.79 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.358 1.063 . . . . 0.0 109.645 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.538 ' HA ' ' HE1' ' A' ' 110' ' ' MET . 25.9 mmt -72.33 159.79 33.45 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.805 0.842 . . . . 0.0 111.936 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.0 t90 -85.52 -44.31 12.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.15 0.58 . . . . 0.0 110.704 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -60.37 -14.51 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 0.0 113.326 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.497 HG22 HG21 ' A' ' 114' ' ' THR . 23.5 m -59.16 -23.64 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 172.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 116' ' ' GLY . 10.0 t -155.86 -166.19 2.14 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.627 1.171 . . . . 0.0 109.261 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -117.64 17.97 14.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.162 0.585 . . . . 0.0 110.461 168.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.529 ' H ' HG23 ' A' ' 114' ' ' THR . . . 106.45 54.86 0.68 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 124.038 0.827 . . . . 0.0 111.574 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.03 160.01 16.56 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.2 0.524 . . . . 0.0 111.811 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 127' ' ' GLU . 14.5 p -81.03 159.28 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.678 1.191 . . . . 0.0 110.249 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.8 mt -113.88 172.17 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.393 0.542 . . . . 0.0 111.67 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.557 ' HB3' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -171.49 178.03 3.3 Favored 'General case' 0 C--O 1.267 2.003 0 CA-C-O 123.706 1.717 . . . . 0.0 114.793 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.542 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 43.9 t60 -114.78 100.39 8.2 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 110.615 -2.993 . . . . 0.0 108.816 164.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.573 ' HE3' ' CD1' ' A' ' 66' ' ' TRP . 8.9 mtmp? 1.98 72.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 127.313 2.245 . . . . 0.0 114.172 -173.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.0 19.55 16.69 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 121' ' ' HIS . 1.2 tmmt? -139.71 112.13 7.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 167.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.557 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 41.2 ttp85 -98.69 140.75 32.43 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -162.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.55 130.33 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 126.088 1.755 . . . . 0.0 109.438 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HA ' HG21 ' A' ' 118' ' ' VAL . 5.2 mp0 -91.05 138.39 26.02 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.639 -0.663 . . . . 0.0 111.649 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.84 156.95 63.78 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.032 2.488 . . . . 0.0 112.139 167.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 p -98.85 -17.76 18.26 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.392 0.677 . . . . 0.0 111.829 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 21.6 t-105 -152.02 148.88 28.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.23 0.612 . . . . 0.0 110.87 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -149.25 122.28 8.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.647 1.179 . . . . 0.0 109.263 169.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.54 118.35 20.94 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.027 0.441 . . . . 0.0 111.29 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.86 -28.6 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.978 1.311 . . . . 0.0 111.805 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -65.82 -56.52 11.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.76 0.824 . . . . 0.0 111.951 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -79.86 -23.99 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.499 0.72 . . . . 0.0 109.892 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 79.84 44.15 0.05 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.077 1.751 . . . . 0.0 109.989 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.706 HD11 ' HB1' ' A' ' 227' ' ' ALA . 9.4 mp -131.65 129.43 40.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 111.327 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 131' ' ' ALA . 24.0 mt -114.01 144.09 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.548 1.539 . . . . 0.0 110.749 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.652 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 7.2 m -125.87 154.85 42.11 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.629 0.728 . . . . 0.0 111.548 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 10.9 t80 -136.68 138.47 41.1 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.591 1.556 . . . . 0.0 107.698 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 -45.15 1.51 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.68 36.45 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.41 135.71 31.55 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -69.84 142.05 53.15 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 117.262 0.531 . . . . 0.0 110.763 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -151.33 114.24 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.494 HD23 HG21 ' A' ' 229' ' ' THR . 3.9 mm? -123.64 -91.64 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 167.8 -69.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.689 ' HA3' ' HA ' ' A' ' 207' ' ' VAL . . . -77.12 153.86 42.13 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.817 -166.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.3 121.96 11.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.499 -0.85 . . . . 0.0 108.784 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.499 ' HZ3' ' HB ' ' A' ' 187' ' ' VAL . 16.3 t90 -91.12 148.47 22.35 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -153.37 160.3 42.62 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.03 93.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.294 1.045 . . . . 0.0 111.047 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.87 -46.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.433 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.6 160.23 14.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.316 1.046 . . . . 0.0 109.218 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 173' ' ' LYS . 13.6 pt-20 -93.71 145.52 24.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.964 0.506 . . . . 0.0 110.12 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.553 HG13 HG22 ' A' ' 200' ' ' ILE . 1.4 p -140.29 -173.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 122.193 -0.317 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 38.4 mt-30 -126.35 148.07 49.63 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.964 -0.46 . . . . 0.0 110.088 166.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.84 125.82 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.1 88.79 6.66 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.17 112.51 25.54 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.235 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 167' ' ' PRO . 59.7 mt -66.99 125.73 26.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 168' ' ' ARG . 45.4 mt-10 -81.22 155.57 72.04 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.145 0.578 . . . . 0.0 111.112 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 113.51 2.79 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.536 2.158 . . . . 0.0 112.563 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.91 53.42 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.302 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 88.3 mttt -129.98 -171.04 2.43 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.483 0.713 . . . . 0.0 111.666 -171.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -76.53 158.1 81.59 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.889 0.875 . . . . 0.0 112.405 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.544 ' HB3' HD21 ' A' ' 161' ' ' LEU . 18.3 Cg_endo -60.07 106.05 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.869 2.379 . . . . 0.0 112.113 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.443 ' HB2' ' HG3' ' A' ' 162' ' ' GLU . 3.3 tpt180 -75.09 97.25 3.39 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.113 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -76.97 104.91 7.72 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.74 128.22 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 9.1 tt0 -78.99 108.02 12.16 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 p -115.64 104.72 11.98 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.394 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 155' ' ' GLU . 90.3 mttt -83.33 164.75 44.19 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.142 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.85 140.04 58.54 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.992 2.462 . . . . 0.0 113.934 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.52 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -134.88 176.86 19.71 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 173.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -163.68 156.51 18.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.449 0.642 . . . . 0.0 110.455 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.401 ' CE2' HD12 ' A' ' 184' ' ' ILE . 40.4 p90 -138.84 151.41 46.98 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.209 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.46 142.42 41.01 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.583 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 181' ' ' ALA . 49.6 m -137.96 162.58 33.7 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.52 1.128 . . . . 0.0 108.704 -167.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.16 -34.27 76.08 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.613 ' H ' HG22 ' A' ' 179' ' ' THR . . . -80.55 6.67 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.43 174.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.14 -78.56 0.27 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.4 t -157.46 142.85 17.17 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.704 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 177' ' ' PHE . 69.5 mt -104.93 137.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.32 128.95 9.74 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 224' ' ' SER . . . -156.53 -168.26 2.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.504 0.722 . . . . 0.0 110.433 -169.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.499 ' HB ' ' HZ3' ' A' ' 150' ' ' TRP . 7.6 p -93.95 105.81 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.535 ' HA ' HG21 ' A' ' 223' ' ' VAL . 21.0 t -102.88 114.21 28.29 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.452 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 19.6 tp -127.98 127.15 42.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.761 0.824 . . . . 0.0 111.162 -172.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.34 102.92 14.99 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -176.46 169.48 2.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.325 1.05 . . . . 0.0 108.633 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.7 m -60.9 150.44 77.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.913 0.885 . . . . 0.0 110.627 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -45.17 103.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.535 2.823 . . . . 0.0 113.289 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.23 149.35 49.98 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.21 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.555 HG23 ' HG ' ' A' ' 198' ' ' SER . 2.6 t -61.86 138.48 58.35 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.441 0.696 . . . . 0.0 112.426 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.508 ' HA ' ' CE1' ' A' ' 211' ' ' TYR . 37.1 m -72.34 119.92 17.21 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.006 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.57 ' H ' ' HE1' ' A' ' 211' ' ' TYR . . . 107.7 -4.75 34.59 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 118.166 -1.352 . . . . 0.0 112.756 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.555 ' HG ' HG23 ' A' ' 195' ' ' THR . 39.1 m -44.62 117.74 3.13 Favored Pre-proline 0 N--CA 1.498 1.961 0 CA-C-N 117.951 0.876 . . . . 0.0 112.51 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.493 ' HG3' HG22 ' A' ' 101' ' ' VAL . 3.0 Cg_exo -76.59 135.86 16.69 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.235 1.957 . . . . 0.0 112.168 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.553 HG22 HG13 ' A' ' 156' ' ' VAL . 30.3 mt -83.59 97.38 4.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 0.0 109.1 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.4 mt -117.76 134.38 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.89 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -80.52 164.33 23.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.353 0.661 . . . . 0.0 109.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -59.19 -31.91 69.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.227 0.611 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.64 13.92 12.94 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.599 0.76 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.72 24.79 75.4 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.223 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.97 162.03 15.59 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.988 0.915 . . . . 0.0 110.011 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.689 ' HA ' ' HA3' ' A' ' 148' ' ' GLY 0.365 16.4 m 68.25 -62.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.487 2.315 . . . . 0.0 113.385 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 32.9 m 55.47 33.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 C-N-CA 124.493 1.117 . . . . 0.0 111.666 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.52 -145.11 1.73 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.176 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.437 ' HB3' ' HE3' ' A' ' 110' ' ' MET . 87.2 mt -138.91 146.43 41.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.265 0.626 . . . . 0.0 109.785 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . 0.57 ' HE1' ' H ' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -73.52 132.53 42.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.79 -154.15 2.38 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 118.35 0.523 . . . . 0.0 113.968 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -94.35 130.35 40.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.471 -0.429 . . . . 0.0 110.364 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -157.23 -143.67 3.72 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.682 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.436 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.0 p -165.15 161.5 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.593 0 CA-C-N 117.276 0.538 . . . . 0.0 110.925 -170.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.47 111.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.734 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 164.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.1 t -105.61 153.55 21.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.449 1.099 . . . . 0.0 108.903 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 62.77 12.53 5.75 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.923 0.889 . . . . 0.0 111.605 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.7 m 55.93 23.42 6.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.582 1.153 . . . . 0.0 111.586 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.89 -50.52 0.01 OUTLIER Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.387 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.83 158.42 24.06 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -121.25 109.5 15.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 188' ' ' SER . 84.1 t -121.68 134.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.589 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 32.0 t -146.4 159.23 43.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.829 0.851 . . . . 0.0 109.334 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.33 167.48 4.14 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.124 0.569 . . . . 0.0 111.304 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -99.61 122.18 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 171.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -111.22 143.59 41.73 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -148.08 166.72 26.96 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 122.072 -0.393 . . . . 0.0 110.927 -172.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.494 HG21 HD23 ' A' ' 146' ' ' LEU . 62.4 p -91.58 110.42 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.1 -0.04 56.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.023 0.929 . . . . 0.0 110.616 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 C--N 1.366 1.293 0 C-N-CA 124.731 1.212 . . . . 0.0 109.449 -169.636 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.646 ' N ' HD12 ' A' ' 97' ' ' ILE . 13.4 tppt? . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . 0.521 ' NH2' ' HG3' ' A' ' 45' ' ' GLU . 37.4 ttt180 . . . . . 0 N--CA 1.478 0.941 0 O-C-N 120.909 -1.12 . . . . 0.0 111.425 -171.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 121.406 0.622 . . . . 0.0 112.63 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.17 31.64 0.54 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.521 1.128 . . . . 0.0 109.006 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -166.81 61.59 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.667 HD11 ' HB1' ' A' ' 117' ' ' ALA . 52.3 mt -101.52 94.21 5.77 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.287 0.635 . . . . 0.0 110.243 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 120' ' ' MET . 4.5 mm-40 -95.3 130.85 41.92 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 123.672 0.789 . . . . 0.0 112.27 -172.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.77 ' HB2' HG11 ' A' ' 68' ' ' VAL . 24.3 mt -97.82 143.42 28.46 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 32.0 tt0 -134.23 142.8 47.5 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 124.163 0.985 . . . . 0.0 108.953 162.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -86.7 128.43 35.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 118.034 0.379 . . . . 0.0 110.732 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.776 ' HB1' ' HG3' ' A' ' 85' ' ' ARG . . . -85.86 -52.37 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.227 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.67 -164.49 0.91 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.746 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 27.5 t70 -108.33 146.23 33.27 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.484 0.714 . . . . 0.0 109.556 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.564 ' HB ' HG21 ' A' ' 201' ' ' ILE . 2.4 m -75.34 100.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.241 0.543 . . . . 0.0 109.766 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 38.1 ttmt -172.39 117.43 0.35 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.849 1.259 . . . . 0.0 107.839 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 203' ' ' LYS . 84.4 t90 -87.74 91.65 8.83 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.622 0.249 . . . . 0.0 111.647 -172.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -158.79 65.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 156.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 1.1 t70 -85.25 -61.91 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.412 HE21 ' NH2' ' A' ' 168' ' ' ARG . 45.6 mt-30 -150.59 33.07 0.63 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.796 1.238 . . . . 0.0 109.014 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 13.65 73.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.188 1.795 . . . . 0.0 113.661 -163.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 170' ' ' VAL . 13.2 mm-40 -75.91 162.08 28.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.608 -173.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.72 117.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.8 m -146.97 -51.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.791 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -59.45 105.58 0.76 Allowed Glycine 0 C--N 1.355 1.621 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.796 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p 179.88 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.923 1.289 . . . . 0.0 110.482 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.602 ' HB2' ' HB3' ' A' ' 188' ' ' SER . 9.1 m -64.37 137.67 97.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.322 0.649 . . . . 0.0 110.527 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.41 178.24 0.24 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.525 2.816 . . . . 0.0 114.542 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 115.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.124 0.569 . . . . 0.0 110.103 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.536 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 51.7 tp -112.4 159.0 19.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.955 0.902 . . . . 0.0 109.839 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -112.45 119.56 38.64 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.483 0.713 . . . . 0.0 109.479 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -114.23 142.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.263 1.025 . . . . 0.0 108.694 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.6 p -88.22 110.4 20.69 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.41 143.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.697 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 t -144.84 129.36 17.99 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 56.5 20.74 5.06 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.472 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 72.87 -68.43 0.23 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.405 1.882 . . . . 0.0 111.523 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.66 -11.27 72.76 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 114.91 0.724 . . . . 0.0 114.91 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.6 m -105.11 156.98 17.58 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 118.391 1.095 . . . . 0.0 109.037 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 ptm -158.34 138.48 12.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.427 0.691 . . . . 0.0 109.475 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 p -172.21 176.16 3.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.723 0.809 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.45 94.79 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 49.94 29.12 3.2 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.368 1.467 . . . . 0.0 113.12 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 53.68 33.97 17.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.956 1.702 . . . . 0.0 113.026 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.04 93.53 2.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.821 0.82 . . . . 0.0 108.992 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.324 -179.261 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.639 HG21 ' HD2' ' A' ' 87' ' ' LYS . 2.6 p . . . . . 0 CA--C 1.564 1.503 0 CA-C-O 123.248 1.499 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 96' ' ' GLN . 16.7 mt 81.39 127.68 0.04 OUTLIER 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.775 2.03 . . . . 0.0 116.475 156.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.457 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.2 m0 -125.02 87.43 2.71 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.619 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 4.4 t70 175.23 105.15 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.383 1.052 . . . . 0.0 111.028 157.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 8' ' ' LEU . 18.8 m . . . . . 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.162 . . . . 0.0 111.201 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HD1' ' A' ' 102' ' ' TYR . 22.9 t70 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 138.22 -132.14 5.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 114.873 0.709 . . . . 0.0 114.873 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 140.12 42.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.805 1.242 . . . . 0.0 110.096 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.538 ' HH ' ' HB3' ' A' ' 102' ' ' TYR . 62.7 m-85 -125.49 146.44 49.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.881 0.473 . . . . 0.0 112.095 -168.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.776 ' HG3' ' HB1' ' A' ' 11' ' ' ALA . 20.6 mtm180 -98.26 124.49 42.89 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 163.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 HG23 ' HA ' ' A' ' 8' ' ' LEU . 21.8 pt -130.98 138.8 52.66 Favored 'Isoleucine or valine' 0 C--O 1.26 1.641 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -165.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.639 ' HD2' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.78 151.22 47.03 Favored 'General case' 0 C--N 1.386 2.195 0 C-N-CA 124.256 1.022 . . . . 0.0 111.284 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.67 154.62 46.46 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 166.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -104.75 91.59 3.91 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.057 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -171.17 177.0 44.33 Favored Glycine 0 C--O 1.238 0.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.176 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 11.3 mt 59.63 37.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.515 0 CA-C-O 122.212 1.006 . . . . 0.0 109.602 165.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.3 mt 65.16 33.84 9.05 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.691 1.596 . . . . 0.0 111.644 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.45 157.69 28.59 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 121.47 0.483 . . . . 0.0 114.241 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -130.28 87.29 2.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.402 ' HB2' ' HZ1' ' B' ' 253' ' ' LYS . 14.6 m -147.77 147.17 29.59 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -172.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.554 ' HG3' HD11 ' A' ' 65' ' ' LEU . 7.3 tt0 -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 125.189 1.556 . . . . 0.0 108.397 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.56 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.5 pp -135.07 -33.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -170.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.56 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.22 176.86 29.54 Favored Glycine 0 C--O 1.258 1.612 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.051 -161.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -118.49 124.49 47.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.772 -0.714 . . . . 0.0 109.777 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.46 162.11 17.89 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.3 t -138.6 133.09 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.3 0.64 . . . . 0.0 109.527 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.557 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 24.9 t80 -149.67 135.28 18.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HZ1' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.78 133.42 30.39 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 65.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.871 1.357 . . . . 0.0 111.985 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.29 19.95 0.63 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.513 -0.312 . . . . 0.0 112.399 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 p -135.74 126.73 27.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.518 0.727 . . . . 0.0 110.043 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 49.1 t80 -102.19 137.63 40.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.59 1.156 . . . . 0.0 108.72 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -132.1 122.15 24.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.377 0.671 . . . . 0.0 110.062 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.437 HG22 ' HB ' ' A' ' 138' ' ' ILE . 14.6 t -136.42 -155.59 0.64 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.848 0.859 . . . . 0.0 109.892 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.437 ' HE2' ' HB2' ' A' ' 110' ' ' MET . 18.6 ttm -136.97 153.59 50.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 111.239 -158.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -46.43 11.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -174.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.421 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 13.8 p-80 -65.56 -16.91 64.15 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 118.743 0.701 . . . . 0.0 112.286 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.432 HG12 ' O ' ' B' ' 254' ' ' ARG . 4.5 m -80.27 -38.89 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 123.826 0.85 . . . . 0.0 111.769 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.546 HG23 HD22 ' A' ' 6' ' ' LEU . 23.1 m -156.24 151.91 27.11 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.937 0.789 . . . . 0.0 110.079 170.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -73.15 26.43 0.06 Allowed 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -167.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.647 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 82.79 38.2 12.16 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 119.031 0.832 . . . . 0.0 111.425 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB1' HD11 ' A' ' 6' ' ' LEU . . . -87.71 -165.58 1.35 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.697 0.799 . . . . 0.0 112.383 -168.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.01 136.47 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.733 0.813 . . . . 0.0 111.331 -174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 mm? -86.79 171.61 10.76 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.933 1.293 . . . . 0.0 111.998 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -172.53 173.04 4.14 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 41.8 t60 -132.41 97.49 4.12 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.448 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.412 ' HD2' ' NE1' ' A' ' 66' ' ' TRP . 85.3 mttt 39.14 38.84 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.775 1.23 . . . . 0.0 112.149 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 21.18 12.85 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 34.2 mmtp -115.27 112.12 21.96 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.984 1.392 . . . . 0.0 110.094 172.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -80.54 148.95 30.16 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.467 1.107 . . . . 0.0 113.171 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.5 mt -140.06 125.2 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.208 1.803 . . . . 0.0 107.428 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.06 148.83 36.46 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.19 0.596 . . . . 0.0 112.356 -168.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.445 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 76.5 Cg_endo -79.0 163.46 25.67 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.597 2.865 . . . . 0.0 114.764 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 p -127.04 -29.45 2.79 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.781 0.833 . . . . 0.0 111.602 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 32.1 t-105 -147.91 149.03 31.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.165 0.586 . . . . 0.0 110.522 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.93 140.83 23.72 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.751 1.22 . . . . 0.0 109.279 166.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -134.73 114.56 12.79 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.56 -27.37 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.853 1.261 . . . . 0.0 112.356 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -76.85 -59.36 2.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.792 0.33 . . . . 0.0 111.766 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.33 6.14 48.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.371 0.669 . . . . 0.0 110.646 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 68.62 51.18 0.63 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.392 1.077 . . . . 0.0 110.989 162.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 227' ' ' ALA . 52.0 mt -140.14 142.33 36.01 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.459 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.647 HD11 ' HA2' ' A' ' 116' ' ' GLY . 49.3 mt -128.74 151.37 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.537 1.135 . . . . 0.0 109.07 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 23.9 t -139.1 144.04 38.53 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.082 0.468 . . . . 0.0 111.01 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.742 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 63.1 m-85 -128.95 144.18 51.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.027 1.331 . . . . 0.0 109.077 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.66 -8.86 79.17 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.738 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.48 -154.76 26.14 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.45 132.01 10.93 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.694 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 2.6 p90 -79.02 130.87 35.99 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -175.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -149.16 116.35 6.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.841 0.456 . . . . 0.0 111.021 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.82 -80.1 0.36 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 159.35 3.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 125.699 1.6 . . . . 0.0 109.366 -163.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 207' ' ' VAL . . . -56.12 91.2 0.02 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 123.985 0.802 . . . . 0.0 114.684 -175.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.27 95.86 3.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.502 ' HE3' HD11 ' A' ' 200' ' ' ILE . 2.0 t90 -46.43 121.65 3.57 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 163.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 88.4 tttt -81.78 116.5 21.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.68 108.48 2.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.217 1.007 . . . . 0.0 109.623 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.34 -37.96 2.8 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . 42.0 tt0 -95.33 148.15 22.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.125 0.97 . . . . 0.0 109.763 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 13.1 pt-20 -89.71 139.94 30.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.809 0.844 . . . . 0.0 110.679 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.75 159.63 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.439 ' OE1' ' HG3' ' A' ' 171' ' ' GLN . 2.2 mm-40 -93.51 160.64 14.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.083 0.553 . . . . 0.0 111.914 -161.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 199' ' ' PRO . 14.5 p -140.05 152.66 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.524 0.73 . . . . 0.0 111.05 176.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 14' ' ' VAL . 88.0 mt -103.39 93.39 4.94 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 164.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 193' ' ' PRO . . . -77.1 97.23 4.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.433 HD23 ' HB3' ' A' ' 167' ' ' PRO . 91.1 mt -73.49 103.92 4.29 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.45 141.1 87.8 Favored Pre-proline 0 CA--C 1.554 1.125 0 O-C-N 123.625 0.578 . . . . 0.0 110.652 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.82 117.87 4.72 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.597 2.865 . . . . 0.0 112.511 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.05 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.419 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -141.09 -173.56 3.76 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.867 0.841 . . . . 0.0 112.02 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.38 159.71 70.86 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 126.016 1.726 . . . . 0.0 113.126 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.433 ' HB3' HD23 ' A' ' 161' ' ' LEU . 5.0 Cg_exo -77.32 117.7 4.44 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.196 2.597 . . . . 0.0 111.433 170.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 168' ' ' ARG . 11.4 mmp_? -75.64 99.55 4.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 18' ' ' ASP . . . -76.1 100.66 5.04 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.508 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 28.4 t -110.02 141.65 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.857 0.863 . . . . 0.0 109.57 -173.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.439 ' HG3' ' OE1' ' A' ' 157' ' ' GLN . 28.1 tt0 -89.73 121.4 31.85 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 34.0 p -123.75 132.22 53.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.343 0.657 . . . . 0.0 111.226 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.535 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 62.3 mttp -92.5 149.72 38.67 Favored Pre-proline 0 C--O 1.246 0.909 0 C-N-CA 125.78 1.632 . . . . 0.0 110.765 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.19 126.72 7.14 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.614 2.209 . . . . 0.0 111.878 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' A' ' 188' ' ' SER . . . -111.93 -173.25 19.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.45 140.11 19.84 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.193 0.597 . . . . 0.0 110.0 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.583 ' HE2' ' HB1' ' A' ' 186' ' ' ALA . 13.4 m-85 -128.65 150.33 50.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.134 0.974 . . . . 0.0 110.631 -165.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -61.23 127.97 34.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.83 0.852 . . . . 0.0 110.8 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.7 m -130.44 156.83 44.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.179 0.992 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -84.83 54.61 3.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.152 0.977 . . . . 0.0 109.122 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -173.68 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.975 1.71 . . . . 0.0 109.038 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.87 -106.77 0.36 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -140.97 133.4 28.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.05 137.09 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.022 0.529 . . . . 0.0 109.661 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.98 109.42 3.66 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.583 ' HB1' ' HE2' ' A' ' 177' ' ' PHE . . . -149.95 167.91 25.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.978 -173.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.59 128.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.441 0.639 . . . . 0.0 111.346 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.602 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 19.1 m -103.76 80.18 1.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.397 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.492 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 37.9 tp -105.39 104.96 14.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.048 0.451 . . . . 0.0 110.017 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.79 104.51 16.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.42 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 27.3 t80 -178.28 168.26 1.9 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -174.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.6 m -117.16 74.78 7.69 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 117.953 0.342 . . . . 0.0 111.577 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 19.5 Cg_endo -88.2 -60.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.151 1.901 . . . . 0.0 110.016 160.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.93 -29.98 4.85 Favored Glycine 0 C--N 1.361 1.942 0 C-N-CA 123.731 0.682 . . . . 0.0 112.577 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.522 HG21 ' HG ' ' A' ' 198' ' ' SER . 8.0 t -61.94 99.51 0.13 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.62 1.168 . . . . 0.0 113.244 -165.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.9 m -63.02 121.85 14.61 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.14 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.49 6.48 33.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.398 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.522 ' HG ' HG21 ' A' ' 195' ' ' THR . 62.3 m -45.23 115.14 2.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 123.295 0.638 . . . . 0.0 112.227 168.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.435 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.6 Cg_endo -74.33 119.84 5.97 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.203 2.602 . . . . 0.0 113.96 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.502 HD11 ' HE3' ' A' ' 150' ' ' TRP . 73.3 mt -79.68 93.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.955 0.902 . . . . 0.0 109.261 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.564 HG21 ' HB ' ' A' ' 14' ' ' VAL . 29.2 pt -111.21 178.68 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.015 0.912 . . . . 0.0 111.662 -174.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.4 174.04 6.05 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 166.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 16' ' ' TRP . 84.3 tttt -59.78 -31.76 69.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.746 0.418 . . . . 0.0 111.786 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -82.43 -3.78 56.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.097 0.559 . . . . 0.0 111.994 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.01 26.06 54.06 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -99.54 167.1 10.81 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.032 1.333 . . . . 0.0 109.324 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.585 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 68.9 t 85.68 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 125.606 1.562 . . . . 0.0 109.49 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.6 m 58.25 30.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 125.131 1.372 . . . . 0.0 112.844 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.08 -169.65 2.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.347 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.0 mt -144.94 149.61 35.54 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.485 -1.009 . . . . 0.0 110.994 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -74.6 107.72 6.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 166.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.87 -138.98 3.83 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 124.328 1.018 . . . . 0.0 114.046 -166.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -70.88 87.59 0.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.302 0.641 . . . . 0.0 109.586 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -135.59 -147.67 5.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.189 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.0 167.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.641 0.776 . . . . 0.0 109.589 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 13.9 t -91.91 111.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.424 ' HG1' ' HB ' ' A' ' 223' ' ' VAL . 91.8 m -71.57 140.06 49.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.126 0.97 . . . . 0.0 109.906 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 59.73 12.1 2.78 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.705 0.802 . . . . 0.0 111.861 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t 62.58 18.69 10.7 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.91 1.284 . . . . 0.0 112.072 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.19 7.97 0.39 Allowed Glycine 0 C--N 1.354 1.54 0 CA-C-O 119.682 -0.51 . . . . 0.0 114.345 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.42 ' HA ' ' H ' ' A' ' 191' ' ' PHE . . . -140.61 92.0 2.48 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.759 0.78 . . . . 0.0 110.03 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 15.4 t80 -71.04 101.32 2.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.242 0.544 . . . . 0.0 110.773 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.424 ' HB ' ' HG1' ' A' ' 217' ' ' THR . 54.2 t -116.14 123.42 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.055 1.342 . . . . 0.0 108.841 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.553 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 24.7 t -143.88 158.45 43.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.011 0.524 . . . . 0.0 110.888 -171.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.79 55.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.594 0.758 . . . . 0.0 110.795 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.431 HG13 ' HA ' ' A' ' 186' ' ' ALA . 87.9 mt -81.83 98.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.964 0.411 . . . . 0.0 110.026 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 137' ' ' LEU . . . -81.06 135.41 35.82 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.55 159.33 36.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.793 0.837 . . . . 0.0 110.398 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.694 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 10.9 p -82.83 113.89 20.77 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -145.36 101.6 3.61 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.518 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.239 0.503 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.695 172.474 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 17.4 tppt? . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . 0.432 ' O ' HG12 ' A' ' 113' ' ' VAL . 36.5 ttt180 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 123.953 0.901 . . . . 0.0 109.684 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.79 45.46 0.96 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.171 0.989 . . . . 0.0 108.659 -170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.6 m-20 -146.0 26.48 1.22 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.117 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 88' ' ' GLN . 34.9 mt -91.6 93.63 9.03 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.545 0.738 . . . . 0.0 110.14 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.669 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 4.8 mp0 -95.12 131.06 41.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.805 0.842 . . . . 0.0 111.865 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.38 130.45 56.69 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.91 129.08 51.17 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 122.886 0.474 . . . . 0.0 110.527 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.677 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 5.8 tmm_? -75.6 127.61 33.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.356 0.662 . . . . 0.0 110.327 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.677 ' HB1' ' HG3' ' A' ' 85' ' ' ARG . . . -96.1 -56.81 2.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.425 0.69 . . . . 0.0 110.577 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 167' ' ' PRO . . . -145.49 -175.08 4.58 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.711 -171.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.26 146.41 23.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.006 0.922 . . . . 0.0 109.839 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.588 HG22 ' HA2' ' A' ' 82' ' ' GLY . 15.1 t -79.49 97.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' N ' HD11 ' A' ' 201' ' ' ILE . 17.6 pttp -173.58 176.36 2.78 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 108.402 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -73.49 136.52 44.16 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.512 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -112.94 144.45 42.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.091 0.956 . . . . 0.0 109.598 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.03 -6.28 8.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.301 1.04 . . . . 0.0 112.667 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -71.15 -2.8 16.99 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.556 1.143 . . . . 0.0 111.61 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -36.6 100.08 0.02 OUTLIER 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.915 2.086 . . . . 0.0 114.052 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.12 148.39 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.64 1.176 . . . . 0.0 109.619 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 mm -102.75 104.39 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -144.84 -20.4 0.51 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.849 0.46 . . . . 0.0 111.284 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.66 -173.13 17.25 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.768 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m 71.82 37.9 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.545 1.138 . . . . 0.0 109.278 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -66.86 142.73 97.62 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.692 0.797 . . . . 0.0 110.842 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.63 -176.14 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.225 2.617 . . . . 0.0 114.253 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.43 119.46 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.807 0.843 . . . . 0.0 112.142 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.539 HD12 HG21 ' A' ' 223' ' ' VAL . 7.0 mt -108.28 163.9 12.78 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.967 0.907 . . . . 0.0 111.075 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -120.14 122.51 41.18 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.285 0.634 . . . . 0.0 109.29 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.571 HG23 ' HE2' ' A' ' 39' ' ' MET . 10.5 mt -127.11 149.09 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.98 0.912 . . . . 0.0 110.201 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.2 m -96.99 119.46 35.5 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.096 0.958 . . . . 0.0 110.449 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 179' ' ' THR . 35.6 mm -68.63 114.21 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 23.0 t -79.84 134.51 36.33 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.24 4.56 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.35 -13.71 60.12 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 0.0 110.891 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.21 17.51 29.28 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -166.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 55.3 m -105.69 164.81 11.63 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.686 0.794 . . . . 0.0 109.986 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.615 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 2.4 ppp? -127.77 135.83 50.66 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 p -171.29 173.45 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.658 0.783 . . . . 0.0 110.536 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.31 134.09 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 161.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.21 90.19 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.638 0.586 . . . . 0.0 110.371 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -157.08 157.19 34.1 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 108.852 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.36 75.43 1.01 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.239 0.548 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.202 174.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.669 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.883 HD23 HH22 ' A' ' 85' ' ' ARG . 3.3 pp -37.45 157.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -175.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -165.74 158.57 15.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.462 1.125 . . . . 0.0 111.779 -175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.677 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 29.5 t0 -154.81 60.39 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 154.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 121' ' ' HIS . 7.6 p . . . . . 0 CA--C 1.561 1.368 0 CA-C-N 111.598 -2.546 . . . . 0.0 106.735 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 121.33 0.585 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 14' ' ' VAL . . . 142.77 -167.08 26.38 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.919 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.16 109.57 12.37 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 1.6 m-85 -87.32 146.28 25.99 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.883 HH22 HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.64 136.9 40.7 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 160.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG12 ' C ' ' A' ' 98' ' ' GLY . 10.8 pt -132.71 142.89 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -162.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 73.4 tttt -123.02 142.84 50.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.187 1.795 . . . . 0.0 111.369 -174.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.803 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 51.7 tt0 -136.1 150.37 49.08 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.568 0.223 . . . . 0.0 110.646 167.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 91.1 mttt -96.14 92.0 6.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 162.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 169.77 42.4 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.616 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt 67.48 -77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.009 1.324 . . . . 0.0 112.235 163.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.96 -15.04 1.79 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.891 0.876 . . . . 0.0 109.78 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.55 ' HA3' ' HE3' ' B' ' 253' ' ' LYS . . . -144.21 -161.11 8.79 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 26.7 t80 -150.88 33.86 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -165.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 p -151.8 173.07 15.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -154.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.737 ' HB3' HD21 ' A' ' 65' ' ' LEU . 5.5 pt20 -87.31 120.04 28.19 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.791 1.637 . . . . 0.0 110.909 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -136.0 -37.56 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.576 ' N ' HD13 ' A' ' 97' ' ' ILE . . . -105.76 -172.67 23.68 Favored Glycine 0 N--CA 1.48 1.594 0 C-N-CA 120.214 -0.993 . . . . 0.0 114.811 -159.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.59 125.04 33.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.101 0.56 . . . . 0.0 110.324 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.56 111.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 14' ' ' VAL . 91.9 t -88.64 101.83 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.408 0.683 . . . . 0.0 110.829 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 15.0 t80 -91.51 110.19 21.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 23.3 tptp -144.53 143.78 31.01 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.778 0.674 . . . . 0.0 110.168 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 146' ' ' LEU . 11.8 mm-40 64.92 15.58 10.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.927 1.291 . . . . 0.0 112.739 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.54 -5.22 67.15 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 122.946 0.308 . . . . 0.0 112.981 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.3 p -121.66 138.19 54.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 110.23 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.68 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 73.5 t80 -81.08 137.55 35.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.67 119.33 18.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.191 0.997 . . . . 0.0 110.372 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.661 HG23 ' HB ' ' A' ' 138' ' ' ILE . 2.9 t -138.74 176.72 8.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 0.0 110.517 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.9 mmm -84.62 170.73 13.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.595 0.758 . . . . 0.0 110.593 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.56 -54.84 4.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -57.28 -13.66 3.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -168.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.82 -45.92 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 C-N-CA 124.68 1.192 . . . . 0.0 112.983 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -155.12 149.54 26.19 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.874 1.27 . . . . 0.0 107.59 170.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 13.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 97.5 62.62 0.9 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 6' ' ' LEU . . . -117.17 -164.76 1.01 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.269 0.628 . . . . 0.0 111.764 -171.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 93.6 t -92.04 129.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.471 1.109 . . . . 0.0 112.47 -162.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.81 157.69 16.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.032 -176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 2.2 ptm -172.88 179.84 2.23 Favored 'General case' 0 C--O 1.272 2.242 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -171.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.548 ' HB2' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -147.94 111.14 4.89 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 112.053 -2.34 . . . . 0.0 108.874 178.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 4.5 mptp? 49.95 34.09 7.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.139 0.975 . . . . 0.0 112.624 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.3 -21.02 46.18 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.561 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 115.5 10.8 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.45 0.7 . . . . 0.0 109.891 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -83.18 149.21 26.98 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.883 1.273 . . . . 0.0 112.555 -164.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.3 mt -142.35 134.29 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 125.471 1.508 . . . . 0.0 109.172 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.49 117.66 68.16 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.449 1.1 . . . . 0.0 110.754 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.16 145.39 66.52 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.414 2.076 . . . . 0.0 111.461 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 72.4 p -98.78 -18.64 17.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.735 0.414 . . . . 0.0 111.945 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 132' ' ' ASP . 49.2 t-105 -155.91 154.26 30.94 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.701 0.4 . . . . 0.0 111.261 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -160.92 122.0 2.9 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.379 1.472 . . . . 0.0 109.32 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 130' ' ' TRP . 27.2 t70 -139.25 135.29 33.74 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.458 0.572 . . . . 0.0 111.998 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.43 -42.07 42.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.028 -172.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.55 -48.67 38.21 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.949 0.78 . . . . 0.0 111.543 -168.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.45 -16.57 61.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.329 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 62.83 45.14 5.83 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.703 1.201 . . . . 0.0 109.584 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 80.8 mt -142.4 129.37 20.71 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.772 -171.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.661 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.4 mt -115.66 155.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.511 1.524 . . . . 0.0 108.16 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.0 p -156.95 151.79 25.87 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.094 0.473 . . . . 0.0 112.104 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.68 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.9 t80 -120.25 149.12 42.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.64 1.176 . . . . 0.0 109.133 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.51 -78.58 0.24 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.98 85.44 0.06 OUTLIER Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 170.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.63 133.77 2.22 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -98.52 105.7 17.88 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -166.38 124.11 1.4 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.466 HD22 HG23 ' A' ' 229' ' ' THR . 6.0 mp -124.17 -63.52 1.2 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 175.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 177.97 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.298 0.999 . . . . 0.0 110.646 167.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.27 -171.84 23.16 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -157.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.65 153.66 47.9 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.836 0.854 . . . . 0.0 110.041 -164.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.448 ' HA ' HG13 ' A' ' 208' ' ' VAL . 31.8 t90 -67.28 106.49 2.07 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 165.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -96.25 99.68 11.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.07 110.57 0.37 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.628 1.171 . . . . 0.0 111.748 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.612 ' H ' ' HG2' ' A' ' 174' ' ' PRO . . . 131.02 -42.08 1.44 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.63 121.41 11.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.594 1.158 . . . . 0.0 110.9 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.87 99.47 9.06 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 208' ' ' VAL . 32.9 m -91.59 172.36 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.158 -168.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.432 ' NE2' ' HB2' ' A' ' 171' ' ' GLN . 71.8 mm-40 -108.82 154.9 21.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.438 1.095 . . . . 0.0 109.49 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.57 136.78 40.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.26 88.54 7.24 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.77 101.15 4.96 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.11 95.6 0.57 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -60.45 113.29 7.14 Favored Pre-proline 0 C--N 1.353 0.725 0 O-C-N 124.439 1.087 . . . . 0.0 110.145 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.21 114.89 2.4 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.054 1.836 . . . . 0.0 112.087 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.27 -14.16 56.92 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.061 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -129.75 -172.73 2.84 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.464 0.706 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -62.32 162.92 16.17 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 125.337 1.455 . . . . 0.0 112.602 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HG3' ' HB2' ' A' ' 12' ' ' ALA . 21.1 Cg_endo -58.91 140.95 97.51 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.108 2.539 . . . . 0.0 111.514 169.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.454 ' HG3' ' HZ ' ' A' ' 191' ' ' PHE . 47.5 mmm-85 -116.05 100.97 8.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.212 0.605 . . . . 0.0 109.841 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.1 118.91 13.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 168.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.46 134.41 49.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.863 0.363 . . . . 0.0 110.282 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.547 ' NE2' ' HE3' ' A' ' 203' ' ' LYS . 59.3 tt0 -87.9 143.18 27.26 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.891 0.876 . . . . 0.0 111.122 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.599 ' HB ' HD12 ' A' ' 189' ' ' LEU . 8.1 t -146.31 133.96 21.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.086 1.354 . . . . 0.0 109.175 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -93.12 140.67 23.4 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.612 ' HG2' ' H ' ' A' ' 153' ' ' GLY . 67.0 Cg_exo -45.34 122.69 4.82 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.83 2.354 . . . . 0.0 114.195 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.04 -173.1 26.39 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -156.36 132.66 10.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.704 0.764 . . . . 0.0 110.076 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.473 ' HE1' ' HB2' ' A' ' 186' ' ' ALA . 22.9 p90 -115.37 121.8 43.91 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.999 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.461 ' HG3' ' HG1' ' A' ' 183' ' ' THR . 87.3 tttt -80.19 153.55 28.52 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.531 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.834 HG23 HG12 ' A' ' 33' ' ' ILE . 27.0 m -137.34 162.17 34.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.466 1.106 . . . . 0.0 108.358 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -59.32 -24.56 63.43 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.644 0.777 . . . . 0.0 111.546 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.442 ' H ' HG22 ' A' ' 179' ' ' THR . . . -82.03 -36.51 27.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.061 0.944 . . . . 0.0 112.085 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.85 -131.68 1.68 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.56 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.461 ' HG1' ' HG3' ' A' ' 178' ' ' LYS . 37.9 m -156.45 127.88 7.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 108.374 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.47 133.81 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.34 116.11 5.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.473 ' HB2' ' HE1' ' A' ' 177' ' ' PHE . . . -162.69 -166.15 1.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.334 0.654 . . . . 0.0 111.152 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 172' ' ' THR . 4.6 p -74.84 100.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 CA-C-O 121.719 0.771 . . . . 0.0 110.641 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 223' ' ' VAL . 29.1 m -96.16 100.2 11.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.599 HD12 ' HB ' ' A' ' 172' ' ' THR . 7.6 tt -135.05 107.46 7.3 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.41 124.91 27.41 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.454 ' HZ ' ' HG3' ' A' ' 168' ' ' ARG . 48.4 t80 -170.11 -179.53 3.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.672 1.189 . . . . 0.0 107.829 -175.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.2 m -58.19 159.19 11.75 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.99 0.916 . . . . 0.0 111.032 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.712 ' HA ' HG11 ' A' ' 216' ' ' VAL . 9.2 Cg_endo -50.13 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.09 2.526 . . . . 0.0 112.252 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.82 163.41 44.25 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.2 t -102.0 137.85 39.74 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.424 0.631 . . . . 0.0 111.361 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.3 m -70.78 105.65 3.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.887 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.75 5.14 8.46 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.027 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.3 m -49.1 116.92 5.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 C-N-CA 123.399 0.679 . . . . 0.0 111.662 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.54 125.11 9.84 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.252 1.968 . . . . 0.0 112.455 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 226' ' ' ILE . 40.8 mt -93.04 106.95 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 122.167 0.984 . . . . 0.0 108.865 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.495 HG21 ' H ' ' A' ' 202' ' ' ASP . 8.7 mt -114.05 -175.58 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.053 1.341 . . . . 0.0 107.616 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.495 ' H ' HG21 ' A' ' 201' ' ' ILE . 33.7 t70 -125.04 170.11 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.464 0.574 . . . . 0.0 110.397 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.547 ' HE3' ' NE2' ' A' ' 171' ' ' GLN . 19.5 mttp -47.17 -50.32 20.82 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.667 1.987 . . . . 0.0 111.403 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.58 -19.9 64.49 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.991 0.917 . . . . 0.0 111.259 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 102.63 6.03 47.44 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -61.63 128.7 37.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.379 0.672 . . . . 0.0 109.203 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 146' ' ' LEU . 7.6 p -80.74 109.94 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 156' ' ' VAL . 80.0 t -83.23 -30.72 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.5 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.693 ' HA2' HG21 ' A' ' 229' ' ' THR . . . 156.97 -149.88 20.8 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.455 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.426 HD21 HG23 ' A' ' 101' ' ' VAL . 78.3 mt -131.54 174.0 10.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.355 1.062 . . . . 0.0 109.554 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -59.94 123.45 17.08 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 164.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.85 177.69 43.41 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.76 97.99 0.68 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.493 0.647 . . . . 0.0 110.402 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.615 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -140.73 -152.72 5.83 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.652 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.25 179.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -169.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.712 HG11 ' HA ' ' A' ' 193' ' ' PRO . 27.2 m -98.41 125.78 51.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 162.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 29' ' ' LEU . 10.0 t -95.46 140.58 30.11 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.685 0.394 . . . . 0.0 111.092 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 38.95 -80.65 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.871 2.068 . . . . 0.0 114.401 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.1 p -87.15 16.58 4.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.283 1.033 . . . . 0.0 111.892 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.98 19.34 63.24 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.86 0.267 . . . . 0.0 112.709 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.16 123.09 25.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.269 0.628 . . . . 0.0 110.535 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -65.23 99.03 0.36 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.445 0.698 . . . . 0.0 109.718 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.539 HG21 HD12 ' A' ' 29' ' ' LEU . 63.4 t -131.42 109.74 16.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 122.353 1.073 . . . . 0.0 109.264 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.599 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 15.8 m -137.2 160.16 39.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.997 -169.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.96 153.77 32.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 164.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 200' ' ' ILE . 71.6 mt -101.38 113.15 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.53 147.87 33.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.409 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 9.6 pt20 -134.04 149.88 51.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.506 0.722 . . . . 0.0 109.363 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.693 HG21 ' HA2' ' A' ' 209' ' ' GLY . 51.1 p -105.39 108.54 20.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.518 0.199 . . . . 0.0 111.314 -168.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.29 141.61 13.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.144 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.803 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 2.5 tmtt? . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 156.954 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.471 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 120.534 0.207 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.87 15.83 0.11 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 110.552 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.532 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.6 m-20 -137.67 65.14 1.49 Allowed 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 5.5 mp -106.57 113.2 26.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.117 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 24.2 mm-40 -112.33 127.87 56.12 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.935 0.894 . . . . 0.0 111.809 -165.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.46 148.83 27.69 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.951 -0.468 . . . . 0.0 112.217 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -145.82 140.68 27.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.273 1.029 . . . . 0.0 109.24 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.692 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 7.1 ptm180 -60.97 143.28 55.53 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.677 0.672 . . . . 0.0 110.353 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.33 -39.08 3.92 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 170.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.01 -171.27 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.96 148.58 24.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.989 0.916 . . . . 0.0 110.095 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.62 97.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -157.53 157.28 33.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.914 1.286 . . . . 0.0 108.606 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -70.43 115.24 9.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 160.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.88 143.97 32.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.0 -4.81 18.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.865 0.466 . . . . 0.0 111.766 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.69 49.68 0.64 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.921 1.288 . . . . 0.0 110.723 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -64.6 89.98 0.07 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.261 1.024 . . . . 0.0 110.54 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.0 tp10 -90.75 101.92 14.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.318 1.047 . . . . 0.0 108.717 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.44 101.68 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.5 m -160.12 96.05 1.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.556 1.142 . . . . 0.0 109.512 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -133.36 2.92 Favored Glycine 0 N--CA 1.467 0.734 0 CA-C-O 119.334 -0.704 . . . . 0.0 111.983 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m 62.99 40.75 8.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.359 1.064 . . . . 0.0 109.6 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 m -62.98 116.87 27.59 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.176 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.94 -78.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.418 2.745 . . . . 0.0 112.573 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 178' ' ' LYS . 7.7 tp -113.52 145.59 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.022 0.529 . . . . 0.0 109.717 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 177' ' ' PHE . 52.8 tp -132.72 155.16 49.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.653 0.781 . . . . 0.0 109.403 172.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.1 p -97.99 122.37 41.04 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 177' ' ' PHE . 9.4 tp -117.89 152.29 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 122.73 0.412 . . . . 0.0 110.343 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.9 m -105.47 107.49 18.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.695 0.798 . . . . 0.0 109.998 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.61 116.87 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.057 0.943 . . . . 0.0 108.544 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 m -104.29 114.31 28.46 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 110.534 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.88 19.83 10.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.973 1.309 . . . . 0.0 112.025 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 p30 51.4 8.8 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.987 2.115 . . . . 0.0 114.788 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.29 -48.64 0.98 Allowed Glycine 0 C--N 1.349 1.284 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.2 p -106.0 164.79 11.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.454 0.701 . . . . 0.0 109.671 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 213' ' ' ASN . 2.5 ppp? -124.14 149.95 45.67 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 76.3 p -178.94 -175.82 0.41 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.26 1.024 . . . . 0.0 109.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.563 ' H ' HG12 ' A' ' 215' ' ' VAL . 3.2 mp -106.51 152.24 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 157.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.73 82.99 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -121.77 152.66 39.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.288 1.435 . . . . 0.0 108.85 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.34 49.73 1.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.744 0.783 . . . . 0.0 109.899 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.825 -178.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.407 ' H ' ' HD3' ' A' ' 122' ' ' LYS . 3.5 t . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.4 tp -164.69 139.25 5.32 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.029 1.331 . . . . 0.0 108.001 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.488 ' CD1' ' HE2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -164.74 67.72 0.15 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.692 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t0 -104.76 71.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 119.566 -1.959 . . . . 0.0 107.156 163.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.551 HG13 ' HD1' ' A' ' 121' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.563 1.457 0 CA-C-N 112.815 -1.993 . . . . 0.0 106.573 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.81 -170.44 31.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.759 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.53 108.31 17.23 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 16.3 m-85 -88.64 140.01 29.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 110.1 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -80.71 126.02 30.77 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 161.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.2 pt -122.14 135.45 62.23 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 CA-C-O 121.31 0.576 . . . . 0.0 111.251 -171.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 86.8 tttt -135.16 138.96 44.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.857 1.663 . . . . 0.0 108.586 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -143.43 151.8 40.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 27.1 tttm -97.35 93.13 6.32 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 125.857 1.973 . . . . 0.0 107.698 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.448 ' HA3' HE22 ' A' ' 88' ' ' GLN . . . -172.88 173.45 45.55 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-O 118.705 -1.053 . . . . 0.0 110.932 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 52.2 mt 72.42 -64.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.802 0.841 . . . . 0.0 112.049 165.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.452 HD13 ' HD2' ' B' ' 253' ' ' LYS . 1.3 pp -132.68 -9.31 3.17 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.946 0.898 . . . . 0.0 111.87 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.71 -153.74 24.8 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.93 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 6.6 m-85 -88.57 120.89 30.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.219 1.007 . . . . 0.0 109.866 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.457 ' HB2' ' HE2' ' B' ' 253' ' ' LYS . 15.2 m -141.38 133.96 28.47 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 118.346 0.521 . . . . 0.0 110.912 167.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.532 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 6.6 pt20 -95.5 105.15 17.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.03 1.332 . . . . 0.0 108.899 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.546 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -134.0 -41.32 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -164.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.546 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -111.5 -177.91 20.25 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 119.639 1.109 . . . . 0.0 115.639 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -124.17 124.11 41.75 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.398 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.94 121.02 3.8 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.424 HG13 ' HG3' ' A' ' 199' ' ' PRO . 33.5 m -105.71 118.69 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.984 0.892 . . . . 0.0 111.525 -166.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.543 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 18.5 t80 -98.56 125.5 43.82 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -138.43 149.35 45.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.073 0.949 . . . . 0.0 109.187 168.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 145' ' ' LYS . 13.0 tp10 64.81 -82.19 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.796 1.238 . . . . 0.0 111.229 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -156.96 25.95 0.5 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 t -143.97 129.05 18.62 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.329 0.652 . . . . 0.0 110.876 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 68.9 t80 -96.48 86.55 4.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.566 ' HD2' ' HB3' ' A' ' 139' ' ' SER . 28.6 t-80 -95.14 120.39 35.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.272 -173.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 t -136.15 -156.56 0.72 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.929 0.891 . . . . 0.0 109.944 -174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.73 22.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.528 1.131 . . . . 0.0 110.677 -166.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -86.25 -49.96 7.31 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -60.59 -17.17 44.9 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.0 m -68.04 -57.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 C-N-CA 123.318 0.647 . . . . 0.0 110.81 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 23.2 m -149.43 142.93 25.36 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -75.81 18.74 0.24 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.91 62.57 0.75 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.41 168.85 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.645 0.778 . . . . 0.0 110.23 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.27 134.61 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.583 0.753 . . . . 0.0 113.016 -164.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HG ' ' HG3' ' A' ' 128' ' ' PRO . 13.7 mt -98.14 161.06 13.9 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.532 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -172.11 175.02 3.87 Favored 'General case' 0 C--O 1.267 1.986 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 21.7 t60 -121.18 95.48 4.71 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.819 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.488 ' HE2' ' CD1' ' A' ' 66' ' ' TRP . 46.1 mttm 25.77 60.32 0.07 Allowed 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 125.376 1.471 . . . . 0.0 113.667 -164.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.63 58.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.0 -0.889 . . . . 0.0 114.777 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 121' ' ' HIS . 8.9 tmtt? -83.79 113.37 20.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.526 1.163 . . . . 0.0 108.836 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.65 131.48 50.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.444 1.498 . . . . 0.0 113.384 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -139.43 115.52 9.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 C-N-CA 125.137 1.375 . . . . 0.0 108.526 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.55 121.56 72.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.37 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.511 ' HG3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 Cg_exo -62.73 179.03 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.024 2.483 . . . . 0.0 113.595 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.1 t -120.39 -34.09 3.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 111.887 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.663 ' HB3' ' HG ' ' A' ' 139' ' ' SER . 25.0 t-105 -156.45 151.74 26.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.38 0.272 . . . . 0.0 110.937 -170.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -151.24 124.33 8.72 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.233 1.413 . . . . 0.0 109.799 168.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.81 128.04 43.13 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.288 0.635 . . . . 0.0 109.621 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 t -75.48 -46.65 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.644 1.178 . . . . 0.0 110.872 -172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -75.02 -45.94 38.38 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.367 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -15.9 60.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 61.98 43.33 9.17 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.562 1.164 . . . . 0.0 110.687 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.401 HD13 ' HE1' ' A' ' 108' ' ' HIS . 82.0 mt -140.72 135.71 31.85 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.677 -172.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 130' ' ' TRP . 46.3 mt -122.03 160.5 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.761 1.624 . . . . 0.0 108.479 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.663 ' HG ' ' HB3' ' A' ' 130' ' ' TRP . 53.9 p -153.86 155.53 35.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.185 0.448 . . . . 0.0 111.585 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.5 t80 -115.38 149.81 37.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.134 1.374 . . . . 0.0 108.917 170.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.78 -109.56 2.16 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.16 82.38 0.05 OUTLIER Glycine 0 C--O 1.239 0.452 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.51 136.92 2.95 Favored Glycine 0 C--O 1.239 0.425 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 146' ' ' LEU . 3.0 t-105 -105.76 106.31 16.75 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.536 1.168 . . . . 0.0 108.557 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.405 ' HE3' ' HG2' ' A' ' 104' ' ' GLU . 53.4 mtmt -131.19 123.44 28.49 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.984 0.913 . . . . 0.0 109.816 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 144' ' ' TRP . 23.9 tp -129.63 -85.93 0.54 Allowed 'General case' 0 C--N 1.348 0.511 0 O-C-N 123.855 0.722 . . . . 0.0 109.285 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 176.98 -66.02 0.01 OUTLIER 'General case' 0 C--N 1.361 1.077 0 O-C-N 123.759 0.662 . . . . 0.0 110.868 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' A' ' 206' ' ' LYS . . . -140.35 -161.94 8.91 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -166.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 228' ' ' GLN . 34.5 tt0 -148.32 163.86 35.79 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.046 1.339 . . . . 0.0 108.966 -167.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.529 ' HA ' HG22 ' A' ' 208' ' ' VAL . 30.8 t90 -66.84 146.88 53.95 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 176.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.54 132.94 21.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.558 1.143 . . . . 0.0 109.218 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.82 162.95 28.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.339 0.656 . . . . 0.0 110.578 174.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.38 -31.21 4.91 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.28 138.66 31.23 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.921 0.888 . . . . 0.0 109.39 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.32 135.24 38.38 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 200' ' ' ILE . 36.0 m -106.11 140.43 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 123.434 0.694 . . . . 0.0 110.351 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -109.21 150.74 27.47 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.83 113.44 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.512 0.325 . . . . 0.0 110.77 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 167' ' ' PRO . 2.3 pt? -67.92 87.56 0.25 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 0.0 109.26 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 167' ' ' PRO . . . -71.13 111.61 6.62 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.392 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 167' ' ' PRO . 96.7 mt -68.78 80.34 0.29 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.34 125.33 86.94 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.791 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.81 114.27 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.108 2.539 . . . . 0.0 114.06 -170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.35 61.42 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.401 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -151.43 163.29 39.32 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.409 0.684 . . . . 0.0 110.286 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 157.67 48.3 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.146 0.978 . . . . 0.0 112.233 174.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 159' ' ' LEU . 69.3 Cg_endo -69.8 117.02 4.84 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.675 2.25 . . . . 0.0 112.292 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -97.84 112.74 24.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 159' ' ' LEU . . . -72.05 101.78 2.82 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.207 0.527 . . . . 0.0 110.084 -175.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.419 HG11 HD23 ' A' ' 189' ' ' LEU . 44.9 t -85.33 109.52 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.413 -174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -84.46 105.57 15.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.095 0.872 . . . . 0.0 108.879 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.487 HG21 HD11 ' A' ' 189' ' ' LEU . 9.8 t -127.99 157.61 40.13 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.865 1.266 . . . . 0.0 109.627 -174.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -99.41 160.23 28.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.49 159.05 33.39 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.198 1.932 . . . . 0.0 113.151 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -145.95 -171.14 15.18 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.12 149.52 30.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.661 0.73 . . . . 0.0 111.013 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 1.3 p90 -131.63 127.58 37.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.427 1.091 . . . . 0.0 109.453 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.556 ' HB2' HD12 ' A' ' 28' ' ' ILE . 43.9 tttm -78.58 132.01 36.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 -165.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.467 HG21 ' H ' ' A' ' 181' ' ' ALA . 32.7 m -90.68 162.98 14.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 109.228 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -54.34 -40.67 68.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.467 ' H ' HG21 ' A' ' 179' ' ' THR . . . -103.97 2.34 32.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.957 0.903 . . . . 0.0 112.995 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.47 -126.44 1.27 Allowed Glycine 0 C--N 1.351 1.408 0 C-N-CA 121.471 -0.395 . . . . 0.0 113.11 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.8 t -157.38 153.93 28.07 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.437 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mt -116.17 127.93 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.17 119.96 6.66 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.79 -156.22 0.49 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 0.0 109.798 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.42 106.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.876 0.846 . . . . 0.0 109.296 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.571 ' HA ' HG12 ' A' ' 223' ' ' VAL . 23.0 t -103.8 106.07 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 172' ' ' THR . 3.8 tt -128.54 129.63 46.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -172.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 221' ' ' ALA . 8.7 p-10 -107.22 120.53 42.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.028 0.531 . . . . 0.0 109.708 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -170.88 168.48 7.13 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.553 1.141 . . . . 0.0 108.793 -171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.9 p -54.36 136.07 60.91 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.284 0.634 . . . . 0.0 110.832 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.3 95.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 124.272 3.315 . . . . 0.0 114.932 -167.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.46 44.45 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.189 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 161' ' ' LEU . 7.7 t -103.87 143.98 32.11 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 112.244 -170.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.468 ' HA ' ' OH ' ' A' ' 222' ' ' TYR . 48.2 m -68.29 116.15 8.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.427 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.02 -4.48 23.97 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.356 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 75.5 m -52.19 118.81 13.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 122.963 0.505 . . . . 0.0 111.922 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.457 ' HG2' HD23 ' A' ' 159' ' ' LEU . 85.9 Cg_endo -79.53 141.07 15.46 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.755 2.303 . . . . 0.0 113.129 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 226' ' ' ILE . 14.4 mt -93.49 111.07 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 159' ' ' LEU . 45.6 mt -119.23 155.76 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 110.236 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.63 164.61 12.34 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.665 1.186 . . . . 0.0 108.377 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.27 -24.27 64.8 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.653 1.181 . . . . 0.0 112.098 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -71.1 -16.66 62.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.043 1.337 . . . . 0.0 111.818 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.86 78.18 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.437 ' HE3' ' HA3' ' A' ' 148' ' ' GLY . 41.2 tttp -86.83 121.53 29.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.475 1.11 . . . . 0.0 108.437 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.42 109.31 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 150' ' ' TRP . 10.7 p -92.61 7.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.192 0.997 . . . . 0.0 110.237 -173.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.3 -164.9 32.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.846 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 49.5 mt -137.16 150.61 48.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . 0.488 ' HB3' ' HH ' ' A' ' 222' ' ' TYR . 7.8 m-85 -69.37 108.27 3.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.14 -133.78 4.93 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.833 1.333 . . . . 0.0 112.9 -171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.445 ' O ' ' SD ' ' A' ' 39' ' ' MET . 3.3 t-20 -67.38 97.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -162.16 -162.46 13.34 Favored Glycine 0 C--O 1.244 0.738 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.221 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 41' ' ' ILE . 12.2 p -167.03 168.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.6 0.76 . . . . 0.0 109.625 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 17.3 m -68.99 114.32 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.543 ' HG1' HD11 ' A' ' 29' ' ' LEU . 6.0 t -81.18 -178.65 7.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.382 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -36.39 117.42 0.48 Allowed 'General case' 0 C--N 1.36 1.036 0 O-C-N 125.375 1.672 . . . . 0.0 112.403 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.5 t 86.46 6.04 0.36 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.063 1.745 . . . . 0.0 112.085 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.8 32.28 9.3 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.596 -0.275 . . . . 0.0 113.149 174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.709 ' HB3' ' HA ' ' A' ' 190' ' ' ASP . . . -98.07 105.01 17.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 10.3 t80 -67.09 103.45 1.19 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 188' ' ' SER . 87.6 t -118.33 139.6 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.112 1.365 . . . . 0.0 108.694 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.51 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 44.8 t -153.4 156.58 38.51 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.025 0.44 . . . . 0.0 111.932 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.0 130.62 41.4 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 200' ' ' ILE . 69.2 mt -70.85 111.88 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.607 0.363 . . . . 0.0 110.67 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -74.64 152.51 39.19 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 11.0 pt20 -145.1 162.27 37.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.653 0.781 . . . . 0.0 110.439 -172.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 26.6 m -85.21 108.88 17.94 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -105.24 32.87 3.96 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.956 0.902 . . . . 0.0 109.827 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 123.007 0.523 . . . . 0.0 109.954 -175.541 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 95' ' ' SER . 2.9 tppp? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 124.43 1.092 . . . . 0.0 111.396 178.721 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 81.0 21.63 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.116 1.367 . . . . 0.0 112.028 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.753 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.2 t70 -168.07 52.47 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 88' ' ' GLN . 53.2 mt -86.59 91.02 8.44 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.677 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HB3' ' NE2' ' A' ' 121' ' ' HIS . 13.0 mm-40 -87.23 124.37 33.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.2 1.0 . . . . 0.0 110.988 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.49 HD22 HD12 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.15 125.99 43.41 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . 33.2 tt0 -109.61 157.94 18.54 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 167.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 21.3 ttt180 -92.96 141.7 28.12 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.822 1.192 . . . . 0.0 110.904 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.29 -55.71 2.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.44 -159.97 0.84 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.899 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.47 153.44 20.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.185 0.594 . . . . 0.0 110.141 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.575 HG12 HG21 ' A' ' 201' ' ' ILE . 3.0 t -79.58 97.93 2.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -173.94 164.47 4.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.643 0.777 . . . . 0.0 109.19 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -64.48 126.31 27.45 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.107 0.563 . . . . 0.0 111.475 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 10.8 tp10 -97.1 145.57 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.164 0.986 . . . . 0.0 109.042 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -9.72 2.3 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.679 1.191 . . . . 0.0 113.49 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 28.5 mm-40 -80.81 51.78 1.59 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.954 1.302 . . . . 0.0 111.161 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.29 3.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.286 1.034 . . . . 0.0 112.05 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -94.42 91.54 6.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.003 0.921 . . . . 0.0 110.443 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' ' 171' ' ' GLN . 17.7 mt -79.25 102.85 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -158.11 -35.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.114 0.566 . . . . 0.0 111.023 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.09 99.43 0.04 OUTLIER Glycine 0 C--N 1.356 1.654 0 O-C-N 124.067 0.854 . . . . 0.0 113.979 -170.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.6 p 168.3 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.927 1.691 . . . . 0.0 108.093 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 190' ' ' ASP . 77.4 p -70.13 159.79 83.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.28 175.66 1.02 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.183 1.922 . . . . 0.0 112.931 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.79 111.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 55.9 tp -102.93 134.88 45.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -164.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.6 t -80.55 114.3 19.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.583 HG23 ' HE2' ' A' ' 39' ' ' MET . 33.1 mt -113.38 148.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.474 ' OG1' ' HG3' ' A' ' 42' ' ' LYS . 6.7 m -91.83 105.37 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 179' ' ' THR . 10.1 tp -79.85 156.5 4.58 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.015 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.7 m -145.34 114.24 6.9 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.224 0.61 . . . . 0.0 110.178 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 62.4 14.51 6.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.748 1.219 . . . . 0.0 112.142 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.2 t70 74.74 -20.07 0.35 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.557 1.943 . . . . 0.0 112.482 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.67 -48.23 3.49 Favored Glycine 0 C--N 1.353 1.489 0 C-N-CA 123.137 0.398 . . . . 0.0 112.675 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.8 p -100.56 157.52 16.6 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.583 ' HE2' HG23 ' A' ' 31' ' ' ILE . 4.7 ppp? -145.42 135.58 23.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.137 0.575 . . . . 0.0 110.156 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.3 p -154.12 -178.15 6.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 109.592 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 ' H ' HG23 ' A' ' 215' ' ' VAL . 9.4 tp -107.05 156.16 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.474 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 7.3 mtpm? -67.84 113.24 5.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 163.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.55 91.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.368 1.467 . . . . 0.0 110.528 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.51 116.68 32.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.285 0.634 . . . . 0.0 109.8 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 C--O 1.243 0.735 0 C-N-CA 123.532 0.733 . . . . 0.0 109.275 176.401 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.669 HG13 ' HZ1' ' A' ' 87' ' ' LYS . 7.0 t . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -93.34 140.42 29.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.419 0.688 . . . . 0.0 112.105 173.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.527 ' HB3' ' CE1' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -152.79 -176.38 5.72 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 27.4 t70 -177.98 68.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.613 HG11 ' HE2' ' A' ' 84' ' ' TYR . 15.4 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.958 -162.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 103' ' ' LYS . 7.8 p-10 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.774 0.321 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.82 -146.86 9.34 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.019 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.14 108.87 17.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 14.0 m-85 -89.44 158.42 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.642 0.777 . . . . 0.0 112.064 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 83.4 mtt180 -93.43 156.85 16.52 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.089 1.356 . . . . 0.0 110.136 163.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.558 HG22 HD13 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -126.36 106.32 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.641 -166.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.669 ' HZ1' HG13 ' A' ' 64' ' ' VAL . 80.7 tttt -124.4 131.91 53.51 Favored 'General case' 0 C--N 1.406 3.045 0 C-N-CA 124.725 1.21 . . . . 0.0 113.048 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.69 ' HB2' HD22 ' A' ' 6' ' ' LEU . 6.9 tp60 -134.27 151.2 51.15 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -87.48 85.58 7.14 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.71 169.85 40.91 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 114.032 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.787 HG12 ' HD2' ' B' ' 253' ' ' LYS 0.254 0.1 OUTLIER 30.2 39.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.3 2.24 . . . . 0.0 114.323 178.708 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp 158.13 -57.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 128.261 2.624 . . . . 0.0 106.177 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.0 -152.43 24.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.573 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -58.96 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.727 0.811 . . . . 0.0 110.227 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.4 m -143.54 123.79 13.78 Favored 'General case' 0 C--O 1.256 1.418 0 CA-C-N 118.471 0.578 . . . . 0.0 111.171 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.53 119.61 32.17 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 166.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 86' ' ' ILE . 1.9 pp -124.84 -42.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.514 ' N ' HD13 ' A' ' 97' ' ' ILE . . . -115.79 -163.9 13.88 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.01 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.17 122.33 36.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.912 0.485 . . . . 0.0 110.101 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.97 174.87 26.95 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.518 HG12 HG23 ' A' ' 14' ' ' VAL . 54.9 t -137.24 135.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.52 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 34.9 t80 -151.27 122.57 7.8 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 5.9 mtmp? -135.92 136.46 40.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 61.95 -81.67 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.948 1.405 . . . . 0.0 111.989 170.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.05 28.98 1.12 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-O 120.188 -0.229 . . . . 0.0 112.666 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -144.47 125.27 14.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 0.0 110.139 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.711 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 5.7 t80 -97.91 121.22 39.56 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -110.14 108.25 18.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.069 0.948 . . . . 0.0 109.41 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.555 HG22 ' HB ' ' A' ' 138' ' ' ILE . 10.1 t -136.46 -156.37 0.7 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.366 0.666 . . . . 0.0 110.261 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.515 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 31.6 ttm -149.37 152.44 35.79 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -154.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -43.25 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.438 1.095 . . . . 0.0 113.019 -176.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 4.3 p-80 -64.86 -22.44 66.99 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.144 0.429 . . . . 0.0 111.31 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.72 -44.23 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 96.8 m -148.89 147.61 28.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 119.242 0.928 . . . . 0.0 109.214 166.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -71.52 32.73 0.05 Allowed 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 126.275 1.83 . . . . 0.0 115.857 -168.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 87.41 45.77 5.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.68 0.673 . . . . 0.0 113.264 171.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.636 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . -97.46 -169.73 1.89 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.115 0.566 . . . . 0.0 112.296 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 127' ' ' GLU . 8.9 p -100.45 139.75 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.642 1.177 . . . . 0.0 111.986 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 140' ' ' TYR . 16.0 mt -85.27 171.4 11.95 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 118.078 0.399 . . . . 0.0 111.271 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.753 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.9 ptp -178.5 177.3 0.94 Allowed 'General case' 0 C--O 1.283 2.845 0 CA-C-O 122.17 0.986 . . . . 0.0 112.37 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -166.33 120.87 1.14 Allowed 'General case' 0 C--N 1.365 1.26 0 CA-C-N 113.384 -1.735 . . . . 0.0 114.173 167.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 19.1 mtpp 48.48 40.62 15.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.82 1.325 . . . . 0.0 113.34 158.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.28 19.25 14.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.742 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' MET . 13.0 tppt? -137.11 158.83 43.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.353 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -143.58 124.95 14.68 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.859 1.209 . . . . 0.0 112.795 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 60.3 mt -103.74 118.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.264 1.425 . . . . 0.0 109.592 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.587 ' HA ' HG21 ' A' ' 118' ' ' VAL . 33.8 mt-10 -87.92 138.42 31.13 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.642 0.777 . . . . 0.0 112.096 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 73.9 Cg_endo -71.86 156.37 56.75 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.312 2.674 . . . . 0.0 113.69 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 p -124.06 -20.68 5.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.554 0.742 . . . . 0.0 110.975 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 17.5 t-105 -148.77 146.02 27.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.544 0.737 . . . . 0.0 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.49 125.75 8.0 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.205 1.402 . . . . 0.0 108.573 167.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -138.47 128.21 25.08 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.506 0.593 . . . . 0.0 111.114 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.34 -32.18 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.913 0.885 . . . . 0.0 111.341 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.37 -38.1 65.81 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.065 0.946 . . . . 0.0 110.051 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.51 -17.07 37.47 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.727 0.811 . . . . 0.0 109.461 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 59.53 36.39 22.88 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 125.025 1.33 . . . . 0.0 109.482 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 1.5 mp -137.84 140.67 40.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.671 0.748 . . . . 0.0 110.563 -169.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.555 ' HB ' HG22 ' A' ' 109' ' ' THR . 73.1 mt -124.09 148.03 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.765 1.626 . . . . 0.0 108.251 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 32.9 t -141.91 143.7 33.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 111.265 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.711 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 3.5 m-85 -119.88 146.26 45.93 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.998 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.08 35.97 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.499 0.499 . . . . 0.0 112.2 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 159.3 -161.39 32.05 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.9 132.7 11.35 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 166.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.692 ' NE1' ' HA ' ' A' ' 229' ' ' THR . 4.9 p90 -75.7 107.68 8.03 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.193 0.997 . . . . 0.0 111.169 -169.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -116.33 116.37 27.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HB2' HG23 ' A' ' 229' ' ' THR . 5.7 mp -131.62 -66.51 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 172.11 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.708 0.803 . . . . 0.0 109.407 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 207' ' ' VAL . . . -47.31 109.64 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 118.065 1.986 . . . . 0.0 118.065 -162.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -142.59 94.23 2.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.564 ' HE3' HD13 ' A' ' 200' ' ' ILE . 7.8 t90 -56.75 109.91 0.71 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.25 123.64 32.47 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.407 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.82 135.86 35.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.984 0.914 . . . . 0.0 111.663 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.48 -59.22 0.36 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.0 111.28 17.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.622 0.769 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.46 152.39 40.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.194 0.598 . . . . 0.0 111.736 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.76 HG23 HG22 ' A' ' 200' ' ' ILE . 34.6 m -124.8 -169.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.532 1.133 . . . . 0.0 109.89 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.675 ' HG2' ' HG3' ' A' ' 171' ' ' GLN . 9.9 mt-30 -126.04 167.12 15.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.965 1.306 . . . . 0.0 109.065 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 13.5 p -140.26 148.92 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 122.985 0.514 . . . . 0.0 110.51 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.9 mt -97.54 95.21 7.47 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.98 0.809 . . . . 0.0 109.907 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 168' ' ' ARG . . . -76.48 99.97 5.1 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 168.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 167' ' ' PRO . 88.0 mt -86.66 106.02 17.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.544 0.738 . . . . 0.0 109.494 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.27 159.63 29.04 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.551 0.74 . . . . 0.0 111.135 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.37 113.61 1.2 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 124.123 3.216 . . . . 0.0 115.165 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.45 8.81 40.44 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.016 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.2 158.91 16.5 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.982 0.913 . . . . 0.0 110.636 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.47 157.62 63.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.539 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 161' ' ' LEU . 38.9 Cg_exo -60.55 103.19 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.544 2.163 . . . . 0.0 111.134 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.416 ' HB2' ' HB1' ' A' ' 160' ' ' ALA . 80.2 mtp180 -72.99 96.71 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.02 99.84 7.86 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.9 t -102.72 122.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.362 0.665 . . . . 0.0 109.751 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.675 ' HG3' ' HG2' ' A' ' 157' ' ' GLN . 2.1 mp0 -82.15 119.35 23.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -127.67 141.29 51.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.142 0.977 . . . . 0.0 111.368 -173.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -98.27 160.14 28.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.539 1.536 . . . . 0.0 109.481 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.52 124.1 9.1 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.696 1.597 . . . . 0.0 111.216 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.06 -172.79 26.34 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.291 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.1 133.58 9.9 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.574 ' HD1' ' HB3' ' A' ' 29' ' ' LEU . 29.0 m-85 -121.79 126.5 48.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.818 0.847 . . . . 0.0 109.298 -165.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -73.06 117.92 15.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.604 0.716 . . . . 0.0 109.215 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.477 HG21 ' HB ' ' A' ' 33' ' ' ILE . 91.0 m -120.65 147.82 44.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.927 1.291 . . . . 0.0 109.479 -170.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -78.98 65.57 4.2 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 178.46 -43.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.832 1.653 . . . . 0.0 108.214 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 178.28 -127.33 1.15 Allowed Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.131 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 m -144.18 128.58 17.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.647 0.779 . . . . 0.0 109.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.2 mt -104.1 122.88 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.877 0.871 . . . . 0.0 109.245 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.31 106.61 3.17 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.32 178.55 9.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.971 0.909 . . . . 0.0 109.975 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.05 131.83 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.3 p -111.0 89.67 3.11 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.168 0.987 . . . . 0.0 109.385 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 222' ' ' TYR . 3.4 tm? -106.78 124.81 50.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 30.5 t70 -125.49 105.18 8.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 108.678 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -163.86 -173.5 3.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.075 1.35 . . . . 0.0 109.043 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 77.6 p -51.9 149.41 9.02 Favored Pre-proline 0 CA--C 1.556 1.185 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.759 159.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.71 114.42 1.07 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.139 2.56 . . . . 0.0 112.834 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 222' ' ' TYR . . . -72.67 163.02 54.82 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.898 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.515 ' HB ' ' HG ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -85.9 120.72 27.61 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.979 0.512 . . . . 0.0 110.025 -172.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.0 m -59.88 115.1 3.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.639 0.776 . . . . 0.0 110.343 173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.93 17.18 33.36 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 124.107 0.879 . . . . 0.0 112.426 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . 0.515 ' HG ' ' HB ' ' A' ' 195' ' ' THR . 56.5 m -64.61 127.65 92.63 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 117.113 0.457 . . . . 0.0 111.059 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.79 138.45 11.78 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.085 2.524 . . . . 0.0 114.483 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.76 HG22 HG23 ' A' ' 156' ' ' VAL . 62.3 mt -85.25 99.72 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.039 1.336 . . . . 0.0 109.121 176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.575 HG21 HG12 ' A' ' 14' ' ' VAL . 20.8 pt -124.25 156.6 31.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.058 0 CA-C-O 121.368 0.604 . . . . 0.0 111.895 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 15.5 t70 -90.84 176.01 6.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.643 1.177 . . . . 0.0 108.975 174.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.403 ' HA ' HE22 ' A' ' 157' ' ' GLN . 38.0 mtpt -56.61 -27.19 57.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.695 1.198 . . . . 0.0 112.681 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -95.54 -6.58 40.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.68 0.792 . . . . 0.0 111.941 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.81 46.64 5.34 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 57.9 tttm -115.25 162.49 17.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.278 1.431 . . . . 0.0 108.932 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.561 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 59.4 t 79.99 -58.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 C-N-CA 125.191 1.396 . . . . 0.0 110.731 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 146' ' ' LEU . 10.9 m 57.09 26.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 124.278 1.031 . . . . 0.0 112.521 167.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.18 -153.96 1.97 Allowed Glycine 0 C--N 1.361 1.969 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.7 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.0 mt -150.04 155.85 40.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 117.969 0.884 . . . . 0.0 111.27 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -82.12 104.12 12.23 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 165.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.75 -137.12 3.2 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 123.469 0.557 . . . . 0.0 114.202 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -71.22 103.64 2.86 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -141.27 -136.69 3.32 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.456 HG23 ' H ' ' A' ' 41' ' ' ILE . 8.7 p -165.95 156.61 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.61 110.26 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 95.0 m -85.97 148.24 25.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.283 1.033 . . . . 0.0 109.407 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 49.52 30.38 3.44 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.476 1.51 . . . . 0.0 112.846 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 93.4 p 56.45 27.45 12.18 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.289 1.836 . . . . 0.0 112.733 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -162.34 -53.83 0.02 OUTLIER Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.202 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.36 95.18 0.59 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.119 0.567 . . . . 0.0 110.478 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.512 ' O ' ' HB3' ' A' ' 189' ' ' LEU . 30.9 t80 -74.41 98.62 3.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.48 HG12 HD13 ' A' ' 31' ' ' ILE . 78.0 t -98.78 146.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.733 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 23.1 t -159.21 158.93 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.43 142.12 46.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.572 167.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.8 mt -73.28 102.5 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.62 0.768 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -91.03 143.29 26.86 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.788 0.435 . . . . 0.0 110.037 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.58 172.43 12.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.411 1.084 . . . . 0.0 111.44 -167.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.692 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 65.8 p -74.2 133.17 42.71 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.255 0.622 . . . . 0.0 111.668 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.34 -29.31 69.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.762 0.825 . . . . 0.0 110.588 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 CA--C 1.554 1.121 0 CA-C-O 122.372 1.082 . . . . 0.0 109.229 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.787 ' HD2' HG12 ' A' ' 91' ' ' ILE . 8.3 tmtt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' B' ' 253' ' ' LYS . 16.5 tpt180 . . . . . 0 N--CA 1.488 1.473 0 C-N-CA 127.726 2.41 . . . . 0.0 107.9 -163.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB2' ' NH2' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.531 ' O ' ' HE1' ' A' ' 120' ' ' MET . . . -161.56 -24.47 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.212 0.605 . . . . 0.0 111.367 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.82 36.59 0.77 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 126.713 2.005 . . . . 0.0 110.579 -159.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.716 ' HG ' ' HG3' ' A' ' 88' ' ' GLN . 4.3 mp -118.84 103.46 9.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 0.0 109.737 -165.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' MET . 62.2 tt0 -109.13 153.02 24.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.509 ' HB2' HG23 ' A' ' 68' ' ' VAL . 3.7 mp -91.8 148.95 21.85 Favored 'General case' 0 N--CA 1.515 2.791 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.532 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.829 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 25.2 tt0 -140.63 133.5 29.08 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.264 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -73.88 127.27 32.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.221 0.919 . . . . 0.0 111.857 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB3' ' HG3' ' A' ' 85' ' ' ARG . . . -96.56 -42.38 8.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.038 0.935 . . . . 0.0 109.569 174.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.53 -162.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -107.16 158.45 17.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.467 0.707 . . . . 0.0 109.814 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 103' ' ' LYS . 2.3 t -74.78 97.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 169.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -168.39 151.74 5.63 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -164.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.488 ' HE1' HE22 ' A' ' 157' ' ' GLN . 28.8 t90 -71.87 137.49 47.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HB3' ' H ' ' A' ' 169' ' ' ALA . 11.2 tp10 -106.77 133.77 50.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.512 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.7 -8.21 52.73 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.789 0.836 . . . . 0.0 113.076 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -84.69 50.78 1.97 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.651 0.78 . . . . 0.0 109.815 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -81.54 118.83 23.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.42 -174.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -132.48 138.41 47.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.636 0.774 . . . . 0.0 109.4 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.47 126.69 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -145.06 -41.8 0.23 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.294 0.638 . . . . 0.0 109.851 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.56 97.35 0.33 Allowed Glycine 0 C--N 1.356 1.66 0 O-C-N 123.455 0.472 . . . . 0.0 113.807 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -171.92 90.45 0.12 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.599 1.16 . . . . 0.0 109.055 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -115.13 151.53 45.79 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.394 0.677 . . . . 0.0 109.767 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 -163.71 0.19 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.57 110.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.2 tp -101.83 143.04 32.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.04 0.448 . . . . 0.0 111.499 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -91.61 112.24 24.08 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.258 0.623 . . . . 0.0 109.722 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.622 HG21 ' HE3' ' A' ' 39' ' ' MET . 42.8 mt -118.27 157.48 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 124.705 1.202 . . . . 0.0 108.139 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 HG23 ' HE3' ' A' ' 42' ' ' LYS . 53.6 p -93.97 107.42 19.33 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.954 0.797 . . . . 0.0 109.353 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 39' ' ' MET . 1.8 mp -83.13 123.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.783 0.833 . . . . 0.0 109.138 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -102.95 138.67 39.52 Favored 'General case' 0 C--O 1.264 1.819 0 C-N-CA 123.896 0.878 . . . . 0.0 112.479 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 55.69 -86.59 0.02 OUTLIER 'General case' 0 C--N 1.356 0.871 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.056 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -156.56 100.8 1.97 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.66 -0.83 87.62 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.172 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 m -95.61 160.46 14.49 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 118.835 1.318 . . . . 0.0 108.527 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.622 ' HE3' HG21 ' A' ' 31' ' ' ILE . 2.8 ppp? -160.42 144.32 13.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.903 0.481 . . . . 0.0 110.203 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 p -165.73 174.33 9.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.462 0.705 . . . . 0.0 110.265 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 217' ' ' THR . 10.3 tp -104.89 155.87 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.455 ' HE3' HG23 ' A' ' 32' ' ' THR . 99.6 mttt -81.57 123.34 28.58 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 71.99 114.45 0.05 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.668 1.587 . . . . 0.0 110.451 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.12 93.22 0.95 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.677 0.791 . . . . 0.0 110.847 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.485 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 7' ' ' GLU . 4.5 t . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.829 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 88.6 mt -143.11 -155.15 0.57 Allowed 'General case' 0 C--O 1.201 -1.469 0 C-N-CA 124.35 1.06 . . . . 0.0 109.854 -170.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 6.0 m0 -166.98 87.47 0.3 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 124.036 0.934 . . . . 0.0 112.881 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 5.6 t0 174.65 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 124.757 1.223 . . . . 0.0 109.729 159.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 8' ' ' LEU . 74.5 t . . . . . 0 N--CA 1.506 2.342 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.295 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.51 -155.81 26.35 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.19 129.82 50.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.994 1.318 . . . . 0.0 109.066 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 12.6 m-85 -123.92 146.69 48.28 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -162.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 11' ' ' ALA . 30.4 mtt85 -86.8 126.92 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 161.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.88 134.45 66.18 Favored 'Isoleucine or valine' 0 C--O 1.267 2.016 0 O-C-N 122.032 -0.417 . . . . 0.0 110.971 -171.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 80.7 tttt -125.66 142.82 51.32 Favored 'General case' 0 C--N 1.387 2.2 0 C-N-CA 125.681 1.592 . . . . 0.0 111.795 -169.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.716 ' HG3' ' HG ' ' A' ' 6' ' ' LEU . 48.1 tt0 -121.88 152.71 39.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.588 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -105.0 90.9 3.59 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 123.05 1.405 . . . . 0.0 107.883 155.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.8 172.59 43.78 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.292 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.59 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 48.0 mt 60.91 -81.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.097 1.359 . . . . 0.0 111.021 166.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' B' ' 253' ' ' LYS . 50.6 tp -93.69 -46.12 7.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.3 1.04 . . . . 0.0 110.535 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.46 -150.08 11.16 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 116.386 -0.37 . . . . 0.0 113.513 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -104.41 88.11 2.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.621 1.168 . . . . 0.0 107.899 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -141.55 132.93 26.68 Favored 'General case' 0 C--O 1.257 1.48 0 CA-C-N 118.514 0.597 . . . . 0.0 112.521 -170.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 2.2 pt20 -94.09 114.87 27.11 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 125.36 1.464 . . . . 0.0 109.077 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.566 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -133.67 -35.66 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.13 -166.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.78 168.95 21.78 Favored Glycine 0 N--CA 1.48 1.625 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.249 -162.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -110.15 123.21 49.32 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.44 129.56 9.52 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.54 HG12 ' HZ3' ' A' ' 145' ' ' LYS . 27.8 t -110.83 103.76 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.68 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 21.2 t80 -116.36 140.11 49.69 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 170.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.464 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 79.5 tttt -169.34 152.88 5.05 Favored 'General case' 0 C--O 1.245 0.841 0 O-C-N 123.955 0.785 . . . . 0.0 109.358 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 69.97 -69.58 0.17 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.785 1.634 . . . . 0.0 110.119 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.43 10.85 0.07 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.25 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -133.64 150.13 51.58 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.802 0.801 . . . . 0.0 111.371 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 90.7 t80 -109.96 122.55 47.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.543 1.137 . . . . 0.0 108.435 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.501 ' HE1' HD21 ' A' ' 137' ' ' LEU . 54.3 t-80 -132.2 111.76 11.69 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -175.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.69 -165.22 1.63 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.089 1.356 . . . . 0.0 108.388 -170.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.817 ' SD ' ' HA3' ' A' ' 212' ' ' GLY . 31.5 mmt -99.65 162.19 13.16 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.828 1.195 . . . . 0.0 113.722 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -86.24 -52.99 5.3 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.6 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -57.34 -24.33 54.48 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.872 1.269 . . . . 0.0 113.09 -170.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' B' ' 254' ' ' ARG . 22.6 m -62.51 -12.63 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 124.432 1.093 . . . . 0.0 113.038 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.729 HG22 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -160.72 -157.24 0.52 Allowed 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.727 1.211 . . . . 0.0 109.535 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.411 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 27.8 ptt180 -119.65 14.85 12.71 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.252 1.021 . . . . 0.0 111.021 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.729 ' H ' HG22 ' A' ' 114' ' ' THR . . . 94.28 58.54 1.21 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 124.152 0.882 . . . . 0.0 111.437 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.6 165.1 12.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 ' HA ' ' A' ' 127' ' ' GLU . 2.2 p -98.58 144.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.326 1.05 . . . . 0.0 109.844 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.46 179.22 4.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.403 0.681 . . . . 0.0 111.965 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.531 ' HE1' ' O ' ' A' ' 4' ' ' ALA . 11.4 ptp -168.96 178.44 4.51 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 13.7 t60 -127.23 95.0 4.15 Favored 'General case' 0 C--N 1.369 1.42 0 CA-C-N 110.214 -3.175 . . . . 0.0 107.946 164.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 mttt 34.81 64.29 0.42 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 125.234 1.414 . . . . 0.0 113.778 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.42 24.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.246 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -88.33 111.66 21.98 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.532 0.666 . . . . 0.0 109.624 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -105.08 130.37 53.29 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.289 -0.257 . . . . 0.0 111.1 -163.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.8 pt -119.53 130.37 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.308 1.043 . . . . 0.0 109.772 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.718 ' HA ' HG22 ' A' ' 118' ' ' VAL . 10.6 pt-20 -95.63 139.8 22.06 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.089 0.556 . . . . 0.0 111.658 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.7 149.38 54.61 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.655 2.236 . . . . 0.0 111.734 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.449 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 9.9 p -85.68 -17.48 35.9 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.704 0.802 . . . . 0.0 111.784 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -163.24 157.85 20.83 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 120.665 0.269 . . . . 0.0 111.231 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.12 118.8 14.02 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.381 1.072 . . . . 0.0 109.535 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 135' ' ' LYS . 14.7 m-20 -102.58 110.26 22.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.387 1.475 . . . . 0.0 110.857 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.08 -48.81 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.882 0.473 . . . . 0.0 110.807 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.04 -44.58 76.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.095 0.558 . . . . 0.0 111.23 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . 72.5 mmtt -69.09 -20.86 64.08 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.008 0.523 . . . . 0.0 110.825 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 t0 66.13 59.52 0.68 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.045 1.338 . . . . 0.0 110.401 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 3.8 pp -165.21 157.14 15.19 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.76 151.34 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 125.081 1.353 . . . . 0.0 107.958 171.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -131.3 143.4 50.5 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.706 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.0 t80 -135.89 142.57 44.71 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 108.532 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.1 -5.98 64.72 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.812 0.695 . . . . 0.0 113.453 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.47 -152.67 23.94 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.13 50.18 Favored Glycine 0 C--O 1.242 0.65 0 CA-C-O 120.97 0.205 . . . . 0.0 112.909 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -54.45 134.21 45.91 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.809 1.244 . . . . 0.0 110.297 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.603 ' HG3' ' HG ' ' A' ' 146' ' ' LEU . 56.7 pttt -109.82 -166.49 1.1 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.335 0.654 . . . . 0.0 111.403 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.603 ' HG ' ' HG3' ' A' ' 145' ' ' LYS . 50.2 mt 70.63 178.45 0.25 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.457 1.503 . . . . 0.0 111.501 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -143.09 -39.04 0.33 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.471 0.309 . . . . 0.0 111.587 -161.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.89 169.35 45.64 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 123.095 0.247 . . . . 0.0 113.155 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.0 153.13 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.221 0.608 . . . . 0.0 110.093 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.618 ' HA ' HG12 ' A' ' 208' ' ' VAL . 26.3 t90 -58.51 131.33 50.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.971 172.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.498 ' HZ2' ' HB3' ' A' ' 151' ' ' LYS . 7.0 mtpm? -119.33 105.17 11.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 152.84 32.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.748 0.819 . . . . 0.0 111.507 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.01 -52.44 4.74 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.17 138.03 53.79 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.093 0.957 . . . . 0.0 110.425 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.58 ' HG3' ' HZ1' ' A' ' 203' ' ' LYS . 9.6 pt-20 -76.38 141.09 41.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.539 . . . . 0.0 110.516 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.11 -177.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.307 1.043 . . . . 0.0 108.557 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 49.7 mt-30 -133.63 162.61 31.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.582 -0.699 . . . . 0.0 110.09 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 200' ' ' ILE . 7.4 p -137.09 136.67 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.149 0.58 . . . . 0.0 109.867 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 35.8 mt -69.52 86.94 0.46 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 165' ' ' LYS . . . -80.79 105.23 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.6 176.8 8.36 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 163' ' ' PRO . 49.1 mp0 -28.4 155.58 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.175 0 C-N-CA 127.861 2.464 . . . . 0.0 114.326 168.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 162' ' ' GLU . 25.6 Cg_exo -1.16 137.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.638 1 C-N-CA 128.162 5.908 . . . . 0.0 118.945 -162.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 192' ' ' SER . . . 99.69 -36.72 3.9 Favored Glycine 0 C--O 1.24 0.495 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -163.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.401 ' HG2' ' HB2' ' A' ' 160' ' ' ALA . 3.1 mptp? -143.56 178.95 7.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.363 1.465 . . . . 0.0 108.42 164.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 12.3 m120 -98.35 133.74 22.57 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.045 -0.978 . . . . 0.0 108.838 167.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 25.6 Cg_endo -59.47 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.965 3.11 . . . . 0.0 113.378 -175.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 39.2 ptt180 -160.68 165.16 31.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.943 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.475 ' H ' ' HB3' ' A' ' 17' ' ' GLU . . . -88.58 102.85 15.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.5 t -86.07 133.93 28.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 109.591 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 49.1 mt-30 -79.73 139.02 37.46 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.916 0.886 . . . . 0.0 109.37 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.8 t -150.28 130.06 13.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.902 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 59.7 mttp -90.71 155.07 45.89 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.046 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.57 121.26 9.3 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.373 1.382 . . . . 0.0 111.616 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -98.12 -170.71 32.28 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.1 144.27 5.64 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.345 0.573 . . . . 0.0 110.331 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.489 ' CE2' HD11 ' A' ' 184' ' ' ILE . 43.4 p90 -123.47 135.01 53.85 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.903 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -70.74 163.74 26.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.882 1.273 . . . . 0.0 111.99 -173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 181' ' ' ALA . 27.4 m -139.12 165.6 26.73 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.889 1.676 . . . . 0.0 108.173 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -52.91 -41.53 64.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.973 0.909 . . . . 0.0 110.213 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . 0.446 ' H ' HG23 ' A' ' 179' ' ' THR . . . -76.39 -74.41 0.23 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.863 176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.17 -107.02 0.65 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.702 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t -162.8 147.16 11.57 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 0.0 109.967 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 177' ' ' PHE . 4.3 mp -108.45 151.38 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.72 139.3 14.35 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.41 144.22 19.44 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.05 113.08 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 165.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.3 m -116.86 91.18 3.51 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.437 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 62.4 tp -104.62 105.02 14.94 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.522 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.37 111.45 14.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.329 0.651 . . . . 0.0 110.121 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -164.35 -174.3 3.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.126 1.37 . . . . 0.0 109.029 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' SER . . . . . 0.608 ' HB2' ' HA2' ' A' ' 164' ' ' GLY . 7.4 m -61.69 175.1 0.55 Allowed Pre-proline 0 CA--C 1.587 2.388 0 C-N-CA 124.787 1.235 . . . . 0.0 111.165 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 192' ' ' SER . 31.3 Cg_exo -24.57 123.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.407 3.633 1 C-N-CA 125.968 4.446 . . . . 0.0 116.925 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.46 131.55 26.93 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.006 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.1 m -81.5 97.12 7.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.912 0.485 . . . . 0.0 109.993 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.49 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 73.3 m -66.45 98.27 0.48 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -166.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 131.57 -5.05 5.52 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.631 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.9 m -47.43 124.48 9.29 Favored Pre-proline 0 N--CA 1.496 1.862 0 C-N-CA 124.275 1.03 . . . . 0.0 113.631 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 4.0 Cg_exo -72.4 121.23 7.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.738 2.292 . . . . 0.0 112.464 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 51.5 mt -84.2 110.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 207' ' ' VAL . 59.4 mt -120.46 162.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.713 0.805 . . . . 0.0 109.848 -171.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -103.04 167.48 9.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.538 0.735 . . . . 0.0 110.246 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.58 ' HZ1' ' HG3' ' A' ' 155' ' ' GLU . 44.1 mttp -58.18 -40.6 81.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.565 1.546 . . . . 0.0 111.154 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -73.58 -20.84 60.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 111.77 -4.73 27.58 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.456 -0.636 . . . . 0.0 113.839 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -73.65 128.69 36.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.78 0.79 . . . . 0.0 110.183 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.413 HG13 HD11 ' A' ' 146' ' ' LEU . 57.9 t -73.44 109.94 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 150' ' ' TRP . 55.1 t -64.37 -30.19 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.798 1.239 . . . . 0.0 110.576 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.87 -154.14 25.24 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.058 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.444 HD22 HG21 ' A' ' 101' ' ' VAL . 75.8 mt -134.75 162.33 32.67 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.641 0.777 . . . . 0.0 109.596 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.8 OUTLIER -77.05 112.47 13.73 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 165.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.817 ' HA3' ' SD ' ' A' ' 110' ' ' MET . . . -174.26 67.31 0.1 Allowed Glycine 0 CA--C 1.496 -1.13 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 163.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.479 ' HB3' ' H ' ' A' ' 225' ' ' ALA . 11.0 t-20 -160.54 176.97 11.0 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.509 ' HA2' ' HE1' ' A' ' 39' ' ' MET . . . 61.62 -144.78 48.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 114.3 0.48 . . . . 0.0 114.3 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 216' ' ' VAL . 13.6 p -177.63 175.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 124.372 1.069 . . . . 0.0 108.863 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 215' ' ' VAL . 34.5 m -70.58 149.59 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 163.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.417 HG23 HD11 ' A' ' 41' ' ' ILE . 45.1 p -136.14 -165.14 1.66 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -32.4 108.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.201 1.4 . . . . 0.0 113.357 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.0 t 77.3 28.08 0.63 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.652 1.581 . . . . 0.0 111.907 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.57 15.84 80.22 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.793 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.61 116.53 6.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.497 0.719 . . . . 0.0 111.818 -171.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 189' ' ' LEU . 5.7 t80 -64.88 116.61 6.53 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.67 0.788 . . . . 0.0 109.388 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.6 t -134.16 115.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -137.09 141.98 42.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 109.25 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 213' ' ' ASN . . . -81.56 16.58 1.67 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.779 0.718 . . . . 0.0 112.49 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.9 mt 58.57 98.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.723 1.609 . . . . 0.0 111.462 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.33 130.03 40.89 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -108.8 125.86 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 38.5 p -80.72 106.26 12.59 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 110.171 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 -19.65 25.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.032 0.933 . . . . 0.0 111.456 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 C--N 1.364 1.222 0 C-N-CA 125.46 1.504 . . . . 0.0 110.525 -172.72 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.59 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 31.7 ttm180 . . . . . 0 N--CA 1.481 1.08 0 CA-C-N 118.678 0.672 . . . . 0.0 109.84 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.422 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.53 16.43 0.2 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.916 0.78 . . . . 0.0 112.122 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.72 44.48 0.76 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.176 0.988 . . . . 0.0 109.321 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 120' ' ' MET . 26.7 mt -86.73 95.03 9.67 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.891 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 120' ' ' MET . 25.6 mt-10 -111.19 129.39 55.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.631 0.772 . . . . 0.0 111.982 -166.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.696 ' HB2' HG23 ' A' ' 68' ' ' VAL . 4.3 mp -101.43 146.98 26.89 Favored 'General case' 0 N--CA 1.513 2.68 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 65' ' ' LEU . 14.1 tt0 -130.46 158.46 39.83 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.014 1.726 . . . . 0.0 109.153 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 9' ' ' GLU . 6.3 ppt_? -90.61 148.49 22.63 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 122.95 0.5 . . . . 0.0 110.958 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.15 -37.67 3.04 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.036 0.534 . . . . 0.0 110.767 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.99 -155.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.055 1.342 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -98.25 153.65 18.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.5 1.12 . . . . 0.0 109.382 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.82 91.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -170.43 117.44 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.57 1.548 . . . . 0.0 107.484 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.584 ' HZ2' ' HB3' ' A' ' 21' ' ' GLU . 80.0 t90 -75.88 94.7 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -158.9 59.55 0.42 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.88 0.472 . . . . 0.0 110.542 163.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 4.1 t70 -89.72 -65.28 1.03 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.442 -0.787 . . . . 0.0 111.235 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.96 -42.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' H ' ' HB1' ' A' ' 169' ' ' ALA . . . -136.45 -170.38 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -154.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 3.3 pt-20 -166.93 90.74 0.39 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.003 1.321 . . . . 0.0 109.408 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.539 ' HB ' HG12 ' A' ' 170' ' ' VAL . 62.9 mt -85.45 103.54 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -55.25 -24.81 29.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.476 1.11 . . . . 0.0 112.202 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.33 -94.25 0.01 OUTLIER Glycine 0 C--N 1.365 2.179 0 O-C-N 124.519 1.137 . . . . 0.0 112.462 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 173' ' ' LYS . 7.0 t 57.94 75.62 0.37 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.044 1.338 . . . . 0.0 109.564 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.7 m -64.61 147.96 97.21 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.237 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.46 168.74 3.65 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.783 2.322 . . . . 0.0 112.094 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.57 109.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.634 0.774 . . . . 0.0 110.617 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.24 159.57 14.9 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.903 0.881 . . . . 0.0 111.733 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -124.6 127.73 47.82 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.9 165.45 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -93.74 108.03 19.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.334 -0.854 . . . . 0.0 109.556 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.0 106.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -89.61 129.55 36.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.971 0.908 . . . . 0.0 110.048 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.38 8.54 5.05 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.72 1.208 . . . . 0.0 112.672 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.71 21.45 12.39 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.893 1.277 . . . . 0.0 112.745 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.86 -40.45 0.06 OUTLIER Glycine 0 N--CA 1.478 1.489 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 t -90.89 166.67 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.839 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.5 ppp? -132.72 149.42 52.29 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 p -169.2 157.18 7.49 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.955 0.902 . . . . 0.0 109.414 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.516 HD12 HG22 ' A' ' 217' ' ' THR . 10.3 tp -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -81.64 70.31 8.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.466 0.651 . . . . 0.0 109.978 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 219' ' ' SER . 51.3 t30 176.18 126.71 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.889 1.675 . . . . 0.0 107.299 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.28 118.06 12.36 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 124.075 0.95 . . . . 0.0 110.559 -176.349 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.656 HG11 ' HD3' ' A' ' 87' ' ' LYS . 43.4 t . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 9' ' ' GLU . 69.4 mt -156.87 134.82 11.03 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 126.364 1.866 . . . . 0.0 106.314 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.493 ' HB2' ' CG ' ' A' ' 121' ' ' HIS . 0.5 OUTLIER -158.75 70.63 0.52 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.155 0.979 . . . . 0.0 113.638 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.53 70.93 0.74 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 162.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 8' ' ' LEU . 2.1 t . . . . . 0 CA--C 1.545 0.787 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.298 -166.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 . . . . . 0 CA--C 1.546 0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.15 -167.39 34.89 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.398 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.76 108.25 9.65 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -95.0 175.98 6.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 110.824 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 51.1 ttt180 -144.52 143.1 30.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.616 HG23 ' HA ' ' A' ' 8' ' ' LEU . 1.1 pt -138.85 140.44 38.85 Favored 'Isoleucine or valine' 0 C--O 1.269 2.131 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.656 ' HD3' HG11 ' A' ' 64' ' ' VAL . 26.2 tttm -131.2 136.57 48.39 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.434 1.494 . . . . 0.0 110.83 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.545 ' HB3' HD12 ' A' ' 97' ' ' ILE . 3.5 tp60 -115.89 133.48 55.99 Favored 'General case' 0 C--O 1.26 1.642 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.74 97.21 9.01 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 163.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.42 -179.16 29.48 Favored Glycine 0 N--CA 1.462 0.374 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.298 -163.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.636 HD11 ' HG2' ' B' ' 253' ' ' LYS . 0.2 OUTLIER -39.79 132.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.614 166.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt 78.0 6.67 2.67 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.815 1.646 . . . . 0.0 111.976 -171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.84 -156.87 20.62 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 122.007 0.782 . . . . 0.0 114.834 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.94 69.37 7.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.285 1.434 . . . . 0.0 107.886 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB2' ' HZ3' ' B' ' 253' ' ' LYS . 19.0 m -109.99 144.35 38.65 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -159.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -74.95 116.47 15.73 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.845 1.341 . . . . 0.0 109.162 163.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 88' ' ' GLN . 0.4 OUTLIER -144.38 9.08 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -152.17 170.53 31.48 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.873 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -116.4 124.64 50.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.7 155.17 22.46 Favored Glycine 0 CA--C 1.503 -0.67 0 O-C-N 123.695 0.622 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.7 t -137.56 101.83 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -107.16 107.3 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -141.2 134.96 30.26 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.45 23.01 12.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.349 1.059 . . . . 0.0 112.349 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.23 76.74 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.088 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.2 p -127.52 133.06 49.84 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.031 0.532 . . . . 0.0 110.426 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.78 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 49.0 t80 -85.44 142.51 29.19 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.555 ' HB3' ' HZ3' ' A' ' 144' ' ' TRP . 94.4 m-70 -137.28 113.28 9.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.432 1.093 . . . . 0.0 110.035 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' HB ' ' A' ' 138' ' ' ILE . 9.7 t -139.81 -164.64 1.73 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.773 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 137' ' ' LEU . 22.2 mtp -121.6 170.47 9.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.045 0.938 . . . . 0.0 111.52 -171.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -40.44 13.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.257 0.623 . . . . 0.0 112.441 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.403 ' HE1' ' SD ' ' A' ' 110' ' ' MET . 25.2 p-80 -62.01 -20.76 64.25 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.521 0.676 . . . . 0.0 111.328 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 253' ' ' LYS . 19.1 m -82.75 -35.1 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.934 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.546 HG21 ' H ' ' A' ' 116' ' ' GLY . 52.8 m -145.03 145.78 31.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.141 -1.599 . . . . 0.0 112.158 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.77 -5.52 0.95 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 126.221 1.808 . . . . 0.0 113.541 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.546 ' H ' HG21 ' A' ' 114' ' ' THR . . . 88.45 55.13 2.25 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.72 -175.0 3.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.918 0.487 . . . . 0.0 111.919 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.1 138.61 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.405 1.082 . . . . 0.0 112.947 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.511 ' HB2' HG13 ' A' ' 126' ' ' ILE . 7.5 mt -102.86 174.77 5.73 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.935 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.556 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -169.47 174.87 5.73 Favored 'General case' 0 C--O 1.261 1.707 0 CA-C-O 123.74 1.733 . . . . 0.0 115.208 -177.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 21.0 t60 -127.59 88.5 2.8 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.645 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 93.1 mttt 38.11 46.85 0.88 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.013 0.925 . . . . 0.0 111.798 -171.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.6 -26.57 20.92 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 11.9 mptt -73.61 109.68 7.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.214 1.507 . . . . 0.0 109.211 175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 15.6 ttm180 -93.8 120.23 33.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.506 0.722 . . . . 0.0 112.494 -157.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.511 HG13 ' HB2' ' A' ' 119' ' ' LEU . 17.0 pt -111.95 161.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.99 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.27 135.25 24.33 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.35 0.66 . . . . 0.0 109.725 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.84 163.5 38.24 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.395 2.063 . . . . 0.0 112.404 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 p -99.78 -30.28 12.15 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.749 0.819 . . . . 0.0 112.182 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -140.84 147.82 39.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.723 0.809 . . . . 0.0 109.875 -172.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.61 119.99 5.51 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.343 1.057 . . . . 0.0 109.047 169.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.86 114.77 11.36 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.914 0.486 . . . . 0.0 110.902 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.78 -22.19 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.788 1.235 . . . . 0.0 111.833 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.1 -50.2 69.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.471 0.708 . . . . 0.0 110.869 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -94.4 -8.14 39.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.868 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 63.88 44.1 5.01 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.156 1.382 . . . . 0.0 110.645 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.564 HD21 HD11 ' A' ' 210' ' ' LEU . 77.6 mt -136.53 137.93 40.79 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.618 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.502 ' HB ' HG22 ' A' ' 109' ' ' THR . 64.6 mt -120.63 151.96 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.788 1.635 . . . . 0.0 108.009 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 p -152.34 160.28 43.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.558 0.694 . . . . 0.0 112.014 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.78 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 27.4 t80 -129.09 135.6 49.12 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.446 1.499 . . . . 0.0 107.622 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.9 64.97 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 122.919 0.295 . . . . 0.0 113.152 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.14 -177.3 42.92 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.23 -178.21 44.59 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.563 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 76.5 t-105 -81.84 105.01 12.62 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 122.441 -0.446 . . . . 0.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -165.7 113.84 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 107.946 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 229' ' ' THR . 69.5 mt -131.92 -88.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.695 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -172.52 -73.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.94 0.791 . . . . 0.0 110.716 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.07 149.73 47.95 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.64 0.588 . . . . 0.0 113.476 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.28 139.77 20.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.953 0.501 . . . . 0.0 110.009 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -68.89 122.32 18.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.699 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.585 ' HZ2' ' HB3' ' A' ' 151' ' ' LYS . 5.4 ttpm? -105.11 116.5 32.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 166.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.35 150.09 31.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.466 0.707 . . . . 0.0 112.435 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.15 -20.75 31.59 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.499 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.46 136.4 41.37 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.726 0.811 . . . . 0.0 109.896 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 0.0 OUTLIER -73.32 140.22 46.6 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.491 0.662 . . . . 0.0 110.083 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.13 179.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.635 0.774 . . . . 0.0 108.96 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.435 HE22 ' HG3' ' A' ' 171' ' ' GLN . 69.5 mm-40 -121.66 160.7 23.89 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.091 -0.38 . . . . 0.0 110.784 -170.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.6 155.68 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.705 0.802 . . . . 0.0 110.28 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 52.5 mt -107.19 105.9 16.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 164.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.44 104.67 5.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.326 0.65 . . . . 0.0 109.474 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 167' ' ' PRO . 54.8 mt -69.65 104.64 2.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.192 0.52 . . . . 0.0 110.796 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 165' ' ' LYS . 56.7 mm-40 -76.26 141.6 70.58 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.123 -176.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 12.4 Cg_exo -71.89 116.64 4.78 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.906 3.071 . . . . 0.0 112.011 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.35 9.67 58.38 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.577 0.548 . . . . 0.0 113.894 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 162' ' ' GLU . 96.3 mttt -135.91 -177.31 4.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 0.0 110.219 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -88.26 142.96 31.99 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.848 0.859 . . . . 0.0 110.655 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.62 ' HB3' HD23 ' A' ' 161' ' ' LEU . 10.4 Cg_endo -52.86 115.65 2.39 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.515 2.81 . . . . 0.0 112.737 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -69.46 129.96 41.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.602 0.761 . . . . 0.0 109.888 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.597 ' HB1' ' H ' ' A' ' 20' ' ' ALA . . . -71.73 118.79 15.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' A' ' 22' ' ' ILE . 41.0 t -134.68 144.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.727 ' HB2' ' HB2' ' A' ' 21' ' ' GLU . 27.7 tt0 -84.81 163.81 18.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.5 p -136.16 97.11 3.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 54.4 tttp -85.73 129.43 54.73 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 155' ' ' GLU . 84.0 Cg_exo -47.49 125.5 10.91 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.289 2.659 . . . . 0.0 113.714 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.36 178.41 18.13 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.928 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -139.07 128.82 24.75 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -133.75 122.06 22.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 178' ' ' LYS . 5.0 ttpm? -122.39 138.83 54.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.36 1.064 . . . . 0.0 108.843 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 52.0 p -120.67 -178.68 3.78 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.026 0.931 . . . . 0.0 109.271 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -71.21 -19.63 62.36 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.36 0.664 . . . . 0.0 109.932 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.09 -48.92 8.71 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.345 1.058 . . . . 0.0 110.507 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -175.67 160.76 29.25 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.408 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 9.7 t -97.83 139.95 32.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.985 0.914 . . . . 0.0 110.145 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.49 127.73 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.93 111.51 4.0 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -163.57 -172.29 2.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.954 . . . . 0.0 109.946 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.67 100.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 121.807 0.813 . . . . 0.0 111.059 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.7 m -98.86 101.02 12.29 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.14 151.48 40.91 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.62 0.248 . . . . 0.0 110.998 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.93 159.95 32.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.818 0.847 . . . . 0.0 109.069 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.475 ' HA ' ' HD1' ' A' ' 222' ' ' TYR . 34.0 p90 -75.63 121.92 23.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.113 0.959 . . . . 0.0 111.63 -164.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.2 m -137.14 132.12 17.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.28 2.653 . . . . 0.0 113.062 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.43 100.37 0.37 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -173.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 37.3 p -73.59 140.65 46.38 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.294 0.638 . . . . 0.0 111.223 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -53.95 127.01 24.58 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.902 0.881 . . . . 0.0 112.153 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.07 -3.84 35.58 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.772 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.2 m -44.43 119.64 3.64 Favored Pre-proline 0 C--N 1.383 2.043 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.16 115.47 3.0 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.398 2.065 . . . . 0.0 111.517 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.24 106.4 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -98.38 163.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.507 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -98.85 157.65 16.16 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.245 1.418 . . . . 0.0 108.909 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -63.94 -34.27 77.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.5 1.12 . . . . 0.0 111.128 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.25 -20.36 44.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.714 0.406 . . . . 0.0 111.162 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.4 14.44 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.91 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 161.89 30.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.442 0.621 . . . . 0.0 109.843 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 146' ' ' LEU . 2.7 p -94.02 112.12 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.38 -40.39 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 228' ' ' GLN . . . 158.23 -142.83 8.78 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.564 HD11 HD21 ' A' ' 137' ' ' LEU . 70.4 mt -127.99 159.57 34.59 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.658 0.783 . . . . 0.0 110.449 -174.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . 0.481 ' O ' ' SD ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -62.98 107.87 1.09 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 170.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.07 -179.97 6.53 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 124.343 1.027 . . . . 0.0 114.837 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -69.19 86.99 0.4 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.516 1.15 . . . . 0.0 109.633 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.839 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -134.44 -151.23 6.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 113.677 -1.602 . . . . 0.0 111.661 -176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 41' ' ' ILE . 8.8 p -157.28 168.63 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 111.591 -172.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.7 t -85.59 108.54 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.516 HG22 HD12 ' A' ' 41' ' ' ILE . 99.6 m -86.63 144.02 27.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.536 1.134 . . . . 0.0 110.005 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 67.79 10.3 7.69 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.613 1.165 . . . . 0.0 110.305 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' SER . . . . . 0.409 ' HB3' HD21 ' A' ' 43' ' ' ASN . 95.0 p 52.92 30.05 8.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.353 1.461 . . . . 0.0 111.43 -166.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.13 -70.16 0.05 OUTLIER Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.349 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.06 137.88 40.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.338 0.655 . . . . 0.0 111.164 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.475 ' HD1' ' HA ' ' A' ' 191' ' ' PHE . 82.3 m-85 -86.03 102.49 13.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.141 0.496 . . . . 0.0 110.124 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.1 104.64 14.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.601 0.761 . . . . 0.0 108.972 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.669 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 63.4 m -132.04 162.48 30.67 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.306 1.042 . . . . 0.0 109.959 -171.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -58.65 162.72 3.71 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.006 162.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.58 103.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.343 -0.848 . . . . 0.0 109.023 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.403 ' HB3' HD11 ' A' ' 137' ' ' LEU . . . -78.91 136.58 37.31 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.47 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 8.8 pt20 -129.06 167.72 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.208 0.603 . . . . 0.0 109.494 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.563 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 1.6 p -82.72 110.69 17.99 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -72.01 -13.78 61.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.768 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.358 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 109.214 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.636 ' HG2' HD11 ' A' ' 91' ' ' ILE . 17.2 tppt? . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 . . . . . 0 N--CA 1.48 1.064 0 C-N-CA 124.872 1.269 . . . . 0.0 108.361 -165.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.706 ' HB1' HD23 ' A' ' 6' ' ' LEU . . . . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.35 21.12 4.0 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.522 0.729 . . . . 0.0 111.143 -167.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -142.33 49.76 1.52 Allowed 'General case' 0 C--O 1.254 1.307 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.706 HD23 ' HB1' ' A' ' 3' ' ' ALA . 34.6 mt -96.59 94.13 7.16 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.98 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 120' ' ' MET . 6.9 tm-20 -107.55 129.34 54.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.35 0.66 . . . . 0.0 111.095 -170.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.5 mp -94.78 137.16 34.22 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 34.3 tt0 -132.3 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.694 -0.629 . . . . 0.0 109.673 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.602 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 6.7 ptp180 -67.09 153.78 42.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.64 0.733 . . . . 0.0 112.454 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.31 -36.04 3.02 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.696 166.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.16 -162.39 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.52 156.81 25.08 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.647 0.779 . . . . 0.0 109.028 168.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.06 96.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.604 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 164.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -166.84 136.84 3.06 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -167.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.424 ' H ' ' HA2' ' A' ' 205' ' ' GLY . 63.7 t90 -66.69 120.16 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.748 0.655 . . . . 0.0 109.829 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -87.69 143.91 26.92 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.2 -6.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.808 1.243 . . . . 0.0 112.784 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.29 50.28 0.5 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.49 1.516 . . . . 0.0 111.709 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -65.72 100.47 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.543 0.737 . . . . 0.0 110.906 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.69 102.55 15.09 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.774 0.83 . . . . 0.0 110.246 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.59 100.91 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -153.4 144.08 22.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.54 1.536 . . . . 0.0 107.631 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.67 ' HA2' ' H ' ' A' ' 190' ' ' ASP . . . 109.46 -138.09 14.59 Favored Glycine 0 CA--C 1.503 -0.716 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.311 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m 58.82 26.79 15.22 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.413 0.685 . . . . 0.0 110.37 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 t -66.21 143.06 98.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.602 1.161 . . . . 0.0 111.039 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 175.68 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.91 2.407 . . . . 0.0 113.49 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.37 131.52 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.851 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.0 mt -109.1 160.16 16.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.852 0.861 . . . . 0.0 109.936 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 t -122.9 115.4 21.89 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.538 HG23 ' HE3' ' A' ' 39' ' ' MET . 30.0 mt -121.3 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.007 0.923 . . . . 0.0 109.337 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.3 p -92.96 111.9 23.68 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.34 132.45 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.935 0.894 . . . . 0.0 108.773 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -138.37 146.4 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.82 0.448 . . . . 0.0 110.341 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 52.85 32.63 12.74 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.237 1.015 . . . . 0.0 111.898 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.254 3.2 p30 52.54 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 126.975 2.11 . . . . 0.0 114.135 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.46 -10.45 66.6 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -106.55 160.55 15.34 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.186 0.993 . . . . 0.0 110.06 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.538 ' HE3' HG23 ' A' ' 31' ' ' ILE . 4.5 ppp? -161.62 133.88 5.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.757 ' HA ' HG13 ' A' ' 215' ' ' VAL . 15.1 p -166.33 174.97 8.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.331 0.652 . . . . 0.0 110.161 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 217' ' ' THR . 1.8 mp -89.22 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.71 73.33 1.08 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.41 0.624 . . . . 0.0 109.549 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -143.7 -179.44 6.45 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.59 1.156 . . . . 0.0 109.274 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.51 96.6 8.65 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 123.548 0.739 . . . . 0.0 110.187 175.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.332 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.069 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 73.0 mt 74.76 -172.62 0.11 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 125.001 1.32 . . . . 0.0 111.861 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -165.24 106.21 0.78 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.602 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t70 178.66 73.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.063 0.945 . . . . 0.0 112.441 151.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 165.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.664 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 27.2 t70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.34 -178.04 39.09 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.89 110.75 18.16 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 124.355 1.062 . . . . 0.0 108.786 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -99.54 140.66 33.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.39 122.7 28.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.2 pt -107.63 135.44 46.23 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.62 -166.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 79.5 tttt -124.06 137.47 54.57 Favored 'General case' 0 C--N 1.379 1.851 0 O-C-N 125.041 1.463 . . . . 0.0 112.64 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -108.66 147.76 31.42 Favored 'General case' 0 C--O 1.252 1.195 0 C-N-CA 125.388 1.475 . . . . 0.0 109.001 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -59.53 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 158.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' H ' ' HA ' ' A' ' 94' ' ' TYR . . . -59.5 154.41 30.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 124.4 1.063 . . . . 0.0 115.44 -145.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.74 -34.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.842 1.257 . . . . 0.0 110.221 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.5 mt -126.23 23.62 7.0 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.032 0.933 . . . . 0.0 111.301 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.24 -97.77 0.17 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 122.199 -0.313 . . . . 0.0 112.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.539 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 61.5 m-85 -145.06 116.21 7.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.206 1.402 . . . . 0.0 108.186 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -129.26 101.31 5.94 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -167.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 4.0 pm0 -94.24 104.19 16.2 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' H ' ' B' ' 253' ' ' LYS . 1.4 pp -137.77 -37.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -154.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . -121.56 -159.5 10.7 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.312 -1.423 . . . . 0.0 114.265 -163.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.471 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -133.36 125.29 28.83 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 174.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.13 110.82 2.36 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 108' ' ' HIS . 17.7 m -105.58 102.82 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.664 ' HD2' ' HA ' ' A' ' 81' ' ' ASP . 80.2 t80 -94.06 119.95 33.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -140.06 124.53 18.01 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.891 0.876 . . . . 0.0 108.703 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 50.13 55.58 9.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.407 1.483 . . . . 0.0 112.366 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.2 15.64 79.98 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.054 -0.975 . . . . 0.0 114.219 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 m -135.62 115.39 12.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.402 0.601 . . . . 0.0 111.332 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -85.26 112.21 20.55 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.666 ' HB2' HG22 ' A' ' 101' ' ' VAL . 58.4 m80 -98.91 110.38 23.0 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.867 1.354 . . . . 0.0 110.207 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.562 HG22 ' HB ' ' A' ' 138' ' ' ILE . 15.3 t -139.97 -159.35 0.95 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.86 0.464 . . . . 0.0 110.489 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.609 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 23.2 ttm -156.55 160.73 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -157.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -80.73 -35.34 33.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 3.2 p-80 -75.6 -23.6 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.65 ' HB ' ' HZ2' ' B' ' 253' ' ' LYS . 5.8 m -81.06 -10.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.609 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.4 m 165.58 144.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 127.113 2.165 . . . . 0.0 107.914 160.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -83.04 34.81 0.46 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.726 1.21 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.21 54.68 1.25 Allowed Glycine 0 C--N 1.347 1.173 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 3' ' ' ALA . . . -106.15 -174.48 2.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.208 0.603 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -116.14 134.68 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.43 0.634 . . . . 0.0 112.66 -163.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.692 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 mm? -90.97 179.28 5.79 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.392 1.477 . . . . 0.0 111.637 -167.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.3 ptp -175.69 163.23 2.84 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 123.088 1.423 . . . . 0.0 114.632 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.594 ' HB2' HG23 ' A' ' 68' ' ' VAL . 70.3 t60 -109.75 105.39 14.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 111.535 -2.575 . . . . 0.0 105.485 155.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.461 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 53.9 pttt -41.14 116.14 0.69 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 125.408 1.483 . . . . 0.0 113.211 -156.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.72 -7.51 55.61 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.048 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -138.58 113.1 8.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.319 1.448 . . . . 0.0 107.196 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -106.63 128.66 54.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.381 0.537 . . . . 0.0 111.636 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.51 129.85 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.007 1.323 . . . . 0.0 109.803 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 118' ' ' VAL . 32.0 mt-10 -91.46 151.7 42.9 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.144 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.93 -178.56 3.59 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.084 2.523 . . . . 0.0 112.586 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 19.4 p -126.36 -21.53 4.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.879 0.472 . . . . 0.0 112.195 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.421 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 21.8 t-105 -140.2 146.53 38.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.438 0.695 . . . . 0.0 110.065 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.51 120.83 3.64 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.37 1.044 . . . . 0.0 109.215 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.68 128.64 39.42 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.3 0.571 . . . . 0.0 110.039 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.96 -36.15 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.083 -166.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.35 -35.41 71.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.495 0.718 . . . . 0.0 112.376 -167.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.18 -7.39 56.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.974 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 110' ' ' MET . 22.2 t70 65.75 47.35 2.13 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.227 0.955 . . . . 0.0 109.022 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 53.5 mt -144.66 139.96 28.35 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.562 ' HB ' HG22 ' A' ' 109' ' ' THR . 60.8 mt -132.61 142.78 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 125.506 1.522 . . . . 0.0 108.558 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.441 ' HB3' ' CE3' ' A' ' 144' ' ' TRP . 74.6 p -139.1 159.54 41.9 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 118.813 0.733 . . . . 0.0 112.259 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.433 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 20.7 t80 -129.91 146.78 51.63 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.815 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.69 4.43 54.63 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.37 -162.53 28.44 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.7 173.05 31.13 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 168.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.45 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 66.6 t-105 -63.8 129.26 39.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.7 0.75 . . . . 0.0 109.408 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -164.74 176.51 8.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.923 0.489 . . . . 0.0 111.709 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.451 HD12 ' HE1' ' A' ' 108' ' ' HIS . 3.3 tm? 67.72 97.6 0.06 Allowed 'General case' 0 C--N 1.358 0.97 0 O-C-N 125.013 1.446 . . . . 0.0 111.74 169.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.685 ' HG3' ' HA2' ' A' ' 209' ' ' GLY . 7.1 mm-40 160.1 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.105 2.562 . . . . 0.0 107.336 154.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.16 85.16 0.49 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.662 ' HG2' ' HB2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -75.84 163.77 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -156.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -55.81 142.0 36.58 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 111.611 -2.54 . . . . 0.0 112.035 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -131.75 153.8 49.7 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.24 104.51 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.381 1.072 . . . . 0.0 113.374 -166.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.84 -43.56 0.64 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.485 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -78.38 167.92 20.6 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.524 0.73 . . . . 0.0 112.757 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.14 174.33 7.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.803 0.841 . . . . 0.0 110.576 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 155.87 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 0.0 109.471 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 40.3 mt-30 -126.81 128.72 47.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 200' ' ' ILE . 91.0 t -93.02 110.07 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.472 0.709 . . . . 0.0 109.718 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 199' ' ' PRO . 1.3 tm? -77.21 76.13 3.76 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.21 124.53 31.29 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.444 -171.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.02 120.59 15.12 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 123.662 0.601 . . . . 0.0 109.823 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.94 107.8 30.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.64 115.47 2.48 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.923 2.415 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.57 -16.83 60.45 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.596 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -124.2 -171.69 2.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.454 0.702 . . . . 0.0 110.252 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.86 139.25 57.6 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.345 0.658 . . . . 0.0 109.893 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.73 129.14 28.85 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.814 3.01 . . . . 0.0 113.463 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -97.0 125.54 41.51 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 109.496 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -85.37 104.07 14.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.128 0.571 . . . . 0.0 109.863 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 68.5 t -87.96 109.68 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.541 1.136 . . . . 0.0 110.387 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.495 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 7.9 tt0 -80.1 125.88 30.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 109.952 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 t -151.35 151.24 31.48 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 110.676 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.88 156.45 42.52 Favored Pre-proline 0 C--O 1.244 0.778 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.443 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 172.26 13.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.9 2.4 . . . . 0.0 112.941 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.03 -174.46 28.76 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.981 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 144.76 26.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.1 0.45 . . . . 0.0 110.519 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 183' ' ' THR . 5.9 m-85 -97.4 119.39 35.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 183' ' ' THR . 62.7 tttp -99.12 98.74 9.71 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 109.424 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 180' ' ' ASN . 2.0 m -95.51 -178.37 4.39 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.524 ' H ' HG23 ' A' ' 179' ' ' THR . 7.8 p30 -61.34 -25.31 67.06 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.8 -38.13 0.36 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.429 0.691 . . . . 0.0 110.719 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.45 118.7 5.28 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.587 -0.279 . . . . 0.0 112.506 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.616 HG21 ' HA ' ' A' ' 178' ' ' LYS . 22.6 p -119.01 111.96 18.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.47 135.34 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.78 111.27 4.11 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 225' ' ' ALA . . . -143.77 -161.02 1.19 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.4 0.68 . . . . 0.0 110.424 -167.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.51 108.89 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.475 0.655 . . . . 0.0 109.454 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.614 ' HA ' HG11 ' A' ' 223' ' ' VAL . 10.0 t -80.71 112.48 18.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.837 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 191' ' ' PHE . 1.4 tt -130.22 132.34 45.95 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.899 0.38 . . . . 0.0 110.566 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.67 ' H ' ' HA2' ' A' ' 24' ' ' GLY . 10.4 m-20 -96.55 104.92 16.94 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.6 ' HB2' HD21 ' A' ' 189' ' ' LEU . 31.7 t80 -153.5 163.45 39.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.5 p -58.04 151.31 46.06 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.429 167.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . 0.472 ' HA ' ' HB2' ' A' ' 222' ' ' TYR . 84.0 Cg_exo -46.92 95.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.84 2.36 . . . . 0.0 113.691 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.61 179.25 12.92 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.556 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.449 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 71.0 p -115.19 145.93 41.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.354 0.597 . . . . 0.0 112.46 -169.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.618 ' HB3' HG13 ' A' ' 113' ' ' VAL . 62.8 m -67.91 99.1 0.8 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.296 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 132.86 3.83 3.53 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.054 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 71.4 m -55.1 122.64 43.62 Favored Pre-proline 0 C--N 1.368 1.397 0 C-N-CA 123.3 0.64 . . . . 0.0 111.3 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 210' ' ' LEU . 83.8 Cg_endo -78.43 144.66 20.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.979 2.453 . . . . 0.0 113.403 -174.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' A' ' 208' ' ' VAL . 8.2 pt -111.3 110.37 31.94 Favored 'Isoleucine or valine' 0 C--O 1.268 2.047 0 CA-C-O 123.105 1.431 . . . . 0.0 109.347 171.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 159' ' ' LEU . 13.7 pt -130.94 161.34 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 112.339 -2.209 . . . . 0.0 109.663 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 207' ' ' VAL . 23.6 t70 -90.82 -178.69 5.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.532 0.733 . . . . 0.0 109.585 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -58.87 -18.88 36.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . 0.441 ' HE3' ' HD2' ' A' ' 206' ' ' LYS . 62.4 tttp -71.01 -13.44 62.0 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.579 1.151 . . . . 0.0 111.365 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 16' ' ' TRP . . . 86.25 9.41 76.45 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 123.359 0.504 . . . . 0.0 112.92 -176.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.441 ' HD2' ' HE3' ' A' ' 204' ' ' LYS . 18.1 ptpt -157.81 151.89 24.35 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.255 1.022 . . . . 0.0 109.51 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.572 HG11 HG22 ' A' ' 208' ' ' VAL 0.25 7.9 p -178.11 -71.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 O-C-N 124.613 1.196 . . . . 0.0 108.489 161.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 200' ' ' ILE . 2.1 t -90.6 -44.69 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 120.494 1.497 . . . . 0.0 111.253 -162.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.685 ' HA2' ' HG3' ' A' ' 147' ' ' GLU . . . 127.47 -98.17 0.49 Allowed Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 113.514 -1.676 . . . . 0.0 110.824 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 199' ' ' PRO . 2.0 pt? -146.27 172.52 13.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.281 0.562 . . . . 0.0 110.669 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . 0.736 ' HB2' ' HB3' ' A' ' 224' ' ' SER . 0.0 OUTLIER -74.88 142.28 44.09 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.576 ' HA2' ' HE3' ' A' ' 110' ' ' MET . . . -82.35 -145.16 5.29 Favored Glycine 0 C--N 1.343 0.972 0 C-N-CA 123.03 0.347 . . . . 0.0 112.251 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -78.54 86.44 4.55 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.462 0.649 . . . . 0.0 109.751 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.79 -174.72 19.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.866 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.757 HG13 ' HA ' ' A' ' 40' ' ' SER . 10.5 p -168.63 168.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.874 0.469 . . . . 0.0 110.116 -168.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.417 HG13 ' HD1' ' A' ' 222' ' ' TYR . 6.6 m -69.66 115.25 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 165.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.645 ' HA ' HD12 ' A' ' 41' ' ' ILE . 5.2 t -79.27 168.99 18.79 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.553 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -51.73 137.42 25.56 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 124.389 1.056 . . . . 0.0 110.52 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.9 m 86.07 -4.36 0.78 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.712 2.005 . . . . 0.0 111.139 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.39 29.53 36.33 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.103 0.382 . . . . 0.0 113.233 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -95.85 115.28 27.19 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 193' ' ' PRO . 23.0 t80 -74.22 101.08 3.88 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.678 0.752 . . . . 0.0 109.925 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 188' ' ' SER . 91.9 t -94.97 152.52 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.492 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 211' ' ' TYR . 69.9 m -130.1 135.03 47.78 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 186' ' ' ALA . . . -73.29 163.89 27.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.645 HG22 HG13 ' A' ' 208' ' ' VAL . 43.5 mt -98.18 106.04 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.806 0.443 . . . . 0.0 110.536 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -99.36 108.49 21.01 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 121.794 0.807 . . . . 0.0 108.903 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.662 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 11.0 pt20 -95.25 167.39 11.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.945 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.45 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 3.9 p -117.3 126.86 53.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.01 1.98 17.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.416 1.086 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 124.374 1.07 . . . . 0.0 111.181 -167.906 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.65 ' HZ2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.34 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 . . . . . 0 CA--C 1.561 1.381 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 155.664 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.583 0.23 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.23 42.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -172.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.463 ' H ' HD13 ' A' ' 6' ' ' LEU . 5.9 m-20 -145.75 28.11 1.17 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.351 1.06 . . . . 0.0 111.474 -171.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.463 HD13 ' H ' ' A' ' 5' ' ' ASP . 1.6 mp -114.92 99.8 7.74 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.925 0.784 . . . . 0.0 111.289 -167.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 120' ' ' MET . 36.1 mp0 -106.95 142.92 35.8 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.207 0.527 . . . . 0.0 112.056 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -116.04 166.56 11.86 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.954 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 33.3 tt0 -155.13 137.51 14.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.298 1.439 . . . . 0.0 108.892 -171.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' ' HD1' ' A' ' 84' ' ' TYR . 35.7 ttt-85 -72.58 125.61 27.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.544 0.611 . . . . 0.0 110.711 -172.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -86.72 -56.42 3.41 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.26 -161.68 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.912 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -96.09 156.76 16.2 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.828 1.251 . . . . 0.0 107.682 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.69 97.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -172.61 132.92 0.59 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.572 0.749 . . . . 0.0 109.783 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.6 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 78.8 t90 -87.58 93.7 9.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.9 0.48 . . . . 0.0 110.964 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.98 58.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.035 0.534 . . . . 0.0 110.302 161.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.98 -55.86 3.45 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.652 0.381 . . . . 0.0 111.403 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.02 21.14 1.25 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.63 -168.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.24 72.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 127.137 2.175 . . . . 0.0 114.84 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.69 145.25 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.113 0.965 . . . . 0.0 110.332 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.82 143.34 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 124.08 0.952 . . . . 0.0 109.159 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -152.0 -165.56 2.26 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.251 1.02 . . . . 0.0 110.805 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.54 121.64 2.3 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -75.99 -80.22 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.983 0.513 . . . . 0.0 111.582 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.6 t -140.59 145.03 38.72 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.286 0.635 . . . . 0.0 109.887 -166.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.59 -39.57 11.87 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.731 2.287 . . . . 0.0 112.158 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.47 124.44 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.231 0.612 . . . . 0.0 109.703 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.749 HD23 ' HB2' ' A' ' 218' ' ' ARG . 3.8 tt -143.68 119.59 10.62 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.3 p -78.03 127.96 33.12 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.19 0.996 . . . . 0.0 112.085 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.7 167.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.431 1.492 . . . . 0.0 107.277 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -99.18 126.27 44.93 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.954 1.252 . . . . 0.0 110.24 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -70.26 129.75 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.0 t -136.18 135.51 39.21 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.44 7.07 6.08 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.677 1.191 . . . . 0.0 111.782 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 57.35 27.21 13.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.834 1.254 . . . . 0.0 112.775 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.45 -29.83 0.03 OUTLIER Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.875 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -106.79 165.87 11.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.269 0.627 . . . . 0.0 110.12 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.2 ptm -140.54 130.75 24.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.402 0.681 . . . . 0.0 109.267 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 p -164.78 178.29 7.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.776 HD13 HG22 ' A' ' 217' ' ' THR . 10.5 tp -86.55 152.35 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.6 126.51 27.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.5 t30 70.9 99.59 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.269 1.428 . . . . 0.0 110.476 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.71 131.37 53.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.546 0.738 . . . . 0.0 109.231 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 123.556 0.742 . . . . 0.0 110.126 178.314 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.537 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 2.3 t . . . . . 0 CA--C 1.565 1.54 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 42.1 mt -147.55 163.91 35.09 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 123.725 0.81 . . . . 0.0 111.9 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -132.08 94.0 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.487 ' HB2' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER 171.71 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 126.565 1.946 . . . . 0.0 109.645 158.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 121' ' ' HIS . 29.4 m . . . . . 0 N--CA 1.501 2.078 0 CA-C-N 119.339 0.972 . . . . 0.0 111.955 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.393 0 CA-C-O 122.311 1.053 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.39 -153.59 24.65 Favored Glycine 0 C--O 1.254 1.381 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.281 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.99 44.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.429 1.092 . . . . 0.0 108.894 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 8.7 m-85 -122.18 138.92 54.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.352 0.261 . . . . 0.0 110.69 -171.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.637 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 43.5 mtm180 -73.34 122.67 22.4 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 165.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.772 HG13 HG21 ' A' ' 97' ' ' ILE . 24.5 pt -120.69 146.95 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.639 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 51.6 tttm -152.32 141.51 21.39 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 126.388 1.875 . . . . 0.0 110.984 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.601 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 44.8 tt0 -123.09 150.91 42.56 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.918 -0.489 . . . . 0.0 111.713 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 16.6 ttpp -101.96 84.53 2.54 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.81 176.17 44.34 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.235 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' B' ' 253' ' ' LYS . 49.0 mt 59.17 -83.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.342 1.457 . . . . 0.0 111.604 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -113.13 -30.83 6.84 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.545 0.738 . . . . 0.0 110.205 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.87 -173.82 38.29 Favored Glycine 0 C--N 1.349 1.254 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.673 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 1.8 m-30 -105.98 72.12 0.93 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.748 ' HB3' ' HE3' ' B' ' 253' ' ' LYS . 37.1 t -135.39 155.61 50.29 Favored 'General case' 0 C--O 1.265 1.875 0 CA-C-O 121.92 0.866 . . . . 0.0 112.737 -163.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.454 ' NE2' ' HD2' ' A' ' 87' ' ' LYS . 22.8 mp0 -75.3 149.63 38.71 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.062 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.772 HG21 HG13 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -136.73 -43.15 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -167.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.699 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . 169.32 -124.17 1.14 Allowed Glycine 0 N--CA 1.481 1.672 0 C-N-CA 116.604 -2.712 . . . . 0.0 118.019 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -128.58 126.47 40.36 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -165.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.16 149.97 18.83 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 164.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.86 116.41 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.064 0.932 . . . . 0.0 109.93 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.541 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 50.8 t80 -133.09 138.35 46.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -161.65 151.23 16.47 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 124.008 0.818 . . . . 0.0 109.135 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 65.08 -77.66 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.462 1.505 . . . . 0.0 110.652 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.57 19.88 0.15 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t -123.48 116.73 23.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.507 0.723 . . . . 0.0 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.541 ' HD2' ' HB2' ' A' ' 102' ' ' TYR . 59.9 t80 -97.53 102.91 14.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 137' ' ' LEU . 2.3 t60 -121.24 126.21 49.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -135.47 -174.26 3.58 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 108.507 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.449 ' HA ' HD23 ' A' ' 137' ' ' LEU . 82.4 mmm -79.8 160.01 26.31 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.027 0.531 . . . . 0.0 111.535 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -84.08 -46.08 12.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.019 170.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -59.29 -19.15 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.95 0.9 . . . . 0.0 113.351 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 196' ' ' SER . 24.9 m -65.02 -14.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.439 0.696 . . . . 0.0 112.107 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -151.28 -162.14 1.48 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.604 1.162 . . . . 0.0 109.365 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 -133.47 21.03 3.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 114' ' ' THR . . . 103.4 54.63 0.83 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.87 -176.71 3.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.771 0.828 . . . . 0.0 111.429 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.555 HG22 ' HE ' ' A' ' 125' ' ' ARG . 3.0 p -90.75 178.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 118' ' ' VAL . 20.9 mt -124.52 166.01 16.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.528 . . . . 0.0 111.183 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -164.82 174.84 10.2 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . 0.468 ' HB2' HG11 ' A' ' 68' ' ' VAL . 15.8 t60 -137.54 97.53 3.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.514 1.926 . . . . 0.0 106.795 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.436 ' N ' ' HG2' ' A' ' 7' ' ' GLU . 9.0 mtmp? 8.91 75.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.282 1.833 . . . . 0.0 114.064 -159.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.32 -27.49 19.72 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 115.108 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -82.91 112.43 19.69 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.565 1.183 . . . . 0.0 109.939 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.555 ' HE ' HG22 ' A' ' 118' ' ' VAL . 75.0 ttt180 -106.4 134.44 49.53 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.514 0.725 . . . . 0.0 112.029 -164.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.62 142.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.142 1.377 . . . . 0.0 109.138 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.71 144.1 27.54 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 122.95 0.5 . . . . 0.0 112.067 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 140' ' ' TYR . 22.6 Cg_exo -68.61 138.27 41.26 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.662 2.241 . . . . 0.0 111.562 165.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 p -88.85 -7.43 56.16 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 5.1 t-105 -151.24 148.14 27.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.353 0.661 . . . . 0.0 110.151 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.63 124.21 11.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.923 0.889 . . . . 0.0 109.438 171.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.22 117.79 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.623 0.769 . . . . 0.0 110.727 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -27.73 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.78 0.832 . . . . 0.0 111.492 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -62.69 -56.66 15.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.61 0.764 . . . . 0.0 111.128 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.673 ' HB2' ' HZ1' ' A' ' 135' ' ' LYS . 3.3 ttmp? -97.34 1.09 49.03 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.513 0.725 . . . . 0.0 109.895 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 61.41 54.34 3.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.627 1.571 . . . . 0.0 111.686 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.524 ' HB3' ' NE2' ' A' ' 108' ' ' HIS . 36.6 mt -144.31 145.8 32.21 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.393 0.616 . . . . 0.0 112.456 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mt -120.84 143.8 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.841 1.657 . . . . 0.0 110.253 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 2.2 m -120.32 158.19 27.62 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.228 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 3.4 t80 -151.41 135.66 16.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.846 1.258 . . . . 0.0 107.881 172.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.26 9.53 56.8 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.26 -172.6 27.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.13 -179.84 49.29 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -75.37 123.19 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.503 0.721 . . . . 0.0 110.342 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -164.01 147.22 9.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.238 1.415 . . . . 0.0 107.568 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.52 -142.06 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 O-C-N 124.314 1.009 . . . . 0.0 108.716 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 64.55 37.21 8.09 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.743 1.617 . . . . 0.0 111.353 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.84 168.08 0.96 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.786 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 150' ' ' TRP . 25.3 tt0 -143.86 129.97 19.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.236 0.614 . . . . 0.0 109.888 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.525 ' HH2' HG21 ' A' ' 226' ' ' ILE . 1.5 p90 -65.28 150.61 47.94 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.677 0.791 . . . . 0.0 110.166 164.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.69 148.82 26.2 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.765 1.226 . . . . 0.0 111.705 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 155.66 -18.7 0.5 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.494 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.414 ' HB2' ' HD1' ' A' ' 150' ' ' TRP . 32.9 mt-10 -96.6 152.67 18.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.879 0.872 . . . . 0.0 109.311 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.75 114.03 25.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.2 p -97.01 164.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 120.754 0.312 . . . . 0.0 111.143 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 171' ' ' GLN . 22.3 mp0 -105.91 147.68 28.48 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.931 0.892 . . . . 0.0 109.169 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.04 143.07 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.901 0.48 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.41 93.72 8.74 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 171.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.33 100.62 10.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.89 97.79 1.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -57.66 133.04 82.51 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.239 0.616 . . . . 0.0 111.645 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.83 113.15 1.51 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.506 2.137 . . . . 0.0 112.49 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.43 64.69 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.056 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 166' ' ' ASN . 81.4 tttt -151.84 177.27 10.59 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 117.351 0.575 . . . . 0.0 110.045 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 165' ' ' LYS . 1.8 p-10 -57.72 160.51 7.78 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 112.343 170.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.89 141.1 88.6 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.97 2.447 . . . . 0.0 112.378 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -112.37 116.03 29.68 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -96.37 108.14 20.62 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.182 0.593 . . . . 0.0 109.561 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.68 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.536 0.734 . . . . 0.0 110.082 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 157' ' ' GLN . 30.5 tt0 -87.8 149.85 23.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.864 0.866 . . . . 0.0 109.173 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.5 t -154.66 147.97 24.98 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.765 0.826 . . . . 0.0 110.744 -172.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -75.61 158.39 83.18 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.08 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.17 146.1 93.95 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.203 1.935 . . . . 0.0 112.821 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -145.7 130.87 3.93 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-O 122.114 0.841 . . . . 0.0 114.515 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.453 ' HA ' ' HA3' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -127.24 149.71 49.88 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.345 -1.091 . . . . 0.0 112.564 -171.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.11 123.25 35.32 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.682 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -89.13 106.21 18.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.5 m -82.81 158.01 22.94 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.655 0.782 . . . . 0.0 110.756 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -82.85 57.32 3.79 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.053 0.93 . . . . 0.0 108.535 168.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -175.43 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.009 1.724 . . . . 0.0 108.003 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -153.31 -131.0 1.55 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.718 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 t -162.1 131.72 4.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.583 0.753 . . . . 0.0 109.751 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.45 138.1 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.44 0.696 . . . . 0.0 109.44 175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.82 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 138.42 161.96 9.01 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.886 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -176.35 42.29 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.316 0 O-C-N 124.655 0.856 . . . . 0.0 110.382 170.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 9.5 p -166.46 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 120.232 -1.543 . . . . 0.0 109.73 166.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.7 m -129.76 106.19 8.53 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.542 0.737 . . . . 0.0 109.54 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 191' ' ' PHE . 3.8 pp -131.88 159.15 39.45 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.924 0.49 . . . . 0.0 111.436 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.8 103.2 15.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.459 0.704 . . . . 0.0 110.333 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.533 ' HD2' HD13 ' A' ' 189' ' ' LEU . 17.7 m-85 -157.72 -175.74 5.54 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 108.455 172.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -44.07 139.91 2.94 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.549 1.14 . . . . 0.0 110.769 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.22 116.48 2.27 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.484 2.122 . . . . 0.0 111.204 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.74 111.87 1.63 Allowed Glycine 0 C--N 1.349 1.29 0 O-C-N 124.153 0.908 . . . . 0.0 112.194 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' THR . . . . . 0.699 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 25.2 p -50.66 124.26 10.56 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.004 1.322 . . . . 0.0 111.129 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . 0.579 ' HB3' HG13 ' A' ' 113' ' ' VAL . 36.1 m -55.65 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.563 0 O-C-N 123.901 0.751 . . . . 0.0 110.071 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 110' ' ' MET . . . 127.87 4.96 5.48 Favored Glycine 0 C--N 1.366 2.226 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.4 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 67.1 m -49.67 129.67 19.89 Favored Pre-proline 0 N--CA 1.5 2.041 0 C-N-CA 124.462 1.105 . . . . 0.0 113.456 -171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.39 133.84 6.46 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 113.223 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.424 HG21 ' CZ3' ' A' ' 150' ' ' TRP . 50.3 mt -105.81 110.97 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.801 1.241 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 208' ' ' VAL . 12.8 pt -131.8 -175.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.803 1.241 . . . . 0.0 112.432 -168.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 36.3 t70 -114.98 175.98 5.26 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.139 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . 0.6 ' HB3' ' HE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -60.54 -30.45 69.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.967 0.507 . . . . 0.0 112.053 172.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -84.98 -0.77 55.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.731 0.413 . . . . 0.0 111.963 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.56 23.85 77.52 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.921 -0.471 . . . . 0.0 111.921 -168.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 64.5 tttp -76.31 165.1 25.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.729 1.211 . . . . 0.0 109.605 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 208' ' ' VAL . 94.4 t 81.99 -89.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.959 1.304 . . . . 0.0 108.048 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 201' ' ' ILE 0.28 3.1 m 68.21 31.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 125.08 1.352 . . . . 0.0 110.187 175.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 207' ' ' VAL . . . -72.43 -174.22 23.83 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.87 168.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.3 154.53 50.06 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.349 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.0 OUTLIER -68.37 116.16 8.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 225' ' ' ALA . . . -71.61 -162.68 5.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.688 -0.292 . . . . 0.0 113.733 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -71.63 84.12 0.87 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.852 0.834 . . . . 0.0 109.523 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -127.15 -174.62 13.84 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.219 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.407 HG13 ' HG1' ' A' ' 217' ' ' THR . 7.2 p -160.12 176.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.323 0.649 . . . . 0.0 109.277 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.7 115.15 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.776 HG22 HD13 ' A' ' 41' ' ' ILE . 14.8 m -129.6 158.77 38.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.68 1.192 . . . . 0.0 109.783 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.749 ' HB2' HD23 ' A' ' 29' ' ' LEU . 4.1 tmm_? 63.65 76.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.647 1.179 . . . . 0.0 110.581 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 59.2 p 49.12 23.07 0.7 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.865 1.666 . . . . 0.0 114.577 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.05 0.67 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 113.794 0.278 . . . . 0.0 113.794 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.83 152.11 50.52 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.782 0.833 . . . . 0.0 109.065 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -83.36 118.84 23.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.676 0.39 . . . . 0.0 110.428 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 t -134.39 116.65 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.168 0.587 . . . . 0.0 109.577 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.417 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 45.7 t -130.88 156.76 44.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.82 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -101.8 93.26 5.22 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.171 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.525 HG21 ' HH2' ' A' ' 150' ' ' TRP . 22.9 pt -53.05 141.55 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -161.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . 0.518 ' HB1' HD13 ' A' ' 137' ' ' LEU . . . -91.35 138.34 31.66 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.68 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.91 171.56 13.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.6 t -67.46 149.07 50.7 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.066 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -13.64 6.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.136 155.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--N 1.38 1.914 0 C-N-CA 126.03 1.732 . . . . 0.0 112.821 -176.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.748 ' HE3' ' HB3' ' A' ' 95' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -164.543 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . 65.12 26.62 12.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.778 1.231 . . . . 0.0 110.876 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 89' ' ' LYS . 8.5 m-20 -155.19 40.04 0.42 Allowed 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.405 1.482 . . . . 0.0 107.166 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 119' ' ' LEU . 90.2 mt -79.91 92.86 5.58 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.542 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 120' ' ' MET . 21.1 mt-10 -98.61 126.84 44.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.448 1.099 . . . . 0.0 110.177 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.489 HD21 ' CD2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -117.42 162.75 17.44 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.934 -1.104 . . . . 0.0 113.67 -177.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 9.3 pt-20 -148.35 161.36 41.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.443 1.097 . . . . 0.0 110.269 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.654 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 12.7 tpt180 -66.98 153.28 44.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.647 0.779 . . . . 0.0 111.43 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.7 -52.39 1.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.906 0.883 . . . . 0.0 109.915 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.26 -166.66 0.55 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 108.88 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 36.7 t70 -95.82 153.09 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.584 HG21 ' HA2' ' A' ' 82' ' ' GLY . 5.1 t -73.28 99.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -162.44 149.12 13.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -168.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.62 112.05 5.16 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 166.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.15 144.2 42.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.037 0.535 . . . . 0.0 109.827 -178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.28 -19.43 64.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 48.99 1.67 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.833 0.825 . . . . 0.0 109.605 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.719 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -162.03 83.57 0.58 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 165.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.58 ' HB ' ' H ' ' A' ' 171' ' ' GLN . 29.4 mm -149.69 163.28 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 p -162.79 101.63 1.02 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.297 1.439 . . . . 0.0 108.077 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.34 -107.14 1.47 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.038 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 11.6 t 63.64 41.71 6.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.958 0.903 . . . . 0.0 109.927 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.6 m -64.65 146.0 98.5 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.16 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -54.12 178.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.917 3.078 . . . . 0.0 114.992 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.69 108.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -93.0 158.37 15.83 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.757 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 118.27 36.14 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.62 -0.675 . . . . 0.0 110.574 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 223' ' ' VAL . 40.9 mt -126.21 150.94 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.895 0.878 . . . . 0.0 108.997 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.9 p -98.42 113.11 24.97 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.407 HD12 ' HG2' ' A' ' 39' ' ' MET . 7.1 tp -65.22 159.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.156 0.583 . . . . 0.0 110.346 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -135.59 120.14 18.17 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 123.525 0.73 . . . . 0.0 109.422 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 67.8 -74.56 0.07 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 125.221 1.576 . . . . 0.0 110.876 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -158.64 -57.9 0.07 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.69 0.796 . . . . 0.0 109.309 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.78 -11.3 33.02 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.232 -0.894 . . . . 0.0 114.238 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -92.24 159.9 15.41 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.482 1.141 . . . . 0.0 108.981 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.425 ' HE2' ' CE1' ' A' ' 177' ' ' PHE . 68.6 mtp -132.97 143.01 49.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.676 0.39 . . . . 0.0 110.454 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -143.37 153.7 42.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.433 0.693 . . . . 0.0 110.521 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.635 HG13 ' H ' ' A' ' 43' ' ' ASN . 7.3 tp -95.99 145.31 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -77.19 1.31 18.76 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-O 121.694 0.759 . . . . 0.0 111.323 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.635 ' H ' HG13 ' A' ' 41' ' ' ILE . 21.0 m120 -100.89 179.8 4.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.318 1.047 . . . . 0.0 109.5 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.3 143.28 33.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.736 0.814 . . . . 0.0 109.458 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 123.266 0.626 . . . . 0.0 109.569 179.026 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.503 ' O ' ' HD2' ' A' ' 122' ' ' LYS . 30.3 m . . . . . 0 CA--C 1.556 1.197 0 CA-C-O 121.706 0.765 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 6.0 mt 85.48 87.53 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.874 1.67 . . . . 0.0 111.825 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HE1' ' HG2' ' A' ' 122' ' ' LYS . 6.4 m0 -102.06 105.39 16.12 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.654 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 28.6 t70 177.63 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.225 1.578 . . . . 0.0 109.233 155.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.3 t . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 123.488 0.715 . . . . 0.0 110.374 -172.36 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 14' ' ' VAL . . . 147.28 -154.12 25.76 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.55 137.55 46.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.489 ' CD2' HD21 ' A' ' 8' ' ' LEU . 7.7 m-85 -123.39 139.82 53.64 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.944 0.498 . . . . 0.0 111.348 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 161' ' ' LEU . 21.9 mtp180 -92.75 126.57 37.9 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 pt -129.93 143.95 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -139.52 138.12 36.05 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.329 1.852 . . . . 0.0 112.151 -172.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.5 153.55 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 170.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 45.1 mtpt -106.97 88.97 2.86 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' B' ' 253' ' ' LYS . . . -168.64 178.11 42.24 Favored Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.435 ' HB ' ' HZ1' ' B' ' 253' ' ' LYS . 20.7 mt 59.42 23.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 118.008 0.904 . . . . 0.0 111.409 166.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp 71.45 41.65 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.052 1.341 . . . . 0.0 111.538 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.07 156.09 24.92 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 121.728 -0.272 . . . . 0.0 113.57 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.63 68.94 0.83 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.564 1.146 . . . . 0.0 108.2 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 m -113.26 125.06 53.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -159.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 65' ' ' LEU . 3.4 pm0 -95.82 104.21 16.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.318 1.447 . . . . 0.0 108.893 170.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.49 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.8 pp -137.14 -37.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.49 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -120.13 -168.96 13.91 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.284 -1.436 . . . . 0.0 116.129 -154.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -125.97 138.49 53.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.879 -172.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -133.37 -176.26 14.32 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 108' ' ' HIS . 0.2 OUTLIER -152.46 109.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.426 0.69 . . . . 0.0 109.323 -178.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.498 ' HB2' ' HD1' ' A' ' 107' ' ' PHE . 84.2 t80 -107.09 136.21 47.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -147.99 110.83 4.78 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 109.087 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 45.38 68.5 0.56 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.587 1.555 . . . . 0.0 113.101 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 -30.08 6.18 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.555 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 9.8 m -105.41 116.34 31.79 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.555 -172.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.649 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 87.8 t80 -93.81 144.25 25.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 172.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.81 ' HB2' HG11 ' A' ' 101' ' ' VAL . 25.2 m80 -132.19 122.68 25.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.866 0.866 . . . . 0.0 109.174 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -141.98 -179.67 6.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.569 0.748 . . . . 0.0 111.462 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . 0.628 ' SD ' ' HB3' ' A' ' 210' ' ' LEU . 79.9 mmm -89.66 173.25 8.4 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.639 1.176 . . . . 0.0 109.856 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -59.45 2.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 122.091 -0.381 . . . . 0.0 111.609 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -53.72 -28.21 32.71 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 125.131 1.372 . . . . 0.0 114.16 -168.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -56.1 -25.63 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 124.531 1.132 . . . . 0.0 113.021 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.568 HG21 ' H ' ' A' ' 116' ' ' GLY . 2.9 t -142.19 -166.63 2.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -111.42 33.51 4.66 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 121.065 0.459 . . . . 0.0 111.443 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.568 ' H ' HG21 ' A' ' 114' ' ' THR . . . 71.73 58.57 5.25 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.965 176.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.69 -172.37 2.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.516 0.726 . . . . 0.0 111.972 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 4' ' ' ALA . 14.9 p -100.14 148.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 124.442 1.097 . . . . 0.0 111.755 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.536 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 mm? -91.11 168.99 11.22 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.549 1.14 . . . . 0.0 111.211 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -172.77 163.81 5.14 Favored 'General case' 0 C--O 1.263 1.772 0 CA-C-O 123.869 1.795 . . . . 0.0 114.862 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -106.76 95.21 5.57 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.78 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.579 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 0.9 OUTLIER 48.97 48.09 21.01 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.005 0.922 . . . . 0.0 112.45 164.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.64 -8.48 56.5 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -100.25 110.55 22.8 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.997 0.899 . . . . 0.0 109.068 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.464 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 11.5 ttp180 -82.1 151.04 27.19 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -162.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 66.8 mt -142.51 121.68 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.038 1.735 . . . . 0.0 108.151 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -77.4 129.91 76.08 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.14 0.576 . . . . 0.0 111.395 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.62 170.57 19.95 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.781 2.321 . . . . 0.0 111.015 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 p -125.14 -29.69 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.575 0.75 . . . . 0.0 111.861 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TRP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 14.4 t-105 -131.22 143.74 50.8 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.762 0.825 . . . . 0.0 109.721 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.82 122.42 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.498 1.119 . . . . 0.0 108.285 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -140.98 119.81 12.61 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.276 0.631 . . . . 0.0 110.178 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -76.4 -24.39 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.291 1.037 . . . . 0.0 113.056 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.449 ' HB3' ' HZ1' ' A' ' 134' ' ' LYS . 7.4 mtpm? -72.99 -42.41 63.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.16 0.505 . . . . 0.0 110.924 -171.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.18 -8.89 34.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.532 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 t70 60.22 57.78 2.83 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.992 1.317 . . . . 0.0 110.644 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 98.0 mt -144.87 137.07 26.03 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.412 0.685 . . . . 0.0 110.961 -174.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.2 mt -128.27 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.273 1.429 . . . . 0.0 108.864 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 130' ' ' TRP . 51.3 p -142.93 161.15 38.87 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.874 0.845 . . . . 0.0 112.99 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.9 t80 -116.52 143.64 45.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.956 1.702 . . . . 0.0 107.847 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.14 -13.45 44.59 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.53 -151.41 22.97 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 173.69 38.93 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.605 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 59.4 t-105 -69.12 108.84 3.75 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 231' ' ' LYS . 22.8 pttp -147.92 137.87 22.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.829 0.452 . . . . 0.0 110.278 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 229' ' ' THR . 15.8 tp -160.81 -90.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.497 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -172.42 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.91 0.777 . . . . 0.0 110.1 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.79 152.34 48.39 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.644 -1.162 . . . . 0.0 115.391 -161.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.13 127.26 17.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.998 0.919 . . . . 0.0 108.893 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -91.8 136.86 32.83 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.065 0.46 . . . . 0.0 111.35 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.614 ' HZ1' ' HB2' ' A' ' 151' ' ' LYS . 4.9 ttmp? -134.82 127.48 30.91 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.42 125.93 25.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.965 0.906 . . . . 0.0 112.482 -170.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.36 -69.49 0.06 OUTLIER Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.84 -177.65 6.66 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.718 0.807 . . . . 0.0 109.817 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 8.1 pt-20 -104.14 147.46 27.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 110.859 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.36 171.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.586 0.754 . . . . 0.0 110.746 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.415 ' HG3' ' HB3' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -128.03 147.76 50.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 108.507 176.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.429 HG13 HG12 ' A' ' 200' ' ' ILE . 29.4 m -122.86 139.59 49.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 109.449 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.675 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 90.4 mt -80.54 86.07 5.88 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.69 100.39 5.39 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 167' ' ' PRO . 62.5 mt -68.94 106.03 2.59 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 165' ' ' LYS . 19.4 mm-40 -67.58 133.83 92.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.21 112.43 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.476 2.117 . . . . 0.0 112.169 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.81 20.92 72.81 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.046 -0.979 . . . . 0.0 114.846 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 76.1 mmtt -138.57 -175.0 3.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.831 0.852 . . . . 0.0 109.99 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.36 152.16 70.1 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.539 0.736 . . . . 0.0 110.717 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PRO . . . . . 0.768 ' HB3' HD21 ' A' ' 161' ' ' LEU . 30.4 Cg_endo -62.98 137.59 63.18 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.868 2.379 . . . . 0.0 113.585 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -81.08 135.3 35.79 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.168 167.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -81.4 105.2 12.39 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 166.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.5 HG13 HG13 ' A' ' 22' ' ' ILE . 51.3 t -112.17 116.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.441 0.696 . . . . 0.0 109.305 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . 0.58 ' H ' ' HB ' ' A' ' 22' ' ' ILE . 9.3 tt0 -108.71 137.41 46.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.834 0.349 . . . . 0.0 110.606 -165.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.4 t -153.75 147.02 24.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.82 0.848 . . . . 0.0 110.298 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 97.3 mttt -72.37 162.15 75.37 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.652 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 186' ' ' ALA . 50.0 Cg_exo -55.86 131.83 48.37 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.724 2.282 . . . . 0.0 111.717 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -147.66 150.75 23.03 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.254 0.919 . . . . 0.0 114.897 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.407 HD21 ' N ' ' A' ' 176' ' ' LEU . 1.0 OUTLIER -140.38 167.85 21.19 Favored 'General case' 0 C--O 1.239 0.55 0 O-C-N 121.101 -1.235 . . . . 0.0 111.235 -170.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PHE . . . . . 0.425 ' CE1' ' HE2' ' A' ' 39' ' ' MET . 0.7 OUTLIER -140.22 136.16 33.1 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.191 -1.822 . . . . 0.0 108.946 -171.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -77.63 144.47 37.41 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.3 m -102.85 179.25 4.33 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.776 1.231 . . . . 0.0 108.932 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.427 ' H ' HG22 ' A' ' 179' ' ' THR . 20.2 m120 -68.03 -18.24 64.64 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.877 0.471 . . . . 0.0 111.893 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.38 -68.21 0.87 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.053 0.941 . . . . 0.0 110.016 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.8 -142.2 11.85 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.662 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.8 t -163.25 135.85 5.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.465 1.106 . . . . 0.0 108.842 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 165.89 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.164 0.586 . . . . 0.0 109.801 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 133.82 167.98 11.71 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-O 120.278 -0.179 . . . . 0.0 113.313 174.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 174' ' ' PRO . . . -171.03 34.28 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.635 0 O-C-N 124.163 0.567 . . . . 0.0 110.812 173.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.406 ' N ' ' H ' ' A' ' 175' ' ' GLY . 2.2 t -164.87 117.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 126.565 1.946 . . . . 0.0 106.837 163.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.7 t -129.45 121.71 27.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.5 tp -144.42 151.46 39.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.86 0.864 . . . . 0.0 110.084 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.68 105.16 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 62.2 t80 -160.86 162.34 32.15 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.767 0.827 . . . . 0.0 109.121 -172.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.8 p -60.12 158.62 25.7 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.955 0.902 . . . . 0.0 111.422 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.81 107.88 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.683 2.922 . . . . 0.0 113.016 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -72.74 158.53 53.18 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.072 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.6 p -84.12 105.26 14.84 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 122.977 0.511 . . . . 0.0 109.959 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -56.75 110.06 0.73 Allowed 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.574 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 118.89 12.9 6.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.145 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.0 m -57.2 117.32 17.36 Favored Pre-proline 0 C--N 1.366 1.291 0 C-N-CA 122.899 0.48 . . . . 0.0 110.794 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PRO . . . . . 0.675 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 49.3 Cg_exo -58.7 112.77 1.3 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.933 2.422 . . . . 0.0 112.256 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.429 HG12 HG13 ' A' ' 158' ' ' VAL . 58.9 mt -80.48 96.56 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.788 0.835 . . . . 0.0 109.304 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.447 HG12 HG11 ' A' ' 208' ' ' VAL . 30.8 mt -119.57 134.18 63.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.26 -179.86 6.49 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.951 0.796 . . . . 0.0 109.456 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -63.41 -25.72 68.41 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.186 0.594 . . . . 0.0 112.527 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.43 -19.71 55.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.982 0.513 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 95.18 36.28 5.5 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.417 0.448 . . . . 0.0 112.221 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -130.22 166.79 19.57 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.215 1.006 . . . . 0.0 110.133 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 79.9 t 99.51 -60.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.14 2.176 . . . . 0.0 109.518 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . 0.447 HG11 HG12 ' A' ' 201' ' ' ILE . 33.2 m 49.74 32.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.869 1.267 . . . . 0.0 112.268 170.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.507 ' HA2' HG23 ' A' ' 229' ' ' THR . . . -76.78 -157.16 7.69 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.434 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.628 ' HB3' ' SD ' ' A' ' 110' ' ' MET . 24.4 mt -139.75 124.8 18.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.452 0.644 . . . . 0.0 112.582 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.16 124.35 26.17 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.989 164.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 176.81 66.82 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 158.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 225' ' ' ALA . 14.6 m120 -154.8 171.96 18.75 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 66.4 -118.65 11.22 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 31' ' ' ILE . 9.5 p 179.13 168.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.257 1.476 0 CA-C-O 121.707 0.765 . . . . 0.0 110.217 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.02 113.81 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 160.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 221' ' ' ALA . 6.5 t -119.89 158.33 26.88 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.865 0.866 . . . . 0.0 111.159 -165.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 59.93 16.2 5.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.272 1.029 . . . . 0.0 111.17 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.8 t 53.6 28.54 8.01 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.561 1.544 . . . . 0.0 112.382 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 178.99 30.55 0.05 OUTLIER Glycine 0 C--N 1.358 1.794 0 C-N-CA 120.768 -0.73 . . . . 0.0 114.447 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.602 ' HB2' HG21 ' A' ' 217' ' ' THR . . . -135.88 145.47 46.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.253 0.527 . . . . 0.0 109.596 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -105.13 101.67 11.21 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.9 1.28 . . . . 0.0 109.162 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.46 HG21 HD13 ' A' ' 31' ' ' ILE . 17.9 m -122.67 141.44 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 119.103 0.865 . . . . 0.0 110.512 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.4 m -144.9 129.41 17.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.581 -166.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . 0.767 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -81.52 -16.28 52.28 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.61 0.364 . . . . 0.0 110.648 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 17.5 pt 56.52 140.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 128.276 2.63 . . . . 0.0 116.527 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.48 27.54 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.985 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.29 143.01 51.17 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 172.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' THR . . . . . 0.605 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 62.2 p -76.03 104.4 6.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.555 0.693 . . . . 0.0 111.046 -169.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.26 107.74 19.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.424 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . 0.542 ' HD3' ' H ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.343 0 C-N-CA 124.204 1.002 . . . . 0.0 111.485 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' LYS . . . . . 0.435 ' HZ1' ' HB ' ' A' ' 91' ' ' ILE . 2.0 tppp? . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 110.941 -178.422 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.45 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 m -135.09 -163.19 1.35 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.078 0.951 . . . . 0.0 109.489 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.71 37.21 5.87 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.958 0.903 . . . . 0.0 110.772 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.18 -4.68 1.69 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.251 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -174.84 90.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.344 0.592 . . . . 0.0 109.632 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' B' ' 252' ' ' NLE . 4.7 mp -133.69 95.05 3.39 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.149 1.78 . . . . 0.0 108.502 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.632 ' HB3' HG11 ' A' ' 64' ' ' VAL . 3.7 tp10 -97.53 140.67 31.62 Favored 'General case' 0 C--O 1.26 1.622 0 CA-C-O 121.76 0.79 . . . . 0.0 112.639 -170.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 86' ' ' ILE . 57.0 mt -86.28 149.16 25.25 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.409 175.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -147.47 111.06 4.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.621 -0.674 . . . . 0.0 109.757 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.453 ' N ' ' HB3' ' A' ' 67' ' ' ASP . 55.7 ttp180 -62.78 137.17 58.2 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.629 1.104 . . . . 0.0 110.363 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.43 -28.8 3.58 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.281 0.632 . . . . 0.0 110.477 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.06 -169.67 2.44 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.077 0.951 . . . . 0.0 109.583 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 18.7 t70 -109.5 151.14 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.545 0.738 . . . . 0.0 109.524 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.448 HG21 HG13 ' A' ' 101' ' ' VAL . 44.8 t -75.29 98.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.708 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.94 160.22 4.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -172.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 43.0 t90 -64.05 126.07 26.52 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 172.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 11.0 tp10 -95.62 143.96 26.46 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.523 0.729 . . . . 0.0 109.039 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.03 -3.85 11.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.971 0.908 . . . . 0.0 113.278 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.442 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 14.3 mm100 -82.61 36.06 0.48 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.452 0.701 . . . . 0.0 110.867 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -61.69 112.59 2.32 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 125.125 1.37 . . . . 0.0 111.769 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -124.1 119.41 29.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.013 0.925 . . . . 0.0 110.096 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.86 114.24 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -144.62 -24.37 0.52 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.352 0.661 . . . . 0.0 111.683 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.14 -145.39 0.06 OUTLIER Glycine 0 C--N 1.359 1.858 0 N-CA-C 114.351 0.501 . . . . 0.0 114.351 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m 64.57 18.4 11.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 9.9 m -65.54 120.21 66.31 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.386 0.674 . . . . 0.0 109.61 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 15.3 Cg_exo -65.67 -96.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.384 2.723 . . . . 0.0 114.549 -161.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 42.2 mm -113.37 119.51 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.447 HD21 HG22 ' A' ' 223' ' ' VAL . 7.2 mp -110.92 164.07 13.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.245 0.618 . . . . 0.0 110.687 172.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 p -115.23 110.88 20.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.58 HG21 ' HE1' ' A' ' 39' ' ' MET . 44.0 mt -114.09 143.43 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.307 1.043 . . . . 0.0 108.33 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 p -90.99 108.08 19.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.69 0.757 . . . . 0.0 108.971 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.551 HG13 HG21 ' A' ' 179' ' ' THR . 27.2 mm -79.18 127.68 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.951 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 19.7 m -100.79 95.51 6.69 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.098 0.559 . . . . 0.0 110.07 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 58.23 27.78 15.65 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.228 1.411 . . . . 0.0 111.84 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 75.95 -42.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.523 1.529 . . . . 0.0 113.586 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.06 -42.48 98.13 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 49.2 m -106.33 161.4 14.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.59 0.356 . . . . 0.0 110.732 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.58 ' HE1' HG21 ' A' ' 31' ' ' ILE . 4.3 ppp? -150.41 136.7 18.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.04 0.936 . . . . 0.0 108.948 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 p -163.52 177.27 8.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.968 0.414 . . . . 0.0 111.026 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.436 ' H ' HG21 ' A' ' 215' ' ' VAL . 2.8 tp -102.13 146.6 9.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.92 70.69 6.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.078 0.942 . . . . 0.0 109.729 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.94 114.86 3.49 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.794 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.98 103.93 1.61 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.698 0.624 . . . . 0.0 110.276 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HG3' ' NH2' ' B' ' 254' ' ' ARG . 2.2 pt-20 -82.91 164.28 20.56 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.378 1.071 . . . . 0.0 109.961 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -160.81 116.93 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.07 0.948 . . . . 0.0 108.619 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.84 41.03 0.16 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.4 0.68 . . . . 0.0 112.255 -167.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.587 ' HG2' ' HA ' ' B' ' 254' ' ' ARG . 20.3 mt-30 -73.53 76.63 1.46 Allowed 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 123.333 0.653 . . . . 0.0 111.78 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 m -155.89 121.16 4.82 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.308 0.643 . . . . 0.0 111.233 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.52 HD13 ' HA3' ' A' ' 98' ' ' GLY . 38.6 mt -160.29 -71.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.192 1.397 . . . . 0.0 110.448 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.695 ' HA2' ' HD3' ' A' ' 85' ' ' ARG . . . -63.65 152.13 48.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.585 177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.12 -131.11 17.25 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.86 78.25 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.98 0.459 . . . . 0.0 112.771 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.18 160.51 8.75 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.5 t -82.12 78.25 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.651 0.738 . . . . 0.0 109.404 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.84 40.31 2.57 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.932 -175.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 -71.06 2.01 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.85 125.29 22.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.074 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.81 -171.71 37.81 Favored Glycine 0 C--O 1.239 0.443 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -175.0 -50.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.872 0.869 . . . . 0.0 109.593 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.0 t80 59.78 64.83 1.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.27 1.028 . . . . 0.0 109.671 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.88 -60.71 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.481 1.112 . . . . 0.0 108.12 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.79 -87.29 1.94 Allowed Glycine 0 C--N 1.345 1.057 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.39 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.632 HG11 ' HB3' ' A' ' 7' ' ' GLU . 3.4 t -127.84 -122.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 117.736 0.768 . . . . 0.0 109.388 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -179.68 142.41 0.17 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.671 1.588 . . . . 0.0 107.385 -166.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.573 ' CD1' ' HE3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -147.32 178.12 8.67 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.453 ' HB3' ' N ' ' A' ' 10' ' ' ARG . 59.1 t0 179.73 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 111.267 -2.697 . . . . 0.0 105.318 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 8.2 m -127.14 118.57 21.98 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.471 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 68' ' ' VAL . 22.9 Cg_endo -106.07 29.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.922 3.081 . . . . 0.0 114.661 -171.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 p -62.27 105.41 0.62 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 117.944 0.338 . . . . 0.0 110.223 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -89.98 136.88 2.59 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.018 2.479 . . . . 0.0 112.865 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.57 -44.89 33.48 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.91 2.407 . . . . 0.0 114.185 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.98 101.39 1.46 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 CA-C-N 121.677 1.635 . . . . 0.0 111.736 170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 58.37 94.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.963 1.305 . . . . 0.0 111.861 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.16 -70.56 0.01 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.264 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 64.68 -75.06 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.32 1.448 . . . . 0.0 112.622 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.43 171.59 13.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.071 0.548 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -101.25 137.1 40.04 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.158 0.583 . . . . 0.0 109.615 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.99 102.38 1.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.613 0.72 . . . . 0.0 109.974 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . 1.3 mp0 -94.02 -23.73 17.9 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.202 1.001 . . . . 0.0 109.011 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 72.39 101.82 0.07 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.255 1.822 . . . . 0.0 111.955 170.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 126.47 -151.41 18.03 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.253 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.88 120.21 32.99 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 124.795 1.238 . . . . 0.0 109.295 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 11.3 m-85 -105.56 144.4 32.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 123.609 0.764 . . . . 0.0 110.473 -171.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.695 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 99.1 mtt180 -82.38 131.82 35.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 153.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.761 ' HB ' ' HE3' ' B' ' 252' ' ' NLE . 7.1 pt -132.58 142.84 41.44 Favored 'Isoleucine or valine' 0 C--O 1.254 1.322 0 O-C-N 121.083 -1.011 . . . . 0.0 109.283 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 94' ' ' TYR . 48.8 tttm -148.98 134.67 18.77 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.59 1.156 . . . . 0.0 110.17 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -110.02 157.93 18.79 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -99.69 92.16 5.2 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 155.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.48 175.16 42.57 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 118.962 -0.91 . . . . 0.0 111.352 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.562 HD12 ' HG2' ' B' ' 253' ' ' LYS . 78.0 mt 59.07 -80.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 124.921 1.288 . . . . 0.0 112.052 173.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 tp -127.09 29.77 5.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.962 0.905 . . . . 0.0 109.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.02 -143.78 16.33 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.638 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 87' ' ' LYS . 11.9 m-85 -86.84 95.57 9.91 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.919 0.888 . . . . 0.0 109.234 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.416 ' HB3' ' HB3' ' A' ' 48' ' ' GLN . 7.8 m -140.42 146.98 39.01 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.854 1.206 . . . . 0.0 111.646 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.568 ' HG3' ' H ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -102.46 130.97 49.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.143 1.777 . . . . 0.0 113.48 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.68 ' HB ' ' HA ' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -90.36 -30.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.626 0.77 . . . . 0.0 110.13 174.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 100.83 -86.41 0.63 Allowed Glycine 0 C--O 1.2 -2.002 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.633 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -99.44 119.58 38.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.568 2.684 . . . . 0.0 111.127 -149.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.05 122.36 5.3 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.303 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 199' ' ' PRO . 60.0 t -108.58 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 110.096 -165.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.635 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 24.4 t80 -123.09 117.27 25.03 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -123.53 127.21 48.01 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.67 1.188 . . . . 0.0 108.646 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 65.73 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.955 1.302 . . . . 0.0 111.391 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.86 -0.44 1.27 Allowed Glycine 0 N--CA 1.472 1.038 0 CA-C-O 120.052 -0.304 . . . . 0.0 113.254 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -116.57 126.84 53.86 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.279 0.632 . . . . 0.0 110.87 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.803 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 70.1 t80 -99.64 110.98 23.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.634 ' NE2' HD23 ' A' ' 137' ' ' LEU . 29.2 t60 -130.23 114.57 15.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.693 0.397 . . . . 0.0 110.752 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.61 -171.49 2.79 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.358 1.063 . . . . 0.0 109.645 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.538 ' HA ' ' HE1' ' A' ' 110' ' ' MET . 25.9 mmt -72.33 159.79 33.45 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.805 0.842 . . . . 0.0 111.936 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.0 t90 -85.52 -44.31 12.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.15 0.58 . . . . 0.0 110.704 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -60.37 -14.51 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 0.0 113.326 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.497 HG22 HG21 ' A' ' 114' ' ' THR . 23.5 m -59.16 -23.64 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 172.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.529 HG23 ' H ' ' A' ' 116' ' ' GLY . 10.0 t -155.86 -166.19 2.14 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.627 1.171 . . . . 0.0 109.261 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -117.64 17.97 14.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.162 0.585 . . . . 0.0 110.461 168.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.529 ' H ' HG23 ' A' ' 114' ' ' THR . . . 106.45 54.86 0.68 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 124.038 0.827 . . . . 0.0 111.574 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.03 160.01 16.56 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.2 0.524 . . . . 0.0 111.811 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 127' ' ' GLU . 14.5 p -81.03 159.28 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.678 1.191 . . . . 0.0 110.249 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.478 HD23 ' HD2' ' B' ' 252' ' ' NLE . 10.8 mt -113.88 172.17 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.393 0.542 . . . . 0.0 111.67 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.557 ' HB3' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -171.49 178.03 3.3 Favored 'General case' 0 C--O 1.267 2.003 0 CA-C-O 123.706 1.717 . . . . 0.0 114.793 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.542 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 43.9 t60 -114.78 100.39 8.2 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 110.615 -2.993 . . . . 0.0 108.816 164.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.573 ' HE3' ' CD1' ' A' ' 66' ' ' TRP . 8.9 mtmp? 1.98 72.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 127.313 2.245 . . . . 0.0 114.172 -173.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.0 19.55 16.69 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.542 ' HE3' ' HB3' ' A' ' 121' ' ' HIS . 1.2 tmmt? -139.71 112.13 7.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 167.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.557 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 41.2 ttp85 -98.69 140.75 32.43 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -162.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.55 130.33 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 126.088 1.755 . . . . 0.0 109.438 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.551 ' HA ' HG21 ' A' ' 118' ' ' VAL . 5.2 mp0 -91.05 138.39 26.02 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.639 -0.663 . . . . 0.0 111.649 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -68.84 156.95 63.78 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.032 2.488 . . . . 0.0 112.139 167.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 p -98.85 -17.76 18.26 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.392 0.677 . . . . 0.0 111.829 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 21.6 t-105 -152.02 148.88 28.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.23 0.612 . . . . 0.0 110.87 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -149.25 122.28 8.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.647 1.179 . . . . 0.0 109.263 169.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.54 118.35 20.94 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.027 0.441 . . . . 0.0 111.29 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.86 -28.6 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.978 1.311 . . . . 0.0 111.805 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -65.82 -56.52 11.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.76 0.824 . . . . 0.0 111.951 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -79.86 -23.99 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.499 0.72 . . . . 0.0 109.892 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 79.84 44.15 0.05 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.077 1.751 . . . . 0.0 109.989 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.706 HD11 ' HB1' ' A' ' 227' ' ' ALA . 9.4 mp -131.65 129.43 40.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 111.327 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 131' ' ' ALA . 24.0 mt -114.01 144.09 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.548 1.539 . . . . 0.0 110.749 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.652 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 7.2 m -125.87 154.85 42.11 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.629 0.728 . . . . 0.0 111.548 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.803 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 10.9 t80 -136.68 138.47 41.1 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.591 1.556 . . . . 0.0 107.698 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 -45.15 1.51 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.68 36.45 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.41 135.71 31.55 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -69.84 142.05 53.15 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 117.262 0.531 . . . . 0.0 110.763 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -151.33 114.24 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.494 HD23 HG21 ' A' ' 229' ' ' THR . 3.9 mm? -123.64 -91.64 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 167.8 -69.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.689 ' HA3' ' HA ' ' A' ' 207' ' ' VAL . . . -77.12 153.86 42.13 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.817 -166.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.3 121.96 11.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.499 -0.85 . . . . 0.0 108.784 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.499 ' HZ3' ' HB ' ' A' ' 187' ' ' VAL . 16.3 t90 -91.12 148.47 22.35 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -153.37 160.3 42.62 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.03 93.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.294 1.045 . . . . 0.0 111.047 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.87 -46.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.433 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.6 160.23 14.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.316 1.046 . . . . 0.0 109.218 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 173' ' ' LYS . 13.6 pt-20 -93.71 145.52 24.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.964 0.506 . . . . 0.0 110.12 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.553 HG13 HG22 ' A' ' 200' ' ' ILE . 1.4 p -140.29 -173.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 122.193 -0.317 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 38.4 mt-30 -126.35 148.07 49.63 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.964 -0.46 . . . . 0.0 110.088 166.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.84 125.82 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.1 88.79 6.66 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.17 112.51 25.54 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.235 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 167' ' ' PRO . 59.7 mt -66.99 125.73 26.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.443 ' HG3' ' HB2' ' A' ' 168' ' ' ARG . 45.4 mt-10 -81.22 155.57 72.04 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.145 0.578 . . . . 0.0 111.112 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 113.51 2.79 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.536 2.158 . . . . 0.0 112.563 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.91 53.42 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.302 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 88.3 mttt -129.98 -171.04 2.43 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.483 0.713 . . . . 0.0 111.666 -171.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -76.53 158.1 81.59 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.889 0.875 . . . . 0.0 112.405 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.544 ' HB3' HD21 ' A' ' 161' ' ' LEU . 18.3 Cg_endo -60.07 106.05 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.869 2.379 . . . . 0.0 112.113 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.443 ' HB2' ' HG3' ' A' ' 162' ' ' GLU . 3.3 tpt180 -75.09 97.25 3.39 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.113 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -76.97 104.91 7.72 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.74 128.22 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.43 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 9.1 tt0 -78.99 108.02 12.16 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 p -115.64 104.72 11.98 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.394 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 155' ' ' GLU . 90.3 mttt -83.33 164.75 44.19 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.142 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.85 140.04 58.54 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.992 2.462 . . . . 0.0 113.934 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.52 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -134.88 176.86 19.71 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 173.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -163.68 156.51 18.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.449 0.642 . . . . 0.0 110.455 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.401 ' CE2' HD12 ' A' ' 184' ' ' ILE . 40.4 p90 -138.84 151.41 46.98 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.209 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.46 142.42 41.01 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.583 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.613 HG22 ' H ' ' A' ' 181' ' ' ALA . 49.6 m -137.96 162.58 33.7 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.52 1.128 . . . . 0.0 108.704 -167.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.16 -34.27 76.08 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.613 ' H ' HG22 ' A' ' 179' ' ' THR . . . -80.55 6.67 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.43 174.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.14 -78.56 0.27 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.4 t -157.46 142.85 17.17 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.704 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.401 HD12 ' CE2' ' A' ' 177' ' ' PHE . 69.5 mt -104.93 137.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.32 128.95 9.74 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 224' ' ' SER . . . -156.53 -168.26 2.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.504 0.722 . . . . 0.0 110.433 -169.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.499 ' HB ' ' HZ3' ' A' ' 150' ' ' TRP . 7.6 p -93.95 105.81 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.535 ' HA ' HG21 ' A' ' 223' ' ' VAL . 21.0 t -102.88 114.21 28.29 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.452 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 19.6 tp -127.98 127.15 42.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.761 0.824 . . . . 0.0 111.162 -172.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.34 102.92 14.99 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -176.46 169.48 2.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.325 1.05 . . . . 0.0 108.633 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.7 m -60.9 150.44 77.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.913 0.885 . . . . 0.0 110.627 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -45.17 103.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.535 2.823 . . . . 0.0 113.289 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.23 149.35 49.98 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.21 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.555 HG23 ' HG ' ' A' ' 198' ' ' SER . 2.6 t -61.86 138.48 58.35 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.441 0.696 . . . . 0.0 112.426 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.508 ' HA ' ' CE1' ' A' ' 211' ' ' TYR . 37.1 m -72.34 119.92 17.21 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.006 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.57 ' H ' ' HE1' ' A' ' 211' ' ' TYR . . . 107.7 -4.75 34.59 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 118.166 -1.352 . . . . 0.0 112.756 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.555 ' HG ' HG23 ' A' ' 195' ' ' THR . 39.1 m -44.62 117.74 3.13 Favored Pre-proline 0 N--CA 1.498 1.961 0 CA-C-N 117.951 0.876 . . . . 0.0 112.51 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.493 ' HG3' HG22 ' A' ' 101' ' ' VAL . 3.0 Cg_exo -76.59 135.86 16.69 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.235 1.957 . . . . 0.0 112.168 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.553 HG22 HG13 ' A' ' 156' ' ' VAL . 30.3 mt -83.59 97.38 4.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 0.0 109.1 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.4 mt -117.76 134.38 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.89 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -80.52 164.33 23.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.353 0.661 . . . . 0.0 109.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -59.19 -31.91 69.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.227 0.611 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.64 13.92 12.94 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.599 0.76 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.72 24.79 75.4 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.223 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -89.97 162.03 15.59 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.988 0.915 . . . . 0.0 110.011 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.689 ' HA ' ' HA3' ' A' ' 148' ' ' GLY 0.365 16.4 m 68.25 -62.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.487 2.315 . . . . 0.0 113.385 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 32.9 m 55.47 33.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 C-N-CA 124.493 1.117 . . . . 0.0 111.666 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.52 -145.11 1.73 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.176 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.437 ' HB3' ' HE3' ' A' ' 110' ' ' MET . 87.2 mt -138.91 146.43 41.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.265 0.626 . . . . 0.0 109.785 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.57 ' HE1' ' H ' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -73.52 132.53 42.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.275 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.79 -154.15 2.38 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 118.35 0.523 . . . . 0.0 113.968 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -94.35 130.35 40.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.471 -0.429 . . . . 0.0 110.364 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -157.23 -143.67 3.72 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.682 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.436 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.0 p -165.15 161.5 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.593 0 CA-C-N 117.276 0.538 . . . . 0.0 110.925 -170.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.47 111.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.734 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 164.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.1 t -105.61 153.55 21.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.449 1.099 . . . . 0.0 108.903 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 62.77 12.53 5.75 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.923 0.889 . . . . 0.0 111.605 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.7 m 55.93 23.42 6.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.582 1.153 . . . . 0.0 111.586 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.89 -50.52 0.01 OUTLIER Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.387 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.83 158.42 24.06 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -121.25 109.5 15.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 188' ' ' SER . 84.1 t -121.68 134.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.589 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 32.0 t -146.4 159.23 43.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.829 0.851 . . . . 0.0 109.334 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.33 167.48 4.14 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.124 0.569 . . . . 0.0 111.304 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -99.61 122.18 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 171.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.706 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -111.22 143.59 41.73 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -148.08 166.72 26.96 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 122.072 -0.393 . . . . 0.0 110.927 -172.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.494 HG21 HD23 ' A' ' 146' ' ' LEU . 62.4 p -91.58 110.42 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.1 -0.04 56.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.023 0.929 . . . . 0.0 110.616 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 68.01 129.79 0.02 OUTLIER 'General case' 0 C--N 1.366 1.293 0 C-N-CA 124.731 1.212 . . . . 0.0 109.449 -169.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 52.2 p -56.45 121.53 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.518 0.727 . . . . 0.0 111.142 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.6 tt -69.26 88.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.633 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -92.71 74.58 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.55 -33.88 69.5 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.521 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.02 146.07 86.96 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.264 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.45 131.88 38.19 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.124 1.883 . . . . 0.0 111.56 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.426 ' HG3' HG21 ' A' ' 239' ' ' ILE . 12.3 pt-20 -63.86 -18.97 64.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.9 0.88 . . . . 0.0 112.703 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.426 HG21 ' HG3' ' A' ' 238' ' ' GLU . 15.4 tt -152.33 -52.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 122.864 0.465 . . . . 0.0 111.086 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--O 1.25 1.125 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.367 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.462 ' C4 ' HD21 ' A' ' 119' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.761 ' HE3' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.646 ' N ' HD12 ' A' ' 97' ' ' ILE . 13.4 tppt? 172.02 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 126.454 1.902 . . . . 0.0 109.992 -174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.587 ' HA ' ' HG2' ' A' ' 48' ' ' GLN . 37.4 ttt180 -102.38 -90.12 0.36 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.909 -1.12 . . . . 0.0 111.425 -171.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.403 HNHB ' HG ' ' A' ' 50' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -150.24 156.85 42.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.556 0.742 . . . . 0.0 110.291 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 117' ' ' ALA . . . 56.63 26.05 10.7 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 124.296 0.997 . . . . 0.0 112.63 174.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.17 31.64 0.54 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.521 1.128 . . . . 0.0 109.006 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -166.81 61.59 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.667 HD11 ' HB1' ' A' ' 117' ' ' ALA . 52.3 mt -101.52 94.21 5.77 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.287 0.635 . . . . 0.0 110.243 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 120' ' ' MET . 4.5 mm-40 -95.3 130.85 41.92 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 123.672 0.789 . . . . 0.0 112.27 -172.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.77 ' HB2' HG11 ' A' ' 68' ' ' VAL . 24.3 mt -97.82 143.42 28.46 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 32.0 tt0 -134.23 142.8 47.5 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 124.163 0.985 . . . . 0.0 108.953 162.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -86.7 128.43 35.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 118.034 0.379 . . . . 0.0 110.732 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.776 ' HB1' ' HG3' ' A' ' 85' ' ' ARG . . . -85.86 -52.37 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.227 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.67 -164.49 0.91 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.746 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.574 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 27.5 t70 -108.33 146.23 33.27 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.484 0.714 . . . . 0.0 109.556 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.564 ' HB ' HG21 ' A' ' 201' ' ' ILE . 2.4 m -75.34 100.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.241 0.543 . . . . 0.0 109.766 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 38.1 ttmt -172.39 117.43 0.35 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.849 1.259 . . . . 0.0 107.839 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.48 ' HB3' ' HA ' ' A' ' 203' ' ' LYS . 84.4 t90 -87.74 91.65 8.83 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.622 0.249 . . . . 0.0 111.647 -172.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -158.79 65.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 156.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 1.1 t70 -85.25 -61.91 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.412 HE21 ' NH2' ' A' ' 168' ' ' ARG . 45.6 mt-30 -150.59 33.07 0.63 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.796 1.238 . . . . 0.0 109.014 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 13.65 73.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.188 1.795 . . . . 0.0 113.661 -163.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 170' ' ' VAL . 13.2 mm-40 -75.91 162.08 28.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.608 -173.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.72 117.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.8 m -146.97 -51.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.791 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -59.45 105.58 0.76 Allowed Glycine 0 C--N 1.355 1.621 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.796 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p 179.88 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.923 1.289 . . . . 0.0 110.482 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.602 ' HB2' ' HB3' ' A' ' 188' ' ' SER . 9.1 m -64.37 137.67 97.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.322 0.649 . . . . 0.0 110.527 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.41 178.24 0.24 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.525 2.816 . . . . 0.0 114.542 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 115.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.124 0.569 . . . . 0.0 110.103 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.536 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 51.7 tp -112.4 159.0 19.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.955 0.902 . . . . 0.0 109.839 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -112.45 119.56 38.64 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.483 0.713 . . . . 0.0 109.479 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -114.23 142.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.263 1.025 . . . . 0.0 108.694 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.6 p -88.22 110.4 20.69 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.41 143.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.697 177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 t -144.84 129.36 17.99 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 56.5 20.74 5.06 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.472 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 72.87 -68.43 0.23 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.405 1.882 . . . . 0.0 111.523 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.66 -11.27 72.76 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 114.91 0.724 . . . . 0.0 114.91 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.6 m -105.11 156.98 17.58 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 118.391 1.095 . . . . 0.0 109.037 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 ptm -158.34 138.48 12.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.427 0.691 . . . . 0.0 109.475 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 p -172.21 176.16 3.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.723 0.809 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.45 94.79 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 49.94 29.12 3.2 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.368 1.467 . . . . 0.0 113.12 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 53.68 33.97 17.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.956 1.702 . . . . 0.0 113.026 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.04 93.53 2.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.821 0.82 . . . . 0.0 108.992 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.06 157.09 20.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.324 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.43 136.96 11.02 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.901 0.48 . . . . 0.0 109.98 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.664 ' HB2' HG22 ' A' ' 97' ' ' ILE . 14.7 pt-20 -101.77 158.04 16.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.619 0.768 . . . . 0.0 110.646 175.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.607 ' HB3' ' NH2' ' B' ' 255' ' ' M9P . 25.9 tt0 -166.45 141.57 4.44 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.287 0.635 . . . . 0.0 110.364 -164.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 65.6 p -86.42 138.88 31.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.788 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -106.78 -44.88 4.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.727 0.811 . . . . 0.0 110.027 -177.154 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.24 172.27 29.02 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.3 22.56 54.07 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.32 138.86 29.79 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -158.94 15.42 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.2 t -84.4 -26.34 28.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.16 0.584 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.22 -82.05 0.79 Allowed Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.71 -122.33 27.58 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.428 0.537 . . . . 0.0 113.311 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.61 -78.01 0.36 Allowed Glycine 0 C--N 1.352 1.441 0 C-N-CA 123.85 0.738 . . . . 0.0 111.888 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.45 -55.67 0.08 OUTLIER Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.91 -43.66 53.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 110.599 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.3 t80 63.55 28.77 15.29 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.428 1.08 . . . . 0.0 109.8 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.65 70.68 9.67 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.47 65.36 4.14 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.639 HG21 ' HD2' ' A' ' 87' ' ' LYS . 2.6 p -109.9 23.71 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 CA-C-O 123.248 1.499 . . . . 0.0 109.012 -175.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 96' ' ' GLN . 16.7 mt 81.39 127.68 0.04 OUTLIER 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.775 2.03 . . . . 0.0 116.475 156.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.457 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.2 m0 -125.02 87.43 2.71 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.619 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 4.4 t70 175.23 105.15 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.383 1.052 . . . . 0.0 111.028 157.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 8' ' ' LEU . 18.8 m -132.13 175.15 3.92 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.162 . . . . 0.0 111.201 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.58 ' HD2' HD11 ' A' ' 126' ' ' ILE . 74.3 Cg_endo -92.52 113.4 0.29 Allowed 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.439 2.092 . . . . 0.0 110.702 162.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.2 p -64.81 113.02 9.34 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.237 0.615 . . . . 0.0 110.771 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -58.54 -42.19 57.12 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.769 2.313 . . . . 0.0 115.653 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 118.53 5.09 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 121.82 1.686 . . . . 0.0 110.859 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.14 90.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.286 2.657 . . . . 0.0 112.395 174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.31 -33.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.997 0.919 . . . . 0.0 110.508 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.88 -51.39 4.06 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 122.968 0.318 . . . . 0.0 112.779 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -79.63 75.76 6.28 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.666 0.746 . . . . 0.0 109.0 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.53 -174.55 0.71 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.82 1.648 . . . . 0.0 108.125 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.79 136.37 37.42 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.484 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 27.4 tp -107.06 -3.0 20.47 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.67 0.788 . . . . 0.0 109.618 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 50.91 168.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.443 2.297 . . . . 0.0 114.135 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HD1' ' A' ' 102' ' ' TYR . 22.9 t70 -179.9 111.41 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.575 0.75 . . . . 0.0 110.409 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 138.22 -132.14 5.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 114.873 0.709 . . . . 0.0 114.873 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 140.12 42.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.805 1.242 . . . . 0.0 110.096 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.538 ' HH ' ' HB3' ' A' ' 102' ' ' TYR . 62.7 m-85 -125.49 146.44 49.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.881 0.473 . . . . 0.0 112.095 -168.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.776 ' HG3' ' HB1' ' A' ' 11' ' ' ALA . 20.6 mtm180 -98.26 124.49 42.89 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 163.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.628 HD11 ' H6 ' ' B' ' 251' ' ' BEZ . 21.8 pt -130.98 138.8 52.66 Favored 'Isoleucine or valine' 0 C--O 1.26 1.641 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -165.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.639 ' HD2' HG21 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.78 151.22 47.03 Favored 'General case' 0 C--N 1.386 2.195 0 C-N-CA 124.256 1.022 . . . . 0.0 111.284 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.578 ' HB3' ' HG2' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -140.67 154.62 46.46 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 166.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -104.75 91.59 3.91 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.057 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -171.17 177.0 44.33 Favored Glycine 0 C--O 1.238 0.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.176 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 11.3 mt 59.63 37.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.515 0 CA-C-O 122.212 1.006 . . . . 0.0 109.602 165.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.3 mt 65.16 33.84 9.05 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.691 1.596 . . . . 0.0 111.644 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.45 157.69 28.59 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 121.47 0.483 . . . . 0.0 114.241 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -130.28 87.29 2.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.402 ' HB2' ' HZ1' ' B' ' 253' ' ' LYS . 14.6 m -147.77 147.17 29.59 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -172.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 49' ' ' THR . 7.3 tt0 -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 125.189 1.556 . . . . 0.0 108.397 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.664 HG22 ' HB2' ' A' ' 47' ' ' GLU . 2.5 pp -135.07 -33.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -170.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.56 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.22 176.86 29.54 Favored Glycine 0 C--O 1.258 1.612 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.051 -161.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -118.49 124.49 47.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.772 -0.714 . . . . 0.0 109.777 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.46 162.11 17.89 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.3 t -138.6 133.09 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.3 0.64 . . . . 0.0 109.527 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.557 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 24.9 t80 -149.67 135.28 18.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HZ1' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.78 133.42 30.39 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 65.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.871 1.357 . . . . 0.0 111.985 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.29 19.95 0.63 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.513 -0.312 . . . . 0.0 112.399 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 p -135.74 126.73 27.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.518 0.727 . . . . 0.0 110.043 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.742 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 49.1 t80 -102.19 137.63 40.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.59 1.156 . . . . 0.0 108.72 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -132.1 122.15 24.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.377 0.671 . . . . 0.0 110.062 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.437 HG22 ' HB ' ' A' ' 138' ' ' ILE . 14.6 t -136.42 -155.59 0.64 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.848 0.859 . . . . 0.0 109.892 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.437 ' HE2' ' HB2' ' A' ' 110' ' ' MET . 18.6 ttm -136.97 153.59 50.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 111.239 -158.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -46.43 11.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -174.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.421 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 13.8 p-80 -65.56 -16.91 64.15 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 118.743 0.701 . . . . 0.0 112.286 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.479 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 4.5 m -80.27 -38.89 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 123.826 0.85 . . . . 0.0 111.769 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.546 HG23 HD22 ' A' ' 6' ' ' LEU . 23.1 m -156.24 151.91 27.11 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.937 0.789 . . . . 0.0 110.079 170.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -73.15 26.43 0.06 Allowed 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -167.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.647 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 82.79 38.2 12.16 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 119.031 0.832 . . . . 0.0 111.425 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.667 ' HB1' HD11 ' A' ' 6' ' ' LEU . . . -87.71 -165.58 1.35 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.697 0.799 . . . . 0.0 112.383 -168.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.01 136.47 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.733 0.813 . . . . 0.0 111.331 -174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.643 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 mm? -86.79 171.61 10.76 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.933 1.293 . . . . 0.0 111.998 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -172.53 173.04 4.14 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 41.8 t60 -132.41 97.49 4.12 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.448 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.412 ' HD2' ' NE1' ' A' ' 66' ' ' TRP . 85.3 mttt 39.14 38.84 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.775 1.23 . . . . 0.0 112.149 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 21.18 12.85 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 34.2 mmtp -115.27 112.12 21.96 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.984 1.392 . . . . 0.0 110.094 172.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -80.54 148.95 30.16 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.467 1.107 . . . . 0.0 113.171 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.58 HD11 ' HD2' ' A' ' 69' ' ' PRO . 29.5 mt -140.06 125.2 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.208 1.803 . . . . 0.0 107.428 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.06 148.83 36.46 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.19 0.596 . . . . 0.0 112.356 -168.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.445 ' HA ' ' CD2' ' A' ' 140' ' ' TYR . 76.5 Cg_endo -79.0 163.46 25.67 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.597 2.865 . . . . 0.0 114.764 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 p -127.04 -29.45 2.79 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.781 0.833 . . . . 0.0 111.602 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 32.1 t-105 -147.91 149.03 31.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.165 0.586 . . . . 0.0 110.522 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.93 140.83 23.72 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.751 1.22 . . . . 0.0 109.279 166.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -134.73 114.56 12.79 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.56 -27.37 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.853 1.261 . . . . 0.0 112.356 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -76.85 -59.36 2.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.792 0.33 . . . . 0.0 111.766 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.33 6.14 48.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.371 0.669 . . . . 0.0 110.646 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 68.62 51.18 0.63 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.392 1.077 . . . . 0.0 110.989 162.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 227' ' ' ALA . 52.0 mt -140.14 142.33 36.01 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.459 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.647 HD11 ' HA2' ' A' ' 116' ' ' GLY . 49.3 mt -128.74 151.37 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.537 1.135 . . . . 0.0 109.07 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.595 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 23.9 t -139.1 144.04 38.53 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.082 0.468 . . . . 0.0 111.01 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.742 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 63.1 m-85 -128.95 144.18 51.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.027 1.331 . . . . 0.0 109.077 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.66 -8.86 79.17 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.738 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.48 -154.76 26.14 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.45 132.01 10.93 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.694 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 2.6 p90 -79.02 130.87 35.99 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -175.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.638 ' HB3' ' HB2' ' A' ' 232' ' ' SER . 56.1 pttt -149.16 116.35 6.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.841 0.456 . . . . 0.0 111.021 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.82 -80.1 0.36 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 159.35 3.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 125.699 1.6 . . . . 0.0 109.366 -163.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 207' ' ' VAL . . . -56.12 91.2 0.02 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 123.985 0.802 . . . . 0.0 114.684 -175.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.27 95.86 3.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.502 ' HE3' HD11 ' A' ' 200' ' ' ILE . 2.0 t90 -46.43 121.65 3.57 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 163.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 88.4 tttt -81.78 116.5 21.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.68 108.48 2.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.217 1.007 . . . . 0.0 109.623 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.34 -37.96 2.8 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . 42.0 tt0 -95.33 148.15 22.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.125 0.97 . . . . 0.0 109.763 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.535 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 13.1 pt-20 -89.71 139.94 30.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.809 0.844 . . . . 0.0 110.679 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.3 t -131.75 159.63 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.439 ' OE1' ' HG3' ' A' ' 171' ' ' GLN . 2.2 mm-40 -93.51 160.64 14.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.083 0.553 . . . . 0.0 111.914 -161.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 199' ' ' PRO . 14.5 p -140.05 152.66 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.524 0.73 . . . . 0.0 111.05 176.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 14' ' ' VAL . 88.0 mt -103.39 93.39 4.94 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 164.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 193' ' ' PRO . . . -77.1 97.23 4.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.433 HD23 ' HB3' ' A' ' 167' ' ' PRO . 91.1 mt -73.49 103.92 4.29 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.45 141.1 87.8 Favored Pre-proline 0 CA--C 1.554 1.125 0 O-C-N 123.625 0.578 . . . . 0.0 110.652 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 50' ' ' LEU . 32.3 Cg_endo -61.82 117.87 4.72 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.597 2.865 . . . . 0.0 112.511 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.05 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.419 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -141.09 -173.56 3.76 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.867 0.841 . . . . 0.0 112.02 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.38 159.71 70.86 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 126.016 1.726 . . . . 0.0 113.126 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.433 ' HB3' HD23 ' A' ' 161' ' ' LEU . 5.0 Cg_exo -77.32 117.7 4.44 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.196 2.597 . . . . 0.0 111.433 170.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 168' ' ' ARG . 11.4 mmp_? -75.64 99.55 4.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 18' ' ' ASP . . . -76.1 100.66 5.04 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.508 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 28.4 t -110.02 141.65 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.857 0.863 . . . . 0.0 109.57 -173.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.439 ' HG3' ' OE1' ' A' ' 157' ' ' GLN . 28.1 tt0 -89.73 121.4 31.85 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 34.0 p -123.75 132.22 53.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.343 0.657 . . . . 0.0 111.226 -172.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.535 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 62.3 mttp -92.5 149.72 38.67 Favored Pre-proline 0 C--O 1.246 0.909 0 C-N-CA 125.78 1.632 . . . . 0.0 110.765 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.19 126.72 7.14 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.614 2.209 . . . . 0.0 111.878 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.412 ' HA3' ' OG ' ' A' ' 188' ' ' SER . . . -111.93 -173.25 19.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.45 140.11 19.84 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.193 0.597 . . . . 0.0 110.0 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.583 ' HE2' ' HB1' ' A' ' 186' ' ' ALA . 13.4 m-85 -128.65 150.33 50.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.134 0.974 . . . . 0.0 110.631 -165.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -61.23 127.97 34.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.83 0.852 . . . . 0.0 110.8 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.7 m -130.44 156.83 44.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.179 0.992 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -84.83 54.61 3.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.152 0.977 . . . . 0.0 109.122 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -173.68 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.975 1.71 . . . . 0.0 109.038 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.87 -106.77 0.36 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -140.97 133.4 28.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.05 137.09 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.022 0.529 . . . . 0.0 109.661 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.98 109.42 3.66 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.583 ' HB1' ' HE2' ' A' ' 177' ' ' PHE . . . -149.95 167.91 25.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.978 -173.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.59 128.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.441 0.639 . . . . 0.0 111.346 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.602 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 19.1 m -103.76 80.18 1.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.397 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.492 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 37.9 tp -105.39 104.96 14.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.048 0.451 . . . . 0.0 110.017 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.79 104.51 16.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.42 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 27.3 t80 -178.28 168.26 1.9 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -174.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.6 m -117.16 74.78 7.69 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 117.953 0.342 . . . . 0.0 111.577 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.504 ' HB3' ' HB2' ' A' ' 160' ' ' ALA . 19.5 Cg_endo -88.2 -60.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.151 1.901 . . . . 0.0 110.016 160.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.474 ' O ' ' HBA' ' B' ' 255' ' ' M9P . . . 86.93 -29.98 4.85 Favored Glycine 0 C--N 1.361 1.942 0 C-N-CA 123.731 0.682 . . . . 0.0 112.577 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.53 ' HA ' ' HNE' ' B' ' 255' ' ' M9P . 8.0 t -61.94 99.51 0.13 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.62 1.168 . . . . 0.0 113.244 -165.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.9 m -63.02 121.85 14.61 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.14 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.49 6.48 33.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.398 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.522 ' HG ' HG21 ' A' ' 195' ' ' THR . 62.3 m -45.23 115.14 2.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 123.295 0.638 . . . . 0.0 112.227 168.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.435 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.6 Cg_endo -74.33 119.84 5.97 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.203 2.602 . . . . 0.0 113.96 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.502 HD11 ' HE3' ' A' ' 150' ' ' TRP . 73.3 mt -79.68 93.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.955 0.902 . . . . 0.0 109.261 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.564 HG21 ' HB ' ' A' ' 14' ' ' VAL . 29.2 pt -111.21 178.68 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.015 0.912 . . . . 0.0 111.662 -174.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.4 174.04 6.05 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 166.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 16' ' ' TRP . 84.3 tttt -59.78 -31.76 69.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.746 0.418 . . . . 0.0 111.786 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -82.43 -3.78 56.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.097 0.559 . . . . 0.0 111.994 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.01 26.06 54.06 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -99.54 167.1 10.81 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.032 1.333 . . . . 0.0 109.324 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.585 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 68.9 t 85.68 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 125.606 1.562 . . . . 0.0 109.49 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.6 m 58.25 30.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 125.131 1.372 . . . . 0.0 112.844 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.08 -169.65 2.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.347 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.0 mt -144.94 149.61 35.54 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.485 -1.009 . . . . 0.0 110.994 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -74.6 107.72 6.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 166.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.87 -138.98 3.83 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 124.328 1.018 . . . . 0.0 114.046 -166.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -70.88 87.59 0.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.302 0.641 . . . . 0.0 109.586 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -135.59 -147.67 5.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.189 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.0 167.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.641 0.776 . . . . 0.0 109.589 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 13.9 t -91.91 111.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.424 ' HG1' ' HB ' ' A' ' 223' ' ' VAL . 91.8 m -71.57 140.06 49.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.126 0.97 . . . . 0.0 109.906 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 59.73 12.1 2.78 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.705 0.802 . . . . 0.0 111.861 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t 62.58 18.69 10.7 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.91 1.284 . . . . 0.0 112.072 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.19 7.97 0.39 Allowed Glycine 0 C--N 1.354 1.54 0 CA-C-O 119.682 -0.51 . . . . 0.0 114.345 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.42 ' HA ' ' H ' ' A' ' 191' ' ' PHE . . . -140.61 92.0 2.48 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.759 0.78 . . . . 0.0 110.03 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 15.4 t80 -71.04 101.32 2.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.242 0.544 . . . . 0.0 110.773 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.424 ' HB ' ' HG1' ' A' ' 217' ' ' THR . 54.2 t -116.14 123.42 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.055 1.342 . . . . 0.0 108.841 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.553 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 24.7 t -143.88 158.45 43.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.011 0.524 . . . . 0.0 110.888 -171.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.79 55.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.594 0.758 . . . . 0.0 110.795 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.431 HG13 ' HA ' ' A' ' 186' ' ' ALA . 87.9 mt -81.83 98.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.964 0.411 . . . . 0.0 110.026 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 137' ' ' LEU . . . -81.06 135.41 35.82 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.55 159.33 36.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.793 0.837 . . . . 0.0 110.398 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.694 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 10.9 p -82.83 113.89 20.77 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -145.36 101.6 3.61 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.518 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -158.93 -64.03 0.08 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.695 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.638 ' HB2' ' HB3' ' A' ' 145' ' ' LYS . 7.6 m -119.02 101.72 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.714 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 23.0 pt -111.44 -30.23 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.734 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 236' ' ' ASN . 11.9 tp10 -114.88 160.95 18.9 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.959 1.303 . . . . 0.0 109.055 -171.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.04 -18.32 64.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.365 1.066 . . . . 0.0 111.353 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.556 ' H ' ' HG3' ' A' ' 234' ' ' GLU . 1.1 m120 -59.41 151.15 61.26 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.979 1.312 . . . . 0.0 111.006 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -21.18 92.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.396 1 C-N-CA 126.527 4.818 . . . . 0.0 116.481 -170.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.633 ' HG3' HG13 ' A' ' 239' ' ' ILE . 5.1 pt-20 -92.2 -39.43 11.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.471 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.633 HG13 ' HG3' ' A' ' 238' ' ' GLU . 28.7 mt -88.82 57.34 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--O 1.252 1.205 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -177.735 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.628 ' H6 ' HD11 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.578 ' HG2' ' HB3' ' A' ' 88' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 17.4 tppt? -137.26 134.78 36.54 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 161.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.432 ' O ' HG12 ' A' ' 113' ' ' VAL . 36.5 ttt180 71.43 144.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.953 0.901 . . . . 0.0 109.684 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.645 ' HG ' HNHB ' B' ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.339 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.645 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 t -171.37 150.69 2.93 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.448 0.624 . . . . 0.0 110.185 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 74.86 -57.94 0.59 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.739 1.615 . . . . 0.0 113.261 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.79 45.46 0.96 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.171 0.989 . . . . 0.0 108.659 -170.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.6 m-20 -146.0 26.48 1.22 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.117 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD23 ' HB2' ' A' ' 88' ' ' GLN . 34.9 mt -91.6 93.63 9.03 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.545 0.738 . . . . 0.0 110.14 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.669 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 4.8 mp0 -95.12 131.06 41.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.805 0.842 . . . . 0.0 111.865 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.38 130.45 56.69 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.91 129.08 51.17 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 122.886 0.474 . . . . 0.0 110.527 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.677 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 5.8 tmm_? -75.6 127.61 33.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.356 0.662 . . . . 0.0 110.327 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.677 ' HB1' ' HG3' ' A' ' 85' ' ' ARG . . . -96.1 -56.81 2.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.425 0.69 . . . . 0.0 110.577 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' HB2' ' HG3' ' A' ' 167' ' ' PRO . . . -145.49 -175.08 4.58 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.711 -171.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.26 146.41 23.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.006 0.922 . . . . 0.0 109.839 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.588 HG22 ' HA2' ' A' ' 82' ' ' GLY . 15.1 t -79.49 97.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' N ' HD11 ' A' ' 201' ' ' ILE . 17.6 pttp -173.58 176.36 2.78 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 108.402 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -73.49 136.52 44.16 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.512 176.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -112.94 144.45 42.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.091 0.956 . . . . 0.0 109.598 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.03 -6.28 8.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.301 1.04 . . . . 0.0 112.667 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -71.15 -2.8 16.99 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.556 1.143 . . . . 0.0 111.61 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -36.6 100.08 0.02 OUTLIER 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.915 2.086 . . . . 0.0 114.052 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.12 148.39 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.64 1.176 . . . . 0.0 109.619 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 mm -102.75 104.39 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -144.84 -20.4 0.51 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.849 0.46 . . . . 0.0 111.284 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.66 -173.13 17.25 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.768 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m 71.82 37.9 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.545 1.138 . . . . 0.0 109.278 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -66.86 142.73 97.62 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.692 0.797 . . . . 0.0 110.842 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.63 -176.14 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.225 2.617 . . . . 0.0 114.253 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.43 119.46 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.807 0.843 . . . . 0.0 112.142 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.539 HD12 HG21 ' A' ' 223' ' ' VAL . 7.0 mt -108.28 163.9 12.78 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.967 0.907 . . . . 0.0 111.075 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -120.14 122.51 41.18 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.285 0.634 . . . . 0.0 109.29 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.571 HG23 ' HE2' ' A' ' 39' ' ' MET . 10.5 mt -127.11 149.09 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.98 0.912 . . . . 0.0 110.201 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.2 m -96.99 119.46 35.5 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.096 0.958 . . . . 0.0 110.449 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.834 HG12 HG23 ' A' ' 179' ' ' THR . 35.6 mm -68.63 114.21 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 23.0 t -79.84 134.51 36.33 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.24 4.56 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.35 -13.71 60.12 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 0.0 110.891 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.21 17.51 29.28 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -166.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 55.3 m -105.69 164.81 11.63 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.686 0.794 . . . . 0.0 109.986 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.615 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 2.4 ppp? -127.77 135.83 50.66 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 p -171.29 173.45 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.658 0.783 . . . . 0.0 110.536 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.31 134.09 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 161.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.21 90.19 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.638 0.586 . . . . 0.0 110.371 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -157.08 157.19 34.1 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 108.852 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.36 75.43 1.01 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -114.7 138.46 50.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.202 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.78 161.69 41.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.595 ' HA ' HG22 ' A' ' 97' ' ' ILE . 36.9 tt0 85.15 137.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.622 1.569 . . . . 0.0 113.754 164.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -169.54 134.16 1.4 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.219 1.408 . . . . 0.0 109.299 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 m -78.07 101.92 7.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.081 0.952 . . . . 0.0 111.211 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.4 ' HB3' ' HA ' ' A' ' 163' ' ' PRO . 0.4 OUTLIER -120.43 96.46 5.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.713 0.805 . . . . 0.0 109.288 176.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -163.64 127.36 1.66 Allowed Glycine 0 N--CA 1.469 0.845 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.092 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 -71.4 2.25 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.75 -79.96 1.73 Allowed Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.13 0.395 . . . . 0.0 112.43 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 94.23 0.33 Allowed Glycine 0 C--N 1.342 0.878 0 O-C-N 124.055 0.503 . . . . 0.0 112.217 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.3 m 69.97 23.18 5.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.82 92.05 0.25 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.71 -21.84 22.77 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.658 0.229 . . . . 0.0 112.705 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.22 -77.13 1.28 Allowed Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.41 -63.84 4.27 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' H ' ' A' ' 62' ' ' ALA . 8.0 pt-20 -73.8 1.13 11.16 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.283 1.033 . . . . 0.0 112.462 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 68.78 9.48 7.38 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.832 1.253 . . . . 0.0 111.066 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' H ' ' HG3' ' A' ' 60' ' ' GLU . . . 55.41 18.83 2.78 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 125.4 1.48 . . . . 0.0 112.06 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.92 -78.61 0.03 OUTLIER Glycine 0 C--N 1.354 1.565 0 C-N-CA 122.974 0.321 . . . . 0.0 112.606 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.669 ' HB ' ' HG2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -147.69 70.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.77 0 C-N-CA 124.601 1.16 . . . . 0.0 108.316 176.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.883 HD23 HH22 ' A' ' 85' ' ' ARG . 3.3 pp -37.45 157.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -175.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -165.74 158.57 15.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.462 1.125 . . . . 0.0 111.779 -175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.677 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 29.5 t0 -154.81 60.39 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 154.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 121' ' ' HIS . 7.6 p -141.17 94.09 7.87 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-N 111.598 -2.546 . . . . 0.0 106.735 176.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.532 ' HD2' ' H ' ' A' ' 78' ' ' GLU . 2.1 Cg_endo -85.44 106.12 0.92 Allowed 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 123.134 2.556 . . . . 0.0 111.063 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 p -54.38 104.95 0.46 Allowed Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.885 0.874 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -15.17 83.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.404 1 C-N-CA 127.169 5.246 . . . . 0.0 118.419 -158.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 76' ' ' LYS . 79.9 Cg_endo -99.69 147.82 0.47 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 123.637 2.891 . . . . 0.0 112.844 172.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.77 38.19 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.138 2.558 . . . . 0.0 112.488 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.42 -29.48 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.792 0.837 . . . . 0.0 110.503 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.33 -88.24 0.07 OUTLIER Glycine 0 C--N 1.347 1.167 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 64.4 mttp -89.96 178.45 6.21 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.733 0.813 . . . . 0.0 111.07 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.37 75.28 0.12 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.532 ' H ' ' HD2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER 55.92 -167.45 0.1 Allowed 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.025 0.93 . . . . 0.0 110.885 -160.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp 71.87 25.4 3.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.011 0.924 . . . . 0.0 111.077 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.49 -30.76 69.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 64.42 111.95 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 125.168 1.542 . . . . 0.0 112.215 164.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.588 ' HA2' HG22 ' A' ' 14' ' ' VAL . . . 142.77 -167.08 26.38 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.919 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.16 109.57 12.37 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 1.6 m-85 -87.32 146.28 25.99 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.883 HH22 HD23 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.64 136.9 40.7 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 160.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.69 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 10.8 pt -132.71 142.89 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -162.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 73.4 tttt -123.02 142.84 50.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.187 1.795 . . . . 0.0 111.369 -174.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.803 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 51.7 tt0 -136.1 150.37 49.08 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.568 0.223 . . . . 0.0 110.646 167.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.669 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 91.1 mttt -96.14 92.0 6.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 162.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 169.77 42.4 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.616 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt 67.48 -77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.009 1.324 . . . . 0.0 112.235 163.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.96 -15.04 1.79 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.891 0.876 . . . . 0.0 109.78 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.55 ' HA3' ' HE3' ' B' ' 253' ' ' LYS . . . -144.21 -161.11 8.79 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.669 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 26.7 t80 -150.88 33.86 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -165.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 p -151.8 173.07 15.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -154.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.737 ' HB3' HD21 ' A' ' 65' ' ' LEU . 5.5 pt20 -87.31 120.04 28.19 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.791 1.637 . . . . 0.0 110.909 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.616 ' HB ' ' HG ' ' B' ' 255' ' ' M9P . 2.7 pp -136.0 -37.56 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.576 ' N ' HD13 ' A' ' 97' ' ' ILE . . . -105.76 -172.67 23.68 Favored Glycine 0 N--CA 1.48 1.594 0 C-N-CA 120.214 -0.993 . . . . 0.0 114.811 -159.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.59 125.04 33.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.101 0.56 . . . . 0.0 110.324 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.56 111.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.522 HG13 HG21 ' A' ' 14' ' ' VAL . 91.9 t -88.64 101.83 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.408 0.683 . . . . 0.0 110.829 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 15.0 t80 -91.51 110.19 21.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.489 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 23.3 tptp -144.53 143.78 31.01 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.778 0.674 . . . . 0.0 110.168 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.438 ' HG3' ' HA ' ' A' ' 146' ' ' LEU . 11.8 mm-40 64.92 15.58 10.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.927 1.291 . . . . 0.0 112.739 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.54 -5.22 67.15 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 122.946 0.308 . . . . 0.0 112.981 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.3 p -121.66 138.19 54.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 110.23 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.68 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 73.5 t80 -81.08 137.55 35.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.67 119.33 18.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.191 0.997 . . . . 0.0 110.372 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.661 HG23 ' HB ' ' A' ' 138' ' ' ILE . 2.9 t -138.74 176.72 8.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 0.0 110.517 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 65.9 mmm -84.62 170.73 13.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.595 0.758 . . . . 0.0 110.593 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.56 -54.84 4.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -57.28 -13.66 3.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -168.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.82 -45.92 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 C-N-CA 124.68 1.192 . . . . 0.0 112.983 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.506 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 20.3 m -155.12 149.54 26.19 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.874 1.27 . . . . 0.0 107.59 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 13.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 97.5 62.62 0.9 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 6' ' ' LEU . . . -117.17 -164.76 1.01 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.269 0.628 . . . . 0.0 111.764 -171.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 93.6 t -92.04 129.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.471 1.109 . . . . 0.0 112.47 -162.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.617 HD22 ' H4 ' ' B' ' 251' ' ' BEZ . 1.1 mt -91.81 157.69 16.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.032 -176.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.478 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 2.2 ptm -172.88 179.84 2.23 Favored 'General case' 0 C--O 1.272 2.242 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -171.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.548 ' HB2' HG12 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -147.94 111.14 4.89 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 112.053 -2.34 . . . . 0.0 108.874 178.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.567 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 4.5 mptp? 49.95 34.09 7.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.139 0.975 . . . . 0.0 112.624 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.3 -21.02 46.18 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.561 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 115.5 10.8 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.45 0.7 . . . . 0.0 109.891 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -83.18 149.21 26.98 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.883 1.273 . . . . 0.0 112.555 -164.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.3 mt -142.35 134.29 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 125.471 1.508 . . . . 0.0 109.172 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.49 117.66 68.16 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.449 1.1 . . . . 0.0 110.754 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.16 145.39 66.52 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.414 2.076 . . . . 0.0 111.461 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 72.4 p -98.78 -18.64 17.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.735 0.414 . . . . 0.0 111.945 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.435 ' CZ2' ' HB2' ' A' ' 132' ' ' ASP . 49.2 t-105 -155.91 154.26 30.94 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.701 0.4 . . . . 0.0 111.261 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -160.92 122.0 2.9 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.379 1.472 . . . . 0.0 109.32 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.435 ' HB2' ' CZ2' ' A' ' 130' ' ' TRP . 27.2 t70 -139.25 135.29 33.74 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.458 0.572 . . . . 0.0 111.998 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.43 -42.07 42.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.028 -172.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.55 -48.67 38.21 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.949 0.78 . . . . 0.0 111.543 -168.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.45 -16.57 61.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.329 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 t70 62.83 45.14 5.83 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.703 1.201 . . . . 0.0 109.584 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 80.8 mt -142.4 129.37 20.71 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.772 -171.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.661 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.4 mt -115.66 155.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.511 1.524 . . . . 0.0 108.16 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.0 p -156.95 151.79 25.87 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.094 0.473 . . . . 0.0 112.104 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.68 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.9 t80 -120.25 149.12 42.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.64 1.176 . . . . 0.0 109.133 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.51 -78.58 0.24 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.98 85.44 0.06 OUTLIER Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 170.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.63 133.77 2.22 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -98.52 105.7 17.88 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -166.38 124.11 1.4 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.466 HD22 HG23 ' A' ' 229' ' ' THR . 6.0 mp -124.17 -63.52 1.2 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 175.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 177.97 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.298 0.999 . . . . 0.0 110.646 167.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.27 -171.84 23.16 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -157.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.65 153.66 47.9 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.836 0.854 . . . . 0.0 110.041 -164.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.448 ' HA ' HG13 ' A' ' 208' ' ' VAL . 31.8 t90 -67.28 106.49 2.07 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 165.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -96.25 99.68 11.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.07 110.57 0.37 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.628 1.171 . . . . 0.0 111.748 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.612 ' H ' ' HG2' ' A' ' 174' ' ' PRO . . . 131.02 -42.08 1.44 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.63 121.41 11.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.594 1.158 . . . . 0.0 110.9 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.87 99.47 9.06 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 208' ' ' VAL . 32.9 m -91.59 172.36 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.158 -168.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.432 ' NE2' ' HB2' ' A' ' 171' ' ' GLN . 71.8 mm-40 -108.82 154.9 21.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.438 1.095 . . . . 0.0 109.49 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.57 136.78 40.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.26 88.54 7.24 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.77 101.15 4.96 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.11 95.6 0.57 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -60.45 113.29 7.14 Favored Pre-proline 0 C--N 1.353 0.725 0 O-C-N 124.439 1.087 . . . . 0.0 110.145 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . 31.8 Cg_exo -61.21 114.89 2.4 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.054 1.836 . . . . 0.0 112.087 177.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.27 -14.16 56.92 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.061 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -129.75 -172.73 2.84 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.464 0.706 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -62.32 162.92 16.17 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 125.337 1.455 . . . . 0.0 112.602 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HG3' ' HB2' ' A' ' 12' ' ' ALA . 21.1 Cg_endo -58.91 140.95 97.51 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.108 2.539 . . . . 0.0 111.514 169.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.454 ' HG3' ' HZ ' ' A' ' 191' ' ' PHE . 47.5 mmm-85 -116.05 100.97 8.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.212 0.605 . . . . 0.0 109.841 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.1 118.91 13.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 168.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.46 134.41 49.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.863 0.363 . . . . 0.0 110.282 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.547 ' NE2' ' HE3' ' A' ' 203' ' ' LYS . 59.3 tt0 -87.9 143.18 27.26 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.891 0.876 . . . . 0.0 111.122 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.599 ' HB ' HD12 ' A' ' 189' ' ' LEU . 8.1 t -146.31 133.96 21.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.086 1.354 . . . . 0.0 109.175 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -93.12 140.67 23.4 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.612 ' HG2' ' H ' ' A' ' 153' ' ' GLY . 67.0 Cg_exo -45.34 122.69 4.82 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.83 2.354 . . . . 0.0 114.195 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.04 -173.1 26.39 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -156.36 132.66 10.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.704 0.764 . . . . 0.0 110.076 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.473 ' HE1' ' HB2' ' A' ' 186' ' ' ALA . 22.9 p90 -115.37 121.8 43.91 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.999 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.461 ' HG3' ' HG1' ' A' ' 183' ' ' THR . 87.3 tttt -80.19 153.55 28.52 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.531 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.834 HG23 HG12 ' A' ' 33' ' ' ILE . 27.0 m -137.34 162.17 34.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.466 1.106 . . . . 0.0 108.358 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -59.32 -24.56 63.43 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.644 0.777 . . . . 0.0 111.546 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.442 ' H ' HG22 ' A' ' 179' ' ' THR . . . -82.03 -36.51 27.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.061 0.944 . . . . 0.0 112.085 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.85 -131.68 1.68 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.56 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.461 ' HG1' ' HG3' ' A' ' 178' ' ' LYS . 37.9 m -156.45 127.88 7.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 108.374 175.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.47 133.81 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.34 116.11 5.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.473 ' HB2' ' HE1' ' A' ' 177' ' ' PHE . . . -162.69 -166.15 1.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.334 0.654 . . . . 0.0 111.152 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 172' ' ' THR . 4.6 p -74.84 100.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 CA-C-O 121.719 0.771 . . . . 0.0 110.641 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.479 ' HA ' HG23 ' A' ' 223' ' ' VAL . 29.1 m -96.16 100.2 11.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.599 HD12 ' HB ' ' A' ' 172' ' ' THR . 7.6 tt -135.05 107.46 7.3 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.41 124.91 27.41 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.454 ' HZ ' ' HG3' ' A' ' 168' ' ' ARG . 48.4 t80 -170.11 -179.53 3.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.672 1.189 . . . . 0.0 107.829 -175.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.2 m -58.19 159.19 11.75 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.99 0.916 . . . . 0.0 111.032 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.712 ' HA ' HG11 ' A' ' 216' ' ' VAL . 9.2 Cg_endo -50.13 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.09 2.526 . . . . 0.0 112.252 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.82 163.41 44.25 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.2 t -102.0 137.85 39.74 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.424 0.631 . . . . 0.0 111.361 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' B' ' 255' ' ' M9P . 73.3 m -70.78 105.65 3.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.887 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.75 5.14 8.46 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.027 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.3 m -49.1 116.92 5.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 C-N-CA 123.399 0.679 . . . . 0.0 111.662 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.54 125.11 9.84 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.252 1.968 . . . . 0.0 112.455 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 226' ' ' ILE . 40.8 mt -93.04 106.95 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 122.167 0.984 . . . . 0.0 108.865 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.495 HG21 ' H ' ' A' ' 202' ' ' ASP . 8.7 mt -114.05 -175.58 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.053 1.341 . . . . 0.0 107.616 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.495 ' H ' HG21 ' A' ' 201' ' ' ILE . 33.7 t70 -125.04 170.11 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.464 0.574 . . . . 0.0 110.397 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.547 ' HE3' ' NE2' ' A' ' 171' ' ' GLN . 19.5 mttp -47.17 -50.32 20.82 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.667 1.987 . . . . 0.0 111.403 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.58 -19.9 64.49 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.991 0.917 . . . . 0.0 111.259 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 102.63 6.03 47.44 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -61.63 128.7 37.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.379 0.672 . . . . 0.0 109.203 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.456 HG12 ' HB3' ' A' ' 146' ' ' LEU . 7.6 p -80.74 109.94 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.605 HG12 HG12 ' A' ' 156' ' ' VAL . 80.0 t -83.23 -30.72 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.5 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.693 ' HA2' HG21 ' A' ' 229' ' ' THR . . . 156.97 -149.88 20.8 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.455 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.426 HD21 HG23 ' A' ' 101' ' ' VAL . 78.3 mt -131.54 174.0 10.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.355 1.062 . . . . 0.0 109.554 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -59.94 123.45 17.08 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 164.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.85 177.69 43.41 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.76 97.99 0.68 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.493 0.647 . . . . 0.0 110.402 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.615 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -140.73 -152.72 5.83 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.652 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.25 179.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -169.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.712 HG11 ' HA ' ' A' ' 193' ' ' PRO . 27.2 m -98.41 125.78 51.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 162.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.427 HG22 HD12 ' A' ' 29' ' ' LEU . 10.0 t -95.46 140.58 30.11 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.685 0.394 . . . . 0.0 111.092 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 38.95 -80.65 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.871 2.068 . . . . 0.0 114.401 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.1 p -87.15 16.58 4.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.283 1.033 . . . . 0.0 111.892 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.98 19.34 63.24 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.86 0.267 . . . . 0.0 112.709 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.16 123.09 25.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.269 0.628 . . . . 0.0 110.535 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -65.23 99.03 0.36 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.445 0.698 . . . . 0.0 109.718 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.539 HG21 HD12 ' A' ' 29' ' ' LEU . 63.4 t -131.42 109.74 16.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 122.353 1.073 . . . . 0.0 109.264 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.599 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 15.8 m -137.2 160.16 39.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.997 -169.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.96 153.77 32.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 164.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 200' ' ' ILE . 71.6 mt -101.38 113.15 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.53 147.87 33.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.409 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 9.6 pt20 -134.04 149.88 51.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.506 0.722 . . . . 0.0 109.363 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.693 HG21 ' HA2' ' A' ' 209' ' ' GLY . 51.1 p -105.39 108.54 20.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.518 0.199 . . . . 0.0 111.314 -168.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.29 141.61 13.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -171.0 -59.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.2 p -135.76 91.67 2.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.459 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.49 -18.53 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.716 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.7 101.55 0.26 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.761 1.224 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -122.77 -10.94 8.24 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.432 0.693 . . . . 0.0 111.619 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -76.77 153.19 83.16 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.296 0.638 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.28 154.27 29.82 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.145 2.563 . . . . 0.0 112.537 173.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 69.48 78.83 0.2 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.482 1.113 . . . . 0.0 109.492 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 12.1 tt -130.37 -2.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 124.704 1.202 . . . . 0.0 109.921 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 123.461 0.704 . . . . 0.0 110.686 -175.914 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.69 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.511 ' HD2' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.803 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 2.5 tmtt? -141.98 52.48 1.49 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.23 1.377 . . . . 0.0 113.726 165.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -172.9 131.22 0.51 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 156.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.616 ' HG ' ' HB ' ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.5 p 53.36 -160.77 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.758 1.623 . . . . 0.0 112.609 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.471 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . -103.74 -179.71 4.03 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.523 0.729 . . . . 0.0 110.798 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.87 15.83 0.11 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 110.552 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.532 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.6 m-20 -137.67 65.14 1.49 Allowed 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 5.5 mp -106.57 113.2 26.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.117 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 24.2 mm-40 -112.33 127.87 56.12 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.935 0.894 . . . . 0.0 111.809 -165.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.46 148.83 27.69 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.951 -0.468 . . . . 0.0 112.217 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -145.82 140.68 27.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.273 1.029 . . . . 0.0 109.24 173.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.692 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 7.1 ptm180 -60.97 143.28 55.53 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.677 0.672 . . . . 0.0 110.353 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.33 -39.08 3.92 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 170.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.01 -171.27 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.96 148.58 24.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.989 0.916 . . . . 0.0 110.095 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.62 97.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -157.53 157.28 33.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.914 1.286 . . . . 0.0 108.606 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -70.43 115.24 9.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 160.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.88 143.97 32.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.0 -4.81 18.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.865 0.466 . . . . 0.0 111.766 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.69 49.68 0.64 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.921 1.288 . . . . 0.0 110.723 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -64.6 89.98 0.07 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.261 1.024 . . . . 0.0 110.54 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.0 tp10 -90.75 101.92 14.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.318 1.047 . . . . 0.0 108.717 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.44 101.68 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.5 m -160.12 96.05 1.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.556 1.142 . . . . 0.0 109.512 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -133.36 2.92 Favored Glycine 0 N--CA 1.467 0.734 0 CA-C-O 119.334 -0.704 . . . . 0.0 111.983 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m 62.99 40.75 8.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.359 1.064 . . . . 0.0 109.6 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 m -62.98 116.87 27.59 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.176 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.94 -78.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.418 2.745 . . . . 0.0 112.573 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 178' ' ' LYS . 7.7 tp -113.52 145.59 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.022 0.529 . . . . 0.0 109.717 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.705 ' HB3' ' HB3' ' A' ' 177' ' ' PHE . 52.8 tp -132.72 155.16 49.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.653 0.781 . . . . 0.0 109.403 172.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.1 p -97.99 122.37 41.04 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 177' ' ' PHE . 9.4 tp -117.89 152.29 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 122.73 0.412 . . . . 0.0 110.343 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.9 m -105.47 107.49 18.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.695 0.798 . . . . 0.0 109.998 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.61 116.87 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.057 0.943 . . . . 0.0 108.544 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 m -104.29 114.31 28.46 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 110.534 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.88 19.83 10.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.973 1.309 . . . . 0.0 112.025 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 p30 51.4 8.8 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.987 2.115 . . . . 0.0 114.788 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.29 -48.64 0.98 Allowed Glycine 0 C--N 1.349 1.284 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.2 p -106.0 164.79 11.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.454 0.701 . . . . 0.0 109.671 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 213' ' ' ASN . 2.5 ppp? -124.14 149.95 45.67 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 76.3 p -178.94 -175.82 0.41 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.26 1.024 . . . . 0.0 109.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.563 ' H ' HG12 ' A' ' 215' ' ' VAL . 3.2 mp -106.51 152.24 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 157.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -68.73 82.99 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -121.77 152.66 39.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.288 1.435 . . . . 0.0 108.85 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.34 49.73 1.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.744 0.783 . . . . 0.0 109.899 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.78 104.41 11.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.825 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.05 -38.48 63.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.665 0.786 . . . . 0.0 110.925 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 85.71 -49.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.374 1.869 . . . . 0.0 110.982 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 47.98 31.47 2.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 126.196 1.798 . . . . 0.0 113.717 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -145.73 112.0 5.75 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.845 0.858 . . . . 0.0 109.668 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.496 HD22 ' HB3' ' A' ' 161' ' ' LEU . 0.4 OUTLIER -168.63 -52.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.041 0.936 . . . . 0.0 108.76 174.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.671 ' HA2' ' HD3' ' A' ' 85' ' ' ARG . . . -75.04 62.32 2.54 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 115.451 -0.795 . . . . 0.0 114.124 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 -75.01 1.29 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.92 25.08 67.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.77 0.335 . . . . 0.0 113.406 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.66 -35.79 0.06 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.2 m 62.82 32.91 15.64 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.547 1.139 . . . . 0.0 112.172 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.99 -167.52 40.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.601 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.56 -77.78 1.55 Allowed Glycine 0 C--N 1.351 1.378 0 N-CA-C 112.402 -0.279 . . . . 0.0 112.402 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.2 59.96 0.53 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.58 48.13 3.91 Favored Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -143.62 -68.68 0.33 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.024 1.33 . . . . 0.0 107.759 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.99 -62.53 1.59 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.26 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.71 39.07 29.77 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.735 1.214 . . . . 0.0 110.183 -169.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' ' HD3' ' A' ' 122' ' ' LYS . . . 84.06 -103.33 2.58 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -161.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.407 ' H ' ' HD3' ' A' ' 122' ' ' LYS . 3.5 t -145.0 -88.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.4 tp -164.69 139.25 5.32 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.029 1.331 . . . . 0.0 108.001 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.488 ' CD1' ' HE2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -164.74 67.72 0.15 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.692 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t0 -104.76 71.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 119.566 -1.959 . . . . 0.0 107.156 163.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.551 HG13 ' HD1' ' A' ' 121' ' ' HIS . 0.3 OUTLIER -132.46 102.14 14.2 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 112.815 -1.993 . . . . 0.0 106.573 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.504 ' HG2' ' H ' ' A' ' 79' ' ' LEU . 60.4 Cg_endo -70.4 118.12 5.51 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 123.356 2.704 . . . . 0.0 113.517 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 m -74.95 139.39 73.19 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.696 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.7 118.67 5.56 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.182 2.588 . . . . 0.0 113.085 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.88 -39.6 89.42 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 123.273 2.649 . . . . 0.0 114.039 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.6 -84.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.49 1.568 . . . . 0.0 110.752 164.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 p -174.81 -46.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.104 0.962 . . . . 0.0 110.74 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.04 78.7 1.68 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.914 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -168.84 158.67 9.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.38 1.072 . . . . 0.0 109.216 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.529 ' HB1' ' HH ' ' A' ' 140' ' ' TYR . . . -95.01 -173.73 3.04 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 169.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.88 143.66 30.6 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.504 ' H ' ' HG2' ' A' ' 69' ' ' PRO . 1.8 pt? -166.69 80.95 0.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.61 0.719 . . . . 0.0 110.873 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB2' ' HD3' ' A' ' 69' ' ' PRO . 13.5 tp10 -76.05 -19.73 58.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.83 104.18 0.03 OUTLIER 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.53 1.532 . . . . 0.0 111.937 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.81 -170.44 31.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.759 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.53 108.31 17.23 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 16.3 m-85 -88.64 140.01 29.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 110.1 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.671 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 6.0 ptp180 -80.71 126.02 30.77 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 161.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.621 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 17.2 pt -122.14 135.45 62.23 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 CA-C-O 121.31 0.576 . . . . 0.0 111.251 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.532 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 86.8 tttt -135.16 138.96 44.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.857 1.663 . . . . 0.0 108.586 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.675 ' HB3' ' HB3' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -143.43 151.8 40.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 27.1 tttm -97.35 93.13 6.32 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 125.857 1.973 . . . . 0.0 107.698 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.448 ' HA3' HE22 ' A' ' 88' ' ' GLN . . . -172.88 173.45 45.55 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-O 118.705 -1.053 . . . . 0.0 110.932 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 52.2 mt 72.42 -64.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.802 0.841 . . . . 0.0 112.049 165.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.452 HD13 ' HD2' ' B' ' 253' ' ' LYS . 1.3 pp -132.68 -9.31 3.17 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.946 0.898 . . . . 0.0 111.87 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.71 -153.74 24.8 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.93 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 6.6 m-85 -88.57 120.89 30.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.219 1.007 . . . . 0.0 109.866 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.457 ' HB2' ' HE2' ' B' ' 253' ' ' LYS . 15.2 m -141.38 133.96 28.47 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 118.346 0.521 . . . . 0.0 110.912 167.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' HB2' ' H ' ' A' ' 51' ' ' GLY . 6.6 pt20 -95.5 105.15 17.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.03 1.332 . . . . 0.0 108.899 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.587 ' HB ' ' HG ' ' B' ' 255' ' ' M9P . 2.7 pp -134.0 -41.32 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -164.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.546 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -111.5 -177.91 20.25 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 119.639 1.109 . . . . 0.0 115.639 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -124.17 124.11 41.75 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.398 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.94 121.02 3.8 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.424 HG13 ' HG3' ' A' ' 199' ' ' PRO . 33.5 m -105.71 118.69 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.984 0.892 . . . . 0.0 111.525 -166.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.543 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 18.5 t80 -98.56 125.5 43.82 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -138.43 149.35 45.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.073 0.949 . . . . 0.0 109.187 168.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 145' ' ' LYS . 13.0 tp10 64.81 -82.19 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.796 1.238 . . . . 0.0 111.229 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -156.96 25.95 0.5 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 t -143.97 129.05 18.62 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.329 0.652 . . . . 0.0 110.876 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.751 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 68.9 t80 -96.48 86.55 4.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.566 ' HD2' ' HB3' ' A' ' 139' ' ' SER . 28.6 t-80 -95.14 120.39 35.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.272 -173.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 t -136.15 -156.56 0.72 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.929 0.891 . . . . 0.0 109.944 -174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.73 22.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.528 1.131 . . . . 0.0 110.677 -166.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -86.25 -49.96 7.31 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -60.59 -17.17 44.9 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.0 m -68.04 -57.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 C-N-CA 123.318 0.647 . . . . 0.0 110.81 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.586 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 23.2 m -149.43 142.93 25.36 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -75.81 18.74 0.24 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.91 62.57 0.75 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.41 168.85 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.645 0.778 . . . . 0.0 110.23 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.27 134.61 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.583 0.753 . . . . 0.0 113.016 -164.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.61 HD21 ' HE1' ' B' ' 252' ' ' NLE . 13.7 mt -98.14 161.06 13.9 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.532 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -172.11 175.02 3.87 Favored 'General case' 0 C--O 1.267 1.986 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 21.7 t60 -121.18 95.48 4.71 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.819 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.511 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 46.1 mttm 25.77 60.32 0.07 Allowed 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 125.376 1.471 . . . . 0.0 113.667 -164.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.63 58.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.0 -0.889 . . . . 0.0 114.777 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 121' ' ' HIS . 8.9 tmtt? -83.79 113.37 20.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.526 1.163 . . . . 0.0 108.836 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.65 131.48 50.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.444 1.498 . . . . 0.0 113.384 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -139.43 115.52 9.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 C-N-CA 125.137 1.375 . . . . 0.0 108.526 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.55 121.56 72.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.37 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.511 ' HG3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 Cg_exo -62.73 179.03 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.024 2.483 . . . . 0.0 113.595 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.1 t -120.39 -34.09 3.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 111.887 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.663 ' HB3' ' HG ' ' A' ' 139' ' ' SER . 25.0 t-105 -156.45 151.74 26.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.38 0.272 . . . . 0.0 110.937 -170.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -151.24 124.33 8.72 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.233 1.413 . . . . 0.0 109.799 168.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -128.81 128.04 43.13 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.288 0.635 . . . . 0.0 109.621 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 t -75.48 -46.65 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.644 1.178 . . . . 0.0 110.872 -172.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -75.02 -45.94 38.38 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.367 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -15.9 60.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 61.98 43.33 9.17 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.562 1.164 . . . . 0.0 110.687 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.401 HD13 ' HE1' ' A' ' 108' ' ' HIS . 82.0 mt -140.72 135.71 31.85 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.677 -172.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 130' ' ' TRP . 46.3 mt -122.03 160.5 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.761 1.624 . . . . 0.0 108.479 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.663 ' HG ' ' HB3' ' A' ' 130' ' ' TRP . 53.9 p -153.86 155.53 35.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.185 0.448 . . . . 0.0 111.585 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.5 t80 -115.38 149.81 37.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.134 1.374 . . . . 0.0 108.917 170.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.78 -109.56 2.16 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.16 82.38 0.05 OUTLIER Glycine 0 C--O 1.239 0.452 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.51 136.92 2.95 Favored Glycine 0 C--O 1.239 0.425 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.423 ' CH2' ' HB2' ' A' ' 146' ' ' LEU . 3.0 t-105 -105.76 106.31 16.75 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.536 1.168 . . . . 0.0 108.557 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.5 ' HA ' ' OG ' ' A' ' 232' ' ' SER . 53.4 mtmt -131.19 123.44 28.49 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.984 0.913 . . . . 0.0 109.816 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 144' ' ' TRP . 23.9 tp -129.63 -85.93 0.54 Allowed 'General case' 0 C--N 1.348 0.511 0 O-C-N 123.855 0.722 . . . . 0.0 109.285 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 233' ' ' ILE . 10.5 tp10 176.98 -66.02 0.01 OUTLIER 'General case' 0 C--N 1.361 1.077 0 O-C-N 123.759 0.662 . . . . 0.0 110.868 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' A' ' 206' ' ' LYS . . . -140.35 -161.94 8.91 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -166.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 228' ' ' GLN . 34.5 tt0 -148.32 163.86 35.79 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.046 1.339 . . . . 0.0 108.966 -167.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.529 ' HA ' HG22 ' A' ' 208' ' ' VAL . 30.8 t90 -66.84 146.88 53.95 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 176.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.54 132.94 21.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.558 1.143 . . . . 0.0 109.218 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.82 162.95 28.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.339 0.656 . . . . 0.0 110.578 174.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.38 -31.21 4.91 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.28 138.66 31.23 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.921 0.888 . . . . 0.0 109.39 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.32 135.24 38.38 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.403 ' HB ' ' CG2' ' A' ' 200' ' ' ILE . 36.0 m -106.11 140.43 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 123.434 0.694 . . . . 0.0 110.351 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -109.21 150.74 27.47 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.83 113.44 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.512 0.325 . . . . 0.0 110.77 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 167' ' ' PRO . 2.3 pt? -67.92 87.56 0.25 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 0.0 109.26 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 167' ' ' PRO . . . -71.13 111.61 6.62 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.392 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 167' ' ' PRO . 96.7 mt -68.78 80.34 0.29 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.34 125.33 86.94 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.791 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.81 114.27 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.108 2.539 . . . . 0.0 114.06 -170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.35 61.42 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.401 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -151.43 163.29 39.32 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.409 0.684 . . . . 0.0 110.286 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 157.67 48.3 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.146 0.978 . . . . 0.0 112.233 174.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.642 ' HB2' ' HB2' ' A' ' 159' ' ' LEU . 69.3 Cg_endo -69.8 117.02 4.84 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.675 2.25 . . . . 0.0 112.292 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -97.84 112.74 24.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 159' ' ' LEU . . . -72.05 101.78 2.82 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.207 0.527 . . . . 0.0 110.084 -175.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.419 HG11 HD23 ' A' ' 189' ' ' LEU . 44.9 t -85.33 109.52 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.413 -174.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -84.46 105.57 15.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.095 0.872 . . . . 0.0 108.879 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.487 HG21 HD11 ' A' ' 189' ' ' LEU . 9.8 t -127.99 157.61 40.13 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.865 1.266 . . . . 0.0 109.627 -174.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -99.41 160.23 28.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.49 159.05 33.39 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.198 1.932 . . . . 0.0 113.151 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -145.95 -171.14 15.18 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.12 149.52 30.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.661 0.73 . . . . 0.0 111.013 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 1.3 p90 -131.63 127.58 37.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.427 1.091 . . . . 0.0 109.453 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.556 ' HB2' HD12 ' A' ' 28' ' ' ILE . 43.9 tttm -78.58 132.01 36.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 -165.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.467 HG21 ' H ' ' A' ' 181' ' ' ALA . 32.7 m -90.68 162.98 14.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 109.228 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -54.34 -40.67 68.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.467 ' H ' HG21 ' A' ' 179' ' ' THR . . . -103.97 2.34 32.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.957 0.903 . . . . 0.0 112.995 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.47 -126.44 1.27 Allowed Glycine 0 C--N 1.351 1.408 0 C-N-CA 121.471 -0.395 . . . . 0.0 113.11 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.8 t -157.38 153.93 28.07 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.437 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mt -116.17 127.93 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.17 119.96 6.66 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.79 -156.22 0.49 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 0.0 109.798 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.42 106.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.876 0.846 . . . . 0.0 109.296 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.571 ' HA ' HG12 ' A' ' 223' ' ' VAL . 23.0 t -103.8 106.07 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 172' ' ' THR . 3.8 tt -128.54 129.63 46.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -172.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.709 ' HA ' ' HB3' ' A' ' 221' ' ' ALA . 8.7 p-10 -107.22 120.53 42.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.028 0.531 . . . . 0.0 109.708 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -170.88 168.48 7.13 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.553 1.141 . . . . 0.0 108.793 -171.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.9 p -54.36 136.07 60.91 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.284 0.634 . . . . 0.0 110.832 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.3 95.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 124.272 3.315 . . . . 0.0 114.932 -167.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.46 44.45 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.189 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 161' ' ' LEU . 7.7 t -103.87 143.98 32.11 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 112.244 -170.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.468 ' HA ' ' OH ' ' A' ' 222' ' ' TYR . 48.2 m -68.29 116.15 8.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.427 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.02 -4.48 23.97 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.356 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 75.5 m -52.19 118.81 13.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 122.963 0.505 . . . . 0.0 111.922 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.457 ' HG2' HD23 ' A' ' 159' ' ' LEU . 85.9 Cg_endo -79.53 141.07 15.46 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.755 2.303 . . . . 0.0 113.129 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 226' ' ' ILE . 14.4 mt -93.49 111.07 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.468 HD13 HD22 ' A' ' 159' ' ' LEU . 45.6 mt -119.23 155.76 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 110.236 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.63 164.61 12.34 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.665 1.186 . . . . 0.0 108.377 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.27 -24.27 64.8 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.653 1.181 . . . . 0.0 112.098 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -71.1 -16.66 62.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.043 1.337 . . . . 0.0 111.818 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.86 78.18 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.437 ' HE3' ' HA3' ' A' ' 148' ' ' GLY . 41.2 tttp -86.83 121.53 29.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.475 1.11 . . . . 0.0 108.437 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.42 109.31 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 150' ' ' TRP . 10.7 p -92.61 7.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.192 0.997 . . . . 0.0 110.237 -173.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.3 -164.9 32.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.846 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 49.5 mt -137.16 150.61 48.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.488 ' HB3' ' HH ' ' A' ' 222' ' ' TYR . 7.8 m-85 -69.37 108.27 3.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.14 -133.78 4.93 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.833 1.333 . . . . 0.0 112.9 -171.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.445 ' O ' ' SD ' ' A' ' 39' ' ' MET . 3.3 t-20 -67.38 97.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -162.16 -162.46 13.34 Favored Glycine 0 C--O 1.244 0.738 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.221 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 41' ' ' ILE . 12.2 p -167.03 168.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.6 0.76 . . . . 0.0 109.625 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 17.3 m -68.99 114.32 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.543 ' HG1' HD11 ' A' ' 29' ' ' LEU . 6.0 t -81.18 -178.65 7.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.382 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -36.39 117.42 0.48 Allowed 'General case' 0 C--N 1.36 1.036 0 O-C-N 125.375 1.672 . . . . 0.0 112.403 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.5 t 86.46 6.04 0.36 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.063 1.745 . . . . 0.0 112.085 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.8 32.28 9.3 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.596 -0.275 . . . . 0.0 113.149 174.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.709 ' HB3' ' HA ' ' A' ' 190' ' ' ASP . . . -98.07 105.01 17.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 10.3 t80 -67.09 103.45 1.19 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 188' ' ' SER . 87.6 t -118.33 139.6 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.112 1.365 . . . . 0.0 108.694 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.51 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 44.8 t -153.4 156.58 38.51 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.025 0.44 . . . . 0.0 111.932 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.0 130.62 41.4 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 200' ' ' ILE . 69.2 mt -70.85 111.88 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.607 0.363 . . . . 0.0 110.67 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -74.64 152.51 39.19 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 11.0 pt20 -145.1 162.27 37.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.653 0.781 . . . . 0.0 110.439 -172.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 26.6 m -85.21 108.88 17.94 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -105.24 32.87 3.96 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.956 0.902 . . . . 0.0 109.827 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -141.21 -70.13 0.37 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.007 0.523 . . . . 0.0 109.954 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 145' ' ' LYS . 19.8 p -107.31 99.16 8.71 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.795 0.838 . . . . 0.0 111.829 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 147' ' ' GLU . 48.6 mt -124.68 122.82 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -131.21 106.92 8.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 110.276 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -92.3 -18.34 23.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.586 0.754 . . . . 0.0 111.678 175.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -71.49 113.67 21.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 123.157 0.583 . . . . 0.0 109.946 -172.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -86.54 12.06 3.11 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.324 2.683 . . . . 0.0 114.409 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 -32.1 67.97 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.353 0.524 . . . . 0.0 110.756 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.7 -27.52 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.762 0.825 . . . . 0.0 110.146 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 123.562 0.745 . . . . 0.0 109.462 178.478 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.621 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 95' ' ' SER . 2.9 tppp? -130.24 140.51 50.7 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.612 1.165 . . . . 0.0 108.713 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 70.79 138.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.43 1.092 . . . . 0.0 111.396 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.587 ' HG ' ' HB ' ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.279 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 p -165.1 134.57 3.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.471 1.108 . . . . 0.0 108.023 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.89 165.54 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.758 1.223 . . . . 0.0 111.756 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 81.0 21.63 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.116 1.367 . . . . 0.0 112.028 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.753 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.2 t70 -168.07 52.47 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 88' ' ' GLN . 53.2 mt -86.59 91.02 8.44 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.677 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.44 ' HB3' ' NE2' ' A' ' 121' ' ' HIS . 13.0 mm-40 -87.23 124.37 33.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.2 1.0 . . . . 0.0 110.988 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD22 HD12 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.15 125.99 43.41 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . 33.2 tt0 -109.61 157.94 18.54 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 167.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 84' ' ' TYR . 21.3 ttt180 -92.96 141.7 28.12 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.822 1.192 . . . . 0.0 110.904 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.29 -55.71 2.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.44 -159.97 0.84 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.899 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.47 153.44 20.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.185 0.594 . . . . 0.0 110.141 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.575 HG12 HG21 ' A' ' 201' ' ' ILE . 3.0 t -79.58 97.93 2.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -173.94 164.47 4.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.643 0.777 . . . . 0.0 109.19 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -64.48 126.31 27.45 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.107 0.563 . . . . 0.0 111.475 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 10.8 tp10 -97.1 145.57 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.164 0.986 . . . . 0.0 109.042 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -9.72 2.3 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.679 1.191 . . . . 0.0 113.49 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 28.5 mm-40 -80.81 51.78 1.59 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.954 1.302 . . . . 0.0 111.161 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.29 3.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.286 1.034 . . . . 0.0 112.05 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -94.42 91.54 6.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.003 0.921 . . . . 0.0 110.443 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' ' 171' ' ' GLN . 17.7 mt -79.25 102.85 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -158.11 -35.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.114 0.566 . . . . 0.0 111.023 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.09 99.43 0.04 OUTLIER Glycine 0 C--N 1.356 1.654 0 O-C-N 124.067 0.854 . . . . 0.0 113.979 -170.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.6 p 168.3 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.927 1.691 . . . . 0.0 108.093 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.517 ' HB3' ' HB2' ' A' ' 190' ' ' ASP . 77.4 p -70.13 159.79 83.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.28 175.66 1.02 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.183 1.922 . . . . 0.0 112.931 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.79 111.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.574 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 55.9 tp -102.93 134.88 45.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -164.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.6 t -80.55 114.3 19.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.583 HG23 ' HE2' ' A' ' 39' ' ' MET . 33.1 mt -113.38 148.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.474 ' OG1' ' HG3' ' A' ' 42' ' ' LYS . 6.7 m -91.83 105.37 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' HB ' HG21 ' A' ' 179' ' ' THR . 10.1 tp -79.85 156.5 4.58 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.015 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.7 m -145.34 114.24 6.9 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.224 0.61 . . . . 0.0 110.178 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 62.4 14.51 6.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.748 1.219 . . . . 0.0 112.142 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.2 t70 74.74 -20.07 0.35 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.557 1.943 . . . . 0.0 112.482 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.67 -48.23 3.49 Favored Glycine 0 C--N 1.353 1.489 0 C-N-CA 123.137 0.398 . . . . 0.0 112.675 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.8 p -100.56 157.52 16.6 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.583 ' HE2' HG23 ' A' ' 31' ' ' ILE . 4.7 ppp? -145.42 135.58 23.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.137 0.575 . . . . 0.0 110.156 -176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.3 p -154.12 -178.15 6.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 109.592 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' H ' HG23 ' A' ' 215' ' ' VAL . 9.4 tp -107.05 156.16 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.474 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 7.3 mtpm? -67.84 113.24 5.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 163.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.55 91.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.368 1.467 . . . . 0.0 110.528 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.51 116.68 32.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.285 0.634 . . . . 0.0 109.8 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.02 114.49 4.23 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.532 0.733 . . . . 0.0 109.275 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.74 138.27 12.9 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -173.79 116.14 0.23 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -156.5 136.76 12.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 14.7 t -77.48 -168.24 1.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.653 0.781 . . . . 0.0 111.525 -173.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 161' ' ' LEU . 1.9 tt -153.14 -54.84 0.12 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.09 -19.55 60.78 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.064 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.65 28.58 6.91 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.051 0.358 . . . . 0.0 113.494 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.17 68.27 3.47 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 169.65 71.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -74.35 166.81 22.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.539 0.735 . . . . 0.0 112.234 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.08 -20.72 2.83 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.232 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.56 -114.01 1.45 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.55 172.54 38.06 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 122.969 0.319 . . . . 0.0 113.552 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.84 19.01 35.97 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.661 -0.521 . . . . 0.0 112.978 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -22.36 62.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.889 1.276 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -65.54 -47.17 76.8 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.248 1.019 . . . . 0.0 111.094 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.65 -72.34 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.848 0.459 . . . . 0.0 110.533 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.04 123.35 7.31 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.669 HG13 ' HZ1' ' A' ' 87' ' ' LYS . 7.0 t -91.11 171.29 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 117.714 0.757 . . . . 0.0 108.994 -165.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -93.34 140.42 29.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.419 0.688 . . . . 0.0 112.105 173.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.527 ' HB3' ' CE1' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -152.79 -176.38 5.72 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 27.4 t70 -177.98 68.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG11 ' HE2' ' A' ' 84' ' ' TYR . 15.4 m -134.73 164.31 44.93 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.958 -162.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.606 ' HB3' HD22 ' A' ' 79' ' ' LEU . 29.3 Cg_endo -60.76 124.57 15.25 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.893 2.395 . . . . 0.0 112.892 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 46.7 m -100.72 -179.33 0.8 Allowed Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.389 1.076 . . . . 0.0 109.312 176.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 5.2 Cg_exo -38.22 137.71 0.48 Allowed 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 123.864 3.042 . . . . 0.0 114.805 169.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.13 -36.12 54.18 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 124.342 3.361 . . . . 0.0 116.023 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.54 -141.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.096 1.864 . . . . 0.0 110.989 165.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 p 57.56 16.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 C-N-CA 125.571 1.548 . . . . 0.0 113.135 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.83 -31.56 5.12 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.828 -0.429 . . . . 0.0 112.462 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 76.29 -45.76 0.52 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.042 1.737 . . . . 0.0 113.401 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.94 85.07 0.08 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.542 0.737 . . . . 0.0 110.123 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -173.73 93.61 0.09 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.571 1.148 . . . . 0.0 108.263 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -146.54 -59.6 0.3 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER 60.4 41.58 15.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.851 0.861 . . . . 0.0 112.524 168.245 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 103' ' ' LYS . 7.8 p-10 -70.48 129.32 38.92 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.774 0.321 . . . . 0.0 110.483 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 172.82 -146.86 9.34 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.019 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.14 108.87 17.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 14.0 m-85 -89.44 158.42 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.642 0.777 . . . . 0.0 112.064 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 83.4 mtt180 -93.43 156.85 16.52 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.089 1.356 . . . . 0.0 110.136 163.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.794 HG21 ' HA ' ' B' ' 252' ' ' NLE . 0.6 OUTLIER -126.36 106.32 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.641 -166.099 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.669 ' HZ1' HG13 ' A' ' 64' ' ' VAL . 80.7 tttt -124.4 131.91 53.51 Favored 'General case' 0 C--N 1.406 3.045 0 C-N-CA 124.725 1.21 . . . . 0.0 113.048 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.69 ' HB2' HD22 ' A' ' 6' ' ' LEU . 6.9 tp60 -134.27 151.2 51.15 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -87.48 85.58 7.14 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.71 169.85 40.91 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 114.032 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.787 HG12 ' HD2' ' B' ' 253' ' ' LYS 0.254 0.1 OUTLIER 30.2 39.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.3 2.24 . . . . 0.0 114.323 178.708 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp 158.13 -57.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 128.261 2.624 . . . . 0.0 106.177 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.0 -152.43 24.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.573 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -58.96 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.727 0.811 . . . . 0.0 110.227 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.4 m -143.54 123.79 13.78 Favored 'General case' 0 C--O 1.256 1.418 0 CA-C-N 118.471 0.578 . . . . 0.0 111.171 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.53 119.61 32.17 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 166.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 86' ' ' ILE . 1.9 pp -124.84 -42.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.514 ' N ' HD13 ' A' ' 97' ' ' ILE . . . -115.79 -163.9 13.88 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.01 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.17 122.33 36.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.912 0.485 . . . . 0.0 110.101 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.97 174.87 26.95 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.518 HG12 HG23 ' A' ' 14' ' ' VAL . 54.9 t -137.24 135.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.52 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 34.9 t80 -151.27 122.57 7.8 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 5.9 mtmp? -135.92 136.46 40.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 61.95 -81.67 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.948 1.405 . . . . 0.0 111.989 170.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.05 28.98 1.12 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-O 120.188 -0.229 . . . . 0.0 112.666 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -144.47 125.27 14.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 0.0 110.139 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.711 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 5.7 t80 -97.91 121.22 39.56 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -110.14 108.25 18.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.069 0.948 . . . . 0.0 109.41 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.555 HG22 ' HB ' ' A' ' 138' ' ' ILE . 10.1 t -136.46 -156.37 0.7 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.366 0.666 . . . . 0.0 110.261 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.515 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 31.6 ttm -149.37 152.44 35.79 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -154.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -43.25 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.438 1.095 . . . . 0.0 113.019 -176.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 4.3 p-80 -64.86 -22.44 66.99 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.144 0.429 . . . . 0.0 111.31 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.72 -44.23 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.722 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 96.8 m -148.89 147.61 28.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 119.242 0.928 . . . . 0.0 109.214 166.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -71.52 32.73 0.05 Allowed 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 126.275 1.83 . . . . 0.0 115.857 -168.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.463 ' HA2' HD11 ' A' ' 138' ' ' ILE . . . 87.41 45.77 5.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.68 0.673 . . . . 0.0 113.264 171.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.636 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . -97.46 -169.73 1.89 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.115 0.566 . . . . 0.0 112.296 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.587 HG21 ' HA ' ' A' ' 127' ' ' GLU . 8.9 p -100.45 139.75 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.642 1.177 . . . . 0.0 111.986 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 140' ' ' TYR . 16.0 mt -85.27 171.4 11.95 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 118.078 0.399 . . . . 0.0 111.271 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.753 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.9 ptp -178.5 177.3 0.94 Allowed 'General case' 0 C--O 1.283 2.845 0 CA-C-O 122.17 0.986 . . . . 0.0 112.37 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.527 ' CE1' ' HB3' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -166.33 120.87 1.14 Allowed 'General case' 0 C--N 1.365 1.26 0 CA-C-N 113.384 -1.735 . . . . 0.0 114.173 167.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.489 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 19.1 mtpp 48.48 40.62 15.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.82 1.325 . . . . 0.0 113.34 158.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.28 19.25 14.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.742 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 120' ' ' MET . 13.0 tppt? -137.11 158.83 43.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.353 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -143.58 124.95 14.68 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.859 1.209 . . . . 0.0 112.795 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 60.3 mt -103.74 118.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.264 1.425 . . . . 0.0 109.592 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.587 ' HA ' HG21 ' A' ' 118' ' ' VAL . 33.8 mt-10 -87.92 138.42 31.13 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.642 0.777 . . . . 0.0 112.096 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 73.9 Cg_endo -71.86 156.37 56.75 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.312 2.674 . . . . 0.0 113.69 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 p -124.06 -20.68 5.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.554 0.742 . . . . 0.0 110.975 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 17.5 t-105 -148.77 146.02 27.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.544 0.737 . . . . 0.0 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.49 125.75 8.0 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.205 1.402 . . . . 0.0 108.573 167.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -138.47 128.21 25.08 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.506 0.593 . . . . 0.0 111.114 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.34 -32.18 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.913 0.885 . . . . 0.0 111.341 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -73.37 -38.1 65.81 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.065 0.946 . . . . 0.0 110.051 -171.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.51 -17.07 37.47 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.727 0.811 . . . . 0.0 109.461 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 59.53 36.39 22.88 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 125.025 1.33 . . . . 0.0 109.482 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 1.5 mp -137.84 140.67 40.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.671 0.748 . . . . 0.0 110.563 -169.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.555 ' HB ' HG22 ' A' ' 109' ' ' THR . 73.1 mt -124.09 148.03 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.765 1.626 . . . . 0.0 108.251 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 32.9 t -141.91 143.7 33.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 111.265 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.711 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 3.5 m-85 -119.88 146.26 45.93 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.998 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.08 35.97 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.499 0.499 . . . . 0.0 112.2 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 159.3 -161.39 32.05 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.9 132.7 11.35 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 166.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.692 ' NE1' ' HA ' ' A' ' 229' ' ' THR . 4.9 p90 -75.7 107.68 8.03 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.193 0.997 . . . . 0.0 111.169 -169.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -116.33 116.37 27.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.535 ' HB2' HG23 ' A' ' 229' ' ' THR . 5.7 mp -131.62 -66.51 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 172.11 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.708 0.803 . . . . 0.0 109.407 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 207' ' ' VAL . . . -47.31 109.64 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 118.065 1.986 . . . . 0.0 118.065 -162.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -142.59 94.23 2.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.564 ' HE3' HD13 ' A' ' 200' ' ' ILE . 7.8 t90 -56.75 109.91 0.71 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.25 123.64 32.47 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.407 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.82 135.86 35.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.984 0.914 . . . . 0.0 111.663 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 110.48 -59.22 0.36 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -172.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.0 111.28 17.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.622 0.769 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.46 152.39 40.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.194 0.598 . . . . 0.0 111.736 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.76 HG23 HG22 ' A' ' 200' ' ' ILE . 34.6 m -124.8 -169.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.532 1.133 . . . . 0.0 109.89 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.675 ' HG2' ' HG3' ' A' ' 171' ' ' GLN . 9.9 mt-30 -126.04 167.12 15.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.965 1.306 . . . . 0.0 109.065 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 13.5 p -140.26 148.92 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 122.985 0.514 . . . . 0.0 110.51 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.9 mt -97.54 95.21 7.47 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.98 0.809 . . . . 0.0 109.907 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.416 ' HB1' ' HB2' ' A' ' 168' ' ' ARG . . . -76.48 99.97 5.1 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 168.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.504 ' HB3' HD22 ' A' ' 50' ' ' LEU . 88.0 mt -86.66 106.02 17.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.544 0.738 . . . . 0.0 109.494 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.27 159.63 29.04 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.551 0.74 . . . . 0.0 111.135 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.37 113.61 1.2 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 124.123 3.216 . . . . 0.0 115.165 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.45 8.81 40.44 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.016 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.2 158.91 16.5 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.982 0.913 . . . . 0.0 110.636 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.47 157.62 63.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.539 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 161' ' ' LEU . 38.9 Cg_exo -60.55 103.19 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.544 2.163 . . . . 0.0 111.134 175.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.416 ' HB2' ' HB1' ' A' ' 160' ' ' ALA . 80.2 mtp180 -72.99 96.71 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.02 99.84 7.86 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.9 t -102.72 122.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.362 0.665 . . . . 0.0 109.751 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.675 ' HG3' ' HG2' ' A' ' 157' ' ' GLN . 2.1 mp0 -82.15 119.35 23.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -127.67 141.29 51.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.142 0.977 . . . . 0.0 111.368 -173.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -98.27 160.14 28.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.539 1.536 . . . . 0.0 109.481 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.52 124.1 9.1 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.696 1.597 . . . . 0.0 111.216 172.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.06 -172.79 26.34 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.291 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.1 133.58 9.9 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.574 ' HD1' ' HB3' ' A' ' 29' ' ' LEU . 29.0 m-85 -121.79 126.5 48.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.818 0.847 . . . . 0.0 109.298 -165.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -73.06 117.92 15.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.604 0.716 . . . . 0.0 109.215 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.477 HG21 ' HB ' ' A' ' 33' ' ' ILE . 91.0 m -120.65 147.82 44.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.927 1.291 . . . . 0.0 109.479 -170.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -78.98 65.57 4.2 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 178.46 -43.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.832 1.653 . . . . 0.0 108.214 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 178.28 -127.33 1.15 Allowed Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.131 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 m -144.18 128.58 17.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.647 0.779 . . . . 0.0 109.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.2 mt -104.1 122.88 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.877 0.871 . . . . 0.0 109.245 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.31 106.61 3.17 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.32 178.55 9.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.971 0.909 . . . . 0.0 109.975 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.05 131.83 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.3 p -111.0 89.67 3.11 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.168 0.987 . . . . 0.0 109.385 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.512 ' HB3' ' O ' ' A' ' 222' ' ' TYR . 3.4 tm? -106.78 124.81 50.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 30.5 t70 -125.49 105.18 8.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 108.678 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -163.86 -173.5 3.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.075 1.35 . . . . 0.0 109.043 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 77.6 p -51.9 149.41 9.02 Favored Pre-proline 0 CA--C 1.556 1.185 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.759 159.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.415 ' HB2' ' NH1' ' B' ' 255' ' ' M9P . 9.4 Cg_endo -47.71 114.42 1.07 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.139 2.56 . . . . 0.0 112.834 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . 0.477 ' H ' ' HB2' ' A' ' 222' ' ' TYR . . . -72.67 163.02 54.82 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.898 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.515 ' HB ' ' HG ' ' A' ' 198' ' ' SER . 0.3 OUTLIER -85.9 120.72 27.61 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.979 0.512 . . . . 0.0 110.025 -172.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.674 ' H ' ' HGA' ' B' ' 255' ' ' M9P . 15.0 m -59.88 115.1 3.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.639 0.776 . . . . 0.0 110.343 173.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.93 17.18 33.36 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 124.107 0.879 . . . . 0.0 112.426 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . 0.515 ' HG ' ' HB ' ' A' ' 195' ' ' THR . 56.5 m -64.61 127.65 92.63 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 117.113 0.457 . . . . 0.0 111.059 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.79 138.45 11.78 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.085 2.524 . . . . 0.0 114.483 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.76 HG22 HG23 ' A' ' 156' ' ' VAL . 62.3 mt -85.25 99.72 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.039 1.336 . . . . 0.0 109.121 176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.575 HG21 HG12 ' A' ' 14' ' ' VAL . 20.8 pt -124.25 156.6 31.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.058 0 CA-C-O 121.368 0.604 . . . . 0.0 111.895 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.543 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 15.5 t70 -90.84 176.01 6.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.643 1.177 . . . . 0.0 108.975 174.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.403 ' HA ' HE22 ' A' ' 157' ' ' GLN . 38.0 mtpt -56.61 -27.19 57.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.695 1.198 . . . . 0.0 112.681 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -95.54 -6.58 40.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.68 0.792 . . . . 0.0 111.941 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.81 46.64 5.34 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 57.9 tttm -115.25 162.49 17.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.278 1.431 . . . . 0.0 108.932 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.561 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 59.4 t 79.99 -58.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 C-N-CA 125.191 1.396 . . . . 0.0 110.731 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.444 HG22 HD21 ' A' ' 146' ' ' LEU . 10.9 m 57.09 26.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 124.278 1.031 . . . . 0.0 112.521 167.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.18 -153.96 1.97 Allowed Glycine 0 C--N 1.361 1.969 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.7 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.0 mt -150.04 155.85 40.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 117.969 0.884 . . . . 0.0 111.27 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -82.12 104.12 12.23 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 165.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.75 -137.12 3.2 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 123.469 0.557 . . . . 0.0 114.202 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -71.22 103.64 2.86 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -141.27 -136.69 3.32 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.456 HG23 ' H ' ' A' ' 41' ' ' ILE . 8.7 p -165.95 156.61 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.61 110.26 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 95.0 m -85.97 148.24 25.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.283 1.033 . . . . 0.0 109.407 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 49.52 30.38 3.44 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.476 1.51 . . . . 0.0 112.846 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 93.4 p 56.45 27.45 12.18 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.289 1.836 . . . . 0.0 112.733 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -162.34 -53.83 0.02 OUTLIER Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.202 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.36 95.18 0.59 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.119 0.567 . . . . 0.0 110.478 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.512 ' O ' ' HB3' ' A' ' 189' ' ' LEU . 30.9 t80 -74.41 98.62 3.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.48 HG12 HD13 ' A' ' 31' ' ' ILE . 78.0 t -98.78 146.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.733 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 23.1 t -159.21 158.93 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.43 142.12 46.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.572 167.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.8 mt -73.28 102.5 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.62 0.768 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -91.03 143.29 26.86 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.788 0.435 . . . . 0.0 110.037 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.58 172.43 12.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.411 1.084 . . . . 0.0 111.44 -167.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.692 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 65.8 p -74.2 133.17 42.71 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.255 0.622 . . . . 0.0 111.668 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.34 -29.31 69.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.762 0.825 . . . . 0.0 110.588 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 63.5 tttp 60.65 35.04 19.96 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 122.372 1.082 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 11.6 p -71.7 100.36 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.649 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.582 HG23 ' HG3' ' A' ' 238' ' ' GLU . 7.6 tp -137.82 10.25 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.101 0.96 . . . . 0.0 110.392 -172.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -60.77 -26.14 67.03 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.617 0.767 . . . . 0.0 113.009 -172.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.3 -33.23 75.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.102 0.561 . . . . 0.0 111.751 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.413 HD21 ' N ' ' A' ' 236' ' ' ASN . 0.8 OUTLIER -108.52 159.61 30.18 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.244 1.017 . . . . 0.0 108.877 178.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -56.31 131.32 45.05 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 121.443 1.429 . . . . 0.0 110.688 165.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . 0.582 ' HG3' HG23 ' A' ' 233' ' ' ILE . 1.9 mp0 -68.51 79.96 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.796 0.838 . . . . 0.0 111.527 -172.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 50.8 mt -121.15 82.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.549 0.931 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.414 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.722 ' H2 ' ' HB ' ' A' ' 114' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.794 ' HA ' HG21 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.787 ' HD2' HG12 ' A' ' 91' ' ' ILE . 8.3 tmtt? -147.23 138.18 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 108.718 172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' B' ' 253' ' ' LYS . 16.5 tpt180 97.37 111.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 127.726 2.41 . . . . 0.0 107.9 -163.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.674 ' HGA' ' H ' ' A' ' 196' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m 65.88 22.18 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.811 1.244 . . . . 0.0 113.229 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB2' ' NH2' ' A' ' 115' ' ' ARG . . . -167.55 16.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -165.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.531 ' O ' ' HE1' ' A' ' 120' ' ' MET . . . -161.56 -24.47 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.212 0.605 . . . . 0.0 111.367 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.82 36.59 0.77 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 126.713 2.005 . . . . 0.0 110.579 -159.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.716 ' HG ' ' HG3' ' A' ' 88' ' ' GLN . 4.3 mp -118.84 103.46 9.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 0.0 109.737 -165.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 120' ' ' MET . 62.2 tt0 -109.13 153.02 24.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.509 ' HB2' HG23 ' A' ' 68' ' ' VAL . 3.7 mp -91.8 148.95 21.85 Favored 'General case' 0 N--CA 1.515 2.791 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.532 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.829 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 25.2 tt0 -140.63 133.5 29.08 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.264 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -73.88 127.27 32.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.221 0.919 . . . . 0.0 111.857 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.623 ' HB3' ' HG3' ' A' ' 85' ' ' ARG . . . -96.56 -42.38 8.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.038 0.935 . . . . 0.0 109.569 174.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.53 -162.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -107.16 158.45 17.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.467 0.707 . . . . 0.0 109.814 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 103' ' ' LYS . 2.3 t -74.78 97.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 169.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -168.39 151.74 5.63 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -164.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.488 ' HE1' HE22 ' A' ' 157' ' ' GLN . 28.8 t90 -71.87 137.49 47.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HB3' ' H ' ' A' ' 169' ' ' ALA . 11.2 tp10 -106.77 133.77 50.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.512 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.7 -8.21 52.73 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.789 0.836 . . . . 0.0 113.076 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -84.69 50.78 1.97 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.651 0.78 . . . . 0.0 109.815 176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -81.54 118.83 23.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.42 -174.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -132.48 138.41 47.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.636 0.774 . . . . 0.0 109.4 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.47 126.69 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -145.06 -41.8 0.23 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.294 0.638 . . . . 0.0 109.851 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.56 97.35 0.33 Allowed Glycine 0 C--N 1.356 1.66 0 O-C-N 123.455 0.472 . . . . 0.0 113.807 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -171.92 90.45 0.12 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.599 1.16 . . . . 0.0 109.055 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -115.13 151.53 45.79 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.394 0.677 . . . . 0.0 109.767 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 -163.71 0.19 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.57 110.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.2 tp -101.83 143.04 32.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.04 0.448 . . . . 0.0 111.499 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -91.61 112.24 24.08 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.258 0.623 . . . . 0.0 109.722 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.622 HG21 ' HE3' ' A' ' 39' ' ' MET . 42.8 mt -118.27 157.48 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 124.705 1.202 . . . . 0.0 108.139 172.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 HG23 ' HE3' ' A' ' 42' ' ' LYS . 53.6 p -93.97 107.42 19.33 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.954 0.797 . . . . 0.0 109.353 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.504 HG13 ' HB3' ' A' ' 39' ' ' MET . 1.8 mp -83.13 123.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.783 0.833 . . . . 0.0 109.138 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -102.95 138.67 39.52 Favored 'General case' 0 C--O 1.264 1.819 0 C-N-CA 123.896 0.878 . . . . 0.0 112.479 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 55.69 -86.59 0.02 OUTLIER 'General case' 0 C--N 1.356 0.871 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.056 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -156.56 100.8 1.97 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.66 -0.83 87.62 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.172 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 m -95.61 160.46 14.49 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 118.835 1.318 . . . . 0.0 108.527 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.622 ' HE3' HG21 ' A' ' 31' ' ' ILE . 2.8 ppp? -160.42 144.32 13.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.903 0.481 . . . . 0.0 110.203 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 p -165.73 174.33 9.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.462 0.705 . . . . 0.0 110.265 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 217' ' ' THR . 10.3 tp -104.89 155.87 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.455 ' HE3' HG23 ' A' ' 32' ' ' THR . 99.6 mttt -81.57 123.34 28.58 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 71.99 114.45 0.05 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.668 1.587 . . . . 0.0 110.451 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.12 93.22 0.95 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.677 0.791 . . . . 0.0 110.847 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.29 -77.33 0.52 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 63.84 120.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.858 1.663 . . . . 0.0 113.121 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.38 177.71 11.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.166 0.586 . . . . 0.0 111.403 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.495 HE21 ' HA ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER 55.48 -137.76 1.11 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 124.959 1.304 . . . . 0.0 110.745 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 163' ' ' PRO . 49.1 p 55.41 41.69 30.76 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.92 1.288 . . . . 0.0 113.164 169.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -169.43 118.72 0.65 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.056 1.743 . . . . 0.0 107.682 170.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.65 -72.15 1.04 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 123.807 0.692 . . . . 0.0 112.957 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.69 -96.64 0.1 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.85 -62.18 0.36 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.61 57.23 0.03 OUTLIER Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.6 t -71.32 100.35 2.13 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.784 0.833 . . . . 0.0 109.729 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.83 117.28 0.4 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.45 85.44 0.34 Allowed Glycine 0 C--N 1.352 1.433 0 CA-C-N 117.086 0.443 . . . . 0.0 112.097 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.64 170.72 38.98 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -172.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.38 -167.35 14.23 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 122.545 0.117 . . . . 0.0 112.949 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.52 35.75 2.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.765 0.826 . . . . 0.0 111.018 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -72.57 9.0 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.099 0.56 . . . . 0.0 112.149 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.2 61.93 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.922 1.289 . . . . 0.0 111.148 160.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.65 119.9 12.44 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 163.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.454 ' CG1' ' HB3' ' A' ' 7' ' ' GLU . 4.5 t -87.21 -86.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -161.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.829 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 88.6 mt -143.11 -155.15 0.57 Allowed 'General case' 0 C--O 1.201 -1.469 0 C-N-CA 124.35 1.06 . . . . 0.0 109.854 -170.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.417 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 6.0 m0 -166.98 87.47 0.3 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 124.036 0.934 . . . . 0.0 112.881 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 5.6 t0 174.65 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 124.757 1.223 . . . . 0.0 109.729 159.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 8' ' ' LEU . 74.5 t -133.87 150.99 76.07 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.295 -168.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.26 80.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.535 0 C-N-CA 123.32 2.68 . . . . 0.0 112.579 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 t -130.45 85.73 55.5 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 73.0 Cg_endo -92.1 105.27 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.495 2.13 . . . . 0.0 114.197 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.66 -177.69 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.984 2.456 . . . . 0.0 110.393 165.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.44 19.19 1.42 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 121.857 1.704 . . . . 0.0 112.694 166.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 137.69 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.283 1.033 . . . . 0.0 110.377 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.14 57.53 13.33 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 123.686 0.616 . . . . 0.0 113.522 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 61.83 15.18 6.86 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.946 1.298 . . . . 0.0 112.444 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.515 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 68.83 0.38 2.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.322 1.449 . . . . 0.0 112.938 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 55.14 -75.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.631 -168.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 80.33 -48.99 0.33 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 127.008 2.123 . . . . 0.0 110.374 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 77.78 133.88 0.06 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.579 1.551 . . . . 0.0 109.122 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -168.45 114.98 0.66 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.51 -155.81 26.35 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.19 129.82 50.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.994 1.318 . . . . 0.0 109.066 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 12.6 m-85 -123.92 146.69 48.28 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -162.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.623 ' HG3' ' HB3' ' A' ' 11' ' ' ALA . 30.4 mtt85 -86.8 126.92 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 161.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.547 HD13 ' H6 ' ' B' ' 251' ' ' BEZ . 9.2 pt -126.88 134.45 66.18 Favored 'Isoleucine or valine' 0 C--O 1.267 2.016 0 O-C-N 122.032 -0.417 . . . . 0.0 110.971 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.798 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 80.7 tttt -125.66 142.82 51.32 Favored 'General case' 0 C--N 1.387 2.2 0 C-N-CA 125.681 1.592 . . . . 0.0 111.795 -169.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.716 ' HG3' ' HG ' ' A' ' 6' ' ' LEU . 48.1 tt0 -121.88 152.71 39.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.588 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -105.0 90.9 3.59 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 123.05 1.405 . . . . 0.0 107.883 155.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.8 172.59 43.78 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.292 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.59 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 48.0 mt 60.91 -81.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.097 1.359 . . . . 0.0 111.021 166.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.477 ' HB3' ' HD2' ' B' ' 253' ' ' LYS . 50.6 tp -93.69 -46.12 7.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.3 1.04 . . . . 0.0 110.535 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.46 -150.08 11.16 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 116.386 -0.37 . . . . 0.0 113.513 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -104.41 88.11 2.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.621 1.168 . . . . 0.0 107.899 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -141.55 132.93 26.68 Favored 'General case' 0 C--O 1.257 1.48 0 CA-C-N 118.514 0.597 . . . . 0.0 112.521 -170.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.798 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 2.2 pt20 -94.09 114.87 27.11 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 125.36 1.464 . . . . 0.0 109.077 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.566 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -133.67 -35.66 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.13 -166.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.78 168.95 21.78 Favored Glycine 0 N--CA 1.48 1.625 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.249 -162.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -110.15 123.21 49.32 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.44 129.56 9.52 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.54 HG12 ' HZ3' ' A' ' 145' ' ' LYS . 27.8 t -110.83 103.76 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.68 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 21.2 t80 -116.36 140.11 49.69 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 170.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.464 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 79.5 tttt -169.34 152.88 5.05 Favored 'General case' 0 C--O 1.245 0.841 0 O-C-N 123.955 0.785 . . . . 0.0 109.358 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 69.97 -69.58 0.17 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.785 1.634 . . . . 0.0 110.119 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.43 10.85 0.07 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.25 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -133.64 150.13 51.58 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.802 0.801 . . . . 0.0 111.371 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.706 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 90.7 t80 -109.96 122.55 47.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.543 1.137 . . . . 0.0 108.435 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.501 ' HE1' HD21 ' A' ' 137' ' ' LEU . 54.3 t-80 -132.2 111.76 11.69 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -175.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.579 HG23 ' H5 ' ' B' ' 251' ' ' BEZ . 15.1 t -134.69 -165.22 1.63 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.089 1.356 . . . . 0.0 108.388 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.817 ' SD ' ' HA3' ' A' ' 212' ' ' GLY . 31.5 mmt -99.65 162.19 13.16 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.828 1.195 . . . . 0.0 113.722 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -86.24 -52.99 5.3 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.6 175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -57.34 -24.33 54.48 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.872 1.269 . . . . 0.0 113.09 -170.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.449 ' HA ' ' HB3' ' B' ' 254' ' ' ARG . 22.6 m -62.51 -12.63 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 124.432 1.093 . . . . 0.0 113.038 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.729 HG22 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -160.72 -157.24 0.52 Allowed 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.727 1.211 . . . . 0.0 109.535 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.411 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 27.8 ptt180 -119.65 14.85 12.71 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.252 1.021 . . . . 0.0 111.021 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.729 ' H ' HG22 ' A' ' 114' ' ' THR . . . 94.28 58.54 1.21 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 124.152 0.882 . . . . 0.0 111.437 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.6 165.1 12.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG22 ' HA ' ' A' ' 127' ' ' GLU . 2.2 p -98.58 144.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.326 1.05 . . . . 0.0 109.844 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.506 HD22 ' C4 ' ' B' ' 251' ' ' BEZ . 29.1 mt -103.46 179.22 4.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.403 0.681 . . . . 0.0 111.965 -166.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.531 ' HE1' ' O ' ' A' ' 4' ' ' ALA . 11.4 ptp -168.96 178.44 4.51 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 13.7 t60 -127.23 95.0 4.15 Favored 'General case' 0 C--N 1.369 1.42 0 CA-C-N 110.214 -3.175 . . . . 0.0 107.946 164.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 mttt 34.81 64.29 0.42 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 125.234 1.414 . . . . 0.0 113.778 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.42 24.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.246 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -88.33 111.66 21.98 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.532 0.666 . . . . 0.0 109.624 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -105.08 130.37 53.29 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.289 -0.257 . . . . 0.0 111.1 -163.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.8 pt -119.53 130.37 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.308 1.043 . . . . 0.0 109.772 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.718 ' HA ' HG22 ' A' ' 118' ' ' VAL . 10.6 pt-20 -95.63 139.8 22.06 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.089 0.556 . . . . 0.0 111.658 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -71.7 149.38 54.61 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.655 2.236 . . . . 0.0 111.734 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.449 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 9.9 p -85.68 -17.48 35.9 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.704 0.802 . . . . 0.0 111.784 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -163.24 157.85 20.83 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 120.665 0.269 . . . . 0.0 111.231 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.12 118.8 14.02 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.381 1.072 . . . . 0.0 109.535 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 135' ' ' LYS . 14.7 m-20 -102.58 110.26 22.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.387 1.475 . . . . 0.0 110.857 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.08 -48.81 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.882 0.473 . . . . 0.0 110.807 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.04 -44.58 76.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.095 0.558 . . . . 0.0 111.23 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . 72.5 mmtt -69.09 -20.86 64.08 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.008 0.523 . . . . 0.0 110.825 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 t0 66.13 59.52 0.68 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.045 1.338 . . . . 0.0 110.401 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 3.8 pp -165.21 157.14 15.19 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.76 151.34 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 125.081 1.353 . . . . 0.0 107.958 171.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -131.3 143.4 50.5 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.706 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.0 t80 -135.89 142.57 44.71 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 108.532 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.1 -5.98 64.72 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.812 0.695 . . . . 0.0 113.453 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.47 -152.67 23.94 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.13 50.18 Favored Glycine 0 C--O 1.242 0.65 0 CA-C-O 120.97 0.205 . . . . 0.0 112.909 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -54.45 134.21 45.91 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.809 1.244 . . . . 0.0 110.297 174.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.603 ' HG3' ' HG ' ' A' ' 146' ' ' LEU . 56.7 pttt -109.82 -166.49 1.1 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.335 0.654 . . . . 0.0 111.403 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.603 ' HG ' ' HG3' ' A' ' 145' ' ' LYS . 50.2 mt 70.63 178.45 0.25 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.457 1.503 . . . . 0.0 111.501 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -143.09 -39.04 0.33 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.471 0.309 . . . . 0.0 111.587 -161.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.89 169.35 45.64 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 123.095 0.247 . . . . 0.0 113.155 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.0 153.13 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.221 0.608 . . . . 0.0 110.093 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.618 ' HA ' HG12 ' A' ' 208' ' ' VAL . 26.3 t90 -58.51 131.33 50.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.971 172.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.498 ' HZ2' ' HB3' ' A' ' 151' ' ' LYS . 7.0 mtpm? -119.33 105.17 11.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 152.84 32.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.748 0.819 . . . . 0.0 111.507 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.01 -52.44 4.74 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.17 138.03 53.79 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.093 0.957 . . . . 0.0 110.425 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.58 ' HG3' ' HZ1' ' A' ' 203' ' ' LYS . 9.6 pt-20 -76.38 141.09 41.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.539 . . . . 0.0 110.516 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.11 -177.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.307 1.043 . . . . 0.0 108.557 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 49.7 mt-30 -133.63 162.61 31.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.582 -0.699 . . . . 0.0 110.09 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 200' ' ' ILE . 7.4 p -137.09 136.67 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.149 0.58 . . . . 0.0 109.867 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.594 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 35.8 mt -69.52 86.94 0.46 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . 0.401 ' HB2' ' HG2' ' A' ' 165' ' ' LYS . . . -80.79 105.23 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.6 176.8 8.36 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 163' ' ' PRO . 49.1 mp0 -28.4 155.58 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.175 0 C-N-CA 127.861 2.464 . . . . 0.0 114.326 168.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 162' ' ' GLU . 25.6 Cg_exo -1.16 137.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.638 1 C-N-CA 128.162 5.908 . . . . 0.0 118.945 -162.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 192' ' ' SER . . . 99.69 -36.72 3.9 Favored Glycine 0 C--O 1.24 0.495 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -163.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.401 ' HG2' ' HB2' ' A' ' 160' ' ' ALA . 3.1 mptp? -143.56 178.95 7.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.363 1.465 . . . . 0.0 108.42 164.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 12.3 m120 -98.35 133.74 22.57 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.045 -0.978 . . . . 0.0 108.838 167.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.524 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 25.6 Cg_endo -59.47 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.965 3.11 . . . . 0.0 113.378 -175.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 39.2 ptt180 -160.68 165.16 31.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.943 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.475 ' H ' ' HB3' ' A' ' 17' ' ' GLU . . . -88.58 102.85 15.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.5 t -86.07 133.93 28.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 109.591 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 49.1 mt-30 -79.73 139.02 37.46 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.916 0.886 . . . . 0.0 109.37 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.8 t -150.28 130.06 13.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.902 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 59.7 mttp -90.71 155.07 45.89 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.046 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.57 121.26 9.3 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.373 1.382 . . . . 0.0 111.616 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -98.12 -170.71 32.28 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.1 144.27 5.64 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.345 0.573 . . . . 0.0 110.331 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.489 ' CE2' HD11 ' A' ' 184' ' ' ILE . 43.4 p90 -123.47 135.01 53.85 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.903 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -70.74 163.74 26.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.882 1.273 . . . . 0.0 111.99 -173.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.446 HG23 ' H ' ' A' ' 181' ' ' ALA . 27.4 m -139.12 165.6 26.73 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.889 1.676 . . . . 0.0 108.173 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -52.91 -41.53 64.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.973 0.909 . . . . 0.0 110.213 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.446 ' H ' HG23 ' A' ' 179' ' ' THR . . . -76.39 -74.41 0.23 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.863 176.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.17 -107.02 0.65 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.702 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t -162.8 147.16 11.57 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 0.0 109.967 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.489 HD11 ' CE2' ' A' ' 177' ' ' PHE . 4.3 mp -108.45 151.38 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.72 139.3 14.35 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.41 144.22 19.44 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.05 113.08 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 165.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.3 m -116.86 91.18 3.51 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.437 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 62.4 tp -104.62 105.02 14.94 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.522 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.37 111.45 14.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.329 0.651 . . . . 0.0 110.121 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -164.35 -174.3 3.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.126 1.37 . . . . 0.0 109.029 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.608 ' HB2' ' HA2' ' A' ' 164' ' ' GLY . 7.4 m -61.69 175.1 0.55 Allowed Pre-proline 0 CA--C 1.587 2.388 0 C-N-CA 124.787 1.235 . . . . 0.0 111.165 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 192' ' ' SER . 31.3 Cg_exo -24.57 123.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.407 3.633 1 C-N-CA 125.968 4.446 . . . . 0.0 116.925 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.46 131.55 26.93 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.006 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.1 m -81.5 97.12 7.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.912 0.485 . . . . 0.0 109.993 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.49 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 73.3 m -66.45 98.27 0.48 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -166.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 131.57 -5.05 5.52 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.631 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.9 m -47.43 124.48 9.29 Favored Pre-proline 0 N--CA 1.496 1.862 0 C-N-CA 124.275 1.03 . . . . 0.0 113.631 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 4.0 Cg_exo -72.4 121.23 7.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.738 2.292 . . . . 0.0 112.464 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 51.5 mt -84.2 110.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 207' ' ' VAL . 59.4 mt -120.46 162.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.713 0.805 . . . . 0.0 109.848 -171.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -103.04 167.48 9.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.538 0.735 . . . . 0.0 110.246 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.58 ' HZ1' ' HG3' ' A' ' 155' ' ' GLU . 44.1 mttp -58.18 -40.6 81.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.565 1.546 . . . . 0.0 111.154 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -73.58 -20.84 60.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 111.77 -4.73 27.58 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.456 -0.636 . . . . 0.0 113.839 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -73.65 128.69 36.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.78 0.79 . . . . 0.0 110.183 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.413 HG13 HD11 ' A' ' 146' ' ' LEU . 57.9 t -73.44 109.94 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 150' ' ' TRP . 55.1 t -64.37 -30.19 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.798 1.239 . . . . 0.0 110.576 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.87 -154.14 25.24 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.058 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.444 HD22 HG21 ' A' ' 101' ' ' VAL . 75.8 mt -134.75 162.33 32.67 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.641 0.777 . . . . 0.0 109.596 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.49 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.8 OUTLIER -77.05 112.47 13.73 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 165.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.817 ' HA3' ' SD ' ' A' ' 110' ' ' MET . . . -174.26 67.31 0.1 Allowed Glycine 0 CA--C 1.496 -1.13 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 163.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.479 ' HB3' ' H ' ' A' ' 225' ' ' ALA . 11.0 t-20 -160.54 176.97 11.0 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.509 ' HA2' ' HE1' ' A' ' 39' ' ' MET . . . 61.62 -144.78 48.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 114.3 0.48 . . . . 0.0 114.3 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 216' ' ' VAL . 13.6 p -177.63 175.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 124.372 1.069 . . . . 0.0 108.863 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 215' ' ' VAL . 34.5 m -70.58 149.59 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 163.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.417 HG23 HD11 ' A' ' 41' ' ' ILE . 45.1 p -136.14 -165.14 1.66 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -32.4 108.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.201 1.4 . . . . 0.0 113.357 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.0 t 77.3 28.08 0.63 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.652 1.581 . . . . 0.0 111.907 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.57 15.84 80.22 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.793 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.61 116.53 6.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.497 0.719 . . . . 0.0 111.818 -171.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 189' ' ' LEU . 5.7 t80 -64.88 116.61 6.53 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.67 0.788 . . . . 0.0 109.388 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.6 t -134.16 115.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -137.09 141.98 42.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 109.25 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.479 ' H ' ' HB3' ' A' ' 213' ' ' ASN . . . -81.56 16.58 1.67 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.779 0.718 . . . . 0.0 112.49 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.9 mt 58.57 98.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.723 1.609 . . . . 0.0 111.462 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.33 130.03 40.89 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -108.8 125.86 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 38.5 p -80.72 106.26 12.59 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 110.171 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 -19.65 25.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.032 0.933 . . . . 0.0 111.456 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.7 tptm 74.45 147.73 0.09 Allowed 'General case' 0 C--N 1.364 1.222 0 C-N-CA 125.46 1.504 . . . . 0.0 110.525 -172.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 12.4 p -63.54 118.18 7.81 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.15 0.98 . . . . 0.0 111.134 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.9 tt -77.39 89.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 122.367 1.08 . . . . 0.0 109.012 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.11 -15.26 63.61 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.81 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.11 -32.21 63.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.59 1.156 . . . . 0.0 113.256 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.415 ' N ' HD21 ' A' ' 236' ' ' ASN . 0.9 OUTLIER -74.75 107.63 4.11 Favored Pre-proline 0 CA--C 1.548 0.902 0 O-C-N 123.661 0.601 . . . . 0.0 109.941 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -98.49 134.06 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.57 2.847 . . . . 0.0 112.462 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.09 -52.43 62.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.896 0.478 . . . . 0.0 109.988 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 16.8 tt -172.76 -46.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.349 1.059 . . . . 0.0 110.513 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 123.196 0.599 . . . . 0.0 110.046 -177.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.579 ' H5 ' HG23 ' A' ' 109' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.585 ' HD3' ' HB3' ' A' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.59 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -141.58 -27.54 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 173.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 31.7 ttm180 -106.79 145.42 32.12 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.678 0.672 . . . . 0.0 109.84 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.442 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t 68.8 177.08 0.26 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.625 1.17 . . . . 0.0 111.87 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.422 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 61.0 9.92 2.57 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.46 1.504 . . . . 0.0 114.863 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.53 16.43 0.2 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.916 0.78 . . . . 0.0 112.122 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.72 44.48 0.76 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.176 0.988 . . . . 0.0 109.321 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 120' ' ' MET . 26.7 mt -86.73 95.03 9.67 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.891 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 120' ' ' MET . 25.6 mt-10 -111.19 129.39 55.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.631 0.772 . . . . 0.0 111.982 -166.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.696 ' HB2' HG23 ' A' ' 68' ' ' VAL . 4.3 mp -101.43 146.98 26.89 Favored 'General case' 0 N--CA 1.513 2.68 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' HB2' HD21 ' A' ' 65' ' ' LEU . 14.1 tt0 -130.46 158.46 39.83 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.014 1.726 . . . . 0.0 109.153 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 9' ' ' GLU . 6.3 ppt_? -90.61 148.49 22.63 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 122.95 0.5 . . . . 0.0 110.958 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.15 -37.67 3.04 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.036 0.534 . . . . 0.0 110.767 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.99 -155.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.055 1.342 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -98.25 153.65 18.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.5 1.12 . . . . 0.0 109.382 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.82 91.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -170.43 117.44 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.57 1.548 . . . . 0.0 107.484 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.584 ' HZ2' ' HB3' ' A' ' 21' ' ' GLU . 80.0 t90 -75.88 94.7 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -158.9 59.55 0.42 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.88 0.472 . . . . 0.0 110.542 163.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 4.1 t70 -89.72 -65.28 1.03 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.442 -0.787 . . . . 0.0 111.235 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.96 -42.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' H ' ' HB1' ' A' ' 169' ' ' ALA . . . -136.45 -170.38 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -154.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.727 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 3.3 pt-20 -166.93 90.74 0.39 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.003 1.321 . . . . 0.0 109.408 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.539 ' HB ' HG12 ' A' ' 170' ' ' VAL . 62.9 mt -85.45 103.54 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -55.25 -24.81 29.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.476 1.11 . . . . 0.0 112.202 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.33 -94.25 0.01 OUTLIER Glycine 0 C--N 1.365 2.179 0 O-C-N 124.519 1.137 . . . . 0.0 112.462 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 173' ' ' LYS . 7.0 t 57.94 75.62 0.37 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.044 1.338 . . . . 0.0 109.564 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.7 m -64.61 147.96 97.21 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.237 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.46 168.74 3.65 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.783 2.322 . . . . 0.0 112.094 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.57 109.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.634 0.774 . . . . 0.0 110.617 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.24 159.57 14.9 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.903 0.881 . . . . 0.0 111.733 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -124.6 127.73 47.82 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.9 165.45 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -93.74 108.03 19.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.334 -0.854 . . . . 0.0 109.556 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.0 106.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -89.61 129.55 36.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.971 0.908 . . . . 0.0 110.048 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.38 8.54 5.05 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.72 1.208 . . . . 0.0 112.672 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.71 21.45 12.39 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.893 1.277 . . . . 0.0 112.745 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.86 -40.45 0.06 OUTLIER Glycine 0 N--CA 1.478 1.489 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 t -90.89 166.67 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.839 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.5 ppp? -132.72 149.42 52.29 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 p -169.2 157.18 7.49 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.955 0.902 . . . . 0.0 109.414 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.516 HD12 HG22 ' A' ' 217' ' ' THR . 10.3 tp -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -81.64 70.31 8.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.466 0.651 . . . . 0.0 109.978 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 219' ' ' SER . 51.3 t30 176.18 126.71 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.889 1.675 . . . . 0.0 107.299 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.28 118.06 12.36 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.77 -174.64 2.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.075 0.95 . . . . 0.0 110.559 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.9 161.92 28.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.108 0.963 . . . . 0.0 110.709 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -119.24 -149.2 0.43 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.386 1.075 . . . . 0.0 110.139 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 71.38 114.78 0.05 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.774 1.23 . . . . 0.0 113.733 168.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.669 ' HB ' ' HB3' ' A' ' 163' ' ' PRO . 13.9 p -140.44 -67.21 0.43 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.328 1.051 . . . . 0.0 109.13 167.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.651 HD22 HD22 ' A' ' 65' ' ' LEU . 8.6 tp 84.85 140.26 0.06 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 125.564 1.546 . . . . 0.0 111.998 168.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.84 -91.96 0.35 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.684 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.43 -35.82 90.67 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 123.637 0.257 . . . . 0.0 113.045 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 16.58 59.08 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.197 0.427 . . . . 0.0 112.725 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.97 53.76 4.9 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.131 0.396 . . . . 0.0 113.018 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 p -86.96 -32.41 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.067 0.947 . . . . 0.0 110.586 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.23 115.69 0.79 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.246 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.02 -46.34 3.27 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.725 0.263 . . . . 0.0 113.072 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.31 -42.71 0.27 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.87 -125.18 18.97 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.271 -0.465 . . . . 0.0 113.831 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -84.36 55.05 3.2 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.527 0.731 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 46.03 43.44 10.64 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 125.124 1.37 . . . . 0.0 111.302 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.35 -24.56 67.9 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.075 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -89.06 0.19 Allowed Glycine 0 C--N 1.349 1.262 0 O-C-N 124.03 0.831 . . . . 0.0 111.855 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.656 HG11 ' HD3' ' A' ' 87' ' ' LYS . 43.4 t -138.98 -107.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.651 HD22 HD22 ' A' ' 50' ' ' LEU . 69.4 mt -156.87 134.82 11.03 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 126.364 1.866 . . . . 0.0 106.314 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.493 ' HB2' ' CG ' ' A' ' 121' ' ' HIS . 0.5 OUTLIER -158.75 70.63 0.52 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.155 0.979 . . . . 0.0 113.638 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.53 70.93 0.74 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 162.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 8' ' ' LEU . 2.1 t -131.74 132.97 23.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.298 -166.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.88 83.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.461 2.774 . . . . 0.0 112.511 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.8 m -70.06 154.42 94.62 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.449 1.1 . . . . 0.0 112.171 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.71 -38.78 91.35 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.466 2.777 . . . . 0.0 116.46 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -44.01 136.36 7.57 Favored 'Trans proline' 0 C--N 1.408 3.702 0 C-N-CA 123.053 2.502 . . . . 0.0 115.471 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.01 144.48 36.71 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.464 2.776 . . . . 0.0 113.638 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 t 64.49 66.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.538 1.135 . . . . 0.0 110.012 -174.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.3 24.52 29.95 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.121 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.18 -27.52 60.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.453 0.701 . . . . 0.0 109.877 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.71 -1.64 32.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.19 0.996 . . . . 0.0 111.768 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -102.11 6.3 40.84 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.038 0.935 . . . . 0.0 111.096 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.32 86.53 2.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.834 0.854 . . . . 0.0 110.307 -171.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.71 -45.41 29.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 61.87 94.62 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.619 1.199 . . . . 0.0 110.175 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.15 -167.39 34.89 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.398 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.76 108.25 9.65 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -95.0 175.98 6.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 110.824 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 51.1 ttt180 -144.52 143.1 30.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.624 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 1.1 pt -138.85 140.44 38.85 Favored 'Isoleucine or valine' 0 C--O 1.269 2.131 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.656 ' HD3' HG11 ' A' ' 64' ' ' VAL . 26.2 tttm -131.2 136.57 48.39 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.434 1.494 . . . . 0.0 110.83 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.545 ' HB3' HD12 ' A' ' 97' ' ' ILE . 3.5 tp60 -115.89 133.48 55.99 Favored 'General case' 0 C--O 1.26 1.642 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.74 97.21 9.01 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 163.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.42 -179.16 29.48 Favored Glycine 0 N--CA 1.462 0.374 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.298 -163.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.636 HD11 ' HG2' ' B' ' 253' ' ' LYS . 0.2 OUTLIER -39.79 132.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.614 166.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt 78.0 6.67 2.67 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.815 1.646 . . . . 0.0 111.976 -171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.84 -156.87 20.62 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 122.007 0.782 . . . . 0.0 114.834 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.94 69.37 7.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.285 1.434 . . . . 0.0 107.886 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB2' ' HZ3' ' B' ' 253' ' ' LYS . 19.0 m -109.99 144.35 38.65 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -159.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.608 HE21 HD13 ' A' ' 50' ' ' LEU . 2.1 tp-100 -74.95 116.47 15.73 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.845 1.341 . . . . 0.0 109.162 163.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 88' ' ' GLN . 0.4 OUTLIER -144.38 9.08 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -152.17 170.53 31.48 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.873 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -116.4 124.64 50.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.7 155.17 22.46 Favored Glycine 0 CA--C 1.503 -0.67 0 O-C-N 123.695 0.622 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.7 t -137.56 101.83 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -107.16 107.3 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -141.2 134.96 30.26 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.45 23.01 12.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.349 1.059 . . . . 0.0 112.349 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.23 76.74 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.088 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.2 p -127.52 133.06 49.84 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.031 0.532 . . . . 0.0 110.426 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.78 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 49.0 t80 -85.44 142.51 29.19 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.555 ' HB3' ' HZ3' ' A' ' 144' ' ' TRP . 94.4 m-70 -137.28 113.28 9.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.432 1.093 . . . . 0.0 110.035 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.502 HG22 ' HB ' ' A' ' 138' ' ' ILE . 9.7 t -139.81 -164.64 1.73 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.773 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 137' ' ' LEU . 22.2 mtp -121.6 170.47 9.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.045 0.938 . . . . 0.0 111.52 -171.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -40.44 13.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.257 0.623 . . . . 0.0 112.441 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.453 ' HE2' HOI2 ' B' ' 255' ' ' M9P . 25.2 p-80 -62.01 -20.76 64.25 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.521 0.676 . . . . 0.0 111.328 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.495 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 19.1 m -82.75 -35.1 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.934 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.546 HG21 ' H ' ' A' ' 116' ' ' GLY . 52.8 m -145.03 145.78 31.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.141 -1.599 . . . . 0.0 112.158 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.77 -5.52 0.95 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 126.221 1.808 . . . . 0.0 113.541 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.546 ' H ' HG21 ' A' ' 114' ' ' THR . . . 88.45 55.13 2.25 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.72 -175.0 3.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.918 0.487 . . . . 0.0 111.919 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.1 138.61 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.405 1.082 . . . . 0.0 112.947 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.647 HD23 ' H4 ' ' B' ' 251' ' ' BEZ . 7.5 mt -102.86 174.77 5.73 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.935 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.556 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -169.47 174.87 5.73 Favored 'General case' 0 C--O 1.261 1.707 0 CA-C-O 123.74 1.733 . . . . 0.0 115.208 -177.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.625 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 21.0 t60 -127.59 88.5 2.8 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.645 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 93.1 mttt 38.11 46.85 0.88 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.013 0.925 . . . . 0.0 111.798 -171.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.6 -26.57 20.92 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.519 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 11.9 mptt -73.61 109.68 7.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.214 1.507 . . . . 0.0 109.211 175.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.441 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 15.6 ttm180 -93.8 120.23 33.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.506 0.722 . . . . 0.0 112.494 -157.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.511 HG13 ' HB2' ' A' ' 119' ' ' LEU . 17.0 pt -111.95 161.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.99 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.27 135.25 24.33 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.35 0.66 . . . . 0.0 109.725 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.84 163.5 38.24 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.395 2.063 . . . . 0.0 112.404 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 p -99.78 -30.28 12.15 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.749 0.819 . . . . 0.0 112.182 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -140.84 147.82 39.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.723 0.809 . . . . 0.0 109.875 -172.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.61 119.99 5.51 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.343 1.057 . . . . 0.0 109.047 169.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.86 114.77 11.36 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.914 0.486 . . . . 0.0 110.902 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.78 -22.19 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.788 1.235 . . . . 0.0 111.833 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.1 -50.2 69.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.471 0.708 . . . . 0.0 110.869 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -94.4 -8.14 39.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.868 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 63.88 44.1 5.01 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.156 1.382 . . . . 0.0 110.645 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.564 HD21 HD11 ' A' ' 210' ' ' LEU . 77.6 mt -136.53 137.93 40.79 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.618 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.502 ' HB ' HG22 ' A' ' 109' ' ' THR . 64.6 mt -120.63 151.96 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.788 1.635 . . . . 0.0 108.009 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 p -152.34 160.28 43.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.558 0.694 . . . . 0.0 112.014 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.78 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 27.4 t80 -129.09 135.6 49.12 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.446 1.499 . . . . 0.0 107.622 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.9 64.97 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 122.919 0.295 . . . . 0.0 113.152 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.14 -177.3 42.92 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.23 -178.21 44.59 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.563 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 76.5 t-105 -81.84 105.01 12.62 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 122.441 -0.446 . . . . 0.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -165.7 113.84 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 107.946 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.465 ' HB2' HG21 ' A' ' 229' ' ' THR . 69.5 mt -131.92 -88.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.695 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -172.52 -73.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.94 0.791 . . . . 0.0 110.716 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.07 149.73 47.95 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.64 0.588 . . . . 0.0 113.476 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.28 139.77 20.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.953 0.501 . . . . 0.0 110.009 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -68.89 122.32 18.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.699 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.585 ' HZ2' ' HB3' ' A' ' 151' ' ' LYS . 5.4 ttpm? -105.11 116.5 32.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 166.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.35 150.09 31.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.466 0.707 . . . . 0.0 112.435 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.15 -20.75 31.59 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.499 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.46 136.4 41.37 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.726 0.811 . . . . 0.0 109.896 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 0.0 OUTLIER -73.32 140.22 46.6 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.491 0.662 . . . . 0.0 110.083 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 m -120.13 179.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.635 0.774 . . . . 0.0 108.96 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.435 HE22 ' HG3' ' A' ' 171' ' ' GLN . 69.5 mm-40 -121.66 160.7 23.89 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.091 -0.38 . . . . 0.0 110.784 -170.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.6 155.68 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.705 0.802 . . . . 0.0 110.28 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 52.5 mt -107.19 105.9 16.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 164.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.44 104.67 5.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.326 0.65 . . . . 0.0 109.474 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.62 HD23 ' HB3' ' A' ' 167' ' ' PRO . 54.8 mt -69.65 104.64 2.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.192 0.52 . . . . 0.0 110.796 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 165' ' ' LYS . 56.7 mm-40 -76.26 141.6 70.58 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.123 -176.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 12.4 Cg_exo -71.89 116.64 4.78 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.906 3.071 . . . . 0.0 112.011 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.35 9.67 58.38 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.577 0.548 . . . . 0.0 113.894 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 162' ' ' GLU . 96.3 mttt -135.91 -177.31 4.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 0.0 110.219 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -88.26 142.96 31.99 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.848 0.859 . . . . 0.0 110.655 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.62 ' HB3' HD23 ' A' ' 161' ' ' LEU . 10.4 Cg_endo -52.86 115.65 2.39 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.515 2.81 . . . . 0.0 112.737 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -69.46 129.96 41.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.602 0.761 . . . . 0.0 109.888 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.597 ' HB1' ' H ' ' A' ' 20' ' ' ALA . . . -71.73 118.79 15.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.539 HG12 ' HB ' ' A' ' 22' ' ' ILE . 41.0 t -134.68 144.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.727 ' HB2' ' HB2' ' A' ' 21' ' ' GLU . 27.7 tt0 -84.81 163.81 18.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.5 p -136.16 97.11 3.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 54.4 tttp -85.73 129.43 54.73 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 155' ' ' GLU . 84.0 Cg_exo -47.49 125.5 10.91 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.289 2.659 . . . . 0.0 113.714 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.36 178.41 18.13 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.928 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -139.07 128.82 24.75 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -133.75 122.06 22.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.668 ' HB3' ' HZ3' ' A' ' 178' ' ' LYS . 5.0 ttpm? -122.39 138.83 54.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.36 1.064 . . . . 0.0 108.843 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 52.0 p -120.67 -178.68 3.78 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.026 0.931 . . . . 0.0 109.271 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -71.21 -19.63 62.36 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.36 0.664 . . . . 0.0 109.932 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.09 -48.92 8.71 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.345 1.058 . . . . 0.0 110.507 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -175.67 160.76 29.25 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.408 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 9.7 t -97.83 139.95 32.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.985 0.914 . . . . 0.0 110.145 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.49 127.73 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.93 111.51 4.0 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -163.57 -172.29 2.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.954 . . . . 0.0 109.946 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.67 100.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 121.807 0.813 . . . . 0.0 111.059 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.7 m -98.86 101.02 12.29 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 165.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.14 151.48 40.91 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.62 0.248 . . . . 0.0 110.998 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.93 159.95 32.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.818 0.847 . . . . 0.0 109.069 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.475 ' HA ' ' HD1' ' A' ' 222' ' ' TYR . 34.0 p90 -75.63 121.92 23.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.113 0.959 . . . . 0.0 111.63 -164.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.2 m -137.14 132.12 17.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.28 2.653 . . . . 0.0 113.062 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.43 100.37 0.37 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -173.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.45 HG22 ' HDA' ' B' ' 255' ' ' M9P . 37.3 p -73.59 140.65 46.38 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.294 0.638 . . . . 0.0 111.223 -176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' B' ' 255' ' ' M9P . 44.8 m -53.95 127.01 24.58 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.902 0.881 . . . . 0.0 112.153 -173.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.07 -3.84 35.58 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.772 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.2 m -44.43 119.64 3.64 Favored Pre-proline 0 C--N 1.383 2.043 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.16 115.47 3.0 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.398 2.065 . . . . 0.0 111.517 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.24 106.4 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -98.38 163.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.507 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -98.85 157.65 16.16 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.245 1.418 . . . . 0.0 108.909 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -63.94 -34.27 77.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.5 1.12 . . . . 0.0 111.128 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.25 -20.36 44.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.714 0.406 . . . . 0.0 111.162 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.4 14.44 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.91 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 161.89 30.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.442 0.621 . . . . 0.0 109.843 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.457 HG13 HD11 ' A' ' 146' ' ' LEU . 2.7 p -94.02 112.12 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.38 -40.39 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 228' ' ' GLN . . . 158.23 -142.83 8.78 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.564 HD11 HD21 ' A' ' 137' ' ' LEU . 70.4 mt -127.99 159.57 34.59 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.658 0.783 . . . . 0.0 110.449 -174.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.481 ' O ' ' SD ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -62.98 107.87 1.09 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 170.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.07 -179.97 6.53 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 124.343 1.027 . . . . 0.0 114.837 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -69.19 86.99 0.4 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.516 1.15 . . . . 0.0 109.633 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.839 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -134.44 -151.23 6.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 113.677 -1.602 . . . . 0.0 111.661 -176.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.472 HG23 ' H ' ' A' ' 41' ' ' ILE . 8.8 p -157.28 168.63 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 111.591 -172.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.7 t -85.59 108.54 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.516 HG22 HD12 ' A' ' 41' ' ' ILE . 99.6 m -86.63 144.02 27.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.536 1.134 . . . . 0.0 110.005 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 67.79 10.3 7.69 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.613 1.165 . . . . 0.0 110.305 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . 0.409 ' HB3' HD21 ' A' ' 43' ' ' ASN . 95.0 p 52.92 30.05 8.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.353 1.461 . . . . 0.0 111.43 -166.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.13 -70.16 0.05 OUTLIER Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.349 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.06 137.88 40.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.338 0.655 . . . . 0.0 111.164 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.475 ' HD1' ' HA ' ' A' ' 191' ' ' PHE . 82.3 m-85 -86.03 102.49 13.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.141 0.496 . . . . 0.0 110.124 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 50.6 t -124.1 104.64 14.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.601 0.761 . . . . 0.0 108.972 -175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.669 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 63.4 m -132.04 162.48 30.67 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.306 1.042 . . . . 0.0 109.959 -171.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -58.65 162.72 3.71 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.006 162.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.58 103.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.343 -0.848 . . . . 0.0 109.023 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.403 ' HB3' HD11 ' A' ' 137' ' ' LEU . . . -78.91 136.58 37.31 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.47 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 8.8 pt20 -129.06 167.72 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.208 0.603 . . . . 0.0 109.494 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.563 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 1.6 p -82.72 110.69 17.99 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -72.01 -13.78 61.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.768 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.6 37.66 22.49 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 109.214 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.3 m -58.85 96.31 0.03 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.532 1.133 . . . . 0.0 111.077 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . 0.438 HG12 ' ND2' ' A' ' 236' ' ' ASN . 14.7 tt -97.43 27.03 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-O 122.576 1.179 . . . . 0.0 108.986 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -74.17 -8.11 55.01 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.531 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.34 -11.72 44.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.384 1.074 . . . . 0.0 111.849 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.438 ' ND2' HG12 ' A' ' 233' ' ' ILE . 34.6 m-80 -56.87 117.43 17.45 Favored Pre-proline 0 CA--C 1.554 1.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.92 129.91 29.14 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.878 2.385 . . . . 0.0 111.516 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.44 -39.48 77.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.227 0.611 . . . . 0.0 111.275 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.84 -49.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.134 0.574 . . . . 0.0 109.582 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--O 1.248 1.0 0 C-N-CA 123.219 0.608 . . . . 0.0 110.021 -175.797 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.647 ' H4 ' HD23 ' A' ' 119' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.499 ' C ' HD13 ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.636 ' HG2' HD11 ' A' ' 91' ' ' ILE . 17.2 tppt? 164.43 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.521 1.928 . . . . 0.0 109.473 161.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 69.28 115.95 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.872 1.269 . . . . 0.0 108.361 -165.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.453 HOI2 ' HE2' ' A' ' 112' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 72.63 167.75 0.31 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.392 1.477 . . . . 0.0 111.607 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.706 ' HB1' HD23 ' A' ' 6' ' ' LEU . . . -68.62 120.49 14.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.189 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.35 21.12 4.0 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.522 0.729 . . . . 0.0 111.143 -167.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -142.33 49.76 1.52 Allowed 'General case' 0 C--O 1.254 1.307 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.797 HD22 ' HG3' ' B' ' 252' ' ' NLE . 34.6 mt -96.59 94.13 7.16 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.98 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 120' ' ' MET . 6.9 tm-20 -107.55 129.34 54.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.35 0.66 . . . . 0.0 111.095 -170.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.5 mp -94.78 137.16 34.22 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 34.3 tt0 -132.3 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.694 -0.629 . . . . 0.0 109.673 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.602 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 6.7 ptp180 -67.09 153.78 42.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.64 0.733 . . . . 0.0 112.454 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.31 -36.04 3.02 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.696 166.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.16 -162.39 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.52 156.81 25.08 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.647 0.779 . . . . 0.0 109.028 168.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.06 96.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.604 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 164.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -166.84 136.84 3.06 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -167.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.424 ' H ' ' HA2' ' A' ' 205' ' ' GLY . 63.7 t90 -66.69 120.16 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.748 0.655 . . . . 0.0 109.829 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -87.69 143.91 26.92 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.2 -6.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.808 1.243 . . . . 0.0 112.784 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.29 50.28 0.5 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.49 1.516 . . . . 0.0 111.709 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -65.72 100.47 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.543 0.737 . . . . 0.0 110.906 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.69 102.55 15.09 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.774 0.83 . . . . 0.0 110.246 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.59 100.91 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -153.4 144.08 22.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.54 1.536 . . . . 0.0 107.631 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.67 ' HA2' ' H ' ' A' ' 190' ' ' ASP . . . 109.46 -138.09 14.59 Favored Glycine 0 CA--C 1.503 -0.716 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.311 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m 58.82 26.79 15.22 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.413 0.685 . . . . 0.0 110.37 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 t -66.21 143.06 98.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.602 1.161 . . . . 0.0 111.039 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 175.68 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.91 2.407 . . . . 0.0 113.49 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.37 131.52 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.851 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.0 mt -109.1 160.16 16.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.852 0.861 . . . . 0.0 109.936 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 t -122.9 115.4 21.89 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.538 HG23 ' HE3' ' A' ' 39' ' ' MET . 30.0 mt -121.3 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.007 0.923 . . . . 0.0 109.337 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.3 p -92.96 111.9 23.68 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.34 132.45 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.935 0.894 . . . . 0.0 108.773 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -138.37 146.4 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.82 0.448 . . . . 0.0 110.341 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 52.85 32.63 12.74 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.237 1.015 . . . . 0.0 111.898 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.254 3.2 p30 52.54 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 126.975 2.11 . . . . 0.0 114.135 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.46 -10.45 66.6 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -106.55 160.55 15.34 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.186 0.993 . . . . 0.0 110.06 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.538 ' HE3' HG23 ' A' ' 31' ' ' ILE . 4.5 ppp? -161.62 133.88 5.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.757 ' HA ' HG13 ' A' ' 215' ' ' VAL . 15.1 p -166.33 174.97 8.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.331 0.652 . . . . 0.0 110.161 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.645 HD12 ' HA ' ' A' ' 217' ' ' THR . 1.8 mp -89.22 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.71 73.33 1.08 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.41 0.624 . . . . 0.0 109.549 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -143.7 -179.44 6.45 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.59 1.156 . . . . 0.0 109.274 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.51 96.6 8.65 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 119.41 10.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.548 0.739 . . . . 0.0 110.187 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -148.6 141.74 24.98 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.217 0.607 . . . . 0.0 109.595 172.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.606 ' HA ' ' HB3' ' A' ' 193' ' ' PRO . 1.4 mp0 -125.05 -123.29 0.25 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.315 -165.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.532 ' O ' ' HDA' ' B' ' 255' ' ' M9P . 10.1 tt0 -156.17 150.2 25.27 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.852 1.66 . . . . 0.0 113.121 -169.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -116.98 123.8 47.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.55 1.14 . . . . 0.0 109.009 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.633 ' HB3' ' HG3' ' A' ' 163' ' ' PRO . 0.4 OUTLIER -140.26 119.71 13.1 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 122.669 1.223 . . . . 0.0 111.579 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.35 -37.82 0.02 OUTLIER Glycine 0 N--CA 1.466 0.681 0 CA-C-N 113.045 -1.889 . . . . 0.0 110.042 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.58 -76.03 2.16 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.46 -0.37 . . . . 0.0 113.085 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.57 -63.68 3.36 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.23 171.63 32.16 Favored Glycine 0 C--O 1.243 0.683 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -70.45 105.15 2.96 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.77 32.38 21.62 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 -171.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.28 96.48 0.72 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.98 -110.01 0.22 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 113.93 0.332 . . . . 0.0 113.93 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.57 51.0 1.38 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 123.092 0.377 . . . . 0.0 112.204 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.97 -54.63 4.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 61.29 95.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.312 1.445 . . . . 0.0 110.523 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 63.37 4.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.312 0.645 . . . . 0.0 109.775 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.539 ' HA3' ' HZ2' ' A' ' 122' ' ' LYS . . . 54.93 -121.74 22.9 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.085 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -109.29 28.51 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 C-N-CA 123.853 0.861 . . . . 0.0 110.069 177.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 73.0 mt 74.76 -172.62 0.11 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 125.001 1.32 . . . . 0.0 111.861 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -165.24 106.21 0.78 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.602 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t70 178.66 73.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.063 0.945 . . . . 0.0 112.441 151.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.594 HG23 ' HB2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -134.33 158.76 74.49 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 165.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -23.93 138.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.999 1 C-N-CA 125.766 4.311 . . . . 0.0 116.258 175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -61.8 148.47 87.39 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.417 1.087 . . . . 0.0 112.157 -171.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HD2' ' A' ' 121' ' ' HIS . 5.0 Cg_endo -45.61 -38.5 16.77 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 124.303 3.335 . . . . 0.0 117.345 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.45 166.71 1.09 Allowed 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.484 2.123 . . . . 0.0 115.133 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -69.54 -163.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.929 2.419 . . . . 0.0 112.415 172.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.3 t 74.66 -61.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 125.049 1.34 . . . . 0.0 110.004 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.43 67.37 3.72 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -89.58 -31.1 17.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.102 0.561 . . . . 0.0 109.713 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HA ' ' HH ' ' A' ' 140' ' ' TYR . . . -71.96 146.09 47.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.333 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -62.9 137.56 58.3 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 123.984 0.802 . . . . 0.0 109.719 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.4 mt -149.14 -164.4 2.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.043 1.337 . . . . 0.0 107.92 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 71.57 25.06 3.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.181 1.392 . . . . 0.0 109.982 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.664 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 27.2 t70 -17.96 113.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.323 2.649 . . . . 0.0 115.734 -170.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.34 -178.04 39.09 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.89 110.75 18.16 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 124.355 1.062 . . . . 0.0 108.786 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -99.54 140.66 33.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 50' ' ' LEU . 12.5 ptt180 -83.39 122.7 28.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.674 HD13 ' H ' ' B' ' 252' ' ' NLE . 18.2 pt -107.63 135.44 46.23 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.62 -166.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.607 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 79.5 tttt -124.06 137.47 54.57 Favored 'General case' 0 C--N 1.379 1.851 0 O-C-N 125.041 1.463 . . . . 0.0 112.64 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -108.66 147.76 31.42 Favored 'General case' 0 C--O 1.252 1.195 0 C-N-CA 125.388 1.475 . . . . 0.0 109.001 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -59.53 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 158.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' H ' ' HA ' ' A' ' 94' ' ' TYR . . . -59.5 154.41 30.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 124.4 1.063 . . . . 0.0 115.44 -145.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.74 -34.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.842 1.257 . . . . 0.0 110.221 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.5 mt -126.23 23.62 7.0 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.032 0.933 . . . . 0.0 111.301 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.24 -97.77 0.17 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 122.199 -0.313 . . . . 0.0 112.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.539 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 61.5 m-85 -145.06 116.21 7.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.206 1.402 . . . . 0.0 108.186 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -129.26 101.31 5.94 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -167.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 4.0 pm0 -94.24 104.19 16.2 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.648 ' HB ' ' HD ' ' B' ' 255' ' ' M9P . 1.4 pp -137.77 -37.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -154.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . -121.56 -159.5 10.7 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.312 -1.423 . . . . 0.0 114.265 -163.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.471 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -133.36 125.29 28.83 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 174.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.13 110.82 2.36 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.666 HG22 ' HB2' ' A' ' 108' ' ' HIS . 17.7 m -105.58 102.82 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.664 ' HD2' ' HA ' ' A' ' 81' ' ' ASP . 80.2 t80 -94.06 119.95 33.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -140.06 124.53 18.01 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.891 0.876 . . . . 0.0 108.703 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 50.13 55.58 9.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.407 1.483 . . . . 0.0 112.366 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.2 15.64 79.98 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.054 -0.975 . . . . 0.0 114.219 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 m -135.62 115.39 12.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.402 0.601 . . . . 0.0 111.332 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -85.26 112.21 20.55 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.666 ' HB2' HG22 ' A' ' 101' ' ' VAL . 58.4 m80 -98.91 110.38 23.0 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.867 1.354 . . . . 0.0 110.207 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.562 HG22 ' HB ' ' A' ' 138' ' ' ILE . 15.3 t -139.97 -159.35 0.95 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.86 0.464 . . . . 0.0 110.489 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.609 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 23.2 ttm -156.55 160.73 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -157.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -80.73 -35.34 33.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 3.2 p-80 -75.6 -23.6 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.65 ' HB ' ' HZ2' ' B' ' 253' ' ' LYS . 5.8 m -81.06 -10.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.609 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.876 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 8.4 m 165.58 144.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 127.113 2.165 . . . . 0.0 107.914 160.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -83.04 34.81 0.46 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.726 1.21 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.21 54.68 1.25 Allowed Glycine 0 C--N 1.347 1.173 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 3' ' ' ALA . . . -106.15 -174.48 2.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.208 0.603 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -116.14 134.68 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.43 0.634 . . . . 0.0 112.66 -163.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.692 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 mm? -90.97 179.28 5.79 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.392 1.477 . . . . 0.0 111.637 -167.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.545 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.3 ptp -175.69 163.23 2.84 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 123.088 1.423 . . . . 0.0 114.632 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.594 ' HB2' HG23 ' A' ' 68' ' ' VAL . 70.3 t60 -109.75 105.39 14.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 111.535 -2.575 . . . . 0.0 105.485 155.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.539 ' HZ2' ' HA3' ' A' ' 63' ' ' GLY . 53.9 pttt -41.14 116.14 0.69 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 125.408 1.483 . . . . 0.0 113.211 -156.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.72 -7.51 55.61 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.048 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -138.58 113.1 8.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.319 1.448 . . . . 0.0 107.196 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -106.63 128.66 54.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.381 0.537 . . . . 0.0 111.636 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.51 129.85 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.007 1.323 . . . . 0.0 109.803 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HA ' HG23 ' A' ' 118' ' ' VAL . 32.0 mt-10 -91.46 151.7 42.9 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.144 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.93 -178.56 3.59 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.084 2.523 . . . . 0.0 112.586 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 19.4 p -126.36 -21.53 4.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.879 0.472 . . . . 0.0 112.195 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.421 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 21.8 t-105 -140.2 146.53 38.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.438 0.695 . . . . 0.0 110.065 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.51 120.83 3.64 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.37 1.044 . . . . 0.0 109.215 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.68 128.64 39.42 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.3 0.571 . . . . 0.0 110.039 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.96 -36.15 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.083 -166.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.35 -35.41 71.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.495 0.718 . . . . 0.0 112.376 -167.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.18 -7.39 56.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.974 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.511 ' O ' ' HG3' ' A' ' 110' ' ' MET . 22.2 t70 65.75 47.35 2.13 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.227 0.955 . . . . 0.0 109.022 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 53.5 mt -144.66 139.96 28.35 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.562 ' HB ' HG22 ' A' ' 109' ' ' THR . 60.8 mt -132.61 142.78 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 125.506 1.522 . . . . 0.0 108.558 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.441 ' HB3' ' CE3' ' A' ' 144' ' ' TRP . 74.6 p -139.1 159.54 41.9 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 118.813 0.733 . . . . 0.0 112.259 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.513 ' HH ' ' HA ' ' A' ' 77' ' ' ALA . 20.7 t80 -129.91 146.78 51.63 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.815 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.69 4.43 54.63 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.37 -162.53 28.44 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.7 173.05 31.13 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 168.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.45 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 66.6 t-105 -63.8 129.26 39.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.7 0.75 . . . . 0.0 109.408 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -164.74 176.51 8.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.923 0.489 . . . . 0.0 111.709 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.451 HD12 ' HE1' ' A' ' 108' ' ' HIS . 3.3 tm? 67.72 97.6 0.06 Allowed 'General case' 0 C--N 1.358 0.97 0 O-C-N 125.013 1.446 . . . . 0.0 111.74 169.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.685 ' HG3' ' HA2' ' A' ' 209' ' ' GLY . 7.1 mm-40 160.1 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.105 2.562 . . . . 0.0 107.336 154.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.16 85.16 0.49 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.662 ' HG2' ' HB2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -75.84 163.77 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -156.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 49.8 t90 -55.81 142.0 36.58 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 111.611 -2.54 . . . . 0.0 112.035 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -131.75 153.8 49.7 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.24 104.51 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.381 1.072 . . . . 0.0 113.374 -166.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.84 -43.56 0.64 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.485 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -78.38 167.92 20.6 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.524 0.73 . . . . 0.0 112.757 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.14 174.33 7.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.803 0.841 . . . . 0.0 110.576 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 155.87 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 0.0 109.471 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 40.3 mt-30 -126.81 128.72 47.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.439 HG23 HG23 ' A' ' 200' ' ' ILE . 91.0 t -93.02 110.07 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.472 0.709 . . . . 0.0 109.718 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.6 ' HB3' ' HG2' ' A' ' 199' ' ' PRO . 1.3 tm? -77.21 76.13 3.76 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.21 124.53 31.29 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.444 -171.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.468 ' HB2' HD22 ' A' ' 50' ' ' LEU . 18.1 mt -69.02 120.59 15.12 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 123.662 0.601 . . . . 0.0 109.823 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.94 107.8 30.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.633 ' HG3' ' HB3' ' A' ' 50' ' ' LEU . 47.0 Cg_exo -55.64 115.47 2.48 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.923 2.415 . . . . 0.0 112.686 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.57 -16.83 60.45 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.596 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -124.2 -171.69 2.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.454 0.702 . . . . 0.0 110.252 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.86 139.25 57.6 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.345 0.658 . . . . 0.0 109.893 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.73 129.14 28.85 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.814 3.01 . . . . 0.0 113.463 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -97.0 125.54 41.51 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 109.496 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -85.37 104.07 14.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.128 0.571 . . . . 0.0 109.863 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 68.5 t -87.96 109.68 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.541 1.136 . . . . 0.0 110.387 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.495 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 7.9 tt0 -80.1 125.88 30.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 109.952 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 t -151.35 151.24 31.48 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 110.676 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.88 156.45 42.52 Favored Pre-proline 0 C--O 1.244 0.778 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.443 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 172.26 13.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.9 2.4 . . . . 0.0 112.941 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.03 -174.46 28.76 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.981 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 144.76 26.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.1 0.45 . . . . 0.0 110.519 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 183' ' ' THR . 5.9 m-85 -97.4 119.39 35.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.616 ' HA ' HG21 ' A' ' 183' ' ' THR . 62.7 tttp -99.12 98.74 9.71 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 109.424 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 180' ' ' ASN . 2.0 m -95.51 -178.37 4.39 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.524 ' H ' HG23 ' A' ' 179' ' ' THR . 7.8 p30 -61.34 -25.31 67.06 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.8 -38.13 0.36 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.429 0.691 . . . . 0.0 110.719 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.45 118.7 5.28 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.587 -0.279 . . . . 0.0 112.506 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.616 HG21 ' HA ' ' A' ' 178' ' ' LYS . 22.6 p -119.01 111.96 18.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.47 135.34 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.78 111.27 4.11 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.528 ' HB2' ' HA ' ' A' ' 225' ' ' ALA . . . -143.77 -161.02 1.19 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.4 0.68 . . . . 0.0 110.424 -167.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.51 108.89 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.475 0.655 . . . . 0.0 109.454 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.614 ' HA ' HG11 ' A' ' 223' ' ' VAL . 10.0 t -80.71 112.48 18.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.837 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 191' ' ' PHE . 1.4 tt -130.22 132.34 45.95 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.899 0.38 . . . . 0.0 110.566 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.67 ' H ' ' HA2' ' A' ' 24' ' ' GLY . 10.4 m-20 -96.55 104.92 16.94 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.6 ' HB2' HD21 ' A' ' 189' ' ' LEU . 31.7 t80 -153.5 163.45 39.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.5 p -58.04 151.31 46.06 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.429 167.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . 0.606 ' HB3' ' HA ' ' A' ' 47' ' ' GLU . 84.0 Cg_exo -46.92 95.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.84 2.36 . . . . 0.0 113.691 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.61 179.25 12.92 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.556 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.449 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 71.0 p -115.19 145.93 41.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.354 0.597 . . . . 0.0 112.46 -169.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.618 ' HB3' HG13 ' A' ' 113' ' ' VAL . 62.8 m -67.91 99.1 0.8 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.296 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 132.86 3.83 3.53 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.054 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 71.4 m -55.1 122.64 43.62 Favored Pre-proline 0 C--N 1.368 1.397 0 C-N-CA 123.3 0.64 . . . . 0.0 111.3 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.612 ' HA ' ' HA ' ' A' ' 210' ' ' LEU . 83.8 Cg_endo -78.43 144.66 20.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.979 2.453 . . . . 0.0 113.403 -174.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.705 HG13 ' HB ' ' A' ' 208' ' ' VAL . 8.2 pt -111.3 110.37 31.94 Favored 'Isoleucine or valine' 0 C--O 1.268 2.047 0 CA-C-O 123.105 1.431 . . . . 0.0 109.347 171.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 159' ' ' LEU . 13.7 pt -130.94 161.34 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 112.339 -2.209 . . . . 0.0 109.663 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 207' ' ' VAL . 23.6 t70 -90.82 -178.69 5.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.532 0.733 . . . . 0.0 109.585 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -58.87 -18.88 36.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . 0.441 ' HE3' ' HD2' ' A' ' 206' ' ' LYS . 62.4 tttp -71.01 -13.44 62.0 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.579 1.151 . . . . 0.0 111.365 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 16' ' ' TRP . . . 86.25 9.41 76.45 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 123.359 0.504 . . . . 0.0 112.92 -176.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.441 ' HD2' ' HE3' ' A' ' 204' ' ' LYS . 18.1 ptpt -157.81 151.89 24.35 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.255 1.022 . . . . 0.0 109.51 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.572 HG11 HG22 ' A' ' 208' ' ' VAL 0.25 7.9 p -178.11 -71.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 O-C-N 124.613 1.196 . . . . 0.0 108.489 161.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.705 ' HB ' HG13 ' A' ' 200' ' ' ILE . 2.1 t -90.6 -44.69 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 120.494 1.497 . . . . 0.0 111.253 -162.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.685 ' HA2' ' HG3' ' A' ' 147' ' ' GLU . . . 127.47 -98.17 0.49 Allowed Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 113.514 -1.676 . . . . 0.0 110.824 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.612 ' HA ' ' HA ' ' A' ' 199' ' ' PRO . 2.0 pt? -146.27 172.52 13.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.281 0.562 . . . . 0.0 110.669 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.736 ' HB2' ' HB3' ' A' ' 224' ' ' SER . 0.0 OUTLIER -74.88 142.28 44.09 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.576 ' HA2' ' HE3' ' A' ' 110' ' ' MET . . . -82.35 -145.16 5.29 Favored Glycine 0 C--N 1.343 0.972 0 C-N-CA 123.03 0.347 . . . . 0.0 112.251 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -78.54 86.44 4.55 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.462 0.649 . . . . 0.0 109.751 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.79 -174.72 19.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.866 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.757 HG13 ' HA ' ' A' ' 40' ' ' SER . 10.5 p -168.63 168.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.874 0.469 . . . . 0.0 110.116 -168.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.417 HG13 ' HD1' ' A' ' 222' ' ' TYR . 6.6 m -69.66 115.25 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 165.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.645 ' HA ' HD12 ' A' ' 41' ' ' ILE . 5.2 t -79.27 168.99 18.79 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.553 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -51.73 137.42 25.56 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 124.389 1.056 . . . . 0.0 110.52 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.9 m 86.07 -4.36 0.78 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.712 2.005 . . . . 0.0 111.139 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.39 29.53 36.33 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.103 0.382 . . . . 0.0 113.233 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -95.85 115.28 27.19 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 193' ' ' PRO . 23.0 t80 -74.22 101.08 3.88 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.678 0.752 . . . . 0.0 109.925 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 188' ' ' SER . 91.9 t -94.97 152.52 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.492 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.736 ' HB3' ' HB2' ' A' ' 211' ' ' TYR . 69.9 m -130.1 135.03 47.78 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.528 ' HA ' ' HB2' ' A' ' 186' ' ' ALA . . . -73.29 163.89 27.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.645 HG22 HG13 ' A' ' 208' ' ' VAL . 43.5 mt -98.18 106.04 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.806 0.443 . . . . 0.0 110.536 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -99.36 108.49 21.01 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 121.794 0.807 . . . . 0.0 108.903 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.662 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 11.0 pt20 -95.25 167.39 11.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.945 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.45 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 3.9 p -117.3 126.86 53.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.01 1.98 17.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.416 1.086 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 54.51 92.62 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.374 1.07 . . . . 0.0 111.181 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 22.3 m -61.99 91.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.229 1.012 . . . . 0.0 111.393 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.3 pt -86.31 -31.21 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.506 1.122 . . . . 0.0 109.966 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -161.56 154.62 20.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.383 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.08 -50.06 2.97 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.03 0.932 . . . . 0.0 109.211 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.23 124.72 90.86 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.076 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.92 112.32 1.62 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.456 2.104 . . . . 0.0 110.409 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.05 -39.76 79.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.159 0.912 . . . . 0.0 111.915 -175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 -42.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 170.384 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.876 ' H2 ' ' HB ' ' A' ' 114' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.797 ' HG3' HD22 ' A' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.65 ' HZ2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -166.29 -148.4 0.1 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.062 -148.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.513 ' O ' ' HD ' ' B' ' 255' ' ' M9P . 81.6 mtt85 -68.96 -110.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 155.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.648 ' HD ' ' HB ' ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 120.81 0.117 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.576 ' HB3' ' HB3' ' A' ' 117' ' ' ALA . 35.6 t -72.03 -31.98 66.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -163.49 176.08 10.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.389 0.676 . . . . 0.0 110.82 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.23 42.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -172.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.463 ' H ' HD13 ' A' ' 6' ' ' LEU . 5.9 m-20 -145.75 28.11 1.17 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.351 1.06 . . . . 0.0 111.474 -171.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.59 ' HB3' ' HD3' ' B' ' 252' ' ' NLE . 1.6 mp -114.92 99.8 7.74 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.925 0.784 . . . . 0.0 111.289 -167.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 120' ' ' MET . 36.1 mp0 -106.95 142.92 35.8 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.207 0.527 . . . . 0.0 112.056 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 67' ' ' ASP . 0.4 OUTLIER -116.04 166.56 11.86 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.954 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 33.3 tt0 -155.13 137.51 14.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.298 1.439 . . . . 0.0 108.892 -171.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' ' HD1' ' A' ' 84' ' ' TYR . 35.7 ttt-85 -72.58 125.61 27.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.544 0.611 . . . . 0.0 110.711 -172.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.637 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -86.72 -56.42 3.41 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.26 -161.68 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.912 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -96.09 156.76 16.2 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.828 1.251 . . . . 0.0 107.682 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.69 97.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -172.61 132.92 0.59 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.572 0.749 . . . . 0.0 109.783 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.6 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 78.8 t90 -87.58 93.7 9.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.9 0.48 . . . . 0.0 110.964 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.98 58.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.035 0.534 . . . . 0.0 110.302 161.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -89.98 -55.86 3.45 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.652 0.381 . . . . 0.0 111.403 172.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.02 21.14 1.25 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.63 -168.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.24 72.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 127.137 2.175 . . . . 0.0 114.84 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.69 145.25 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.113 0.965 . . . . 0.0 110.332 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.82 143.34 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 124.08 0.952 . . . . 0.0 109.159 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -152.0 -165.56 2.26 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.251 1.02 . . . . 0.0 110.805 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.54 121.64 2.3 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -75.99 -80.22 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.983 0.513 . . . . 0.0 111.582 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.6 t -140.59 145.03 38.72 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.286 0.635 . . . . 0.0 109.887 -166.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.59 -39.57 11.87 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.731 2.287 . . . . 0.0 112.158 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.47 124.44 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.231 0.612 . . . . 0.0 109.703 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.749 HD23 ' HB2' ' A' ' 218' ' ' ARG . 3.8 tt -143.68 119.59 10.62 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.3 p -78.03 127.96 33.12 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.19 0.996 . . . . 0.0 112.085 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 54.7 mt -112.7 167.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.431 1.492 . . . . 0.0 107.277 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -99.18 126.27 44.93 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.954 1.252 . . . . 0.0 110.24 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -70.26 129.75 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.0 t -136.18 135.51 39.21 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.44 7.07 6.08 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.677 1.191 . . . . 0.0 111.782 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 57.35 27.21 13.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.834 1.254 . . . . 0.0 112.775 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.45 -29.83 0.03 OUTLIER Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.875 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -106.79 165.87 11.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.269 0.627 . . . . 0.0 110.12 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.2 ptm -140.54 130.75 24.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.402 0.681 . . . . 0.0 109.267 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 p -164.78 178.29 7.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.776 HD13 HG22 ' A' ' 217' ' ' THR . 10.5 tp -86.55 152.35 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.6 126.51 27.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.5 t30 70.9 99.59 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.269 1.428 . . . . 0.0 110.476 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.71 131.37 53.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.546 0.738 . . . . 0.0 109.231 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -122.26 106.23 10.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.556 0.742 . . . . 0.0 110.126 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.81 -168.7 2.15 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.232 1.013 . . . . 0.0 109.732 169.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 73.42 100.16 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.571 1.149 . . . . 0.0 109.932 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -131.01 164.78 24.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.189 0.996 . . . . 0.0 108.866 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.458 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 9.5 t -128.84 134.51 48.35 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 164.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.746 ' HA ' ' H ' ' A' ' 164' ' ' GLY . 1.4 pt? -137.53 -17.44 1.3 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.342 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.32 -55.81 27.11 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 123.637 0.586 . . . . 0.0 111.892 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.97 -83.37 0.09 OUTLIER Glycine 0 C--N 1.356 1.651 0 O-C-N 123.918 0.422 . . . . 0.0 113.19 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.73 -44.02 16.63 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.1 -175.37 39.7 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 113.357 0.103 . . . . 0.0 113.357 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.5 ' HB2' ' HG3' ' A' ' 9' ' ' GLU . 32.2 t -90.01 108.37 19.68 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.845 0.858 . . . . 0.0 109.152 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.67 -86.32 0.09 OUTLIER Glycine 0 C--N 1.355 1.639 0 O-C-N 124.012 0.82 . . . . 0.0 112.498 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.19 11.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.771 0 CA-C-O 119.923 -0.376 . . . . 0.0 113.212 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.09 10.63 73.4 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.806 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.723 ' HA2' ' HE2' ' A' ' 122' ' ' LYS . . . -75.43 -64.98 2.16 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.99 4.21 3.46 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.662 1.585 . . . . 0.0 113.94 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.9 t80 68.06 -0.13 2.2 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.724 1.21 . . . . 0.0 111.326 -167.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.45 11.62 3.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.793 0.837 . . . . 0.0 111.04 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.45 -127.23 0.92 Allowed Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.537 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 2.3 t -126.35 -95.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 C-N-CA 124.181 0.992 . . . . 0.0 109.877 -174.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 42.1 mt -147.55 163.91 35.09 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 123.725 0.81 . . . . 0.0 111.9 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -132.08 94.0 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.559 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER 171.71 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 126.565 1.946 . . . . 0.0 109.645 158.714 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.468 HG11 ' HB2' ' A' ' 121' ' ' HIS . 29.4 m -132.19 157.34 78.51 Favored Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 119.339 0.972 . . . . 0.0 111.955 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.18 79.32 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.414 2.076 . . . . 0.0 111.099 171.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 t -66.99 126.03 91.84 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.088 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -51.08 -43.73 46.49 Favored 'Trans proline' 0 CA--C 1.575 2.54 0 C-N-CA 122.984 2.456 . . . . 0.0 115.576 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -99.29 108.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.254 1.969 . . . . 0.0 113.45 171.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.91 83.83 2.13 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.286 1.991 . . . . 0.0 111.315 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.69 -30.5 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.208 1.003 . . . . 0.0 112.627 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.6 28.68 3.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 63.7 8.22 3.6 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.917 1.287 . . . . 0.0 112.725 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.28 169.07 11.42 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.003 0.921 . . . . 0.0 108.557 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' HG2' ' HE2' ' A' ' 124' ' ' LYS . 3.9 tp10 60.5 35.16 20.29 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.07 0.938 . . . . 0.0 110.492 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.71 86.64 1.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -83.37 -52.95 6.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.76 -164.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 57.22 100.91 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.074 1.75 . . . . 0.0 111.656 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.39 -153.59 24.65 Favored Glycine 0 C--O 1.254 1.381 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.281 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.99 44.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.429 1.092 . . . . 0.0 108.894 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 8.7 m-85 -122.18 138.92 54.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.352 0.261 . . . . 0.0 110.69 -171.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.637 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 43.5 mtm180 -73.34 122.67 22.4 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 165.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.772 HG13 HG21 ' A' ' 97' ' ' ILE . 24.5 pt -120.69 146.95 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.639 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.537 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 51.6 tttm -152.32 141.51 21.39 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 126.388 1.875 . . . . 0.0 110.984 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.601 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 44.8 tt0 -123.09 150.91 42.56 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.918 -0.489 . . . . 0.0 111.713 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 16.6 ttpp -101.96 84.53 2.54 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.81 176.17 44.34 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.235 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' B' ' 253' ' ' LYS . 49.0 mt 59.17 -83.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.342 1.457 . . . . 0.0 111.604 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -113.13 -30.83 6.84 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.545 0.738 . . . . 0.0 110.205 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.87 -173.82 38.29 Favored Glycine 0 C--N 1.349 1.254 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.673 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 1.8 m-30 -105.98 72.12 0.93 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.748 ' HB3' ' HE3' ' B' ' 253' ' ' LYS . 37.1 t -135.39 155.61 50.29 Favored 'General case' 0 C--O 1.265 1.875 0 CA-C-O 121.92 0.866 . . . . 0.0 112.737 -163.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.487 ' HB3' HD22 ' A' ' 50' ' ' LEU . 22.8 mp0 -75.3 149.63 38.71 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.062 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.772 HG21 HG13 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -136.73 -43.15 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -167.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.699 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . 169.32 -124.17 1.14 Allowed Glycine 0 N--CA 1.481 1.672 0 C-N-CA 116.604 -2.712 . . . . 0.0 118.019 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -128.58 126.47 40.36 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -165.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.16 149.97 18.83 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 164.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.86 116.41 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.064 0.932 . . . . 0.0 109.93 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.541 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 50.8 t80 -133.09 138.35 46.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -161.65 151.23 16.47 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 124.008 0.818 . . . . 0.0 109.135 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 65.08 -77.66 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.462 1.505 . . . . 0.0 110.652 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.57 19.88 0.15 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t -123.48 116.73 23.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.507 0.723 . . . . 0.0 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.541 ' HD2' ' HB2' ' A' ' 102' ' ' TYR . 59.9 t80 -97.53 102.91 14.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.524 ' NE2' ' HB3' ' A' ' 137' ' ' LEU . 2.3 t60 -121.24 126.21 49.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -135.47 -174.26 3.58 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 108.507 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.449 ' HA ' HD23 ' A' ' 137' ' ' LEU . 82.4 mmm -79.8 160.01 26.31 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.027 0.531 . . . . 0.0 111.535 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -84.08 -46.08 12.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.019 170.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -59.29 -19.15 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.95 0.9 . . . . 0.0 113.351 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.579 HG13 ' HB3' ' A' ' 196' ' ' SER . 24.9 m -65.02 -14.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.439 0.696 . . . . 0.0 112.107 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -151.28 -162.14 1.48 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.604 1.162 . . . . 0.0 109.365 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 -133.47 21.03 3.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.507 ' H ' HG22 ' A' ' 114' ' ' THR . . . 103.4 54.63 0.83 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 2' ' ' SER . . . -101.87 -176.71 3.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.771 0.828 . . . . 0.0 111.429 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.555 HG22 ' HE ' ' A' ' 125' ' ' ARG . 3.0 p -90.75 178.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 118' ' ' VAL . 20.9 mt -124.52 166.01 16.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.528 . . . . 0.0 111.183 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.532 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -164.82 174.84 10.2 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.468 ' HB2' HG11 ' A' ' 68' ' ' VAL . 15.8 t60 -137.54 97.53 3.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.514 1.926 . . . . 0.0 106.795 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.723 ' HE2' ' HA2' ' A' ' 59' ' ' GLY . 9.0 mtmp? 8.91 75.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.282 1.833 . . . . 0.0 114.064 -159.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.32 -27.49 19.72 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 115.108 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.528 ' HE2' ' HG2' ' A' ' 78' ' ' GLU . 63.7 tttp -82.91 112.43 19.69 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.565 1.183 . . . . 0.0 109.939 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.555 ' HE ' HG22 ' A' ' 118' ' ' VAL . 75.0 ttt180 -106.4 134.44 49.53 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.514 0.725 . . . . 0.0 112.029 -164.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.62 142.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.142 1.377 . . . . 0.0 109.138 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.71 144.1 27.54 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 122.95 0.5 . . . . 0.0 112.067 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.467 ' HA ' ' HB2' ' A' ' 140' ' ' TYR . 22.6 Cg_exo -68.61 138.27 41.26 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.662 2.241 . . . . 0.0 111.562 165.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 34.5 p -88.85 -7.43 56.16 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.671 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 5.1 t-105 -151.24 148.14 27.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.353 0.661 . . . . 0.0 110.151 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -146.63 124.21 11.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.923 0.889 . . . . 0.0 109.438 171.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.22 117.79 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.623 0.769 . . . . 0.0 110.727 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -27.73 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.78 0.832 . . . . 0.0 111.492 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -62.69 -56.66 15.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.61 0.764 . . . . 0.0 111.128 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.673 ' HB2' ' HZ1' ' A' ' 135' ' ' LYS . 3.3 ttmp? -97.34 1.09 49.03 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.513 0.725 . . . . 0.0 109.895 178.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 61.41 54.34 3.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.627 1.571 . . . . 0.0 111.686 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.524 ' HB3' ' NE2' ' A' ' 108' ' ' HIS . 36.6 mt -144.31 145.8 32.21 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.393 0.616 . . . . 0.0 112.456 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 30.8 mt -120.84 143.8 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.841 1.657 . . . . 0.0 110.253 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.671 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 2.2 m -120.32 158.19 27.62 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.228 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 3.4 t80 -151.41 135.66 16.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.846 1.258 . . . . 0.0 107.881 172.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.26 9.53 56.8 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.26 -172.6 27.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.13 -179.84 49.29 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -75.37 123.19 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.503 0.721 . . . . 0.0 110.342 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -164.01 147.22 9.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.238 1.415 . . . . 0.0 107.568 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.52 -142.06 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 O-C-N 124.314 1.009 . . . . 0.0 108.716 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 64.55 37.21 8.09 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.743 1.617 . . . . 0.0 111.353 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.84 168.08 0.96 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.786 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 150' ' ' TRP . 25.3 tt0 -143.86 129.97 19.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.236 0.614 . . . . 0.0 109.888 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.525 ' HH2' HG21 ' A' ' 226' ' ' ILE . 1.5 p90 -65.28 150.61 47.94 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.677 0.791 . . . . 0.0 110.166 164.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.69 148.82 26.2 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.765 1.226 . . . . 0.0 111.705 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 155.66 -18.7 0.5 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.494 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.414 ' HB2' ' HD1' ' A' ' 150' ' ' TRP . 32.9 mt-10 -96.6 152.67 18.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.879 0.872 . . . . 0.0 109.311 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.75 114.03 25.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.2 p -97.01 164.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 120.754 0.312 . . . . 0.0 111.143 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 171' ' ' GLN . 22.3 mp0 -105.91 147.68 28.48 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.931 0.892 . . . . 0.0 109.169 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.04 143.07 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.901 0.48 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.41 93.72 8.74 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 171.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.33 100.62 10.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.89 97.79 1.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -57.66 133.04 82.51 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.239 0.616 . . . . 0.0 111.645 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.83 113.15 1.51 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.506 2.137 . . . . 0.0 112.49 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.746 ' H ' ' HA ' ' A' ' 50' ' ' LEU . . . 73.08 29.43 64.69 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.056 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.408 ' HG2' ' N ' ' A' ' 166' ' ' ASN . 81.4 tttt -151.84 177.27 10.59 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 117.351 0.575 . . . . 0.0 110.045 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.408 ' N ' ' HG2' ' A' ' 165' ' ' LYS . 1.8 p-10 -57.72 160.51 7.78 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 112.343 170.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.89 141.1 88.6 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.97 2.447 . . . . 0.0 112.378 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -112.37 116.03 29.68 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -96.37 108.14 20.62 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.182 0.593 . . . . 0.0 109.561 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.68 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.536 0.734 . . . . 0.0 110.082 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 157' ' ' GLN . 30.5 tt0 -87.8 149.85 23.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.864 0.866 . . . . 0.0 109.173 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.5 t -154.66 147.97 24.98 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.765 0.826 . . . . 0.0 110.744 -172.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -75.61 158.39 83.18 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.08 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.17 146.1 93.95 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.203 1.935 . . . . 0.0 112.821 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -145.7 130.87 3.93 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-O 122.114 0.841 . . . . 0.0 114.515 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.453 ' HA ' ' HA3' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -127.24 149.71 49.88 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.345 -1.091 . . . . 0.0 112.564 -171.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.11 123.25 35.32 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.682 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -89.13 106.21 18.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 23.5 m -82.81 158.01 22.94 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.655 0.782 . . . . 0.0 110.756 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -82.85 57.32 3.79 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.053 0.93 . . . . 0.0 108.535 168.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -175.43 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.009 1.724 . . . . 0.0 108.003 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -153.31 -131.0 1.55 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.718 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 t -162.1 131.72 4.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.583 0.753 . . . . 0.0 109.751 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.45 138.1 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.44 0.696 . . . . 0.0 109.44 175.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.82 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 138.42 161.96 9.01 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.886 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -176.35 42.29 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.316 0 O-C-N 124.655 0.856 . . . . 0.0 110.382 170.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 9.5 p -166.46 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 120.232 -1.543 . . . . 0.0 109.73 166.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.7 m -129.76 106.19 8.53 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.542 0.737 . . . . 0.0 109.54 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.533 HD13 ' HD2' ' A' ' 191' ' ' PHE . 3.8 pp -131.88 159.15 39.45 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.924 0.49 . . . . 0.0 111.436 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.8 103.2 15.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.459 0.704 . . . . 0.0 110.333 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.533 ' HD2' HD13 ' A' ' 189' ' ' LEU . 17.7 m-85 -157.72 -175.74 5.54 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 108.455 172.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -44.07 139.91 2.94 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.549 1.14 . . . . 0.0 110.769 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.22 116.48 2.27 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.484 2.122 . . . . 0.0 111.204 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.74 111.87 1.63 Allowed Glycine 0 C--N 1.349 1.29 0 O-C-N 124.153 0.908 . . . . 0.0 112.194 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.699 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 25.2 p -50.66 124.26 10.56 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.004 1.322 . . . . 0.0 111.129 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.579 ' HB3' HG13 ' A' ' 113' ' ' VAL . 36.1 m -55.65 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.563 0 O-C-N 123.901 0.751 . . . . 0.0 110.071 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 110' ' ' MET . . . 127.87 4.96 5.48 Favored Glycine 0 C--N 1.366 2.226 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.4 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 67.1 m -49.67 129.67 19.89 Favored Pre-proline 0 N--CA 1.5 2.041 0 C-N-CA 124.462 1.105 . . . . 0.0 113.456 -171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.39 133.84 6.46 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 113.223 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.424 HG21 ' CZ3' ' A' ' 150' ' ' TRP . 50.3 mt -105.81 110.97 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.801 1.241 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 208' ' ' VAL . 12.8 pt -131.8 -175.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.803 1.241 . . . . 0.0 112.432 -168.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 36.3 t70 -114.98 175.98 5.26 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.139 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.6 ' HB3' ' HE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -60.54 -30.45 69.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.967 0.507 . . . . 0.0 112.053 172.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -84.98 -0.77 55.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.731 0.413 . . . . 0.0 111.963 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.56 23.85 77.52 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.921 -0.471 . . . . 0.0 111.921 -168.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 64.5 tttp -76.31 165.1 25.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.729 1.211 . . . . 0.0 109.605 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 208' ' ' VAL . 94.4 t 81.99 -89.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.959 1.304 . . . . 0.0 108.048 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.477 HG13 HG21 ' A' ' 201' ' ' ILE 0.28 3.1 m 68.21 31.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 125.08 1.352 . . . . 0.0 110.187 175.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.41 ' H ' HG12 ' A' ' 207' ' ' VAL . . . -72.43 -174.22 23.83 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.87 168.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.3 154.53 50.06 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.349 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . 0.56 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.0 OUTLIER -68.37 116.16 8.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.644 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 225' ' ' ALA . . . -71.61 -162.68 5.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.688 -0.292 . . . . 0.0 113.733 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -71.63 84.12 0.87 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.852 0.834 . . . . 0.0 109.523 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -127.15 -174.62 13.84 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.219 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.407 HG13 ' HG1' ' A' ' 217' ' ' THR . 7.2 p -160.12 176.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.323 0.649 . . . . 0.0 109.277 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.7 115.15 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.776 HG22 HD13 ' A' ' 41' ' ' ILE . 14.8 m -129.6 158.77 38.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.68 1.192 . . . . 0.0 109.783 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.749 ' HB2' HD23 ' A' ' 29' ' ' LEU . 4.1 tmm_? 63.65 76.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.647 1.179 . . . . 0.0 110.581 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 59.2 p 49.12 23.07 0.7 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.865 1.666 . . . . 0.0 114.577 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.05 0.67 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 113.794 0.278 . . . . 0.0 113.794 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.83 152.11 50.52 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.782 0.833 . . . . 0.0 109.065 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -83.36 118.84 23.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.676 0.39 . . . . 0.0 110.428 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 14.6 t -134.39 116.65 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.168 0.587 . . . . 0.0 109.577 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.417 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 45.7 t -130.88 156.76 44.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.82 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -101.8 93.26 5.22 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.171 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.525 HG21 ' HH2' ' A' ' 150' ' ' TRP . 22.9 pt -53.05 141.55 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -161.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.518 ' HB1' HD13 ' A' ' 137' ' ' LEU . . . -91.35 138.34 31.66 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.68 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.91 171.56 13.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -166.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.6 t -67.46 149.07 50.7 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.066 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -13.64 6.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.136 155.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt 33.2 87.77 0.01 OUTLIER 'General case' 0 C--N 1.38 1.914 0 C-N-CA 126.03 1.732 . . . . 0.0 112.821 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.5 m -52.66 99.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.742 0.817 . . . . 0.0 111.552 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.4 mm 68.91 146.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.623 1.569 . . . . 0.0 111.665 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.12 61.55 6.94 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.915 0.864 . . . . 0.0 111.438 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -76.21 -29.65 57.68 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.047 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.427 HD21 ' HA ' ' A' ' 239' ' ' ILE . 5.7 t30 -55.65 114.71 7.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 124.527 1.142 . . . . 0.0 110.874 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.03 120.14 7.26 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.161 1.908 . . . . 0.0 110.102 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 62.99 67.07 0.7 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 124.39 1.056 . . . . 0.0 108.718 -170.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.427 ' HA ' HD21 ' A' ' 236' ' ' ASN . 10.0 tt -70.8 -30.58 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.93 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.927 0.891 . . . . 0.0 109.272 178.588 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.527 ' H6 ' HD11 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.613 ' HE3' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.748 ' HE3' ' HB3' ' A' ' 95' ' ' SER . 0.1 OUTLIER 69.95 -63.13 0.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 127.597 2.359 . . . . 0.0 114.219 -172.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -43.87 -44.28 6.87 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -164.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.746 ' HA ' HG13 ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -107.26 91.59 3.72 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -177.6 -78.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.194 1.398 . . . . 0.0 108.384 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . 65.12 26.62 12.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.778 1.231 . . . . 0.0 110.876 175.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 89' ' ' LYS . 8.5 m-20 -155.19 40.04 0.42 Allowed 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.405 1.482 . . . . 0.0 107.166 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 119' ' ' LEU . 90.2 mt -79.91 92.86 5.58 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.542 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 120' ' ' MET . 21.1 mt-10 -98.61 126.84 44.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.448 1.099 . . . . 0.0 110.177 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD23 ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -117.42 162.75 17.44 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.934 -1.104 . . . . 0.0 113.67 -177.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 9.3 pt-20 -148.35 161.36 41.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.443 1.097 . . . . 0.0 110.269 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.654 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 12.7 tpt180 -66.98 153.28 44.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.647 0.779 . . . . 0.0 111.43 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.7 -52.39 1.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.906 0.883 . . . . 0.0 109.915 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.26 -166.66 0.55 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 108.88 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 36.7 t70 -95.82 153.09 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.584 HG21 ' HA2' ' A' ' 82' ' ' GLY . 5.1 t -73.28 99.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -162.44 149.12 13.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -168.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.62 112.05 5.16 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 166.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.15 144.2 42.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.037 0.535 . . . . 0.0 109.827 -178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.28 -19.43 64.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 48.99 1.67 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.833 0.825 . . . . 0.0 109.605 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.719 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -162.03 83.57 0.58 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 165.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.58 ' HB ' ' H ' ' A' ' 171' ' ' GLN . 29.4 mm -149.69 163.28 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 p -162.79 101.63 1.02 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.297 1.439 . . . . 0.0 108.077 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.34 -107.14 1.47 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.038 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.581 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 11.6 t 63.64 41.71 6.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.958 0.903 . . . . 0.0 109.927 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.6 m -64.65 146.0 98.5 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.16 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -54.12 178.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.917 3.078 . . . . 0.0 114.992 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.69 108.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -93.0 158.37 15.83 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.757 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 118.27 36.14 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.62 -0.675 . . . . 0.0 110.574 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 223' ' ' VAL . 40.9 mt -126.21 150.94 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.895 0.878 . . . . 0.0 108.997 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.9 p -98.42 113.11 24.97 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.407 HD12 ' HG2' ' A' ' 39' ' ' MET . 7.1 tp -65.22 159.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.156 0.583 . . . . 0.0 110.346 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -135.59 120.14 18.17 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 123.525 0.73 . . . . 0.0 109.422 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 67.8 -74.56 0.07 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 125.221 1.576 . . . . 0.0 110.876 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -158.64 -57.9 0.07 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.69 0.796 . . . . 0.0 109.309 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.78 -11.3 33.02 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.232 -0.894 . . . . 0.0 114.238 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -92.24 159.9 15.41 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.482 1.141 . . . . 0.0 108.981 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.425 ' HE2' ' CE1' ' A' ' 177' ' ' PHE . 68.6 mtp -132.97 143.01 49.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.676 0.39 . . . . 0.0 110.454 -175.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -143.37 153.7 42.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.433 0.693 . . . . 0.0 110.521 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.635 HG13 ' H ' ' A' ' 43' ' ' ASN . 7.3 tp -95.99 145.31 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -77.19 1.31 18.76 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-O 121.694 0.759 . . . . 0.0 111.323 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.635 ' H ' HG13 ' A' ' 41' ' ' ILE . 21.0 m120 -100.89 179.8 4.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.318 1.047 . . . . 0.0 109.5 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.3 143.28 33.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.736 0.814 . . . . 0.0 109.458 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -162.0 141.77 9.96 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.266 0.626 . . . . 0.0 109.569 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.13 108.49 14.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.57 -107.55 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.717 0.807 . . . . 0.0 111.155 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.659 ' HA ' HG21 ' A' ' 97' ' ' ILE . 49.7 mt-30 64.74 -176.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.9 p 64.45 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.711 2.004 . . . . 0.0 113.82 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.51 HD13 ' HB2' ' A' ' 161' ' ' LEU . 0.3 OUTLIER -156.4 -77.17 0.09 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 167.05 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -26.37 73.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.636 -0.711 . . . . 0.0 114.46 -168.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.57 56.84 5.03 Favored Glycine 0 C--N 1.345 1.048 0 C-N-CA 122.84 0.257 . . . . 0.0 113.322 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.08 4.36 4.57 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 170.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.88 175.31 16.61 Favored Glycine 0 C--N 1.356 1.661 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -130.73 137.56 49.56 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.305 0.642 . . . . 0.0 110.441 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.69 -29.34 35.77 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.59 -82.2 1.13 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 122.909 0.29 . . . . 0.0 113.158 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -141.78 127.82 3.41 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.07 -124.37 0.77 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -94.58 -63.48 1.17 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -113.24 -66.08 1.12 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.539 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.32 -41.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.167 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.87 113.79 0.94 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.503 ' O ' ' HD2' ' A' ' 122' ' ' LYS . 30.3 m -82.49 76.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-O 121.706 0.765 . . . . 0.0 111.595 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.466 ' HB3' ' HB3' ' A' ' 9' ' ' GLU . 6.0 mt 85.48 87.53 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.874 1.67 . . . . 0.0 111.825 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TRP . . . . . 0.579 ' HE1' ' HG2' ' A' ' 122' ' ' LYS . 6.4 m0 -102.06 105.39 16.12 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.654 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 28.6 t70 177.63 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.225 1.578 . . . . 0.0 109.233 155.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.36 146.73 60.91 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.488 0.715 . . . . 0.0 110.374 -172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.575 ' HD2' HD23 ' A' ' 8' ' ' LEU . 10.7 Cg_endo -54.89 79.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.421 2.081 . . . . 0.0 110.645 157.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 p -65.32 128.49 93.84 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.833 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HG3' HG12 ' A' ' 126' ' ' ILE . 72.4 Cg_exo -49.39 -47.3 22.91 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.369 2.713 . . . . 0.0 115.422 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.43 124.2 15.01 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 121.927 1.751 . . . . 0.0 113.06 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -86.03 49.83 2.36 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.408 2.739 . . . . 0.0 112.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.55 2.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 112.793 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.34 -58.28 2.71 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.99 -83.77 0.15 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.102 0.561 . . . . 0.0 109.489 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.02 -158.93 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.999 0.92 . . . . 0.0 112.894 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.402 ' HB2' ' H ' ' A' ' 79' ' ' LEU . 23.5 mt-10 -79.37 -85.64 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.402 ' H ' ' HB2' ' A' ' 78' ' ' GLU . 2.8 tm? 40.59 86.63 0.02 OUTLIER 'General case' 0 C--N 1.361 1.074 0 C-N-CA 126.197 1.799 . . . . 0.0 112.797 173.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -118.78 -169.18 1.68 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.4 142.23 20.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.08 0.552 . . . . 0.0 109.736 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.584 ' HA2' HG21 ' A' ' 14' ' ' VAL . . . 147.28 -154.12 25.76 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.55 137.55 46.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.489 ' CD2' HD21 ' A' ' 8' ' ' LEU . 7.7 m-85 -123.39 139.82 53.64 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.944 0.498 . . . . 0.0 111.348 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.492 ' HG3' HD13 ' A' ' 161' ' ' LEU . 21.9 mtp180 -92.75 126.57 37.9 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.662 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 15.1 pt -129.93 143.95 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -139.52 138.12 36.05 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.329 1.852 . . . . 0.0 112.151 -172.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.655 ' HB3' ' HG2' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -132.5 153.55 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 170.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 45.1 mtpt -106.97 88.97 2.86 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' B' ' 253' ' ' LYS . . . -168.64 178.11 42.24 Favored Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.435 ' HB ' ' HZ1' ' B' ' 253' ' ' LYS . 20.7 mt 59.42 23.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 118.008 0.904 . . . . 0.0 111.409 166.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp 71.45 41.65 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.052 1.341 . . . . 0.0 111.538 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.07 156.09 24.92 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 121.728 -0.272 . . . . 0.0 113.57 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.63 68.94 0.83 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.564 1.146 . . . . 0.0 108.2 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 m -113.26 125.06 53.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -159.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.459 ' HB2' HD11 ' A' ' 65' ' ' LEU . 3.4 pm0 -95.82 104.21 16.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.318 1.447 . . . . 0.0 108.893 170.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.659 HG21 ' HA ' ' A' ' 48' ' ' GLN . 2.8 pp -137.14 -37.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.49 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -120.13 -168.96 13.91 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.284 -1.436 . . . . 0.0 116.129 -154.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -125.97 138.49 53.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.879 -172.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -133.37 -176.26 14.32 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.81 HG11 ' HB2' ' A' ' 108' ' ' HIS . 0.2 OUTLIER -152.46 109.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.426 0.69 . . . . 0.0 109.323 -178.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.498 ' HB2' ' HD1' ' A' ' 107' ' ' PHE . 84.2 t80 -107.09 136.21 47.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -147.99 110.83 4.78 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 109.087 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 45.38 68.5 0.56 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.587 1.555 . . . . 0.0 113.101 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 -30.08 6.18 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.555 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 9.8 m -105.41 116.34 31.79 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.555 -172.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.649 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 87.8 t80 -93.81 144.25 25.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 172.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.81 ' HB2' HG11 ' A' ' 101' ' ' VAL . 25.2 m80 -132.19 122.68 25.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.866 0.866 . . . . 0.0 109.174 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -141.98 -179.67 6.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.569 0.748 . . . . 0.0 111.462 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.628 ' SD ' ' HB3' ' A' ' 210' ' ' LEU . 79.9 mmm -89.66 173.25 8.4 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.639 1.176 . . . . 0.0 109.856 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -59.45 2.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 122.091 -0.381 . . . . 0.0 111.609 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.46 ' NE2' HOI2 ' B' ' 255' ' ' M9P . 13.8 p-80 -53.72 -28.21 32.71 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 125.131 1.372 . . . . 0.0 114.16 -168.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -56.1 -25.63 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 124.531 1.132 . . . . 0.0 113.021 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.568 HG21 ' H ' ' A' ' 116' ' ' GLY . 2.9 t -142.19 -166.63 2.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -111.42 33.51 4.66 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 121.065 0.459 . . . . 0.0 111.443 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.568 ' H ' HG21 ' A' ' 114' ' ' THR . . . 71.73 58.57 5.25 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.965 176.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.69 -172.37 2.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.516 0.726 . . . . 0.0 111.972 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.401 HG13 ' HA ' ' A' ' 4' ' ' ALA . 14.9 p -100.14 148.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 124.442 1.097 . . . . 0.0 111.755 -173.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.634 HD23 ' H4 ' ' B' ' 251' ' ' BEZ . 2.9 mm? -91.11 168.99 11.22 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.549 1.14 . . . . 0.0 111.211 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -172.77 163.81 5.14 Favored 'General case' 0 C--O 1.263 1.772 0 CA-C-O 123.869 1.795 . . . . 0.0 114.862 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -106.76 95.21 5.57 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.78 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.579 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 0.9 OUTLIER 48.97 48.09 21.01 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.005 0.922 . . . . 0.0 112.45 164.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.64 -8.48 56.5 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -100.25 110.55 22.8 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.997 0.899 . . . . 0.0 109.068 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.464 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 11.5 ttp180 -82.1 151.04 27.19 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -162.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.437 HG12 ' HG3' ' A' ' 71' ' ' PRO . 66.8 mt -142.51 121.68 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.038 1.735 . . . . 0.0 108.151 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -77.4 129.91 76.08 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.14 0.576 . . . . 0.0 111.395 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.62 170.57 19.95 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.781 2.321 . . . . 0.0 111.015 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 p -125.14 -29.69 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.575 0.75 . . . . 0.0 111.861 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 14.4 t-105 -131.22 143.74 50.8 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.762 0.825 . . . . 0.0 109.721 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.82 122.42 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.498 1.119 . . . . 0.0 108.285 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -140.98 119.81 12.61 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.276 0.631 . . . . 0.0 110.178 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -76.4 -24.39 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.291 1.037 . . . . 0.0 113.056 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.449 ' HB3' ' HZ1' ' A' ' 134' ' ' LYS . 7.4 mtpm? -72.99 -42.41 63.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.16 0.505 . . . . 0.0 110.924 -171.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.18 -8.89 34.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.532 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 t70 60.22 57.78 2.83 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.992 1.317 . . . . 0.0 110.644 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 98.0 mt -144.87 137.07 26.03 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.412 0.685 . . . . 0.0 110.961 -174.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.2 mt -128.27 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.273 1.429 . . . . 0.0 108.864 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 130' ' ' TRP . 51.3 p -142.93 161.15 38.87 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.874 0.845 . . . . 0.0 112.99 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.649 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.9 t80 -116.52 143.64 45.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.956 1.702 . . . . 0.0 107.847 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.14 -13.45 44.59 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.53 -151.41 22.97 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 173.69 38.93 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.605 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 59.4 t-105 -69.12 108.84 3.75 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 231' ' ' LYS . 22.8 pttp -147.92 137.87 22.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.829 0.452 . . . . 0.0 110.278 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.48 HD21 HG22 ' A' ' 229' ' ' THR . 15.8 tp -160.81 -90.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.497 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -172.42 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.91 0.777 . . . . 0.0 110.1 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.79 152.34 48.39 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.644 -1.162 . . . . 0.0 115.391 -161.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.13 127.26 17.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.998 0.919 . . . . 0.0 108.893 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -91.8 136.86 32.83 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.065 0.46 . . . . 0.0 111.35 176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.614 ' HZ1' ' HB2' ' A' ' 151' ' ' LYS . 4.9 ttmp? -134.82 127.48 30.91 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.42 125.93 25.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.965 0.906 . . . . 0.0 112.482 -170.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.36 -69.49 0.06 OUTLIER Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.84 -177.65 6.66 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.718 0.807 . . . . 0.0 109.817 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 8.1 pt-20 -104.14 147.46 27.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 110.859 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.36 171.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.586 0.754 . . . . 0.0 110.746 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.415 ' HG3' ' HB3' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -128.03 147.76 50.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 108.507 176.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.429 HG13 HG12 ' A' ' 200' ' ' ILE . 29.4 m -122.86 139.59 49.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 109.449 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.675 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 90.4 mt -80.54 86.07 5.88 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.69 100.39 5.39 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 167' ' ' PRO . 62.5 mt -68.94 106.03 2.59 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 165' ' ' LYS . 19.4 mm-40 -67.58 133.83 92.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 50' ' ' LEU . 50.0 Cg_exo -56.21 112.43 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.476 2.117 . . . . 0.0 112.169 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.81 20.92 72.81 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.046 -0.979 . . . . 0.0 114.846 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 76.1 mmtt -138.57 -175.0 3.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.831 0.852 . . . . 0.0 109.99 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.36 152.16 70.1 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.539 0.736 . . . . 0.0 110.717 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . 0.768 ' HB3' HD21 ' A' ' 161' ' ' LEU . 30.4 Cg_endo -62.98 137.59 63.18 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.868 2.379 . . . . 0.0 113.585 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -81.08 135.3 35.79 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.168 167.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -81.4 105.2 12.39 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 166.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.5 HG13 HG13 ' A' ' 22' ' ' ILE . 51.3 t -112.17 116.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.441 0.696 . . . . 0.0 109.305 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . 0.58 ' H ' ' HB ' ' A' ' 22' ' ' ILE . 9.3 tt0 -108.71 137.41 46.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.834 0.349 . . . . 0.0 110.606 -165.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.4 t -153.75 147.02 24.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.82 0.848 . . . . 0.0 110.298 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 97.3 mttt -72.37 162.15 75.37 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.652 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 186' ' ' ALA . 50.0 Cg_exo -55.86 131.83 48.37 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.724 2.282 . . . . 0.0 111.717 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -147.66 150.75 23.03 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.254 0.919 . . . . 0.0 114.897 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.407 HD21 ' N ' ' A' ' 176' ' ' LEU . 1.0 OUTLIER -140.38 167.85 21.19 Favored 'General case' 0 C--O 1.239 0.55 0 O-C-N 121.101 -1.235 . . . . 0.0 111.235 -170.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.425 ' CE1' ' HE2' ' A' ' 39' ' ' MET . 0.7 OUTLIER -140.22 136.16 33.1 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.191 -1.822 . . . . 0.0 108.946 -171.043 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -77.63 144.47 37.41 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.3 m -102.85 179.25 4.33 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.776 1.231 . . . . 0.0 108.932 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.427 ' H ' HG22 ' A' ' 179' ' ' THR . 20.2 m120 -68.03 -18.24 64.64 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.877 0.471 . . . . 0.0 111.893 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.38 -68.21 0.87 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.053 0.941 . . . . 0.0 110.016 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.8 -142.2 11.85 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.662 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.8 t -163.25 135.85 5.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.465 1.106 . . . . 0.0 108.842 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 165.89 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.164 0.586 . . . . 0.0 109.801 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 133.82 167.98 11.71 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-O 120.278 -0.179 . . . . 0.0 113.313 174.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 174' ' ' PRO . . . -171.03 34.28 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.635 0 O-C-N 124.163 0.567 . . . . 0.0 110.812 173.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.406 ' N ' ' H ' ' A' ' 175' ' ' GLY . 2.2 t -164.87 117.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 126.565 1.946 . . . . 0.0 106.837 163.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.7 t -129.45 121.71 27.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.5 tp -144.42 151.46 39.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.86 0.864 . . . . 0.0 110.084 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.68 105.16 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.447 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 62.2 t80 -160.86 162.34 32.15 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.767 0.827 . . . . 0.0 109.121 -172.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.8 p -60.12 158.62 25.7 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.955 0.902 . . . . 0.0 111.422 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.81 107.88 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.683 2.922 . . . . 0.0 113.016 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -72.74 158.53 53.18 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.072 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' THR . . . . . 0.478 ' HA ' ' HDA' ' B' ' 255' ' ' M9P . 47.6 p -84.12 105.26 14.84 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 122.977 0.511 . . . . 0.0 109.959 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.41 ' HB2' ' HA ' ' B' ' 255' ' ' M9P . 71.7 m -56.75 110.06 0.73 Allowed 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.574 -177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 118.89 12.9 6.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.145 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.0 m -57.2 117.32 17.36 Favored Pre-proline 0 C--N 1.366 1.291 0 C-N-CA 122.899 0.48 . . . . 0.0 110.794 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PRO . . . . . 0.675 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 49.3 Cg_exo -58.7 112.77 1.3 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.933 2.422 . . . . 0.0 112.256 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.429 HG12 HG13 ' A' ' 158' ' ' VAL . 58.9 mt -80.48 96.56 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.788 0.835 . . . . 0.0 109.304 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.447 HG12 HG11 ' A' ' 208' ' ' VAL . 30.8 mt -119.57 134.18 63.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.26 -179.86 6.49 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.951 0.796 . . . . 0.0 109.456 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -63.41 -25.72 68.41 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.186 0.594 . . . . 0.0 112.527 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.43 -19.71 55.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.982 0.513 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 95.18 36.28 5.5 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.417 0.448 . . . . 0.0 112.221 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -130.22 166.79 19.57 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.215 1.006 . . . . 0.0 110.133 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 79.9 t 99.51 -60.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.14 2.176 . . . . 0.0 109.518 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . 0.447 HG11 HG12 ' A' ' 201' ' ' ILE . 33.2 m 49.74 32.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.869 1.267 . . . . 0.0 112.268 170.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.507 ' HA2' HG23 ' A' ' 229' ' ' THR . . . -76.78 -157.16 7.69 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.434 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.628 ' HB3' ' SD ' ' A' ' 110' ' ' MET . 24.4 mt -139.75 124.8 18.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.452 0.644 . . . . 0.0 112.582 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.16 124.35 26.17 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.989 164.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 176.81 66.82 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 158.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 225' ' ' ALA . 14.6 m120 -154.8 171.96 18.75 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 66.4 -118.65 11.22 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' VAL . . . . . 0.442 HG12 HD11 ' A' ' 31' ' ' ILE . 9.5 p 179.13 168.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.257 1.476 0 CA-C-O 121.707 0.765 . . . . 0.0 110.217 176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.02 113.81 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 160.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 221' ' ' ALA . 6.5 t -119.89 158.33 26.88 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.865 0.866 . . . . 0.0 111.159 -165.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 59.93 16.2 5.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.272 1.029 . . . . 0.0 111.17 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.8 t 53.6 28.54 8.01 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.561 1.544 . . . . 0.0 112.382 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 178.99 30.55 0.05 OUTLIER Glycine 0 C--N 1.358 1.794 0 C-N-CA 120.768 -0.73 . . . . 0.0 114.447 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.602 ' HB2' HG21 ' A' ' 217' ' ' THR . . . -135.88 145.47 46.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.253 0.527 . . . . 0.0 109.596 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -105.13 101.67 11.21 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.9 1.28 . . . . 0.0 109.162 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.46 HG21 HD13 ' A' ' 31' ' ' ILE . 17.9 m -122.67 141.44 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 119.103 0.865 . . . . 0.0 110.512 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.4 m -144.9 129.41 17.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.581 -166.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . 0.767 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -81.52 -16.28 52.28 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.61 0.364 . . . . 0.0 110.648 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 17.5 pt 56.52 140.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 128.276 2.63 . . . . 0.0 116.527 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.48 27.54 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.985 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.29 143.01 51.17 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 172.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' THR . . . . . 0.605 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 62.2 p -76.03 104.4 6.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.555 0.693 . . . . 0.0 111.046 -169.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.26 107.74 19.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.424 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . 0.542 ' HD3' ' H ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -56.98 80.57 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.204 1.002 . . . . 0.0 111.485 172.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 52.3 p -70.27 93.49 0.85 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.854 0.861 . . . . 0.0 109.877 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.8 tp -97.36 14.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.568 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.16 92.3 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.894 0.878 . . . . 0.0 110.375 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.71 -39.56 94.62 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -55.32 132.54 69.83 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.04 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.01 -52.2 8.51 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.838 2.359 . . . . 0.0 113.259 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -134.24 -77.8 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.132 0.573 . . . . 0.0 110.002 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 42.6 mm 49.91 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.928 1.291 . . . . 0.0 112.245 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 124.235 1.014 . . . . 0.0 110.487 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' BEZ . . . . . 0.662 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' NLE . . . . . 0.655 ' HG2' ' HB3' ' A' ' 88' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' LYS . . . . . 0.435 ' HZ1' ' HB ' ' A' ' 91' ' ' ILE . 2.0 tppp? -121.71 -49.45 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.331 0.653 . . . . 0.0 110.739 167.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -104.32 158.58 16.36 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 110.941 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' M9P . . . . . 0.478 ' HDA' ' HA ' ' A' ' 195' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.18 -4.68 1.69 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.251 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -174.84 90.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.344 0.592 . . . . 0.0 109.632 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 118' ' ' VAL . 4.7 mp -133.69 95.05 3.39 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.149 1.78 . . . . 0.0 108.502 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.628 ' HB3' HG11 ' A' ' 64' ' ' VAL . 3.7 tp10 -97.53 140.67 31.62 Favored 'General case' 0 C--O 1.26 1.622 0 CA-C-O 121.76 0.79 . . . . 0.0 112.639 -170.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' A' ' 86' ' ' ILE . 57.0 mt -86.28 149.16 25.25 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.409 175.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -147.47 111.06 4.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.621 -0.674 . . . . 0.0 109.757 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' HB3' ' A' ' 67' ' ' ASP . 55.7 ttp180 -62.78 137.17 58.2 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.629 1.104 . . . . 0.0 110.363 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.43 -28.8 3.58 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.281 0.632 . . . . 0.0 110.477 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.06 -169.67 2.44 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.077 0.951 . . . . 0.0 109.583 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 18.7 t70 -109.5 151.14 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.545 0.738 . . . . 0.0 109.524 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 101' ' ' VAL . 44.8 t -75.29 98.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.708 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.94 160.22 4.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.442 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 43.0 t90 -64.05 126.07 26.52 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 172.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 11.0 tp10 -95.62 143.96 26.46 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.523 0.729 . . . . 0.0 109.039 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.03 -3.85 11.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.971 0.908 . . . . 0.0 113.278 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.49 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 14.3 mm100 -82.61 36.06 0.48 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.452 0.701 . . . . 0.0 110.867 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -61.69 112.59 2.32 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 125.125 1.37 . . . . 0.0 111.769 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -124.1 119.41 29.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.013 0.925 . . . . 0.0 110.096 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.86 114.24 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -144.62 -24.37 0.52 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.352 0.661 . . . . 0.0 111.683 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.14 -145.39 0.06 OUTLIER Glycine 0 C--N 1.359 1.858 0 N-CA-C 114.351 0.501 . . . . 0.0 114.351 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m 64.57 18.4 11.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 9.9 m -65.54 120.21 66.31 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.386 0.674 . . . . 0.0 109.61 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 15.3 Cg_exo -65.67 -96.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.384 2.723 . . . . 0.0 114.549 -161.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.436 ' H ' ' HB2' ' A' ' 27' ' ' PRO . 42.2 mm -113.37 119.51 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 223' ' ' VAL . 7.2 mp -110.92 164.07 13.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.245 0.618 . . . . 0.0 110.687 172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 p -115.23 110.88 20.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.09 143.43 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.307 1.043 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 p -90.99 108.08 19.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.69 0.757 . . . . 0.0 108.971 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG13 HG23 ' A' ' 179' ' ' THR . 27.2 mm -79.18 127.68 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.951 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 19.7 m -100.79 95.51 6.69 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.098 0.559 . . . . 0.0 110.07 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 58.23 27.78 15.65 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.228 1.411 . . . . 0.0 111.84 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 75.95 -42.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.523 1.529 . . . . 0.0 113.586 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.06 -42.48 98.13 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 49.2 m -106.33 161.4 14.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.59 0.356 . . . . 0.0 110.732 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.479 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.3 ppp? -150.41 136.7 18.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.04 0.936 . . . . 0.0 108.948 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 p -163.52 177.27 8.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.968 0.414 . . . . 0.0 111.026 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.526 ' H ' HG21 ' A' ' 215' ' ' VAL . 2.8 tp -102.13 146.6 9.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.92 70.69 6.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.078 0.942 . . . . 0.0 109.729 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.94 114.86 3.49 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.794 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.98 103.93 1.61 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.698 0.624 . . . . 0.0 110.276 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG3' ' NH2' ' B' ' 254' ' ' ARG . 2.2 pt-20 . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 124.378 1.071 . . . . 0.0 109.961 170.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 7' ' ' GLU . 3.4 t . . . . . 0 CA--C 1.557 1.247 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -179.68 142.41 0.17 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.671 1.588 . . . . 0.0 107.385 -166.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.596 ' CD1' ' HE3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -147.32 178.12 8.67 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.456 ' HB3' ' N ' ' A' ' 10' ' ' ARG . 59.1 t0 179.73 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 111.267 -2.697 . . . . 0.0 105.318 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 CA--C 1.566 1.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.471 -174.878 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.686 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 36.7 m-20 . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 126.47 -151.41 18.03 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.253 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.88 120.21 32.99 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 124.795 1.238 . . . . 0.0 109.295 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.686 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 11.3 m-85 -105.56 144.4 32.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 123.609 0.764 . . . . 0.0 110.473 -171.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.38 131.82 35.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 153.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 98' ' ' GLY . 7.1 pt -132.58 142.84 41.44 Favored 'Isoleucine or valine' 0 C--O 1.254 1.322 0 O-C-N 121.083 -1.011 . . . . 0.0 109.283 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 tttm -148.98 134.67 18.77 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.59 1.156 . . . . 0.0 110.17 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -110.02 157.93 18.79 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -99.69 92.16 5.2 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 155.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.48 175.16 42.57 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 118.962 -0.91 . . . . 0.0 111.352 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' B' ' 253' ' ' LYS . 78.0 mt 59.07 -80.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 124.921 1.288 . . . . 0.0 112.052 173.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 tp -127.09 29.77 5.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.962 0.905 . . . . 0.0 109.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.02 -143.78 16.33 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.638 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.465 ' HB3' ' HZ1' ' A' ' 87' ' ' LYS . 11.9 m-85 -86.84 95.57 9.91 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.919 0.888 . . . . 0.0 109.234 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' B' ' 253' ' ' LYS . 7.8 m -140.42 146.98 39.01 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.854 1.206 . . . . 0.0 111.646 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -102.46 130.97 49.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.143 1.777 . . . . 0.0 113.48 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.633 HD12 ' N ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -90.36 -30.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.626 0.77 . . . . 0.0 110.13 174.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.512 ' O ' HG12 ' A' ' 86' ' ' ILE . . . 100.83 -86.41 0.63 Allowed Glycine 0 C--O 1.2 -2.002 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.633 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -99.44 119.58 38.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.568 2.684 . . . . 0.0 111.127 -149.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.05 122.36 5.3 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.303 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.512 HG13 HG21 ' A' ' 14' ' ' VAL . 60.0 t -108.58 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 110.096 -165.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 24.4 t80 -123.09 117.27 25.03 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -123.53 127.21 48.01 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.67 1.188 . . . . 0.0 108.646 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 65.73 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.955 1.302 . . . . 0.0 111.391 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.86 -0.44 1.27 Allowed Glycine 0 N--CA 1.472 1.038 0 CA-C-O 120.052 -0.304 . . . . 0.0 113.254 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -116.57 126.84 53.86 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.279 0.632 . . . . 0.0 110.87 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.805 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 70.1 t80 -99.64 110.98 23.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.756 ' HE2' HD23 ' A' ' 137' ' ' LEU . 29.2 t60 -130.23 114.57 15.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.693 0.397 . . . . 0.0 110.752 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.61 -171.49 2.79 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.358 1.063 . . . . 0.0 109.645 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 211' ' ' TYR . 25.9 mmt -72.33 159.79 33.45 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.805 0.842 . . . . 0.0 111.936 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.0 t90 -85.52 -44.31 12.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.15 0.58 . . . . 0.0 110.704 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -60.37 -14.51 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 0.0 113.326 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 114' ' ' THR . 23.5 m -59.16 -23.64 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 172.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 116' ' ' GLY . 10.0 t -155.86 -166.19 2.14 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.627 1.171 . . . . 0.0 109.261 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -117.64 17.97 14.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.162 0.585 . . . . 0.0 110.461 168.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 114' ' ' THR . . . 106.45 54.86 0.68 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 124.038 0.827 . . . . 0.0 111.574 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.03 160.01 16.56 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.2 0.524 . . . . 0.0 111.811 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 127' ' ' GLU . 14.5 p -81.03 159.28 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.678 1.191 . . . . 0.0 110.249 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.41 HD13 HD21 ' A' ' 8' ' ' LEU . 10.8 mt -113.88 172.17 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.393 0.542 . . . . 0.0 111.67 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.55 ' HB3' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -171.49 178.03 3.3 Favored 'General case' 0 C--O 1.267 2.003 0 CA-C-O 123.706 1.717 . . . . 0.0 114.793 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.538 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 43.9 t60 -114.78 100.39 8.2 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 110.615 -2.993 . . . . 0.0 108.816 164.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.596 ' HE3' ' CD1' ' A' ' 66' ' ' TRP . 8.9 mtmp? 1.98 72.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 127.313 2.245 . . . . 0.0 114.172 -173.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.0 19.55 16.69 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 121' ' ' HIS . 1.2 tmmt? -139.71 112.13 7.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 167.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 41.2 ttp85 -98.69 140.75 32.43 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -162.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.55 130.33 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 126.088 1.755 . . . . 0.0 109.438 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.556 ' HA ' HG23 ' A' ' 118' ' ' VAL . 5.2 mp0 -91.05 138.39 26.02 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.639 -0.663 . . . . 0.0 111.649 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 19.8 Cg_exo -68.84 156.95 63.78 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.032 2.488 . . . . 0.0 112.139 167.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 p -98.85 -17.76 18.26 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.392 0.677 . . . . 0.0 111.829 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 21.6 t-105 -152.02 148.88 28.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.23 0.612 . . . . 0.0 110.87 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -149.25 122.28 8.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.647 1.179 . . . . 0.0 109.263 169.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.54 118.35 20.94 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.027 0.441 . . . . 0.0 111.29 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.86 -28.6 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.978 1.311 . . . . 0.0 111.805 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -65.82 -56.52 11.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.76 0.824 . . . . 0.0 111.951 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -79.86 -23.99 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.499 0.72 . . . . 0.0 109.892 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 79.84 44.15 0.05 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.077 1.751 . . . . 0.0 109.989 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.756 HD23 ' HE2' ' A' ' 108' ' ' HIS . 9.4 mp -131.65 129.43 40.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 111.327 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 131' ' ' ALA . 24.0 mt -114.01 144.09 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.548 1.539 . . . . 0.0 110.749 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 7.2 m -125.87 154.85 42.11 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.629 0.728 . . . . 0.0 111.548 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 10.9 t80 -136.68 138.47 41.1 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.591 1.556 . . . . 0.0 107.698 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 -45.15 1.51 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.68 36.45 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.41 135.71 31.55 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -69.84 142.05 53.15 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 117.262 0.531 . . . . 0.0 110.763 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -151.33 114.24 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 229' ' ' THR . 3.9 mm? -123.64 -91.64 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 167.8 -69.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 207' ' ' VAL . . . -77.12 153.86 42.13 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.817 -166.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.3 121.96 11.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.499 -0.85 . . . . 0.0 108.784 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.499 ' HE3' HD13 ' A' ' 200' ' ' ILE . 16.3 t90 -91.12 148.47 22.35 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -153.37 160.3 42.62 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.411 ' HG3' ' HA3' ' A' ' 185' ' ' GLY . 2.0 pm0 -63.03 93.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.294 1.045 . . . . 0.0 111.047 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.87 -46.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.433 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.6 160.23 14.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.316 1.046 . . . . 0.0 109.218 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 173' ' ' LYS . 13.6 pt-20 -93.71 145.52 24.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.964 0.506 . . . . 0.0 110.12 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.626 HG11 HG23 ' A' ' 200' ' ' ILE . 1.4 p -140.29 -173.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 122.193 -0.317 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 38.4 mt-30 -126.35 148.07 49.63 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.964 -0.46 . . . . 0.0 110.088 166.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.84 125.82 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.1 88.79 6.66 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.17 112.51 25.54 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.235 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 167' ' ' PRO . 59.7 mt -66.99 125.73 26.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 168' ' ' ARG . 45.4 mt-10 -81.22 155.57 72.04 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.145 0.578 . . . . 0.0 111.112 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 113.51 2.79 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.536 2.158 . . . . 0.0 112.563 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.91 53.42 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.302 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 88.3 mttt -129.98 -171.04 2.43 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.483 0.713 . . . . 0.0 111.666 -171.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -76.53 158.1 81.59 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.889 0.875 . . . . 0.0 112.405 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.539 ' HB3' HD23 ' A' ' 161' ' ' LEU . 18.3 Cg_endo -60.07 106.05 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.869 2.379 . . . . 0.0 112.113 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 162' ' ' GLU . 3.3 tpt180 -75.09 97.25 3.39 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.113 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -76.97 104.91 7.72 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.74 128.22 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.425 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 9.1 tt0 -78.99 108.02 12.16 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 p -115.64 104.72 11.98 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.394 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HG2' ' HB2' ' A' ' 155' ' ' GLU . 90.3 mttt -83.33 164.75 44.19 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.142 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.85 140.04 58.54 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.992 2.462 . . . . 0.0 113.934 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -134.88 176.86 19.71 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 173.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -163.68 156.51 18.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.449 0.642 . . . . 0.0 110.455 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.84 151.41 46.98 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.209 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.46 142.42 41.01 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.583 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 181' ' ' ALA . 49.6 m -137.96 162.58 33.7 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.52 1.128 . . . . 0.0 108.704 -167.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.16 -34.27 76.08 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.678 ' H ' HG22 ' A' ' 179' ' ' THR . . . -80.55 6.67 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.43 174.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.14 -78.56 0.27 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.4 t -157.46 142.85 17.17 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.704 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.93 137.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 152' ' ' GLU . . . -100.32 128.95 9.74 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 224' ' ' SER . . . -156.53 -168.26 2.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.504 0.722 . . . . 0.0 110.433 -169.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.479 ' HB ' ' HZ3' ' A' ' 150' ' ' TRP . 7.6 p -93.95 105.81 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.576 ' HA ' HG22 ' A' ' 223' ' ' VAL . 21.0 t -102.88 114.21 28.29 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.461 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 19.6 tp -127.98 127.15 42.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.761 0.824 . . . . 0.0 111.162 -172.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.34 102.92 14.99 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -176.46 169.48 2.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.325 1.05 . . . . 0.0 108.633 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.7 m -60.9 150.44 77.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.913 0.885 . . . . 0.0 110.627 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -45.17 103.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.535 2.823 . . . . 0.0 113.289 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.23 149.35 49.98 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.21 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.442 ' OG1' ' HA3' ' A' ' 98' ' ' GLY . 2.6 t -61.86 138.48 58.35 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.441 0.696 . . . . 0.0 112.426 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 211' ' ' TYR . 37.1 m -72.34 119.92 17.21 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.006 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' H ' ' HE1' ' A' ' 211' ' ' TYR . . . 107.7 -4.75 34.59 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 118.166 -1.352 . . . . 0.0 112.756 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 39.1 m -44.62 117.74 3.13 Favored Pre-proline 0 N--CA 1.498 1.961 0 CA-C-N 117.951 0.876 . . . . 0.0 112.51 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 101' ' ' VAL . 3.0 Cg_exo -76.59 135.86 16.69 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.235 1.957 . . . . 0.0 112.168 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.626 HG23 HG11 ' A' ' 156' ' ' VAL . 30.3 mt -83.59 97.38 4.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 0.0 109.1 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.4 mt -117.76 134.38 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.89 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -80.52 164.33 23.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.353 0.661 . . . . 0.0 109.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -59.19 -31.91 69.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.227 0.611 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.64 13.92 12.94 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.599 0.76 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.72 24.79 75.4 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.223 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 206' ' ' LYS . 33.5 ttpt -89.97 162.03 15.59 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.988 0.915 . . . . 0.0 110.011 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 148' ' ' GLY 0.365 16.4 m 68.25 -62.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.487 2.315 . . . . 0.0 113.385 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 32.9 m 55.47 33.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 C-N-CA 124.493 1.117 . . . . 0.0 111.666 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.52 -145.11 1.73 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.176 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 87.2 mt -138.91 146.43 41.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.265 0.626 . . . . 0.0 109.785 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' TYR . . . . . 0.599 ' HE1' ' H ' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -73.52 132.53 42.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.275 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.79 -154.15 2.38 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 118.35 0.523 . . . . 0.0 113.968 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -94.35 130.35 40.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.471 -0.429 . . . . 0.0 110.364 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -157.23 -143.67 3.72 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.682 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.0 p -165.15 161.5 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.593 0 CA-C-N 117.276 0.538 . . . . 0.0 110.925 -170.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.47 111.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.734 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 164.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.1 t -105.61 153.55 21.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.449 1.099 . . . . 0.0 108.903 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 62.77 12.53 5.75 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.923 0.889 . . . . 0.0 111.605 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.7 m 55.93 23.42 6.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.582 1.153 . . . . 0.0 111.586 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.89 -50.52 0.01 OUTLIER Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.387 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.83 158.42 24.06 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -121.25 109.5 15.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.576 HG22 ' HA ' ' A' ' 188' ' ' SER . 84.1 t -121.68 134.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.608 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 32.0 t -146.4 159.23 43.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.829 0.851 . . . . 0.0 109.334 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.33 167.48 4.14 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.124 0.569 . . . . 0.0 111.304 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -99.61 122.18 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 171.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.736 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -111.22 143.59 41.73 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -148.08 166.72 26.96 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 122.072 -0.393 . . . . 0.0 110.927 -172.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 146' ' ' LEU . 62.4 p -91.58 110.42 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.1 -0.04 56.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.023 0.929 . . . . 0.0 110.616 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 C--N 1.366 1.293 0 C-N-CA 124.731 1.212 . . . . 0.0 109.449 -169.636 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 97' ' ' ILE . 13.4 tppt? . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ARG . . . . . 0.513 ' NH2' ' HG3' ' A' ' 45' ' ' GLU . 37.4 ttt180 . . . . . 0 N--CA 1.478 0.941 0 O-C-N 120.909 -1.12 . . . . 0.0 111.425 -171.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.427 ' O ' ' HB1' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 121.406 0.622 . . . . 0.0 112.63 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.17 31.64 0.54 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.521 1.128 . . . . 0.0 109.006 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -166.81 61.59 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 117' ' ' ALA . 52.3 mt -101.52 94.21 5.77 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.287 0.635 . . . . 0.0 110.243 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 120' ' ' MET . 4.5 mm-40 -95.3 130.85 41.92 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 123.672 0.789 . . . . 0.0 112.27 -172.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HB2' HG12 ' A' ' 68' ' ' VAL . 24.3 mt -97.82 143.42 28.46 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 32.0 tt0 -134.23 142.8 47.5 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 124.163 0.985 . . . . 0.0 108.953 162.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -86.7 128.43 35.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 118.034 0.379 . . . . 0.0 110.732 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -85.86 -52.37 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.227 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.67 -164.49 0.91 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.746 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.561 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 27.5 t70 -108.33 146.23 33.27 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.484 0.714 . . . . 0.0 109.556 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HB ' HG21 ' A' ' 201' ' ' ILE . 2.4 m -75.34 100.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.241 0.543 . . . . 0.0 109.766 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 38.1 ttmt -172.39 117.43 0.35 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.849 1.259 . . . . 0.0 107.839 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.495 ' CD1' ' HB1' ' A' ' 169' ' ' ALA . 84.4 t90 -87.74 91.65 8.83 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.622 0.249 . . . . 0.0 111.647 -172.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -158.79 65.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 156.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 1.1 t70 -85.25 -61.91 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -150.59 33.07 0.63 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.796 1.238 . . . . 0.0 109.014 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 13.65 73.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.188 1.795 . . . . 0.0 113.661 -163.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 170' ' ' VAL . 13.2 mm-40 -75.91 162.08 28.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.608 -173.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.72 117.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.8 m -146.97 -51.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.791 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -59.45 105.58 0.76 Allowed Glycine 0 C--N 1.355 1.621 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.796 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p 179.88 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.923 1.289 . . . . 0.0 110.482 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 188' ' ' SER . 9.1 m -64.37 137.67 97.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.322 0.649 . . . . 0.0 110.527 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.41 178.24 0.24 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.525 2.816 . . . . 0.0 114.542 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 115.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.124 0.569 . . . . 0.0 110.103 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 51.7 tp -112.4 159.0 19.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.955 0.902 . . . . 0.0 109.839 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -112.45 119.56 38.64 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.483 0.713 . . . . 0.0 109.479 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -114.23 142.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.263 1.025 . . . . 0.0 108.694 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.6 p -88.22 110.4 20.69 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 180' ' ' ASN . 45.3 mm -73.41 143.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.697 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 t -144.84 129.36 17.99 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 56.5 20.74 5.06 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.472 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 72.87 -68.43 0.23 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.405 1.882 . . . . 0.0 111.523 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.66 -11.27 72.76 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 114.91 0.724 . . . . 0.0 114.91 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.6 m -105.11 156.98 17.58 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 118.391 1.095 . . . . 0.0 109.037 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 ptm -158.34 138.48 12.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.427 0.691 . . . . 0.0 109.475 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 p -172.21 176.16 3.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.723 0.809 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.45 94.79 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 49.94 29.12 3.2 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.368 1.467 . . . . 0.0 113.12 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 53.68 33.97 17.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.956 1.702 . . . . 0.0 113.026 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.04 93.53 2.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.821 0.82 . . . . 0.0 108.992 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.324 -179.261 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.613 HG23 ' HD2' ' A' ' 87' ' ' LYS . 2.6 p . . . . . 0 CA--C 1.564 1.503 0 CA-C-O 123.248 1.499 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 96' ' ' GLN . 16.7 mt 81.39 127.68 0.04 OUTLIER 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.775 2.03 . . . . 0.0 116.475 156.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.452 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.2 m0 -125.02 87.43 2.71 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.619 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 4.4 t70 175.23 105.15 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.383 1.052 . . . . 0.0 111.028 157.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 8' ' ' LEU . 18.8 m . . . . . 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.162 . . . . 0.0 111.201 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.479 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 22.9 t70 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 138.22 -132.14 5.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 114.873 0.709 . . . . 0.0 114.873 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 140.12 42.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.805 1.242 . . . . 0.0 110.096 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.479 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 62.7 m-85 -125.49 146.44 49.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.881 0.473 . . . . 0.0 112.095 -168.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.825 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 20.6 mtm180 -98.26 124.49 42.89 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 163.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 8' ' ' LEU . 21.8 pt -130.98 138.8 52.66 Favored 'Isoleucine or valine' 0 C--O 1.26 1.641 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -165.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.78 151.22 47.03 Favored 'General case' 0 C--N 1.386 2.195 0 C-N-CA 124.256 1.022 . . . . 0.0 111.284 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.67 154.62 46.46 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 166.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -104.75 91.59 3.91 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.057 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -171.17 177.0 44.33 Favored Glycine 0 C--O 1.238 0.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.176 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 11.3 mt 59.63 37.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.515 0 CA-C-O 122.212 1.006 . . . . 0.0 109.602 165.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.3 mt 65.16 33.84 9.05 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.691 1.596 . . . . 0.0 111.644 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.45 157.69 28.59 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 121.47 0.483 . . . . 0.0 114.241 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -130.28 87.29 2.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.6 m -147.77 147.17 29.59 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.546 ' HG3' HD11 ' A' ' 65' ' ' LEU . 7.3 tt0 -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 125.189 1.556 . . . . 0.0 108.397 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.5 pp -135.07 -33.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -170.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.653 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.22 176.86 29.54 Favored Glycine 0 C--O 1.258 1.612 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.051 -161.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -118.49 124.49 47.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.772 -0.714 . . . . 0.0 109.777 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.46 162.11 17.89 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.3 t -138.6 133.09 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.3 0.64 . . . . 0.0 109.527 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.567 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 24.9 t80 -149.67 135.28 18.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.78 133.42 30.39 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 65.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.871 1.357 . . . . 0.0 111.985 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.29 19.95 0.63 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.513 -0.312 . . . . 0.0 112.399 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 p -135.74 126.73 27.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.518 0.727 . . . . 0.0 110.043 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 49.1 t80 -102.19 137.63 40.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.59 1.156 . . . . 0.0 108.72 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -132.1 122.15 24.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.377 0.671 . . . . 0.0 110.062 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 138' ' ' ILE . 14.6 t -136.42 -155.59 0.64 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.848 0.859 . . . . 0.0 109.892 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.436 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 18.6 ttm -136.97 153.59 50.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 111.239 -158.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -46.43 11.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -174.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.421 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 13.8 p-80 -65.56 -16.91 64.15 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 118.743 0.701 . . . . 0.0 112.286 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 ' O ' ' B' ' 254' ' ' ARG . 4.5 m -80.27 -38.89 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 123.826 0.85 . . . . 0.0 111.769 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 6' ' ' LEU . 23.1 m -156.24 151.91 27.11 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.937 0.789 . . . . 0.0 110.079 170.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -73.15 26.43 0.06 Allowed 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -167.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.674 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 82.79 38.2 12.16 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 119.031 0.832 . . . . 0.0 111.425 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -87.71 -165.58 1.35 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.697 0.799 . . . . 0.0 112.383 -168.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.01 136.47 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.733 0.813 . . . . 0.0 111.331 -174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 mm? -86.79 171.61 10.76 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.933 1.293 . . . . 0.0 111.998 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -172.53 173.04 4.14 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 41.8 t60 -132.41 97.49 4.12 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.448 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 64' ' ' VAL . 85.3 mttt 39.14 38.84 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.775 1.23 . . . . 0.0 112.149 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 21.18 12.85 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 34.2 mmtp -115.27 112.12 21.96 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.984 1.392 . . . . 0.0 110.094 172.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -80.54 148.95 30.16 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.467 1.107 . . . . 0.0 113.171 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 68' ' ' VAL . 29.5 mt -140.06 125.2 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.208 1.803 . . . . 0.0 107.428 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.06 148.83 36.46 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.19 0.596 . . . . 0.0 112.356 -168.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.0 163.46 25.67 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.597 2.865 . . . . 0.0 114.764 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 p -127.04 -29.45 2.79 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.781 0.833 . . . . 0.0 111.602 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 32.1 t-105 -147.91 149.03 31.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.165 0.586 . . . . 0.0 110.522 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.93 140.83 23.72 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.751 1.22 . . . . 0.0 109.279 166.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -134.73 114.56 12.79 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.56 -27.37 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.853 1.261 . . . . 0.0 112.356 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -76.85 -59.36 2.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.792 0.33 . . . . 0.0 111.766 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.33 6.14 48.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.371 0.669 . . . . 0.0 110.646 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 68.62 51.18 0.63 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.392 1.077 . . . . 0.0 110.989 162.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 227' ' ' ALA . 52.0 mt -140.14 142.33 36.01 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.459 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.674 HD13 ' HA2' ' A' ' 116' ' ' GLY . 49.3 mt -128.74 151.37 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.537 1.135 . . . . 0.0 109.07 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 23.9 t -139.1 144.04 38.53 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.082 0.468 . . . . 0.0 111.01 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 63.1 m-85 -128.95 144.18 51.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.027 1.331 . . . . 0.0 109.077 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.66 -8.86 79.17 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.738 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.48 -154.76 26.14 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.45 132.01 10.93 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.734 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 2.6 p90 -79.02 130.87 35.99 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -175.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -149.16 116.35 6.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.841 0.456 . . . . 0.0 111.021 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.82 -80.1 0.36 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.441 ' H ' ' H ' ' A' ' 148' ' ' GLY . 4.8 mt-10 159.35 3.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 125.699 1.6 . . . . 0.0 109.366 -163.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 207' ' ' VAL . . . -56.12 91.2 0.02 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 123.985 0.802 . . . . 0.0 114.684 -175.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.27 95.86 3.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.501 ' HE3' HD13 ' A' ' 200' ' ' ILE . 2.0 t90 -46.43 121.65 3.57 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 163.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 88.4 tttt -81.78 116.5 21.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.68 108.48 2.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.217 1.007 . . . . 0.0 109.623 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.34 -37.96 2.8 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . 42.0 tt0 -95.33 148.15 22.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.125 0.97 . . . . 0.0 109.763 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 13.1 pt-20 -89.71 139.94 30.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.809 0.844 . . . . 0.0 110.679 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 150' ' ' TRP . 15.3 t -131.75 159.63 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.438 ' OE1' ' HG3' ' A' ' 171' ' ' GLN . 2.2 mm-40 -93.51 160.64 14.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.083 0.553 . . . . 0.0 111.914 -161.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' PRO . 14.5 p -140.05 152.66 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.524 0.73 . . . . 0.0 111.05 176.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 14' ' ' VAL . 88.0 mt -103.39 93.39 4.94 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 164.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 193' ' ' PRO . . . -77.1 97.23 4.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 167' ' ' PRO . 91.1 mt -73.49 103.92 4.29 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.45 141.1 87.8 Favored Pre-proline 0 CA--C 1.554 1.125 0 O-C-N 123.625 0.578 . . . . 0.0 110.652 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.82 117.87 4.72 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.597 2.865 . . . . 0.0 112.511 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.05 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.419 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -141.09 -173.56 3.76 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.867 0.841 . . . . 0.0 112.02 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -66.38 159.71 70.86 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 126.016 1.726 . . . . 0.0 113.126 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.425 ' HB3' HD23 ' A' ' 161' ' ' LEU . 5.0 Cg_exo -77.32 117.7 4.44 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.196 2.597 . . . . 0.0 111.433 170.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 168' ' ' ARG . 11.4 mmp_? -75.64 99.55 4.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -76.1 100.66 5.04 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 28.4 t -110.02 141.65 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.857 0.863 . . . . 0.0 109.57 -173.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.438 ' HG3' ' OE1' ' A' ' 157' ' ' GLN . 28.1 tt0 -89.73 121.4 31.85 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' HA3' ' A' ' 24' ' ' GLY . 34.0 p -123.75 132.22 53.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.343 0.657 . . . . 0.0 111.226 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 62.3 mttp -92.5 149.72 38.67 Favored Pre-proline 0 C--O 1.246 0.909 0 C-N-CA 125.78 1.632 . . . . 0.0 110.765 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.19 126.72 7.14 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.614 2.209 . . . . 0.0 111.878 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.408 ' HA3' ' OG ' ' A' ' 188' ' ' SER . . . -111.93 -173.25 19.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.45 140.11 19.84 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.193 0.597 . . . . 0.0 110.0 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 186' ' ' ALA . 13.4 m-85 -128.65 150.33 50.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.134 0.974 . . . . 0.0 110.631 -165.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -61.23 127.97 34.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.83 0.852 . . . . 0.0 110.8 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.7 m -130.44 156.83 44.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.179 0.992 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.404 ' H ' HG13 ' A' ' 33' ' ' ILE . 21.5 m120 -84.83 54.61 3.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.152 0.977 . . . . 0.0 109.122 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -173.68 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.975 1.71 . . . . 0.0 109.038 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.87 -106.77 0.36 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -140.97 133.4 28.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.05 137.09 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.022 0.529 . . . . 0.0 109.661 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.98 109.42 3.66 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 177' ' ' PHE . . . -149.95 167.91 25.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.978 -173.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.59 128.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.441 0.639 . . . . 0.0 111.346 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 19.1 m -103.76 80.18 1.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.397 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.488 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 37.9 tp -105.39 104.96 14.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.048 0.451 . . . . 0.0 110.017 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.79 104.51 16.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.427 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 27.3 t80 -178.28 168.26 1.9 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -174.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.6 m -117.16 74.78 7.69 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 117.953 0.342 . . . . 0.0 111.577 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.52 ' HB3' ' HB1' ' A' ' 160' ' ' ALA . 19.5 Cg_endo -88.2 -60.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.151 1.901 . . . . 0.0 110.016 160.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.93 -29.98 4.85 Favored Glycine 0 C--N 1.361 1.942 0 C-N-CA 123.731 0.682 . . . . 0.0 112.577 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.0 t -61.94 99.51 0.13 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.62 1.168 . . . . 0.0 113.244 -165.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.9 m -63.02 121.85 14.61 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.14 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.49 6.48 33.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.398 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 62.3 m -45.23 115.14 2.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 123.295 0.638 . . . . 0.0 112.227 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.6 Cg_endo -74.33 119.84 5.97 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.203 2.602 . . . . 0.0 113.96 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.501 HD13 ' HE3' ' A' ' 150' ' ' TRP . 73.3 mt -79.68 93.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.955 0.902 . . . . 0.0 109.261 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 14' ' ' VAL . 29.2 pt -111.21 178.68 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.015 0.912 . . . . 0.0 111.662 -174.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.4 174.04 6.05 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 166.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 16' ' ' TRP . 84.3 tttt -59.78 -31.76 69.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.746 0.418 . . . . 0.0 111.786 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -82.43 -3.78 56.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.097 0.559 . . . . 0.0 111.994 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.01 26.06 54.06 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -99.54 167.1 10.81 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.032 1.333 . . . . 0.0 109.324 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 68.9 t 85.68 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 125.606 1.562 . . . . 0.0 109.49 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.6 m 58.25 30.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 125.131 1.372 . . . . 0.0 112.844 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.08 -169.65 2.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.347 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.0 mt -144.94 149.61 35.54 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.485 -1.009 . . . . 0.0 110.994 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -74.6 107.72 6.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 166.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.436 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -83.87 -138.98 3.83 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 124.328 1.018 . . . . 0.0 114.046 -166.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -70.88 87.59 0.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.302 0.641 . . . . 0.0 109.586 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -135.59 -147.67 5.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.189 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.0 167.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.641 0.776 . . . . 0.0 109.589 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 13.9 t -91.91 111.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 29' ' ' LEU . 91.8 m -71.57 140.06 49.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.126 0.97 . . . . 0.0 109.906 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 59.73 12.1 2.78 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.705 0.802 . . . . 0.0 111.861 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t 62.58 18.69 10.7 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.91 1.284 . . . . 0.0 112.072 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.19 7.97 0.39 Allowed Glycine 0 C--N 1.354 1.54 0 CA-C-O 119.682 -0.51 . . . . 0.0 114.345 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 191' ' ' PHE . . . -140.61 92.0 2.48 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.759 0.78 . . . . 0.0 110.03 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 15.4 t80 -71.04 101.32 2.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.242 0.544 . . . . 0.0 110.773 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.14 123.42 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.055 1.342 . . . . 0.0 108.841 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.559 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 24.7 t -143.88 158.45 43.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.011 0.524 . . . . 0.0 110.888 -171.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.79 55.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.594 0.758 . . . . 0.0 110.795 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.427 HG13 ' HA ' ' A' ' 186' ' ' ALA . 87.9 mt -81.83 98.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.964 0.411 . . . . 0.0 110.026 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -81.06 135.41 35.82 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 159.33 36.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.793 0.837 . . . . 0.0 110.398 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.734 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 10.9 p -82.83 113.89 20.77 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -145.36 101.6 3.61 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.518 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.239 0.503 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.695 172.474 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.604 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 17.4 tppt? . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ARG . . . . . 0.446 ' O ' HG12 ' A' ' 113' ' ' VAL . 36.5 ttt180 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 123.953 0.901 . . . . 0.0 109.684 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.79 45.46 0.96 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.171 0.989 . . . . 0.0 108.659 -170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.6 m-20 -146.0 26.48 1.22 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.117 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 88' ' ' GLN . 34.9 mt -91.6 93.63 9.03 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.545 0.738 . . . . 0.0 110.14 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 4.8 mp0 -95.12 131.06 41.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.805 0.842 . . . . 0.0 111.865 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.38 130.45 56.69 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.91 129.08 51.17 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 122.886 0.474 . . . . 0.0 110.527 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 5.8 tmm_? -75.6 127.61 33.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.356 0.662 . . . . 0.0 110.327 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.1 -56.81 2.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.425 0.69 . . . . 0.0 110.577 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 167' ' ' PRO . . . -145.49 -175.08 4.58 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.711 -171.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.26 146.41 23.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.006 0.922 . . . . 0.0 109.839 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.59 HG23 ' HA2' ' A' ' 82' ' ' GLY . 15.1 t -79.49 97.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' N ' HD13 ' A' ' 201' ' ' ILE . 17.6 pttp -173.58 176.36 2.78 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 108.402 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 39.0 t90 -73.49 136.52 44.16 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.512 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -112.94 144.45 42.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.091 0.956 . . . . 0.0 109.598 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.03 -6.28 8.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.301 1.04 . . . . 0.0 112.667 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.15 -2.8 16.99 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.556 1.143 . . . . 0.0 111.61 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 16' ' ' TRP . . . -36.6 100.08 0.02 OUTLIER 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.915 2.086 . . . . 0.0 114.052 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.12 148.39 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.64 1.176 . . . . 0.0 109.619 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 mm -102.75 104.39 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -144.84 -20.4 0.51 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.849 0.46 . . . . 0.0 111.284 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -71.66 -173.13 17.25 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.768 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m 71.82 37.9 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.545 1.138 . . . . 0.0 109.278 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -66.86 142.73 97.62 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.692 0.797 . . . . 0.0 110.842 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.63 -176.14 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.225 2.617 . . . . 0.0 114.253 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.43 119.46 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.807 0.843 . . . . 0.0 112.142 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 223' ' ' VAL . 7.0 mt -108.28 163.9 12.78 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.967 0.907 . . . . 0.0 111.075 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -120.14 122.51 41.18 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.285 0.634 . . . . 0.0 109.29 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 41' ' ' ILE . 10.5 mt -127.11 149.09 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.98 0.912 . . . . 0.0 110.201 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.2 m -96.99 119.46 35.5 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.096 0.958 . . . . 0.0 110.449 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.853 HG12 HG21 ' A' ' 179' ' ' THR . 35.6 mm -68.63 114.21 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 23.0 t -79.84 134.51 36.33 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.24 4.56 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.35 -13.71 60.12 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 0.0 110.891 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.21 17.51 29.28 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -166.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 55.3 m -105.69 164.81 11.63 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.686 0.794 . . . . 0.0 109.986 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.627 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 2.4 ppp? -127.77 135.83 50.66 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 p -171.29 173.45 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.658 0.783 . . . . 0.0 110.536 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 31' ' ' ILE . 1.6 mp -90.31 134.09 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 161.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.21 90.19 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.638 0.586 . . . . 0.0 110.371 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.08 157.19 34.1 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 108.852 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.36 75.43 1.01 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.239 0.548 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.202 174.973 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.682 HG13 ' HE3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.932 HD22 HH22 ' A' ' 85' ' ' ARG . 3.3 pp -37.45 157.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -175.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -165.74 158.57 15.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.462 1.125 . . . . 0.0 111.779 -175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.724 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 29.5 t0 -154.81 60.39 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 154.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 ' HB2' ' A' ' 121' ' ' HIS . 7.6 p . . . . . 0 CA--C 1.561 1.368 0 CA-C-N 111.598 -2.546 . . . . 0.0 106.735 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 121.33 0.585 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.59 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 142.77 -167.08 26.38 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.919 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.16 109.57 12.37 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 1.6 m-85 -87.32 146.28 25.99 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.932 HH22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.64 136.9 40.7 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 160.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG12 ' C ' ' A' ' 98' ' ' GLY . 10.8 pt -132.71 142.89 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -162.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 73.4 tttt -123.02 142.84 50.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.187 1.795 . . . . 0.0 111.369 -174.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.801 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 51.7 tt0 -136.1 150.37 49.08 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.568 0.223 . . . . 0.0 110.646 167.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 91.1 mttt -96.14 92.0 6.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 162.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 169.77 42.4 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.616 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt 67.48 -77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.009 1.324 . . . . 0.0 112.235 163.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.96 -15.04 1.79 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.891 0.876 . . . . 0.0 109.78 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' B' ' 253' ' ' LYS . . . -144.21 -161.11 8.79 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 26.7 t80 -150.88 33.86 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -165.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 p -151.8 173.07 15.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -154.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.755 ' HB3' HD21 ' A' ' 65' ' ' LEU . 5.5 pt20 -87.31 120.04 28.19 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.791 1.637 . . . . 0.0 110.909 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.668 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -136.0 -37.56 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -105.76 -172.67 23.68 Favored Glycine 0 N--CA 1.48 1.594 0 C-N-CA 120.214 -0.993 . . . . 0.0 114.811 -159.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.59 125.04 33.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.101 0.56 . . . . 0.0 110.324 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.56 111.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.571 HG13 HG21 ' A' ' 14' ' ' VAL . 91.9 t -88.64 101.83 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.408 0.683 . . . . 0.0 110.829 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 15.0 t80 -91.51 110.19 21.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 23.3 tptp -144.53 143.78 31.01 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.778 0.674 . . . . 0.0 110.168 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 146' ' ' LEU . 11.8 mm-40 64.92 15.58 10.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.927 1.291 . . . . 0.0 112.739 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.54 -5.22 67.15 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 122.946 0.308 . . . . 0.0 112.981 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.3 p -121.66 138.19 54.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 110.23 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 73.5 t80 -81.08 137.55 35.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.67 119.33 18.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.191 0.997 . . . . 0.0 110.372 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 138' ' ' ILE . 2.9 t -138.74 176.72 8.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 0.0 110.517 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.424 ' HE3' ' O ' ' A' ' 136' ' ' ASP . 65.9 mmm -84.62 170.73 13.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.595 0.758 . . . . 0.0 110.593 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.56 -54.84 4.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -57.28 -13.66 3.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -168.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.82 -45.92 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 C-N-CA 124.68 1.192 . . . . 0.0 112.983 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -155.12 149.54 26.19 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.874 1.27 . . . . 0.0 107.59 170.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 13.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.5 62.62 0.9 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -117.17 -164.76 1.01 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.269 0.628 . . . . 0.0 111.764 -171.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 93.6 t -92.04 129.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.471 1.109 . . . . 0.0 112.47 -162.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.81 157.69 16.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.032 -176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 2.2 ptm -172.88 179.84 2.23 Favored 'General case' 0 C--O 1.272 2.242 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.6 ' HB2' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -147.94 111.14 4.89 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 112.053 -2.34 . . . . 0.0 108.874 178.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.583 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 4.5 mptp? 49.95 34.09 7.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.139 0.975 . . . . 0.0 112.624 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.3 -21.02 46.18 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.561 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 115.5 10.8 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.45 0.7 . . . . 0.0 109.891 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -83.18 149.21 26.98 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.883 1.273 . . . . 0.0 112.555 -164.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.3 mt -142.35 134.29 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 125.471 1.508 . . . . 0.0 109.172 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.49 117.66 68.16 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.449 1.1 . . . . 0.0 110.754 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.16 145.39 66.52 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.414 2.076 . . . . 0.0 111.461 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 72.4 p -98.78 -18.64 17.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.735 0.414 . . . . 0.0 111.945 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 132' ' ' ASP . 49.2 t-105 -155.91 154.26 30.94 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.701 0.4 . . . . 0.0 111.261 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -160.92 122.0 2.9 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.379 1.472 . . . . 0.0 109.32 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 130' ' ' TRP . 27.2 t70 -139.25 135.29 33.74 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.458 0.572 . . . . 0.0 111.998 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.43 -42.07 42.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.028 -172.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.55 -48.67 38.21 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.949 0.78 . . . . 0.0 111.543 -168.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.45 -16.57 61.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.329 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.424 ' O ' ' HE3' ' A' ' 110' ' ' MET . 35.0 t70 62.83 45.14 5.83 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.703 1.201 . . . . 0.0 109.584 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 80.8 mt -142.4 129.37 20.71 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.772 -171.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.4 mt -115.66 155.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.511 1.524 . . . . 0.0 108.16 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.0 p -156.95 151.79 25.87 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.094 0.473 . . . . 0.0 112.104 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.9 t80 -120.25 149.12 42.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.64 1.176 . . . . 0.0 109.133 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.51 -78.58 0.24 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.98 85.44 0.06 OUTLIER Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 170.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.63 133.77 2.22 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -98.52 105.7 17.88 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -166.38 124.11 1.4 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 207' ' ' VAL . 6.0 mp -124.17 -63.52 1.2 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 175.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 177.97 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.298 0.999 . . . . 0.0 110.646 167.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.27 -171.84 23.16 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -157.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.65 153.66 47.9 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.836 0.854 . . . . 0.0 110.041 -164.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.457 ' HA ' HG13 ' A' ' 208' ' ' VAL . 31.8 t90 -67.28 106.49 2.07 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 165.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -96.25 99.68 11.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.07 110.57 0.37 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.628 1.171 . . . . 0.0 111.748 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.687 ' H ' ' HG2' ' A' ' 174' ' ' PRO . . . 131.02 -42.08 1.44 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.63 121.41 11.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.594 1.158 . . . . 0.0 110.9 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.87 99.47 9.06 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 208' ' ' VAL . 32.9 m -91.59 172.36 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.158 -168.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 171' ' ' GLN . 71.8 mm-40 -108.82 154.9 21.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.438 1.095 . . . . 0.0 109.49 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.57 136.78 40.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.26 88.54 7.24 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.77 101.15 4.96 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.11 95.6 0.57 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -60.45 113.29 7.14 Favored Pre-proline 0 C--N 1.353 0.725 0 O-C-N 124.439 1.087 . . . . 0.0 110.145 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.21 114.89 2.4 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.054 1.836 . . . . 0.0 112.087 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.27 -14.16 56.92 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.061 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -129.75 -172.73 2.84 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.464 0.706 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -62.32 162.92 16.17 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 125.337 1.455 . . . . 0.0 112.602 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.525 ' HG3' ' HB2' ' A' ' 12' ' ' ALA . 21.1 Cg_endo -58.91 140.95 97.51 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.108 2.539 . . . . 0.0 111.514 169.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.451 ' HG3' ' HZ ' ' A' ' 191' ' ' PHE . 47.5 mmm-85 -116.05 100.97 8.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.212 0.605 . . . . 0.0 109.841 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.1 118.91 13.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 168.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.46 134.41 49.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.863 0.363 . . . . 0.0 110.282 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.554 ' NE2' ' HE3' ' A' ' 203' ' ' LYS . 59.3 tt0 -87.9 143.18 27.26 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.891 0.876 . . . . 0.0 111.122 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.635 ' HB ' HD12 ' A' ' 189' ' ' LEU . 8.1 t -146.31 133.96 21.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.086 1.354 . . . . 0.0 109.175 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -93.12 140.67 23.4 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.687 ' HG2' ' H ' ' A' ' 153' ' ' GLY . 67.0 Cg_exo -45.34 122.69 4.82 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.83 2.354 . . . . 0.0 114.195 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.04 -173.1 26.39 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -156.36 132.66 10.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.704 0.764 . . . . 0.0 110.076 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.475 ' HE1' ' HB3' ' A' ' 186' ' ' ALA . 22.9 p90 -115.37 121.8 43.91 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.999 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -80.19 153.55 28.52 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.853 HG21 HG12 ' A' ' 33' ' ' ILE . 27.0 m -137.34 162.17 34.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.466 1.106 . . . . 0.0 108.358 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -59.32 -24.56 63.43 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.644 0.777 . . . . 0.0 111.546 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.466 ' H ' HG22 ' A' ' 179' ' ' THR . . . -82.03 -36.51 27.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.061 0.944 . . . . 0.0 112.085 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.85 -131.68 1.68 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.56 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 37.9 m -156.45 127.88 7.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 108.374 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.47 133.81 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.34 116.11 5.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 177' ' ' PHE . . . -162.69 -166.15 1.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.334 0.654 . . . . 0.0 111.152 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 172' ' ' THR . 4.6 p -74.84 100.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 CA-C-O 121.719 0.771 . . . . 0.0 110.641 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 223' ' ' VAL . 29.1 m -96.16 100.2 11.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.635 HD12 ' HB ' ' A' ' 172' ' ' THR . 7.6 tt -135.05 107.46 7.3 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.41 124.91 27.41 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.451 ' HZ ' ' HG3' ' A' ' 168' ' ' ARG . 48.4 t80 -170.11 -179.53 3.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.672 1.189 . . . . 0.0 107.829 -175.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.2 m -58.19 159.19 11.75 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.99 0.916 . . . . 0.0 111.032 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.706 ' HA ' HG11 ' A' ' 216' ' ' VAL . 9.2 Cg_endo -50.13 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.09 2.526 . . . . 0.0 112.252 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.82 163.41 44.25 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.2 t -102.0 137.85 39.74 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.424 0.631 . . . . 0.0 111.361 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.3 m -70.78 105.65 3.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.887 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.75 5.14 8.46 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.027 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.3 m -49.1 116.92 5.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 C-N-CA 123.399 0.679 . . . . 0.0 111.662 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.54 125.11 9.84 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.252 1.968 . . . . 0.0 112.455 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 208' ' ' VAL . 40.8 mt -93.04 106.95 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 122.167 0.984 . . . . 0.0 108.865 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 202' ' ' ASP . 8.7 mt -114.05 -175.58 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.053 1.341 . . . . 0.0 107.616 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' HG22 ' A' ' 201' ' ' ILE . 33.7 t70 -125.04 170.11 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.464 0.574 . . . . 0.0 110.397 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.554 ' HE3' ' NE2' ' A' ' 171' ' ' GLN . 19.5 mttp -47.17 -50.32 20.82 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.667 1.987 . . . . 0.0 111.403 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.58 -19.9 64.49 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.991 0.917 . . . . 0.0 111.259 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 102.63 6.03 47.44 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -61.63 128.7 37.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.379 0.672 . . . . 0.0 109.203 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 146' ' ' LEU . 7.6 p -80.74 109.94 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 156' ' ' VAL . 80.0 t -83.23 -30.72 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.5 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 229' ' ' THR . . . 156.97 -149.88 20.8 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.455 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 101' ' ' VAL . 78.3 mt -131.54 174.0 10.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.355 1.062 . . . . 0.0 109.554 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -59.94 123.45 17.08 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 164.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.85 177.69 43.41 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.76 97.99 0.68 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.493 0.647 . . . . 0.0 110.402 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.627 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -140.73 -152.72 5.83 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.652 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.25 179.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -169.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 193' ' ' PRO . 27.2 m -98.41 125.78 51.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 162.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 29' ' ' LEU . 10.0 t -95.46 140.58 30.11 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.685 0.394 . . . . 0.0 111.092 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 38.95 -80.65 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.871 2.068 . . . . 0.0 114.401 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.1 p -87.15 16.58 4.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.283 1.033 . . . . 0.0 111.892 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.98 19.34 63.24 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.86 0.267 . . . . 0.0 112.709 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.16 123.09 25.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.269 0.628 . . . . 0.0 110.535 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -65.23 99.03 0.36 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.445 0.698 . . . . 0.0 109.718 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 29' ' ' LEU . 63.4 t -131.42 109.74 16.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 122.353 1.073 . . . . 0.0 109.264 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.616 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 15.8 m -137.2 160.16 39.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.997 -169.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.96 153.77 32.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 164.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 200' ' ' ILE . 71.6 mt -101.38 113.15 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.53 147.87 33.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 9.6 pt20 -134.04 149.88 51.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.506 0.722 . . . . 0.0 109.363 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.709 HG23 ' HA2' ' A' ' 209' ' ' GLY . 51.1 p -105.39 108.54 20.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.518 0.199 . . . . 0.0 111.314 -168.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.29 141.61 13.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.144 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 2.5 tmtt? . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 156.954 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.443 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 120.534 0.207 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.87 15.83 0.11 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 110.552 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.6 m-20 -137.67 65.14 1.49 Allowed 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 5.5 mp -106.57 113.2 26.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.117 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 24.2 mm-40 -112.33 127.87 56.12 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.935 0.894 . . . . 0.0 111.809 -165.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -106.46 148.83 27.69 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.951 -0.468 . . . . 0.0 112.217 -175.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HA ' ' H ' ' A' ' 67' ' ' ASP . 31.9 tt0 -145.82 140.68 27.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.273 1.029 . . . . 0.0 109.24 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.71 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 7.1 ptm180 -60.97 143.28 55.53 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.677 0.672 . . . . 0.0 110.353 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.33 -39.08 3.92 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 170.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.415 ' CB ' ' HG3' ' A' ' 167' ' ' PRO . . . -169.01 -171.27 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.96 148.58 24.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.989 0.916 . . . . 0.0 110.095 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.62 97.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -157.53 157.28 33.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.914 1.286 . . . . 0.0 108.606 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -70.43 115.24 9.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 160.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.88 143.97 32.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.0 -4.81 18.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.865 0.466 . . . . 0.0 111.766 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.69 49.68 0.64 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.921 1.288 . . . . 0.0 110.723 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -64.6 89.98 0.07 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.261 1.024 . . . . 0.0 110.54 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.0 tp10 -90.75 101.92 14.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.318 1.047 . . . . 0.0 108.717 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.44 101.68 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.5 m -160.12 96.05 1.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.556 1.142 . . . . 0.0 109.512 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -133.36 2.92 Favored Glycine 0 N--CA 1.467 0.734 0 CA-C-O 119.334 -0.704 . . . . 0.0 111.983 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m 62.99 40.75 8.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.359 1.064 . . . . 0.0 109.6 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 m -62.98 116.87 27.59 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.176 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.94 -78.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.418 2.745 . . . . 0.0 112.573 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 178' ' ' LYS . 7.7 tp -113.52 145.59 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.022 0.529 . . . . 0.0 109.717 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 177' ' ' PHE . 52.8 tp -132.72 155.16 49.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.653 0.781 . . . . 0.0 109.403 172.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.1 p -97.99 122.37 41.04 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 177' ' ' PHE . 9.4 tp -117.89 152.29 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 122.73 0.412 . . . . 0.0 110.343 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.412 HG21 ' HG3' ' A' ' 42' ' ' LYS . 89.9 m -105.47 107.49 18.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.695 0.798 . . . . 0.0 109.998 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.61 116.87 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.057 0.943 . . . . 0.0 108.544 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 m -104.29 114.31 28.46 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 110.534 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.88 19.83 10.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.973 1.309 . . . . 0.0 112.025 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 p30 51.4 8.8 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.987 2.115 . . . . 0.0 114.788 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.29 -48.64 0.98 Allowed Glycine 0 C--N 1.349 1.284 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.2 p -106.0 164.79 11.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.454 0.701 . . . . 0.0 109.671 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 213' ' ' ASN . 2.5 ppp? -124.14 149.95 45.67 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 76.3 p -178.94 -175.82 0.41 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.26 1.024 . . . . 0.0 109.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.614 ' H ' HG11 ' A' ' 215' ' ' VAL . 3.2 mp -106.51 152.24 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 157.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 32' ' ' THR . 67.1 mttm -68.73 82.99 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -121.77 152.66 39.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.288 1.435 . . . . 0.0 108.85 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.34 49.73 1.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.744 0.783 . . . . 0.0 109.899 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.825 -178.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.4 tp -164.69 139.25 5.32 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.029 1.331 . . . . 0.0 108.001 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.505 ' CD1' ' HE2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -164.74 67.72 0.15 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t0 -104.76 71.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 119.566 -1.959 . . . . 0.0 107.156 163.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.488 HG13 ' ND1' ' A' ' 121' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.563 1.457 0 CA-C-N 112.815 -1.993 . . . . 0.0 106.573 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.597 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 29.8 t70 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.81 -170.44 31.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.759 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.53 108.31 17.23 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 16.3 m-85 -88.64 140.01 29.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 110.1 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -80.71 126.02 30.77 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 161.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.2 pt -122.14 135.45 62.23 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 CA-C-O 121.31 0.576 . . . . 0.0 111.251 -171.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 86.8 tttt -135.16 138.96 44.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.857 1.663 . . . . 0.0 108.586 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -143.43 151.8 40.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 27.1 tttm -97.35 93.13 6.32 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 125.857 1.973 . . . . 0.0 107.698 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.458 ' HA3' HE22 ' A' ' 88' ' ' GLN . . . -172.88 173.45 45.55 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-O 118.705 -1.053 . . . . 0.0 110.932 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 52.2 mt 72.42 -64.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.802 0.841 . . . . 0.0 112.049 165.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.445 HD11 ' HD2' ' B' ' 253' ' ' LYS . 1.3 pp -132.68 -9.31 3.17 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.946 0.898 . . . . 0.0 111.87 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.71 -153.74 24.8 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.93 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 6.6 m-85 -88.57 120.89 30.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.219 1.007 . . . . 0.0 109.866 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB2' ' HE2' ' B' ' 253' ' ' LYS . 15.2 m -141.38 133.96 28.47 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 118.346 0.521 . . . . 0.0 110.912 167.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 6.6 pt20 -95.5 105.15 17.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.03 1.332 . . . . 0.0 108.899 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -134.0 -41.32 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -164.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -111.5 -177.91 20.25 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 119.639 1.109 . . . . 0.0 115.639 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -124.17 124.11 41.75 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.398 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.94 121.02 3.8 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -105.71 118.69 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.984 0.892 . . . . 0.0 111.525 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 18.5 t80 -98.56 125.5 43.82 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -138.43 149.35 45.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.073 0.949 . . . . 0.0 109.187 168.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 145' ' ' LYS . 13.0 tp10 64.81 -82.19 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.796 1.238 . . . . 0.0 111.229 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -156.96 25.95 0.5 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 t -143.97 129.05 18.62 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.329 0.652 . . . . 0.0 110.876 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 68.9 t80 -96.48 86.55 4.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.447 ' HD2' HD11 ' A' ' 210' ' ' LEU . 67.1 t60 -95.14 120.39 35.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.272 -173.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 t -136.15 -156.56 0.72 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.929 0.891 . . . . 0.0 109.944 -174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.73 22.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.528 1.131 . . . . 0.0 110.677 -166.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -86.25 -49.96 7.31 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -60.59 -17.17 44.9 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 114' ' ' THR . 16.0 m -68.04 -57.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 C-N-CA 123.318 0.647 . . . . 0.0 110.81 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 113' ' ' VAL . 23.2 m -149.43 142.93 25.36 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -75.81 18.74 0.24 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.91 62.57 0.75 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.41 168.85 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.645 0.778 . . . . 0.0 110.23 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.27 134.61 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.583 0.753 . . . . 0.0 113.016 -164.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' HG ' ' HG3' ' A' ' 128' ' ' PRO . 13.7 mt -98.14 161.06 13.9 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -172.11 175.02 3.87 Favored 'General case' 0 C--O 1.267 1.986 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 21.7 t60 -121.18 95.48 4.71 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.819 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.505 ' HE2' ' CD1' ' A' ' 66' ' ' TRP . 46.1 mttm 25.77 60.32 0.07 Allowed 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 125.376 1.471 . . . . 0.0 113.667 -164.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.63 58.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.0 -0.889 . . . . 0.0 114.777 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 121' ' ' HIS . 8.9 tmtt? -83.79 113.37 20.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.526 1.163 . . . . 0.0 108.836 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.65 131.48 50.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.444 1.498 . . . . 0.0 113.384 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -139.43 115.52 9.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 C-N-CA 125.137 1.375 . . . . 0.0 108.526 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.55 121.56 72.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.37 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.52 ' HG3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 Cg_exo -62.73 179.03 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.024 2.483 . . . . 0.0 113.595 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.1 t -120.39 -34.09 3.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 111.887 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.463 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.0 t-105 -156.45 151.74 26.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.38 0.272 . . . . 0.0 110.937 -170.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -151.24 124.33 8.72 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.233 1.413 . . . . 0.0 109.799 168.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.404 ' HB2' ' NE1' ' A' ' 130' ' ' TRP . 10.3 t70 -128.81 128.04 43.13 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.288 0.635 . . . . 0.0 109.621 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 t -75.48 -46.65 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.644 1.178 . . . . 0.0 110.872 -172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -75.02 -45.94 38.38 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.367 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -15.9 60.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 61.98 43.33 9.17 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.562 1.164 . . . . 0.0 110.687 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -140.72 135.71 31.85 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.677 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 130' ' ' TRP . 46.3 mt -122.03 160.5 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.761 1.624 . . . . 0.0 108.479 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 53.9 p -153.86 155.53 35.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.185 0.448 . . . . 0.0 111.585 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.764 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.5 t80 -115.38 149.81 37.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.134 1.374 . . . . 0.0 108.917 170.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.78 -109.56 2.16 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.16 82.38 0.05 OUTLIER Glycine 0 C--O 1.239 0.452 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.51 136.92 2.95 Favored Glycine 0 C--O 1.239 0.425 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 146' ' ' LEU . 3.0 t-105 -105.76 106.31 16.75 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.536 1.168 . . . . 0.0 108.557 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HE3' ' HG2' ' A' ' 104' ' ' GLU . 53.4 mtmt -131.19 123.44 28.49 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.984 0.913 . . . . 0.0 109.816 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.427 ' HB2' ' CH2' ' A' ' 144' ' ' TRP . 23.9 tp -129.63 -85.93 0.54 Allowed 'General case' 0 C--N 1.348 0.511 0 O-C-N 123.855 0.722 . . . . 0.0 109.285 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 176.98 -66.02 0.01 OUTLIER 'General case' 0 C--N 1.361 1.077 0 O-C-N 123.759 0.662 . . . . 0.0 110.868 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.452 ' HA3' ' HE3' ' A' ' 206' ' ' LYS . . . -140.35 -161.94 8.91 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -166.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 228' ' ' GLN . 34.5 tt0 -148.32 163.86 35.79 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.046 1.339 . . . . 0.0 108.966 -167.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 208' ' ' VAL . 30.8 t90 -66.84 146.88 53.95 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 176.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.54 132.94 21.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.558 1.143 . . . . 0.0 109.218 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.82 162.95 28.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.339 0.656 . . . . 0.0 110.578 174.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.38 -31.21 4.91 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.28 138.66 31.23 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.921 0.888 . . . . 0.0 109.39 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.32 135.24 38.38 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 200' ' ' ILE . 36.0 m -106.11 140.43 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 123.434 0.694 . . . . 0.0 110.351 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -109.21 150.74 27.47 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.83 113.44 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.512 0.325 . . . . 0.0 110.77 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 167' ' ' PRO . 2.3 pt? -67.92 87.56 0.25 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 0.0 109.26 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 167' ' ' PRO . . . -71.13 111.61 6.62 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.392 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 167' ' ' PRO . 96.7 mt -68.78 80.34 0.29 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.34 125.33 86.94 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.791 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.81 114.27 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.108 2.539 . . . . 0.0 114.06 -170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.35 61.42 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.401 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -151.43 163.29 39.32 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.409 0.684 . . . . 0.0 110.286 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -61.85 157.67 48.3 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.146 0.978 . . . . 0.0 112.233 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.652 ' HB2' ' HB2' ' A' ' 159' ' ' LEU . 69.3 Cg_endo -69.8 117.02 4.84 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.675 2.25 . . . . 0.0 112.292 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -97.84 112.74 24.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 159' ' ' LEU . . . -72.05 101.78 2.82 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.207 0.527 . . . . 0.0 110.084 -175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.428 HG11 HD21 ' A' ' 189' ' ' LEU . 44.9 t -85.33 109.52 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.413 -174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -84.46 105.57 15.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.095 0.872 . . . . 0.0 108.879 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 HD12 ' A' ' 189' ' ' LEU . 9.8 t -127.99 157.61 40.13 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.865 1.266 . . . . 0.0 109.627 -174.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -99.41 160.23 28.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.49 159.05 33.39 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.198 1.932 . . . . 0.0 113.151 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -145.95 -171.14 15.18 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.12 149.52 30.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.661 0.73 . . . . 0.0 111.013 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 1.3 p90 -131.63 127.58 37.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.427 1.091 . . . . 0.0 109.453 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.552 ' HB2' HD11 ' A' ' 28' ' ' ILE . 43.9 tttm -78.58 132.01 36.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 -165.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 181' ' ' ALA . 32.7 m -90.68 162.98 14.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 109.228 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -54.34 -40.67 68.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 179' ' ' THR . . . -103.97 2.34 32.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.957 0.903 . . . . 0.0 112.995 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.47 -126.44 1.27 Allowed Glycine 0 C--N 1.351 1.408 0 C-N-CA 121.471 -0.395 . . . . 0.0 113.11 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.8 t -157.38 153.93 28.07 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.437 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mt -116.17 127.93 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.17 119.96 6.66 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.79 -156.22 0.49 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 0.0 109.798 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.42 106.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.876 0.846 . . . . 0.0 109.296 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.582 ' HA ' HG13 ' A' ' 223' ' ' VAL . 23.0 t -103.8 106.07 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 172' ' ' THR . 3.8 tt -128.54 129.63 46.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -172.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.752 ' HA ' ' HB1' ' A' ' 221' ' ' ALA . 8.7 p-10 -107.22 120.53 42.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.028 0.531 . . . . 0.0 109.708 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -170.88 168.48 7.13 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.553 1.141 . . . . 0.0 108.793 -171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.9 p -54.36 136.07 60.91 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.284 0.634 . . . . 0.0 110.832 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.3 95.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 124.272 3.315 . . . . 0.0 114.932 -167.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.46 44.45 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.189 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 161' ' ' LEU . 7.7 t -103.87 143.98 32.11 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 112.244 -170.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.474 ' HA ' ' OH ' ' A' ' 222' ' ' TYR . 48.2 m -68.29 116.15 8.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.427 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.02 -4.48 23.97 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.356 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 75.5 m -52.19 118.81 13.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 122.963 0.505 . . . . 0.0 111.922 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.484 ' HG2' HD21 ' A' ' 159' ' ' LEU . 85.9 Cg_endo -79.53 141.07 15.46 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.755 2.303 . . . . 0.0 113.129 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.476 HD12 HG23 ' A' ' 226' ' ' ILE . 14.4 mt -93.49 111.07 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.552 HD12 HD22 ' A' ' 159' ' ' LEU . 45.6 mt -119.23 155.76 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 110.236 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.63 164.61 12.34 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.665 1.186 . . . . 0.0 108.377 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.27 -24.27 64.8 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.653 1.181 . . . . 0.0 112.098 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -71.1 -16.66 62.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.043 1.337 . . . . 0.0 111.818 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.86 78.18 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HE3' ' HA3' ' A' ' 148' ' ' GLY . 41.2 tttp -86.83 121.53 29.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.475 1.11 . . . . 0.0 108.437 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.42 109.31 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 150' ' ' TRP . 10.7 p -92.61 7.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.192 0.997 . . . . 0.0 110.237 -173.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.3 -164.9 32.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.846 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 49.5 mt -137.16 150.61 48.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -69.37 108.27 3.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.14 -133.78 4.93 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.833 1.333 . . . . 0.0 112.9 -171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.445 ' O ' ' SD ' ' A' ' 39' ' ' MET . 3.3 t-20 -67.38 97.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -162.16 -162.46 13.34 Favored Glycine 0 C--O 1.244 0.738 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.221 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 41' ' ' ILE . 12.2 p -167.03 168.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.6 0.76 . . . . 0.0 109.625 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 17.3 m -68.99 114.32 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 221' ' ' ALA . 6.0 t -81.18 -178.65 7.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.382 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -36.39 117.42 0.48 Allowed 'General case' 0 C--N 1.36 1.036 0 O-C-N 125.375 1.672 . . . . 0.0 112.403 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.5 t 86.46 6.04 0.36 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.063 1.745 . . . . 0.0 112.085 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.8 32.28 9.3 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.596 -0.275 . . . . 0.0 113.149 174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -98.07 105.01 17.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 196' ' ' SER . 10.3 t80 -67.09 103.45 1.19 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 188' ' ' SER . 87.6 t -118.33 139.6 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.112 1.365 . . . . 0.0 108.694 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.507 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 44.8 t -153.4 156.58 38.51 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.025 0.44 . . . . 0.0 111.932 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.0 130.62 41.4 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.476 HG23 HD12 ' A' ' 200' ' ' ILE . 69.2 mt -70.85 111.88 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.607 0.363 . . . . 0.0 110.67 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -74.64 152.51 39.19 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 11.0 pt20 -145.1 162.27 37.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.653 0.781 . . . . 0.0 110.439 -172.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 26.6 m -85.21 108.88 17.94 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -105.24 32.87 3.96 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.956 0.902 . . . . 0.0 109.827 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 123.007 0.523 . . . . 0.0 109.954 -175.541 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 95' ' ' SER . 2.9 tppp? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 124.43 1.092 . . . . 0.0 111.396 178.721 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 81.0 21.63 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.116 1.367 . . . . 0.0 112.028 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.2 t70 -168.07 52.47 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 88' ' ' GLN . 53.2 mt -86.59 91.02 8.44 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.677 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 121' ' ' HIS . 13.0 mm-40 -87.23 124.37 33.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.2 1.0 . . . . 0.0 110.988 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.15 125.99 43.41 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . 33.2 tt0 -109.61 157.94 18.54 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 167.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 67' ' ' ASP . 21.3 ttt180 -92.96 141.7 28.12 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.822 1.192 . . . . 0.0 110.904 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.29 -55.71 2.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.44 -159.97 0.84 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.899 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.47 153.44 20.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.185 0.594 . . . . 0.0 110.141 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.585 HG12 HG21 ' A' ' 201' ' ' ILE . 3.0 t -79.58 97.93 2.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -173.94 164.47 4.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.643 0.777 . . . . 0.0 109.19 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -64.48 126.31 27.45 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.107 0.563 . . . . 0.0 111.475 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 10.8 tp10 -97.1 145.57 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.164 0.986 . . . . 0.0 109.042 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -9.72 2.3 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.679 1.191 . . . . 0.0 113.49 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.499 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 28.5 mm-40 -80.81 51.78 1.59 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.954 1.302 . . . . 0.0 111.161 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.29 3.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.286 1.034 . . . . 0.0 112.05 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 170' ' ' VAL . 48.5 mt-10 -94.42 91.54 6.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.003 0.921 . . . . 0.0 110.443 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 171' ' ' GLN . 17.7 mt -79.25 102.85 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -158.11 -35.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.114 0.566 . . . . 0.0 111.023 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.09 99.43 0.04 OUTLIER Glycine 0 C--N 1.356 1.654 0 O-C-N 124.067 0.854 . . . . 0.0 113.979 -170.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.6 p 168.3 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.927 1.691 . . . . 0.0 108.093 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 190' ' ' ASP . 77.4 p -70.13 159.79 83.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.28 175.66 1.02 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.183 1.922 . . . . 0.0 112.931 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.79 111.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.573 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 55.9 tp -102.93 134.88 45.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -164.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.6 t -80.55 114.3 19.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 223' ' ' VAL . 33.1 mt -113.38 148.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.476 ' OG1' ' HG3' ' A' ' 42' ' ' LYS . 6.7 m -91.83 105.37 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 179' ' ' THR . 10.1 tp -79.85 156.5 4.58 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.015 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.7 m -145.34 114.24 6.9 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.224 0.61 . . . . 0.0 110.178 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 62.4 14.51 6.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.748 1.219 . . . . 0.0 112.142 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.2 t70 74.74 -20.07 0.35 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.557 1.943 . . . . 0.0 112.482 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.67 -48.23 3.49 Favored Glycine 0 C--N 1.353 1.489 0 C-N-CA 123.137 0.398 . . . . 0.0 112.675 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.8 p -100.56 157.52 16.6 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -145.42 135.58 23.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.137 0.575 . . . . 0.0 110.156 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.3 p -154.12 -178.15 6.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 109.592 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 215' ' ' VAL . 9.4 tp -107.05 156.16 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 7.3 mtpm? -67.84 113.24 5.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 163.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.55 91.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.368 1.467 . . . . 0.0 110.528 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.51 116.68 32.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.285 0.634 . . . . 0.0 109.8 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 C--O 1.243 0.735 0 C-N-CA 123.532 0.733 . . . . 0.0 109.275 176.401 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HD2' ' A' ' 122' ' ' LYS . 7.0 t . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -93.34 140.42 29.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.419 0.688 . . . . 0.0 112.105 173.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.532 ' HB3' ' CE1' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -152.79 -176.38 5.72 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.232 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 27.4 t70 -177.98 68.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 84' ' ' TYR . 15.4 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.958 -162.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 103' ' ' LYS . 7.8 p-10 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.774 0.321 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' H ' ' HE1' ' A' ' 84' ' ' TYR . . . 172.82 -146.86 9.34 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.019 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.14 108.87 17.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.618 ' HE2' HG12 ' A' ' 68' ' ' VAL . 14.0 m-85 -89.44 158.42 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.642 0.777 . . . . 0.0 112.064 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 83.4 mtt180 -93.43 156.85 16.52 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.089 1.356 . . . . 0.0 110.136 163.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.576 HG22 HD12 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -126.36 106.32 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.641 -166.099 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 80.7 tttt -124.4 131.91 53.51 Favored 'General case' 0 C--N 1.406 3.045 0 C-N-CA 124.725 1.21 . . . . 0.0 113.048 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB2' HD23 ' A' ' 6' ' ' LEU . 6.9 tp60 -134.27 151.2 51.15 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -87.48 85.58 7.14 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.71 169.85 40.91 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 114.032 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.801 HG12 ' HD2' ' B' ' 253' ' ' LYS 0.254 0.1 OUTLIER 30.2 39.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.3 2.24 . . . . 0.0 114.323 178.708 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp 158.13 -57.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 128.261 2.624 . . . . 0.0 106.177 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.0 -152.43 24.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.573 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -58.96 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.727 0.811 . . . . 0.0 110.227 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.4 m -143.54 123.79 13.78 Favored 'General case' 0 C--O 1.256 1.418 0 CA-C-N 118.471 0.578 . . . . 0.0 111.171 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.53 119.61 32.17 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 166.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 86' ' ' ILE . 1.9 pp -124.84 -42.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -115.79 -163.9 13.88 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.01 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.17 122.33 36.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.912 0.485 . . . . 0.0 110.101 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.97 174.87 26.95 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 14' ' ' VAL . 54.9 t -137.24 135.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 34.9 t80 -151.27 122.57 7.8 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 5.9 mtmp? -135.92 136.46 40.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 61.95 -81.67 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.948 1.405 . . . . 0.0 111.989 170.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.05 28.98 1.12 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-O 120.188 -0.229 . . . . 0.0 112.666 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -144.47 125.27 14.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 0.0 110.139 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 5.7 t80 -97.91 121.22 39.56 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -110.14 108.25 18.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.069 0.948 . . . . 0.0 109.41 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 138' ' ' ILE . 10.1 t -136.46 -156.37 0.7 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.366 0.666 . . . . 0.0 110.261 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.515 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 31.6 ttm -149.37 152.44 35.79 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -154.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -43.25 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.438 1.095 . . . . 0.0 113.019 -176.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 4.3 p-80 -64.86 -22.44 66.99 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.144 0.429 . . . . 0.0 111.31 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.72 -44.23 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 6' ' ' LEU . 96.8 m -148.89 147.61 28.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 119.242 0.928 . . . . 0.0 109.214 166.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -71.52 32.73 0.05 Allowed 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 126.275 1.83 . . . . 0.0 115.857 -168.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.446 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 87.41 45.77 5.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.68 0.673 . . . . 0.0 113.264 171.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -97.46 -169.73 1.89 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.115 0.566 . . . . 0.0 112.296 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 127' ' ' GLU . 8.9 p -100.45 139.75 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.642 1.177 . . . . 0.0 111.986 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' ' CZ ' ' A' ' 140' ' ' TYR . 16.0 mt -85.27 171.4 11.95 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 118.078 0.399 . . . . 0.0 111.271 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.73 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.9 ptp -178.5 177.3 0.94 Allowed 'General case' 0 C--O 1.283 2.845 0 CA-C-O 122.17 0.986 . . . . 0.0 112.37 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -166.33 120.87 1.14 Allowed 'General case' 0 C--N 1.365 1.26 0 CA-C-N 113.384 -1.735 . . . . 0.0 114.173 167.239 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 19.1 mtpp 48.48 40.62 15.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.82 1.325 . . . . 0.0 113.34 158.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.28 19.25 14.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.742 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' MET . 13.0 tppt? -137.11 158.83 43.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.353 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -143.58 124.95 14.68 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.859 1.209 . . . . 0.0 112.795 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.462 HD12 HD21 ' A' ' 8' ' ' LEU . 60.3 mt -103.74 118.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.264 1.425 . . . . 0.0 109.592 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HA ' HG23 ' A' ' 118' ' ' VAL . 33.8 mt-10 -87.92 138.42 31.13 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.642 0.777 . . . . 0.0 112.096 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 73.9 Cg_endo -71.86 156.37 56.75 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.312 2.674 . . . . 0.0 113.69 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 p -124.06 -20.68 5.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.554 0.742 . . . . 0.0 110.975 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 17.5 t-105 -148.77 146.02 27.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.544 0.737 . . . . 0.0 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.49 125.75 8.0 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.205 1.402 . . . . 0.0 108.573 167.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -138.47 128.21 25.08 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.506 0.593 . . . . 0.0 111.114 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.34 -32.18 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.913 0.885 . . . . 0.0 111.341 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 134' ' ' LYS . 3.4 mptp? -73.37 -38.1 65.81 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.065 0.946 . . . . 0.0 110.051 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.51 -17.07 37.47 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.727 0.811 . . . . 0.0 109.461 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 59.53 36.39 22.88 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 125.025 1.33 . . . . 0.0 109.482 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 1.5 mp -137.84 140.67 40.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.671 0.748 . . . . 0.0 110.563 -169.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 109' ' ' THR . 73.1 mt -124.09 148.03 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.765 1.626 . . . . 0.0 108.251 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 32.9 t -141.91 143.7 33.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 111.265 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.721 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 3.5 m-85 -119.88 146.26 45.93 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.998 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.08 35.97 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.499 0.499 . . . . 0.0 112.2 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 159.3 -161.39 32.05 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.9 132.7 11.35 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 166.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.695 ' NE1' ' HA ' ' A' ' 229' ' ' THR . 4.9 p90 -75.7 107.68 8.03 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.193 0.997 . . . . 0.0 111.169 -169.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -116.33 116.37 27.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.525 ' HB2' HG21 ' A' ' 229' ' ' THR . 5.7 mp -131.62 -66.51 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 172.11 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.708 0.803 . . . . 0.0 109.407 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 207' ' ' VAL . . . -47.31 109.64 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 118.065 1.986 . . . . 0.0 118.065 -162.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -142.59 94.23 2.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.574 ' HE3' HD13 ' A' ' 200' ' ' ILE . 7.8 t90 -56.75 109.91 0.71 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.25 123.64 32.47 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.407 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.82 135.86 35.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.984 0.914 . . . . 0.0 111.663 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.429 ' H ' ' HG3' ' A' ' 174' ' ' PRO . . . 110.48 -59.22 0.36 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.0 111.28 17.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.622 0.769 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.46 152.39 40.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.194 0.598 . . . . 0.0 111.736 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.782 HG21 HG23 ' A' ' 200' ' ' ILE . 34.6 m -124.8 -169.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.532 1.133 . . . . 0.0 109.89 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.683 ' HG2' ' HG3' ' A' ' 171' ' ' GLN . 59.8 mt-30 -126.04 167.12 15.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.965 1.306 . . . . 0.0 109.065 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 13.5 p -140.26 148.92 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 122.985 0.514 . . . . 0.0 110.51 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.9 mt -97.54 95.21 7.47 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.98 0.809 . . . . 0.0 109.907 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 168' ' ' ARG . . . -76.48 99.97 5.1 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 168.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.66 106.02 17.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.544 0.738 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.27 159.63 29.04 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.551 0.74 . . . . 0.0 111.135 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.37 113.61 1.2 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 124.123 3.216 . . . . 0.0 115.165 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.45 8.81 40.44 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.016 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.2 158.91 16.5 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.982 0.913 . . . . 0.0 110.636 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -63.47 157.62 63.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.539 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.55 103.19 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.544 2.163 . . . . 0.0 111.134 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 160' ' ' ALA . 80.2 mtp180 -72.99 96.71 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.02 99.84 7.86 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 21' ' ' GLU . 94.9 t -102.72 122.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.362 0.665 . . . . 0.0 109.751 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.683 ' HG3' ' HG2' ' A' ' 157' ' ' GLN . 2.1 mp0 -82.15 119.35 23.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -127.67 141.29 51.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.142 0.977 . . . . 0.0 111.368 -173.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -98.27 160.14 28.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.539 1.536 . . . . 0.0 109.481 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HG3' ' H ' ' A' ' 153' ' ' GLY . 64.3 Cg_endo -73.52 124.1 9.1 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.696 1.597 . . . . 0.0 111.216 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.06 -172.79 26.34 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.291 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.1 133.58 9.9 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.573 ' HD1' ' HB3' ' A' ' 29' ' ' LEU . 29.0 m-85 -121.79 126.5 48.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.818 0.847 . . . . 0.0 109.298 -165.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -73.06 117.92 15.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.604 0.716 . . . . 0.0 109.215 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.473 HG23 ' HB ' ' A' ' 33' ' ' ILE . 91.0 m -120.65 147.82 44.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.927 1.291 . . . . 0.0 109.479 -170.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -78.98 65.57 4.2 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 178.46 -43.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.832 1.653 . . . . 0.0 108.214 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 178.28 -127.33 1.15 Allowed Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.131 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 m -144.18 128.58 17.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.647 0.779 . . . . 0.0 109.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.2 mt -104.1 122.88 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.877 0.871 . . . . 0.0 109.245 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.31 106.61 3.17 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.32 178.55 9.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.971 0.909 . . . . 0.0 109.975 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.05 131.83 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.3 p -111.0 89.67 3.11 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.168 0.987 . . . . 0.0 109.385 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.518 ' HB3' ' O ' ' A' ' 222' ' ' TYR . 3.4 tm? -106.78 124.81 50.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 30.5 t70 -125.49 105.18 8.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 108.678 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -163.86 -173.5 3.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.075 1.35 . . . . 0.0 109.043 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 77.6 p -51.9 149.41 9.02 Favored Pre-proline 0 CA--C 1.556 1.185 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.759 159.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.71 114.42 1.07 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.139 2.56 . . . . 0.0 112.834 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 222' ' ' TYR . . . -72.67 163.02 54.82 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.898 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 120.72 27.61 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.979 0.512 . . . . 0.0 110.025 -172.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.0 m -59.88 115.1 3.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.639 0.776 . . . . 0.0 110.343 173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.93 17.18 33.36 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 124.107 0.879 . . . . 0.0 112.426 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . 0.414 ' HB3' HG22 ' A' ' 158' ' ' VAL . 56.5 m -64.61 127.65 92.63 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 117.113 0.457 . . . . 0.0 111.059 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.79 138.45 11.78 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.085 2.524 . . . . 0.0 114.483 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.782 HG23 HG21 ' A' ' 156' ' ' VAL . 62.3 mt -85.25 99.72 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.039 1.336 . . . . 0.0 109.121 176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.585 HG21 HG12 ' A' ' 14' ' ' VAL . 20.8 pt -124.25 156.6 31.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.058 0 CA-C-O 121.368 0.604 . . . . 0.0 111.895 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 15.5 t70 -90.84 176.01 6.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.643 1.177 . . . . 0.0 108.975 174.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.484 ' HG2' ' NE2' ' A' ' 157' ' ' GLN . 38.0 mtpt -56.61 -27.19 57.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.695 1.198 . . . . 0.0 112.681 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -95.54 -6.58 40.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.68 0.792 . . . . 0.0 111.941 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.81 46.64 5.34 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 57.9 tttm -115.25 162.49 17.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.278 1.431 . . . . 0.0 108.932 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.583 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 59.4 t 79.99 -58.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 C-N-CA 125.191 1.396 . . . . 0.0 110.731 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 146' ' ' LEU . 10.9 m 57.09 26.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 124.278 1.031 . . . . 0.0 112.521 167.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.18 -153.96 1.97 Allowed Glycine 0 C--N 1.361 1.969 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.7 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.0 mt -150.04 155.85 40.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 117.969 0.884 . . . . 0.0 111.27 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -82.12 104.12 12.23 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 165.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.75 -137.12 3.2 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 123.469 0.557 . . . . 0.0 114.202 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -71.22 103.64 2.86 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -141.27 -136.69 3.32 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.7 p -165.95 156.61 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 222' ' ' TYR . 22.2 t -84.61 110.26 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.447 HG21 HD21 ' A' ' 29' ' ' LEU . 95.0 m -85.97 148.24 25.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.283 1.033 . . . . 0.0 109.407 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 49.52 30.38 3.44 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.476 1.51 . . . . 0.0 112.846 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 93.4 p 56.45 27.45 12.18 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.289 1.836 . . . . 0.0 112.733 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -162.34 -53.83 0.02 OUTLIER Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.202 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.36 95.18 0.59 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.119 0.567 . . . . 0.0 110.478 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.57 ' HB2' ' H ' ' A' ' 194' ' ' GLY . 30.9 t80 -74.41 98.62 3.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 31' ' ' ILE . 78.0 t -98.78 146.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.746 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 23.1 t -159.21 158.93 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.43 142.12 46.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.572 167.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.8 mt -73.28 102.5 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.62 0.768 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -91.03 143.29 26.86 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.788 0.435 . . . . 0.0 110.037 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.58 172.43 12.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.411 1.084 . . . . 0.0 111.44 -167.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.695 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 65.8 p -74.2 133.17 42.71 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.255 0.622 . . . . 0.0 111.668 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.34 -29.31 69.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.762 0.825 . . . . 0.0 110.588 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 CA--C 1.554 1.121 0 CA-C-O 122.372 1.082 . . . . 0.0 109.229 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HD2' HG12 ' A' ' 91' ' ' ILE . 8.3 tmtt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' ARG . . . . . 0.451 ' H ' ' HD3' ' B' ' 253' ' ' LYS . 16.5 tpt180 . . . . . 0 N--CA 1.488 1.473 0 C-N-CA 127.726 2.41 . . . . 0.0 107.9 -163.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB2' ' NH2' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -161.56 -24.47 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.212 0.605 . . . . 0.0 111.367 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -87.82 36.59 0.77 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 126.713 2.005 . . . . 0.0 110.579 -159.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.703 ' HG ' ' HG3' ' A' ' 88' ' ' GLN . 4.3 mp -118.84 103.46 9.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 0.0 109.737 -165.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.498 ' O ' HD12 ' A' ' 65' ' ' LEU . 62.2 tt0 -109.13 153.02 24.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 68' ' ' VAL . 3.7 mp -91.8 148.95 21.85 Favored 'General case' 0 N--CA 1.515 2.791 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.532 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.852 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 25.2 tt0 -140.63 133.5 29.08 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.264 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -73.88 127.27 32.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.221 0.919 . . . . 0.0 111.857 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.56 -42.38 8.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.038 0.935 . . . . 0.0 109.569 174.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.53 -162.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -107.16 158.45 17.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.467 0.707 . . . . 0.0 109.814 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 103' ' ' LYS . 2.3 t -74.78 97.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 169.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -168.39 151.74 5.63 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -164.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -71.87 137.49 47.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 169' ' ' ALA . 11.2 tp10 -106.77 133.77 50.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.512 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.7 -8.21 52.73 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.789 0.836 . . . . 0.0 113.076 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 1.4 mp0 -84.69 50.78 1.97 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.651 0.78 . . . . 0.0 109.815 176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.54 118.83 23.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.42 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -132.48 138.41 47.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.636 0.774 . . . . 0.0 109.4 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.47 126.69 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -145.06 -41.8 0.23 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.294 0.638 . . . . 0.0 109.851 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.56 97.35 0.33 Allowed Glycine 0 C--N 1.356 1.66 0 O-C-N 123.455 0.472 . . . . 0.0 113.807 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -171.92 90.45 0.12 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.599 1.16 . . . . 0.0 109.055 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -115.13 151.53 45.79 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.394 0.677 . . . . 0.0 109.767 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 -163.71 0.19 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.57 110.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.2 tp -101.83 143.04 32.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.04 0.448 . . . . 0.0 111.499 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -91.61 112.24 24.08 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.258 0.623 . . . . 0.0 109.722 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.8 mt -118.27 157.48 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 124.705 1.202 . . . . 0.0 108.139 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.46 HG21 ' HE3' ' A' ' 42' ' ' LYS . 53.6 p -93.97 107.42 19.33 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.954 0.797 . . . . 0.0 109.353 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 39' ' ' MET . 1.8 mp -83.13 123.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.783 0.833 . . . . 0.0 109.138 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -102.95 138.67 39.52 Favored 'General case' 0 C--O 1.264 1.819 0 C-N-CA 123.896 0.878 . . . . 0.0 112.479 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 55.69 -86.59 0.02 OUTLIER 'General case' 0 C--N 1.356 0.871 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.056 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -156.56 100.8 1.97 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.66 -0.83 87.62 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.172 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 m -95.61 160.46 14.49 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 118.835 1.318 . . . . 0.0 108.527 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.518 ' HB3' HG13 ' A' ' 33' ' ' ILE . 2.8 ppp? -160.42 144.32 13.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.903 0.481 . . . . 0.0 110.203 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 p -165.73 174.33 9.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.462 0.705 . . . . 0.0 110.265 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 217' ' ' THR . 10.3 tp -104.89 155.87 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HE3' HG21 ' A' ' 32' ' ' THR . 99.6 mttt -81.57 123.34 28.58 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 71.99 114.45 0.05 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.668 1.587 . . . . 0.0 110.451 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.12 93.22 0.95 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.677 0.791 . . . . 0.0 110.847 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.485 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 7' ' ' GLU . 4.5 t . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.852 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 88.6 mt -143.11 -155.15 0.57 Allowed 'General case' 0 C--O 1.201 -1.469 0 C-N-CA 124.35 1.06 . . . . 0.0 109.854 -170.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 6.0 m0 -166.98 87.47 0.3 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 124.036 0.934 . . . . 0.0 112.881 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 5.6 t0 174.65 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 124.757 1.223 . . . . 0.0 109.729 159.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 8' ' ' LEU . 74.5 t . . . . . 0 N--CA 1.506 2.342 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.295 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.51 -155.81 26.35 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.19 129.82 50.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.994 1.318 . . . . 0.0 109.066 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 12.6 m-85 -123.92 146.69 48.28 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -162.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.662 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 30.4 mtt85 -86.8 126.92 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 161.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.88 134.45 66.18 Favored 'Isoleucine or valine' 0 C--O 1.267 2.016 0 O-C-N 122.032 -0.417 . . . . 0.0 110.971 -171.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.814 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 80.7 tttt -125.66 142.82 51.32 Favored 'General case' 0 C--N 1.387 2.2 0 C-N-CA 125.681 1.592 . . . . 0.0 111.795 -169.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.703 ' HG3' ' HG ' ' A' ' 6' ' ' LEU . 48.1 tt0 -121.88 152.71 39.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.588 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -105.0 90.9 3.59 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 123.05 1.405 . . . . 0.0 107.883 155.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.8 172.59 43.78 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.292 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 48.0 mt 60.91 -81.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.097 1.359 . . . . 0.0 111.021 166.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' B' ' 253' ' ' LYS . 50.6 tp -93.69 -46.12 7.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.3 1.04 . . . . 0.0 110.535 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.46 -150.08 11.16 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 116.386 -0.37 . . . . 0.0 113.513 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -104.41 88.11 2.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.621 1.168 . . . . 0.0 107.899 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -141.55 132.93 26.68 Favored 'General case' 0 C--O 1.257 1.48 0 CA-C-N 118.514 0.597 . . . . 0.0 112.521 -170.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 2.2 pt20 -94.09 114.87 27.11 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 125.36 1.464 . . . . 0.0 109.077 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -133.67 -35.66 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.13 -166.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.78 168.95 21.78 Favored Glycine 0 N--CA 1.48 1.625 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.249 -162.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -110.15 123.21 49.32 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.44 129.56 9.52 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 199' ' ' PRO . 27.8 t -110.83 103.76 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.692 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 21.2 t80 -116.36 140.11 49.69 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 170.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 79.5 tttt -169.34 152.88 5.05 Favored 'General case' 0 C--O 1.245 0.841 0 O-C-N 123.955 0.785 . . . . 0.0 109.358 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 69.97 -69.58 0.17 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.785 1.634 . . . . 0.0 110.119 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.43 10.85 0.07 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.25 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -133.64 150.13 51.58 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.802 0.801 . . . . 0.0 111.371 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 90.7 t80 -109.96 122.55 47.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.543 1.137 . . . . 0.0 108.435 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HE1' HD22 ' A' ' 137' ' ' LEU . 54.3 t-80 -132.2 111.76 11.69 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -175.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.69 -165.22 1.63 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.089 1.356 . . . . 0.0 108.388 -170.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.842 ' SD ' ' HA3' ' A' ' 212' ' ' GLY . 31.5 mmt -99.65 162.19 13.16 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.828 1.195 . . . . 0.0 113.722 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.402 ' HB2' ' N ' ' A' ' 137' ' ' LEU . 1.5 t90 -86.24 -52.99 5.3 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.6 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -57.34 -24.33 54.48 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.872 1.269 . . . . 0.0 113.09 -170.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 254' ' ' ARG . 22.6 m -62.51 -12.63 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 124.432 1.093 . . . . 0.0 113.038 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.83 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -160.72 -157.24 0.52 Allowed 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.727 1.211 . . . . 0.0 109.535 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 27.8 ptt180 -119.65 14.85 12.71 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.252 1.021 . . . . 0.0 111.021 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.83 ' H ' HG23 ' A' ' 114' ' ' THR . . . 94.28 58.54 1.21 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 124.152 0.882 . . . . 0.0 111.437 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.6 165.1 12.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 127' ' ' GLU . 2.2 p -98.58 144.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.326 1.05 . . . . 0.0 109.844 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.46 179.22 4.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.403 0.681 . . . . 0.0 111.965 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.4 ptp -168.96 178.44 4.51 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 13.7 t60 -127.23 95.0 4.15 Favored 'General case' 0 C--N 1.369 1.42 0 CA-C-N 110.214 -3.175 . . . . 0.0 107.946 164.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 mttt 34.81 64.29 0.42 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 125.234 1.414 . . . . 0.0 113.778 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.42 24.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.246 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -88.33 111.66 21.98 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.532 0.666 . . . . 0.0 109.624 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -105.08 130.37 53.29 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.289 -0.257 . . . . 0.0 111.1 -163.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.8 pt -119.53 130.37 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.308 1.043 . . . . 0.0 109.772 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.758 ' HA ' HG23 ' A' ' 118' ' ' VAL . 10.6 pt-20 -95.63 139.8 22.06 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.089 0.556 . . . . 0.0 111.658 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 62.4 Cg_endo -71.7 149.38 54.61 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.655 2.236 . . . . 0.0 111.734 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 9.9 p -85.68 -17.48 35.9 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.704 0.802 . . . . 0.0 111.784 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -163.24 157.85 20.83 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 120.665 0.269 . . . . 0.0 111.231 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.12 118.8 14.02 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.381 1.072 . . . . 0.0 109.535 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 135' ' ' LYS . 14.7 m-20 -102.58 110.26 22.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.387 1.475 . . . . 0.0 110.857 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.08 -48.81 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.882 0.473 . . . . 0.0 110.807 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.04 -44.58 76.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.095 0.558 . . . . 0.0 111.23 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . 72.5 mmtt -69.09 -20.86 64.08 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.008 0.523 . . . . 0.0 110.825 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 t0 66.13 59.52 0.68 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.045 1.338 . . . . 0.0 110.401 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 3.8 pp -165.21 157.14 15.19 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.76 151.34 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 125.081 1.353 . . . . 0.0 107.958 171.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -131.3 143.4 50.5 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.0 t80 -135.89 142.57 44.71 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 108.532 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.1 -5.98 64.72 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.812 0.695 . . . . 0.0 113.453 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.47 -152.67 23.94 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.13 50.18 Favored Glycine 0 C--O 1.242 0.65 0 CA-C-O 120.97 0.205 . . . . 0.0 112.909 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.401 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 3.1 t90 -54.45 134.21 45.91 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.809 1.244 . . . . 0.0 110.297 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HG3' ' HG ' ' A' ' 146' ' ' LEU . 56.7 pttt -109.82 -166.49 1.1 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.335 0.654 . . . . 0.0 111.403 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.61 ' HG ' ' HG3' ' A' ' 145' ' ' LYS . 50.2 mt 70.63 178.45 0.25 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.457 1.503 . . . . 0.0 111.501 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -143.09 -39.04 0.33 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.471 0.309 . . . . 0.0 111.587 -161.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.89 169.35 45.64 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 123.095 0.247 . . . . 0.0 113.155 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.0 153.13 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.221 0.608 . . . . 0.0 110.093 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.61 ' HA ' HG13 ' A' ' 208' ' ' VAL . 26.3 t90 -58.51 131.33 50.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.971 172.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -119.33 105.17 11.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 152.84 32.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.748 0.819 . . . . 0.0 111.507 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.01 -52.44 4.74 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.17 138.03 53.79 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.093 0.957 . . . . 0.0 110.425 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 9.6 pt-20 -76.38 141.09 41.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.539 . . . . 0.0 110.516 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.11 -177.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.307 1.043 . . . . 0.0 108.557 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 48.4 mt-30 -133.63 162.61 31.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.582 -0.699 . . . . 0.0 110.09 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 200' ' ' ILE . 7.4 p -137.09 136.67 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.149 0.58 . . . . 0.0 109.867 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 35.8 mt -69.52 86.94 0.46 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.79 105.23 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.6 176.8 8.36 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 163' ' ' PRO . 49.1 mp0 -28.4 155.58 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.175 0 C-N-CA 127.861 2.464 . . . . 0.0 114.326 168.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 162' ' ' GLU . 25.6 Cg_exo -1.16 137.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.638 1 C-N-CA 128.162 5.908 . . . . 0.0 118.945 -162.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.634 ' HA2' ' HB2' ' A' ' 192' ' ' SER . . . 99.69 -36.72 3.9 Favored Glycine 0 C--O 1.24 0.495 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -163.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -143.56 178.95 7.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.363 1.465 . . . . 0.0 108.42 164.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 89.7 m-20 -98.35 133.74 22.57 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.045 -0.978 . . . . 0.0 108.838 167.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 25.6 Cg_endo -59.47 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.965 3.11 . . . . 0.0 113.378 -175.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 39.2 ptt180 -160.68 165.16 31.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.943 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.503 ' H ' ' HB3' ' A' ' 17' ' ' GLU . . . -88.58 102.85 15.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.5 t -86.07 133.93 28.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 109.591 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 49.1 mt-30 -79.73 139.02 37.46 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.916 0.886 . . . . 0.0 109.37 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.8 t -150.28 130.06 13.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.902 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 59.7 mttp -90.71 155.07 45.89 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.046 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.57 121.26 9.3 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.373 1.382 . . . . 0.0 111.616 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -98.12 -170.71 32.28 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.1 144.27 5.64 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.345 0.573 . . . . 0.0 110.331 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 184' ' ' ILE . 43.4 p90 -123.47 135.01 53.85 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.903 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -70.74 163.74 26.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.882 1.273 . . . . 0.0 111.99 -173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 181' ' ' ALA . 27.4 m -139.12 165.6 26.73 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.889 1.676 . . . . 0.0 108.173 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -52.91 -41.53 64.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.973 0.909 . . . . 0.0 110.213 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 179' ' ' THR . . . -76.39 -74.41 0.23 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.863 176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.17 -107.02 0.65 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.702 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t -162.8 147.16 11.57 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 0.0 109.967 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.48 HD13 ' CE2' ' A' ' 177' ' ' PHE . 4.3 mp -108.45 151.38 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.72 139.3 14.35 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.41 144.22 19.44 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.05 113.08 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 165.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.3 m -116.86 91.18 3.51 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . 62.4 tp -104.62 105.02 14.94 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.522 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.37 111.45 14.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.329 0.651 . . . . 0.0 110.121 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -164.35 -174.3 3.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.126 1.37 . . . . 0.0 109.029 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' SER . . . . . 0.634 ' HB2' ' HA2' ' A' ' 164' ' ' GLY . 7.4 m -61.69 175.1 0.55 Allowed Pre-proline 0 CA--C 1.587 2.388 0 C-N-CA 124.787 1.235 . . . . 0.0 111.165 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 192' ' ' SER . 31.3 Cg_exo -24.57 123.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.407 3.633 1 C-N-CA 125.968 4.446 . . . . 0.0 116.925 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.46 131.55 26.93 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.006 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.1 m -81.5 97.12 7.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.912 0.485 . . . . 0.0 109.993 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 73.3 m -66.45 98.27 0.48 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -166.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 131.57 -5.05 5.52 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.631 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.9 m -47.43 124.48 9.29 Favored Pre-proline 0 N--CA 1.496 1.862 0 C-N-CA 124.275 1.03 . . . . 0.0 113.631 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.601 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 4.0 Cg_exo -72.4 121.23 7.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.738 2.292 . . . . 0.0 112.464 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 51.5 mt -84.2 110.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.46 162.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.713 0.805 . . . . 0.0 109.848 -171.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -103.04 167.48 9.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.538 0.735 . . . . 0.0 110.246 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -58.18 -40.6 81.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.565 1.546 . . . . 0.0 111.154 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -73.58 -20.84 60.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 111.77 -4.73 27.58 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.456 -0.636 . . . . 0.0 113.839 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -73.65 128.69 36.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.78 0.79 . . . . 0.0 110.183 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 146' ' ' LEU . 57.9 t -73.44 109.94 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 150' ' ' TRP . 55.1 t -64.37 -30.19 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.798 1.239 . . . . 0.0 110.576 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.87 -154.14 25.24 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.058 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 101' ' ' VAL . 75.8 mt -134.75 162.33 32.67 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.641 0.777 . . . . 0.0 109.596 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.8 OUTLIER -77.05 112.47 13.73 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 165.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.842 ' HA3' ' SD ' ' A' ' 110' ' ' MET . . . -174.26 67.31 0.1 Allowed Glycine 0 CA--C 1.496 -1.13 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 163.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.533 ' HB3' ' H ' ' A' ' 225' ' ' ALA . 11.0 t-20 -160.54 176.97 11.0 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.479 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . 61.62 -144.78 48.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 114.3 0.48 . . . . 0.0 114.3 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.437 HG22 ' N ' ' A' ' 216' ' ' VAL . 13.6 p -177.63 175.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 124.372 1.069 . . . . 0.0 108.863 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 215' ' ' VAL . 34.5 m -70.58 149.59 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 163.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.439 HG22 HD13 ' A' ' 41' ' ' ILE . 45.1 p -136.14 -165.14 1.66 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -32.4 108.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.201 1.4 . . . . 0.0 113.357 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.0 t 77.3 28.08 0.63 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.652 1.581 . . . . 0.0 111.907 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.57 15.84 80.22 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.793 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.61 116.53 6.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.497 0.719 . . . . 0.0 111.818 -171.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 189' ' ' LEU . 5.7 t80 -64.88 116.61 6.53 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.67 0.788 . . . . 0.0 109.388 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.6 t -134.16 115.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -137.09 141.98 42.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 109.25 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.533 ' H ' ' HB3' ' A' ' 213' ' ' ASN . . . -81.56 16.58 1.67 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.779 0.718 . . . . 0.0 112.49 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.9 mt 58.57 98.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.723 1.609 . . . . 0.0 111.462 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.33 130.03 40.89 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -108.8 125.86 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.411 HG21 HD12 ' A' ' 146' ' ' LEU . 38.5 p -80.72 106.26 12.59 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 110.171 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 -19.65 25.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.032 0.933 . . . . 0.0 111.456 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 C--N 1.364 1.222 0 C-N-CA 125.46 1.504 . . . . 0.0 110.525 -172.72 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 254' ' ' ARG . . . . . 0.479 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 31.7 ttm180 . . . . . 0 N--CA 1.481 1.08 0 CA-C-N 118.678 0.672 . . . . 0.0 109.84 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.53 16.43 0.2 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.916 0.78 . . . . 0.0 112.122 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.72 44.48 0.76 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.176 0.988 . . . . 0.0 109.321 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 120' ' ' MET . 26.7 mt -86.73 95.03 9.67 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.891 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' HG2' ' HG2' ' A' ' 120' ' ' MET . 25.6 mt-10 -111.19 129.39 55.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.631 0.772 . . . . 0.0 111.982 -166.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 68' ' ' VAL . 4.3 mp -101.43 146.98 26.89 Favored 'General case' 0 N--CA 1.513 2.68 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 65' ' ' LEU . 14.1 tt0 -130.46 158.46 39.83 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.014 1.726 . . . . 0.0 109.153 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 6.3 ppt_? -90.61 148.49 22.63 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 122.95 0.5 . . . . 0.0 110.958 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.15 -37.67 3.04 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.036 0.534 . . . . 0.0 110.767 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.99 -155.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.055 1.342 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -98.25 153.65 18.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.5 1.12 . . . . 0.0 109.382 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.82 91.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -170.43 117.44 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.57 1.548 . . . . 0.0 107.484 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 21' ' ' GLU . 80.0 t90 -75.88 94.7 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -158.9 59.55 0.42 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.88 0.472 . . . . 0.0 110.542 163.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 4.1 t70 -89.72 -65.28 1.03 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.442 -0.787 . . . . 0.0 111.235 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -152.96 -42.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.649 ' H ' ' HB3' ' A' ' 169' ' ' ALA . . . -136.45 -170.38 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -154.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 3.3 pt-20 -166.93 90.74 0.39 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.003 1.321 . . . . 0.0 109.408 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 170' ' ' VAL . 62.9 mt -85.45 103.54 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -55.25 -24.81 29.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.476 1.11 . . . . 0.0 112.202 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.33 -94.25 0.01 OUTLIER Glycine 0 C--N 1.365 2.179 0 O-C-N 124.519 1.137 . . . . 0.0 112.462 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 173' ' ' LYS . 7.0 t 57.94 75.62 0.37 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.044 1.338 . . . . 0.0 109.564 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.7 m -64.61 147.96 97.21 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.237 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.46 168.74 3.65 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.783 2.322 . . . . 0.0 112.094 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.57 109.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.634 0.774 . . . . 0.0 110.617 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.24 159.57 14.9 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.903 0.881 . . . . 0.0 111.733 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -124.6 127.73 47.82 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.9 165.45 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -93.74 108.03 19.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.334 -0.854 . . . . 0.0 109.556 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.0 106.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -89.61 129.55 36.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.971 0.908 . . . . 0.0 110.048 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.38 8.54 5.05 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.72 1.208 . . . . 0.0 112.672 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.71 21.45 12.39 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.893 1.277 . . . . 0.0 112.745 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.86 -40.45 0.06 OUTLIER Glycine 0 N--CA 1.478 1.489 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 t -90.89 166.67 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.84 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.5 ppp? -132.72 149.42 52.29 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 p -169.2 157.18 7.49 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.955 0.902 . . . . 0.0 109.414 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' H ' HG21 ' A' ' 215' ' ' VAL . 10.3 tp -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -81.64 70.31 8.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.466 0.651 . . . . 0.0 109.978 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 176.18 126.71 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.889 1.675 . . . . 0.0 107.299 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.28 118.06 12.36 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 124.075 0.95 . . . . 0.0 110.559 -176.349 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.641 HG13 ' HD3' ' A' ' 87' ' ' LYS . 43.4 t . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.549 HD22 ' HB2' ' A' ' 9' ' ' GLU . 69.4 mt -156.87 134.82 11.03 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 126.364 1.866 . . . . 0.0 106.314 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.523 ' HB2' ' CG ' ' A' ' 121' ' ' HIS . 0.5 OUTLIER -158.75 70.63 0.52 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.155 0.979 . . . . 0.0 113.638 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.53 70.93 0.74 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 162.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 8' ' ' LEU . 2.1 t . . . . . 0 CA--C 1.545 0.787 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.298 -166.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.512 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 15.4 t70 . . . . . 0 CA--C 1.546 0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.15 -167.39 34.89 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.398 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.76 108.25 9.65 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 4.9 m-30 -95.0 175.98 6.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 110.824 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 51.1 ttt180 -144.52 143.1 30.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 8' ' ' LEU . 1.1 pt -138.85 140.44 38.85 Favored 'Isoleucine or valine' 0 C--O 1.269 2.131 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HD3' HG13 ' A' ' 64' ' ' VAL . 26.2 tttm -131.2 136.57 48.39 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.434 1.494 . . . . 0.0 110.83 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.614 ' H ' HD11 ' A' ' 97' ' ' ILE . 3.5 tp60 -115.89 133.48 55.99 Favored 'General case' 0 C--O 1.26 1.642 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.74 97.21 9.01 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 163.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.42 -179.16 29.48 Favored Glycine 0 N--CA 1.462 0.374 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.298 -163.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' B' ' 253' ' ' LYS . 0.2 OUTLIER -39.79 132.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.614 166.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt 78.0 6.67 2.67 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.815 1.646 . . . . 0.0 111.976 -171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.84 -156.87 20.62 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 122.007 0.782 . . . . 0.0 114.834 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.94 69.37 7.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.285 1.434 . . . . 0.0 107.886 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 m -109.99 144.35 38.65 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -159.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -74.95 116.47 15.73 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.845 1.341 . . . . 0.0 109.162 163.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.614 HD11 ' H ' ' A' ' 88' ' ' GLN . 0.4 OUTLIER -144.38 9.08 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -152.17 170.53 31.48 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.873 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -116.4 124.64 50.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.7 155.17 22.46 Favored Glycine 0 CA--C 1.503 -0.67 0 O-C-N 123.695 0.622 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 210' ' ' LEU . 31.7 t -137.56 101.83 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -107.16 107.3 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -141.2 134.96 30.26 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.45 23.01 12.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.349 1.059 . . . . 0.0 112.349 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.23 76.74 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.088 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.2 p -127.52 133.06 49.84 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.031 0.532 . . . . 0.0 110.426 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.789 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 49.0 t80 -85.44 142.51 29.19 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB3' ' HZ3' ' A' ' 144' ' ' TRP . 94.4 m-70 -137.28 113.28 9.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.432 1.093 . . . . 0.0 110.035 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' HB ' ' A' ' 138' ' ' ILE . 9.7 t -139.81 -164.64 1.73 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.773 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' LEU . 22.2 mtp -121.6 170.47 9.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.045 0.938 . . . . 0.0 111.52 -171.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -40.44 13.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.257 0.623 . . . . 0.0 112.441 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.409 ' HE1' ' SD ' ' A' ' 110' ' ' MET . 25.2 p-80 -62.01 -20.76 64.25 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.521 0.676 . . . . 0.0 111.328 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' B' ' 253' ' ' LYS . 19.1 m -82.75 -35.1 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.934 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 116' ' ' GLY . 52.8 m -145.03 145.78 31.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.141 -1.599 . . . . 0.0 112.158 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.77 -5.52 0.95 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 126.221 1.808 . . . . 0.0 113.541 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 114' ' ' THR . . . 88.45 55.13 2.25 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.72 -175.0 3.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.918 0.487 . . . . 0.0 111.919 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.1 138.61 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.405 1.082 . . . . 0.0 112.947 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.524 ' HB2' HG13 ' A' ' 126' ' ' ILE . 7.5 mt -102.86 174.77 5.73 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.935 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.564 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -169.47 174.87 5.73 Favored 'General case' 0 C--O 1.261 1.707 0 CA-C-O 123.74 1.733 . . . . 0.0 115.208 -177.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 21.0 t60 -127.59 88.5 2.8 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.645 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 93.1 mttt 38.11 46.85 0.88 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.013 0.925 . . . . 0.0 111.798 -171.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.6 -26.57 20.92 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 11.9 mptt -73.61 109.68 7.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.214 1.507 . . . . 0.0 109.211 175.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 15.6 ttm180 -93.8 120.23 33.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.506 0.722 . . . . 0.0 112.494 -157.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 119' ' ' LEU . 17.0 pt -111.95 161.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.99 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.27 135.25 24.33 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.35 0.66 . . . . 0.0 109.725 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.84 163.5 38.24 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.395 2.063 . . . . 0.0 112.404 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 p -99.78 -30.28 12.15 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.749 0.819 . . . . 0.0 112.182 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.5 t-105 -140.84 147.82 39.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.723 0.809 . . . . 0.0 109.875 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.61 119.99 5.51 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.343 1.057 . . . . 0.0 109.047 169.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.86 114.77 11.36 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.914 0.486 . . . . 0.0 110.902 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.78 -22.19 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.788 1.235 . . . . 0.0 111.833 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.1 -50.2 69.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.471 0.708 . . . . 0.0 110.869 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -94.4 -8.14 39.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.868 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 63.88 44.1 5.01 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.156 1.382 . . . . 0.0 110.645 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 210' ' ' LEU . 77.6 mt -136.53 137.93 40.79 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.618 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.6 mt -120.63 151.96 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.788 1.635 . . . . 0.0 108.009 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 p -152.34 160.28 43.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.558 0.694 . . . . 0.0 112.014 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.789 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 27.4 t80 -129.09 135.6 49.12 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.446 1.499 . . . . 0.0 107.622 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.9 64.97 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 122.919 0.295 . . . . 0.0 113.152 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.14 -177.3 42.92 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.23 -178.21 44.59 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.538 ' HZ3' ' HB3' ' A' ' 108' ' ' HIS . 76.5 t-105 -81.84 105.01 12.62 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 122.441 -0.446 . . . . 0.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -165.7 113.84 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 107.946 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.536 HD13 HG11 ' A' ' 207' ' ' VAL . 69.5 mt -131.92 -88.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.695 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -172.52 -73.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.94 0.791 . . . . 0.0 110.716 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.07 149.73 47.95 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.64 0.588 . . . . 0.0 113.476 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.28 139.77 20.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.953 0.501 . . . . 0.0 110.009 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -68.89 122.32 18.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.699 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -105.11 116.5 32.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 166.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.35 150.09 31.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.466 0.707 . . . . 0.0 112.435 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.15 -20.75 31.59 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.499 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.46 136.4 41.37 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.726 0.811 . . . . 0.0 109.896 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 0.0 OUTLIER -73.32 140.22 46.6 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.491 0.662 . . . . 0.0 110.083 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 172' ' ' THR . 3.2 m -120.13 179.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.635 0.774 . . . . 0.0 108.96 175.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -121.66 160.7 23.89 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.091 -0.38 . . . . 0.0 110.784 -170.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.6 155.68 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.705 0.802 . . . . 0.0 110.28 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 52.5 mt -107.19 105.9 16.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 164.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.44 104.67 5.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.326 0.65 . . . . 0.0 109.474 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 167' ' ' PRO . 54.8 mt -69.65 104.64 2.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.192 0.52 . . . . 0.0 110.796 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 165' ' ' LYS . 56.7 mm-40 -76.26 141.6 70.58 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.123 -176.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 12.4 Cg_exo -71.89 116.64 4.78 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.906 3.071 . . . . 0.0 112.011 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.35 9.67 58.38 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.577 0.548 . . . . 0.0 113.894 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 162' ' ' GLU . 96.3 mttt -135.91 -177.31 4.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 0.0 110.219 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -88.26 142.96 31.99 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.848 0.859 . . . . 0.0 110.655 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.687 ' HB3' HD23 ' A' ' 161' ' ' LEU . 10.4 Cg_endo -52.86 115.65 2.39 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.515 2.81 . . . . 0.0 112.737 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -69.46 129.96 41.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.602 0.761 . . . . 0.0 109.888 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.649 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -71.73 118.79 15.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 22' ' ' ILE . 41.0 t -134.68 144.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.744 ' HB2' ' HB2' ' A' ' 21' ' ' GLU . 27.7 tt0 -84.81 163.81 18.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 156' ' ' VAL . 18.5 p -136.16 97.11 3.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 54.4 tttp -85.73 129.43 54.73 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 155' ' ' GLU . 84.0 Cg_exo -47.49 125.5 10.91 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.289 2.659 . . . . 0.0 113.714 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.36 178.41 18.13 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.928 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -139.07 128.82 24.75 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -133.75 122.06 22.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 183' ' ' THR . 5.0 ttpm? -122.39 138.83 54.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.36 1.064 . . . . 0.0 108.843 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 52.0 p -120.67 -178.68 3.78 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.026 0.931 . . . . 0.0 109.271 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -71.21 -19.63 62.36 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.36 0.664 . . . . 0.0 109.932 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.09 -48.92 8.71 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.345 1.058 . . . . 0.0 110.507 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -175.67 160.76 29.25 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.408 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 9.7 t -97.83 139.95 32.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.985 0.914 . . . . 0.0 110.145 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.49 127.73 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.93 111.51 4.0 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -163.57 -172.29 2.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.954 . . . . 0.0 109.946 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.67 100.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 121.807 0.813 . . . . 0.0 111.059 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.413 ' HA ' HG13 ' A' ' 223' ' ' VAL . 20.7 m -98.86 101.02 12.29 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 165.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.14 151.48 40.91 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.62 0.248 . . . . 0.0 110.998 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.93 159.95 32.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.818 0.847 . . . . 0.0 109.069 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.476 ' HA ' ' HD1' ' A' ' 222' ' ' TYR . 34.0 p90 -75.63 121.92 23.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.113 0.959 . . . . 0.0 111.63 -164.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.2 m -137.14 132.12 17.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.28 2.653 . . . . 0.0 113.062 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.43 100.37 0.37 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -173.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 37.3 p -73.59 140.65 46.38 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.294 0.638 . . . . 0.0 111.223 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -53.95 127.01 24.58 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.902 0.881 . . . . 0.0 112.153 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.07 -3.84 35.58 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.772 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.2 m -44.43 119.64 3.64 Favored Pre-proline 0 C--N 1.383 2.043 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.16 115.47 3.0 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.398 2.065 . . . . 0.0 111.517 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.24 106.4 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -98.38 163.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.507 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -98.85 157.65 16.16 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.245 1.418 . . . . 0.0 108.909 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -63.94 -34.27 77.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.5 1.12 . . . . 0.0 111.128 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.25 -20.36 44.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.714 0.406 . . . . 0.0 111.162 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.4 14.44 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.91 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 161.89 30.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.442 0.621 . . . . 0.0 109.843 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.536 HG11 HD13 ' A' ' 146' ' ' LEU . 2.7 p -94.02 112.12 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.38 -40.39 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 228' ' ' GLN . . . 158.23 -142.83 8.78 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 137' ' ' LEU . 70.4 mt -127.99 159.57 34.59 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.658 0.783 . . . . 0.0 110.449 -174.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' TYR . . . . . 0.481 ' O ' ' SD ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -62.98 107.87 1.09 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 170.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.07 -179.97 6.53 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 124.343 1.027 . . . . 0.0 114.837 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -69.19 86.99 0.4 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.516 1.15 . . . . 0.0 109.633 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.84 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -134.44 -151.23 6.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 113.677 -1.602 . . . . 0.0 111.661 -176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.568 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.8 p -157.28 168.63 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 111.591 -172.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.7 t -85.59 108.54 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.518 HG23 HD13 ' A' ' 41' ' ' ILE . 99.6 m -86.63 144.02 27.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.536 1.134 . . . . 0.0 110.005 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 67.79 10.3 7.69 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.613 1.165 . . . . 0.0 110.305 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 95.0 p 52.92 30.05 8.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.353 1.461 . . . . 0.0 111.43 -166.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.13 -70.16 0.05 OUTLIER Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.349 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.06 137.88 40.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.338 0.655 . . . . 0.0 111.164 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 191' ' ' PHE . 82.3 m-85 -86.03 102.49 13.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.141 0.496 . . . . 0.0 110.124 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 188' ' ' SER . 50.6 t -124.1 104.64 14.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.601 0.761 . . . . 0.0 108.972 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.702 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 63.4 m -132.04 162.48 30.67 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.306 1.042 . . . . 0.0 109.959 -171.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -58.65 162.72 3.71 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.006 162.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.58 103.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.343 -0.848 . . . . 0.0 109.023 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -78.91 136.58 37.31 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.459 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 8.8 pt20 -129.06 167.72 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.208 0.603 . . . . 0.0 109.494 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.532 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 1.6 p -82.72 110.69 17.99 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -72.01 -13.78 61.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.768 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.358 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 109.214 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 91' ' ' ILE . 17.2 tppt? . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 . . . . . 0 N--CA 1.48 1.064 0 C-N-CA 124.872 1.269 . . . . 0.0 108.361 -165.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -133.35 21.12 4.0 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.522 0.729 . . . . 0.0 111.143 -167.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -142.33 49.76 1.52 Allowed 'General case' 0 C--O 1.254 1.307 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 3' ' ' ALA . 34.6 mt -96.59 94.13 7.16 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.98 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' MET . 6.9 tm-20 -107.55 129.34 54.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.35 0.66 . . . . 0.0 111.095 -170.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.556 HD11 HD12 ' A' ' 119' ' ' LEU . 1.5 mp -94.78 137.16 34.22 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 34.3 tt0 -132.3 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.694 -0.629 . . . . 0.0 109.673 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.627 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 6.7 ptp180 -67.09 153.78 42.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.64 0.733 . . . . 0.0 112.454 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.31 -36.04 3.02 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.696 166.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.16 -162.39 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.52 156.81 25.08 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.647 0.779 . . . . 0.0 109.028 168.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.06 96.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.604 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 164.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -166.84 136.84 3.06 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -167.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.512 ' H ' ' HA2' ' A' ' 205' ' ' GLY . 63.7 t90 -66.69 120.16 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.748 0.655 . . . . 0.0 109.829 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -87.69 143.91 26.92 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.2 -6.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.808 1.243 . . . . 0.0 112.784 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.29 50.28 0.5 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.49 1.516 . . . . 0.0 111.709 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -65.72 100.47 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.543 0.737 . . . . 0.0 110.906 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.69 102.55 15.09 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.774 0.83 . . . . 0.0 110.246 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.59 100.91 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -153.4 144.08 22.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.54 1.536 . . . . 0.0 107.631 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 190' ' ' ASP . . . 109.46 -138.09 14.59 Favored Glycine 0 CA--C 1.503 -0.716 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.311 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m 58.82 26.79 15.22 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.413 0.685 . . . . 0.0 110.37 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 t -66.21 143.06 98.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.602 1.161 . . . . 0.0 111.039 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 175.68 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.91 2.407 . . . . 0.0 113.49 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.37 131.52 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.851 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.0 mt -109.1 160.16 16.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.852 0.861 . . . . 0.0 109.936 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 t -122.9 115.4 21.89 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 41' ' ' ILE . 30.0 mt -121.3 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.007 0.923 . . . . 0.0 109.337 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.3 p -92.96 111.9 23.68 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.34 132.45 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.935 0.894 . . . . 0.0 108.773 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -138.37 146.4 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.82 0.448 . . . . 0.0 110.341 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 52.85 32.63 12.74 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.237 1.015 . . . . 0.0 111.898 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.254 3.2 p30 52.54 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 126.975 2.11 . . . . 0.0 114.135 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.46 -10.45 66.6 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -106.55 160.55 15.34 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.186 0.993 . . . . 0.0 110.06 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -161.62 133.88 5.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.771 ' HA ' HG11 ' A' ' 215' ' ' VAL . 15.1 p -166.33 174.97 8.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.331 0.652 . . . . 0.0 110.161 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' A' ' 217' ' ' THR . 1.8 mp -89.22 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.71 73.33 1.08 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.41 0.624 . . . . 0.0 109.549 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -143.7 -179.44 6.45 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.59 1.156 . . . . 0.0 109.274 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.51 96.6 8.65 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 123.548 0.739 . . . . 0.0 110.187 175.423 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.332 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.069 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 73.0 mt 74.76 -172.62 0.11 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 125.001 1.32 . . . . 0.0 111.861 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -165.24 106.21 0.78 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.627 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t70 178.66 73.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.063 0.945 . . . . 0.0 112.441 151.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 165.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.64 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 27.2 t70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.34 -178.04 39.09 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.89 110.75 18.16 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 124.355 1.062 . . . . 0.0 108.786 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 6.9 m-85 -99.54 140.66 33.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.39 122.7 28.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.2 pt -107.63 135.44 46.23 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.62 -166.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 79.5 tttt -124.06 137.47 54.57 Favored 'General case' 0 C--N 1.379 1.851 0 O-C-N 125.041 1.463 . . . . 0.0 112.64 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -108.66 147.76 31.42 Favored 'General case' 0 C--O 1.252 1.195 0 C-N-CA 125.388 1.475 . . . . 0.0 109.001 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -59.53 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 158.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' A' ' 94' ' ' TYR . . . -59.5 154.41 30.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 124.4 1.063 . . . . 0.0 115.44 -145.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.74 -34.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.842 1.257 . . . . 0.0 110.221 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.5 mt -126.23 23.62 7.0 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.032 0.933 . . . . 0.0 111.301 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.24 -97.77 0.17 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 122.199 -0.313 . . . . 0.0 112.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 61.5 m-85 -145.06 116.21 7.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.206 1.402 . . . . 0.0 108.186 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -129.26 101.31 5.94 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -167.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.62 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 4.0 pm0 -94.24 104.19 16.2 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.579 HD13 ' HD2' ' B' ' 253' ' ' LYS . 1.4 pp -137.77 -37.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -154.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -121.56 -159.5 10.7 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.312 -1.423 . . . . 0.0 114.265 -163.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -133.36 125.29 28.83 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 174.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.13 110.82 2.36 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 108' ' ' HIS . 17.7 m -105.58 102.82 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 81' ' ' ASP . 80.2 t80 -94.06 119.95 33.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -140.06 124.53 18.01 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.891 0.876 . . . . 0.0 108.703 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 50.13 55.58 9.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.407 1.483 . . . . 0.0 112.366 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.2 15.64 79.98 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.054 -0.975 . . . . 0.0 114.219 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 m -135.62 115.39 12.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.402 0.601 . . . . 0.0 111.332 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -85.26 112.21 20.55 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.686 ' HB2' HG23 ' A' ' 101' ' ' VAL . 58.4 m80 -98.91 110.38 23.0 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.867 1.354 . . . . 0.0 110.207 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.61 HG23 ' HB ' ' A' ' 138' ' ' ILE . 15.3 t -139.97 -159.35 0.95 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.86 0.464 . . . . 0.0 110.489 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.739 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 23.2 ttm -156.55 160.73 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -157.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -80.73 -35.34 33.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 3.2 p-80 -75.6 -23.6 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 196' ' ' SER . 5.8 m -81.06 -10.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.609 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.4 m 165.58 144.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 127.113 2.165 . . . . 0.0 107.914 160.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -83.04 34.81 0.46 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.726 1.21 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.21 54.68 1.25 Allowed Glycine 0 C--N 1.347 1.173 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 3' ' ' ALA . . . -106.15 -174.48 2.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.208 0.603 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -116.14 134.68 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.43 0.634 . . . . 0.0 112.66 -163.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 mm? -90.97 179.28 5.79 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.392 1.477 . . . . 0.0 111.637 -167.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.3 ptp -175.69 163.23 2.84 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 123.088 1.423 . . . . 0.0 114.632 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.649 ' HB2' HG22 ' A' ' 68' ' ' VAL . 70.3 t60 -109.75 105.39 14.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 111.535 -2.575 . . . . 0.0 105.485 155.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.487 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 53.9 pttt -41.14 116.14 0.69 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 125.408 1.483 . . . . 0.0 113.211 -156.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.72 -7.51 55.61 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.048 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -138.58 113.1 8.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.319 1.448 . . . . 0.0 107.196 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -106.63 128.66 54.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.381 0.537 . . . . 0.0 111.636 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.51 129.85 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.007 1.323 . . . . 0.0 109.803 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' HA ' HG23 ' A' ' 118' ' ' VAL . 32.0 mt-10 -91.46 151.7 42.9 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.144 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.93 -178.56 3.59 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.084 2.523 . . . . 0.0 112.586 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 19.4 p -126.36 -21.53 4.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.879 0.472 . . . . 0.0 112.195 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.444 ' O ' HG23 ' A' ' 138' ' ' ILE . 21.8 t-105 -140.2 146.53 38.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.438 0.695 . . . . 0.0 110.065 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.51 120.83 3.64 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.37 1.044 . . . . 0.0 109.215 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.68 128.64 39.42 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.3 0.571 . . . . 0.0 110.039 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.96 -36.15 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.083 -166.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.35 -35.41 71.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.495 0.718 . . . . 0.0 112.376 -167.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.18 -7.39 56.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.974 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 110' ' ' MET . 22.2 t70 65.75 47.35 2.13 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.227 0.955 . . . . 0.0 109.022 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 53.5 mt -144.66 139.96 28.35 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 109' ' ' THR . 60.8 mt -132.61 142.78 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 125.506 1.522 . . . . 0.0 108.558 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.443 ' HB3' ' CE3' ' A' ' 144' ' ' TRP . 74.6 p -139.1 159.54 41.9 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 118.813 0.733 . . . . 0.0 112.259 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 20.7 t80 -129.91 146.78 51.63 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.815 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.69 4.43 54.63 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.37 -162.53 28.44 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.7 173.05 31.13 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 168.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.515 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 66.6 t-105 -63.8 129.26 39.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.7 0.75 . . . . 0.0 109.408 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -164.74 176.51 8.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.923 0.489 . . . . 0.0 111.709 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.46 HD12 ' HE1' ' A' ' 108' ' ' HIS . 3.3 tm? 67.72 97.6 0.06 Allowed 'General case' 0 C--N 1.358 0.97 0 O-C-N 125.013 1.446 . . . . 0.0 111.74 169.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.691 ' HG3' ' HA2' ' A' ' 209' ' ' GLY . 7.1 mm-40 160.1 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.105 2.562 . . . . 0.0 107.336 154.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.16 85.16 0.49 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -75.84 163.77 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -156.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.41 ' HB2' HG22 ' A' ' 208' ' ' VAL . 49.8 t90 -55.81 142.0 36.58 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 111.611 -2.54 . . . . 0.0 112.035 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -131.75 153.8 49.7 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.24 104.51 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.381 1.072 . . . . 0.0 113.374 -166.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.84 -43.56 0.64 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.485 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -78.38 167.92 20.6 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.524 0.73 . . . . 0.0 112.757 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.14 174.33 7.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.803 0.841 . . . . 0.0 110.576 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 155.87 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 0.0 109.471 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 40.3 mt-30 -126.81 128.72 47.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 200' ' ' ILE . 91.0 t -93.02 110.07 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.472 0.709 . . . . 0.0 109.718 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 199' ' ' PRO . 1.3 tm? -77.21 76.13 3.76 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.21 124.53 31.29 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.444 -171.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.02 120.59 15.12 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 123.662 0.601 . . . . 0.0 109.823 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.94 107.8 30.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.64 115.47 2.48 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.923 2.415 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.57 -16.83 60.45 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.596 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -124.2 -171.69 2.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.454 0.702 . . . . 0.0 110.252 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -78.86 139.25 57.6 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.345 0.658 . . . . 0.0 109.893 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.73 129.14 28.85 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.814 3.01 . . . . 0.0 113.463 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -97.0 125.54 41.51 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 109.496 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -85.37 104.07 14.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.128 0.571 . . . . 0.0 109.863 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 68.5 t -87.96 109.68 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.541 1.136 . . . . 0.0 110.387 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.492 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 7.9 tt0 -80.1 125.88 30.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 109.952 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 t -151.35 151.24 31.48 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 110.676 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.88 156.45 42.52 Favored Pre-proline 0 C--O 1.244 0.778 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.443 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 172.26 13.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.9 2.4 . . . . 0.0 112.941 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.03 -174.46 28.76 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.981 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 144.76 26.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.1 0.45 . . . . 0.0 110.519 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 183' ' ' THR . 5.9 m-85 -97.4 119.39 35.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 183' ' ' THR . 62.7 tttp -99.12 98.74 9.71 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 109.424 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.523 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.0 m -95.51 -178.37 4.39 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.523 ' H ' HG22 ' A' ' 179' ' ' THR . 3.0 p-10 -61.34 -25.31 67.06 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.8 -38.13 0.36 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.429 0.691 . . . . 0.0 110.719 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.45 118.7 5.28 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.587 -0.279 . . . . 0.0 112.506 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 178' ' ' LYS . 22.6 p -119.01 111.96 18.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.47 135.34 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.78 111.27 4.11 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 225' ' ' ALA . . . -143.77 -161.02 1.19 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.4 0.68 . . . . 0.0 110.424 -167.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.51 108.89 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.475 0.655 . . . . 0.0 109.454 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.625 ' HA ' HG13 ' A' ' 223' ' ' VAL . 10.0 t -80.71 112.48 18.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.837 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 191' ' ' PHE . 1.4 tt -130.22 132.34 45.95 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.899 0.38 . . . . 0.0 110.566 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 24' ' ' GLY . 10.4 m-20 -96.55 104.92 16.94 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.615 ' HB2' HD22 ' A' ' 189' ' ' LEU . 31.7 t80 -153.5 163.45 39.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.5 p -58.04 151.31 46.06 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.429 167.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 222' ' ' TYR . 84.0 Cg_exo -46.92 95.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.84 2.36 . . . . 0.0 113.691 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.61 179.25 12.92 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.556 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.461 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 71.0 p -115.19 145.93 41.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.354 0.597 . . . . 0.0 112.46 -169.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.748 ' HB3' HG12 ' A' ' 113' ' ' VAL . 62.8 m -67.91 99.1 0.8 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.296 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 132.86 3.83 3.53 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.054 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 71.4 m -55.1 122.64 43.62 Favored Pre-proline 0 C--N 1.368 1.397 0 C-N-CA 123.3 0.64 . . . . 0.0 111.3 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 210' ' ' LEU . 83.8 Cg_endo -78.43 144.66 20.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.979 2.453 . . . . 0.0 113.403 -174.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.693 HG13 ' HB ' ' A' ' 208' ' ' VAL . 8.2 pt -111.3 110.37 31.94 Favored 'Isoleucine or valine' 0 C--O 1.268 2.047 0 CA-C-O 123.105 1.431 . . . . 0.0 109.347 171.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 159' ' ' LEU . 13.7 pt -130.94 161.34 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 112.339 -2.209 . . . . 0.0 109.663 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 207' ' ' VAL . 23.6 t70 -90.82 -178.69 5.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.532 0.733 . . . . 0.0 109.585 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -58.87 -18.88 36.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LYS . . . . . 0.455 ' HE3' ' HD2' ' A' ' 206' ' ' LYS . 62.4 tttp -71.01 -13.44 62.0 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.579 1.151 . . . . 0.0 111.365 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 16' ' ' TRP . . . 86.25 9.41 76.45 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 123.359 0.504 . . . . 0.0 112.92 -176.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.455 ' HD2' ' HE3' ' A' ' 204' ' ' LYS . 18.1 ptpt -157.81 151.89 24.35 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.255 1.022 . . . . 0.0 109.51 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.643 HG13 HG23 ' A' ' 208' ' ' VAL 0.25 7.9 p -178.11 -71.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 O-C-N 124.613 1.196 . . . . 0.0 108.489 161.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.693 ' HB ' HG13 ' A' ' 200' ' ' ILE . 2.1 t -90.6 -44.69 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 120.494 1.497 . . . . 0.0 111.253 -162.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.691 ' HA2' ' HG3' ' A' ' 147' ' ' GLU . . . 127.47 -98.17 0.49 Allowed Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 113.514 -1.676 . . . . 0.0 110.824 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 199' ' ' PRO . 2.0 pt? -146.27 172.52 13.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.281 0.562 . . . . 0.0 110.669 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' TYR . . . . . 0.737 ' HB2' ' HB3' ' A' ' 224' ' ' SER . 0.0 OUTLIER -74.88 142.28 44.09 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.739 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -82.35 -145.16 5.29 Favored Glycine 0 C--N 1.343 0.972 0 C-N-CA 123.03 0.347 . . . . 0.0 112.251 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -78.54 86.44 4.55 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.462 0.649 . . . . 0.0 109.751 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.79 -174.72 19.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.866 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 40' ' ' SER . 10.5 p -168.63 168.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.874 0.469 . . . . 0.0 110.116 -168.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.435 HG13 ' HD1' ' A' ' 222' ' ' TYR . 6.6 m -69.66 115.25 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 165.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.687 ' HA ' HD13 ' A' ' 41' ' ' ILE . 5.2 t -79.27 168.99 18.79 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.553 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -51.73 137.42 25.56 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 124.389 1.056 . . . . 0.0 110.52 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.9 m 86.07 -4.36 0.78 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.712 2.005 . . . . 0.0 111.139 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.39 29.53 36.33 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.103 0.382 . . . . 0.0 113.233 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -95.85 115.28 27.19 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 193' ' ' PRO . 23.0 t80 -74.22 101.08 3.88 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.678 0.752 . . . . 0.0 109.925 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 188' ' ' SER . 91.9 t -94.97 152.52 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.492 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 211' ' ' TYR . 69.9 m -130.1 135.03 47.78 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.521 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . . . -73.29 163.89 27.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 208' ' ' VAL . 43.5 mt -98.18 106.04 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.806 0.443 . . . . 0.0 110.536 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -99.36 108.49 21.01 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 121.794 0.807 . . . . 0.0 108.903 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 11.0 pt20 -95.25 167.39 11.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.945 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.515 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 3.9 p -117.3 126.86 53.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.01 1.98 17.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.416 1.086 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 124.374 1.07 . . . . 0.0 111.181 -167.906 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.652 ' NZ ' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.34 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 . . . . . 0 CA--C 1.561 1.381 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 155.664 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.583 0.23 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 118' ' ' VAL . . . -147.23 42.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -172.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.644 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.9 m-20 -145.75 28.11 1.17 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.351 1.06 . . . . 0.0 111.474 -171.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 5' ' ' ASP . 1.6 mp -114.92 99.8 7.74 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.925 0.784 . . . . 0.0 111.289 -167.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' MET . 36.1 mp0 -106.95 142.92 35.8 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.207 0.527 . . . . 0.0 112.056 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -116.04 166.56 11.86 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.954 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 33.3 tt0 -155.13 137.51 14.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.298 1.439 . . . . 0.0 108.892 -171.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HD1' ' A' ' 84' ' ' TYR . 35.7 ttt-85 -72.58 125.61 27.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.544 0.611 . . . . 0.0 110.711 -172.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -86.72 -56.42 3.41 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.26 -161.68 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.912 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -96.09 156.76 16.2 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.828 1.251 . . . . 0.0 107.682 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -85.69 97.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -172.61 132.92 0.59 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.572 0.749 . . . . 0.0 109.783 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.603 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 78.8 t90 -87.58 93.7 9.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.9 0.48 . . . . 0.0 110.964 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.98 58.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.035 0.534 . . . . 0.0 110.302 161.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 9.2 t70 -89.98 -55.86 3.45 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.652 0.381 . . . . 0.0 111.403 172.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -147.02 21.14 1.25 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.63 -168.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.24 72.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 127.137 2.175 . . . . 0.0 114.84 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.69 145.25 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.113 0.965 . . . . 0.0 110.332 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.82 143.34 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 124.08 0.952 . . . . 0.0 109.159 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -152.0 -165.56 2.26 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.251 1.02 . . . . 0.0 110.805 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.54 121.64 2.3 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -75.99 -80.22 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.983 0.513 . . . . 0.0 111.582 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.6 t -140.59 145.03 38.72 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.286 0.635 . . . . 0.0 109.887 -166.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.59 -39.57 11.87 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.731 2.287 . . . . 0.0 112.158 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.47 124.44 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.231 0.612 . . . . 0.0 109.703 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 218' ' ' ARG . 3.8 tt -143.68 119.59 10.62 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.3 p -78.03 127.96 33.12 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.19 0.996 . . . . 0.0 112.085 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 223' ' ' VAL . 54.7 mt -112.7 167.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.431 1.492 . . . . 0.0 107.277 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -99.18 126.27 44.93 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.954 1.252 . . . . 0.0 110.24 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -70.26 129.75 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.0 t -136.18 135.51 39.21 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.44 7.07 6.08 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.677 1.191 . . . . 0.0 111.782 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 57.35 27.21 13.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.834 1.254 . . . . 0.0 112.775 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.45 -29.83 0.03 OUTLIER Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.875 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -106.79 165.87 11.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.269 0.627 . . . . 0.0 110.12 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.2 ptm -140.54 130.75 24.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.402 0.681 . . . . 0.0 109.267 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 p -164.78 178.29 7.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 217' ' ' THR . 10.5 tp -86.55 152.35 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.6 126.51 27.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.5 t30 70.9 99.59 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.269 1.428 . . . . 0.0 110.476 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.71 131.37 53.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.546 0.738 . . . . 0.0 109.231 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 123.556 0.742 . . . . 0.0 110.126 178.314 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 2.3 t . . . . . 0 CA--C 1.565 1.54 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 42.1 mt -147.55 163.91 35.09 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 123.725 0.81 . . . . 0.0 111.9 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 122' ' ' LYS . 2.7 m0 -132.08 94.0 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER 171.71 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 126.565 1.946 . . . . 0.0 109.645 158.714 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 121' ' ' HIS . 29.4 m . . . . . 0 N--CA 1.501 2.078 0 CA-C-N 119.339 0.972 . . . . 0.0 111.955 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.393 0 CA-C-O 122.311 1.053 . . . . 0.0 111.656 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.39 -153.59 24.65 Favored Glycine 0 C--O 1.254 1.381 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.281 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.99 44.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.429 1.092 . . . . 0.0 108.894 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 8.7 m-85 -122.18 138.92 54.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.352 0.261 . . . . 0.0 110.69 -171.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.682 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 43.5 mtm180 -73.34 122.67 22.4 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 165.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.774 HG13 HG23 ' A' ' 97' ' ' ILE . 24.5 pt -120.69 146.95 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.639 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 51.6 tttm -152.32 141.51 21.39 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 126.388 1.875 . . . . 0.0 110.984 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 44.8 tt0 -123.09 150.91 42.56 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.918 -0.489 . . . . 0.0 111.713 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 16.6 ttpp -101.96 84.53 2.54 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.81 176.17 44.34 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.235 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' B' ' 253' ' ' LYS . 49.0 mt 59.17 -83.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.342 1.457 . . . . 0.0 111.604 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -113.13 -30.83 6.84 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.545 0.738 . . . . 0.0 110.205 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.87 -173.82 38.29 Favored Glycine 0 C--N 1.349 1.254 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.673 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 1.8 m-30 -105.98 72.12 0.93 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HE3' ' B' ' 253' ' ' LYS . 37.1 t -135.39 155.61 50.29 Favored 'General case' 0 C--O 1.265 1.875 0 CA-C-O 121.92 0.866 . . . . 0.0 112.737 -163.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' NE2' ' HD2' ' A' ' 87' ' ' LYS . 22.8 mp0 -75.3 149.63 38.71 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.062 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 HG13 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -136.73 -43.15 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -167.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.727 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . 169.32 -124.17 1.14 Allowed Glycine 0 N--CA 1.481 1.672 0 C-N-CA 116.604 -2.712 . . . . 0.0 118.019 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -128.58 126.47 40.36 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -165.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.16 149.97 18.83 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 164.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.86 116.41 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.064 0.932 . . . . 0.0 109.93 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.561 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 50.8 t80 -133.09 138.35 46.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -161.65 151.23 16.47 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 124.008 0.818 . . . . 0.0 109.135 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 65.08 -77.66 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.462 1.505 . . . . 0.0 110.652 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.57 19.88 0.15 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t -123.48 116.73 23.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.507 0.723 . . . . 0.0 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 102' ' ' TYR . 59.9 t80 -97.53 102.91 14.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 137' ' ' LEU . 2.3 t60 -121.24 126.21 49.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -135.47 -174.26 3.58 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 108.507 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.464 ' HA ' HD23 ' A' ' 137' ' ' LEU . 82.4 mmm -79.8 160.01 26.31 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.027 0.531 . . . . 0.0 111.535 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -84.08 -46.08 12.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.019 170.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -59.29 -19.15 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.95 0.9 . . . . 0.0 113.351 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 196' ' ' SER . 24.9 m -65.02 -14.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.439 0.696 . . . . 0.0 112.107 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -151.28 -162.14 1.48 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.604 1.162 . . . . 0.0 109.365 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 -133.47 21.03 3.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 114' ' ' THR . . . 103.4 54.63 0.83 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.87 -176.71 3.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.771 0.828 . . . . 0.0 111.429 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.592 HG21 ' HE ' ' A' ' 125' ' ' ARG . 3.0 p -90.75 178.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 118' ' ' VAL . 20.9 mt -124.52 166.01 16.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.528 . . . . 0.0 111.183 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -164.82 174.84 10.2 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.414 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' HG13 ' A' ' 68' ' ' VAL . 15.8 t60 -137.54 97.53 3.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.514 1.926 . . . . 0.0 106.795 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 7' ' ' GLU . 9.0 mtmp? 8.91 75.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.282 1.833 . . . . 0.0 114.064 -159.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.32 -27.49 19.72 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 115.108 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -82.91 112.43 19.69 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.565 1.183 . . . . 0.0 109.939 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.592 ' HE ' HG21 ' A' ' 118' ' ' VAL . 75.0 ttt180 -106.4 134.44 49.53 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.514 0.725 . . . . 0.0 112.029 -164.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.62 142.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.142 1.377 . . . . 0.0 109.138 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.71 144.1 27.54 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 122.95 0.5 . . . . 0.0 112.067 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 140' ' ' TYR . 22.6 Cg_exo -68.61 138.27 41.26 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.662 2.241 . . . . 0.0 111.562 165.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 34.5 p -88.85 -7.43 56.16 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 5.1 t-105 -151.24 148.14 27.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.353 0.661 . . . . 0.0 110.151 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -146.63 124.21 11.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.923 0.889 . . . . 0.0 109.438 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.22 117.79 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.623 0.769 . . . . 0.0 110.727 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -27.73 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.78 0.832 . . . . 0.0 111.492 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -62.69 -56.66 15.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.61 0.764 . . . . 0.0 111.128 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -97.34 1.09 49.03 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.513 0.725 . . . . 0.0 109.895 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 61.41 54.34 3.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.627 1.571 . . . . 0.0 111.686 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.561 HD11 ' HB1' ' A' ' 227' ' ' ALA . 36.6 mt -144.31 145.8 32.21 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.393 0.616 . . . . 0.0 112.456 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 131' ' ' ALA . 30.8 mt -120.84 143.8 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.841 1.657 . . . . 0.0 110.253 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 2.2 m -120.32 158.19 27.62 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.228 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 3.4 t80 -151.41 135.66 16.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.846 1.258 . . . . 0.0 107.881 172.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.26 9.53 56.8 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.26 -172.6 27.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.13 -179.84 49.29 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -75.37 123.19 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.503 0.721 . . . . 0.0 110.342 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -164.01 147.22 9.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.238 1.415 . . . . 0.0 107.568 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.52 -142.06 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 O-C-N 124.314 1.009 . . . . 0.0 108.716 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 64.55 37.21 8.09 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.743 1.617 . . . . 0.0 111.353 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.84 168.08 0.96 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.786 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 150' ' ' TRP . 25.3 tt0 -143.86 129.97 19.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.236 0.614 . . . . 0.0 109.888 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.522 ' HH2' HG21 ' A' ' 226' ' ' ILE . 1.5 p90 -65.28 150.61 47.94 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.677 0.791 . . . . 0.0 110.166 164.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.69 148.82 26.2 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.765 1.226 . . . . 0.0 111.705 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 155.66 -18.7 0.5 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.494 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HB2' ' HD1' ' A' ' 150' ' ' TRP . 32.9 mt-10 -96.6 152.67 18.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.879 0.872 . . . . 0.0 109.311 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.75 114.03 25.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.2 p -97.01 164.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 120.754 0.312 . . . . 0.0 111.143 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 171' ' ' GLN . 22.3 mp0 -105.91 147.68 28.48 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.931 0.892 . . . . 0.0 109.169 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.04 143.07 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.901 0.48 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.41 93.72 8.74 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.33 100.62 10.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.89 97.79 1.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -57.66 133.04 82.51 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.239 0.616 . . . . 0.0 111.645 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.83 113.15 1.51 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.506 2.137 . . . . 0.0 112.49 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.43 64.69 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.056 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 166' ' ' ASN . 81.4 tttt -151.84 177.27 10.59 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 117.351 0.575 . . . . 0.0 110.045 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.415 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 1.8 p-10 -57.72 160.51 7.78 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 112.343 170.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.89 141.1 88.6 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.97 2.447 . . . . 0.0 112.378 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -112.37 116.03 29.68 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -96.37 108.14 20.62 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.182 0.593 . . . . 0.0 109.561 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.68 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.536 0.734 . . . . 0.0 110.082 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' GLN . 30.5 tt0 -87.8 149.85 23.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.864 0.866 . . . . 0.0 109.173 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.5 t -154.66 147.97 24.98 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.765 0.826 . . . . 0.0 110.744 -172.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -75.61 158.39 83.18 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.08 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.17 146.1 93.95 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.203 1.935 . . . . 0.0 112.821 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -145.7 130.87 3.93 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-O 122.114 0.841 . . . . 0.0 114.515 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.442 ' HA ' ' HA3' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -127.24 149.71 49.88 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.345 -1.091 . . . . 0.0 112.564 -171.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.11 123.25 35.32 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.682 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -89.13 106.21 18.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 182' ' ' GLY . 23.5 m -82.81 158.01 22.94 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.655 0.782 . . . . 0.0 110.756 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -82.85 57.32 3.79 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.053 0.93 . . . . 0.0 108.535 168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -175.43 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.009 1.724 . . . . 0.0 108.003 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 179' ' ' THR . . . -153.31 -131.0 1.55 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.718 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 t -162.1 131.72 4.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.583 0.753 . . . . 0.0 109.751 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.45 138.1 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.44 0.696 . . . . 0.0 109.44 175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 138.42 161.96 9.01 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.886 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -176.35 42.29 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.316 0 O-C-N 124.655 0.856 . . . . 0.0 110.382 170.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.455 ' N ' ' H ' ' A' ' 175' ' ' GLY . 9.5 p -166.46 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 120.232 -1.543 . . . . 0.0 109.73 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.7 m -129.76 106.19 8.53 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.542 0.737 . . . . 0.0 109.54 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . 0.542 HD13 ' HD2' ' A' ' 191' ' ' PHE . 3.8 pp -131.88 159.15 39.45 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.924 0.49 . . . . 0.0 111.436 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.8 103.2 15.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.459 0.704 . . . . 0.0 110.333 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.542 ' HD2' HD13 ' A' ' 189' ' ' LEU . 17.7 m-85 -157.72 -175.74 5.54 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 108.455 172.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -44.07 139.91 2.94 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.549 1.14 . . . . 0.0 110.769 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.22 116.48 2.27 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.484 2.122 . . . . 0.0 111.204 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.74 111.87 1.63 Allowed Glycine 0 C--N 1.349 1.29 0 O-C-N 124.153 0.908 . . . . 0.0 112.194 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' THR . . . . . 0.727 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 25.2 p -50.66 124.26 10.56 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.004 1.322 . . . . 0.0 111.129 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . 0.592 ' HB3' HG12 ' A' ' 113' ' ' VAL . 36.1 m -55.65 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.563 0 O-C-N 123.901 0.751 . . . . 0.0 110.071 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 110' ' ' MET . . . 127.87 4.96 5.48 Favored Glycine 0 C--N 1.366 2.226 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.4 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 67.1 m -49.67 129.67 19.89 Favored Pre-proline 0 N--CA 1.5 2.041 0 C-N-CA 124.462 1.105 . . . . 0.0 113.456 -171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.39 133.84 6.46 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 113.223 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.426 HG21 ' CZ3' ' A' ' 150' ' ' TRP . 50.3 mt -105.81 110.97 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.801 1.241 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 208' ' ' VAL . 12.8 pt -131.8 -175.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.803 1.241 . . . . 0.0 112.432 -168.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 36.3 t70 -114.98 175.98 5.26 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.139 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LYS . . . . . 0.603 ' HB3' ' HE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -60.54 -30.45 69.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.967 0.507 . . . . 0.0 112.053 172.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -84.98 -0.77 55.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.731 0.413 . . . . 0.0 111.963 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.56 23.85 77.52 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.921 -0.471 . . . . 0.0 111.921 -168.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 64.5 tttp -76.31 165.1 25.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.729 1.211 . . . . 0.0 109.605 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 209' ' ' GLY . 94.4 t 81.99 -89.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.959 1.304 . . . . 0.0 108.048 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 201' ' ' ILE 0.28 3.1 m 68.21 31.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 125.08 1.352 . . . . 0.0 110.187 175.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 207' ' ' VAL . . . -72.43 -174.22 23.83 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.87 168.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.3 154.53 50.06 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.349 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.0 OUTLIER -68.37 116.16 8.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.644 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 225' ' ' ALA . . . -71.61 -162.68 5.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.688 -0.292 . . . . 0.0 113.733 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -71.63 84.12 0.87 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.852 0.834 . . . . 0.0 109.523 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -127.15 -174.62 13.84 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.219 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.12 176.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.323 0.649 . . . . 0.0 109.277 -168.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.7 115.15 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.784 HG23 HD13 ' A' ' 41' ' ' ILE . 14.8 m -129.6 158.77 38.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.68 1.192 . . . . 0.0 109.783 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.77 ' HB2' HD21 ' A' ' 29' ' ' LEU . 4.1 tmm_? 63.65 76.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.647 1.179 . . . . 0.0 110.581 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 59.2 p 49.12 23.07 0.7 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.865 1.666 . . . . 0.0 114.577 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.05 0.67 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 113.794 0.278 . . . . 0.0 113.794 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.83 152.11 50.52 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.782 0.833 . . . . 0.0 109.065 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -83.36 118.84 23.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.676 0.39 . . . . 0.0 110.428 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.41 HG12 HD11 ' A' ' 31' ' ' ILE . 14.6 t -134.39 116.65 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.168 0.587 . . . . 0.0 109.577 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 45.7 t -130.88 156.76 44.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.832 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -101.8 93.26 5.22 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.171 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.522 HG21 ' HH2' ' A' ' 150' ' ' TRP . 22.9 pt -53.05 141.55 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -161.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -91.35 138.34 31.66 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.68 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.91 171.56 13.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.6 t -67.46 149.07 50.7 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.066 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -13.64 6.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.136 155.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--N 1.38 1.914 0 C-N-CA 126.03 1.732 . . . . 0.0 112.821 -176.552 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 95' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -164.543 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.12 26.62 12.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.778 1.231 . . . . 0.0 110.876 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 89' ' ' LYS . 8.5 m-20 -155.19 40.04 0.42 Allowed 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.405 1.482 . . . . 0.0 107.166 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 119' ' ' LEU . 90.2 mt -79.91 92.86 5.58 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.542 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' MET . 21.1 mt-10 -98.61 126.84 44.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.448 1.099 . . . . 0.0 110.177 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.495 HD23 ' CD2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -117.42 162.75 17.44 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.934 -1.104 . . . . 0.0 113.67 -177.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 9.3 pt-20 -148.35 161.36 41.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.443 1.097 . . . . 0.0 110.269 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.719 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 12.7 tpt180 -66.98 153.28 44.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.647 0.779 . . . . 0.0 111.43 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -125.7 -52.39 1.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.906 0.883 . . . . 0.0 109.915 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.26 -166.66 0.55 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 108.88 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 36.7 t70 -95.82 153.09 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 101' ' ' VAL . 5.1 t -73.28 99.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -162.44 149.12 13.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -168.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.62 112.05 5.16 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 166.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 0.6 OUTLIER -75.15 144.2 42.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.037 0.535 . . . . 0.0 109.827 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.28 -19.43 64.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 48.99 1.67 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.833 0.825 . . . . 0.0 109.605 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.719 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -162.03 83.57 0.58 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 165.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.58 ' HB ' ' H ' ' A' ' 171' ' ' GLN . 29.4 mm -149.69 163.28 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 p -162.79 101.63 1.02 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.297 1.439 . . . . 0.0 108.077 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.34 -107.14 1.47 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.038 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 11.6 t 63.64 41.71 6.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.958 0.903 . . . . 0.0 109.927 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.6 m -64.65 146.0 98.5 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.16 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -54.12 178.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.917 3.078 . . . . 0.0 114.992 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.69 108.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -93.0 158.37 15.83 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.757 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 118.27 36.14 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.62 -0.675 . . . . 0.0 110.574 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 223' ' ' VAL . 40.9 mt -126.21 150.94 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.895 0.878 . . . . 0.0 108.997 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.9 p -98.42 113.11 24.97 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -65.22 159.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.156 0.583 . . . . 0.0 110.346 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -135.59 120.14 18.17 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 123.525 0.73 . . . . 0.0 109.422 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 67.8 -74.56 0.07 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 125.221 1.576 . . . . 0.0 110.876 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -158.64 -57.9 0.07 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.69 0.796 . . . . 0.0 109.309 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.78 -11.3 33.02 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.232 -0.894 . . . . 0.0 114.238 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -92.24 159.9 15.41 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.482 1.141 . . . . 0.0 108.981 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.6 mtp -132.97 143.01 49.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.676 0.39 . . . . 0.0 110.454 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -143.37 153.7 42.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.433 0.693 . . . . 0.0 110.521 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.72 HG13 ' H ' ' A' ' 43' ' ' ASN . 7.3 tp -95.99 145.31 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -77.19 1.31 18.76 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-O 121.694 0.759 . . . . 0.0 111.323 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.72 ' H ' HG13 ' A' ' 41' ' ' ILE . 21.0 m120 -100.89 179.8 4.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.318 1.047 . . . . 0.0 109.5 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.3 143.28 33.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.736 0.814 . . . . 0.0 109.458 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 123.266 0.626 . . . . 0.0 109.569 179.026 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.519 ' O ' ' HD2' ' A' ' 122' ' ' LYS . 30.3 m . . . . . 0 CA--C 1.556 1.197 0 CA-C-O 121.706 0.765 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 96' ' ' GLN . 6.0 mt 85.48 87.53 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.874 1.67 . . . . 0.0 111.825 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HE1' ' HG2' ' A' ' 122' ' ' LYS . 6.4 m0 -102.06 105.39 16.12 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.719 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 28.6 t70 177.63 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.225 1.578 . . . . 0.0 109.233 155.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 8' ' ' LEU . 67.3 t . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 123.488 0.715 . . . . 0.0 110.374 -172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 147.28 -154.12 25.76 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.55 137.55 46.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CD2' HD23 ' A' ' 8' ' ' LEU . 7.7 m-85 -123.39 139.82 53.64 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.944 0.498 . . . . 0.0 111.348 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' A' ' 161' ' ' LEU . 21.9 mtp180 -92.75 126.57 37.9 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 pt -129.93 143.95 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -139.52 138.12 36.05 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.329 1.852 . . . . 0.0 112.151 -172.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' CB ' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.5 153.55 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 170.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 45.1 mtpt -106.97 88.97 2.86 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' B' ' 253' ' ' LYS . . . -168.64 178.11 42.24 Favored Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 mt 59.42 23.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 118.008 0.904 . . . . 0.0 111.409 166.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp 71.45 41.65 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.052 1.341 . . . . 0.0 111.538 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.07 156.09 24.92 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 121.728 -0.272 . . . . 0.0 113.57 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.63 68.94 0.83 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.564 1.146 . . . . 0.0 108.2 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 m -113.26 125.06 53.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -159.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 65' ' ' LEU . 3.4 pm0 -95.82 104.21 16.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.318 1.447 . . . . 0.0 108.893 170.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.8 pp -137.14 -37.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -120.13 -168.96 13.91 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.284 -1.436 . . . . 0.0 116.129 -154.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -125.97 138.49 53.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.879 -172.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -133.37 -176.26 14.32 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.815 HG13 ' HB2' ' A' ' 108' ' ' HIS . 0.2 OUTLIER -152.46 109.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.426 0.69 . . . . 0.0 109.323 -178.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 107' ' ' PHE . 84.2 t80 -107.09 136.21 47.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -147.99 110.83 4.78 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 109.087 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 45.38 68.5 0.56 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.587 1.555 . . . . 0.0 113.101 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 -30.08 6.18 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.555 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 9.8 m -105.41 116.34 31.79 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.555 -172.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 87.8 t80 -93.81 144.25 25.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 172.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.815 ' HB2' HG13 ' A' ' 101' ' ' VAL . 25.2 m80 -132.19 122.68 25.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.866 0.866 . . . . 0.0 109.174 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -141.98 -179.67 6.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.569 0.748 . . . . 0.0 111.462 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 210' ' ' LEU . 79.9 mmm -89.66 173.25 8.4 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.639 1.176 . . . . 0.0 109.856 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -59.45 2.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 122.091 -0.381 . . . . 0.0 111.609 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -53.72 -28.21 32.71 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 125.131 1.372 . . . . 0.0 114.16 -168.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -56.1 -25.63 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 124.531 1.132 . . . . 0.0 113.021 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.648 HG23 ' H ' ' A' ' 116' ' ' GLY . 2.9 t -142.19 -166.63 2.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -111.42 33.51 4.66 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 121.065 0.459 . . . . 0.0 111.443 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 114' ' ' THR . . . 71.73 58.57 5.25 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.965 176.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.69 -172.37 2.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.516 0.726 . . . . 0.0 111.972 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 p -100.14 148.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 124.442 1.097 . . . . 0.0 111.755 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 mm? -91.11 168.99 11.22 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.549 1.14 . . . . 0.0 111.211 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -172.77 163.81 5.14 Favored 'General case' 0 C--O 1.263 1.772 0 CA-C-O 123.869 1.795 . . . . 0.0 114.862 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -106.76 95.21 5.57 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.78 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.604 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 0.9 OUTLIER 48.97 48.09 21.01 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.005 0.922 . . . . 0.0 112.45 164.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.64 -8.48 56.5 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -100.25 110.55 22.8 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.997 0.899 . . . . 0.0 109.068 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 11.5 ttp180 -82.1 151.04 27.19 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -162.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 66.8 mt -142.51 121.68 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.038 1.735 . . . . 0.0 108.151 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -77.4 129.91 76.08 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.14 0.576 . . . . 0.0 111.395 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.62 170.57 19.95 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.781 2.321 . . . . 0.0 111.015 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 p -125.14 -29.69 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.575 0.75 . . . . 0.0 111.861 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TRP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 14.4 t-105 -131.22 143.74 50.8 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.762 0.825 . . . . 0.0 109.721 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.82 122.42 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.498 1.119 . . . . 0.0 108.285 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -140.98 119.81 12.61 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.276 0.631 . . . . 0.0 110.178 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -76.4 -24.39 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.291 1.037 . . . . 0.0 113.056 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -72.99 -42.41 63.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.16 0.505 . . . . 0.0 110.924 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.18 -8.89 34.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.532 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 t70 60.22 57.78 2.83 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.992 1.317 . . . . 0.0 110.644 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 144' ' ' TRP . 98.0 mt -144.87 137.07 26.03 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.412 0.685 . . . . 0.0 110.961 -174.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.2 mt -128.27 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.273 1.429 . . . . 0.0 108.864 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 130' ' ' TRP . 51.3 p -142.93 161.15 38.87 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.874 0.845 . . . . 0.0 112.99 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.663 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.9 t80 -116.52 143.64 45.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.956 1.702 . . . . 0.0 107.847 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.14 -13.45 44.59 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.53 -151.41 22.97 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 173.69 38.93 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.661 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 59.4 t-105 -69.12 108.84 3.75 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 231' ' ' LYS . 22.8 pttp -147.92 137.87 22.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.829 0.452 . . . . 0.0 110.278 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 229' ' ' THR . 15.8 tp -160.81 -90.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.497 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -172.42 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.91 0.777 . . . . 0.0 110.1 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.79 152.34 48.39 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.644 -1.162 . . . . 0.0 115.391 -161.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.13 127.26 17.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.998 0.919 . . . . 0.0 108.893 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.411 ' HZ2' ' HG3' ' A' ' 174' ' ' PRO . 47.7 t-105 -91.8 136.86 32.83 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.065 0.46 . . . . 0.0 111.35 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -134.82 127.48 30.91 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.42 125.93 25.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.965 0.906 . . . . 0.0 112.482 -170.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.36 -69.49 0.06 OUTLIER Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.84 -177.65 6.66 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.718 0.807 . . . . 0.0 109.817 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 8.1 pt-20 -104.14 147.46 27.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 110.859 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.36 171.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.586 0.754 . . . . 0.0 110.746 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.447 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -128.03 147.76 50.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 108.507 176.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 200' ' ' ILE . 29.4 m -122.86 139.59 49.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 109.449 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 90.4 mt -80.54 86.07 5.88 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.69 100.39 5.39 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 167' ' ' PRO . 62.5 mt -68.94 106.03 2.59 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' LYS . 19.4 mm-40 -67.58 133.83 92.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.21 112.43 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.476 2.117 . . . . 0.0 112.169 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.81 20.92 72.81 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.046 -0.979 . . . . 0.0 114.846 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 76.1 mmtt -138.57 -175.0 3.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.831 0.852 . . . . 0.0 109.99 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -81.36 152.16 70.1 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.539 0.736 . . . . 0.0 110.717 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PRO . . . . . 0.785 ' HB3' HD23 ' A' ' 161' ' ' LEU . 30.4 Cg_endo -62.98 137.59 63.18 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.868 2.379 . . . . 0.0 113.585 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -81.08 135.3 35.79 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.168 167.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -81.4 105.2 12.39 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 166.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 22' ' ' ILE . 51.3 t -112.17 116.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.441 0.696 . . . . 0.0 109.305 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . 0.58 ' H ' ' HB ' ' A' ' 22' ' ' ILE . 58.4 tt0 -108.71 137.41 46.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.834 0.349 . . . . 0.0 110.606 -165.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.4 t -153.75 147.02 24.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.82 0.848 . . . . 0.0 110.298 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 97.3 mttt -72.37 162.15 75.37 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.652 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' ALA . 50.0 Cg_exo -55.86 131.83 48.37 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.724 2.282 . . . . 0.0 111.717 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -147.66 150.75 23.03 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.254 0.919 . . . . 0.0 114.897 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.425 ' N ' HD23 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -140.38 167.85 21.19 Favored 'General case' 0 C--O 1.239 0.55 0 O-C-N 121.101 -1.235 . . . . 0.0 111.235 -170.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.22 136.16 33.1 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.191 -1.822 . . . . 0.0 108.946 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -77.63 144.47 37.41 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.3 m -102.85 179.25 4.33 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.776 1.231 . . . . 0.0 108.932 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.43 ' H ' HG22 ' A' ' 179' ' ' THR . 20.2 m120 -68.03 -18.24 64.64 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.877 0.471 . . . . 0.0 111.893 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.38 -68.21 0.87 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.053 0.941 . . . . 0.0 110.016 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.8 -142.2 11.85 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.662 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.8 t -163.25 135.85 5.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.465 1.106 . . . . 0.0 108.842 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 165.89 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.164 0.586 . . . . 0.0 109.801 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 133.82 167.98 11.71 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-O 120.278 -0.179 . . . . 0.0 113.313 174.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -171.03 34.28 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.635 0 O-C-N 124.163 0.567 . . . . 0.0 110.812 173.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.475 ' N ' ' H ' ' A' ' 175' ' ' GLY . 2.2 t -164.87 117.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 126.565 1.946 . . . . 0.0 106.837 163.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.7 t -129.45 121.71 27.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.5 tp -144.42 151.46 39.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.86 0.864 . . . . 0.0 110.084 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.68 105.16 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 62.2 t80 -160.86 162.34 32.15 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.767 0.827 . . . . 0.0 109.121 -172.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.8 p -60.12 158.62 25.7 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.955 0.902 . . . . 0.0 111.422 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.81 107.88 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.683 2.922 . . . . 0.0 113.016 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -72.74 158.53 53.18 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.072 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.6 p -84.12 105.26 14.84 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 122.977 0.511 . . . . 0.0 109.959 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -56.75 110.06 0.73 Allowed 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.574 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 118.89 12.9 6.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.145 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.0 m -57.2 117.32 17.36 Favored Pre-proline 0 C--N 1.366 1.291 0 C-N-CA 122.899 0.48 . . . . 0.0 110.794 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 49.3 Cg_exo -58.7 112.77 1.3 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.933 2.422 . . . . 0.0 112.256 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 158' ' ' VAL . 58.9 mt -80.48 96.56 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.788 0.835 . . . . 0.0 109.304 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 208' ' ' VAL . 30.8 mt -119.57 134.18 63.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.26 -179.86 6.49 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.951 0.796 . . . . 0.0 109.456 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -63.41 -25.72 68.41 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.186 0.594 . . . . 0.0 112.527 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.43 -19.71 55.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.982 0.513 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 95.18 36.28 5.5 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.417 0.448 . . . . 0.0 112.221 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -130.22 166.79 19.57 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.215 1.006 . . . . 0.0 110.133 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 79.9 t 99.51 -60.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.14 2.176 . . . . 0.0 109.518 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 201' ' ' ILE . 33.2 m 49.74 32.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.869 1.267 . . . . 0.0 112.268 170.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.518 ' HA2' HG23 ' A' ' 229' ' ' THR . . . -76.78 -157.16 7.69 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.434 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.631 ' HB3' ' SD ' ' A' ' 110' ' ' MET . 24.4 mt -139.75 124.8 18.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.452 0.644 . . . . 0.0 112.582 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.16 124.35 26.17 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.989 164.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 176.81 66.82 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 158.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 225' ' ' ALA . 14.6 m120 -154.8 171.96 18.75 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 66.4 -118.65 11.22 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 p 179.13 168.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.257 1.476 0 CA-C-O 121.707 0.765 . . . . 0.0 110.217 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.02 113.81 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 160.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 221' ' ' ALA . 6.5 t -119.89 158.33 26.88 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.865 0.866 . . . . 0.0 111.159 -165.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 59.93 16.2 5.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.272 1.029 . . . . 0.0 111.17 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.8 t 53.6 28.54 8.01 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.561 1.544 . . . . 0.0 112.382 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 178.99 30.55 0.05 OUTLIER Glycine 0 C--N 1.358 1.794 0 C-N-CA 120.768 -0.73 . . . . 0.0 114.447 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 217' ' ' THR . . . -135.88 145.47 46.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.253 0.527 . . . . 0.0 109.596 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -105.13 101.67 11.21 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.9 1.28 . . . . 0.0 109.162 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 31' ' ' ILE . 17.9 m -122.67 141.44 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 119.103 0.865 . . . . 0.0 110.512 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.4 m -144.9 129.41 17.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.581 -166.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.791 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -81.52 -16.28 52.28 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.61 0.364 . . . . 0.0 110.648 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 17.5 pt 56.52 140.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 128.276 2.63 . . . . 0.0 116.527 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.48 27.54 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.985 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -125.29 143.01 51.17 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' THR . . . . . 0.661 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 62.2 p -76.03 104.4 6.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.555 0.693 . . . . 0.0 111.046 -169.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.26 107.74 19.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.424 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.343 0 C-N-CA 124.204 1.002 . . . . 0.0 111.485 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 253' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' A' ' 90' ' ' GLY . 2.0 tppp? . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 110.941 -178.422 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.45 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 m -135.09 -163.19 1.35 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.078 0.951 . . . . 0.0 109.489 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.71 37.21 5.87 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.958 0.903 . . . . 0.0 110.772 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.18 -4.68 1.69 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.251 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -174.84 90.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.344 0.592 . . . . 0.0 109.632 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' B' ' 252' ' ' NLE . 4.7 mp -133.69 95.05 3.39 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.149 1.78 . . . . 0.0 108.502 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.628 ' HB3' HG11 ' A' ' 64' ' ' VAL . 3.7 tp10 -97.53 140.67 31.62 Favored 'General case' 0 C--O 1.26 1.622 0 CA-C-O 121.76 0.79 . . . . 0.0 112.639 -170.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' A' ' 86' ' ' ILE . 57.0 mt -86.28 149.16 25.25 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.409 175.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -147.47 111.06 4.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.621 -0.674 . . . . 0.0 109.757 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' HB3' ' A' ' 67' ' ' ASP . 55.7 ttp180 -62.78 137.17 58.2 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.629 1.104 . . . . 0.0 110.363 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.43 -28.8 3.58 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.281 0.632 . . . . 0.0 110.477 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.06 -169.67 2.44 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.077 0.951 . . . . 0.0 109.583 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 18.7 t70 -109.5 151.14 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.545 0.738 . . . . 0.0 109.524 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 101' ' ' VAL . 44.8 t -75.29 98.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.708 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.94 160.22 4.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -172.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.442 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 43.0 t90 -64.05 126.07 26.52 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 172.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 11.0 tp10 -95.62 143.96 26.46 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.523 0.729 . . . . 0.0 109.039 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.03 -3.85 11.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.971 0.908 . . . . 0.0 113.278 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.49 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 14.3 mm100 -82.61 36.06 0.48 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.452 0.701 . . . . 0.0 110.867 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -61.69 112.59 2.32 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 125.125 1.37 . . . . 0.0 111.769 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -124.1 119.41 29.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.013 0.925 . . . . 0.0 110.096 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.86 114.24 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -144.62 -24.37 0.52 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.352 0.661 . . . . 0.0 111.683 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.14 -145.39 0.06 OUTLIER Glycine 0 C--N 1.359 1.858 0 N-CA-C 114.351 0.501 . . . . 0.0 114.351 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m 64.57 18.4 11.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 9.9 m -65.54 120.21 66.31 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.386 0.674 . . . . 0.0 109.61 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 15.3 Cg_exo -65.67 -96.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.384 2.723 . . . . 0.0 114.549 -161.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.436 ' H ' ' HB2' ' A' ' 27' ' ' PRO . 42.2 mm -113.37 119.51 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 223' ' ' VAL . 7.2 mp -110.92 164.07 13.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.245 0.618 . . . . 0.0 110.687 172.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 p -115.23 110.88 20.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.09 143.43 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.307 1.043 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 p -90.99 108.08 19.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.69 0.757 . . . . 0.0 108.971 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG13 HG23 ' A' ' 179' ' ' THR . 27.2 mm -79.18 127.68 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.951 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 19.7 m -100.79 95.51 6.69 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.098 0.559 . . . . 0.0 110.07 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 58.23 27.78 15.65 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.228 1.411 . . . . 0.0 111.84 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 75.95 -42.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.523 1.529 . . . . 0.0 113.586 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.06 -42.48 98.13 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 49.2 m -106.33 161.4 14.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.59 0.356 . . . . 0.0 110.732 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.479 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.3 ppp? -150.41 136.7 18.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.04 0.936 . . . . 0.0 108.948 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 p -163.52 177.27 8.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.968 0.414 . . . . 0.0 111.026 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.526 ' H ' HG21 ' A' ' 215' ' ' VAL . 2.8 tp -102.13 146.6 9.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.92 70.69 6.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.078 0.942 . . . . 0.0 109.729 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.94 114.86 3.49 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.794 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.98 103.93 1.61 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.698 0.624 . . . . 0.0 110.276 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG3' ' NH2' ' B' ' 254' ' ' ARG . 2.2 pt-20 -82.91 164.28 20.56 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.378 1.071 . . . . 0.0 109.961 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -160.81 116.93 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.07 0.948 . . . . 0.0 108.619 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.84 41.03 0.16 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.4 0.68 . . . . 0.0 112.255 -167.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' B' ' 254' ' ' ARG . 20.3 mt-30 -73.53 76.63 1.46 Allowed 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 123.333 0.653 . . . . 0.0 111.78 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 m -155.89 121.16 4.82 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.308 0.643 . . . . 0.0 111.233 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.521 HD13 ' HA3' ' A' ' 98' ' ' GLY . 38.6 mt -160.29 -71.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.192 1.397 . . . . 0.0 110.448 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.707 ' HA2' ' HD3' ' A' ' 85' ' ' ARG . . . -63.65 152.13 48.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.585 177.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.12 -131.11 17.25 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.86 78.25 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.98 0.459 . . . . 0.0 112.771 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.18 160.51 8.75 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.5 t -82.12 78.25 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.651 0.738 . . . . 0.0 109.404 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.84 40.31 2.57 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.932 -175.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 -71.06 2.01 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.85 125.29 22.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.074 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.81 -171.71 37.81 Favored Glycine 0 C--O 1.239 0.443 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -175.0 -50.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.872 0.869 . . . . 0.0 109.593 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.0 t80 59.78 64.83 1.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.27 1.028 . . . . 0.0 109.671 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.88 -60.71 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.481 1.112 . . . . 0.0 108.12 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.79 -87.29 1.94 Allowed Glycine 0 C--N 1.345 1.057 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.39 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 7' ' ' GLU . 3.4 t -127.84 -122.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 117.736 0.768 . . . . 0.0 109.388 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -179.68 142.41 0.17 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.671 1.588 . . . . 0.0 107.385 -166.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.596 ' CD1' ' HE3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -147.32 178.12 8.67 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' HB3' ' N ' ' A' ' 10' ' ' ARG . 59.1 t0 179.73 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 111.267 -2.697 . . . . 0.0 105.318 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 8.2 m -127.14 118.57 21.98 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.471 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 68' ' ' VAL . 22.9 Cg_endo -106.07 29.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.922 3.081 . . . . 0.0 114.661 -171.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 p -62.27 105.41 0.62 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 117.944 0.338 . . . . 0.0 110.223 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -89.98 136.88 2.59 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.018 2.479 . . . . 0.0 112.865 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.57 -44.89 33.48 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.91 2.407 . . . . 0.0 114.185 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.98 101.39 1.46 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 CA-C-N 121.677 1.635 . . . . 0.0 111.736 170.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 58.37 94.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.963 1.305 . . . . 0.0 111.861 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.16 -70.56 0.01 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.264 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 64.68 -75.06 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.32 1.448 . . . . 0.0 112.622 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.43 171.59 13.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.071 0.548 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -101.25 137.1 40.04 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.158 0.583 . . . . 0.0 109.615 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.99 102.38 1.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.613 0.72 . . . . 0.0 109.974 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . 1.3 mp0 -94.02 -23.73 17.9 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.202 1.001 . . . . 0.0 109.011 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 72.39 101.82 0.07 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.255 1.822 . . . . 0.0 111.955 170.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 126.47 -151.41 18.03 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.253 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.88 120.21 32.99 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 124.795 1.238 . . . . 0.0 109.295 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 11.3 m-85 -105.56 144.4 32.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 123.609 0.764 . . . . 0.0 110.473 -171.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.707 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 99.1 mtt180 -82.38 131.82 35.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 153.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.783 ' HB ' ' HE2' ' B' ' 252' ' ' NLE . 7.1 pt -132.58 142.84 41.44 Favored 'Isoleucine or valine' 0 C--O 1.254 1.322 0 O-C-N 121.083 -1.011 . . . . 0.0 109.283 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 tttm -148.98 134.67 18.77 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.59 1.156 . . . . 0.0 110.17 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -110.02 157.93 18.79 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -99.69 92.16 5.2 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 155.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.48 175.16 42.57 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 118.962 -0.91 . . . . 0.0 111.352 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' B' ' 253' ' ' LYS . 78.0 mt 59.07 -80.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 124.921 1.288 . . . . 0.0 112.052 173.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 tp -127.09 29.77 5.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.962 0.905 . . . . 0.0 109.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.02 -143.78 16.33 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.638 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' HB3' ' HZ1' ' A' ' 87' ' ' LYS . 11.9 m-85 -86.84 95.57 9.91 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.919 0.888 . . . . 0.0 109.234 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' B' ' 253' ' ' LYS . 7.8 m -140.42 146.98 39.01 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.854 1.206 . . . . 0.0 111.646 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.592 ' HG3' ' H ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -102.46 130.97 49.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.143 1.777 . . . . 0.0 113.48 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.681 ' HB ' ' HA ' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -90.36 -30.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.626 0.77 . . . . 0.0 110.13 174.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.521 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 100.83 -86.41 0.63 Allowed Glycine 0 C--O 1.2 -2.002 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.633 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -99.44 119.58 38.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.568 2.684 . . . . 0.0 111.127 -149.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.05 122.36 5.3 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.303 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.512 HG13 HG21 ' A' ' 14' ' ' VAL . 60.0 t -108.58 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 110.096 -165.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 24.4 t80 -123.09 117.27 25.03 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -123.53 127.21 48.01 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.67 1.188 . . . . 0.0 108.646 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 65.73 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.955 1.302 . . . . 0.0 111.391 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.86 -0.44 1.27 Allowed Glycine 0 N--CA 1.472 1.038 0 CA-C-O 120.052 -0.304 . . . . 0.0 113.254 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -116.57 126.84 53.86 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.279 0.632 . . . . 0.0 110.87 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.805 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 70.1 t80 -99.64 110.98 23.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.756 ' HE2' HD23 ' A' ' 137' ' ' LEU . 29.2 t60 -130.23 114.57 15.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.693 0.397 . . . . 0.0 110.752 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.61 -171.49 2.79 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.358 1.063 . . . . 0.0 109.645 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 211' ' ' TYR . 25.9 mmt -72.33 159.79 33.45 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.805 0.842 . . . . 0.0 111.936 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.0 t90 -85.52 -44.31 12.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.15 0.58 . . . . 0.0 110.704 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -60.37 -14.51 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 0.0 113.326 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 114' ' ' THR . 23.5 m -59.16 -23.64 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 172.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 116' ' ' GLY . 10.0 t -155.86 -166.19 2.14 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.627 1.171 . . . . 0.0 109.261 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -117.64 17.97 14.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.162 0.585 . . . . 0.0 110.461 168.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 114' ' ' THR . . . 106.45 54.86 0.68 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 124.038 0.827 . . . . 0.0 111.574 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.03 160.01 16.56 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.2 0.524 . . . . 0.0 111.811 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 127' ' ' GLU . 14.5 p -81.03 159.28 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.678 1.191 . . . . 0.0 110.249 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.616 HD22 ' HD2' ' B' ' 252' ' ' NLE . 10.8 mt -113.88 172.17 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.393 0.542 . . . . 0.0 111.67 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.55 ' HB3' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -171.49 178.03 3.3 Favored 'General case' 0 C--O 1.267 2.003 0 CA-C-O 123.706 1.717 . . . . 0.0 114.793 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.538 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 43.9 t60 -114.78 100.39 8.2 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 110.615 -2.993 . . . . 0.0 108.816 164.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.596 ' HE3' ' CD1' ' A' ' 66' ' ' TRP . 8.9 mtmp? 1.98 72.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 127.313 2.245 . . . . 0.0 114.172 -173.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.0 19.55 16.69 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 121' ' ' HIS . 1.2 tmmt? -139.71 112.13 7.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 167.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 41.2 ttp85 -98.69 140.75 32.43 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -162.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.55 130.33 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 126.088 1.755 . . . . 0.0 109.438 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.556 ' HA ' HG23 ' A' ' 118' ' ' VAL . 5.2 mp0 -91.05 138.39 26.02 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.639 -0.663 . . . . 0.0 111.649 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 19.8 Cg_exo -68.84 156.95 63.78 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.032 2.488 . . . . 0.0 112.139 167.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 p -98.85 -17.76 18.26 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.392 0.677 . . . . 0.0 111.829 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 21.6 t-105 -152.02 148.88 28.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.23 0.612 . . . . 0.0 110.87 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -149.25 122.28 8.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.647 1.179 . . . . 0.0 109.263 169.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.54 118.35 20.94 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.027 0.441 . . . . 0.0 111.29 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.86 -28.6 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.978 1.311 . . . . 0.0 111.805 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -65.82 -56.52 11.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.76 0.824 . . . . 0.0 111.951 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -79.86 -23.99 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.499 0.72 . . . . 0.0 109.892 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 79.84 44.15 0.05 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.077 1.751 . . . . 0.0 109.989 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.756 HD23 ' HE2' ' A' ' 108' ' ' HIS . 9.4 mp -131.65 129.43 40.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 111.327 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 131' ' ' ALA . 24.0 mt -114.01 144.09 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.548 1.539 . . . . 0.0 110.749 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 7.2 m -125.87 154.85 42.11 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.629 0.728 . . . . 0.0 111.548 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 10.9 t80 -136.68 138.47 41.1 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.591 1.556 . . . . 0.0 107.698 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 -45.15 1.51 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.68 36.45 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.41 135.71 31.55 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -69.84 142.05 53.15 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 117.262 0.531 . . . . 0.0 110.763 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -151.33 114.24 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 229' ' ' THR . 3.9 mm? -123.64 -91.64 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 167.8 -69.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 207' ' ' VAL . . . -77.12 153.86 42.13 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.817 -166.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.3 121.96 11.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.499 -0.85 . . . . 0.0 108.784 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.499 ' HE3' HD13 ' A' ' 200' ' ' ILE . 16.3 t90 -91.12 148.47 22.35 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -153.37 160.3 42.62 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.411 ' HG3' ' HA3' ' A' ' 185' ' ' GLY . 2.0 pm0 -63.03 93.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.294 1.045 . . . . 0.0 111.047 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.87 -46.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.433 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.6 160.23 14.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.316 1.046 . . . . 0.0 109.218 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 173' ' ' LYS . 13.6 pt-20 -93.71 145.52 24.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.964 0.506 . . . . 0.0 110.12 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.626 HG11 HG23 ' A' ' 200' ' ' ILE . 1.4 p -140.29 -173.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 122.193 -0.317 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 38.4 mt-30 -126.35 148.07 49.63 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.964 -0.46 . . . . 0.0 110.088 166.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.84 125.82 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.1 88.79 6.66 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.17 112.51 25.54 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.235 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 167' ' ' PRO . 59.7 mt -66.99 125.73 26.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 168' ' ' ARG . 45.4 mt-10 -81.22 155.57 72.04 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.145 0.578 . . . . 0.0 111.112 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 113.51 2.79 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.536 2.158 . . . . 0.0 112.563 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.91 53.42 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.302 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 88.3 mttt -129.98 -171.04 2.43 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.483 0.713 . . . . 0.0 111.666 -171.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -76.53 158.1 81.59 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.889 0.875 . . . . 0.0 112.405 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.539 ' HB3' HD23 ' A' ' 161' ' ' LEU . 18.3 Cg_endo -60.07 106.05 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.869 2.379 . . . . 0.0 112.113 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 162' ' ' GLU . 3.3 tpt180 -75.09 97.25 3.39 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.113 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -76.97 104.91 7.72 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.74 128.22 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.425 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 9.1 tt0 -78.99 108.02 12.16 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 p -115.64 104.72 11.98 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.394 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HG2' ' HB2' ' A' ' 155' ' ' GLU . 90.3 mttt -83.33 164.75 44.19 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.142 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.85 140.04 58.54 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.992 2.462 . . . . 0.0 113.934 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -134.88 176.86 19.71 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 173.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -163.68 156.51 18.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.449 0.642 . . . . 0.0 110.455 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.84 151.41 46.98 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.209 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.46 142.42 41.01 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.583 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 181' ' ' ALA . 49.6 m -137.96 162.58 33.7 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.52 1.128 . . . . 0.0 108.704 -167.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.16 -34.27 76.08 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.678 ' H ' HG22 ' A' ' 179' ' ' THR . . . -80.55 6.67 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.43 174.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.14 -78.56 0.27 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.4 t -157.46 142.85 17.17 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.704 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.93 137.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 152' ' ' GLU . . . -100.32 128.95 9.74 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 224' ' ' SER . . . -156.53 -168.26 2.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.504 0.722 . . . . 0.0 110.433 -169.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.479 ' HB ' ' HZ3' ' A' ' 150' ' ' TRP . 7.6 p -93.95 105.81 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.576 ' HA ' HG22 ' A' ' 223' ' ' VAL . 21.0 t -102.88 114.21 28.29 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.461 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 19.6 tp -127.98 127.15 42.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.761 0.824 . . . . 0.0 111.162 -172.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.34 102.92 14.99 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -176.46 169.48 2.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.325 1.05 . . . . 0.0 108.633 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.7 m -60.9 150.44 77.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.913 0.885 . . . . 0.0 110.627 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -45.17 103.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.535 2.823 . . . . 0.0 113.289 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.23 149.35 49.98 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.21 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.442 ' OG1' ' HA3' ' A' ' 98' ' ' GLY . 2.6 t -61.86 138.48 58.35 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.441 0.696 . . . . 0.0 112.426 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 211' ' ' TYR . 37.1 m -72.34 119.92 17.21 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.006 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' H ' ' HE1' ' A' ' 211' ' ' TYR . . . 107.7 -4.75 34.59 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 118.166 -1.352 . . . . 0.0 112.756 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 39.1 m -44.62 117.74 3.13 Favored Pre-proline 0 N--CA 1.498 1.961 0 CA-C-N 117.951 0.876 . . . . 0.0 112.51 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 101' ' ' VAL . 3.0 Cg_exo -76.59 135.86 16.69 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.235 1.957 . . . . 0.0 112.168 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.626 HG23 HG11 ' A' ' 156' ' ' VAL . 30.3 mt -83.59 97.38 4.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 0.0 109.1 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.4 mt -117.76 134.38 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.89 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -80.52 164.33 23.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.353 0.661 . . . . 0.0 109.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -59.19 -31.91 69.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.227 0.611 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.64 13.92 12.94 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.599 0.76 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.72 24.79 75.4 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.223 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 206' ' ' LYS . 33.5 ttpt -89.97 162.03 15.59 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.988 0.915 . . . . 0.0 110.011 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 148' ' ' GLY 0.365 16.4 m 68.25 -62.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.487 2.315 . . . . 0.0 113.385 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 32.9 m 55.47 33.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 C-N-CA 124.493 1.117 . . . . 0.0 111.666 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.52 -145.11 1.73 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.176 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 87.2 mt -138.91 146.43 41.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.265 0.626 . . . . 0.0 109.785 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.599 ' HE1' ' H ' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -73.52 132.53 42.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.275 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.79 -154.15 2.38 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 118.35 0.523 . . . . 0.0 113.968 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -94.35 130.35 40.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.471 -0.429 . . . . 0.0 110.364 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -157.23 -143.67 3.72 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.682 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.0 p -165.15 161.5 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.593 0 CA-C-N 117.276 0.538 . . . . 0.0 110.925 -170.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.47 111.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.734 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 164.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.1 t -105.61 153.55 21.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.449 1.099 . . . . 0.0 108.903 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 62.77 12.53 5.75 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.923 0.889 . . . . 0.0 111.605 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.7 m 55.93 23.42 6.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.582 1.153 . . . . 0.0 111.586 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.89 -50.52 0.01 OUTLIER Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.387 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.83 158.42 24.06 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -121.25 109.5 15.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.576 HG22 ' HA ' ' A' ' 188' ' ' SER . 84.1 t -121.68 134.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.608 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 32.0 t -146.4 159.23 43.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.829 0.851 . . . . 0.0 109.334 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.33 167.48 4.14 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.124 0.569 . . . . 0.0 111.304 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -99.61 122.18 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 171.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.736 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -111.22 143.59 41.73 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -148.08 166.72 26.96 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 122.072 -0.393 . . . . 0.0 110.927 -172.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 146' ' ' LEU . 62.4 p -91.58 110.42 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.1 -0.04 56.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.023 0.929 . . . . 0.0 110.616 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 68.01 129.79 0.02 OUTLIER 'General case' 0 C--N 1.366 1.293 0 C-N-CA 124.731 1.212 . . . . 0.0 109.449 -169.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 52.2 p -56.45 121.53 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.518 0.727 . . . . 0.0 111.142 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.6 tt -69.26 88.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.633 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -92.71 74.58 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.55 -33.88 69.5 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.521 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.02 146.07 86.96 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.264 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.45 131.88 38.19 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.124 1.883 . . . . 0.0 111.56 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.462 ' HG3' HG22 ' A' ' 239' ' ' ILE . 12.3 pt-20 -63.86 -18.97 64.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.9 0.88 . . . . 0.0 112.703 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.462 HG22 ' HG3' ' A' ' 238' ' ' GLU . 15.4 tt -152.33 -52.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 122.864 0.465 . . . . 0.0 111.086 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--O 1.25 1.125 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.367 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.477 ' C4 ' HD21 ' A' ' 119' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.783 ' HE2' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 97' ' ' ILE . 13.4 tppt? 172.02 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 126.454 1.902 . . . . 0.0 109.992 -174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.592 ' HA ' ' HG2' ' A' ' 48' ' ' GLN . 37.4 ttt180 -102.38 -90.12 0.36 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.909 -1.12 . . . . 0.0 111.425 -171.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -150.24 156.85 42.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.556 0.742 . . . . 0.0 110.291 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.427 ' O ' ' HB1' ' A' ' 117' ' ' ALA . . . 56.63 26.05 10.7 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 124.296 0.997 . . . . 0.0 112.63 174.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.17 31.64 0.54 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.521 1.128 . . . . 0.0 109.006 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -166.81 61.59 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 117' ' ' ALA . 52.3 mt -101.52 94.21 5.77 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.287 0.635 . . . . 0.0 110.243 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 120' ' ' MET . 4.5 mm-40 -95.3 130.85 41.92 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 123.672 0.789 . . . . 0.0 112.27 -172.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HB2' HG12 ' A' ' 68' ' ' VAL . 24.3 mt -97.82 143.42 28.46 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 32.0 tt0 -134.23 142.8 47.5 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 124.163 0.985 . . . . 0.0 108.953 162.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -86.7 128.43 35.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 118.034 0.379 . . . . 0.0 110.732 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -85.86 -52.37 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.227 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.67 -164.49 0.91 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.746 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.561 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 27.5 t70 -108.33 146.23 33.27 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.484 0.714 . . . . 0.0 109.556 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HB ' HG21 ' A' ' 201' ' ' ILE . 2.4 m -75.34 100.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.241 0.543 . . . . 0.0 109.766 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 38.1 ttmt -172.39 117.43 0.35 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.849 1.259 . . . . 0.0 107.839 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.495 ' CD1' ' HB1' ' A' ' 169' ' ' ALA . 84.4 t90 -87.74 91.65 8.83 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.622 0.249 . . . . 0.0 111.647 -172.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -158.79 65.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 156.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 1.1 t70 -85.25 -61.91 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -150.59 33.07 0.63 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.796 1.238 . . . . 0.0 109.014 178.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 13.65 73.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.188 1.795 . . . . 0.0 113.661 -163.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 170' ' ' VAL . 13.2 mm-40 -75.91 162.08 28.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.608 -173.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.72 117.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.8 m -146.97 -51.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.791 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -59.45 105.58 0.76 Allowed Glycine 0 C--N 1.355 1.621 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.796 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p 179.88 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.923 1.289 . . . . 0.0 110.482 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 188' ' ' SER . 9.1 m -64.37 137.67 97.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.322 0.649 . . . . 0.0 110.527 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.41 178.24 0.24 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.525 2.816 . . . . 0.0 114.542 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 115.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.124 0.569 . . . . 0.0 110.103 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 51.7 tp -112.4 159.0 19.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.955 0.902 . . . . 0.0 109.839 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -112.45 119.56 38.64 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.483 0.713 . . . . 0.0 109.479 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -114.23 142.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.263 1.025 . . . . 0.0 108.694 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.6 p -88.22 110.4 20.69 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 180' ' ' ASN . 45.3 mm -73.41 143.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.697 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 t -144.84 129.36 17.99 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 56.5 20.74 5.06 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.472 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 72.87 -68.43 0.23 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.405 1.882 . . . . 0.0 111.523 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.66 -11.27 72.76 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 114.91 0.724 . . . . 0.0 114.91 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.6 m -105.11 156.98 17.58 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 118.391 1.095 . . . . 0.0 109.037 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 ptm -158.34 138.48 12.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.427 0.691 . . . . 0.0 109.475 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 p -172.21 176.16 3.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.723 0.809 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.45 94.79 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 49.94 29.12 3.2 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.368 1.467 . . . . 0.0 113.12 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 53.68 33.97 17.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.956 1.702 . . . . 0.0 113.026 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.04 93.53 2.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.821 0.82 . . . . 0.0 108.992 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.06 157.09 20.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.324 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.43 136.96 11.02 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.901 0.48 . . . . 0.0 109.98 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.657 ' HB2' HG21 ' A' ' 97' ' ' ILE . 14.7 pt-20 -101.77 158.04 16.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.619 0.768 . . . . 0.0 110.646 175.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.613 ' HB3' ' NH2' ' B' ' 255' ' ' M9P . 25.9 tt0 -166.45 141.57 4.44 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.287 0.635 . . . . 0.0 110.364 -164.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 65.6 p -86.42 138.88 31.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.788 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -106.78 -44.88 4.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.727 0.811 . . . . 0.0 110.027 -177.154 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.24 172.27 29.02 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.3 22.56 54.07 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.32 138.86 29.79 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -158.94 15.42 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.2 t -84.4 -26.34 28.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.16 0.584 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.22 -82.05 0.79 Allowed Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.71 -122.33 27.58 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.428 0.537 . . . . 0.0 113.311 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.61 -78.01 0.36 Allowed Glycine 0 C--N 1.352 1.441 0 C-N-CA 123.85 0.738 . . . . 0.0 111.888 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.45 -55.67 0.08 OUTLIER Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.91 -43.66 53.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 110.599 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.3 t80 63.55 28.77 15.29 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.428 1.08 . . . . 0.0 109.8 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.65 70.68 9.67 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.47 65.36 4.14 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.613 HG23 ' HD2' ' A' ' 87' ' ' LYS . 2.6 p -109.9 23.71 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 CA-C-O 123.248 1.499 . . . . 0.0 109.012 -175.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 96' ' ' GLN . 16.7 mt 81.39 127.68 0.04 OUTLIER 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.775 2.03 . . . . 0.0 116.475 156.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.452 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.2 m0 -125.02 87.43 2.71 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.619 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 4.4 t70 175.23 105.15 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.383 1.052 . . . . 0.0 111.028 157.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 8' ' ' LEU . 18.8 m -132.13 175.15 3.92 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.162 . . . . 0.0 111.201 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.561 ' HD2' HD13 ' A' ' 126' ' ' ILE . 74.3 Cg_endo -92.52 113.4 0.29 Allowed 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.439 2.092 . . . . 0.0 110.702 162.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.2 p -64.81 113.02 9.34 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.237 0.615 . . . . 0.0 110.771 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.4 ' HG3' HG23 ' A' ' 126' ' ' ILE . 37.1 Cg_exo -58.54 -42.19 57.12 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.769 2.313 . . . . 0.0 115.653 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 118.53 5.09 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 121.82 1.686 . . . . 0.0 110.859 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.14 90.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.286 2.657 . . . . 0.0 112.395 174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.31 -33.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.997 0.919 . . . . 0.0 110.508 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.88 -51.39 4.06 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 122.968 0.318 . . . . 0.0 112.779 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -79.63 75.76 6.28 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.666 0.746 . . . . 0.0 109.0 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.53 -174.55 0.71 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.82 1.648 . . . . 0.0 108.125 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.79 136.37 37.42 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 27.4 tp -107.06 -3.0 20.47 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.67 0.788 . . . . 0.0 109.618 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 50.91 168.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.443 2.297 . . . . 0.0 114.135 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HD1' ' A' ' 102' ' ' TYR . 22.9 t70 -179.9 111.41 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.575 0.75 . . . . 0.0 110.409 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 138.22 -132.14 5.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 114.873 0.709 . . . . 0.0 114.873 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 140.12 42.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.805 1.242 . . . . 0.0 110.096 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 62.7 m-85 -125.49 146.44 49.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.881 0.473 . . . . 0.0 112.095 -168.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.825 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 20.6 mtm180 -98.26 124.49 42.89 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 163.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.647 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 21.8 pt -130.98 138.8 52.66 Favored 'Isoleucine or valine' 0 C--O 1.26 1.641 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -165.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.78 151.22 47.03 Favored 'General case' 0 C--N 1.386 2.195 0 C-N-CA 124.256 1.022 . . . . 0.0 111.284 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.571 ' HB3' ' HG2' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -140.67 154.62 46.46 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 166.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -104.75 91.59 3.91 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.057 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -171.17 177.0 44.33 Favored Glycine 0 C--O 1.238 0.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.176 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 11.3 mt 59.63 37.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.515 0 CA-C-O 122.212 1.006 . . . . 0.0 109.602 165.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.3 mt 65.16 33.84 9.05 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.691 1.596 . . . . 0.0 111.644 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.45 157.69 28.59 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 121.47 0.483 . . . . 0.0 114.241 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -130.28 87.29 2.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.6 m -147.77 147.17 29.59 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 49' ' ' THR . 7.3 tt0 -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 125.189 1.556 . . . . 0.0 108.397 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.657 HG21 ' HB2' ' A' ' 47' ' ' GLU . 2.5 pp -135.07 -33.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -170.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.653 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.22 176.86 29.54 Favored Glycine 0 C--O 1.258 1.612 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.051 -161.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -118.49 124.49 47.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.772 -0.714 . . . . 0.0 109.777 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.46 162.11 17.89 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.3 t -138.6 133.09 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.3 0.64 . . . . 0.0 109.527 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.567 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 24.9 t80 -149.67 135.28 18.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.78 133.42 30.39 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 65.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.871 1.357 . . . . 0.0 111.985 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.29 19.95 0.63 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.513 -0.312 . . . . 0.0 112.399 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 p -135.74 126.73 27.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.518 0.727 . . . . 0.0 110.043 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 49.1 t80 -102.19 137.63 40.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.59 1.156 . . . . 0.0 108.72 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -132.1 122.15 24.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.377 0.671 . . . . 0.0 110.062 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 138' ' ' ILE . 14.6 t -136.42 -155.59 0.64 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.848 0.859 . . . . 0.0 109.892 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.436 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 18.6 ttm -136.97 153.59 50.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 111.239 -158.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -46.43 11.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -174.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.421 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 13.8 p-80 -65.56 -16.91 64.15 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 118.743 0.701 . . . . 0.0 112.286 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.517 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 4.5 m -80.27 -38.89 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 123.826 0.85 . . . . 0.0 111.769 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 6' ' ' LEU . 23.1 m -156.24 151.91 27.11 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.937 0.789 . . . . 0.0 110.079 170.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -73.15 26.43 0.06 Allowed 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -167.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.674 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 82.79 38.2 12.16 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 119.031 0.832 . . . . 0.0 111.425 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -87.71 -165.58 1.35 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.697 0.799 . . . . 0.0 112.383 -168.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.01 136.47 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.733 0.813 . . . . 0.0 111.331 -174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 mm? -86.79 171.61 10.76 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.933 1.293 . . . . 0.0 111.998 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -172.53 173.04 4.14 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 41.8 t60 -132.41 97.49 4.12 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.448 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 64' ' ' VAL . 85.3 mttt 39.14 38.84 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.775 1.23 . . . . 0.0 112.149 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 21.18 12.85 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 34.2 mmtp -115.27 112.12 21.96 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.984 1.392 . . . . 0.0 110.094 172.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -80.54 148.95 30.16 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.467 1.107 . . . . 0.0 113.171 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.561 HD13 ' HD2' ' A' ' 69' ' ' PRO . 29.5 mt -140.06 125.2 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.208 1.803 . . . . 0.0 107.428 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.06 148.83 36.46 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.19 0.596 . . . . 0.0 112.356 -168.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.0 163.46 25.67 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.597 2.865 . . . . 0.0 114.764 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 p -127.04 -29.45 2.79 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.781 0.833 . . . . 0.0 111.602 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 32.1 t-105 -147.91 149.03 31.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.165 0.586 . . . . 0.0 110.522 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.93 140.83 23.72 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.751 1.22 . . . . 0.0 109.279 166.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -134.73 114.56 12.79 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.56 -27.37 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.853 1.261 . . . . 0.0 112.356 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -76.85 -59.36 2.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.792 0.33 . . . . 0.0 111.766 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.33 6.14 48.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.371 0.669 . . . . 0.0 110.646 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 68.62 51.18 0.63 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.392 1.077 . . . . 0.0 110.989 162.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 227' ' ' ALA . 52.0 mt -140.14 142.33 36.01 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.459 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.674 HD13 ' HA2' ' A' ' 116' ' ' GLY . 49.3 mt -128.74 151.37 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.537 1.135 . . . . 0.0 109.07 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 23.9 t -139.1 144.04 38.53 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.082 0.468 . . . . 0.0 111.01 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 63.1 m-85 -128.95 144.18 51.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.027 1.331 . . . . 0.0 109.077 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.66 -8.86 79.17 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.738 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.48 -154.76 26.14 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.45 132.01 10.93 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.734 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 2.6 p90 -79.02 130.87 35.99 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -175.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 232' ' ' SER . 56.1 pttt -149.16 116.35 6.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.841 0.456 . . . . 0.0 111.021 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.82 -80.1 0.36 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.441 ' H ' ' H ' ' A' ' 148' ' ' GLY . 4.8 mt-10 159.35 3.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 125.699 1.6 . . . . 0.0 109.366 -163.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 207' ' ' VAL . . . -56.12 91.2 0.02 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 123.985 0.802 . . . . 0.0 114.684 -175.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.27 95.86 3.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.501 ' HE3' HD13 ' A' ' 200' ' ' ILE . 2.0 t90 -46.43 121.65 3.57 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 163.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 88.4 tttt -81.78 116.5 21.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.68 108.48 2.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.217 1.007 . . . . 0.0 109.623 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.34 -37.96 2.8 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . 42.0 tt0 -95.33 148.15 22.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.125 0.97 . . . . 0.0 109.763 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 13.1 pt-20 -89.71 139.94 30.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.809 0.844 . . . . 0.0 110.679 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 150' ' ' TRP . 15.3 t -131.75 159.63 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.438 ' OE1' ' HG3' ' A' ' 171' ' ' GLN . 2.2 mm-40 -93.51 160.64 14.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.083 0.553 . . . . 0.0 111.914 -161.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' PRO . 14.5 p -140.05 152.66 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.524 0.73 . . . . 0.0 111.05 176.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 14' ' ' VAL . 88.0 mt -103.39 93.39 4.94 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 164.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 193' ' ' PRO . . . -77.1 97.23 4.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 167' ' ' PRO . 91.1 mt -73.49 103.92 4.29 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.45 141.1 87.8 Favored Pre-proline 0 CA--C 1.554 1.125 0 O-C-N 123.625 0.578 . . . . 0.0 110.652 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 50' ' ' LEU . 32.3 Cg_endo -61.82 117.87 4.72 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.597 2.865 . . . . 0.0 112.511 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.05 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.419 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -141.09 -173.56 3.76 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.867 0.841 . . . . 0.0 112.02 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -66.38 159.71 70.86 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 126.016 1.726 . . . . 0.0 113.126 173.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.425 ' HB3' HD23 ' A' ' 161' ' ' LEU . 5.0 Cg_exo -77.32 117.7 4.44 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.196 2.597 . . . . 0.0 111.433 170.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.497 ' HA ' ' NE ' ' A' ' 168' ' ' ARG . 11.4 mmp_? -75.64 99.55 4.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -76.1 100.66 5.04 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 28.4 t -110.02 141.65 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.857 0.863 . . . . 0.0 109.57 -173.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.438 ' HG3' ' OE1' ' A' ' 157' ' ' GLN . 28.1 tt0 -89.73 121.4 31.85 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' HA3' ' A' ' 24' ' ' GLY . 34.0 p -123.75 132.22 53.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.343 0.657 . . . . 0.0 111.226 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 62.3 mttp -92.5 149.72 38.67 Favored Pre-proline 0 C--O 1.246 0.909 0 C-N-CA 125.78 1.632 . . . . 0.0 110.765 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.19 126.72 7.14 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.614 2.209 . . . . 0.0 111.878 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.408 ' HA3' ' OG ' ' A' ' 188' ' ' SER . . . -111.93 -173.25 19.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.45 140.11 19.84 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.193 0.597 . . . . 0.0 110.0 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 186' ' ' ALA . 13.4 m-85 -128.65 150.33 50.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.134 0.974 . . . . 0.0 110.631 -165.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -61.23 127.97 34.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.83 0.852 . . . . 0.0 110.8 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.7 m -130.44 156.83 44.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.179 0.992 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.404 ' H ' HG13 ' A' ' 33' ' ' ILE . 21.5 m120 -84.83 54.61 3.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.152 0.977 . . . . 0.0 109.122 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -173.68 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.975 1.71 . . . . 0.0 109.038 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.87 -106.77 0.36 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -140.97 133.4 28.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.05 137.09 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.022 0.529 . . . . 0.0 109.661 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.98 109.42 3.66 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 177' ' ' PHE . . . -149.95 167.91 25.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.978 -173.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.59 128.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.441 0.639 . . . . 0.0 111.346 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 19.1 m -103.76 80.18 1.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.397 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.488 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 37.9 tp -105.39 104.96 14.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.048 0.451 . . . . 0.0 110.017 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.79 104.51 16.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.427 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 27.3 t80 -178.28 168.26 1.9 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -174.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.6 m -117.16 74.78 7.69 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 117.953 0.342 . . . . 0.0 111.577 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.52 ' HB3' ' HB1' ' A' ' 160' ' ' ALA . 19.5 Cg_endo -88.2 -60.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.151 1.901 . . . . 0.0 110.016 160.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.93 -29.98 4.85 Favored Glycine 0 C--N 1.361 1.942 0 C-N-CA 123.731 0.682 . . . . 0.0 112.577 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.0 t -61.94 99.51 0.13 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.62 1.168 . . . . 0.0 113.244 -165.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.9 m -63.02 121.85 14.61 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.14 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.49 6.48 33.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.398 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 62.3 m -45.23 115.14 2.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 123.295 0.638 . . . . 0.0 112.227 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.6 Cg_endo -74.33 119.84 5.97 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.203 2.602 . . . . 0.0 113.96 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.501 HD13 ' HE3' ' A' ' 150' ' ' TRP . 73.3 mt -79.68 93.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.955 0.902 . . . . 0.0 109.261 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 14' ' ' VAL . 29.2 pt -111.21 178.68 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.015 0.912 . . . . 0.0 111.662 -174.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.4 174.04 6.05 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 166.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 16' ' ' TRP . 84.3 tttt -59.78 -31.76 69.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.746 0.418 . . . . 0.0 111.786 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -82.43 -3.78 56.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.097 0.559 . . . . 0.0 111.994 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.01 26.06 54.06 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -99.54 167.1 10.81 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.032 1.333 . . . . 0.0 109.324 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 68.9 t 85.68 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 125.606 1.562 . . . . 0.0 109.49 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.6 m 58.25 30.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 125.131 1.372 . . . . 0.0 112.844 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.08 -169.65 2.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.347 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.0 mt -144.94 149.61 35.54 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.485 -1.009 . . . . 0.0 110.994 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -74.6 107.72 6.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 166.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.436 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -83.87 -138.98 3.83 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 124.328 1.018 . . . . 0.0 114.046 -166.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -70.88 87.59 0.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.302 0.641 . . . . 0.0 109.586 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -135.59 -147.67 5.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.189 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.0 167.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.641 0.776 . . . . 0.0 109.589 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 13.9 t -91.91 111.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 29' ' ' LEU . 91.8 m -71.57 140.06 49.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.126 0.97 . . . . 0.0 109.906 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 59.73 12.1 2.78 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.705 0.802 . . . . 0.0 111.861 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t 62.58 18.69 10.7 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.91 1.284 . . . . 0.0 112.072 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.19 7.97 0.39 Allowed Glycine 0 C--N 1.354 1.54 0 CA-C-O 119.682 -0.51 . . . . 0.0 114.345 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 191' ' ' PHE . . . -140.61 92.0 2.48 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.759 0.78 . . . . 0.0 110.03 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 15.4 t80 -71.04 101.32 2.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.242 0.544 . . . . 0.0 110.773 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.14 123.42 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.055 1.342 . . . . 0.0 108.841 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.559 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 24.7 t -143.88 158.45 43.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.011 0.524 . . . . 0.0 110.888 -171.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.79 55.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.594 0.758 . . . . 0.0 110.795 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.427 HG13 ' HA ' ' A' ' 186' ' ' ALA . 87.9 mt -81.83 98.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.964 0.411 . . . . 0.0 110.026 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -81.06 135.41 35.82 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.55 159.33 36.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.793 0.837 . . . . 0.0 110.398 -172.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.734 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 10.9 p -82.83 113.89 20.77 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -145.36 101.6 3.61 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.518 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -158.93 -64.03 0.08 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.695 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.655 ' HB2' ' HB3' ' A' ' 145' ' ' LYS . 7.6 m -119.02 101.72 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.714 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 23.0 pt -111.44 -30.23 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.734 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.587 ' HG3' ' H ' ' A' ' 236' ' ' ASN . 11.9 tp10 -114.88 160.95 18.9 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.959 1.303 . . . . 0.0 109.055 -171.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.04 -18.32 64.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.365 1.066 . . . . 0.0 111.353 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.587 ' H ' ' HG3' ' A' ' 234' ' ' GLU . 9.9 m-20 -59.41 151.15 61.26 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.979 1.312 . . . . 0.0 111.006 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -21.18 92.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.396 1 C-N-CA 126.527 4.818 . . . . 0.0 116.481 -170.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.649 ' HG3' HG13 ' A' ' 239' ' ' ILE . 5.1 pt-20 -92.2 -39.43 11.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.471 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.649 HG13 ' HG3' ' A' ' 238' ' ' GLU . 28.7 mt -88.82 57.34 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--O 1.252 1.205 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -177.735 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.647 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.583 ' HE3' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.604 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 17.4 tppt? -137.26 134.78 36.54 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 161.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.446 ' O ' HG12 ' A' ' 113' ' ' VAL . 36.5 ttt180 71.43 144.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.953 0.901 . . . . 0.0 109.684 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' M9P . . . . . 0.613 ' NH2' ' HB3' ' A' ' 48' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.339 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.645 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 t -171.37 150.69 2.93 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.448 0.624 . . . . 0.0 110.185 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 74.86 -57.94 0.59 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.739 1.615 . . . . 0.0 113.261 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.79 45.46 0.96 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.171 0.989 . . . . 0.0 108.659 -170.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.6 m-20 -146.0 26.48 1.22 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.117 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 88' ' ' GLN . 34.9 mt -91.6 93.63 9.03 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.545 0.738 . . . . 0.0 110.14 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 4.8 mp0 -95.12 131.06 41.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.805 0.842 . . . . 0.0 111.865 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.38 130.45 56.69 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.91 129.08 51.17 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 122.886 0.474 . . . . 0.0 110.527 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 5.8 tmm_? -75.6 127.61 33.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.356 0.662 . . . . 0.0 110.327 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.1 -56.81 2.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.425 0.69 . . . . 0.0 110.577 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 167' ' ' PRO . . . -145.49 -175.08 4.58 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.711 -171.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.26 146.41 23.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.006 0.922 . . . . 0.0 109.839 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.59 HG23 ' HA2' ' A' ' 82' ' ' GLY . 15.1 t -79.49 97.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' N ' HD13 ' A' ' 201' ' ' ILE . 17.6 pttp -173.58 176.36 2.78 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 108.402 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 39.0 t90 -73.49 136.52 44.16 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.512 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -112.94 144.45 42.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.091 0.956 . . . . 0.0 109.598 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.03 -6.28 8.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.301 1.04 . . . . 0.0 112.667 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.15 -2.8 16.99 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.556 1.143 . . . . 0.0 111.61 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 16' ' ' TRP . . . -36.6 100.08 0.02 OUTLIER 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.915 2.086 . . . . 0.0 114.052 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.12 148.39 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.64 1.176 . . . . 0.0 109.619 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 mm -102.75 104.39 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -144.84 -20.4 0.51 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.849 0.46 . . . . 0.0 111.284 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -71.66 -173.13 17.25 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.768 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m 71.82 37.9 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.545 1.138 . . . . 0.0 109.278 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -66.86 142.73 97.62 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.692 0.797 . . . . 0.0 110.842 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.63 -176.14 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.225 2.617 . . . . 0.0 114.253 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.43 119.46 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.807 0.843 . . . . 0.0 112.142 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 223' ' ' VAL . 7.0 mt -108.28 163.9 12.78 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.967 0.907 . . . . 0.0 111.075 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -120.14 122.51 41.18 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.285 0.634 . . . . 0.0 109.29 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 41' ' ' ILE . 10.5 mt -127.11 149.09 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.98 0.912 . . . . 0.0 110.201 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.2 m -96.99 119.46 35.5 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.096 0.958 . . . . 0.0 110.449 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.853 HG12 HG21 ' A' ' 179' ' ' THR . 35.6 mm -68.63 114.21 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 23.0 t -79.84 134.51 36.33 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.24 4.56 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.35 -13.71 60.12 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 0.0 110.891 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.21 17.51 29.28 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -166.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 55.3 m -105.69 164.81 11.63 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.686 0.794 . . . . 0.0 109.986 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.627 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 2.4 ppp? -127.77 135.83 50.66 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 p -171.29 173.45 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.658 0.783 . . . . 0.0 110.536 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 31' ' ' ILE . 1.6 mp -90.31 134.09 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 161.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.21 90.19 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.638 0.586 . . . . 0.0 110.371 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -157.08 157.19 34.1 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 108.852 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.36 75.43 1.01 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -114.7 138.46 50.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.202 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.78 161.69 41.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 97' ' ' ILE . 36.9 tt0 85.15 137.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.622 1.569 . . . . 0.0 113.754 164.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -169.54 134.16 1.4 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.219 1.408 . . . . 0.0 109.299 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.485 HG23 ' NE2' ' A' ' 96' ' ' GLN . 61.7 m -78.07 101.92 7.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.081 0.952 . . . . 0.0 111.211 -174.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.43 96.46 5.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.713 0.805 . . . . 0.0 109.288 176.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -163.64 127.36 1.66 Allowed Glycine 0 N--CA 1.469 0.845 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.092 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 -71.4 2.25 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.75 -79.96 1.73 Allowed Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.13 0.395 . . . . 0.0 112.43 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 94.23 0.33 Allowed Glycine 0 C--N 1.342 0.878 0 O-C-N 124.055 0.503 . . . . 0.0 112.217 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.3 m 69.97 23.18 5.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.82 92.05 0.25 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.71 -21.84 22.77 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.658 0.229 . . . . 0.0 112.705 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.22 -77.13 1.28 Allowed Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.41 -63.84 4.27 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 62' ' ' ALA . 8.0 pt-20 -73.8 1.13 11.16 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.283 1.033 . . . . 0.0 112.462 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 68.78 9.48 7.38 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.832 1.253 . . . . 0.0 111.066 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.532 ' H ' ' HG3' ' A' ' 60' ' ' GLU . . . 55.41 18.83 2.78 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 125.4 1.48 . . . . 0.0 112.06 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.92 -78.61 0.03 OUTLIER Glycine 0 C--N 1.354 1.565 0 C-N-CA 122.974 0.321 . . . . 0.0 112.606 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.682 HG13 ' HE3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -147.69 70.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.77 0 C-N-CA 124.601 1.16 . . . . 0.0 108.316 176.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.932 HD22 HH22 ' A' ' 85' ' ' ARG . 3.3 pp -37.45 157.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -175.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -165.74 158.57 15.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.462 1.125 . . . . 0.0 111.779 -175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.724 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 29.5 t0 -154.81 60.39 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 154.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 ' HB2' ' A' ' 121' ' ' HIS . 7.6 p -141.17 94.09 7.87 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-N 111.598 -2.546 . . . . 0.0 106.735 176.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HD2' ' H ' ' A' ' 78' ' ' GLU . 2.1 Cg_endo -85.44 106.12 0.92 Allowed 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 123.134 2.556 . . . . 0.0 111.063 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 p -54.38 104.95 0.46 Allowed Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.885 0.874 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -15.17 83.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.404 1 C-N-CA 127.169 5.246 . . . . 0.0 118.419 -158.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 76' ' ' LYS . 79.9 Cg_endo -99.69 147.82 0.47 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 123.637 2.891 . . . . 0.0 112.844 172.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.77 38.19 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.138 2.558 . . . . 0.0 112.488 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.42 -29.48 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.792 0.837 . . . . 0.0 110.503 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.33 -88.24 0.07 OUTLIER Glycine 0 C--N 1.347 1.167 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 64.4 mttp -89.96 178.45 6.21 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.733 0.813 . . . . 0.0 111.07 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.37 75.28 0.12 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.6 ' H ' ' HD2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER 55.92 -167.45 0.1 Allowed 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.025 0.93 . . . . 0.0 110.885 -160.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp 71.87 25.4 3.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.011 0.924 . . . . 0.0 111.077 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.49 -30.76 69.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 64.42 111.95 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 125.168 1.542 . . . . 0.0 112.215 164.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.59 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 142.77 -167.08 26.38 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.919 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.16 109.57 12.37 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 1.6 m-85 -87.32 146.28 25.99 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.932 HH22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.64 136.9 40.7 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 160.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.714 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 10.8 pt -132.71 142.89 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -162.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 73.4 tttt -123.02 142.84 50.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.187 1.795 . . . . 0.0 111.369 -174.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.801 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 51.7 tt0 -136.1 150.37 49.08 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.568 0.223 . . . . 0.0 110.646 167.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 91.1 mttt -96.14 92.0 6.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 162.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 169.77 42.4 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.616 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt 67.48 -77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.009 1.324 . . . . 0.0 112.235 163.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.96 -15.04 1.79 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.891 0.876 . . . . 0.0 109.78 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' B' ' 253' ' ' LYS . . . -144.21 -161.11 8.79 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 26.7 t80 -150.88 33.86 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -165.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 p -151.8 173.07 15.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -154.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.755 ' HB3' HD21 ' A' ' 65' ' ' LEU . 23.4 pt20 -87.31 120.04 28.19 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.791 1.637 . . . . 0.0 110.909 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 47' ' ' GLU . 2.7 pp -136.0 -37.56 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -105.76 -172.67 23.68 Favored Glycine 0 N--CA 1.48 1.594 0 C-N-CA 120.214 -0.993 . . . . 0.0 114.811 -159.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.59 125.04 33.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.101 0.56 . . . . 0.0 110.324 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.56 111.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.571 HG13 HG21 ' A' ' 14' ' ' VAL . 91.9 t -88.64 101.83 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.408 0.683 . . . . 0.0 110.829 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 15.0 t80 -91.51 110.19 21.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 23.3 tptp -144.53 143.78 31.01 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.778 0.674 . . . . 0.0 110.168 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 146' ' ' LEU . 11.8 mm-40 64.92 15.58 10.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.927 1.291 . . . . 0.0 112.739 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.54 -5.22 67.15 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 122.946 0.308 . . . . 0.0 112.981 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.3 p -121.66 138.19 54.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 110.23 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 73.5 t80 -81.08 137.55 35.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.67 119.33 18.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.191 0.997 . . . . 0.0 110.372 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 138' ' ' ILE . 2.9 t -138.74 176.72 8.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 0.0 110.517 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.424 ' HE3' ' O ' ' A' ' 136' ' ' ASP . 65.9 mmm -84.62 170.73 13.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.595 0.758 . . . . 0.0 110.593 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.56 -54.84 4.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -57.28 -13.66 3.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -168.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.82 -45.92 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 C-N-CA 124.68 1.192 . . . . 0.0 112.983 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.489 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 20.3 m -155.12 149.54 26.19 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.874 1.27 . . . . 0.0 107.59 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 13.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.5 62.62 0.9 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -117.17 -164.76 1.01 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.269 0.628 . . . . 0.0 111.764 -171.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 93.6 t -92.04 129.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.471 1.109 . . . . 0.0 112.47 -162.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.633 HD21 ' H4 ' ' B' ' 251' ' ' BEZ . 1.1 mt -91.81 157.69 16.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.032 -176.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 2.2 ptm -172.88 179.84 2.23 Favored 'General case' 0 C--O 1.272 2.242 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -171.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.6 ' HB2' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -147.94 111.14 4.89 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 112.053 -2.34 . . . . 0.0 108.874 178.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.583 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 4.5 mptp? 49.95 34.09 7.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.139 0.975 . . . . 0.0 112.624 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.3 -21.02 46.18 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.561 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 115.5 10.8 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.45 0.7 . . . . 0.0 109.891 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -83.18 149.21 26.98 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.883 1.273 . . . . 0.0 112.555 -164.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.3 mt -142.35 134.29 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 125.471 1.508 . . . . 0.0 109.172 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.49 117.66 68.16 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.449 1.1 . . . . 0.0 110.754 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.16 145.39 66.52 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.414 2.076 . . . . 0.0 111.461 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 72.4 p -98.78 -18.64 17.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.735 0.414 . . . . 0.0 111.945 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 132' ' ' ASP . 49.2 t-105 -155.91 154.26 30.94 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.701 0.4 . . . . 0.0 111.261 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -160.92 122.0 2.9 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.379 1.472 . . . . 0.0 109.32 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 130' ' ' TRP . 27.2 t70 -139.25 135.29 33.74 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.458 0.572 . . . . 0.0 111.998 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.43 -42.07 42.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.028 -172.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.55 -48.67 38.21 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.949 0.78 . . . . 0.0 111.543 -168.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.45 -16.57 61.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.329 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' O ' ' HE3' ' A' ' 110' ' ' MET . 35.0 t70 62.83 45.14 5.83 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.703 1.201 . . . . 0.0 109.584 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 80.8 mt -142.4 129.37 20.71 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.772 -171.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.4 mt -115.66 155.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.511 1.524 . . . . 0.0 108.16 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.0 p -156.95 151.79 25.87 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.094 0.473 . . . . 0.0 112.104 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.9 t80 -120.25 149.12 42.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.64 1.176 . . . . 0.0 109.133 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.51 -78.58 0.24 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.98 85.44 0.06 OUTLIER Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 170.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.63 133.77 2.22 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -98.52 105.7 17.88 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -166.38 124.11 1.4 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 207' ' ' VAL . 6.0 mp -124.17 -63.52 1.2 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 175.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 177.97 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.298 0.999 . . . . 0.0 110.646 167.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.27 -171.84 23.16 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -157.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.65 153.66 47.9 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.836 0.854 . . . . 0.0 110.041 -164.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.457 ' HA ' HG13 ' A' ' 208' ' ' VAL . 31.8 t90 -67.28 106.49 2.07 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 165.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -96.25 99.68 11.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.07 110.57 0.37 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.628 1.171 . . . . 0.0 111.748 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.687 ' H ' ' HG2' ' A' ' 174' ' ' PRO . . . 131.02 -42.08 1.44 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.63 121.41 11.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.594 1.158 . . . . 0.0 110.9 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.87 99.47 9.06 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 208' ' ' VAL . 32.9 m -91.59 172.36 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.158 -168.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 171' ' ' GLN . 71.8 mm-40 -108.82 154.9 21.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.438 1.095 . . . . 0.0 109.49 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.57 136.78 40.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.26 88.54 7.24 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.77 101.15 4.96 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.11 95.6 0.57 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -60.45 113.29 7.14 Favored Pre-proline 0 C--N 1.353 0.725 0 O-C-N 124.439 1.087 . . . . 0.0 110.145 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.21 114.89 2.4 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.054 1.836 . . . . 0.0 112.087 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.27 -14.16 56.92 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.061 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -129.75 -172.73 2.84 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.464 0.706 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -62.32 162.92 16.17 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 125.337 1.455 . . . . 0.0 112.602 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.525 ' HG3' ' HB2' ' A' ' 12' ' ' ALA . 21.1 Cg_endo -58.91 140.95 97.51 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.108 2.539 . . . . 0.0 111.514 169.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.451 ' HG3' ' HZ ' ' A' ' 191' ' ' PHE . 47.5 mmm-85 -116.05 100.97 8.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.212 0.605 . . . . 0.0 109.841 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.1 118.91 13.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 168.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.46 134.41 49.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.863 0.363 . . . . 0.0 110.282 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.554 ' NE2' ' HE3' ' A' ' 203' ' ' LYS . 59.3 tt0 -87.9 143.18 27.26 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.891 0.876 . . . . 0.0 111.122 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.635 ' HB ' HD12 ' A' ' 189' ' ' LEU . 8.1 t -146.31 133.96 21.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.086 1.354 . . . . 0.0 109.175 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -93.12 140.67 23.4 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.687 ' HG2' ' H ' ' A' ' 153' ' ' GLY . 67.0 Cg_exo -45.34 122.69 4.82 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.83 2.354 . . . . 0.0 114.195 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.04 -173.1 26.39 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -156.36 132.66 10.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.704 0.764 . . . . 0.0 110.076 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.475 ' HE1' ' HB3' ' A' ' 186' ' ' ALA . 22.9 p90 -115.37 121.8 43.91 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.999 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -80.19 153.55 28.52 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.853 HG21 HG12 ' A' ' 33' ' ' ILE . 27.0 m -137.34 162.17 34.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.466 1.106 . . . . 0.0 108.358 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -59.32 -24.56 63.43 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.644 0.777 . . . . 0.0 111.546 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.466 ' H ' HG22 ' A' ' 179' ' ' THR . . . -82.03 -36.51 27.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.061 0.944 . . . . 0.0 112.085 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.85 -131.68 1.68 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.56 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 37.9 m -156.45 127.88 7.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 108.374 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.47 133.81 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.34 116.11 5.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 177' ' ' PHE . . . -162.69 -166.15 1.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.334 0.654 . . . . 0.0 111.152 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 172' ' ' THR . 4.6 p -74.84 100.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 CA-C-O 121.719 0.771 . . . . 0.0 110.641 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 223' ' ' VAL . 29.1 m -96.16 100.2 11.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.635 HD12 ' HB ' ' A' ' 172' ' ' THR . 7.6 tt -135.05 107.46 7.3 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.41 124.91 27.41 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.451 ' HZ ' ' HG3' ' A' ' 168' ' ' ARG . 48.4 t80 -170.11 -179.53 3.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.672 1.189 . . . . 0.0 107.829 -175.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.2 m -58.19 159.19 11.75 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.99 0.916 . . . . 0.0 111.032 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.706 ' HA ' HG11 ' A' ' 216' ' ' VAL . 9.2 Cg_endo -50.13 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.09 2.526 . . . . 0.0 112.252 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.82 163.41 44.25 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.2 t -102.0 137.85 39.74 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.424 0.631 . . . . 0.0 111.361 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.3 m -70.78 105.65 3.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.887 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.75 5.14 8.46 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.027 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.3 m -49.1 116.92 5.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 C-N-CA 123.399 0.679 . . . . 0.0 111.662 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.54 125.11 9.84 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.252 1.968 . . . . 0.0 112.455 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 208' ' ' VAL . 40.8 mt -93.04 106.95 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 122.167 0.984 . . . . 0.0 108.865 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 202' ' ' ASP . 8.7 mt -114.05 -175.58 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.053 1.341 . . . . 0.0 107.616 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' HG22 ' A' ' 201' ' ' ILE . 33.7 t70 -125.04 170.11 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.464 0.574 . . . . 0.0 110.397 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.554 ' HE3' ' NE2' ' A' ' 171' ' ' GLN . 19.5 mttp -47.17 -50.32 20.82 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.667 1.987 . . . . 0.0 111.403 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.58 -19.9 64.49 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.991 0.917 . . . . 0.0 111.259 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 102.63 6.03 47.44 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -61.63 128.7 37.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.379 0.672 . . . . 0.0 109.203 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 146' ' ' LEU . 7.6 p -80.74 109.94 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 156' ' ' VAL . 80.0 t -83.23 -30.72 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.5 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 229' ' ' THR . . . 156.97 -149.88 20.8 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.455 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 101' ' ' VAL . 78.3 mt -131.54 174.0 10.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.355 1.062 . . . . 0.0 109.554 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -59.94 123.45 17.08 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 164.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.85 177.69 43.41 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.76 97.99 0.68 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.493 0.647 . . . . 0.0 110.402 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.627 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -140.73 -152.72 5.83 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.652 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.25 179.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -169.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 193' ' ' PRO . 27.2 m -98.41 125.78 51.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 162.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 29' ' ' LEU . 10.0 t -95.46 140.58 30.11 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.685 0.394 . . . . 0.0 111.092 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 38.95 -80.65 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.871 2.068 . . . . 0.0 114.401 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.1 p -87.15 16.58 4.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.283 1.033 . . . . 0.0 111.892 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.98 19.34 63.24 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.86 0.267 . . . . 0.0 112.709 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.16 123.09 25.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.269 0.628 . . . . 0.0 110.535 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -65.23 99.03 0.36 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.445 0.698 . . . . 0.0 109.718 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 29' ' ' LEU . 63.4 t -131.42 109.74 16.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 122.353 1.073 . . . . 0.0 109.264 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.616 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 15.8 m -137.2 160.16 39.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.997 -169.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.96 153.77 32.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 164.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 200' ' ' ILE . 71.6 mt -101.38 113.15 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.53 147.87 33.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 9.6 pt20 -134.04 149.88 51.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.506 0.722 . . . . 0.0 109.363 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.709 HG23 ' HA2' ' A' ' 209' ' ' GLY . 51.1 p -105.39 108.54 20.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.518 0.199 . . . . 0.0 111.314 -168.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.29 141.61 13.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -171.0 -59.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.2 p -135.76 91.67 2.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.459 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.49 -18.53 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.716 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.7 101.55 0.26 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.761 1.224 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -122.77 -10.94 8.24 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.432 0.693 . . . . 0.0 111.619 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -76.77 153.19 83.16 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.296 0.638 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.28 154.27 29.82 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.145 2.563 . . . . 0.0 112.537 173.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 69.48 78.83 0.2 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.482 1.113 . . . . 0.0 109.492 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 12.1 tt -130.37 -2.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 124.704 1.202 . . . . 0.0 109.921 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 123.461 0.704 . . . . 0.0 110.686 -175.914 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.714 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.506 ' HD2' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 2.5 tmtt? -141.98 52.48 1.49 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.23 1.377 . . . . 0.0 113.726 165.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -172.9 131.22 0.51 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 156.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.5 p 53.36 -160.77 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.758 1.623 . . . . 0.0 112.609 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -103.74 -179.71 4.03 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.523 0.729 . . . . 0.0 110.798 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.87 15.83 0.11 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 110.552 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.6 m-20 -137.67 65.14 1.49 Allowed 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 5.5 mp -106.57 113.2 26.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.117 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 24.2 mm-40 -112.33 127.87 56.12 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.935 0.894 . . . . 0.0 111.809 -165.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -106.46 148.83 27.69 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.951 -0.468 . . . . 0.0 112.217 -175.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HA ' ' H ' ' A' ' 67' ' ' ASP . 31.9 tt0 -145.82 140.68 27.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.273 1.029 . . . . 0.0 109.24 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.71 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 7.1 ptm180 -60.97 143.28 55.53 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.677 0.672 . . . . 0.0 110.353 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.33 -39.08 3.92 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 170.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' CB ' ' HG3' ' A' ' 167' ' ' PRO . . . -169.01 -171.27 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.96 148.58 24.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.989 0.916 . . . . 0.0 110.095 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.62 97.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -157.53 157.28 33.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.914 1.286 . . . . 0.0 108.606 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -70.43 115.24 9.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 160.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.88 143.97 32.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.0 -4.81 18.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.865 0.466 . . . . 0.0 111.766 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.69 49.68 0.64 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.921 1.288 . . . . 0.0 110.723 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -64.6 89.98 0.07 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.261 1.024 . . . . 0.0 110.54 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.0 tp10 -90.75 101.92 14.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.318 1.047 . . . . 0.0 108.717 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.44 101.68 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.5 m -160.12 96.05 1.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.556 1.142 . . . . 0.0 109.512 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -133.36 2.92 Favored Glycine 0 N--CA 1.467 0.734 0 CA-C-O 119.334 -0.704 . . . . 0.0 111.983 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m 62.99 40.75 8.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.359 1.064 . . . . 0.0 109.6 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 m -62.98 116.87 27.59 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.176 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.94 -78.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.418 2.745 . . . . 0.0 112.573 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 178' ' ' LYS . 7.7 tp -113.52 145.59 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.022 0.529 . . . . 0.0 109.717 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 177' ' ' PHE . 52.8 tp -132.72 155.16 49.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.653 0.781 . . . . 0.0 109.403 172.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.1 p -97.99 122.37 41.04 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 177' ' ' PHE . 9.4 tp -117.89 152.29 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 122.73 0.412 . . . . 0.0 110.343 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.412 HG21 ' HG3' ' A' ' 42' ' ' LYS . 89.9 m -105.47 107.49 18.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.695 0.798 . . . . 0.0 109.998 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.61 116.87 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.057 0.943 . . . . 0.0 108.544 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 m -104.29 114.31 28.46 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 110.534 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.88 19.83 10.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.973 1.309 . . . . 0.0 112.025 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 p30 51.4 8.8 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.987 2.115 . . . . 0.0 114.788 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.29 -48.64 0.98 Allowed Glycine 0 C--N 1.349 1.284 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.2 p -106.0 164.79 11.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.454 0.701 . . . . 0.0 109.671 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 213' ' ' ASN . 2.5 ppp? -124.14 149.95 45.67 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 76.3 p -178.94 -175.82 0.41 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.26 1.024 . . . . 0.0 109.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.614 ' H ' HG11 ' A' ' 215' ' ' VAL . 3.2 mp -106.51 152.24 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 157.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 32' ' ' THR . 67.1 mttm -68.73 82.99 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -121.77 152.66 39.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.288 1.435 . . . . 0.0 108.85 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.34 49.73 1.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.744 0.783 . . . . 0.0 109.899 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.78 104.41 11.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.825 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.05 -38.48 63.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.665 0.786 . . . . 0.0 110.925 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 85.71 -49.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.374 1.869 . . . . 0.0 110.982 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 47.98 31.47 2.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 126.196 1.798 . . . . 0.0 113.717 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -145.73 112.0 5.75 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.845 0.858 . . . . 0.0 109.668 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 161' ' ' LEU . 0.4 OUTLIER -168.63 -52.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.041 0.936 . . . . 0.0 108.76 174.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.705 ' HA2' ' HD3' ' A' ' 85' ' ' ARG . . . -75.04 62.32 2.54 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 115.451 -0.795 . . . . 0.0 114.124 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 -75.01 1.29 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.92 25.08 67.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.77 0.335 . . . . 0.0 113.406 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.66 -35.79 0.06 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.2 m 62.82 32.91 15.64 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.547 1.139 . . . . 0.0 112.172 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.99 -167.52 40.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.601 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.56 -77.78 1.55 Allowed Glycine 0 C--N 1.351 1.378 0 N-CA-C 112.402 -0.279 . . . . 0.0 112.402 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.2 59.96 0.53 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.58 48.13 3.91 Favored Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -143.62 -68.68 0.33 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.024 1.33 . . . . 0.0 107.759 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.99 -62.53 1.59 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.26 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.71 39.07 29.77 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.735 1.214 . . . . 0.0 110.183 -169.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' HA3' ' HD3' ' A' ' 122' ' ' LYS . . . 84.06 -103.33 2.58 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -161.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.0 -88.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.4 tp -164.69 139.25 5.32 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.029 1.331 . . . . 0.0 108.001 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.505 ' CD1' ' HE2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -164.74 67.72 0.15 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t0 -104.76 71.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 119.566 -1.959 . . . . 0.0 107.156 163.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.488 HG13 ' ND1' ' A' ' 121' ' ' HIS . 0.3 OUTLIER -132.46 102.14 14.2 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 112.815 -1.993 . . . . 0.0 106.573 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HG2' ' H ' ' A' ' 79' ' ' LEU . 60.4 Cg_endo -70.4 118.12 5.51 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 123.356 2.704 . . . . 0.0 113.517 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 m -74.95 139.39 73.19 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.696 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.7 118.67 5.56 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.182 2.588 . . . . 0.0 113.085 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.88 -39.6 89.42 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 123.273 2.649 . . . . 0.0 114.039 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.6 -84.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.49 1.568 . . . . 0.0 110.752 164.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 p -174.81 -46.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.104 0.962 . . . . 0.0 110.74 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.04 78.7 1.68 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.914 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -168.84 158.67 9.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.38 1.072 . . . . 0.0 109.216 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.01 -173.73 3.04 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.88 143.66 30.6 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.562 ' H ' ' HG2' ' A' ' 69' ' ' PRO . 1.8 pt? -166.69 80.95 0.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.61 0.719 . . . . 0.0 110.873 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB2' ' HD3' ' A' ' 69' ' ' PRO . 13.5 tp10 -76.05 -19.73 58.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.83 104.18 0.03 OUTLIER 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.53 1.532 . . . . 0.0 111.937 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.81 -170.44 31.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.759 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.53 108.31 17.23 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 16.3 m-85 -88.64 140.01 29.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 110.1 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.705 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 6.0 ptp180 -80.71 126.02 30.77 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 161.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.668 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 17.2 pt -122.14 135.45 62.23 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 CA-C-O 121.31 0.576 . . . . 0.0 111.251 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 86.8 tttt -135.16 138.96 44.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.857 1.663 . . . . 0.0 108.586 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.689 ' HB3' ' HB3' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -143.43 151.8 40.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 27.1 tttm -97.35 93.13 6.32 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 125.857 1.973 . . . . 0.0 107.698 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.458 ' HA3' HE22 ' A' ' 88' ' ' GLN . . . -172.88 173.45 45.55 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-O 118.705 -1.053 . . . . 0.0 110.932 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 52.2 mt 72.42 -64.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.802 0.841 . . . . 0.0 112.049 165.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.445 HD11 ' HD2' ' B' ' 253' ' ' LYS . 1.3 pp -132.68 -9.31 3.17 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.946 0.898 . . . . 0.0 111.87 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.71 -153.74 24.8 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.93 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 6.6 m-85 -88.57 120.89 30.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.219 1.007 . . . . 0.0 109.866 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB2' ' HE2' ' B' ' 253' ' ' LYS . 15.2 m -141.38 133.96 28.47 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 118.346 0.521 . . . . 0.0 110.912 167.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.63 ' HB2' ' H ' ' A' ' 51' ' ' GLY . 6.6 pt20 -95.5 105.15 17.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.03 1.332 . . . . 0.0 108.899 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -134.0 -41.32 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -164.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -111.5 -177.91 20.25 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 119.639 1.109 . . . . 0.0 115.639 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -124.17 124.11 41.75 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.398 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.94 121.02 3.8 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -105.71 118.69 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.984 0.892 . . . . 0.0 111.525 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 18.5 t80 -98.56 125.5 43.82 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -138.43 149.35 45.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.073 0.949 . . . . 0.0 109.187 168.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 145' ' ' LYS . 13.0 tp10 64.81 -82.19 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.796 1.238 . . . . 0.0 111.229 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -156.96 25.95 0.5 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 t -143.97 129.05 18.62 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.329 0.652 . . . . 0.0 110.876 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 68.9 t80 -96.48 86.55 4.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.447 ' HD2' HD11 ' A' ' 210' ' ' LEU . 67.1 t60 -95.14 120.39 35.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.272 -173.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.456 HG21 ' C5 ' ' B' ' 251' ' ' BEZ . 9.3 t -136.15 -156.56 0.72 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.929 0.891 . . . . 0.0 109.944 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.73 22.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.528 1.131 . . . . 0.0 110.677 -166.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -86.25 -49.96 7.31 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -60.59 -17.17 44.9 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 114' ' ' THR . 16.0 m -68.04 -57.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 C-N-CA 123.318 0.647 . . . . 0.0 110.81 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.573 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 23.2 m -149.43 142.93 25.36 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -75.81 18.74 0.24 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.91 62.57 0.75 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.41 168.85 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.645 0.778 . . . . 0.0 110.23 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.27 134.61 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.583 0.753 . . . . 0.0 113.016 -164.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.64 HD22 ' HE2' ' B' ' 252' ' ' NLE . 13.7 mt -98.14 161.06 13.9 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -172.11 175.02 3.87 Favored 'General case' 0 C--O 1.267 1.986 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 21.7 t60 -121.18 95.48 4.71 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.819 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.52 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 46.1 mttm 25.77 60.32 0.07 Allowed 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 125.376 1.471 . . . . 0.0 113.667 -164.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.63 58.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.0 -0.889 . . . . 0.0 114.777 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 121' ' ' HIS . 8.9 tmtt? -83.79 113.37 20.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.526 1.163 . . . . 0.0 108.836 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.65 131.48 50.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.444 1.498 . . . . 0.0 113.384 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -139.43 115.52 9.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 C-N-CA 125.137 1.375 . . . . 0.0 108.526 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.55 121.56 72.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.37 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.52 ' HG3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 Cg_exo -62.73 179.03 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.024 2.483 . . . . 0.0 113.595 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.1 t -120.39 -34.09 3.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 111.887 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.463 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.0 t-105 -156.45 151.74 26.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.38 0.272 . . . . 0.0 110.937 -170.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -151.24 124.33 8.72 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.233 1.413 . . . . 0.0 109.799 168.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.404 ' HB2' ' NE1' ' A' ' 130' ' ' TRP . 10.3 t70 -128.81 128.04 43.13 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.288 0.635 . . . . 0.0 109.621 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 t -75.48 -46.65 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.644 1.178 . . . . 0.0 110.872 -172.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -75.02 -45.94 38.38 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.367 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -15.9 60.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 61.98 43.33 9.17 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.562 1.164 . . . . 0.0 110.687 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -140.72 135.71 31.85 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.677 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 130' ' ' TRP . 46.3 mt -122.03 160.5 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.761 1.624 . . . . 0.0 108.479 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 53.9 p -153.86 155.53 35.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.185 0.448 . . . . 0.0 111.585 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.764 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.5 t80 -115.38 149.81 37.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.134 1.374 . . . . 0.0 108.917 170.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.78 -109.56 2.16 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.16 82.38 0.05 OUTLIER Glycine 0 C--O 1.239 0.452 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.51 136.92 2.95 Favored Glycine 0 C--O 1.239 0.425 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 146' ' ' LEU . 3.0 t-105 -105.76 106.31 16.75 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.536 1.168 . . . . 0.0 108.557 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HA ' ' OG ' ' A' ' 232' ' ' SER . 53.4 mtmt -131.19 123.44 28.49 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.984 0.913 . . . . 0.0 109.816 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.427 ' HB2' ' CH2' ' A' ' 144' ' ' TRP . 23.9 tp -129.63 -85.93 0.54 Allowed 'General case' 0 C--N 1.348 0.511 0 O-C-N 123.855 0.722 . . . . 0.0 109.285 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 233' ' ' ILE . 10.5 tp10 176.98 -66.02 0.01 OUTLIER 'General case' 0 C--N 1.361 1.077 0 O-C-N 123.759 0.662 . . . . 0.0 110.868 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.452 ' HA3' ' HE3' ' A' ' 206' ' ' LYS . . . -140.35 -161.94 8.91 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -166.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 228' ' ' GLN . 34.5 tt0 -148.32 163.86 35.79 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.046 1.339 . . . . 0.0 108.966 -167.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 208' ' ' VAL . 30.8 t90 -66.84 146.88 53.95 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 176.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.54 132.94 21.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.558 1.143 . . . . 0.0 109.218 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.82 162.95 28.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.339 0.656 . . . . 0.0 110.578 174.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.38 -31.21 4.91 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.28 138.66 31.23 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.921 0.888 . . . . 0.0 109.39 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.32 135.24 38.38 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 200' ' ' ILE . 36.0 m -106.11 140.43 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 123.434 0.694 . . . . 0.0 110.351 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -109.21 150.74 27.47 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.83 113.44 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.512 0.325 . . . . 0.0 110.77 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 167' ' ' PRO . 2.3 pt? -67.92 87.56 0.25 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 0.0 109.26 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 167' ' ' PRO . . . -71.13 111.61 6.62 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.392 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 167' ' ' PRO . 96.7 mt -68.78 80.34 0.29 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.34 125.33 86.94 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.791 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.81 114.27 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.108 2.539 . . . . 0.0 114.06 -170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.35 61.42 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.401 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -151.43 163.29 39.32 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.409 0.684 . . . . 0.0 110.286 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -61.85 157.67 48.3 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.146 0.978 . . . . 0.0 112.233 174.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.652 ' HB2' ' HB2' ' A' ' 159' ' ' LEU . 69.3 Cg_endo -69.8 117.02 4.84 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.675 2.25 . . . . 0.0 112.292 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -97.84 112.74 24.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 159' ' ' LEU . . . -72.05 101.78 2.82 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.207 0.527 . . . . 0.0 110.084 -175.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.428 HG11 HD21 ' A' ' 189' ' ' LEU . 44.9 t -85.33 109.52 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.413 -174.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -84.46 105.57 15.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.095 0.872 . . . . 0.0 108.879 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 HD12 ' A' ' 189' ' ' LEU . 9.8 t -127.99 157.61 40.13 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.865 1.266 . . . . 0.0 109.627 -174.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -99.41 160.23 28.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.49 159.05 33.39 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.198 1.932 . . . . 0.0 113.151 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -145.95 -171.14 15.18 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.12 149.52 30.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.661 0.73 . . . . 0.0 111.013 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 1.3 p90 -131.63 127.58 37.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.427 1.091 . . . . 0.0 109.453 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.552 ' HB2' HD11 ' A' ' 28' ' ' ILE . 43.9 tttm -78.58 132.01 36.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 -165.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 181' ' ' ALA . 32.7 m -90.68 162.98 14.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 109.228 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -54.34 -40.67 68.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 179' ' ' THR . . . -103.97 2.34 32.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.957 0.903 . . . . 0.0 112.995 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.47 -126.44 1.27 Allowed Glycine 0 C--N 1.351 1.408 0 C-N-CA 121.471 -0.395 . . . . 0.0 113.11 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.8 t -157.38 153.93 28.07 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.437 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mt -116.17 127.93 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.17 119.96 6.66 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.79 -156.22 0.49 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 0.0 109.798 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.42 106.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.876 0.846 . . . . 0.0 109.296 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.582 ' HA ' HG13 ' A' ' 223' ' ' VAL . 23.0 t -103.8 106.07 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 172' ' ' THR . 3.8 tt -128.54 129.63 46.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -172.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.752 ' HA ' ' HB1' ' A' ' 221' ' ' ALA . 8.7 p-10 -107.22 120.53 42.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.028 0.531 . . . . 0.0 109.708 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -170.88 168.48 7.13 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.553 1.141 . . . . 0.0 108.793 -171.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.9 p -54.36 136.07 60.91 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.284 0.634 . . . . 0.0 110.832 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.3 95.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 124.272 3.315 . . . . 0.0 114.932 -167.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.46 44.45 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.189 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 161' ' ' LEU . 7.7 t -103.87 143.98 32.11 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 112.244 -170.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.474 ' HA ' ' OH ' ' A' ' 222' ' ' TYR . 48.2 m -68.29 116.15 8.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.427 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.02 -4.48 23.97 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.356 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 75.5 m -52.19 118.81 13.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 122.963 0.505 . . . . 0.0 111.922 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.484 ' HG2' HD21 ' A' ' 159' ' ' LEU . 85.9 Cg_endo -79.53 141.07 15.46 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.755 2.303 . . . . 0.0 113.129 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.476 HD12 HG23 ' A' ' 226' ' ' ILE . 14.4 mt -93.49 111.07 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.552 HD12 HD22 ' A' ' 159' ' ' LEU . 45.6 mt -119.23 155.76 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 110.236 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.63 164.61 12.34 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.665 1.186 . . . . 0.0 108.377 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.27 -24.27 64.8 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.653 1.181 . . . . 0.0 112.098 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -71.1 -16.66 62.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.043 1.337 . . . . 0.0 111.818 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.86 78.18 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HE3' ' HA3' ' A' ' 148' ' ' GLY . 41.2 tttp -86.83 121.53 29.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.475 1.11 . . . . 0.0 108.437 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.42 109.31 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 150' ' ' TRP . 10.7 p -92.61 7.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.192 0.997 . . . . 0.0 110.237 -173.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.3 -164.9 32.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.846 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 49.5 mt -137.16 150.61 48.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -69.37 108.27 3.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.14 -133.78 4.93 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.833 1.333 . . . . 0.0 112.9 -171.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.445 ' O ' ' SD ' ' A' ' 39' ' ' MET . 3.3 t-20 -67.38 97.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -162.16 -162.46 13.34 Favored Glycine 0 C--O 1.244 0.738 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.221 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 41' ' ' ILE . 12.2 p -167.03 168.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.6 0.76 . . . . 0.0 109.625 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 17.3 m -68.99 114.32 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 221' ' ' ALA . 6.0 t -81.18 -178.65 7.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.382 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -36.39 117.42 0.48 Allowed 'General case' 0 C--N 1.36 1.036 0 O-C-N 125.375 1.672 . . . . 0.0 112.403 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.5 t 86.46 6.04 0.36 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.063 1.745 . . . . 0.0 112.085 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.8 32.28 9.3 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.596 -0.275 . . . . 0.0 113.149 174.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -98.07 105.01 17.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 196' ' ' SER . 10.3 t80 -67.09 103.45 1.19 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 188' ' ' SER . 87.6 t -118.33 139.6 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.112 1.365 . . . . 0.0 108.694 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.507 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 44.8 t -153.4 156.58 38.51 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.025 0.44 . . . . 0.0 111.932 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.0 130.62 41.4 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.476 HG23 HD12 ' A' ' 200' ' ' ILE . 69.2 mt -70.85 111.88 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.607 0.363 . . . . 0.0 110.67 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -74.64 152.51 39.19 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 11.0 pt20 -145.1 162.27 37.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.653 0.781 . . . . 0.0 110.439 -172.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 26.6 m -85.21 108.88 17.94 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -105.24 32.87 3.96 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.956 0.902 . . . . 0.0 109.827 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -141.21 -70.13 0.37 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.007 0.523 . . . . 0.0 109.954 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 145' ' ' LYS . 19.8 p -107.31 99.16 8.71 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.795 0.838 . . . . 0.0 111.829 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 147' ' ' GLU . 48.6 mt -124.68 122.82 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -131.21 106.92 8.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 110.276 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -92.3 -18.34 23.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.586 0.754 . . . . 0.0 111.678 175.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -71.49 113.67 21.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 123.157 0.583 . . . . 0.0 109.946 -172.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -86.54 12.06 3.11 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.324 2.683 . . . . 0.0 114.409 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 -32.1 67.97 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.353 0.524 . . . . 0.0 110.756 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.7 -27.52 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.762 0.825 . . . . 0.0 110.146 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 123.562 0.745 . . . . 0.0 109.462 178.478 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.668 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.689 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 95' ' ' SER . 2.9 tppp? -130.24 140.51 50.7 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.612 1.165 . . . . 0.0 108.713 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 70.79 138.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.43 1.092 . . . . 0.0 111.396 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.279 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 p -165.1 134.57 3.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.471 1.108 . . . . 0.0 108.023 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.89 165.54 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.758 1.223 . . . . 0.0 111.756 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 81.0 21.63 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.116 1.367 . . . . 0.0 112.028 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.2 t70 -168.07 52.47 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 88' ' ' GLN . 53.2 mt -86.59 91.02 8.44 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.677 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 121' ' ' HIS . 13.0 mm-40 -87.23 124.37 33.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.2 1.0 . . . . 0.0 110.988 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.15 125.99 43.41 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . 33.2 tt0 -109.61 157.94 18.54 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 167.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 67' ' ' ASP . 21.3 ttt180 -92.96 141.7 28.12 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.822 1.192 . . . . 0.0 110.904 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.29 -55.71 2.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.44 -159.97 0.84 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.899 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.47 153.44 20.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.185 0.594 . . . . 0.0 110.141 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.585 HG12 HG21 ' A' ' 201' ' ' ILE . 3.0 t -79.58 97.93 2.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -173.94 164.47 4.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.643 0.777 . . . . 0.0 109.19 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -64.48 126.31 27.45 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.107 0.563 . . . . 0.0 111.475 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 10.8 tp10 -97.1 145.57 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.164 0.986 . . . . 0.0 109.042 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -9.72 2.3 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.679 1.191 . . . . 0.0 113.49 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.499 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 28.5 mm-40 -80.81 51.78 1.59 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.954 1.302 . . . . 0.0 111.161 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.29 3.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.286 1.034 . . . . 0.0 112.05 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 170' ' ' VAL . 48.5 mt-10 -94.42 91.54 6.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.003 0.921 . . . . 0.0 110.443 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 171' ' ' GLN . 17.7 mt -79.25 102.85 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -158.11 -35.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.114 0.566 . . . . 0.0 111.023 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.09 99.43 0.04 OUTLIER Glycine 0 C--N 1.356 1.654 0 O-C-N 124.067 0.854 . . . . 0.0 113.979 -170.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.6 p 168.3 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.927 1.691 . . . . 0.0 108.093 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 190' ' ' ASP . 77.4 p -70.13 159.79 83.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.28 175.66 1.02 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.183 1.922 . . . . 0.0 112.931 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.79 111.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.573 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 55.9 tp -102.93 134.88 45.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -164.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.6 t -80.55 114.3 19.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 223' ' ' VAL . 33.1 mt -113.38 148.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.476 ' OG1' ' HG3' ' A' ' 42' ' ' LYS . 6.7 m -91.83 105.37 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 179' ' ' THR . 10.1 tp -79.85 156.5 4.58 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.015 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.7 m -145.34 114.24 6.9 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.224 0.61 . . . . 0.0 110.178 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 62.4 14.51 6.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.748 1.219 . . . . 0.0 112.142 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.2 t70 74.74 -20.07 0.35 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.557 1.943 . . . . 0.0 112.482 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.67 -48.23 3.49 Favored Glycine 0 C--N 1.353 1.489 0 C-N-CA 123.137 0.398 . . . . 0.0 112.675 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.8 p -100.56 157.52 16.6 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -145.42 135.58 23.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.137 0.575 . . . . 0.0 110.156 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.3 p -154.12 -178.15 6.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 109.592 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 215' ' ' VAL . 9.4 tp -107.05 156.16 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 7.3 mtpm? -67.84 113.24 5.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 163.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.55 91.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.368 1.467 . . . . 0.0 110.528 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.51 116.68 32.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.285 0.634 . . . . 0.0 109.8 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.02 114.49 4.23 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.532 0.733 . . . . 0.0 109.275 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.74 138.27 12.9 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -173.79 116.14 0.23 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -156.5 136.76 12.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 14.7 t -77.48 -168.24 1.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.653 0.781 . . . . 0.0 111.525 -173.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' ' 161' ' ' LEU . 1.9 tt -153.14 -54.84 0.12 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.09 -19.55 60.78 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.064 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.65 28.58 6.91 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.051 0.358 . . . . 0.0 113.494 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.17 68.27 3.47 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 169.65 71.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -74.35 166.81 22.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.539 0.735 . . . . 0.0 112.234 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.08 -20.72 2.83 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.232 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.56 -114.01 1.45 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.55 172.54 38.06 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 122.969 0.319 . . . . 0.0 113.552 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.84 19.01 35.97 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.661 -0.521 . . . . 0.0 112.978 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -22.36 62.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.889 1.276 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -65.54 -47.17 76.8 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.248 1.019 . . . . 0.0 111.094 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.65 -72.34 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.848 0.459 . . . . 0.0 110.533 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.04 123.35 7.31 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HD2' ' A' ' 122' ' ' LYS . 7.0 t -91.11 171.29 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 117.714 0.757 . . . . 0.0 108.994 -165.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -93.34 140.42 29.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.419 0.688 . . . . 0.0 112.105 173.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.532 ' HB3' ' CE1' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -152.79 -176.38 5.72 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.232 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 27.4 t70 -177.98 68.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 84' ' ' TYR . 15.4 m -134.73 164.31 44.93 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.958 -162.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.645 ' HB3' HD22 ' A' ' 79' ' ' LEU . 29.3 Cg_endo -60.76 124.57 15.25 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.893 2.395 . . . . 0.0 112.892 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 m -100.72 -179.33 0.8 Allowed Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.389 1.076 . . . . 0.0 109.312 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -38.22 137.71 0.48 Allowed 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 123.864 3.042 . . . . 0.0 114.805 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.13 -36.12 54.18 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 124.342 3.361 . . . . 0.0 116.023 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.54 -141.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.096 1.864 . . . . 0.0 110.989 165.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 p 57.56 16.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 C-N-CA 125.571 1.548 . . . . 0.0 113.135 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.83 -31.56 5.12 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.828 -0.429 . . . . 0.0 112.462 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 76.29 -45.76 0.52 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.042 1.737 . . . . 0.0 113.401 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.94 85.07 0.08 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.542 0.737 . . . . 0.0 110.123 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -173.73 93.61 0.09 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.571 1.148 . . . . 0.0 108.263 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -146.54 -59.6 0.3 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER 60.4 41.58 15.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.851 0.861 . . . . 0.0 112.524 168.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 103' ' ' LYS . 7.8 p-10 -70.48 129.32 38.92 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.774 0.321 . . . . 0.0 110.483 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' H ' ' HE1' ' A' ' 84' ' ' TYR . . . 172.82 -146.86 9.34 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.019 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.14 108.87 17.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.618 ' HE2' HG12 ' A' ' 68' ' ' VAL . 14.0 m-85 -89.44 158.42 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.642 0.777 . . . . 0.0 112.064 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 83.4 mtt180 -93.43 156.85 16.52 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.089 1.356 . . . . 0.0 110.136 163.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.81 HG12 ' HD2' ' B' ' 252' ' ' NLE . 0.6 OUTLIER -126.36 106.32 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.641 -166.099 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 80.7 tttt -124.4 131.91 53.51 Favored 'General case' 0 C--N 1.406 3.045 0 C-N-CA 124.725 1.21 . . . . 0.0 113.048 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB2' HD23 ' A' ' 6' ' ' LEU . 6.9 tp60 -134.27 151.2 51.15 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -87.48 85.58 7.14 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.71 169.85 40.91 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 114.032 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.801 HG12 ' HD2' ' B' ' 253' ' ' LYS 0.254 0.1 OUTLIER 30.2 39.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.3 2.24 . . . . 0.0 114.323 178.708 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp 158.13 -57.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 128.261 2.624 . . . . 0.0 106.177 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.0 -152.43 24.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.573 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -58.96 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.727 0.811 . . . . 0.0 110.227 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.4 m -143.54 123.79 13.78 Favored 'General case' 0 C--O 1.256 1.418 0 CA-C-N 118.471 0.578 . . . . 0.0 111.171 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.53 119.61 32.17 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 166.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 86' ' ' ILE . 1.9 pp -124.84 -42.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -115.79 -163.9 13.88 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.01 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.17 122.33 36.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.912 0.485 . . . . 0.0 110.101 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.97 174.87 26.95 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 14' ' ' VAL . 54.9 t -137.24 135.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 34.9 t80 -151.27 122.57 7.8 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 5.9 mtmp? -135.92 136.46 40.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 61.95 -81.67 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.948 1.405 . . . . 0.0 111.989 170.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.05 28.98 1.12 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-O 120.188 -0.229 . . . . 0.0 112.666 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -144.47 125.27 14.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 0.0 110.139 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 5.7 t80 -97.91 121.22 39.56 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -110.14 108.25 18.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.069 0.948 . . . . 0.0 109.41 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 138' ' ' ILE . 10.1 t -136.46 -156.37 0.7 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.366 0.666 . . . . 0.0 110.261 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.515 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 31.6 ttm -149.37 152.44 35.79 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -154.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -43.25 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.438 1.095 . . . . 0.0 113.019 -176.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 4.3 p-80 -64.86 -22.44 66.99 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.144 0.429 . . . . 0.0 111.31 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.72 -44.23 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.699 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 96.8 m -148.89 147.61 28.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 119.242 0.928 . . . . 0.0 109.214 166.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -71.52 32.73 0.05 Allowed 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 126.275 1.83 . . . . 0.0 115.857 -168.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.446 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 87.41 45.77 5.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.68 0.673 . . . . 0.0 113.264 171.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -97.46 -169.73 1.89 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.115 0.566 . . . . 0.0 112.296 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 127' ' ' GLU . 8.9 p -100.45 139.75 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.642 1.177 . . . . 0.0 111.986 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' ' CZ ' ' A' ' 140' ' ' TYR . 16.0 mt -85.27 171.4 11.95 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 118.078 0.399 . . . . 0.0 111.271 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.73 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.9 ptp -178.5 177.3 0.94 Allowed 'General case' 0 C--O 1.283 2.845 0 CA-C-O 122.17 0.986 . . . . 0.0 112.37 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -166.33 120.87 1.14 Allowed 'General case' 0 C--N 1.365 1.26 0 CA-C-N 113.384 -1.735 . . . . 0.0 114.173 167.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 19.1 mtpp 48.48 40.62 15.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.82 1.325 . . . . 0.0 113.34 158.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.28 19.25 14.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.742 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' MET . 13.0 tppt? -137.11 158.83 43.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.353 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -143.58 124.95 14.68 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.859 1.209 . . . . 0.0 112.795 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.462 HD12 HD21 ' A' ' 8' ' ' LEU . 60.3 mt -103.74 118.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.264 1.425 . . . . 0.0 109.592 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HA ' HG23 ' A' ' 118' ' ' VAL . 33.8 mt-10 -87.92 138.42 31.13 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.642 0.777 . . . . 0.0 112.096 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 73.9 Cg_endo -71.86 156.37 56.75 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.312 2.674 . . . . 0.0 113.69 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 p -124.06 -20.68 5.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.554 0.742 . . . . 0.0 110.975 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 17.5 t-105 -148.77 146.02 27.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.544 0.737 . . . . 0.0 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.49 125.75 8.0 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.205 1.402 . . . . 0.0 108.573 167.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -138.47 128.21 25.08 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.506 0.593 . . . . 0.0 111.114 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.34 -32.18 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.913 0.885 . . . . 0.0 111.341 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 134' ' ' LYS . 3.4 mptp? -73.37 -38.1 65.81 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.065 0.946 . . . . 0.0 110.051 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.51 -17.07 37.47 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.727 0.811 . . . . 0.0 109.461 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 59.53 36.39 22.88 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 125.025 1.33 . . . . 0.0 109.482 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 1.5 mp -137.84 140.67 40.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.671 0.748 . . . . 0.0 110.563 -169.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 109' ' ' THR . 73.1 mt -124.09 148.03 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.765 1.626 . . . . 0.0 108.251 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 32.9 t -141.91 143.7 33.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 111.265 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.721 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 3.5 m-85 -119.88 146.26 45.93 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.998 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.08 35.97 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.499 0.499 . . . . 0.0 112.2 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 159.3 -161.39 32.05 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.9 132.7 11.35 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 166.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.695 ' NE1' ' HA ' ' A' ' 229' ' ' THR . 4.9 p90 -75.7 107.68 8.03 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.193 0.997 . . . . 0.0 111.169 -169.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -116.33 116.37 27.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.525 ' HB2' HG21 ' A' ' 229' ' ' THR . 5.7 mp -131.62 -66.51 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 172.11 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.708 0.803 . . . . 0.0 109.407 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 207' ' ' VAL . . . -47.31 109.64 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 118.065 1.986 . . . . 0.0 118.065 -162.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -142.59 94.23 2.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.574 ' HE3' HD13 ' A' ' 200' ' ' ILE . 7.8 t90 -56.75 109.91 0.71 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.25 123.64 32.47 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.407 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.82 135.86 35.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.984 0.914 . . . . 0.0 111.663 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.429 ' H ' ' HG3' ' A' ' 174' ' ' PRO . . . 110.48 -59.22 0.36 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.0 111.28 17.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.622 0.769 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.46 152.39 40.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.194 0.598 . . . . 0.0 111.736 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.782 HG21 HG23 ' A' ' 200' ' ' ILE . 34.6 m -124.8 -169.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.532 1.133 . . . . 0.0 109.89 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.683 ' HG2' ' HG3' ' A' ' 171' ' ' GLN . 59.8 mt-30 -126.04 167.12 15.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.965 1.306 . . . . 0.0 109.065 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 13.5 p -140.26 148.92 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 122.985 0.514 . . . . 0.0 110.51 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.9 mt -97.54 95.21 7.47 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.98 0.809 . . . . 0.0 109.907 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 168' ' ' ARG . . . -76.48 99.97 5.1 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 168.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.513 ' HB3' HD21 ' A' ' 50' ' ' LEU . 88.0 mt -86.66 106.02 17.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.544 0.738 . . . . 0.0 109.494 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.27 159.63 29.04 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.551 0.74 . . . . 0.0 111.135 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.37 113.61 1.2 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 124.123 3.216 . . . . 0.0 115.165 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.45 8.81 40.44 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.016 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.2 158.91 16.5 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.982 0.913 . . . . 0.0 110.636 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.1 p30 -63.47 157.62 63.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.539 174.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.55 103.19 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.544 2.163 . . . . 0.0 111.134 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 160' ' ' ALA . 80.2 mtp180 -72.99 96.71 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.02 99.84 7.86 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 21' ' ' GLU . 94.9 t -102.72 122.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.362 0.665 . . . . 0.0 109.751 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.683 ' HG3' ' HG2' ' A' ' 157' ' ' GLN . 2.1 mp0 -82.15 119.35 23.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -127.67 141.29 51.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.142 0.977 . . . . 0.0 111.368 -173.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -98.27 160.14 28.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.539 1.536 . . . . 0.0 109.481 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HG3' ' H ' ' A' ' 153' ' ' GLY . 64.3 Cg_endo -73.52 124.1 9.1 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.696 1.597 . . . . 0.0 111.216 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.06 -172.79 26.34 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.291 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.1 133.58 9.9 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.573 ' HD1' ' HB3' ' A' ' 29' ' ' LEU . 29.0 m-85 -121.79 126.5 48.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.818 0.847 . . . . 0.0 109.298 -165.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -73.06 117.92 15.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.604 0.716 . . . . 0.0 109.215 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.473 HG23 ' HB ' ' A' ' 33' ' ' ILE . 91.0 m -120.65 147.82 44.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.927 1.291 . . . . 0.0 109.479 -170.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -78.98 65.57 4.2 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 178.46 -43.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.832 1.653 . . . . 0.0 108.214 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 178.28 -127.33 1.15 Allowed Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.131 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 m -144.18 128.58 17.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.647 0.779 . . . . 0.0 109.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.2 mt -104.1 122.88 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.877 0.871 . . . . 0.0 109.245 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.31 106.61 3.17 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.32 178.55 9.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.971 0.909 . . . . 0.0 109.975 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.05 131.83 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.3 p -111.0 89.67 3.11 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.168 0.987 . . . . 0.0 109.385 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.518 ' HB3' ' O ' ' A' ' 222' ' ' TYR . 3.4 tm? -106.78 124.81 50.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 30.5 t70 -125.49 105.18 8.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 108.678 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -163.86 -173.5 3.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.075 1.35 . . . . 0.0 109.043 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 77.6 p -51.9 149.41 9.02 Favored Pre-proline 0 CA--C 1.556 1.185 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.759 159.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.416 ' HB2' ' NH1' ' B' ' 255' ' ' M9P . 9.4 Cg_endo -47.71 114.42 1.07 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.139 2.56 . . . . 0.0 112.834 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 222' ' ' TYR . . . -72.67 163.02 54.82 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.898 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 120.72 27.61 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.979 0.512 . . . . 0.0 110.025 -172.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.0 m -59.88 115.1 3.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.639 0.776 . . . . 0.0 110.343 173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.93 17.18 33.36 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 124.107 0.879 . . . . 0.0 112.426 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . 0.414 ' HB3' HG22 ' A' ' 158' ' ' VAL . 56.5 m -64.61 127.65 92.63 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 117.113 0.457 . . . . 0.0 111.059 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.79 138.45 11.78 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.085 2.524 . . . . 0.0 114.483 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.782 HG23 HG21 ' A' ' 156' ' ' VAL . 62.3 mt -85.25 99.72 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.039 1.336 . . . . 0.0 109.121 176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.585 HG21 HG12 ' A' ' 14' ' ' VAL . 20.8 pt -124.25 156.6 31.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.058 0 CA-C-O 121.368 0.604 . . . . 0.0 111.895 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 15.5 t70 -90.84 176.01 6.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.643 1.177 . . . . 0.0 108.975 174.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.484 ' HG2' ' NE2' ' A' ' 157' ' ' GLN . 38.0 mtpt -56.61 -27.19 57.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.695 1.198 . . . . 0.0 112.681 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -95.54 -6.58 40.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.68 0.792 . . . . 0.0 111.941 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.81 46.64 5.34 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 57.9 tttm -115.25 162.49 17.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.278 1.431 . . . . 0.0 108.932 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.583 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 59.4 t 79.99 -58.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 C-N-CA 125.191 1.396 . . . . 0.0 110.731 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 146' ' ' LEU . 10.9 m 57.09 26.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 124.278 1.031 . . . . 0.0 112.521 167.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.18 -153.96 1.97 Allowed Glycine 0 C--N 1.361 1.969 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.7 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.0 mt -150.04 155.85 40.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 117.969 0.884 . . . . 0.0 111.27 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -82.12 104.12 12.23 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 165.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.75 -137.12 3.2 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 123.469 0.557 . . . . 0.0 114.202 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -71.22 103.64 2.86 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -141.27 -136.69 3.32 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.7 p -165.95 156.61 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 222' ' ' TYR . 22.2 t -84.61 110.26 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.447 HG21 HD21 ' A' ' 29' ' ' LEU . 95.0 m -85.97 148.24 25.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.283 1.033 . . . . 0.0 109.407 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 49.52 30.38 3.44 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.476 1.51 . . . . 0.0 112.846 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 93.4 p 56.45 27.45 12.18 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.289 1.836 . . . . 0.0 112.733 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -162.34 -53.83 0.02 OUTLIER Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.202 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.36 95.18 0.59 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.119 0.567 . . . . 0.0 110.478 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.57 ' HB2' ' H ' ' A' ' 194' ' ' GLY . 30.9 t80 -74.41 98.62 3.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 31' ' ' ILE . 78.0 t -98.78 146.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.746 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 23.1 t -159.21 158.93 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.43 142.12 46.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.572 167.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.8 mt -73.28 102.5 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.62 0.768 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -91.03 143.29 26.86 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.788 0.435 . . . . 0.0 110.037 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.58 172.43 12.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.411 1.084 . . . . 0.0 111.44 -167.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.695 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 65.8 p -74.2 133.17 42.71 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.255 0.622 . . . . 0.0 111.668 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.34 -29.31 69.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.762 0.825 . . . . 0.0 110.588 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 63.5 tttp 60.65 35.04 19.96 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 122.372 1.082 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 11.6 p -71.7 100.36 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.649 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.567 HG23 ' HG3' ' A' ' 238' ' ' GLU . 7.6 tp -137.82 10.25 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.101 0.96 . . . . 0.0 110.392 -172.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -60.77 -26.14 67.03 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.617 0.767 . . . . 0.0 113.009 -172.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.3 -33.23 75.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.102 0.561 . . . . 0.0 111.751 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -108.52 159.61 30.18 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.244 1.017 . . . . 0.0 108.877 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -56.31 131.32 45.05 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 121.443 1.429 . . . . 0.0 110.688 165.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . 0.567 ' HG3' HG23 ' A' ' 233' ' ' ILE . 1.9 mp0 -68.51 79.96 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.796 0.838 . . . . 0.0 111.527 -172.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 50.8 mt -121.15 82.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.549 0.931 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.414 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.699 ' H2 ' ' HB ' ' A' ' 114' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.81 ' HD2' HG12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HD2' HG12 ' A' ' 91' ' ' ILE . 8.3 tmtt? -147.23 138.18 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 108.718 172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.451 ' H ' ' HD3' ' B' ' 253' ' ' LYS . 16.5 tpt180 97.37 111.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 127.726 2.41 . . . . 0.0 107.9 -163.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 255' ' ' M9P . . . . . 0.416 ' NH1' ' HB2' ' A' ' 193' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m 65.88 22.18 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.811 1.244 . . . . 0.0 113.229 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB2' ' NH2' ' A' ' 115' ' ' ARG . . . -167.55 16.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -165.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -161.56 -24.47 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.212 0.605 . . . . 0.0 111.367 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -87.82 36.59 0.77 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 126.713 2.005 . . . . 0.0 110.579 -159.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.703 ' HG ' ' HG3' ' A' ' 88' ' ' GLN . 4.3 mp -118.84 103.46 9.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 0.0 109.737 -165.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.498 ' O ' HD12 ' A' ' 65' ' ' LEU . 62.2 tt0 -109.13 153.02 24.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 68' ' ' VAL . 3.7 mp -91.8 148.95 21.85 Favored 'General case' 0 N--CA 1.515 2.791 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.532 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.852 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 25.2 tt0 -140.63 133.5 29.08 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.264 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -73.88 127.27 32.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.221 0.919 . . . . 0.0 111.857 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.56 -42.38 8.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.038 0.935 . . . . 0.0 109.569 174.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.53 -162.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -107.16 158.45 17.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.467 0.707 . . . . 0.0 109.814 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 103' ' ' LYS . 2.3 t -74.78 97.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 169.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -168.39 151.74 5.63 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -164.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -71.87 137.49 47.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 169' ' ' ALA . 11.2 tp10 -106.77 133.77 50.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.512 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.7 -8.21 52.73 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.789 0.836 . . . . 0.0 113.076 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 1.4 mp0 -84.69 50.78 1.97 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.651 0.78 . . . . 0.0 109.815 176.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.54 118.83 23.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.42 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -132.48 138.41 47.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.636 0.774 . . . . 0.0 109.4 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.47 126.69 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -145.06 -41.8 0.23 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.294 0.638 . . . . 0.0 109.851 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.56 97.35 0.33 Allowed Glycine 0 C--N 1.356 1.66 0 O-C-N 123.455 0.472 . . . . 0.0 113.807 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -171.92 90.45 0.12 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.599 1.16 . . . . 0.0 109.055 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -115.13 151.53 45.79 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.394 0.677 . . . . 0.0 109.767 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 -163.71 0.19 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.57 110.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.2 tp -101.83 143.04 32.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.04 0.448 . . . . 0.0 111.499 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -91.61 112.24 24.08 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.258 0.623 . . . . 0.0 109.722 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.8 mt -118.27 157.48 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 124.705 1.202 . . . . 0.0 108.139 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.46 HG21 ' HE3' ' A' ' 42' ' ' LYS . 53.6 p -93.97 107.42 19.33 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.954 0.797 . . . . 0.0 109.353 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 39' ' ' MET . 1.8 mp -83.13 123.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.783 0.833 . . . . 0.0 109.138 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -102.95 138.67 39.52 Favored 'General case' 0 C--O 1.264 1.819 0 C-N-CA 123.896 0.878 . . . . 0.0 112.479 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 55.69 -86.59 0.02 OUTLIER 'General case' 0 C--N 1.356 0.871 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.056 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -156.56 100.8 1.97 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.66 -0.83 87.62 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.172 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 m -95.61 160.46 14.49 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 118.835 1.318 . . . . 0.0 108.527 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.518 ' HB3' HG13 ' A' ' 33' ' ' ILE . 2.8 ppp? -160.42 144.32 13.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.903 0.481 . . . . 0.0 110.203 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 p -165.73 174.33 9.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.462 0.705 . . . . 0.0 110.265 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 217' ' ' THR . 10.3 tp -104.89 155.87 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HE3' HG21 ' A' ' 32' ' ' THR . 99.6 mttt -81.57 123.34 28.58 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 71.99 114.45 0.05 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.668 1.587 . . . . 0.0 110.451 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.12 93.22 0.95 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.677 0.791 . . . . 0.0 110.847 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.29 -77.33 0.52 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 63.84 120.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.858 1.663 . . . . 0.0 113.121 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.38 177.71 11.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.166 0.586 . . . . 0.0 111.403 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 55.48 -137.76 1.11 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 124.959 1.304 . . . . 0.0 110.745 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 163' ' ' PRO . 49.1 p 55.41 41.69 30.76 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.92 1.288 . . . . 0.0 113.164 169.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -169.43 118.72 0.65 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.056 1.743 . . . . 0.0 107.682 170.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.65 -72.15 1.04 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 123.807 0.692 . . . . 0.0 112.957 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.69 -96.64 0.1 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.85 -62.18 0.36 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.61 57.23 0.03 OUTLIER Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.6 t -71.32 100.35 2.13 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.784 0.833 . . . . 0.0 109.729 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.83 117.28 0.4 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.45 85.44 0.34 Allowed Glycine 0 C--N 1.352 1.433 0 CA-C-N 117.086 0.443 . . . . 0.0 112.097 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.64 170.72 38.98 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -172.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.38 -167.35 14.23 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 122.545 0.117 . . . . 0.0 112.949 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.52 35.75 2.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.765 0.826 . . . . 0.0 111.018 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -72.57 9.0 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.099 0.56 . . . . 0.0 112.149 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.2 61.93 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.922 1.289 . . . . 0.0 111.148 160.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.65 119.9 12.44 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 163.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 7' ' ' GLU . 4.5 t -87.21 -86.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -161.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.852 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 88.6 mt -143.11 -155.15 0.57 Allowed 'General case' 0 C--O 1.201 -1.469 0 C-N-CA 124.35 1.06 . . . . 0.0 109.854 -170.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 6.0 m0 -166.98 87.47 0.3 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 124.036 0.934 . . . . 0.0 112.881 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 5.6 t0 174.65 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 124.757 1.223 . . . . 0.0 109.729 159.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 8' ' ' LEU . 74.5 t -133.87 150.99 76.07 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.295 -168.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.26 80.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.535 0 C-N-CA 123.32 2.68 . . . . 0.0 112.579 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 t -130.45 85.73 55.5 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 73.0 Cg_endo -92.1 105.27 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.495 2.13 . . . . 0.0 114.197 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.66 -177.69 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.984 2.456 . . . . 0.0 110.393 165.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.44 19.19 1.42 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 121.857 1.704 . . . . 0.0 112.694 166.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 137.69 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.283 1.033 . . . . 0.0 110.377 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.14 57.53 13.33 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 123.686 0.616 . . . . 0.0 113.522 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 61.83 15.18 6.86 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.946 1.298 . . . . 0.0 112.444 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 68.83 0.38 2.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.322 1.449 . . . . 0.0 112.938 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 55.14 -75.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.631 -168.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 80.33 -48.99 0.33 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 127.008 2.123 . . . . 0.0 110.374 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 77.78 133.88 0.06 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.579 1.551 . . . . 0.0 109.122 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -168.45 114.98 0.66 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.51 -155.81 26.35 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.19 129.82 50.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.994 1.318 . . . . 0.0 109.066 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 12.6 m-85 -123.92 146.69 48.28 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -162.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.662 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 30.4 mtt85 -86.8 126.92 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 161.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.647 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 9.2 pt -126.88 134.45 66.18 Favored 'Isoleucine or valine' 0 C--O 1.267 2.016 0 O-C-N 122.032 -0.417 . . . . 0.0 110.971 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.814 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 80.7 tttt -125.66 142.82 51.32 Favored 'General case' 0 C--N 1.387 2.2 0 C-N-CA 125.681 1.592 . . . . 0.0 111.795 -169.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.703 ' HG3' ' HG ' ' A' ' 6' ' ' LEU . 48.1 tt0 -121.88 152.71 39.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.588 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -105.0 90.9 3.59 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 123.05 1.405 . . . . 0.0 107.883 155.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.8 172.59 43.78 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.292 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 48.0 mt 60.91 -81.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.097 1.359 . . . . 0.0 111.021 166.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' B' ' 253' ' ' LYS . 50.6 tp -93.69 -46.12 7.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.3 1.04 . . . . 0.0 110.535 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.46 -150.08 11.16 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 116.386 -0.37 . . . . 0.0 113.513 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -104.41 88.11 2.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.621 1.168 . . . . 0.0 107.899 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -141.55 132.93 26.68 Favored 'General case' 0 C--O 1.257 1.48 0 CA-C-N 118.514 0.597 . . . . 0.0 112.521 -170.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 8.6 pt20 -94.09 114.87 27.11 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 125.36 1.464 . . . . 0.0 109.077 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -133.67 -35.66 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.13 -166.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.78 168.95 21.78 Favored Glycine 0 N--CA 1.48 1.625 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.249 -162.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -110.15 123.21 49.32 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.44 129.56 9.52 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 199' ' ' PRO . 27.8 t -110.83 103.76 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.692 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 21.2 t80 -116.36 140.11 49.69 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 170.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 79.5 tttt -169.34 152.88 5.05 Favored 'General case' 0 C--O 1.245 0.841 0 O-C-N 123.955 0.785 . . . . 0.0 109.358 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 69.97 -69.58 0.17 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.785 1.634 . . . . 0.0 110.119 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.43 10.85 0.07 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.25 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -133.64 150.13 51.58 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.802 0.801 . . . . 0.0 111.371 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 90.7 t80 -109.96 122.55 47.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.543 1.137 . . . . 0.0 108.435 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HE1' HD22 ' A' ' 137' ' ' LEU . 54.3 t-80 -132.2 111.76 11.69 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -175.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.588 HG21 ' H5 ' ' B' ' 251' ' ' BEZ . 15.1 t -134.69 -165.22 1.63 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.089 1.356 . . . . 0.0 108.388 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.842 ' SD ' ' HA3' ' A' ' 212' ' ' GLY . 31.5 mmt -99.65 162.19 13.16 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.828 1.195 . . . . 0.0 113.722 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.402 ' HB2' ' N ' ' A' ' 137' ' ' LEU . 1.5 t90 -86.24 -52.99 5.3 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.6 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -57.34 -24.33 54.48 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.872 1.269 . . . . 0.0 113.09 -170.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 254' ' ' ARG . 22.6 m -62.51 -12.63 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 124.432 1.093 . . . . 0.0 113.038 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.83 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -160.72 -157.24 0.52 Allowed 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.727 1.211 . . . . 0.0 109.535 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 27.8 ptt180 -119.65 14.85 12.71 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.252 1.021 . . . . 0.0 111.021 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.83 ' H ' HG23 ' A' ' 114' ' ' THR . . . 94.28 58.54 1.21 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 124.152 0.882 . . . . 0.0 111.437 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.6 165.1 12.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 127' ' ' GLU . 2.2 p -98.58 144.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.326 1.05 . . . . 0.0 109.844 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.713 HD22 ' HE2' ' B' ' 252' ' ' NLE . 29.1 mt -103.46 179.22 4.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.403 0.681 . . . . 0.0 111.965 -166.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.4 ptp -168.96 178.44 4.51 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 13.7 t60 -127.23 95.0 4.15 Favored 'General case' 0 C--N 1.369 1.42 0 CA-C-N 110.214 -3.175 . . . . 0.0 107.946 164.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 mttt 34.81 64.29 0.42 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 125.234 1.414 . . . . 0.0 113.778 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.42 24.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.246 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -88.33 111.66 21.98 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.532 0.666 . . . . 0.0 109.624 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -105.08 130.37 53.29 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.289 -0.257 . . . . 0.0 111.1 -163.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.8 pt -119.53 130.37 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.308 1.043 . . . . 0.0 109.772 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.758 ' HA ' HG23 ' A' ' 118' ' ' VAL . 10.6 pt-20 -95.63 139.8 22.06 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.089 0.556 . . . . 0.0 111.658 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 62.4 Cg_endo -71.7 149.38 54.61 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.655 2.236 . . . . 0.0 111.734 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 9.9 p -85.68 -17.48 35.9 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.704 0.802 . . . . 0.0 111.784 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -163.24 157.85 20.83 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 120.665 0.269 . . . . 0.0 111.231 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.12 118.8 14.02 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.381 1.072 . . . . 0.0 109.535 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 135' ' ' LYS . 14.7 m-20 -102.58 110.26 22.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.387 1.475 . . . . 0.0 110.857 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.08 -48.81 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.882 0.473 . . . . 0.0 110.807 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.04 -44.58 76.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.095 0.558 . . . . 0.0 111.23 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . 72.5 mmtt -69.09 -20.86 64.08 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.008 0.523 . . . . 0.0 110.825 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 t0 66.13 59.52 0.68 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.045 1.338 . . . . 0.0 110.401 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 3.8 pp -165.21 157.14 15.19 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.76 151.34 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 125.081 1.353 . . . . 0.0 107.958 171.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -131.3 143.4 50.5 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.0 t80 -135.89 142.57 44.71 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 108.532 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.1 -5.98 64.72 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.812 0.695 . . . . 0.0 113.453 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.47 -152.67 23.94 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.13 50.18 Favored Glycine 0 C--O 1.242 0.65 0 CA-C-O 120.97 0.205 . . . . 0.0 112.909 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.401 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 3.1 t90 -54.45 134.21 45.91 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.809 1.244 . . . . 0.0 110.297 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HG3' ' HG ' ' A' ' 146' ' ' LEU . 56.7 pttt -109.82 -166.49 1.1 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.335 0.654 . . . . 0.0 111.403 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.61 ' HG ' ' HG3' ' A' ' 145' ' ' LYS . 50.2 mt 70.63 178.45 0.25 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.457 1.503 . . . . 0.0 111.501 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -143.09 -39.04 0.33 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.471 0.309 . . . . 0.0 111.587 -161.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.89 169.35 45.64 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 123.095 0.247 . . . . 0.0 113.155 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.0 153.13 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.221 0.608 . . . . 0.0 110.093 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.61 ' HA ' HG13 ' A' ' 208' ' ' VAL . 26.3 t90 -58.51 131.33 50.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.971 172.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -119.33 105.17 11.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 152.84 32.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.748 0.819 . . . . 0.0 111.507 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.01 -52.44 4.74 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.17 138.03 53.79 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.093 0.957 . . . . 0.0 110.425 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 9.6 pt-20 -76.38 141.09 41.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.539 . . . . 0.0 110.516 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.11 -177.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.307 1.043 . . . . 0.0 108.557 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 48.4 mt-30 -133.63 162.61 31.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.582 -0.699 . . . . 0.0 110.09 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 200' ' ' ILE . 7.4 p -137.09 136.67 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.149 0.58 . . . . 0.0 109.867 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 35.8 mt -69.52 86.94 0.46 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.79 105.23 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.6 176.8 8.36 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 163' ' ' PRO . 49.1 mp0 -28.4 155.58 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.175 0 C-N-CA 127.861 2.464 . . . . 0.0 114.326 168.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 162' ' ' GLU . 25.6 Cg_exo -1.16 137.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.638 1 C-N-CA 128.162 5.908 . . . . 0.0 118.945 -162.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.634 ' HA2' ' HB2' ' A' ' 192' ' ' SER . . . 99.69 -36.72 3.9 Favored Glycine 0 C--O 1.24 0.495 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -163.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -143.56 178.95 7.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.363 1.465 . . . . 0.0 108.42 164.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 89.7 m-20 -98.35 133.74 22.57 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.045 -0.978 . . . . 0.0 108.838 167.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 25.6 Cg_endo -59.47 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.965 3.11 . . . . 0.0 113.378 -175.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 39.2 ptt180 -160.68 165.16 31.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.943 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.503 ' H ' ' HB3' ' A' ' 17' ' ' GLU . . . -88.58 102.85 15.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.5 t -86.07 133.93 28.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 109.591 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 49.1 mt-30 -79.73 139.02 37.46 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.916 0.886 . . . . 0.0 109.37 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.8 t -150.28 130.06 13.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.902 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 59.7 mttp -90.71 155.07 45.89 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.046 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.57 121.26 9.3 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.373 1.382 . . . . 0.0 111.616 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -98.12 -170.71 32.28 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.1 144.27 5.64 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.345 0.573 . . . . 0.0 110.331 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 184' ' ' ILE . 43.4 p90 -123.47 135.01 53.85 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.903 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -70.74 163.74 26.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.882 1.273 . . . . 0.0 111.99 -173.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 181' ' ' ALA . 27.4 m -139.12 165.6 26.73 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.889 1.676 . . . . 0.0 108.173 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -52.91 -41.53 64.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.973 0.909 . . . . 0.0 110.213 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 179' ' ' THR . . . -76.39 -74.41 0.23 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.863 176.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.17 -107.02 0.65 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.702 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t -162.8 147.16 11.57 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 0.0 109.967 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.48 HD13 ' CE2' ' A' ' 177' ' ' PHE . 4.3 mp -108.45 151.38 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.72 139.3 14.35 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.41 144.22 19.44 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.05 113.08 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 165.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.3 m -116.86 91.18 3.51 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . 62.4 tp -104.62 105.02 14.94 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.522 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.37 111.45 14.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.329 0.651 . . . . 0.0 110.121 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -164.35 -174.3 3.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.126 1.37 . . . . 0.0 109.029 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.634 ' HB2' ' HA2' ' A' ' 164' ' ' GLY . 7.4 m -61.69 175.1 0.55 Allowed Pre-proline 0 CA--C 1.587 2.388 0 C-N-CA 124.787 1.235 . . . . 0.0 111.165 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 192' ' ' SER . 31.3 Cg_exo -24.57 123.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.407 3.633 1 C-N-CA 125.968 4.446 . . . . 0.0 116.925 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.46 131.55 26.93 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.006 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.1 m -81.5 97.12 7.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.912 0.485 . . . . 0.0 109.993 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 73.3 m -66.45 98.27 0.48 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -166.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 131.57 -5.05 5.52 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.631 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.9 m -47.43 124.48 9.29 Favored Pre-proline 0 N--CA 1.496 1.862 0 C-N-CA 124.275 1.03 . . . . 0.0 113.631 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.601 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 4.0 Cg_exo -72.4 121.23 7.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.738 2.292 . . . . 0.0 112.464 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 51.5 mt -84.2 110.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.46 162.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.713 0.805 . . . . 0.0 109.848 -171.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -103.04 167.48 9.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.538 0.735 . . . . 0.0 110.246 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -58.18 -40.6 81.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.565 1.546 . . . . 0.0 111.154 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -73.58 -20.84 60.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 111.77 -4.73 27.58 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.456 -0.636 . . . . 0.0 113.839 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -73.65 128.69 36.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.78 0.79 . . . . 0.0 110.183 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 146' ' ' LEU . 57.9 t -73.44 109.94 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 150' ' ' TRP . 55.1 t -64.37 -30.19 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.798 1.239 . . . . 0.0 110.576 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.87 -154.14 25.24 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.058 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 101' ' ' VAL . 75.8 mt -134.75 162.33 32.67 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.641 0.777 . . . . 0.0 109.596 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.8 OUTLIER -77.05 112.47 13.73 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 165.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.842 ' HA3' ' SD ' ' A' ' 110' ' ' MET . . . -174.26 67.31 0.1 Allowed Glycine 0 CA--C 1.496 -1.13 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 163.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.533 ' HB3' ' H ' ' A' ' 225' ' ' ALA . 11.0 t-20 -160.54 176.97 11.0 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.479 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . 61.62 -144.78 48.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 114.3 0.48 . . . . 0.0 114.3 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.437 HG22 ' N ' ' A' ' 216' ' ' VAL . 13.6 p -177.63 175.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 124.372 1.069 . . . . 0.0 108.863 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 215' ' ' VAL . 34.5 m -70.58 149.59 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 163.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.439 HG22 HD13 ' A' ' 41' ' ' ILE . 45.1 p -136.14 -165.14 1.66 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -32.4 108.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.201 1.4 . . . . 0.0 113.357 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.0 t 77.3 28.08 0.63 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.652 1.581 . . . . 0.0 111.907 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.57 15.84 80.22 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.793 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.61 116.53 6.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.497 0.719 . . . . 0.0 111.818 -171.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 189' ' ' LEU . 5.7 t80 -64.88 116.61 6.53 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.67 0.788 . . . . 0.0 109.388 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.6 t -134.16 115.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -137.09 141.98 42.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 109.25 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.533 ' H ' ' HB3' ' A' ' 213' ' ' ASN . . . -81.56 16.58 1.67 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.779 0.718 . . . . 0.0 112.49 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.9 mt 58.57 98.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.723 1.609 . . . . 0.0 111.462 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.33 130.03 40.89 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -108.8 125.86 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.411 HG21 HD12 ' A' ' 146' ' ' LEU . 38.5 p -80.72 106.26 12.59 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 110.171 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 -19.65 25.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.032 0.933 . . . . 0.0 111.456 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.7 tptm 74.45 147.73 0.09 Allowed 'General case' 0 C--N 1.364 1.222 0 C-N-CA 125.46 1.504 . . . . 0.0 110.525 -172.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 12.4 p -63.54 118.18 7.81 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.15 0.98 . . . . 0.0 111.134 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.9 tt -77.39 89.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 122.367 1.08 . . . . 0.0 109.012 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.11 -15.26 63.61 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.81 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.11 -32.21 63.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.59 1.156 . . . . 0.0 113.256 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -74.75 107.63 4.11 Favored Pre-proline 0 CA--C 1.548 0.902 0 O-C-N 123.661 0.601 . . . . 0.0 109.941 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -98.49 134.06 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.57 2.847 . . . . 0.0 112.462 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.09 -52.43 62.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.896 0.478 . . . . 0.0 109.988 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 16.8 tt -172.76 -46.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.349 1.059 . . . . 0.0 110.513 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 123.196 0.599 . . . . 0.0 110.046 -177.81 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.647 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.713 ' HE2' HD22 ' A' ' 119' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -141.58 -27.54 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 173.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.479 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 31.7 ttm180 -106.79 145.42 32.12 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.678 0.672 . . . . 0.0 109.84 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.442 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t 68.8 177.08 0.26 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.625 1.17 . . . . 0.0 111.87 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.0 9.92 2.57 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.46 1.504 . . . . 0.0 114.863 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.53 16.43 0.2 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.916 0.78 . . . . 0.0 112.122 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.72 44.48 0.76 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.176 0.988 . . . . 0.0 109.321 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 120' ' ' MET . 26.7 mt -86.73 95.03 9.67 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.891 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' HG2' ' HG2' ' A' ' 120' ' ' MET . 25.6 mt-10 -111.19 129.39 55.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.631 0.772 . . . . 0.0 111.982 -166.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 68' ' ' VAL . 4.3 mp -101.43 146.98 26.89 Favored 'General case' 0 N--CA 1.513 2.68 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 65' ' ' LEU . 14.1 tt0 -130.46 158.46 39.83 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.014 1.726 . . . . 0.0 109.153 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 6.3 ppt_? -90.61 148.49 22.63 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 122.95 0.5 . . . . 0.0 110.958 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.15 -37.67 3.04 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.036 0.534 . . . . 0.0 110.767 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.99 -155.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.055 1.342 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -98.25 153.65 18.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.5 1.12 . . . . 0.0 109.382 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.82 91.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -170.43 117.44 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.57 1.548 . . . . 0.0 107.484 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 21' ' ' GLU . 80.0 t90 -75.88 94.7 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -158.9 59.55 0.42 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.88 0.472 . . . . 0.0 110.542 163.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 4.1 t70 -89.72 -65.28 1.03 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.442 -0.787 . . . . 0.0 111.235 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -152.96 -42.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.649 ' H ' ' HB3' ' A' ' 169' ' ' ALA . . . -136.45 -170.38 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -154.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 3.3 pt-20 -166.93 90.74 0.39 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.003 1.321 . . . . 0.0 109.408 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 170' ' ' VAL . 62.9 mt -85.45 103.54 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -55.25 -24.81 29.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.476 1.11 . . . . 0.0 112.202 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.33 -94.25 0.01 OUTLIER Glycine 0 C--N 1.365 2.179 0 O-C-N 124.519 1.137 . . . . 0.0 112.462 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 173' ' ' LYS . 7.0 t 57.94 75.62 0.37 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.044 1.338 . . . . 0.0 109.564 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.7 m -64.61 147.96 97.21 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.237 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.46 168.74 3.65 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.783 2.322 . . . . 0.0 112.094 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.57 109.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.634 0.774 . . . . 0.0 110.617 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.24 159.57 14.9 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.903 0.881 . . . . 0.0 111.733 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -124.6 127.73 47.82 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.9 165.45 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -93.74 108.03 19.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.334 -0.854 . . . . 0.0 109.556 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.0 106.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -89.61 129.55 36.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.971 0.908 . . . . 0.0 110.048 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.38 8.54 5.05 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.72 1.208 . . . . 0.0 112.672 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.71 21.45 12.39 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.893 1.277 . . . . 0.0 112.745 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.86 -40.45 0.06 OUTLIER Glycine 0 N--CA 1.478 1.489 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 t -90.89 166.67 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.84 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.5 ppp? -132.72 149.42 52.29 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 p -169.2 157.18 7.49 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.955 0.902 . . . . 0.0 109.414 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' H ' HG21 ' A' ' 215' ' ' VAL . 10.3 tp -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -81.64 70.31 8.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.466 0.651 . . . . 0.0 109.978 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 176.18 126.71 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.889 1.675 . . . . 0.0 107.299 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.28 118.06 12.36 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.77 -174.64 2.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.075 0.95 . . . . 0.0 110.559 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.9 161.92 28.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.108 0.963 . . . . 0.0 110.709 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -119.24 -149.2 0.43 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.386 1.075 . . . . 0.0 110.139 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 71.38 114.78 0.05 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.774 1.23 . . . . 0.0 113.733 168.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.669 ' HB ' ' HB3' ' A' ' 163' ' ' PRO . 13.9 p -140.44 -67.21 0.43 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.328 1.051 . . . . 0.0 109.13 167.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 65' ' ' LEU . 8.6 tp 84.85 140.26 0.06 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 125.564 1.546 . . . . 0.0 111.998 168.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.84 -91.96 0.35 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.684 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.43 -35.82 90.67 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 123.637 0.257 . . . . 0.0 113.045 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 16.58 59.08 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.197 0.427 . . . . 0.0 112.725 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.97 53.76 4.9 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.131 0.396 . . . . 0.0 113.018 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 p -86.96 -32.41 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.067 0.947 . . . . 0.0 110.586 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.23 115.69 0.79 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.246 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.02 -46.34 3.27 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.725 0.263 . . . . 0.0 113.072 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.31 -42.71 0.27 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.87 -125.18 18.97 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.271 -0.465 . . . . 0.0 113.831 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -84.36 55.05 3.2 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.527 0.731 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 46.03 43.44 10.64 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 125.124 1.37 . . . . 0.0 111.302 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.35 -24.56 67.9 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.075 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -89.06 0.19 Allowed Glycine 0 C--N 1.349 1.262 0 O-C-N 124.03 0.831 . . . . 0.0 111.855 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.641 HG13 ' HD3' ' A' ' 87' ' ' LYS . 43.4 t -138.98 -107.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 50' ' ' LEU . 69.4 mt -156.87 134.82 11.03 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 126.364 1.866 . . . . 0.0 106.314 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.523 ' HB2' ' CG ' ' A' ' 121' ' ' HIS . 0.5 OUTLIER -158.75 70.63 0.52 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.155 0.979 . . . . 0.0 113.638 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.53 70.93 0.74 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 162.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 8' ' ' LEU . 2.1 t -131.74 132.97 23.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.298 -166.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.88 83.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.461 2.774 . . . . 0.0 112.511 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.411 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 49.8 m -70.06 154.42 94.62 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.449 1.1 . . . . 0.0 112.171 -172.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.71 -38.78 91.35 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.466 2.777 . . . . 0.0 116.46 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 49.0 Cg_exo -44.01 136.36 7.57 Favored 'Trans proline' 0 C--N 1.408 3.702 0 C-N-CA 123.053 2.502 . . . . 0.0 115.471 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.01 144.48 36.71 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.464 2.776 . . . . 0.0 113.638 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 t 64.49 66.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.538 1.135 . . . . 0.0 110.012 -174.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.3 24.52 29.95 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.121 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.18 -27.52 60.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.453 0.701 . . . . 0.0 109.877 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.71 -1.64 32.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.19 0.996 . . . . 0.0 111.768 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -102.11 6.3 40.84 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.038 0.935 . . . . 0.0 111.096 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.32 86.53 2.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.834 0.854 . . . . 0.0 110.307 -171.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.71 -45.41 29.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 61.87 94.62 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.619 1.199 . . . . 0.0 110.175 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.15 -167.39 34.89 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.398 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.76 108.25 9.65 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -95.0 175.98 6.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 110.824 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 51.1 ttt180 -144.52 143.1 30.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.668 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 1.1 pt -138.85 140.44 38.85 Favored 'Isoleucine or valine' 0 C--O 1.269 2.131 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HD3' HG13 ' A' ' 64' ' ' VAL . 26.2 tttm -131.2 136.57 48.39 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.434 1.494 . . . . 0.0 110.83 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.614 ' H ' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -115.89 133.48 55.99 Favored 'General case' 0 C--O 1.26 1.642 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.74 97.21 9.01 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 163.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.42 -179.16 29.48 Favored Glycine 0 N--CA 1.462 0.374 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.298 -163.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' B' ' 253' ' ' LYS . 0.2 OUTLIER -39.79 132.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.614 166.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt 78.0 6.67 2.67 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.815 1.646 . . . . 0.0 111.976 -171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.84 -156.87 20.62 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 122.007 0.782 . . . . 0.0 114.834 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.94 69.37 7.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.285 1.434 . . . . 0.0 107.886 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 m -109.99 144.35 38.65 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -159.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.636 HE21 HD13 ' A' ' 50' ' ' LEU . 2.1 tp-100 -74.95 116.47 15.73 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.845 1.341 . . . . 0.0 109.162 163.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.648 HD13 ' C ' ' B' ' 252' ' ' NLE . 0.4 OUTLIER -144.38 9.08 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -152.17 170.53 31.48 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.873 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -116.4 124.64 50.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.7 155.17 22.46 Favored Glycine 0 CA--C 1.503 -0.67 0 O-C-N 123.695 0.622 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 210' ' ' LEU . 31.7 t -137.56 101.83 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -107.16 107.3 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -141.2 134.96 30.26 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.45 23.01 12.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.349 1.059 . . . . 0.0 112.349 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.23 76.74 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.088 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.2 p -127.52 133.06 49.84 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.031 0.532 . . . . 0.0 110.426 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.789 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 49.0 t80 -85.44 142.51 29.19 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB3' ' HZ3' ' A' ' 144' ' ' TRP . 94.4 m-70 -137.28 113.28 9.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.432 1.093 . . . . 0.0 110.035 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' HB ' ' A' ' 138' ' ' ILE . 9.7 t -139.81 -164.64 1.73 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.773 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' LEU . 22.2 mtp -121.6 170.47 9.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.045 0.938 . . . . 0.0 111.52 -171.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -40.44 13.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.257 0.623 . . . . 0.0 112.441 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.409 ' HE1' ' SD ' ' A' ' 110' ' ' MET . 25.2 p-80 -62.01 -20.76 64.25 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.521 0.676 . . . . 0.0 111.328 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.5 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 19.1 m -82.75 -35.1 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.934 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 116' ' ' GLY . 52.8 m -145.03 145.78 31.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.141 -1.599 . . . . 0.0 112.158 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.77 -5.52 0.95 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 126.221 1.808 . . . . 0.0 113.541 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 114' ' ' THR . . . 88.45 55.13 2.25 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.72 -175.0 3.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.918 0.487 . . . . 0.0 111.919 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.1 138.61 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.405 1.082 . . . . 0.0 112.947 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.646 HD21 ' H4 ' ' B' ' 251' ' ' BEZ . 7.5 mt -102.86 174.77 5.73 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.935 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.564 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -169.47 174.87 5.73 Favored 'General case' 0 C--O 1.261 1.707 0 CA-C-O 123.74 1.733 . . . . 0.0 115.208 -177.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 21.0 t60 -127.59 88.5 2.8 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.645 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 93.1 mttt 38.11 46.85 0.88 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.013 0.925 . . . . 0.0 111.798 -171.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.6 -26.57 20.92 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 11.9 mptt -73.61 109.68 7.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.214 1.507 . . . . 0.0 109.211 175.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 15.6 ttm180 -93.8 120.23 33.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.506 0.722 . . . . 0.0 112.494 -157.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 119' ' ' LEU . 17.0 pt -111.95 161.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.99 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.27 135.25 24.33 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.35 0.66 . . . . 0.0 109.725 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.84 163.5 38.24 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.395 2.063 . . . . 0.0 112.404 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 p -99.78 -30.28 12.15 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.749 0.819 . . . . 0.0 112.182 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.5 t-105 -140.84 147.82 39.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.723 0.809 . . . . 0.0 109.875 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.61 119.99 5.51 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.343 1.057 . . . . 0.0 109.047 169.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.86 114.77 11.36 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.914 0.486 . . . . 0.0 110.902 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.78 -22.19 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.788 1.235 . . . . 0.0 111.833 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.1 -50.2 69.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.471 0.708 . . . . 0.0 110.869 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -94.4 -8.14 39.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.868 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 63.88 44.1 5.01 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.156 1.382 . . . . 0.0 110.645 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 210' ' ' LEU . 77.6 mt -136.53 137.93 40.79 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.618 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.6 mt -120.63 151.96 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.788 1.635 . . . . 0.0 108.009 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 p -152.34 160.28 43.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.558 0.694 . . . . 0.0 112.014 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.789 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 27.4 t80 -129.09 135.6 49.12 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.446 1.499 . . . . 0.0 107.622 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.9 64.97 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 122.919 0.295 . . . . 0.0 113.152 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.14 -177.3 42.92 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.23 -178.21 44.59 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.538 ' HZ3' ' HB3' ' A' ' 108' ' ' HIS . 76.5 t-105 -81.84 105.01 12.62 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 122.441 -0.446 . . . . 0.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -165.7 113.84 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 107.946 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.536 HD13 HG11 ' A' ' 207' ' ' VAL . 69.5 mt -131.92 -88.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.695 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -172.52 -73.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.94 0.791 . . . . 0.0 110.716 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.07 149.73 47.95 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.64 0.588 . . . . 0.0 113.476 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.28 139.77 20.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.953 0.501 . . . . 0.0 110.009 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -68.89 122.32 18.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.699 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -105.11 116.5 32.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 166.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.35 150.09 31.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.466 0.707 . . . . 0.0 112.435 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.15 -20.75 31.59 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.499 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.46 136.4 41.37 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.726 0.811 . . . . 0.0 109.896 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 0.0 OUTLIER -73.32 140.22 46.6 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.491 0.662 . . . . 0.0 110.083 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 172' ' ' THR . 3.2 m -120.13 179.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.635 0.774 . . . . 0.0 108.96 175.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -121.66 160.7 23.89 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.091 -0.38 . . . . 0.0 110.784 -170.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.6 155.68 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.705 0.802 . . . . 0.0 110.28 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 52.5 mt -107.19 105.9 16.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 164.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.44 104.67 5.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.326 0.65 . . . . 0.0 109.474 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 167' ' ' PRO . 54.8 mt -69.65 104.64 2.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.192 0.52 . . . . 0.0 110.796 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 165' ' ' LYS . 56.7 mm-40 -76.26 141.6 70.58 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.123 -176.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 12.4 Cg_exo -71.89 116.64 4.78 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.906 3.071 . . . . 0.0 112.011 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.35 9.67 58.38 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.577 0.548 . . . . 0.0 113.894 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 162' ' ' GLU . 96.3 mttt -135.91 -177.31 4.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 0.0 110.219 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -88.26 142.96 31.99 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.848 0.859 . . . . 0.0 110.655 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.687 ' HB3' HD23 ' A' ' 161' ' ' LEU . 10.4 Cg_endo -52.86 115.65 2.39 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.515 2.81 . . . . 0.0 112.737 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -69.46 129.96 41.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.602 0.761 . . . . 0.0 109.888 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.649 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -71.73 118.79 15.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 22' ' ' ILE . 41.0 t -134.68 144.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.744 ' HB2' ' HB2' ' A' ' 21' ' ' GLU . 27.7 tt0 -84.81 163.81 18.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 156' ' ' VAL . 18.5 p -136.16 97.11 3.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 54.4 tttp -85.73 129.43 54.73 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 155' ' ' GLU . 84.0 Cg_exo -47.49 125.5 10.91 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.289 2.659 . . . . 0.0 113.714 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.36 178.41 18.13 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.928 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -139.07 128.82 24.75 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -133.75 122.06 22.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 183' ' ' THR . 5.0 ttpm? -122.39 138.83 54.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.36 1.064 . . . . 0.0 108.843 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 52.0 p -120.67 -178.68 3.78 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.026 0.931 . . . . 0.0 109.271 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -71.21 -19.63 62.36 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.36 0.664 . . . . 0.0 109.932 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.09 -48.92 8.71 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.345 1.058 . . . . 0.0 110.507 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -175.67 160.76 29.25 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.408 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 9.7 t -97.83 139.95 32.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.985 0.914 . . . . 0.0 110.145 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.49 127.73 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.93 111.51 4.0 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -163.57 -172.29 2.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.954 . . . . 0.0 109.946 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.67 100.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 121.807 0.813 . . . . 0.0 111.059 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.413 ' HA ' HG13 ' A' ' 223' ' ' VAL . 20.7 m -98.86 101.02 12.29 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 165.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.14 151.48 40.91 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.62 0.248 . . . . 0.0 110.998 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.93 159.95 32.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.818 0.847 . . . . 0.0 109.069 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.476 ' HA ' ' HD1' ' A' ' 222' ' ' TYR . 34.0 p90 -75.63 121.92 23.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.113 0.959 . . . . 0.0 111.63 -164.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.2 m -137.14 132.12 17.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.28 2.653 . . . . 0.0 113.062 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.43 100.37 0.37 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -173.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 37.3 p -73.59 140.65 46.38 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.294 0.638 . . . . 0.0 111.223 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -53.95 127.01 24.58 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.902 0.881 . . . . 0.0 112.153 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.07 -3.84 35.58 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.772 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.2 m -44.43 119.64 3.64 Favored Pre-proline 0 C--N 1.383 2.043 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.16 115.47 3.0 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.398 2.065 . . . . 0.0 111.517 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.24 106.4 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -98.38 163.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.507 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -98.85 157.65 16.16 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.245 1.418 . . . . 0.0 108.909 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -63.94 -34.27 77.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.5 1.12 . . . . 0.0 111.128 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.25 -20.36 44.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.714 0.406 . . . . 0.0 111.162 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.4 14.44 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.91 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 161.89 30.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.442 0.621 . . . . 0.0 109.843 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.536 HG11 HD13 ' A' ' 146' ' ' LEU . 2.7 p -94.02 112.12 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.38 -40.39 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 228' ' ' GLN . . . 158.23 -142.83 8.78 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 137' ' ' LEU . 70.4 mt -127.99 159.57 34.59 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.658 0.783 . . . . 0.0 110.449 -174.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.481 ' O ' ' SD ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -62.98 107.87 1.09 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 170.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.07 -179.97 6.53 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 124.343 1.027 . . . . 0.0 114.837 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -69.19 86.99 0.4 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.516 1.15 . . . . 0.0 109.633 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.84 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -134.44 -151.23 6.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 113.677 -1.602 . . . . 0.0 111.661 -176.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.568 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.8 p -157.28 168.63 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 111.591 -172.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.7 t -85.59 108.54 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.518 HG23 HD13 ' A' ' 41' ' ' ILE . 99.6 m -86.63 144.02 27.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.536 1.134 . . . . 0.0 110.005 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 67.79 10.3 7.69 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.613 1.165 . . . . 0.0 110.305 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 95.0 p 52.92 30.05 8.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.353 1.461 . . . . 0.0 111.43 -166.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.13 -70.16 0.05 OUTLIER Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.349 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.06 137.88 40.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.338 0.655 . . . . 0.0 111.164 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 191' ' ' PHE . 82.3 m-85 -86.03 102.49 13.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.141 0.496 . . . . 0.0 110.124 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 188' ' ' SER . 50.6 t -124.1 104.64 14.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.601 0.761 . . . . 0.0 108.972 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.702 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 63.4 m -132.04 162.48 30.67 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.306 1.042 . . . . 0.0 109.959 -171.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -58.65 162.72 3.71 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.006 162.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.58 103.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.343 -0.848 . . . . 0.0 109.023 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -78.91 136.58 37.31 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.459 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 8.8 pt20 -129.06 167.72 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.208 0.603 . . . . 0.0 109.494 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.532 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 1.6 p -82.72 110.69 17.99 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -72.01 -13.78 61.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.768 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.6 37.66 22.49 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 109.214 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.3 m -58.85 96.31 0.03 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.532 1.133 . . . . 0.0 111.077 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ILE . . . . . 0.438 HG12 ' ND2' ' A' ' 236' ' ' ASN . 14.7 tt -97.43 27.03 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-O 122.576 1.179 . . . . 0.0 108.986 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -74.17 -8.11 55.01 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.531 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.34 -11.72 44.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.384 1.074 . . . . 0.0 111.849 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.438 ' ND2' HG12 ' A' ' 233' ' ' ILE . 34.6 m-80 -56.87 117.43 17.45 Favored Pre-proline 0 CA--C 1.554 1.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.92 129.91 29.14 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.878 2.385 . . . . 0.0 111.516 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.44 -39.48 77.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.227 0.611 . . . . 0.0 111.275 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.84 -49.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.134 0.574 . . . . 0.0 109.582 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--O 1.248 1.0 0 C-N-CA 123.219 0.608 . . . . 0.0 110.021 -175.797 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.668 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.648 ' C ' HD13 ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 91' ' ' ILE . 17.2 tppt? 164.43 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.521 1.928 . . . . 0.0 109.473 161.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 69.28 115.95 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.872 1.269 . . . . 0.0 108.361 -165.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 72.63 167.75 0.31 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.392 1.477 . . . . 0.0 111.607 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . -68.62 120.49 14.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.189 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -133.35 21.12 4.0 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.522 0.729 . . . . 0.0 111.143 -167.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -142.33 49.76 1.52 Allowed 'General case' 0 C--O 1.254 1.307 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD22 ' HG3' ' B' ' 252' ' ' NLE . 34.6 mt -96.59 94.13 7.16 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.98 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' MET . 6.9 tm-20 -107.55 129.34 54.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.35 0.66 . . . . 0.0 111.095 -170.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.556 HD11 HD12 ' A' ' 119' ' ' LEU . 1.5 mp -94.78 137.16 34.22 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 34.3 tt0 -132.3 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.694 -0.629 . . . . 0.0 109.673 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.627 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 6.7 ptp180 -67.09 153.78 42.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.64 0.733 . . . . 0.0 112.454 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.31 -36.04 3.02 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.696 166.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.16 -162.39 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.52 156.81 25.08 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.647 0.779 . . . . 0.0 109.028 168.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.06 96.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.604 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 164.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -166.84 136.84 3.06 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -167.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.512 ' H ' ' HA2' ' A' ' 205' ' ' GLY . 63.7 t90 -66.69 120.16 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.748 0.655 . . . . 0.0 109.829 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -87.69 143.91 26.92 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.2 -6.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.808 1.243 . . . . 0.0 112.784 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.29 50.28 0.5 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.49 1.516 . . . . 0.0 111.709 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -65.72 100.47 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.543 0.737 . . . . 0.0 110.906 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.69 102.55 15.09 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.774 0.83 . . . . 0.0 110.246 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.59 100.91 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -153.4 144.08 22.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.54 1.536 . . . . 0.0 107.631 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 190' ' ' ASP . . . 109.46 -138.09 14.59 Favored Glycine 0 CA--C 1.503 -0.716 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.311 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m 58.82 26.79 15.22 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.413 0.685 . . . . 0.0 110.37 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 t -66.21 143.06 98.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.602 1.161 . . . . 0.0 111.039 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 175.68 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.91 2.407 . . . . 0.0 113.49 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.37 131.52 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.851 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.0 mt -109.1 160.16 16.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.852 0.861 . . . . 0.0 109.936 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 t -122.9 115.4 21.89 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 41' ' ' ILE . 30.0 mt -121.3 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.007 0.923 . . . . 0.0 109.337 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.3 p -92.96 111.9 23.68 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.34 132.45 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.935 0.894 . . . . 0.0 108.773 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -138.37 146.4 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.82 0.448 . . . . 0.0 110.341 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 52.85 32.63 12.74 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.237 1.015 . . . . 0.0 111.898 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.254 3.2 p30 52.54 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 126.975 2.11 . . . . 0.0 114.135 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.46 -10.45 66.6 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -106.55 160.55 15.34 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.186 0.993 . . . . 0.0 110.06 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -161.62 133.88 5.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.771 ' HA ' HG11 ' A' ' 215' ' ' VAL . 15.1 p -166.33 174.97 8.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.331 0.652 . . . . 0.0 110.161 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' A' ' 217' ' ' THR . 1.8 mp -89.22 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.71 73.33 1.08 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.41 0.624 . . . . 0.0 109.549 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -143.7 -179.44 6.45 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.59 1.156 . . . . 0.0 109.274 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.51 96.6 8.65 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 119.41 10.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.548 0.739 . . . . 0.0 110.187 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -148.6 141.74 24.98 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.217 0.607 . . . . 0.0 109.595 172.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 193' ' ' PRO . 1.4 mp0 -125.05 -123.29 0.25 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.315 -165.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -156.17 150.2 25.27 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.852 1.66 . . . . 0.0 113.121 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -116.98 123.8 47.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.55 1.14 . . . . 0.0 109.009 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HB3' ' HG3' ' A' ' 163' ' ' PRO . 0.4 OUTLIER -140.26 119.71 13.1 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 122.669 1.223 . . . . 0.0 111.579 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.35 -37.82 0.02 OUTLIER Glycine 0 N--CA 1.466 0.681 0 CA-C-N 113.045 -1.889 . . . . 0.0 110.042 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.58 -76.03 2.16 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.46 -0.37 . . . . 0.0 113.085 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.57 -63.68 3.36 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.23 171.63 32.16 Favored Glycine 0 C--O 1.243 0.683 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -70.45 105.15 2.96 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.77 32.38 21.62 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 -171.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.28 96.48 0.72 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.98 -110.01 0.22 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 113.93 0.332 . . . . 0.0 113.93 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.57 51.0 1.38 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 123.092 0.377 . . . . 0.0 112.204 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.97 -54.63 4.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 61.29 95.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.312 1.445 . . . . 0.0 110.523 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 63.37 4.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.312 0.645 . . . . 0.0 109.775 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.93 -121.74 22.9 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.085 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -109.29 28.51 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 C-N-CA 123.853 0.861 . . . . 0.0 110.069 177.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 73.0 mt 74.76 -172.62 0.11 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 125.001 1.32 . . . . 0.0 111.861 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -165.24 106.21 0.78 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.627 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t70 178.66 73.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.063 0.945 . . . . 0.0 112.441 151.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -134.33 158.76 74.49 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 165.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.401 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 52.4 Cg_exo -23.93 138.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.999 1 C-N-CA 125.766 4.311 . . . . 0.0 116.258 175.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -61.8 148.47 87.39 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.417 1.087 . . . . 0.0 112.157 -171.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 121' ' ' HIS . 5.0 Cg_endo -45.61 -38.5 16.77 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 124.303 3.335 . . . . 0.0 117.345 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.45 166.71 1.09 Allowed 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.484 2.123 . . . . 0.0 115.133 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -69.54 -163.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.929 2.419 . . . . 0.0 112.415 172.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.3 t 74.66 -61.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 125.049 1.34 . . . . 0.0 110.004 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.43 67.37 3.72 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -89.58 -31.1 17.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.102 0.561 . . . . 0.0 109.713 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 146.09 47.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.333 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -62.9 137.56 58.3 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 123.984 0.802 . . . . 0.0 109.719 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.4 mt -149.14 -164.4 2.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.043 1.337 . . . . 0.0 107.92 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 71.57 25.06 3.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.181 1.392 . . . . 0.0 109.982 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.64 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 27.2 t70 -17.96 113.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.323 2.649 . . . . 0.0 115.734 -170.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.34 -178.04 39.09 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.89 110.75 18.16 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 124.355 1.062 . . . . 0.0 108.786 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 6.9 m-85 -99.54 140.66 33.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HB2' HD13 ' A' ' 50' ' ' LEU . 12.5 ptt180 -83.39 122.7 28.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.666 ' HB ' ' HE2' ' B' ' 252' ' ' NLE . 18.2 pt -107.63 135.44 46.23 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.62 -166.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 79.5 tttt -124.06 137.47 54.57 Favored 'General case' 0 C--N 1.379 1.851 0 O-C-N 125.041 1.463 . . . . 0.0 112.64 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -108.66 147.76 31.42 Favored 'General case' 0 C--O 1.252 1.195 0 C-N-CA 125.388 1.475 . . . . 0.0 109.001 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -59.53 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 158.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' A' ' 94' ' ' TYR . . . -59.5 154.41 30.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 124.4 1.063 . . . . 0.0 115.44 -145.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.74 -34.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.842 1.257 . . . . 0.0 110.221 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.5 mt -126.23 23.62 7.0 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.032 0.933 . . . . 0.0 111.301 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.24 -97.77 0.17 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 122.199 -0.313 . . . . 0.0 112.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 61.5 m-85 -145.06 116.21 7.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.206 1.402 . . . . 0.0 108.186 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -129.26 101.31 5.94 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -167.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.62 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 4.0 pm0 -94.24 104.19 16.2 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.579 HD13 ' HD2' ' B' ' 253' ' ' LYS . 1.4 pp -137.77 -37.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -154.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -121.56 -159.5 10.7 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.312 -1.423 . . . . 0.0 114.265 -163.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -133.36 125.29 28.83 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 174.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.13 110.82 2.36 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 108' ' ' HIS . 17.7 m -105.58 102.82 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 81' ' ' ASP . 80.2 t80 -94.06 119.95 33.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -140.06 124.53 18.01 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.891 0.876 . . . . 0.0 108.703 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 50.13 55.58 9.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.407 1.483 . . . . 0.0 112.366 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.2 15.64 79.98 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.054 -0.975 . . . . 0.0 114.219 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 m -135.62 115.39 12.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.402 0.601 . . . . 0.0 111.332 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -85.26 112.21 20.55 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.686 ' HB2' HG23 ' A' ' 101' ' ' VAL . 58.4 m80 -98.91 110.38 23.0 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.867 1.354 . . . . 0.0 110.207 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.61 HG23 ' HB ' ' A' ' 138' ' ' ILE . 15.3 t -139.97 -159.35 0.95 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.86 0.464 . . . . 0.0 110.489 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.739 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 23.2 ttm -156.55 160.73 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -157.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -80.73 -35.34 33.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 3.2 p-80 -75.6 -23.6 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 196' ' ' SER . 5.8 m -81.06 -10.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.609 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.849 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 8.4 m 165.58 144.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 127.113 2.165 . . . . 0.0 107.914 160.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -83.04 34.81 0.46 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.726 1.21 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.21 54.68 1.25 Allowed Glycine 0 C--N 1.347 1.173 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 3' ' ' ALA . . . -106.15 -174.48 2.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.208 0.603 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -116.14 134.68 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.43 0.634 . . . . 0.0 112.66 -163.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 mm? -90.97 179.28 5.79 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.392 1.477 . . . . 0.0 111.637 -167.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.3 ptp -175.69 163.23 2.84 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 123.088 1.423 . . . . 0.0 114.632 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.649 ' HB2' HG22 ' A' ' 68' ' ' VAL . 70.3 t60 -109.75 105.39 14.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 111.535 -2.575 . . . . 0.0 105.485 155.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.487 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 53.9 pttt -41.14 116.14 0.69 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 125.408 1.483 . . . . 0.0 113.211 -156.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.72 -7.51 55.61 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.048 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 69' ' ' PRO . 10.2 tttp -138.58 113.1 8.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.319 1.448 . . . . 0.0 107.196 175.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -106.63 128.66 54.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.381 0.537 . . . . 0.0 111.636 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.51 129.85 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.007 1.323 . . . . 0.0 109.803 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' HA ' HG23 ' A' ' 118' ' ' VAL . 32.0 mt-10 -91.46 151.7 42.9 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.144 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.93 -178.56 3.59 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.084 2.523 . . . . 0.0 112.586 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 19.4 p -126.36 -21.53 4.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.879 0.472 . . . . 0.0 112.195 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.444 ' O ' HG23 ' A' ' 138' ' ' ILE . 21.8 t-105 -140.2 146.53 38.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.438 0.695 . . . . 0.0 110.065 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.51 120.83 3.64 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.37 1.044 . . . . 0.0 109.215 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.68 128.64 39.42 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.3 0.571 . . . . 0.0 110.039 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.96 -36.15 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.083 -166.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.35 -35.41 71.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.495 0.718 . . . . 0.0 112.376 -167.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.18 -7.39 56.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.974 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 110' ' ' MET . 22.2 t70 65.75 47.35 2.13 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.227 0.955 . . . . 0.0 109.022 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 53.5 mt -144.66 139.96 28.35 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 109' ' ' THR . 60.8 mt -132.61 142.78 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 125.506 1.522 . . . . 0.0 108.558 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.443 ' HB3' ' CE3' ' A' ' 144' ' ' TRP . 74.6 p -139.1 159.54 41.9 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 118.813 0.733 . . . . 0.0 112.259 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 20.7 t80 -129.91 146.78 51.63 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.815 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.69 4.43 54.63 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.37 -162.53 28.44 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.7 173.05 31.13 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 168.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.515 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 66.6 t-105 -63.8 129.26 39.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.7 0.75 . . . . 0.0 109.408 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -164.74 176.51 8.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.923 0.489 . . . . 0.0 111.709 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.46 HD12 ' HE1' ' A' ' 108' ' ' HIS . 3.3 tm? 67.72 97.6 0.06 Allowed 'General case' 0 C--N 1.358 0.97 0 O-C-N 125.013 1.446 . . . . 0.0 111.74 169.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.691 ' HG3' ' HA2' ' A' ' 209' ' ' GLY . 7.1 mm-40 160.1 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.105 2.562 . . . . 0.0 107.336 154.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.16 85.16 0.49 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -75.84 163.77 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -156.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.41 ' HB2' HG22 ' A' ' 208' ' ' VAL . 49.8 t90 -55.81 142.0 36.58 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 111.611 -2.54 . . . . 0.0 112.035 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -131.75 153.8 49.7 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.24 104.51 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.381 1.072 . . . . 0.0 113.374 -166.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.84 -43.56 0.64 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.485 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -78.38 167.92 20.6 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.524 0.73 . . . . 0.0 112.757 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.14 174.33 7.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.803 0.841 . . . . 0.0 110.576 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 155.87 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 0.0 109.471 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 40.3 mt-30 -126.81 128.72 47.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 200' ' ' ILE . 91.0 t -93.02 110.07 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.472 0.709 . . . . 0.0 109.718 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 199' ' ' PRO . 1.3 tm? -77.21 76.13 3.76 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.21 124.53 31.29 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.444 -171.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.473 ' HB2' HD22 ' A' ' 50' ' ' LEU . 18.1 mt -69.02 120.59 15.12 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 123.662 0.601 . . . . 0.0 109.823 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.94 107.8 30.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.65 ' HG3' ' HB3' ' A' ' 50' ' ' LEU . 47.0 Cg_exo -55.64 115.47 2.48 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.923 2.415 . . . . 0.0 112.686 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.57 -16.83 60.45 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.596 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -124.2 -171.69 2.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.454 0.702 . . . . 0.0 110.252 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -78.86 139.25 57.6 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.345 0.658 . . . . 0.0 109.893 174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.73 129.14 28.85 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.814 3.01 . . . . 0.0 113.463 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -97.0 125.54 41.51 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 109.496 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -85.37 104.07 14.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.128 0.571 . . . . 0.0 109.863 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 68.5 t -87.96 109.68 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.541 1.136 . . . . 0.0 110.387 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.492 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 7.9 tt0 -80.1 125.88 30.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 109.952 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 t -151.35 151.24 31.48 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 110.676 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.88 156.45 42.52 Favored Pre-proline 0 C--O 1.244 0.778 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.443 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 172.26 13.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.9 2.4 . . . . 0.0 112.941 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.03 -174.46 28.76 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.981 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 144.76 26.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.1 0.45 . . . . 0.0 110.519 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 183' ' ' THR . 5.9 m-85 -97.4 119.39 35.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 183' ' ' THR . 62.7 tttp -99.12 98.74 9.71 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 109.424 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.523 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.0 m -95.51 -178.37 4.39 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.523 ' H ' HG22 ' A' ' 179' ' ' THR . 3.0 p-10 -61.34 -25.31 67.06 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.8 -38.13 0.36 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.429 0.691 . . . . 0.0 110.719 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.45 118.7 5.28 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.587 -0.279 . . . . 0.0 112.506 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 178' ' ' LYS . 22.6 p -119.01 111.96 18.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.47 135.34 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.78 111.27 4.11 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 225' ' ' ALA . . . -143.77 -161.02 1.19 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.4 0.68 . . . . 0.0 110.424 -167.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.51 108.89 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.475 0.655 . . . . 0.0 109.454 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.625 ' HA ' HG13 ' A' ' 223' ' ' VAL . 10.0 t -80.71 112.48 18.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.837 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 191' ' ' PHE . 1.4 tt -130.22 132.34 45.95 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.899 0.38 . . . . 0.0 110.566 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 24' ' ' GLY . 10.4 m-20 -96.55 104.92 16.94 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.615 ' HB2' HD22 ' A' ' 189' ' ' LEU . 31.7 t80 -153.5 163.45 39.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.5 p -58.04 151.31 46.06 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.429 167.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 47' ' ' GLU . 84.0 Cg_exo -46.92 95.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.84 2.36 . . . . 0.0 113.691 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.61 179.25 12.92 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.556 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.461 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 71.0 p -115.19 145.93 41.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.354 0.597 . . . . 0.0 112.46 -169.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.748 ' HB3' HG12 ' A' ' 113' ' ' VAL . 62.8 m -67.91 99.1 0.8 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.296 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 132.86 3.83 3.53 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.054 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 71.4 m -55.1 122.64 43.62 Favored Pre-proline 0 C--N 1.368 1.397 0 C-N-CA 123.3 0.64 . . . . 0.0 111.3 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 210' ' ' LEU . 83.8 Cg_endo -78.43 144.66 20.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.979 2.453 . . . . 0.0 113.403 -174.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.693 HG13 ' HB ' ' A' ' 208' ' ' VAL . 8.2 pt -111.3 110.37 31.94 Favored 'Isoleucine or valine' 0 C--O 1.268 2.047 0 CA-C-O 123.105 1.431 . . . . 0.0 109.347 171.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 159' ' ' LEU . 13.7 pt -130.94 161.34 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 112.339 -2.209 . . . . 0.0 109.663 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 207' ' ' VAL . 23.6 t70 -90.82 -178.69 5.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.532 0.733 . . . . 0.0 109.585 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -58.87 -18.88 36.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LYS . . . . . 0.455 ' HE3' ' HD2' ' A' ' 206' ' ' LYS . 62.4 tttp -71.01 -13.44 62.0 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.579 1.151 . . . . 0.0 111.365 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 16' ' ' TRP . . . 86.25 9.41 76.45 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 123.359 0.504 . . . . 0.0 112.92 -176.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.455 ' HD2' ' HE3' ' A' ' 204' ' ' LYS . 18.1 ptpt -157.81 151.89 24.35 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.255 1.022 . . . . 0.0 109.51 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.643 HG13 HG23 ' A' ' 208' ' ' VAL 0.25 7.9 p -178.11 -71.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 O-C-N 124.613 1.196 . . . . 0.0 108.489 161.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.693 ' HB ' HG13 ' A' ' 200' ' ' ILE . 2.1 t -90.6 -44.69 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 120.494 1.497 . . . . 0.0 111.253 -162.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.691 ' HA2' ' HG3' ' A' ' 147' ' ' GLU . . . 127.47 -98.17 0.49 Allowed Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 113.514 -1.676 . . . . 0.0 110.824 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 199' ' ' PRO . 2.0 pt? -146.27 172.52 13.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.281 0.562 . . . . 0.0 110.669 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.737 ' HB2' ' HB3' ' A' ' 224' ' ' SER . 0.0 OUTLIER -74.88 142.28 44.09 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.739 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -82.35 -145.16 5.29 Favored Glycine 0 C--N 1.343 0.972 0 C-N-CA 123.03 0.347 . . . . 0.0 112.251 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -78.54 86.44 4.55 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.462 0.649 . . . . 0.0 109.751 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.79 -174.72 19.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.866 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 40' ' ' SER . 10.5 p -168.63 168.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.874 0.469 . . . . 0.0 110.116 -168.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.435 HG13 ' HD1' ' A' ' 222' ' ' TYR . 6.6 m -69.66 115.25 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 165.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.687 ' HA ' HD13 ' A' ' 41' ' ' ILE . 5.2 t -79.27 168.99 18.79 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.553 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -51.73 137.42 25.56 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 124.389 1.056 . . . . 0.0 110.52 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.9 m 86.07 -4.36 0.78 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.712 2.005 . . . . 0.0 111.139 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.39 29.53 36.33 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.103 0.382 . . . . 0.0 113.233 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -95.85 115.28 27.19 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 193' ' ' PRO . 23.0 t80 -74.22 101.08 3.88 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.678 0.752 . . . . 0.0 109.925 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 188' ' ' SER . 91.9 t -94.97 152.52 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.492 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 211' ' ' TYR . 69.9 m -130.1 135.03 47.78 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.521 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . . . -73.29 163.89 27.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 208' ' ' VAL . 43.5 mt -98.18 106.04 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.806 0.443 . . . . 0.0 110.536 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -99.36 108.49 21.01 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 121.794 0.807 . . . . 0.0 108.903 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 11.0 pt20 -95.25 167.39 11.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.945 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.515 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 3.9 p -117.3 126.86 53.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.01 1.98 17.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.416 1.086 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 54.51 92.62 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.374 1.07 . . . . 0.0 111.181 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 22.3 m -61.99 91.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.229 1.012 . . . . 0.0 111.393 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.3 pt -86.31 -31.21 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.506 1.122 . . . . 0.0 109.966 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -161.56 154.62 20.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.383 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.08 -50.06 2.97 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.03 0.932 . . . . 0.0 109.211 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.23 124.72 90.86 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.076 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.92 112.32 1.62 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.456 2.104 . . . . 0.0 110.409 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.05 -39.76 79.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.159 0.912 . . . . 0.0 111.915 -175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 -42.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 170.384 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.849 ' H2 ' ' HB ' ' A' ' 114' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.85 ' HG3' HD22 ' A' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.697 ' HZ2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -166.29 -148.4 0.1 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.062 -148.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 -68.96 -110.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 155.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' M9P . . . . . 0.536 ' NE ' ' HB2' ' A' ' 47' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 120.81 0.117 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 35.6 t -72.03 -31.98 66.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -163.49 176.08 10.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.389 0.676 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 118' ' ' VAL . . . -147.23 42.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -172.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.644 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.9 m-20 -145.75 28.11 1.17 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.351 1.06 . . . . 0.0 111.474 -171.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 5' ' ' ASP . 1.6 mp -114.92 99.8 7.74 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.925 0.784 . . . . 0.0 111.289 -167.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' MET . 36.1 mp0 -106.95 142.92 35.8 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.207 0.527 . . . . 0.0 112.056 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -116.04 166.56 11.86 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.954 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 33.3 tt0 -155.13 137.51 14.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.298 1.439 . . . . 0.0 108.892 -171.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HD1' ' A' ' 84' ' ' TYR . 35.7 ttt-85 -72.58 125.61 27.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.544 0.611 . . . . 0.0 110.711 -172.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -86.72 -56.42 3.41 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.26 -161.68 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.912 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -96.09 156.76 16.2 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.828 1.251 . . . . 0.0 107.682 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -85.69 97.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -172.61 132.92 0.59 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.572 0.749 . . . . 0.0 109.783 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.603 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 78.8 t90 -87.58 93.7 9.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.9 0.48 . . . . 0.0 110.964 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.98 58.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.035 0.534 . . . . 0.0 110.302 161.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 9.2 t70 -89.98 -55.86 3.45 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.652 0.381 . . . . 0.0 111.403 172.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -147.02 21.14 1.25 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.63 -168.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.24 72.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 127.137 2.175 . . . . 0.0 114.84 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.69 145.25 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.113 0.965 . . . . 0.0 110.332 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.82 143.34 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 124.08 0.952 . . . . 0.0 109.159 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -152.0 -165.56 2.26 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.251 1.02 . . . . 0.0 110.805 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.54 121.64 2.3 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -75.99 -80.22 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.983 0.513 . . . . 0.0 111.582 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.6 t -140.59 145.03 38.72 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.286 0.635 . . . . 0.0 109.887 -166.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.59 -39.57 11.87 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.731 2.287 . . . . 0.0 112.158 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.47 124.44 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.231 0.612 . . . . 0.0 109.703 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 218' ' ' ARG . 3.8 tt -143.68 119.59 10.62 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.3 p -78.03 127.96 33.12 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.19 0.996 . . . . 0.0 112.085 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 223' ' ' VAL . 54.7 mt -112.7 167.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.431 1.492 . . . . 0.0 107.277 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -99.18 126.27 44.93 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.954 1.252 . . . . 0.0 110.24 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -70.26 129.75 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.0 t -136.18 135.51 39.21 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.44 7.07 6.08 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.677 1.191 . . . . 0.0 111.782 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 57.35 27.21 13.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.834 1.254 . . . . 0.0 112.775 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.45 -29.83 0.03 OUTLIER Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.875 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -106.79 165.87 11.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.269 0.627 . . . . 0.0 110.12 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.2 ptm -140.54 130.75 24.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.402 0.681 . . . . 0.0 109.267 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 p -164.78 178.29 7.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 217' ' ' THR . 10.5 tp -86.55 152.35 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.6 126.51 27.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.5 t30 70.9 99.59 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.269 1.428 . . . . 0.0 110.476 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.71 131.37 53.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.546 0.738 . . . . 0.0 109.231 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -122.26 106.23 10.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.556 0.742 . . . . 0.0 110.126 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -82.81 -168.7 2.15 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.232 1.013 . . . . 0.0 109.732 169.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 73.42 100.16 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.571 1.149 . . . . 0.0 109.932 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 49' ' ' THR . 6.0 tt0 -131.01 164.78 24.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.189 0.996 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 9.5 t -128.84 134.51 48.35 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 164.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.749 ' HA ' ' H ' ' A' ' 164' ' ' GLY . 1.4 pt? -137.53 -17.44 1.3 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.342 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.32 -55.81 27.11 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 123.637 0.586 . . . . 0.0 111.892 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.97 -83.37 0.09 OUTLIER Glycine 0 C--N 1.356 1.651 0 O-C-N 123.918 0.422 . . . . 0.0 113.19 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.73 -44.02 16.63 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.1 -175.37 39.7 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 113.357 0.103 . . . . 0.0 113.357 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.51 ' HB2' ' HG3' ' A' ' 9' ' ' GLU . 32.2 t -90.01 108.37 19.68 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.845 0.858 . . . . 0.0 109.152 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.67 -86.32 0.09 OUTLIER Glycine 0 C--N 1.355 1.639 0 O-C-N 124.012 0.82 . . . . 0.0 112.498 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.19 11.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.771 0 CA-C-O 119.923 -0.376 . . . . 0.0 113.212 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.09 10.63 73.4 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.806 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.736 ' HA2' ' HE2' ' A' ' 122' ' ' LYS . . . -75.43 -64.98 2.16 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.99 4.21 3.46 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.662 1.585 . . . . 0.0 113.94 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.9 t80 68.06 -0.13 2.2 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.724 1.21 . . . . 0.0 111.326 -167.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.45 11.62 3.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.793 0.837 . . . . 0.0 111.04 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.45 -127.23 0.92 Allowed Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 2.3 t -126.35 -95.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 C-N-CA 124.181 0.992 . . . . 0.0 109.877 -174.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 42.1 mt -147.55 163.91 35.09 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 123.725 0.81 . . . . 0.0 111.9 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 122' ' ' LYS . 2.7 m0 -132.08 94.0 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.566 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER 171.71 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 126.565 1.946 . . . . 0.0 109.645 158.714 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 121' ' ' HIS . 29.4 m -132.19 157.34 78.51 Favored Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 119.339 0.972 . . . . 0.0 111.955 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.18 79.32 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.414 2.076 . . . . 0.0 111.099 171.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 t -66.99 126.03 91.84 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.088 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -51.08 -43.73 46.49 Favored 'Trans proline' 0 CA--C 1.575 2.54 0 C-N-CA 122.984 2.456 . . . . 0.0 115.576 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -99.29 108.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.254 1.969 . . . . 0.0 113.45 171.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.91 83.83 2.13 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.286 1.991 . . . . 0.0 111.315 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.69 -30.5 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.208 1.003 . . . . 0.0 112.627 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.6 28.68 3.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 63.7 8.22 3.6 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.917 1.287 . . . . 0.0 112.725 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.28 169.07 11.42 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.003 0.921 . . . . 0.0 108.557 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.549 ' HG2' ' HE2' ' A' ' 124' ' ' LYS . 3.9 tp10 60.5 35.16 20.29 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.07 0.938 . . . . 0.0 110.492 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.71 86.64 1.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -83.37 -52.95 6.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.76 -164.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 57.22 100.91 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.074 1.75 . . . . 0.0 111.656 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.39 -153.59 24.65 Favored Glycine 0 C--O 1.254 1.381 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.281 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.99 44.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.429 1.092 . . . . 0.0 108.894 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 8.7 m-85 -122.18 138.92 54.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.352 0.261 . . . . 0.0 110.69 -171.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.682 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 43.5 mtm180 -73.34 122.67 22.4 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 165.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.774 HG13 HG23 ' A' ' 97' ' ' ILE . 24.5 pt -120.69 146.95 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.639 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 51.6 tttm -152.32 141.51 21.39 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 126.388 1.875 . . . . 0.0 110.984 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 44.8 tt0 -123.09 150.91 42.56 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.918 -0.489 . . . . 0.0 111.713 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 16.6 ttpp -101.96 84.53 2.54 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.81 176.17 44.34 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.235 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' B' ' 253' ' ' LYS . 49.0 mt 59.17 -83.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.342 1.457 . . . . 0.0 111.604 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -113.13 -30.83 6.84 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.545 0.738 . . . . 0.0 110.205 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.87 -173.82 38.29 Favored Glycine 0 C--N 1.349 1.254 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.673 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 1.8 m-30 -105.98 72.12 0.93 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HE3' ' B' ' 253' ' ' LYS . 37.1 t -135.39 155.61 50.29 Favored 'General case' 0 C--O 1.265 1.875 0 CA-C-O 121.92 0.866 . . . . 0.0 112.737 -163.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.509 ' HB3' HD22 ' A' ' 50' ' ' LEU . 22.8 mp0 -75.3 149.63 38.71 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.062 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 HG13 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -136.73 -43.15 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -167.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.727 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . 169.32 -124.17 1.14 Allowed Glycine 0 N--CA 1.481 1.672 0 C-N-CA 116.604 -2.712 . . . . 0.0 118.019 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -128.58 126.47 40.36 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -165.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.16 149.97 18.83 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 164.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.86 116.41 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.064 0.932 . . . . 0.0 109.93 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.561 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 50.8 t80 -133.09 138.35 46.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -161.65 151.23 16.47 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 124.008 0.818 . . . . 0.0 109.135 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 65.08 -77.66 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.462 1.505 . . . . 0.0 110.652 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.57 19.88 0.15 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t -123.48 116.73 23.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.507 0.723 . . . . 0.0 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 102' ' ' TYR . 59.9 t80 -97.53 102.91 14.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 137' ' ' LEU . 2.3 t60 -121.24 126.21 49.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.411 HG21 ' C4 ' ' B' ' 251' ' ' BEZ . 9.6 t -135.47 -174.26 3.58 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 108.507 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.464 ' HA ' HD23 ' A' ' 137' ' ' LEU . 82.4 mmm -79.8 160.01 26.31 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.027 0.531 . . . . 0.0 111.535 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -84.08 -46.08 12.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.019 170.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -59.29 -19.15 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.95 0.9 . . . . 0.0 113.351 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 196' ' ' SER . 24.9 m -65.02 -14.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.439 0.696 . . . . 0.0 112.107 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -151.28 -162.14 1.48 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.604 1.162 . . . . 0.0 109.365 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 -133.47 21.03 3.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 114' ' ' THR . . . 103.4 54.63 0.83 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 2' ' ' SER . . . -101.87 -176.71 3.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.771 0.828 . . . . 0.0 111.429 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.592 HG21 ' HE ' ' A' ' 125' ' ' ARG . 3.0 p -90.75 178.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 118' ' ' VAL . 20.9 mt -124.52 166.01 16.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.528 . . . . 0.0 111.183 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -164.82 174.84 10.2 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.414 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' HG13 ' A' ' 68' ' ' VAL . 15.8 t60 -137.54 97.53 3.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.514 1.926 . . . . 0.0 106.795 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.736 ' HE2' ' HA2' ' A' ' 59' ' ' GLY . 9.0 mtmp? 8.91 75.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.282 1.833 . . . . 0.0 114.064 -159.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.32 -27.49 19.72 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 115.108 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.549 ' HE2' ' HG2' ' A' ' 78' ' ' GLU . 63.7 tttp -82.91 112.43 19.69 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.565 1.183 . . . . 0.0 109.939 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.592 ' HE ' HG21 ' A' ' 118' ' ' VAL . 75.0 ttt180 -106.4 134.44 49.53 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.514 0.725 . . . . 0.0 112.029 -164.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.62 142.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.142 1.377 . . . . 0.0 109.138 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.71 144.1 27.54 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 122.95 0.5 . . . . 0.0 112.067 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 140' ' ' TYR . 22.6 Cg_exo -68.61 138.27 41.26 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.662 2.241 . . . . 0.0 111.562 165.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 34.5 p -88.85 -7.43 56.16 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 5.1 t-105 -151.24 148.14 27.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.353 0.661 . . . . 0.0 110.151 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -146.63 124.21 11.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.923 0.889 . . . . 0.0 109.438 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.22 117.79 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.623 0.769 . . . . 0.0 110.727 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -27.73 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.78 0.832 . . . . 0.0 111.492 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -62.69 -56.66 15.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.61 0.764 . . . . 0.0 111.128 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -97.34 1.09 49.03 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.513 0.725 . . . . 0.0 109.895 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 61.41 54.34 3.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.627 1.571 . . . . 0.0 111.686 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.561 HD11 ' HB1' ' A' ' 227' ' ' ALA . 36.6 mt -144.31 145.8 32.21 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.393 0.616 . . . . 0.0 112.456 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 131' ' ' ALA . 30.8 mt -120.84 143.8 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.841 1.657 . . . . 0.0 110.253 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 2.2 m -120.32 158.19 27.62 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.228 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 3.4 t80 -151.41 135.66 16.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.846 1.258 . . . . 0.0 107.881 172.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.26 9.53 56.8 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.26 -172.6 27.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.13 -179.84 49.29 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -75.37 123.19 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.503 0.721 . . . . 0.0 110.342 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -164.01 147.22 9.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.238 1.415 . . . . 0.0 107.568 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.52 -142.06 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 O-C-N 124.314 1.009 . . . . 0.0 108.716 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 64.55 37.21 8.09 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.743 1.617 . . . . 0.0 111.353 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.84 168.08 0.96 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.786 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 150' ' ' TRP . 25.3 tt0 -143.86 129.97 19.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.236 0.614 . . . . 0.0 109.888 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.522 ' HH2' HG21 ' A' ' 226' ' ' ILE . 1.5 p90 -65.28 150.61 47.94 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.677 0.791 . . . . 0.0 110.166 164.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.69 148.82 26.2 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.765 1.226 . . . . 0.0 111.705 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 155.66 -18.7 0.5 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.494 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HB2' ' HD1' ' A' ' 150' ' ' TRP . 32.9 mt-10 -96.6 152.67 18.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.879 0.872 . . . . 0.0 109.311 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.75 114.03 25.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.2 p -97.01 164.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 120.754 0.312 . . . . 0.0 111.143 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 171' ' ' GLN . 22.3 mp0 -105.91 147.68 28.48 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.931 0.892 . . . . 0.0 109.169 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.04 143.07 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.901 0.48 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.41 93.72 8.74 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.33 100.62 10.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.89 97.79 1.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -57.66 133.04 82.51 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.239 0.616 . . . . 0.0 111.645 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.83 113.15 1.51 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.506 2.137 . . . . 0.0 112.49 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.749 ' H ' ' HA ' ' A' ' 50' ' ' LEU . . . 73.08 29.43 64.69 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.056 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 166' ' ' ASN . 81.4 tttt -151.84 177.27 10.59 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 117.351 0.575 . . . . 0.0 110.045 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.415 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 1.8 p-10 -57.72 160.51 7.78 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 112.343 170.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.89 141.1 88.6 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.97 2.447 . . . . 0.0 112.378 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -112.37 116.03 29.68 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -96.37 108.14 20.62 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.182 0.593 . . . . 0.0 109.561 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.68 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.536 0.734 . . . . 0.0 110.082 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' GLN . 30.5 tt0 -87.8 149.85 23.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.864 0.866 . . . . 0.0 109.173 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.5 t -154.66 147.97 24.98 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.765 0.826 . . . . 0.0 110.744 -172.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -75.61 158.39 83.18 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.08 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.17 146.1 93.95 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.203 1.935 . . . . 0.0 112.821 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -145.7 130.87 3.93 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-O 122.114 0.841 . . . . 0.0 114.515 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.442 ' HA ' ' HA3' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -127.24 149.71 49.88 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.345 -1.091 . . . . 0.0 112.564 -171.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.11 123.25 35.32 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.682 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -89.13 106.21 18.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 182' ' ' GLY . 23.5 m -82.81 158.01 22.94 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.655 0.782 . . . . 0.0 110.756 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -82.85 57.32 3.79 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.053 0.93 . . . . 0.0 108.535 168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -175.43 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.009 1.724 . . . . 0.0 108.003 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 179' ' ' THR . . . -153.31 -131.0 1.55 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.718 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 t -162.1 131.72 4.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.583 0.753 . . . . 0.0 109.751 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.45 138.1 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.44 0.696 . . . . 0.0 109.44 175.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 138.42 161.96 9.01 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.886 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -176.35 42.29 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.316 0 O-C-N 124.655 0.856 . . . . 0.0 110.382 170.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.455 ' N ' ' H ' ' A' ' 175' ' ' GLY . 9.5 p -166.46 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 120.232 -1.543 . . . . 0.0 109.73 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.7 m -129.76 106.19 8.53 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.542 0.737 . . . . 0.0 109.54 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.542 HD13 ' HD2' ' A' ' 191' ' ' PHE . 3.8 pp -131.88 159.15 39.45 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.924 0.49 . . . . 0.0 111.436 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.8 103.2 15.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.459 0.704 . . . . 0.0 110.333 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.542 ' HD2' HD13 ' A' ' 189' ' ' LEU . 17.7 m-85 -157.72 -175.74 5.54 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 108.455 172.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -44.07 139.91 2.94 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.549 1.14 . . . . 0.0 110.769 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.22 116.48 2.27 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.484 2.122 . . . . 0.0 111.204 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.74 111.87 1.63 Allowed Glycine 0 C--N 1.349 1.29 0 O-C-N 124.153 0.908 . . . . 0.0 112.194 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' THR . . . . . 0.727 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 25.2 p -50.66 124.26 10.56 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.004 1.322 . . . . 0.0 111.129 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.592 ' HB3' HG12 ' A' ' 113' ' ' VAL . 36.1 m -55.65 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.563 0 O-C-N 123.901 0.751 . . . . 0.0 110.071 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 110' ' ' MET . . . 127.87 4.96 5.48 Favored Glycine 0 C--N 1.366 2.226 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.4 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 67.1 m -49.67 129.67 19.89 Favored Pre-proline 0 N--CA 1.5 2.041 0 C-N-CA 124.462 1.105 . . . . 0.0 113.456 -171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.39 133.84 6.46 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 113.223 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.426 HG21 ' CZ3' ' A' ' 150' ' ' TRP . 50.3 mt -105.81 110.97 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.801 1.241 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 208' ' ' VAL . 12.8 pt -131.8 -175.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.803 1.241 . . . . 0.0 112.432 -168.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 36.3 t70 -114.98 175.98 5.26 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.139 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . 0.603 ' HB3' ' HE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -60.54 -30.45 69.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.967 0.507 . . . . 0.0 112.053 172.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -84.98 -0.77 55.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.731 0.413 . . . . 0.0 111.963 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.56 23.85 77.52 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.921 -0.471 . . . . 0.0 111.921 -168.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 64.5 tttp -76.31 165.1 25.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.729 1.211 . . . . 0.0 109.605 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 209' ' ' GLY . 94.4 t 81.99 -89.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.959 1.304 . . . . 0.0 108.048 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 201' ' ' ILE 0.28 3.1 m 68.21 31.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 125.08 1.352 . . . . 0.0 110.187 175.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 207' ' ' VAL . . . -72.43 -174.22 23.83 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.87 168.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.3 154.53 50.06 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.349 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.0 OUTLIER -68.37 116.16 8.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.644 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 225' ' ' ALA . . . -71.61 -162.68 5.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.688 -0.292 . . . . 0.0 113.733 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -71.63 84.12 0.87 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.852 0.834 . . . . 0.0 109.523 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -127.15 -174.62 13.84 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.219 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.12 176.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.323 0.649 . . . . 0.0 109.277 -168.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.7 115.15 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.784 HG23 HD13 ' A' ' 41' ' ' ILE . 14.8 m -129.6 158.77 38.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.68 1.192 . . . . 0.0 109.783 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.77 ' HB2' HD21 ' A' ' 29' ' ' LEU . 4.1 tmm_? 63.65 76.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.647 1.179 . . . . 0.0 110.581 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 59.2 p 49.12 23.07 0.7 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.865 1.666 . . . . 0.0 114.577 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.05 0.67 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 113.794 0.278 . . . . 0.0 113.794 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.83 152.11 50.52 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.782 0.833 . . . . 0.0 109.065 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -83.36 118.84 23.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.676 0.39 . . . . 0.0 110.428 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.41 HG12 HD11 ' A' ' 31' ' ' ILE . 14.6 t -134.39 116.65 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.168 0.587 . . . . 0.0 109.577 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 45.7 t -130.88 156.76 44.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.832 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -101.8 93.26 5.22 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.171 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.522 HG21 ' HH2' ' A' ' 150' ' ' TRP . 22.9 pt -53.05 141.55 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -161.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -91.35 138.34 31.66 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.68 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.91 171.56 13.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -166.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.6 t -67.46 149.07 50.7 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.066 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -13.64 6.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.136 155.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt 33.2 87.77 0.01 OUTLIER 'General case' 0 C--N 1.38 1.914 0 C-N-CA 126.03 1.732 . . . . 0.0 112.821 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.5 m -52.66 99.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.742 0.817 . . . . 0.0 111.552 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.4 mm 68.91 146.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.623 1.569 . . . . 0.0 111.665 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.12 61.55 6.94 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.915 0.864 . . . . 0.0 111.438 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -76.21 -29.65 57.68 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.047 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -55.65 114.71 7.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 124.527 1.142 . . . . 0.0 110.874 -174.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.03 120.14 7.26 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.161 1.908 . . . . 0.0 110.102 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 62.99 67.07 0.7 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 124.39 1.056 . . . . 0.0 108.718 -170.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 10.0 tt -70.8 -30.58 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.93 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.927 0.891 . . . . 0.0 109.272 178.588 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.521 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.701 ' HA ' HD13 ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 95' ' ' SER . 0.1 OUTLIER 69.95 -63.13 0.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 127.597 2.359 . . . . 0.0 114.219 -172.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -43.87 -44.28 6.87 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -164.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 115' ' ' ARG . 15.2 m -107.26 91.59 3.72 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -177.6 -78.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.194 1.398 . . . . 0.0 108.384 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.12 26.62 12.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.778 1.231 . . . . 0.0 110.876 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 89' ' ' LYS . 8.5 m-20 -155.19 40.04 0.42 Allowed 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.405 1.482 . . . . 0.0 107.166 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 119' ' ' LEU . 90.2 mt -79.91 92.86 5.58 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.542 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' MET . 21.1 mt-10 -98.61 126.84 44.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.448 1.099 . . . . 0.0 110.177 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -117.42 162.75 17.44 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.934 -1.104 . . . . 0.0 113.67 -177.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 9.3 pt-20 -148.35 161.36 41.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.443 1.097 . . . . 0.0 110.269 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.719 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 12.7 tpt180 -66.98 153.28 44.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.647 0.779 . . . . 0.0 111.43 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -125.7 -52.39 1.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.906 0.883 . . . . 0.0 109.915 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.26 -166.66 0.55 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 108.88 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 36.7 t70 -95.82 153.09 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 101' ' ' VAL . 5.1 t -73.28 99.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -162.44 149.12 13.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -168.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.62 112.05 5.16 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 166.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 0.6 OUTLIER -75.15 144.2 42.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.037 0.535 . . . . 0.0 109.827 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.28 -19.43 64.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 48.99 1.67 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.833 0.825 . . . . 0.0 109.605 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.719 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -162.03 83.57 0.58 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 165.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.58 ' HB ' ' H ' ' A' ' 171' ' ' GLN . 29.4 mm -149.69 163.28 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 p -162.79 101.63 1.02 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.297 1.439 . . . . 0.0 108.077 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.34 -107.14 1.47 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.038 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 11.6 t 63.64 41.71 6.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.958 0.903 . . . . 0.0 109.927 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.6 m -64.65 146.0 98.5 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.16 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -54.12 178.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.917 3.078 . . . . 0.0 114.992 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.69 108.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -93.0 158.37 15.83 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.757 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 118.27 36.14 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.62 -0.675 . . . . 0.0 110.574 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 223' ' ' VAL . 40.9 mt -126.21 150.94 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.895 0.878 . . . . 0.0 108.997 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.9 p -98.42 113.11 24.97 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -65.22 159.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.156 0.583 . . . . 0.0 110.346 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -135.59 120.14 18.17 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 123.525 0.73 . . . . 0.0 109.422 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 67.8 -74.56 0.07 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 125.221 1.576 . . . . 0.0 110.876 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -158.64 -57.9 0.07 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.69 0.796 . . . . 0.0 109.309 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.78 -11.3 33.02 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.232 -0.894 . . . . 0.0 114.238 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -92.24 159.9 15.41 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.482 1.141 . . . . 0.0 108.981 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.6 mtp -132.97 143.01 49.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.676 0.39 . . . . 0.0 110.454 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -143.37 153.7 42.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.433 0.693 . . . . 0.0 110.521 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.72 HG13 ' H ' ' A' ' 43' ' ' ASN . 7.3 tp -95.99 145.31 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -77.19 1.31 18.76 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-O 121.694 0.759 . . . . 0.0 111.323 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.72 ' H ' HG13 ' A' ' 41' ' ' ILE . 21.0 m120 -100.89 179.8 4.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.318 1.047 . . . . 0.0 109.5 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.3 143.28 33.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.736 0.814 . . . . 0.0 109.458 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -162.0 141.77 9.96 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.266 0.626 . . . . 0.0 109.569 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.13 108.49 14.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.57 -107.55 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.717 0.807 . . . . 0.0 111.155 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.727 ' HA ' HG22 ' A' ' 97' ' ' ILE . 49.7 mt-30 64.74 -176.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.9 p 64.45 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.711 2.004 . . . . 0.0 113.82 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 161' ' ' LEU . 0.3 OUTLIER -156.4 -77.17 0.09 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 167.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -26.37 73.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.636 -0.711 . . . . 0.0 114.46 -168.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.57 56.84 5.03 Favored Glycine 0 C--N 1.345 1.048 0 C-N-CA 122.84 0.257 . . . . 0.0 113.322 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.08 4.36 4.57 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 170.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.88 175.31 16.61 Favored Glycine 0 C--N 1.356 1.661 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -130.73 137.56 49.56 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.305 0.642 . . . . 0.0 110.441 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.69 -29.34 35.77 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.59 -82.2 1.13 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 122.909 0.29 . . . . 0.0 113.158 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -141.78 127.82 3.41 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.07 -124.37 0.77 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -94.58 -63.48 1.17 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -113.24 -66.08 1.12 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.539 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.32 -41.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.167 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.87 113.79 0.94 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.519 ' O ' ' HD2' ' A' ' 122' ' ' LYS . 30.3 m -82.49 76.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-O 121.706 0.765 . . . . 0.0 111.595 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 96' ' ' GLN . 6.0 mt 85.48 87.53 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.874 1.67 . . . . 0.0 111.825 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HE1' ' HG2' ' A' ' 122' ' ' LYS . 6.4 m0 -102.06 105.39 16.12 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.719 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 28.6 t70 177.63 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.225 1.578 . . . . 0.0 109.233 155.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 8' ' ' LEU . 67.3 t -128.36 146.73 60.91 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.488 0.715 . . . . 0.0 110.374 -172.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.575 ' HD2' HD21 ' A' ' 8' ' ' LEU . 10.7 Cg_endo -54.89 79.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.421 2.081 . . . . 0.0 110.645 157.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 p -65.32 128.49 93.84 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.833 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HG3' HG12 ' A' ' 126' ' ' ILE . 72.4 Cg_exo -49.39 -47.3 22.91 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.369 2.713 . . . . 0.0 115.422 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.43 124.2 15.01 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 121.927 1.751 . . . . 0.0 113.06 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -86.03 49.83 2.36 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.408 2.739 . . . . 0.0 112.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.55 2.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 112.793 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.34 -58.28 2.71 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.99 -83.77 0.15 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.102 0.561 . . . . 0.0 109.489 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.02 -158.93 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.999 0.92 . . . . 0.0 112.894 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -79.37 -85.64 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? 40.59 86.63 0.02 OUTLIER 'General case' 0 C--N 1.361 1.074 0 C-N-CA 126.197 1.799 . . . . 0.0 112.797 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -118.78 -169.18 1.68 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.4 142.23 20.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.08 0.552 . . . . 0.0 109.736 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 147.28 -154.12 25.76 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.55 137.55 46.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CD2' HD23 ' A' ' 8' ' ' LEU . 7.7 m-85 -123.39 139.82 53.64 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.944 0.498 . . . . 0.0 111.348 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' A' ' 161' ' ' LEU . 21.9 mtp180 -92.75 126.57 37.9 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.765 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 15.1 pt -129.93 143.95 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -139.52 138.12 36.05 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.329 1.852 . . . . 0.0 112.151 -172.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.654 ' HB3' ' HG2' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -132.5 153.55 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 170.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 45.1 mtpt -106.97 88.97 2.86 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' B' ' 253' ' ' LYS . . . -168.64 178.11 42.24 Favored Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 mt 59.42 23.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 118.008 0.904 . . . . 0.0 111.409 166.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp 71.45 41.65 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.052 1.341 . . . . 0.0 111.538 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.07 156.09 24.92 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 121.728 -0.272 . . . . 0.0 113.57 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.63 68.94 0.83 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.564 1.146 . . . . 0.0 108.2 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 m -113.26 125.06 53.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -159.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 65' ' ' LEU . 3.4 pm0 -95.82 104.21 16.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.318 1.447 . . . . 0.0 108.893 170.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 48' ' ' GLN . 2.8 pp -137.14 -37.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -120.13 -168.96 13.91 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.284 -1.436 . . . . 0.0 116.129 -154.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -125.97 138.49 53.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.879 -172.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -133.37 -176.26 14.32 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.815 HG13 ' HB2' ' A' ' 108' ' ' HIS . 0.2 OUTLIER -152.46 109.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.426 0.69 . . . . 0.0 109.323 -178.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 107' ' ' PHE . 84.2 t80 -107.09 136.21 47.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -147.99 110.83 4.78 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 109.087 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 45.38 68.5 0.56 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.587 1.555 . . . . 0.0 113.101 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 -30.08 6.18 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.555 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 9.8 m -105.41 116.34 31.79 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.555 -172.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 87.8 t80 -93.81 144.25 25.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 172.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.815 ' HB2' HG13 ' A' ' 101' ' ' VAL . 25.2 m80 -132.19 122.68 25.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.866 0.866 . . . . 0.0 109.174 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.41 HG21 ' C4 ' ' B' ' 251' ' ' BEZ . 15.2 t -141.98 -179.67 6.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.569 0.748 . . . . 0.0 111.462 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 210' ' ' LEU . 79.9 mmm -89.66 173.25 8.4 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.639 1.176 . . . . 0.0 109.856 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -59.45 2.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 122.091 -0.381 . . . . 0.0 111.609 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -53.72 -28.21 32.71 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 125.131 1.372 . . . . 0.0 114.16 -168.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.427 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 4.2 m -56.1 -25.63 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 124.531 1.132 . . . . 0.0 113.021 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.648 HG23 ' H ' ' A' ' 116' ' ' GLY . 2.9 t -142.19 -166.63 2.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' HB3' ' H ' ' A' ' 2' ' ' SER . 17.3 tpt180 -111.42 33.51 4.66 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 121.065 0.459 . . . . 0.0 111.443 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 114' ' ' THR . . . 71.73 58.57 5.25 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.965 176.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.69 -172.37 2.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.516 0.726 . . . . 0.0 111.972 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 p -100.14 148.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 124.442 1.097 . . . . 0.0 111.755 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.665 HD21 ' H4 ' ' B' ' 251' ' ' BEZ . 2.9 mm? -91.11 168.99 11.22 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.549 1.14 . . . . 0.0 111.211 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -172.77 163.81 5.14 Favored 'General case' 0 C--O 1.263 1.772 0 CA-C-O 123.869 1.795 . . . . 0.0 114.862 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -106.76 95.21 5.57 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.78 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.604 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 0.9 OUTLIER 48.97 48.09 21.01 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.005 0.922 . . . . 0.0 112.45 164.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.64 -8.48 56.5 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -100.25 110.55 22.8 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.997 0.899 . . . . 0.0 109.068 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 11.5 ttp180 -82.1 151.04 27.19 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -162.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.452 HG12 ' HG3' ' A' ' 71' ' ' PRO . 66.8 mt -142.51 121.68 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.038 1.735 . . . . 0.0 108.151 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -77.4 129.91 76.08 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.14 0.576 . . . . 0.0 111.395 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.62 170.57 19.95 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.781 2.321 . . . . 0.0 111.015 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 p -125.14 -29.69 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.575 0.75 . . . . 0.0 111.861 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 14.4 t-105 -131.22 143.74 50.8 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.762 0.825 . . . . 0.0 109.721 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.82 122.42 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.498 1.119 . . . . 0.0 108.285 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -140.98 119.81 12.61 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.276 0.631 . . . . 0.0 110.178 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -76.4 -24.39 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.291 1.037 . . . . 0.0 113.056 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -72.99 -42.41 63.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.16 0.505 . . . . 0.0 110.924 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.18 -8.89 34.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.532 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 t70 60.22 57.78 2.83 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.992 1.317 . . . . 0.0 110.644 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 144' ' ' TRP . 98.0 mt -144.87 137.07 26.03 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.412 0.685 . . . . 0.0 110.961 -174.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.2 mt -128.27 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.273 1.429 . . . . 0.0 108.864 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 130' ' ' TRP . 51.3 p -142.93 161.15 38.87 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.874 0.845 . . . . 0.0 112.99 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.663 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.9 t80 -116.52 143.64 45.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.956 1.702 . . . . 0.0 107.847 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.14 -13.45 44.59 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.53 -151.41 22.97 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 173.69 38.93 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.661 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 59.4 t-105 -69.12 108.84 3.75 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 231' ' ' LYS . 22.8 pttp -147.92 137.87 22.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.829 0.452 . . . . 0.0 110.278 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 229' ' ' THR . 15.8 tp -160.81 -90.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.497 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -172.42 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.91 0.777 . . . . 0.0 110.1 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.79 152.34 48.39 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.644 -1.162 . . . . 0.0 115.391 -161.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.13 127.26 17.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.998 0.919 . . . . 0.0 108.893 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.411 ' HZ2' ' HG3' ' A' ' 174' ' ' PRO . 47.7 t-105 -91.8 136.86 32.83 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.065 0.46 . . . . 0.0 111.35 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -134.82 127.48 30.91 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.42 125.93 25.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.965 0.906 . . . . 0.0 112.482 -170.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.36 -69.49 0.06 OUTLIER Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.84 -177.65 6.66 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.718 0.807 . . . . 0.0 109.817 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 8.1 pt-20 -104.14 147.46 27.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 110.859 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.36 171.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.586 0.754 . . . . 0.0 110.746 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.447 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -128.03 147.76 50.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 108.507 176.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 200' ' ' ILE . 29.4 m -122.86 139.59 49.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 109.449 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 90.4 mt -80.54 86.07 5.88 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.69 100.39 5.39 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 167' ' ' PRO . 62.5 mt -68.94 106.03 2.59 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' LYS . 19.4 mm-40 -67.58 133.83 92.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.21 112.43 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.476 2.117 . . . . 0.0 112.169 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.81 20.92 72.81 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.046 -0.979 . . . . 0.0 114.846 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 76.1 mmtt -138.57 -175.0 3.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.831 0.852 . . . . 0.0 109.99 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -81.36 152.16 70.1 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.539 0.736 . . . . 0.0 110.717 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . 0.785 ' HB3' HD23 ' A' ' 161' ' ' LEU . 30.4 Cg_endo -62.98 137.59 63.18 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.868 2.379 . . . . 0.0 113.585 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -81.08 135.3 35.79 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.168 167.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -81.4 105.2 12.39 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 166.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 22' ' ' ILE . 51.3 t -112.17 116.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.441 0.696 . . . . 0.0 109.305 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . 0.58 ' H ' ' HB ' ' A' ' 22' ' ' ILE . 58.4 tt0 -108.71 137.41 46.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.834 0.349 . . . . 0.0 110.606 -165.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.4 t -153.75 147.02 24.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.82 0.848 . . . . 0.0 110.298 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 97.3 mttt -72.37 162.15 75.37 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.652 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' ALA . 50.0 Cg_exo -55.86 131.83 48.37 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.724 2.282 . . . . 0.0 111.717 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -147.66 150.75 23.03 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.254 0.919 . . . . 0.0 114.897 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.425 ' N ' HD23 ' A' ' 176' ' ' LEU . 1.0 OUTLIER -140.38 167.85 21.19 Favored 'General case' 0 C--O 1.239 0.55 0 O-C-N 121.101 -1.235 . . . . 0.0 111.235 -170.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.22 136.16 33.1 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.191 -1.822 . . . . 0.0 108.946 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -77.63 144.47 37.41 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.3 m -102.85 179.25 4.33 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.776 1.231 . . . . 0.0 108.932 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.43 ' H ' HG22 ' A' ' 179' ' ' THR . 20.2 m120 -68.03 -18.24 64.64 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.877 0.471 . . . . 0.0 111.893 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.38 -68.21 0.87 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.053 0.941 . . . . 0.0 110.016 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.8 -142.2 11.85 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.662 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.8 t -163.25 135.85 5.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.465 1.106 . . . . 0.0 108.842 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 165.89 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.164 0.586 . . . . 0.0 109.801 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 133.82 167.98 11.71 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-O 120.278 -0.179 . . . . 0.0 113.313 174.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -171.03 34.28 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.635 0 O-C-N 124.163 0.567 . . . . 0.0 110.812 173.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.475 ' N ' ' H ' ' A' ' 175' ' ' GLY . 2.2 t -164.87 117.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 126.565 1.946 . . . . 0.0 106.837 163.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.7 t -129.45 121.71 27.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.5 tp -144.42 151.46 39.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.86 0.864 . . . . 0.0 110.084 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.68 105.16 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 62.2 t80 -160.86 162.34 32.15 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.767 0.827 . . . . 0.0 109.121 -172.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.8 p -60.12 158.62 25.7 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.955 0.902 . . . . 0.0 111.422 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.81 107.88 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.683 2.922 . . . . 0.0 113.016 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -72.74 158.53 53.18 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.072 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.6 p -84.12 105.26 14.84 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 122.977 0.511 . . . . 0.0 109.959 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -56.75 110.06 0.73 Allowed 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.574 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 118.89 12.9 6.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.145 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.0 m -57.2 117.32 17.36 Favored Pre-proline 0 C--N 1.366 1.291 0 C-N-CA 122.899 0.48 . . . . 0.0 110.794 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 49.3 Cg_exo -58.7 112.77 1.3 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.933 2.422 . . . . 0.0 112.256 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 158' ' ' VAL . 58.9 mt -80.48 96.56 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.788 0.835 . . . . 0.0 109.304 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 208' ' ' VAL . 30.8 mt -119.57 134.18 63.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.26 -179.86 6.49 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.951 0.796 . . . . 0.0 109.456 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -63.41 -25.72 68.41 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.186 0.594 . . . . 0.0 112.527 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.43 -19.71 55.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.982 0.513 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 95.18 36.28 5.5 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.417 0.448 . . . . 0.0 112.221 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -130.22 166.79 19.57 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.215 1.006 . . . . 0.0 110.133 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 79.9 t 99.51 -60.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.14 2.176 . . . . 0.0 109.518 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 201' ' ' ILE . 33.2 m 49.74 32.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.869 1.267 . . . . 0.0 112.268 170.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.518 ' HA2' HG23 ' A' ' 229' ' ' THR . . . -76.78 -157.16 7.69 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.434 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.631 ' HB3' ' SD ' ' A' ' 110' ' ' MET . 24.4 mt -139.75 124.8 18.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.452 0.644 . . . . 0.0 112.582 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.16 124.35 26.17 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.989 164.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 176.81 66.82 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 158.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 225' ' ' ALA . 14.6 m120 -154.8 171.96 18.75 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 66.4 -118.65 11.22 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 p 179.13 168.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.257 1.476 0 CA-C-O 121.707 0.765 . . . . 0.0 110.217 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.02 113.81 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 160.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 221' ' ' ALA . 6.5 t -119.89 158.33 26.88 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.865 0.866 . . . . 0.0 111.159 -165.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 59.93 16.2 5.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.272 1.029 . . . . 0.0 111.17 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.8 t 53.6 28.54 8.01 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.561 1.544 . . . . 0.0 112.382 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 178.99 30.55 0.05 OUTLIER Glycine 0 C--N 1.358 1.794 0 C-N-CA 120.768 -0.73 . . . . 0.0 114.447 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 217' ' ' THR . . . -135.88 145.47 46.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.253 0.527 . . . . 0.0 109.596 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -105.13 101.67 11.21 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.9 1.28 . . . . 0.0 109.162 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 31' ' ' ILE . 17.9 m -122.67 141.44 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 119.103 0.865 . . . . 0.0 110.512 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.4 m -144.9 129.41 17.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.581 -166.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.791 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -81.52 -16.28 52.28 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.61 0.364 . . . . 0.0 110.648 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 17.5 pt 56.52 140.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 128.276 2.63 . . . . 0.0 116.527 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.48 27.54 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.985 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -125.29 143.01 51.17 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 172.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' THR . . . . . 0.661 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 62.2 p -76.03 104.4 6.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.555 0.693 . . . . 0.0 111.046 -169.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.26 107.74 19.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.424 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -56.98 80.57 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.204 1.002 . . . . 0.0 111.485 172.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 52.3 p -70.27 93.49 0.85 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.854 0.861 . . . . 0.0 109.877 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.8 tp -97.36 14.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.568 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.16 92.3 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.894 0.878 . . . . 0.0 110.375 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.71 -39.56 94.62 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -55.32 132.54 69.83 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.04 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.01 -52.2 8.51 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.838 2.359 . . . . 0.0 113.259 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -134.24 -77.8 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.132 0.573 . . . . 0.0 110.002 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 42.6 mm 49.91 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.928 1.291 . . . . 0.0 112.245 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 124.235 1.014 . . . . 0.0 110.487 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' BEZ . . . . . 0.765 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' NLE . . . . . 0.654 ' HG2' ' HB3' ' A' ' 88' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' A' ' 90' ' ' GLY . 2.0 tppp? -121.71 -49.45 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.331 0.653 . . . . 0.0 110.739 167.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -104.32 158.58 16.36 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 110.941 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.112 0 CA-C-O 121.197 0.522 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.18 -4.68 1.69 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.251 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -174.84 90.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.344 0.592 . . . . 0.0 109.632 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 118' ' ' VAL . 4.7 mp -133.69 95.05 3.39 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.149 1.78 . . . . 0.0 108.502 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.628 ' HB3' HG11 ' A' ' 64' ' ' VAL . 3.7 tp10 -97.53 140.67 31.62 Favored 'General case' 0 C--O 1.26 1.622 0 CA-C-O 121.76 0.79 . . . . 0.0 112.639 -170.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' A' ' 86' ' ' ILE . 57.0 mt -86.28 149.16 25.25 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.409 175.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -147.47 111.06 4.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.621 -0.674 . . . . 0.0 109.757 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' HB3' ' A' ' 67' ' ' ASP . 55.7 ttp180 -62.78 137.17 58.2 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.629 1.104 . . . . 0.0 110.363 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.43 -28.8 3.58 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.281 0.632 . . . . 0.0 110.477 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.06 -169.67 2.44 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.077 0.951 . . . . 0.0 109.583 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 18.7 t70 -109.5 151.14 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.545 0.738 . . . . 0.0 109.524 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 101' ' ' VAL . 44.8 t -75.29 98.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.708 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.94 160.22 4.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.442 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 43.0 t90 -64.05 126.07 26.52 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 172.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 11.0 tp10 -95.62 143.96 26.46 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.523 0.729 . . . . 0.0 109.039 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.03 -3.85 11.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.971 0.908 . . . . 0.0 113.278 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.49 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 14.3 mm100 -82.61 36.06 0.48 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.452 0.701 . . . . 0.0 110.867 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -61.69 112.59 2.32 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 125.125 1.37 . . . . 0.0 111.769 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -124.1 119.41 29.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.013 0.925 . . . . 0.0 110.096 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.86 114.24 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -144.62 -24.37 0.52 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.352 0.661 . . . . 0.0 111.683 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.14 -145.39 0.06 OUTLIER Glycine 0 C--N 1.359 1.858 0 N-CA-C 114.351 0.501 . . . . 0.0 114.351 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m 64.57 18.4 11.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 9.9 m -65.54 120.21 66.31 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.386 0.674 . . . . 0.0 109.61 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 15.3 Cg_exo -65.67 -96.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.384 2.723 . . . . 0.0 114.549 -161.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.436 ' H ' ' HB2' ' A' ' 27' ' ' PRO . 42.2 mm -113.37 119.51 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 223' ' ' VAL . 7.2 mp -110.92 164.07 13.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.245 0.618 . . . . 0.0 110.687 172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 p -115.23 110.88 20.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.09 143.43 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.307 1.043 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 p -90.99 108.08 19.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.69 0.757 . . . . 0.0 108.971 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG13 HG23 ' A' ' 179' ' ' THR . 27.2 mm -79.18 127.68 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.951 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 19.7 m -100.79 95.51 6.69 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.098 0.559 . . . . 0.0 110.07 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 58.23 27.78 15.65 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.228 1.411 . . . . 0.0 111.84 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 75.95 -42.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.523 1.529 . . . . 0.0 113.586 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.06 -42.48 98.13 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 49.2 m -106.33 161.4 14.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.59 0.356 . . . . 0.0 110.732 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.479 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.3 ppp? -150.41 136.7 18.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.04 0.936 . . . . 0.0 108.948 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 p -163.52 177.27 8.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.968 0.414 . . . . 0.0 111.026 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.526 ' H ' HG21 ' A' ' 215' ' ' VAL . 2.8 tp -102.13 146.6 9.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.92 70.69 6.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.078 0.942 . . . . 0.0 109.729 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.94 114.86 3.49 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.794 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.98 103.93 1.61 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.698 0.624 . . . . 0.0 110.276 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG3' ' NH2' ' B' ' 254' ' ' ARG . 2.2 pt-20 . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 124.378 1.071 . . . . 0.0 109.961 170.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 7' ' ' GLU . 3.4 t . . . . . 0 CA--C 1.557 1.247 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -179.68 142.41 0.17 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.671 1.588 . . . . 0.0 107.385 -166.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.596 ' CD1' ' HE3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -147.32 178.12 8.67 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.456 ' HB3' ' N ' ' A' ' 10' ' ' ARG . 59.1 t0 179.73 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 111.267 -2.697 . . . . 0.0 105.318 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.2 m . . . . . 0 CA--C 1.566 1.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.471 -174.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.686 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 36.7 m-20 . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 126.47 -151.41 18.03 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.253 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.88 120.21 32.99 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 124.795 1.238 . . . . 0.0 109.295 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.686 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 11.3 m-85 -105.56 144.4 32.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 123.609 0.764 . . . . 0.0 110.473 -171.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.38 131.82 35.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 153.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 98' ' ' GLY . 7.1 pt -132.58 142.84 41.44 Favored 'Isoleucine or valine' 0 C--O 1.254 1.322 0 O-C-N 121.083 -1.011 . . . . 0.0 109.283 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 tttm -148.98 134.67 18.77 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.59 1.156 . . . . 0.0 110.17 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -110.02 157.93 18.79 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -99.69 92.16 5.2 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 155.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.48 175.16 42.57 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 118.962 -0.91 . . . . 0.0 111.352 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' B' ' 253' ' ' LYS . 78.0 mt 59.07 -80.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 124.921 1.288 . . . . 0.0 112.052 173.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 tp -127.09 29.77 5.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.962 0.905 . . . . 0.0 109.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.02 -143.78 16.33 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.638 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.465 ' HB3' ' HZ1' ' A' ' 87' ' ' LYS . 11.9 m-85 -86.84 95.57 9.91 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.919 0.888 . . . . 0.0 109.234 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' B' ' 253' ' ' LYS . 7.8 m -140.42 146.98 39.01 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.854 1.206 . . . . 0.0 111.646 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.494 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 0.3 OUTLIER -102.46 130.97 49.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.143 1.777 . . . . 0.0 113.48 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.633 HD12 ' N ' ' B' ' 253' ' ' LYS . 0.0 OUTLIER -90.36 -30.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.626 0.77 . . . . 0.0 110.13 174.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.512 ' O ' HG12 ' A' ' 86' ' ' ILE . . . 100.83 -86.41 0.63 Allowed Glycine 0 C--O 1.2 -2.002 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.633 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -99.44 119.58 38.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.568 2.684 . . . . 0.0 111.127 -149.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.05 122.36 5.3 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.303 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.512 HG13 HG21 ' A' ' 14' ' ' VAL . 60.0 t -108.58 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 110.096 -165.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 24.4 t80 -123.09 117.27 25.03 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -123.53 127.21 48.01 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.67 1.188 . . . . 0.0 108.646 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 65.73 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.955 1.302 . . . . 0.0 111.391 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.86 -0.44 1.27 Allowed Glycine 0 N--CA 1.472 1.038 0 CA-C-O 120.052 -0.304 . . . . 0.0 113.254 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -116.57 126.84 53.86 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.279 0.632 . . . . 0.0 110.87 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.805 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 70.1 t80 -99.64 110.98 23.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.756 ' HE2' HD23 ' A' ' 137' ' ' LEU . 29.2 t60 -130.23 114.57 15.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.693 0.397 . . . . 0.0 110.752 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.61 -171.49 2.79 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.358 1.063 . . . . 0.0 109.645 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 211' ' ' TYR . 25.9 mmt -72.33 159.79 33.45 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.805 0.842 . . . . 0.0 111.936 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.0 t90 -85.52 -44.31 12.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.15 0.58 . . . . 0.0 110.704 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -60.37 -14.51 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 0.0 113.326 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 114' ' ' THR . 23.5 m -59.16 -23.64 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 172.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 116' ' ' GLY . 10.0 t -155.86 -166.19 2.14 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.627 1.171 . . . . 0.0 109.261 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -117.64 17.97 14.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.162 0.585 . . . . 0.0 110.461 168.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 114' ' ' THR . . . 106.45 54.86 0.68 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 124.038 0.827 . . . . 0.0 111.574 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.03 160.01 16.56 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.2 0.524 . . . . 0.0 111.811 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 127' ' ' GLU . 14.5 p -81.03 159.28 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.678 1.191 . . . . 0.0 110.249 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.41 HD13 HD21 ' A' ' 8' ' ' LEU . 10.8 mt -113.88 172.17 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.393 0.542 . . . . 0.0 111.67 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.55 ' HB3' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -171.49 178.03 3.3 Favored 'General case' 0 C--O 1.267 2.003 0 CA-C-O 123.706 1.717 . . . . 0.0 114.793 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.538 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 43.9 t60 -114.78 100.39 8.2 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 110.615 -2.993 . . . . 0.0 108.816 164.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.596 ' HE3' ' CD1' ' A' ' 66' ' ' TRP . 8.9 mtmp? 1.98 72.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 127.313 2.245 . . . . 0.0 114.172 -173.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.0 19.55 16.69 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 121' ' ' HIS . 1.2 tmmt? -139.71 112.13 7.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 167.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 41.2 ttp85 -98.69 140.75 32.43 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -162.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.55 130.33 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 126.088 1.755 . . . . 0.0 109.438 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.556 ' HA ' HG23 ' A' ' 118' ' ' VAL . 5.2 mp0 -91.05 138.39 26.02 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.639 -0.663 . . . . 0.0 111.649 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 19.8 Cg_exo -68.84 156.95 63.78 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.032 2.488 . . . . 0.0 112.139 167.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 p -98.85 -17.76 18.26 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.392 0.677 . . . . 0.0 111.829 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 21.6 t-105 -152.02 148.88 28.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.23 0.612 . . . . 0.0 110.87 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -149.25 122.28 8.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.647 1.179 . . . . 0.0 109.263 169.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.54 118.35 20.94 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.027 0.441 . . . . 0.0 111.29 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.86 -28.6 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.978 1.311 . . . . 0.0 111.805 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -65.82 -56.52 11.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.76 0.824 . . . . 0.0 111.951 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -79.86 -23.99 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.499 0.72 . . . . 0.0 109.892 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 79.84 44.15 0.05 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.077 1.751 . . . . 0.0 109.989 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.756 HD23 ' HE2' ' A' ' 108' ' ' HIS . 9.4 mp -131.65 129.43 40.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 111.327 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 131' ' ' ALA . 24.0 mt -114.01 144.09 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.548 1.539 . . . . 0.0 110.749 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 7.2 m -125.87 154.85 42.11 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.629 0.728 . . . . 0.0 111.548 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 10.9 t80 -136.68 138.47 41.1 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.591 1.556 . . . . 0.0 107.698 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 -45.15 1.51 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.68 36.45 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.41 135.71 31.55 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -69.84 142.05 53.15 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 117.262 0.531 . . . . 0.0 110.763 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -151.33 114.24 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 229' ' ' THR . 3.9 mm? -123.64 -91.64 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 167.8 -69.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 207' ' ' VAL . . . -77.12 153.86 42.13 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.817 -166.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.3 121.96 11.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.499 -0.85 . . . . 0.0 108.784 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.499 ' HE3' HD13 ' A' ' 200' ' ' ILE . 16.3 t90 -91.12 148.47 22.35 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -153.37 160.3 42.62 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.411 ' HG3' ' HA3' ' A' ' 185' ' ' GLY . 2.0 pm0 -63.03 93.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.294 1.045 . . . . 0.0 111.047 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.87 -46.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.433 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.6 160.23 14.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.316 1.046 . . . . 0.0 109.218 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 173' ' ' LYS . 13.6 pt-20 -93.71 145.52 24.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.964 0.506 . . . . 0.0 110.12 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.626 HG11 HG23 ' A' ' 200' ' ' ILE . 1.4 p -140.29 -173.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 122.193 -0.317 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 38.4 mt-30 -126.35 148.07 49.63 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.964 -0.46 . . . . 0.0 110.088 166.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.84 125.82 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.1 88.79 6.66 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.17 112.51 25.54 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.235 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 167' ' ' PRO . 59.7 mt -66.99 125.73 26.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 168' ' ' ARG . 45.4 mt-10 -81.22 155.57 72.04 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.145 0.578 . . . . 0.0 111.112 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 113.51 2.79 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.536 2.158 . . . . 0.0 112.563 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.91 53.42 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.302 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 88.3 mttt -129.98 -171.04 2.43 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.483 0.713 . . . . 0.0 111.666 -171.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -76.53 158.1 81.59 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.889 0.875 . . . . 0.0 112.405 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.539 ' HB3' HD23 ' A' ' 161' ' ' LEU . 18.3 Cg_endo -60.07 106.05 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.869 2.379 . . . . 0.0 112.113 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 162' ' ' GLU . 3.3 tpt180 -75.09 97.25 3.39 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.113 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -76.97 104.91 7.72 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.74 128.22 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.425 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 9.1 tt0 -78.99 108.02 12.16 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 p -115.64 104.72 11.98 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.394 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HG2' ' HB2' ' A' ' 155' ' ' GLU . 90.3 mttt -83.33 164.75 44.19 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.142 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.85 140.04 58.54 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.992 2.462 . . . . 0.0 113.934 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -134.88 176.86 19.71 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 173.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -163.68 156.51 18.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.449 0.642 . . . . 0.0 110.455 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.84 151.41 46.98 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.209 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.46 142.42 41.01 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.583 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 181' ' ' ALA . 49.6 m -137.96 162.58 33.7 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.52 1.128 . . . . 0.0 108.704 -167.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.16 -34.27 76.08 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.678 ' H ' HG22 ' A' ' 179' ' ' THR . . . -80.55 6.67 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.43 174.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.14 -78.56 0.27 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.4 t -157.46 142.85 17.17 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.704 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.93 137.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 152' ' ' GLU . . . -100.32 128.95 9.74 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 224' ' ' SER . . . -156.53 -168.26 2.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.504 0.722 . . . . 0.0 110.433 -169.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.479 ' HB ' ' HZ3' ' A' ' 150' ' ' TRP . 7.6 p -93.95 105.81 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.576 ' HA ' HG22 ' A' ' 223' ' ' VAL . 21.0 t -102.88 114.21 28.29 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.461 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 19.6 tp -127.98 127.15 42.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.761 0.824 . . . . 0.0 111.162 -172.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.34 102.92 14.99 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -176.46 169.48 2.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.325 1.05 . . . . 0.0 108.633 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.7 m -60.9 150.44 77.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.913 0.885 . . . . 0.0 110.627 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -45.17 103.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.535 2.823 . . . . 0.0 113.289 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.23 149.35 49.98 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.21 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.442 ' OG1' ' HA3' ' A' ' 98' ' ' GLY . 2.6 t -61.86 138.48 58.35 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.441 0.696 . . . . 0.0 112.426 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 211' ' ' TYR . 37.1 m -72.34 119.92 17.21 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.006 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.599 ' H ' ' HE1' ' A' ' 211' ' ' TYR . . . 107.7 -4.75 34.59 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 118.166 -1.352 . . . . 0.0 112.756 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 39.1 m -44.62 117.74 3.13 Favored Pre-proline 0 N--CA 1.498 1.961 0 CA-C-N 117.951 0.876 . . . . 0.0 112.51 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 101' ' ' VAL . 3.0 Cg_exo -76.59 135.86 16.69 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.235 1.957 . . . . 0.0 112.168 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.626 HG23 HG11 ' A' ' 156' ' ' VAL . 30.3 mt -83.59 97.38 4.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 0.0 109.1 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.4 mt -117.76 134.38 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.89 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -80.52 164.33 23.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.353 0.661 . . . . 0.0 109.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -59.19 -31.91 69.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.227 0.611 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.64 13.92 12.94 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.599 0.76 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.72 24.79 75.4 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.223 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 206' ' ' LYS . 33.5 ttpt -89.97 162.03 15.59 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.988 0.915 . . . . 0.0 110.011 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 148' ' ' GLY 0.365 16.4 m 68.25 -62.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.487 2.315 . . . . 0.0 113.385 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 32.9 m 55.47 33.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 C-N-CA 124.493 1.117 . . . . 0.0 111.666 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.52 -145.11 1.73 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.176 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 87.2 mt -138.91 146.43 41.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.265 0.626 . . . . 0.0 109.785 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . 0.599 ' HE1' ' H ' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -73.52 132.53 42.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.79 -154.15 2.38 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 118.35 0.523 . . . . 0.0 113.968 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -94.35 130.35 40.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.471 -0.429 . . . . 0.0 110.364 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -157.23 -143.67 3.72 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.682 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.0 p -165.15 161.5 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.593 0 CA-C-N 117.276 0.538 . . . . 0.0 110.925 -170.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.47 111.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.734 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 164.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.1 t -105.61 153.55 21.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.449 1.099 . . . . 0.0 108.903 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 62.77 12.53 5.75 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.923 0.889 . . . . 0.0 111.605 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.7 m 55.93 23.42 6.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.582 1.153 . . . . 0.0 111.586 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.89 -50.52 0.01 OUTLIER Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.387 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.83 158.42 24.06 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -121.25 109.5 15.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.576 HG22 ' HA ' ' A' ' 188' ' ' SER . 84.1 t -121.68 134.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.608 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 32.0 t -146.4 159.23 43.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.829 0.851 . . . . 0.0 109.334 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.33 167.48 4.14 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.124 0.569 . . . . 0.0 111.304 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -99.61 122.18 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 171.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.736 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -111.22 143.59 41.73 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -148.08 166.72 26.96 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 122.072 -0.393 . . . . 0.0 110.927 -172.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 146' ' ' LEU . 62.4 p -91.58 110.42 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.1 -0.04 56.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.023 0.929 . . . . 0.0 110.616 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 C--N 1.366 1.293 0 C-N-CA 124.731 1.212 . . . . 0.0 109.449 -169.636 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 97' ' ' ILE . 13.4 tppt? . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . 0.513 ' NH2' ' HG3' ' A' ' 45' ' ' GLU . 37.4 ttt180 . . . . . 0 N--CA 1.478 0.941 0 O-C-N 120.909 -1.12 . . . . 0.0 111.425 -171.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.427 ' O ' ' HB1' ' A' ' 117' ' ' ALA . . . . . . . . 0 N--CA 1.484 1.275 0 CA-C-O 121.406 0.622 . . . . 0.0 112.63 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.17 31.64 0.54 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.521 1.128 . . . . 0.0 109.006 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -166.81 61.59 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 117' ' ' ALA . 52.3 mt -101.52 94.21 5.77 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.287 0.635 . . . . 0.0 110.243 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 120' ' ' MET . 4.5 mm-40 -95.3 130.85 41.92 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 123.672 0.789 . . . . 0.0 112.27 -172.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HB2' HG12 ' A' ' 68' ' ' VAL . 24.3 mt -97.82 143.42 28.46 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 32.0 tt0 -134.23 142.8 47.5 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 124.163 0.985 . . . . 0.0 108.953 162.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -86.7 128.43 35.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 118.034 0.379 . . . . 0.0 110.732 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -85.86 -52.37 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.227 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.67 -164.49 0.91 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.746 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.561 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 27.5 t70 -108.33 146.23 33.27 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.484 0.714 . . . . 0.0 109.556 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HB ' HG21 ' A' ' 201' ' ' ILE . 2.4 m -75.34 100.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.241 0.543 . . . . 0.0 109.766 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 38.1 ttmt -172.39 117.43 0.35 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.849 1.259 . . . . 0.0 107.839 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.495 ' CD1' ' HB1' ' A' ' 169' ' ' ALA . 84.4 t90 -87.74 91.65 8.83 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.622 0.249 . . . . 0.0 111.647 -172.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -158.79 65.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 156.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 1.1 t70 -85.25 -61.91 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.459 HE21 ' NH2' ' A' ' 168' ' ' ARG . 45.6 mt-30 -150.59 33.07 0.63 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.796 1.238 . . . . 0.0 109.014 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 13.65 73.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.188 1.795 . . . . 0.0 113.661 -163.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 170' ' ' VAL . 13.2 mm-40 -75.91 162.08 28.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.608 -173.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.72 117.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.8 m -146.97 -51.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.791 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -59.45 105.58 0.76 Allowed Glycine 0 C--N 1.355 1.621 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.796 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p 179.88 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.923 1.289 . . . . 0.0 110.482 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 188' ' ' SER . 9.1 m -64.37 137.67 97.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.322 0.649 . . . . 0.0 110.527 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.41 178.24 0.24 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.525 2.816 . . . . 0.0 114.542 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 115.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.124 0.569 . . . . 0.0 110.103 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 51.7 tp -112.4 159.0 19.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.955 0.902 . . . . 0.0 109.839 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -112.45 119.56 38.64 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.483 0.713 . . . . 0.0 109.479 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -114.23 142.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.263 1.025 . . . . 0.0 108.694 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.6 p -88.22 110.4 20.69 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 180' ' ' ASN . 45.3 mm -73.41 143.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.697 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 t -144.84 129.36 17.99 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 56.5 20.74 5.06 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.472 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 72.87 -68.43 0.23 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.405 1.882 . . . . 0.0 111.523 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.66 -11.27 72.76 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 114.91 0.724 . . . . 0.0 114.91 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.421 ' HA ' HD21 ' A' ' 213' ' ' ASN . 13.6 m -105.11 156.98 17.58 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 118.391 1.095 . . . . 0.0 109.037 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 ptm -158.34 138.48 12.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.427 0.691 . . . . 0.0 109.475 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 p -172.21 176.16 3.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.723 0.809 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.45 94.79 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 49.94 29.12 3.2 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.368 1.467 . . . . 0.0 113.12 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 53.68 33.97 17.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.956 1.702 . . . . 0.0 113.026 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.04 93.53 2.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.821 0.82 . . . . 0.0 108.992 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.538 0.512 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.324 -179.261 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.613 HG23 ' HD2' ' A' ' 87' ' ' LYS . 2.6 p . . . . . 0 CA--C 1.564 1.503 0 CA-C-O 123.248 1.499 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 96' ' ' GLN . 16.7 mt 81.39 127.68 0.04 OUTLIER 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.775 2.03 . . . . 0.0 116.475 156.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.452 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.2 m0 -125.02 87.43 2.71 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.619 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 4.4 t70 175.23 105.15 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.383 1.052 . . . . 0.0 111.028 157.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 8' ' ' LEU . 18.8 m . . . . . 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.162 . . . . 0.0 111.201 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.479 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 22.9 t70 . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 138.22 -132.14 5.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 114.873 0.709 . . . . 0.0 114.873 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 140.12 42.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.805 1.242 . . . . 0.0 110.096 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.479 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 62.7 m-85 -125.49 146.44 49.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.881 0.473 . . . . 0.0 112.095 -168.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.825 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 20.6 mtm180 -98.26 124.49 42.89 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 163.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 8' ' ' LEU . 21.8 pt -130.98 138.8 52.66 Favored 'Isoleucine or valine' 0 C--O 1.26 1.641 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -165.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.78 151.22 47.03 Favored 'General case' 0 C--N 1.386 2.195 0 C-N-CA 124.256 1.022 . . . . 0.0 111.284 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.67 154.62 46.46 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 166.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -104.75 91.59 3.91 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.057 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -171.17 177.0 44.33 Favored Glycine 0 C--O 1.238 0.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.176 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 11.3 mt 59.63 37.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.515 0 CA-C-O 122.212 1.006 . . . . 0.0 109.602 165.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.3 mt 65.16 33.84 9.05 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.691 1.596 . . . . 0.0 111.644 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.45 157.69 28.59 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 121.47 0.483 . . . . 0.0 114.241 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -130.28 87.29 2.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.6 m -147.77 147.17 29.59 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.546 ' HG3' HD11 ' A' ' 65' ' ' LEU . 7.3 tt0 -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 125.189 1.556 . . . . 0.0 108.397 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.5 pp -135.07 -33.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -170.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.653 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.22 176.86 29.54 Favored Glycine 0 C--O 1.258 1.612 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.051 -161.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -118.49 124.49 47.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.772 -0.714 . . . . 0.0 109.777 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.46 162.11 17.89 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.3 t -138.6 133.09 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.3 0.64 . . . . 0.0 109.527 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.567 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 24.9 t80 -149.67 135.28 18.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.78 133.42 30.39 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 65.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.871 1.357 . . . . 0.0 111.985 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.29 19.95 0.63 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.513 -0.312 . . . . 0.0 112.399 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 p -135.74 126.73 27.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.518 0.727 . . . . 0.0 110.043 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 49.1 t80 -102.19 137.63 40.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.59 1.156 . . . . 0.0 108.72 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -132.1 122.15 24.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.377 0.671 . . . . 0.0 110.062 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 138' ' ' ILE . 14.6 t -136.42 -155.59 0.64 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.848 0.859 . . . . 0.0 109.892 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.436 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 18.6 ttm -136.97 153.59 50.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 111.239 -158.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -46.43 11.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -174.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.421 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 13.8 p-80 -65.56 -16.91 64.15 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 118.743 0.701 . . . . 0.0 112.286 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.446 HG12 ' O ' ' B' ' 254' ' ' ARG . 4.5 m -80.27 -38.89 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 123.826 0.85 . . . . 0.0 111.769 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 6' ' ' LEU . 23.1 m -156.24 151.91 27.11 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.937 0.789 . . . . 0.0 110.079 170.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -73.15 26.43 0.06 Allowed 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -167.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.674 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 82.79 38.2 12.16 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 119.031 0.832 . . . . 0.0 111.425 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -87.71 -165.58 1.35 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.697 0.799 . . . . 0.0 112.383 -168.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.01 136.47 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.733 0.813 . . . . 0.0 111.331 -174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 mm? -86.79 171.61 10.76 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.933 1.293 . . . . 0.0 111.998 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -172.53 173.04 4.14 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 41.8 t60 -132.41 97.49 4.12 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.448 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 64' ' ' VAL . 85.3 mttt 39.14 38.84 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.775 1.23 . . . . 0.0 112.149 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 21.18 12.85 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 34.2 mmtp -115.27 112.12 21.96 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.984 1.392 . . . . 0.0 110.094 172.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -80.54 148.95 30.16 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.467 1.107 . . . . 0.0 113.171 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' A' ' 68' ' ' VAL . 29.5 mt -140.06 125.2 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.208 1.803 . . . . 0.0 107.428 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.06 148.83 36.46 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.19 0.596 . . . . 0.0 112.356 -168.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.0 163.46 25.67 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.597 2.865 . . . . 0.0 114.764 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 p -127.04 -29.45 2.79 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.781 0.833 . . . . 0.0 111.602 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 32.1 t-105 -147.91 149.03 31.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.165 0.586 . . . . 0.0 110.522 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.93 140.83 23.72 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.751 1.22 . . . . 0.0 109.279 166.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -134.73 114.56 12.79 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.56 -27.37 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.853 1.261 . . . . 0.0 112.356 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -76.85 -59.36 2.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.792 0.33 . . . . 0.0 111.766 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.33 6.14 48.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.371 0.669 . . . . 0.0 110.646 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 68.62 51.18 0.63 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.392 1.077 . . . . 0.0 110.989 162.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 227' ' ' ALA . 52.0 mt -140.14 142.33 36.01 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.459 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.674 HD13 ' HA2' ' A' ' 116' ' ' GLY . 49.3 mt -128.74 151.37 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.537 1.135 . . . . 0.0 109.07 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 23.9 t -139.1 144.04 38.53 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.082 0.468 . . . . 0.0 111.01 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 63.1 m-85 -128.95 144.18 51.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.027 1.331 . . . . 0.0 109.077 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.66 -8.86 79.17 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.738 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.48 -154.76 26.14 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.45 132.01 10.93 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.734 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 2.6 p90 -79.02 130.87 35.99 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -175.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -149.16 116.35 6.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.841 0.456 . . . . 0.0 111.021 -172.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.82 -80.1 0.36 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.441 ' H ' ' H ' ' A' ' 148' ' ' GLY . 4.8 mt-10 159.35 3.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 125.699 1.6 . . . . 0.0 109.366 -163.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 207' ' ' VAL . . . -56.12 91.2 0.02 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 123.985 0.802 . . . . 0.0 114.684 -175.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.27 95.86 3.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.501 ' HE3' HD13 ' A' ' 200' ' ' ILE . 2.0 t90 -46.43 121.65 3.57 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 163.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 88.4 tttt -81.78 116.5 21.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.68 108.48 2.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.217 1.007 . . . . 0.0 109.623 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.34 -37.96 2.8 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . 42.0 tt0 -95.33 148.15 22.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.125 0.97 . . . . 0.0 109.763 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 13.1 pt-20 -89.71 139.94 30.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.809 0.844 . . . . 0.0 110.679 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 150' ' ' TRP . 15.3 t -131.75 159.63 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.438 ' OE1' ' HG3' ' A' ' 171' ' ' GLN . 2.2 mm-40 -93.51 160.64 14.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.083 0.553 . . . . 0.0 111.914 -161.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' PRO . 14.5 p -140.05 152.66 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.524 0.73 . . . . 0.0 111.05 176.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 14' ' ' VAL . 88.0 mt -103.39 93.39 4.94 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 164.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 193' ' ' PRO . . . -77.1 97.23 4.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 167' ' ' PRO . 91.1 mt -73.49 103.92 4.29 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.45 141.1 87.8 Favored Pre-proline 0 CA--C 1.554 1.125 0 O-C-N 123.625 0.578 . . . . 0.0 110.652 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -61.82 117.87 4.72 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.597 2.865 . . . . 0.0 112.511 178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.05 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.419 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -141.09 -173.56 3.76 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.867 0.841 . . . . 0.0 112.02 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.38 159.71 70.86 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 126.016 1.726 . . . . 0.0 113.126 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.425 ' HB3' HD23 ' A' ' 161' ' ' LEU . 5.0 Cg_exo -77.32 117.7 4.44 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.196 2.597 . . . . 0.0 111.433 170.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 168' ' ' ARG . 11.4 mmp_? -75.64 99.55 4.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -76.1 100.66 5.04 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 28.4 t -110.02 141.65 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.857 0.863 . . . . 0.0 109.57 -173.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.438 ' HG3' ' OE1' ' A' ' 157' ' ' GLN . 28.1 tt0 -89.73 121.4 31.85 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' HA3' ' A' ' 24' ' ' GLY . 34.0 p -123.75 132.22 53.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.343 0.657 . . . . 0.0 111.226 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 62.3 mttp -92.5 149.72 38.67 Favored Pre-proline 0 C--O 1.246 0.909 0 C-N-CA 125.78 1.632 . . . . 0.0 110.765 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.19 126.72 7.14 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.614 2.209 . . . . 0.0 111.878 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.408 ' HA3' ' OG ' ' A' ' 188' ' ' SER . . . -111.93 -173.25 19.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.45 140.11 19.84 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.193 0.597 . . . . 0.0 110.0 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 186' ' ' ALA . 13.4 m-85 -128.65 150.33 50.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.134 0.974 . . . . 0.0 110.631 -165.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -61.23 127.97 34.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.83 0.852 . . . . 0.0 110.8 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.7 m -130.44 156.83 44.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.179 0.992 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.404 ' H ' HG13 ' A' ' 33' ' ' ILE . 21.5 m120 -84.83 54.61 3.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.152 0.977 . . . . 0.0 109.122 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -173.68 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.975 1.71 . . . . 0.0 109.038 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.87 -106.77 0.36 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -140.97 133.4 28.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.05 137.09 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.022 0.529 . . . . 0.0 109.661 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.98 109.42 3.66 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 177' ' ' PHE . . . -149.95 167.91 25.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.978 -173.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.59 128.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.441 0.639 . . . . 0.0 111.346 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 19.1 m -103.76 80.18 1.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.397 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.488 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 37.9 tp -105.39 104.96 14.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.048 0.451 . . . . 0.0 110.017 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.79 104.51 16.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.427 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 27.3 t80 -178.28 168.26 1.9 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -174.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.6 m -117.16 74.78 7.69 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 117.953 0.342 . . . . 0.0 111.577 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.52 ' HB3' ' HB1' ' A' ' 160' ' ' ALA . 19.5 Cg_endo -88.2 -60.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.151 1.901 . . . . 0.0 110.016 160.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.93 -29.98 4.85 Favored Glycine 0 C--N 1.361 1.942 0 C-N-CA 123.731 0.682 . . . . 0.0 112.577 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.0 t -61.94 99.51 0.13 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.62 1.168 . . . . 0.0 113.244 -165.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.9 m -63.02 121.85 14.61 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.14 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.49 6.48 33.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.398 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 62.3 m -45.23 115.14 2.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 123.295 0.638 . . . . 0.0 112.227 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.6 Cg_endo -74.33 119.84 5.97 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.203 2.602 . . . . 0.0 113.96 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.501 HD13 ' HE3' ' A' ' 150' ' ' TRP . 73.3 mt -79.68 93.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.955 0.902 . . . . 0.0 109.261 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 14' ' ' VAL . 29.2 pt -111.21 178.68 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.015 0.912 . . . . 0.0 111.662 -174.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.4 174.04 6.05 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 166.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 16' ' ' TRP . 84.3 tttt -59.78 -31.76 69.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.746 0.418 . . . . 0.0 111.786 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -82.43 -3.78 56.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.097 0.559 . . . . 0.0 111.994 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.01 26.06 54.06 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -99.54 167.1 10.81 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.032 1.333 . . . . 0.0 109.324 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 68.9 t 85.68 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 125.606 1.562 . . . . 0.0 109.49 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.6 m 58.25 30.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 125.131 1.372 . . . . 0.0 112.844 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.08 -169.65 2.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.347 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.0 mt -144.94 149.61 35.54 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.485 -1.009 . . . . 0.0 110.994 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -74.6 107.72 6.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 166.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.436 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -83.87 -138.98 3.83 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 124.328 1.018 . . . . 0.0 114.046 -166.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.421 HD21 ' HA ' ' A' ' 38' ' ' SER . 43.4 t30 -70.88 87.59 0.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.302 0.641 . . . . 0.0 109.586 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -135.59 -147.67 5.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.189 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.0 167.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.641 0.776 . . . . 0.0 109.589 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 13.9 t -91.91 111.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 29' ' ' LEU . 91.8 m -71.57 140.06 49.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.126 0.97 . . . . 0.0 109.906 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 59.73 12.1 2.78 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.705 0.802 . . . . 0.0 111.861 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t 62.58 18.69 10.7 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.91 1.284 . . . . 0.0 112.072 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.19 7.97 0.39 Allowed Glycine 0 C--N 1.354 1.54 0 CA-C-O 119.682 -0.51 . . . . 0.0 114.345 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 191' ' ' PHE . . . -140.61 92.0 2.48 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.759 0.78 . . . . 0.0 110.03 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 15.4 t80 -71.04 101.32 2.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.242 0.544 . . . . 0.0 110.773 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.14 123.42 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.055 1.342 . . . . 0.0 108.841 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.559 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 24.7 t -143.88 158.45 43.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.011 0.524 . . . . 0.0 110.888 -171.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.79 55.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.594 0.758 . . . . 0.0 110.795 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.427 HG13 ' HA ' ' A' ' 186' ' ' ALA . 87.9 mt -81.83 98.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.964 0.411 . . . . 0.0 110.026 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -81.06 135.41 35.82 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 228' ' ' GLN . 0.6 OUTLIER -129.55 159.33 36.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.793 0.837 . . . . 0.0 110.398 -172.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.734 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 10.9 p -82.83 113.89 20.77 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -145.36 101.6 3.61 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.518 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 54.6 tttp . . . . . 0 C--O 1.239 0.503 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.695 172.474 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.604 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 17.4 tppt? . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . 0.446 ' O ' HG12 ' A' ' 113' ' ' VAL . 36.5 ttt180 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 123.953 0.901 . . . . 0.0 109.684 -175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.79 45.46 0.96 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.171 0.989 . . . . 0.0 108.659 -170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.6 m-20 -146.0 26.48 1.22 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.117 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 88' ' ' GLN . 34.9 mt -91.6 93.63 9.03 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.545 0.738 . . . . 0.0 110.14 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 4.8 mp0 -95.12 131.06 41.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.805 0.842 . . . . 0.0 111.865 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.38 130.45 56.69 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.91 129.08 51.17 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 122.886 0.474 . . . . 0.0 110.527 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 5.8 tmm_? -75.6 127.61 33.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.356 0.662 . . . . 0.0 110.327 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.1 -56.81 2.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.425 0.69 . . . . 0.0 110.577 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 167' ' ' PRO . . . -145.49 -175.08 4.58 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.711 -171.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.26 146.41 23.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.006 0.922 . . . . 0.0 109.839 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.59 HG23 ' HA2' ' A' ' 82' ' ' GLY . 15.1 t -79.49 97.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' N ' HD13 ' A' ' 201' ' ' ILE . 17.6 pttp -173.58 176.36 2.78 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 108.402 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 39.0 t90 -73.49 136.52 44.16 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.512 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -112.94 144.45 42.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.091 0.956 . . . . 0.0 109.598 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.03 -6.28 8.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.301 1.04 . . . . 0.0 112.667 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -71.15 -2.8 16.99 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.556 1.143 . . . . 0.0 111.61 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 16' ' ' TRP . . . -36.6 100.08 0.02 OUTLIER 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.915 2.086 . . . . 0.0 114.052 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.12 148.39 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.64 1.176 . . . . 0.0 109.619 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 mm -102.75 104.39 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -144.84 -20.4 0.51 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.849 0.46 . . . . 0.0 111.284 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -71.66 -173.13 17.25 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.768 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m 71.82 37.9 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.545 1.138 . . . . 0.0 109.278 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -66.86 142.73 97.62 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.692 0.797 . . . . 0.0 110.842 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.63 -176.14 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.225 2.617 . . . . 0.0 114.253 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.43 119.46 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.807 0.843 . . . . 0.0 112.142 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 223' ' ' VAL . 7.0 mt -108.28 163.9 12.78 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.967 0.907 . . . . 0.0 111.075 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -120.14 122.51 41.18 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.285 0.634 . . . . 0.0 109.29 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 41' ' ' ILE . 10.5 mt -127.11 149.09 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.98 0.912 . . . . 0.0 110.201 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.2 m -96.99 119.46 35.5 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.096 0.958 . . . . 0.0 110.449 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.853 HG12 HG21 ' A' ' 179' ' ' THR . 35.6 mm -68.63 114.21 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 23.0 t -79.84 134.51 36.33 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.24 4.56 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.35 -13.71 60.12 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 0.0 110.891 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.21 17.51 29.28 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -166.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 55.3 m -105.69 164.81 11.63 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.686 0.794 . . . . 0.0 109.986 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.627 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 2.4 ppp? -127.77 135.83 50.66 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 p -171.29 173.45 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.658 0.783 . . . . 0.0 110.536 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 31' ' ' ILE . 1.6 mp -90.31 134.09 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 161.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.21 90.19 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.638 0.586 . . . . 0.0 110.371 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -157.08 157.19 34.1 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 108.852 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.36 75.43 1.01 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 . . . . . 0 C--O 1.239 0.548 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.202 174.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.682 HG13 ' HE3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.77 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.932 HD22 HH22 ' A' ' 85' ' ' ARG . 3.3 pp -37.45 157.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -175.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -165.74 158.57 15.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.462 1.125 . . . . 0.0 111.779 -175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.724 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 29.5 t0 -154.81 60.39 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 154.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 ' HB2' ' A' ' 121' ' ' HIS . 7.6 p . . . . . 0 CA--C 1.561 1.368 0 CA-C-N 111.598 -2.546 . . . . 0.0 106.735 176.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 C--O 1.244 0.802 0 CA-C-O 121.33 0.585 . . . . 0.0 112.215 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.59 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 142.77 -167.08 26.38 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.919 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.16 109.57 12.37 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 1.6 m-85 -87.32 146.28 25.99 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.932 HH22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.64 136.9 40.7 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 160.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.406 HG12 ' C ' ' A' ' 98' ' ' GLY . 10.8 pt -132.71 142.89 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -162.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 73.4 tttt -123.02 142.84 50.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.187 1.795 . . . . 0.0 111.369 -174.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.801 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 51.7 tt0 -136.1 150.37 49.08 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.568 0.223 . . . . 0.0 110.646 167.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 91.1 mttt -96.14 92.0 6.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 162.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 169.77 42.4 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.616 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt 67.48 -77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.009 1.324 . . . . 0.0 112.235 163.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.96 -15.04 1.79 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.891 0.876 . . . . 0.0 109.78 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' B' ' 253' ' ' LYS . . . -144.21 -161.11 8.79 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 26.7 t80 -150.88 33.86 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -165.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 p -151.8 173.07 15.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -154.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.755 ' HB3' HD21 ' A' ' 65' ' ' LEU . 5.5 pt20 -87.31 120.04 28.19 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.791 1.637 . . . . 0.0 110.909 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.668 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -136.0 -37.56 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -105.76 -172.67 23.68 Favored Glycine 0 N--CA 1.48 1.594 0 C-N-CA 120.214 -0.993 . . . . 0.0 114.811 -159.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.59 125.04 33.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.101 0.56 . . . . 0.0 110.324 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.56 111.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.571 HG13 HG21 ' A' ' 14' ' ' VAL . 91.9 t -88.64 101.83 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.408 0.683 . . . . 0.0 110.829 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 15.0 t80 -91.51 110.19 21.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 23.3 tptp -144.53 143.78 31.01 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.778 0.674 . . . . 0.0 110.168 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 146' ' ' LEU . 11.8 mm-40 64.92 15.58 10.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.927 1.291 . . . . 0.0 112.739 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.54 -5.22 67.15 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 122.946 0.308 . . . . 0.0 112.981 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.3 p -121.66 138.19 54.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 110.23 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 73.5 t80 -81.08 137.55 35.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.67 119.33 18.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.191 0.997 . . . . 0.0 110.372 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 138' ' ' ILE . 2.9 t -138.74 176.72 8.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 0.0 110.517 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.424 ' HE3' ' O ' ' A' ' 136' ' ' ASP . 65.9 mmm -84.62 170.73 13.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.595 0.758 . . . . 0.0 110.593 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.56 -54.84 4.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -57.28 -13.66 3.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -168.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.82 -45.92 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 C-N-CA 124.68 1.192 . . . . 0.0 112.983 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 20.3 m -155.12 149.54 26.19 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.874 1.27 . . . . 0.0 107.59 170.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 13.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.5 62.62 0.9 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -117.17 -164.76 1.01 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.269 0.628 . . . . 0.0 111.764 -171.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 93.6 t -92.04 129.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.471 1.109 . . . . 0.0 112.47 -162.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 1.1 mt -91.81 157.69 16.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.032 -176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 2.2 ptm -172.88 179.84 2.23 Favored 'General case' 0 C--O 1.272 2.242 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.6 ' HB2' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -147.94 111.14 4.89 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 112.053 -2.34 . . . . 0.0 108.874 178.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.583 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 4.5 mptp? 49.95 34.09 7.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.139 0.975 . . . . 0.0 112.624 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.3 -21.02 46.18 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.561 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 115.5 10.8 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.45 0.7 . . . . 0.0 109.891 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -83.18 149.21 26.98 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.883 1.273 . . . . 0.0 112.555 -164.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.3 mt -142.35 134.29 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 125.471 1.508 . . . . 0.0 109.172 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.49 117.66 68.16 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.449 1.1 . . . . 0.0 110.754 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.16 145.39 66.52 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.414 2.076 . . . . 0.0 111.461 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 72.4 p -98.78 -18.64 17.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.735 0.414 . . . . 0.0 111.945 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 132' ' ' ASP . 49.2 t-105 -155.91 154.26 30.94 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.701 0.4 . . . . 0.0 111.261 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -160.92 122.0 2.9 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.379 1.472 . . . . 0.0 109.32 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 130' ' ' TRP . 27.2 t70 -139.25 135.29 33.74 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.458 0.572 . . . . 0.0 111.998 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.43 -42.07 42.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.028 -172.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.55 -48.67 38.21 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.949 0.78 . . . . 0.0 111.543 -168.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.45 -16.57 61.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.329 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.424 ' O ' ' HE3' ' A' ' 110' ' ' MET . 35.0 t70 62.83 45.14 5.83 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.703 1.201 . . . . 0.0 109.584 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 80.8 mt -142.4 129.37 20.71 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.772 -171.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.4 mt -115.66 155.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.511 1.524 . . . . 0.0 108.16 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.0 p -156.95 151.79 25.87 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.094 0.473 . . . . 0.0 112.104 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.9 t80 -120.25 149.12 42.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.64 1.176 . . . . 0.0 109.133 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.51 -78.58 0.24 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.98 85.44 0.06 OUTLIER Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 170.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.63 133.77 2.22 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -98.52 105.7 17.88 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -166.38 124.11 1.4 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 207' ' ' VAL . 6.0 mp -124.17 -63.52 1.2 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 175.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 177.97 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.298 0.999 . . . . 0.0 110.646 167.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.27 -171.84 23.16 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -157.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.65 153.66 47.9 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.836 0.854 . . . . 0.0 110.041 -164.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.457 ' HA ' HG13 ' A' ' 208' ' ' VAL . 31.8 t90 -67.28 106.49 2.07 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 165.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -96.25 99.68 11.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.07 110.57 0.37 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.628 1.171 . . . . 0.0 111.748 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.687 ' H ' ' HG2' ' A' ' 174' ' ' PRO . . . 131.02 -42.08 1.44 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.63 121.41 11.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.594 1.158 . . . . 0.0 110.9 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.87 99.47 9.06 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 208' ' ' VAL . 32.9 m -91.59 172.36 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.158 -168.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 171' ' ' GLN . 71.8 mm-40 -108.82 154.9 21.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.438 1.095 . . . . 0.0 109.49 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.57 136.78 40.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.26 88.54 7.24 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.77 101.15 4.96 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.11 95.6 0.57 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -60.45 113.29 7.14 Favored Pre-proline 0 C--N 1.353 0.725 0 O-C-N 124.439 1.087 . . . . 0.0 110.145 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.21 114.89 2.4 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.054 1.836 . . . . 0.0 112.087 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.27 -14.16 56.92 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.061 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -129.75 -172.73 2.84 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.464 0.706 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -62.32 162.92 16.17 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 125.337 1.455 . . . . 0.0 112.602 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.525 ' HG3' ' HB2' ' A' ' 12' ' ' ALA . 21.1 Cg_endo -58.91 140.95 97.51 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.108 2.539 . . . . 0.0 111.514 169.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.451 ' HG3' ' HZ ' ' A' ' 191' ' ' PHE . 47.5 mmm-85 -116.05 100.97 8.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.212 0.605 . . . . 0.0 109.841 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.1 118.91 13.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 168.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.46 134.41 49.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.863 0.363 . . . . 0.0 110.282 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.554 ' NE2' ' HE3' ' A' ' 203' ' ' LYS . 59.3 tt0 -87.9 143.18 27.26 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.891 0.876 . . . . 0.0 111.122 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.635 ' HB ' HD12 ' A' ' 189' ' ' LEU . 8.1 t -146.31 133.96 21.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.086 1.354 . . . . 0.0 109.175 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -93.12 140.67 23.4 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.687 ' HG2' ' H ' ' A' ' 153' ' ' GLY . 67.0 Cg_exo -45.34 122.69 4.82 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.83 2.354 . . . . 0.0 114.195 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.04 -173.1 26.39 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -156.36 132.66 10.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.704 0.764 . . . . 0.0 110.076 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.475 ' HE1' ' HB3' ' A' ' 186' ' ' ALA . 22.9 p90 -115.37 121.8 43.91 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.999 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -80.19 153.55 28.52 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.853 HG21 HG12 ' A' ' 33' ' ' ILE . 27.0 m -137.34 162.17 34.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.466 1.106 . . . . 0.0 108.358 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -59.32 -24.56 63.43 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.644 0.777 . . . . 0.0 111.546 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.466 ' H ' HG22 ' A' ' 179' ' ' THR . . . -82.03 -36.51 27.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.061 0.944 . . . . 0.0 112.085 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.85 -131.68 1.68 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.56 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 37.9 m -156.45 127.88 7.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 108.374 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.47 133.81 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.34 116.11 5.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 177' ' ' PHE . . . -162.69 -166.15 1.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.334 0.654 . . . . 0.0 111.152 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 172' ' ' THR . 4.6 p -74.84 100.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 CA-C-O 121.719 0.771 . . . . 0.0 110.641 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 223' ' ' VAL . 29.1 m -96.16 100.2 11.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.635 HD12 ' HB ' ' A' ' 172' ' ' THR . 7.6 tt -135.05 107.46 7.3 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.41 124.91 27.41 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.451 ' HZ ' ' HG3' ' A' ' 168' ' ' ARG . 48.4 t80 -170.11 -179.53 3.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.672 1.189 . . . . 0.0 107.829 -175.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.2 m -58.19 159.19 11.75 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.99 0.916 . . . . 0.0 111.032 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.706 ' HA ' HG11 ' A' ' 216' ' ' VAL . 9.2 Cg_endo -50.13 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.09 2.526 . . . . 0.0 112.252 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.82 163.41 44.25 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.2 t -102.0 137.85 39.74 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.424 0.631 . . . . 0.0 111.361 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.3 m -70.78 105.65 3.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.887 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.75 5.14 8.46 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.027 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.3 m -49.1 116.92 5.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 C-N-CA 123.399 0.679 . . . . 0.0 111.662 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.54 125.11 9.84 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.252 1.968 . . . . 0.0 112.455 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 208' ' ' VAL . 40.8 mt -93.04 106.95 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 122.167 0.984 . . . . 0.0 108.865 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 202' ' ' ASP . 8.7 mt -114.05 -175.58 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.053 1.341 . . . . 0.0 107.616 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' HG22 ' A' ' 201' ' ' ILE . 33.7 t70 -125.04 170.11 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.464 0.574 . . . . 0.0 110.397 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.554 ' HE3' ' NE2' ' A' ' 171' ' ' GLN . 19.5 mttp -47.17 -50.32 20.82 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.667 1.987 . . . . 0.0 111.403 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.58 -19.9 64.49 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.991 0.917 . . . . 0.0 111.259 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 102.63 6.03 47.44 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -61.63 128.7 37.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.379 0.672 . . . . 0.0 109.203 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 146' ' ' LEU . 7.6 p -80.74 109.94 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 156' ' ' VAL . 80.0 t -83.23 -30.72 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.5 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 229' ' ' THR . . . 156.97 -149.88 20.8 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.455 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 101' ' ' VAL . 78.3 mt -131.54 174.0 10.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.355 1.062 . . . . 0.0 109.554 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -59.94 123.45 17.08 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 164.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.85 177.69 43.41 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.76 97.99 0.68 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.493 0.647 . . . . 0.0 110.402 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.627 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -140.73 -152.72 5.83 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.652 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.25 179.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -169.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 193' ' ' PRO . 27.2 m -98.41 125.78 51.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 162.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 29' ' ' LEU . 10.0 t -95.46 140.58 30.11 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.685 0.394 . . . . 0.0 111.092 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 38.95 -80.65 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.871 2.068 . . . . 0.0 114.401 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.1 p -87.15 16.58 4.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.283 1.033 . . . . 0.0 111.892 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.98 19.34 63.24 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.86 0.267 . . . . 0.0 112.709 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.16 123.09 25.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.269 0.628 . . . . 0.0 110.535 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -65.23 99.03 0.36 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.445 0.698 . . . . 0.0 109.718 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 29' ' ' LEU . 63.4 t -131.42 109.74 16.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 122.353 1.073 . . . . 0.0 109.264 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.616 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 15.8 m -137.2 160.16 39.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.997 -169.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.96 153.77 32.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 164.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 200' ' ' ILE . 71.6 mt -101.38 113.15 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.53 147.87 33.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 9.6 pt20 -134.04 149.88 51.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.506 0.722 . . . . 0.0 109.363 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.709 HG23 ' HA2' ' A' ' 209' ' ' GLY . 51.1 p -105.39 108.54 20.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.518 0.199 . . . . 0.0 111.314 -168.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.29 141.61 13.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? . . . . . 0 N--CA 1.465 0.306 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.144 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 2.5 tmtt? . . . . . 0 N--CA 1.506 2.358 0 N-CA-C 113.726 1.009 . . . . 0.0 113.726 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 156.954 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.443 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 120.534 0.207 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.87 15.83 0.11 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 110.552 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.6 m-20 -137.67 65.14 1.49 Allowed 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 5.5 mp -106.57 113.2 26.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.117 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 24.2 mm-40 -112.33 127.87 56.12 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.935 0.894 . . . . 0.0 111.809 -165.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -106.46 148.83 27.69 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.951 -0.468 . . . . 0.0 112.217 -175.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HA ' ' H ' ' A' ' 67' ' ' ASP . 31.9 tt0 -145.82 140.68 27.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.273 1.029 . . . . 0.0 109.24 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.71 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 7.1 ptm180 -60.97 143.28 55.53 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.677 0.672 . . . . 0.0 110.353 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.33 -39.08 3.92 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 170.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.415 ' CB ' ' HG3' ' A' ' 167' ' ' PRO . . . -169.01 -171.27 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.96 148.58 24.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.989 0.916 . . . . 0.0 110.095 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.62 97.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -157.53 157.28 33.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.914 1.286 . . . . 0.0 108.606 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -70.43 115.24 9.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 160.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.88 143.97 32.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.0 -4.81 18.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.865 0.466 . . . . 0.0 111.766 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.69 49.68 0.64 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.921 1.288 . . . . 0.0 110.723 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -64.6 89.98 0.07 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.261 1.024 . . . . 0.0 110.54 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.0 tp10 -90.75 101.92 14.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.318 1.047 . . . . 0.0 108.717 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.44 101.68 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.5 m -160.12 96.05 1.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.556 1.142 . . . . 0.0 109.512 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -133.36 2.92 Favored Glycine 0 N--CA 1.467 0.734 0 CA-C-O 119.334 -0.704 . . . . 0.0 111.983 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m 62.99 40.75 8.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.359 1.064 . . . . 0.0 109.6 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 m -62.98 116.87 27.59 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.176 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.94 -78.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.418 2.745 . . . . 0.0 112.573 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 178' ' ' LYS . 7.7 tp -113.52 145.59 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.022 0.529 . . . . 0.0 109.717 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 177' ' ' PHE . 52.8 tp -132.72 155.16 49.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.653 0.781 . . . . 0.0 109.403 172.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.1 p -97.99 122.37 41.04 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 177' ' ' PHE . 9.4 tp -117.89 152.29 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 122.73 0.412 . . . . 0.0 110.343 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.412 HG21 ' HG3' ' A' ' 42' ' ' LYS . 89.9 m -105.47 107.49 18.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.695 0.798 . . . . 0.0 109.998 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.61 116.87 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.057 0.943 . . . . 0.0 108.544 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 m -104.29 114.31 28.46 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 110.534 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.88 19.83 10.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.973 1.309 . . . . 0.0 112.025 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 p30 51.4 8.8 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.987 2.115 . . . . 0.0 114.788 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.29 -48.64 0.98 Allowed Glycine 0 C--N 1.349 1.284 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.2 p -106.0 164.79 11.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.454 0.701 . . . . 0.0 109.671 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 213' ' ' ASN . 2.5 ppp? -124.14 149.95 45.67 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 76.3 p -178.94 -175.82 0.41 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.26 1.024 . . . . 0.0 109.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.614 ' H ' HG11 ' A' ' 215' ' ' VAL . 3.2 mp -106.51 152.24 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 157.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 32' ' ' THR . 67.1 mttm -68.73 82.99 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -121.77 152.66 39.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.288 1.435 . . . . 0.0 108.85 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.34 49.73 1.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.744 0.783 . . . . 0.0 109.899 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.825 -178.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.4 tp -164.69 139.25 5.32 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.029 1.331 . . . . 0.0 108.001 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.505 ' CD1' ' HE2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -164.74 67.72 0.15 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t0 -104.76 71.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 119.566 -1.959 . . . . 0.0 107.156 163.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.488 HG13 ' ND1' ' A' ' 121' ' ' HIS . 0.3 OUTLIER . . . . . 0 CA--C 1.563 1.457 0 CA-C-N 112.815 -1.993 . . . . 0.0 106.573 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.597 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 29.8 t70 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.81 -170.44 31.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.759 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.53 108.31 17.23 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 16.3 m-85 -88.64 140.01 29.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 110.1 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -80.71 126.02 30.77 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 161.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.2 pt -122.14 135.45 62.23 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 CA-C-O 121.31 0.576 . . . . 0.0 111.251 -171.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 86.8 tttt -135.16 138.96 44.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.857 1.663 . . . . 0.0 108.586 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.547 ' HB2' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -143.43 151.8 40.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 27.1 tttm -97.35 93.13 6.32 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 125.857 1.973 . . . . 0.0 107.698 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.458 ' HA3' HE22 ' A' ' 88' ' ' GLN . . . -172.88 173.45 45.55 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-O 118.705 -1.053 . . . . 0.0 110.932 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 52.2 mt 72.42 -64.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.802 0.841 . . . . 0.0 112.049 165.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.445 HD11 ' HD2' ' B' ' 253' ' ' LYS . 1.3 pp -132.68 -9.31 3.17 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.946 0.898 . . . . 0.0 111.87 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.71 -153.74 24.8 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.93 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 6.6 m-85 -88.57 120.89 30.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.219 1.007 . . . . 0.0 109.866 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB2' ' HE2' ' B' ' 253' ' ' LYS . 15.2 m -141.38 133.96 28.47 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 118.346 0.521 . . . . 0.0 110.912 167.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.528 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 6.6 pt20 -95.5 105.15 17.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.03 1.332 . . . . 0.0 108.899 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -134.0 -41.32 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -164.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -111.5 -177.91 20.25 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 119.639 1.109 . . . . 0.0 115.639 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -124.17 124.11 41.75 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.398 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.94 121.02 3.8 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -105.71 118.69 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.984 0.892 . . . . 0.0 111.525 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 18.5 t80 -98.56 125.5 43.82 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -138.43 149.35 45.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.073 0.949 . . . . 0.0 109.187 168.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 145' ' ' LYS . 13.0 tp10 64.81 -82.19 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.796 1.238 . . . . 0.0 111.229 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -156.96 25.95 0.5 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 t -143.97 129.05 18.62 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.329 0.652 . . . . 0.0 110.876 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 68.9 t80 -96.48 86.55 4.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.565 ' HD2' ' HB3' ' A' ' 139' ' ' SER . 28.6 t-80 -95.14 120.39 35.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.272 -173.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.3 t -136.15 -156.56 0.72 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.929 0.891 . . . . 0.0 109.944 -174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.73 22.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.528 1.131 . . . . 0.0 110.677 -166.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -86.25 -49.96 7.31 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -60.59 -17.17 44.9 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 114' ' ' THR . 16.0 m -68.04 -57.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 C-N-CA 123.318 0.647 . . . . 0.0 110.81 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 113' ' ' VAL . 23.2 m -149.43 142.93 25.36 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -75.81 18.74 0.24 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.91 62.57 0.75 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.41 168.85 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.645 0.778 . . . . 0.0 110.23 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.27 134.61 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.583 0.753 . . . . 0.0 113.016 -164.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' HG ' ' HG3' ' A' ' 128' ' ' PRO . 13.7 mt -98.14 161.06 13.9 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -172.11 175.02 3.87 Favored 'General case' 0 C--O 1.267 1.986 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 21.7 t60 -121.18 95.48 4.71 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.819 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.505 ' HE2' ' CD1' ' A' ' 66' ' ' TRP . 46.1 mttm 25.77 60.32 0.07 Allowed 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 125.376 1.471 . . . . 0.0 113.667 -164.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.63 58.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.0 -0.889 . . . . 0.0 114.777 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 121' ' ' HIS . 8.9 tmtt? -83.79 113.37 20.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.526 1.163 . . . . 0.0 108.836 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.65 131.48 50.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.444 1.498 . . . . 0.0 113.384 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -139.43 115.52 9.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 C-N-CA 125.137 1.375 . . . . 0.0 108.526 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.55 121.56 72.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.37 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.52 ' HG3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 Cg_exo -62.73 179.03 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.024 2.483 . . . . 0.0 113.595 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.1 t -120.39 -34.09 3.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 111.887 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.463 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.0 t-105 -156.45 151.74 26.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.38 0.272 . . . . 0.0 110.937 -170.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -151.24 124.33 8.72 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.233 1.413 . . . . 0.0 109.799 168.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.404 ' HB2' ' HE1' ' A' ' 130' ' ' TRP . 10.3 t70 -128.81 128.04 43.13 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.288 0.635 . . . . 0.0 109.621 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 t -75.48 -46.65 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.644 1.178 . . . . 0.0 110.872 -172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -75.02 -45.94 38.38 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.367 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -15.9 60.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 61.98 43.33 9.17 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.562 1.164 . . . . 0.0 110.687 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -140.72 135.71 31.85 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.677 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 130' ' ' TRP . 46.3 mt -122.03 160.5 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.761 1.624 . . . . 0.0 108.479 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.565 ' HB3' ' HD2' ' A' ' 108' ' ' HIS . 53.9 p -153.86 155.53 35.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.185 0.448 . . . . 0.0 111.585 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.764 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.5 t80 -115.38 149.81 37.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.134 1.374 . . . . 0.0 108.917 170.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.78 -109.56 2.16 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.16 82.38 0.05 OUTLIER Glycine 0 C--O 1.239 0.452 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.51 136.92 2.95 Favored Glycine 0 C--O 1.239 0.425 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 146' ' ' LEU . 3.0 t-105 -105.76 106.31 16.75 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.536 1.168 . . . . 0.0 108.557 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.424 ' HE3' ' HG2' ' A' ' 104' ' ' GLU . 53.4 mtmt -131.19 123.44 28.49 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.984 0.913 . . . . 0.0 109.816 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.427 ' HB2' ' CH2' ' A' ' 144' ' ' TRP . 23.9 tp -129.63 -85.93 0.54 Allowed 'General case' 0 C--N 1.348 0.511 0 O-C-N 123.855 0.722 . . . . 0.0 109.285 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 176.98 -66.02 0.01 OUTLIER 'General case' 0 C--N 1.361 1.077 0 O-C-N 123.759 0.662 . . . . 0.0 110.868 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.452 ' HA3' ' HE3' ' A' ' 206' ' ' LYS . . . -140.35 -161.94 8.91 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -166.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 228' ' ' GLN . 34.5 tt0 -148.32 163.86 35.79 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.046 1.339 . . . . 0.0 108.966 -167.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 208' ' ' VAL . 30.8 t90 -66.84 146.88 53.95 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 176.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.54 132.94 21.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.558 1.143 . . . . 0.0 109.218 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.82 162.95 28.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.339 0.656 . . . . 0.0 110.578 174.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.38 -31.21 4.91 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.28 138.66 31.23 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.921 0.888 . . . . 0.0 109.39 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.32 135.24 38.38 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 200' ' ' ILE . 36.0 m -106.11 140.43 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 123.434 0.694 . . . . 0.0 110.351 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -109.21 150.74 27.47 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.83 113.44 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.512 0.325 . . . . 0.0 110.77 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 167' ' ' PRO . 2.3 pt? -67.92 87.56 0.25 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 0.0 109.26 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 167' ' ' PRO . . . -71.13 111.61 6.62 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.392 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 167' ' ' PRO . 96.7 mt -68.78 80.34 0.29 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.34 125.33 86.94 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.791 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.81 114.27 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.108 2.539 . . . . 0.0 114.06 -170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.35 61.42 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.401 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -151.43 163.29 39.32 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.409 0.684 . . . . 0.0 110.286 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 157.67 48.3 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.146 0.978 . . . . 0.0 112.233 174.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.652 ' HB2' ' HB2' ' A' ' 159' ' ' LEU . 69.3 Cg_endo -69.8 117.02 4.84 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.675 2.25 . . . . 0.0 112.292 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -97.84 112.74 24.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 159' ' ' LEU . . . -72.05 101.78 2.82 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.207 0.527 . . . . 0.0 110.084 -175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.428 HG11 HD21 ' A' ' 189' ' ' LEU . 44.9 t -85.33 109.52 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.413 -174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -84.46 105.57 15.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.095 0.872 . . . . 0.0 108.879 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 HD12 ' A' ' 189' ' ' LEU . 9.8 t -127.99 157.61 40.13 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.865 1.266 . . . . 0.0 109.627 -174.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -99.41 160.23 28.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.49 159.05 33.39 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.198 1.932 . . . . 0.0 113.151 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -145.95 -171.14 15.18 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.12 149.52 30.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.661 0.73 . . . . 0.0 111.013 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 1.3 p90 -131.63 127.58 37.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.427 1.091 . . . . 0.0 109.453 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.552 ' HB2' HD11 ' A' ' 28' ' ' ILE . 43.9 tttm -78.58 132.01 36.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 -165.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 181' ' ' ALA . 32.7 m -90.68 162.98 14.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 109.228 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -54.34 -40.67 68.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 179' ' ' THR . . . -103.97 2.34 32.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.957 0.903 . . . . 0.0 112.995 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.47 -126.44 1.27 Allowed Glycine 0 C--N 1.351 1.408 0 C-N-CA 121.471 -0.395 . . . . 0.0 113.11 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.8 t -157.38 153.93 28.07 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.437 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mt -116.17 127.93 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.17 119.96 6.66 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.79 -156.22 0.49 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 0.0 109.798 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.42 106.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.876 0.846 . . . . 0.0 109.296 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.582 ' HA ' HG13 ' A' ' 223' ' ' VAL . 23.0 t -103.8 106.07 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 172' ' ' THR . 3.8 tt -128.54 129.63 46.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -172.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.752 ' HA ' ' HB1' ' A' ' 221' ' ' ALA . 8.7 p-10 -107.22 120.53 42.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.028 0.531 . . . . 0.0 109.708 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -170.88 168.48 7.13 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.553 1.141 . . . . 0.0 108.793 -171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.9 p -54.36 136.07 60.91 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.284 0.634 . . . . 0.0 110.832 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.3 95.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 124.272 3.315 . . . . 0.0 114.932 -167.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.46 44.45 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.189 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 161' ' ' LEU . 7.7 t -103.87 143.98 32.11 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 112.244 -170.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.474 ' HA ' ' OH ' ' A' ' 222' ' ' TYR . 48.2 m -68.29 116.15 8.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.427 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.02 -4.48 23.97 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.356 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 75.5 m -52.19 118.81 13.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 122.963 0.505 . . . . 0.0 111.922 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.484 ' HG2' HD21 ' A' ' 159' ' ' LEU . 85.9 Cg_endo -79.53 141.07 15.46 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.755 2.303 . . . . 0.0 113.129 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.476 HD12 HG23 ' A' ' 226' ' ' ILE . 14.4 mt -93.49 111.07 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.552 HD12 HD22 ' A' ' 159' ' ' LEU . 45.6 mt -119.23 155.76 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 110.236 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.63 164.61 12.34 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.665 1.186 . . . . 0.0 108.377 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.27 -24.27 64.8 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.653 1.181 . . . . 0.0 112.098 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -71.1 -16.66 62.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.043 1.337 . . . . 0.0 111.818 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.86 78.18 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HE3' ' HA3' ' A' ' 148' ' ' GLY . 41.2 tttp -86.83 121.53 29.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.475 1.11 . . . . 0.0 108.437 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.42 109.31 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 150' ' ' TRP . 10.7 p -92.61 7.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.192 0.997 . . . . 0.0 110.237 -173.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.3 -164.9 32.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.846 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 49.5 mt -137.16 150.61 48.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -69.37 108.27 3.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.14 -133.78 4.93 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.833 1.333 . . . . 0.0 112.9 -171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.445 ' O ' ' SD ' ' A' ' 39' ' ' MET . 3.3 t-20 -67.38 97.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -162.16 -162.46 13.34 Favored Glycine 0 C--O 1.244 0.738 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.221 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 41' ' ' ILE . 12.2 p -167.03 168.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.6 0.76 . . . . 0.0 109.625 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 17.3 m -68.99 114.32 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 221' ' ' ALA . 6.0 t -81.18 -178.65 7.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.382 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -36.39 117.42 0.48 Allowed 'General case' 0 C--N 1.36 1.036 0 O-C-N 125.375 1.672 . . . . 0.0 112.403 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.5 t 86.46 6.04 0.36 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.063 1.745 . . . . 0.0 112.085 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.8 32.28 9.3 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.596 -0.275 . . . . 0.0 113.149 174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -98.07 105.01 17.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 196' ' ' SER . 10.3 t80 -67.09 103.45 1.19 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 188' ' ' SER . 87.6 t -118.33 139.6 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.112 1.365 . . . . 0.0 108.694 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.507 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 44.8 t -153.4 156.58 38.51 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.025 0.44 . . . . 0.0 111.932 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.0 130.62 41.4 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.476 HG23 HD12 ' A' ' 200' ' ' ILE . 69.2 mt -70.85 111.88 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.607 0.363 . . . . 0.0 110.67 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -74.64 152.51 39.19 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 11.0 pt20 -145.1 162.27 37.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.653 0.781 . . . . 0.0 110.439 -172.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 26.6 m -85.21 108.88 17.94 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -105.24 32.87 3.96 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.956 0.902 . . . . 0.0 109.827 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 55.9 tptt . . . . . 0 CA--C 1.544 0.737 0 C-N-CA 123.007 0.523 . . . . 0.0 109.954 -175.541 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 95' ' ' SER . 2.9 tppp? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 124.43 1.092 . . . . 0.0 111.396 178.721 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 81.0 21.63 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.116 1.367 . . . . 0.0 112.028 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.2 t70 -168.07 52.47 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 88' ' ' GLN . 53.2 mt -86.59 91.02 8.44 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.677 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 121' ' ' HIS . 13.0 mm-40 -87.23 124.37 33.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.2 1.0 . . . . 0.0 110.988 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.15 125.99 43.41 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . 33.2 tt0 -109.61 157.94 18.54 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 167.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 67' ' ' ASP . 21.3 ttt180 -92.96 141.7 28.12 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.822 1.192 . . . . 0.0 110.904 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.29 -55.71 2.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.44 -159.97 0.84 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.899 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.47 153.44 20.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.185 0.594 . . . . 0.0 110.141 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.585 HG12 HG21 ' A' ' 201' ' ' ILE . 3.0 t -79.58 97.93 2.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -173.94 164.47 4.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.643 0.777 . . . . 0.0 109.19 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -64.48 126.31 27.45 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.107 0.563 . . . . 0.0 111.475 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 10.8 tp10 -97.1 145.57 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.164 0.986 . . . . 0.0 109.042 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -9.72 2.3 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.679 1.191 . . . . 0.0 113.49 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.499 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 28.5 mm-40 -80.81 51.78 1.59 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.954 1.302 . . . . 0.0 111.161 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.29 3.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.286 1.034 . . . . 0.0 112.05 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 170' ' ' VAL . 48.5 mt-10 -94.42 91.54 6.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.003 0.921 . . . . 0.0 110.443 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 171' ' ' GLN . 17.7 mt -79.25 102.85 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -158.11 -35.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.114 0.566 . . . . 0.0 111.023 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.09 99.43 0.04 OUTLIER Glycine 0 C--N 1.356 1.654 0 O-C-N 124.067 0.854 . . . . 0.0 113.979 -170.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.6 p 168.3 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.927 1.691 . . . . 0.0 108.093 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 190' ' ' ASP . 77.4 p -70.13 159.79 83.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.28 175.66 1.02 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.183 1.922 . . . . 0.0 112.931 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.79 111.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.573 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 55.9 tp -102.93 134.88 45.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -164.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.6 t -80.55 114.3 19.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 223' ' ' VAL . 33.1 mt -113.38 148.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.476 ' OG1' ' HG3' ' A' ' 42' ' ' LYS . 6.7 m -91.83 105.37 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 179' ' ' THR . 10.1 tp -79.85 156.5 4.58 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.015 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.7 m -145.34 114.24 6.9 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.224 0.61 . . . . 0.0 110.178 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 62.4 14.51 6.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.748 1.219 . . . . 0.0 112.142 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.2 t70 74.74 -20.07 0.35 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.557 1.943 . . . . 0.0 112.482 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.67 -48.23 3.49 Favored Glycine 0 C--N 1.353 1.489 0 C-N-CA 123.137 0.398 . . . . 0.0 112.675 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.8 p -100.56 157.52 16.6 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -145.42 135.58 23.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.137 0.575 . . . . 0.0 110.156 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.3 p -154.12 -178.15 6.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 109.592 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 215' ' ' VAL . 9.4 tp -107.05 156.16 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 7.3 mtpm? -67.84 113.24 5.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 163.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.55 91.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.368 1.467 . . . . 0.0 110.528 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.51 116.68 32.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.285 0.634 . . . . 0.0 109.8 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 C--O 1.243 0.735 0 C-N-CA 123.532 0.733 . . . . 0.0 109.275 176.401 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HD2' ' A' ' 122' ' ' LYS . 7.0 t . . . . . 0 CA--C 1.547 0.858 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -93.34 140.42 29.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.419 0.688 . . . . 0.0 112.105 173.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.532 ' HB3' ' CE1' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -152.79 -176.38 5.72 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 27.4 t70 -177.98 68.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 84' ' ' TYR . 15.4 m . . . . . 0 N--CA 1.491 1.592 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.958 -162.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 103' ' ' LYS . 7.8 p-10 . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.774 0.321 . . . . 0.0 110.483 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' H ' ' HE1' ' A' ' 84' ' ' TYR . . . 172.82 -146.86 9.34 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.019 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.14 108.87 17.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.618 ' HE2' HG12 ' A' ' 68' ' ' VAL . 14.0 m-85 -89.44 158.42 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.642 0.777 . . . . 0.0 112.064 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 83.4 mtt180 -93.43 156.85 16.52 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.089 1.356 . . . . 0.0 110.136 163.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.576 HG22 HD12 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -126.36 106.32 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.641 -166.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 80.7 tttt -124.4 131.91 53.51 Favored 'General case' 0 C--N 1.406 3.045 0 C-N-CA 124.725 1.21 . . . . 0.0 113.048 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB2' HD23 ' A' ' 6' ' ' LEU . 6.9 tp60 -134.27 151.2 51.15 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -87.48 85.58 7.14 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.71 169.85 40.91 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 114.032 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.801 HG12 ' HD2' ' B' ' 253' ' ' LYS 0.254 0.1 OUTLIER 30.2 39.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.3 2.24 . . . . 0.0 114.323 178.708 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp 158.13 -57.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 128.261 2.624 . . . . 0.0 106.177 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.0 -152.43 24.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.573 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -58.96 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.727 0.811 . . . . 0.0 110.227 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.4 m -143.54 123.79 13.78 Favored 'General case' 0 C--O 1.256 1.418 0 CA-C-N 118.471 0.578 . . . . 0.0 111.171 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.53 119.61 32.17 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 166.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 86' ' ' ILE . 1.9 pp -124.84 -42.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -115.79 -163.9 13.88 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.01 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.17 122.33 36.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.912 0.485 . . . . 0.0 110.101 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.97 174.87 26.95 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 14' ' ' VAL . 54.9 t -137.24 135.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 34.9 t80 -151.27 122.57 7.8 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 5.9 mtmp? -135.92 136.46 40.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 61.95 -81.67 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.948 1.405 . . . . 0.0 111.989 170.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.05 28.98 1.12 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-O 120.188 -0.229 . . . . 0.0 112.666 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -144.47 125.27 14.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 0.0 110.139 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 5.7 t80 -97.91 121.22 39.56 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -110.14 108.25 18.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.069 0.948 . . . . 0.0 109.41 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 138' ' ' ILE . 10.1 t -136.46 -156.37 0.7 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.366 0.666 . . . . 0.0 110.261 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.515 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 31.6 ttm -149.37 152.44 35.79 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -154.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -43.25 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.438 1.095 . . . . 0.0 113.019 -176.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 4.3 p-80 -64.86 -22.44 66.99 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.144 0.429 . . . . 0.0 111.31 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.72 -44.23 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.405 HG21 HD21 ' A' ' 6' ' ' LEU . 96.8 m -148.89 147.61 28.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 119.242 0.928 . . . . 0.0 109.214 166.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -71.52 32.73 0.05 Allowed 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 126.275 1.83 . . . . 0.0 115.857 -168.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.446 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 87.41 45.77 5.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.68 0.673 . . . . 0.0 113.264 171.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -97.46 -169.73 1.89 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.115 0.566 . . . . 0.0 112.296 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 127' ' ' GLU . 8.9 p -100.45 139.75 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.642 1.177 . . . . 0.0 111.986 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' ' CZ ' ' A' ' 140' ' ' TYR . 16.0 mt -85.27 171.4 11.95 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 118.078 0.399 . . . . 0.0 111.271 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.73 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.9 ptp -178.5 177.3 0.94 Allowed 'General case' 0 C--O 1.283 2.845 0 CA-C-O 122.17 0.986 . . . . 0.0 112.37 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -166.33 120.87 1.14 Allowed 'General case' 0 C--N 1.365 1.26 0 CA-C-N 113.384 -1.735 . . . . 0.0 114.173 167.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 19.1 mtpp 48.48 40.62 15.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.82 1.325 . . . . 0.0 113.34 158.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.28 19.25 14.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.742 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' MET . 13.0 tppt? -137.11 158.83 43.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.353 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -143.58 124.95 14.68 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.859 1.209 . . . . 0.0 112.795 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.462 HD12 HD21 ' A' ' 8' ' ' LEU . 60.3 mt -103.74 118.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.264 1.425 . . . . 0.0 109.592 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HA ' HG23 ' A' ' 118' ' ' VAL . 33.8 mt-10 -87.92 138.42 31.13 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.642 0.777 . . . . 0.0 112.096 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 73.9 Cg_endo -71.86 156.37 56.75 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.312 2.674 . . . . 0.0 113.69 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 p -124.06 -20.68 5.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.554 0.742 . . . . 0.0 110.975 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 17.5 t-105 -148.77 146.02 27.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.544 0.737 . . . . 0.0 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.49 125.75 8.0 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.205 1.402 . . . . 0.0 108.573 167.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -138.47 128.21 25.08 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.506 0.593 . . . . 0.0 111.114 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.34 -32.18 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.913 0.885 . . . . 0.0 111.341 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 134' ' ' LYS . 3.4 mptp? -73.37 -38.1 65.81 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.065 0.946 . . . . 0.0 110.051 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.51 -17.07 37.47 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.727 0.811 . . . . 0.0 109.461 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 59.53 36.39 22.88 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 125.025 1.33 . . . . 0.0 109.482 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 1.5 mp -137.84 140.67 40.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.671 0.748 . . . . 0.0 110.563 -169.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 109' ' ' THR . 73.1 mt -124.09 148.03 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.765 1.626 . . . . 0.0 108.251 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 32.9 t -141.91 143.7 33.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 111.265 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.721 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 3.5 m-85 -119.88 146.26 45.93 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.998 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.08 35.97 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.499 0.499 . . . . 0.0 112.2 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 159.3 -161.39 32.05 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.9 132.7 11.35 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 166.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.695 ' NE1' ' HA ' ' A' ' 229' ' ' THR . 4.9 p90 -75.7 107.68 8.03 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.193 0.997 . . . . 0.0 111.169 -169.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -116.33 116.37 27.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.525 ' HB2' HG21 ' A' ' 229' ' ' THR . 5.7 mp -131.62 -66.51 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 172.11 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.708 0.803 . . . . 0.0 109.407 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 207' ' ' VAL . . . -47.31 109.64 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 118.065 1.986 . . . . 0.0 118.065 -162.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -142.59 94.23 2.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.574 ' HE3' HD13 ' A' ' 200' ' ' ILE . 7.8 t90 -56.75 109.91 0.71 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.25 123.64 32.47 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.407 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.82 135.86 35.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.984 0.914 . . . . 0.0 111.663 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.429 ' H ' ' HG3' ' A' ' 174' ' ' PRO . . . 110.48 -59.22 0.36 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.0 111.28 17.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.622 0.769 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.46 152.39 40.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.194 0.598 . . . . 0.0 111.736 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.782 HG21 HG23 ' A' ' 200' ' ' ILE . 34.6 m -124.8 -169.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.532 1.133 . . . . 0.0 109.89 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.683 ' HG2' ' HG3' ' A' ' 171' ' ' GLN . 9.9 mt-30 -126.04 167.12 15.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.965 1.306 . . . . 0.0 109.065 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 13.5 p -140.26 148.92 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 122.985 0.514 . . . . 0.0 110.51 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.9 mt -97.54 95.21 7.47 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.98 0.809 . . . . 0.0 109.907 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 168' ' ' ARG . . . -76.48 99.97 5.1 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 168.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -86.66 106.02 17.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.544 0.738 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.27 159.63 29.04 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.551 0.74 . . . . 0.0 111.135 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.37 113.61 1.2 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 124.123 3.216 . . . . 0.0 115.165 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.45 8.81 40.44 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.016 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.2 158.91 16.5 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.982 0.913 . . . . 0.0 110.636 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.47 157.62 63.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.539 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.55 103.19 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.544 2.163 . . . . 0.0 111.134 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 160' ' ' ALA . 80.2 mtp180 -72.99 96.71 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.02 99.84 7.86 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 21' ' ' GLU . 94.9 t -102.72 122.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.362 0.665 . . . . 0.0 109.751 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.683 ' HG3' ' HG2' ' A' ' 157' ' ' GLN . 2.1 mp0 -82.15 119.35 23.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -127.67 141.29 51.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.142 0.977 . . . . 0.0 111.368 -173.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -98.27 160.14 28.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.539 1.536 . . . . 0.0 109.481 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HG3' ' H ' ' A' ' 153' ' ' GLY . 64.3 Cg_endo -73.52 124.1 9.1 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.696 1.597 . . . . 0.0 111.216 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.06 -172.79 26.34 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.291 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.1 133.58 9.9 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.573 ' HD1' ' HB3' ' A' ' 29' ' ' LEU . 29.0 m-85 -121.79 126.5 48.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.818 0.847 . . . . 0.0 109.298 -165.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -73.06 117.92 15.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.604 0.716 . . . . 0.0 109.215 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.473 HG23 ' HB ' ' A' ' 33' ' ' ILE . 91.0 m -120.65 147.82 44.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.927 1.291 . . . . 0.0 109.479 -170.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -78.98 65.57 4.2 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 178.46 -43.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.832 1.653 . . . . 0.0 108.214 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 178.28 -127.33 1.15 Allowed Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.131 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 m -144.18 128.58 17.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.647 0.779 . . . . 0.0 109.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.2 mt -104.1 122.88 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.877 0.871 . . . . 0.0 109.245 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.31 106.61 3.17 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.32 178.55 9.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.971 0.909 . . . . 0.0 109.975 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.05 131.83 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.3 p -111.0 89.67 3.11 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.168 0.987 . . . . 0.0 109.385 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.518 ' HB3' ' O ' ' A' ' 222' ' ' TYR . 3.4 tm? -106.78 124.81 50.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 30.5 t70 -125.49 105.18 8.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 108.678 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -163.86 -173.5 3.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.075 1.35 . . . . 0.0 109.043 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 77.6 p -51.9 149.41 9.02 Favored Pre-proline 0 CA--C 1.556 1.185 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.759 159.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -47.71 114.42 1.07 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.139 2.56 . . . . 0.0 112.834 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 222' ' ' TYR . . . -72.67 163.02 54.82 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.898 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 120.72 27.61 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.979 0.512 . . . . 0.0 110.025 -172.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.0 m -59.88 115.1 3.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.639 0.776 . . . . 0.0 110.343 173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.93 17.18 33.36 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 124.107 0.879 . . . . 0.0 112.426 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . 0.414 ' HB3' HG22 ' A' ' 158' ' ' VAL . 56.5 m -64.61 127.65 92.63 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 117.113 0.457 . . . . 0.0 111.059 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.79 138.45 11.78 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.085 2.524 . . . . 0.0 114.483 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.782 HG23 HG21 ' A' ' 156' ' ' VAL . 62.3 mt -85.25 99.72 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.039 1.336 . . . . 0.0 109.121 176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.585 HG21 HG12 ' A' ' 14' ' ' VAL . 20.8 pt -124.25 156.6 31.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.058 0 CA-C-O 121.368 0.604 . . . . 0.0 111.895 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 15.5 t70 -90.84 176.01 6.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.643 1.177 . . . . 0.0 108.975 174.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.441 ' HA ' HE22 ' A' ' 157' ' ' GLN . 38.0 mtpt -56.61 -27.19 57.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.695 1.198 . . . . 0.0 112.681 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -95.54 -6.58 40.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.68 0.792 . . . . 0.0 111.941 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.81 46.64 5.34 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 57.9 tttm -115.25 162.49 17.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.278 1.431 . . . . 0.0 108.932 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.583 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 59.4 t 79.99 -58.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 C-N-CA 125.191 1.396 . . . . 0.0 110.731 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 146' ' ' LEU . 10.9 m 57.09 26.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 124.278 1.031 . . . . 0.0 112.521 167.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.18 -153.96 1.97 Allowed Glycine 0 C--N 1.361 1.969 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.7 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.0 mt -150.04 155.85 40.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 117.969 0.884 . . . . 0.0 111.27 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -82.12 104.12 12.23 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 165.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.75 -137.12 3.2 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 123.469 0.557 . . . . 0.0 114.202 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -71.22 103.64 2.86 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -141.27 -136.69 3.32 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.7 p -165.95 156.61 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 222' ' ' TYR . 22.2 t -84.61 110.26 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.447 HG21 HD21 ' A' ' 29' ' ' LEU . 95.0 m -85.97 148.24 25.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.283 1.033 . . . . 0.0 109.407 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 49.52 30.38 3.44 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.476 1.51 . . . . 0.0 112.846 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 93.4 p 56.45 27.45 12.18 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.289 1.836 . . . . 0.0 112.733 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -162.34 -53.83 0.02 OUTLIER Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.202 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.36 95.18 0.59 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.119 0.567 . . . . 0.0 110.478 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.57 ' HB2' ' H ' ' A' ' 194' ' ' GLY . 30.9 t80 -74.41 98.62 3.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 31' ' ' ILE . 78.0 t -98.78 146.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.746 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 23.1 t -159.21 158.93 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.43 142.12 46.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.572 167.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.8 mt -73.28 102.5 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.62 0.768 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -91.03 143.29 26.86 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.788 0.435 . . . . 0.0 110.037 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.58 172.43 12.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.411 1.084 . . . . 0.0 111.44 -167.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.695 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 65.8 p -74.2 133.17 42.71 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.255 0.622 . . . . 0.0 111.668 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.34 -29.31 69.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.762 0.825 . . . . 0.0 110.588 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 63.5 tttp . . . . . 0 CA--C 1.554 1.121 0 CA-C-O 122.372 1.082 . . . . 0.0 109.229 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HD2' HG12 ' A' ' 91' ' ' ILE . 8.3 tmtt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . 0.451 ' H ' ' HD3' ' B' ' 253' ' ' LYS . 16.5 tpt180 . . . . . 0 N--CA 1.488 1.473 0 C-N-CA 127.726 2.41 . . . . 0.0 107.9 -163.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB2' ' NH2' ' A' ' 115' ' ' ARG . . . . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -161.56 -24.47 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.212 0.605 . . . . 0.0 111.367 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -87.82 36.59 0.77 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 126.713 2.005 . . . . 0.0 110.579 -159.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.703 ' HG ' ' HG3' ' A' ' 88' ' ' GLN . 4.3 mp -118.84 103.46 9.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 0.0 109.737 -165.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.498 ' O ' HD12 ' A' ' 65' ' ' LEU . 62.2 tt0 -109.13 153.02 24.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 68' ' ' VAL . 3.7 mp -91.8 148.95 21.85 Favored 'General case' 0 N--CA 1.515 2.791 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.532 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.852 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 25.2 tt0 -140.63 133.5 29.08 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.264 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -73.88 127.27 32.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.221 0.919 . . . . 0.0 111.857 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.56 -42.38 8.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.038 0.935 . . . . 0.0 109.569 174.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.53 -162.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -107.16 158.45 17.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.467 0.707 . . . . 0.0 109.814 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 103' ' ' LYS . 2.3 t -74.78 97.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 169.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -168.39 151.74 5.63 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -164.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.605 ' HE1' HE22 ' A' ' 157' ' ' GLN . 28.8 t90 -71.87 137.49 47.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 169' ' ' ALA . 11.2 tp10 -106.77 133.77 50.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.512 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.7 -8.21 52.73 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.789 0.836 . . . . 0.0 113.076 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 1.4 mp0 -84.69 50.78 1.97 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.651 0.78 . . . . 0.0 109.815 176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.54 118.83 23.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.42 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -132.48 138.41 47.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.636 0.774 . . . . 0.0 109.4 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.47 126.69 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -145.06 -41.8 0.23 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.294 0.638 . . . . 0.0 109.851 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.56 97.35 0.33 Allowed Glycine 0 C--N 1.356 1.66 0 O-C-N 123.455 0.472 . . . . 0.0 113.807 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -171.92 90.45 0.12 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.599 1.16 . . . . 0.0 109.055 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -115.13 151.53 45.79 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.394 0.677 . . . . 0.0 109.767 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 -163.71 0.19 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.57 110.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.2 tp -101.83 143.04 32.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.04 0.448 . . . . 0.0 111.499 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -91.61 112.24 24.08 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.258 0.623 . . . . 0.0 109.722 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.8 mt -118.27 157.48 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 124.705 1.202 . . . . 0.0 108.139 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.46 HG21 ' HE3' ' A' ' 42' ' ' LYS . 53.6 p -93.97 107.42 19.33 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.954 0.797 . . . . 0.0 109.353 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 39' ' ' MET . 1.8 mp -83.13 123.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.783 0.833 . . . . 0.0 109.138 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -102.95 138.67 39.52 Favored 'General case' 0 C--O 1.264 1.819 0 C-N-CA 123.896 0.878 . . . . 0.0 112.479 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 55.69 -86.59 0.02 OUTLIER 'General case' 0 C--N 1.356 0.871 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.056 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -156.56 100.8 1.97 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.66 -0.83 87.62 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.172 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 m -95.61 160.46 14.49 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 118.835 1.318 . . . . 0.0 108.527 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.518 ' HB3' HG13 ' A' ' 33' ' ' ILE . 2.8 ppp? -160.42 144.32 13.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.903 0.481 . . . . 0.0 110.203 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 p -165.73 174.33 9.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.462 0.705 . . . . 0.0 110.265 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 217' ' ' THR . 10.3 tp -104.89 155.87 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HE3' HG21 ' A' ' 32' ' ' THR . 99.6 mttt -81.57 123.34 28.58 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 71.99 114.45 0.05 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.668 1.587 . . . . 0.0 110.451 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.12 93.22 0.95 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.677 0.791 . . . . 0.0 110.847 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.485 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 7' ' ' GLU . 4.5 t . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.852 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 88.6 mt -143.11 -155.15 0.57 Allowed 'General case' 0 C--O 1.201 -1.469 0 C-N-CA 124.35 1.06 . . . . 0.0 109.854 -170.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 6.0 m0 -166.98 87.47 0.3 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 124.036 0.934 . . . . 0.0 112.881 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 5.6 t0 174.65 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 124.757 1.223 . . . . 0.0 109.729 159.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 8' ' ' LEU . 74.5 t . . . . . 0 N--CA 1.506 2.342 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.295 -168.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.51 -155.81 26.35 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.19 129.82 50.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.994 1.318 . . . . 0.0 109.066 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 12.6 m-85 -123.92 146.69 48.28 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -162.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.662 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 30.4 mtt85 -86.8 126.92 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 161.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.88 134.45 66.18 Favored 'Isoleucine or valine' 0 C--O 1.267 2.016 0 O-C-N 122.032 -0.417 . . . . 0.0 110.971 -171.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.814 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 80.7 tttt -125.66 142.82 51.32 Favored 'General case' 0 C--N 1.387 2.2 0 C-N-CA 125.681 1.592 . . . . 0.0 111.795 -169.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.703 ' HG3' ' HG ' ' A' ' 6' ' ' LEU . 48.1 tt0 -121.88 152.71 39.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.588 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -105.0 90.9 3.59 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 123.05 1.405 . . . . 0.0 107.883 155.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.8 172.59 43.78 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.292 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 48.0 mt 60.91 -81.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.097 1.359 . . . . 0.0 111.021 166.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' B' ' 253' ' ' LYS . 50.6 tp -93.69 -46.12 7.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.3 1.04 . . . . 0.0 110.535 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.46 -150.08 11.16 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 116.386 -0.37 . . . . 0.0 113.513 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -104.41 88.11 2.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.621 1.168 . . . . 0.0 107.899 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -141.55 132.93 26.68 Favored 'General case' 0 C--O 1.257 1.48 0 CA-C-N 118.514 0.597 . . . . 0.0 112.521 -170.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 2.2 pt20 -94.09 114.87 27.11 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 125.36 1.464 . . . . 0.0 109.077 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -133.67 -35.66 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.13 -166.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.78 168.95 21.78 Favored Glycine 0 N--CA 1.48 1.625 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.249 -162.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -110.15 123.21 49.32 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.44 129.56 9.52 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 199' ' ' PRO . 27.8 t -110.83 103.76 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.692 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 21.2 t80 -116.36 140.11 49.69 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 170.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 79.5 tttt -169.34 152.88 5.05 Favored 'General case' 0 C--O 1.245 0.841 0 O-C-N 123.955 0.785 . . . . 0.0 109.358 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 69.97 -69.58 0.17 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.785 1.634 . . . . 0.0 110.119 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.43 10.85 0.07 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.25 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -133.64 150.13 51.58 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.802 0.801 . . . . 0.0 111.371 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 90.7 t80 -109.96 122.55 47.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.543 1.137 . . . . 0.0 108.435 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HE1' HD22 ' A' ' 137' ' ' LEU . 54.3 t-80 -132.2 111.76 11.69 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -175.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.69 -165.22 1.63 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.089 1.356 . . . . 0.0 108.388 -170.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.842 ' SD ' ' HA3' ' A' ' 212' ' ' GLY . 31.5 mmt -99.65 162.19 13.16 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.828 1.195 . . . . 0.0 113.722 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.402 ' HB2' ' N ' ' A' ' 137' ' ' LEU . 1.5 t90 -86.24 -52.99 5.3 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.6 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -57.34 -24.33 54.48 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.872 1.269 . . . . 0.0 113.09 -170.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 254' ' ' ARG . 22.6 m -62.51 -12.63 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 124.432 1.093 . . . . 0.0 113.038 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.83 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -160.72 -157.24 0.52 Allowed 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.727 1.211 . . . . 0.0 109.535 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 27.8 ptt180 -119.65 14.85 12.71 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.252 1.021 . . . . 0.0 111.021 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.83 ' H ' HG23 ' A' ' 114' ' ' THR . . . 94.28 58.54 1.21 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 124.152 0.882 . . . . 0.0 111.437 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.6 165.1 12.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 127' ' ' GLU . 2.2 p -98.58 144.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.326 1.05 . . . . 0.0 109.844 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.46 179.22 4.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.403 0.681 . . . . 0.0 111.965 -166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.4 ptp -168.96 178.44 4.51 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 13.7 t60 -127.23 95.0 4.15 Favored 'General case' 0 C--N 1.369 1.42 0 CA-C-N 110.214 -3.175 . . . . 0.0 107.946 164.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 mttt 34.81 64.29 0.42 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 125.234 1.414 . . . . 0.0 113.778 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.42 24.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.246 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -88.33 111.66 21.98 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.532 0.666 . . . . 0.0 109.624 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -105.08 130.37 53.29 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.289 -0.257 . . . . 0.0 111.1 -163.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.8 pt -119.53 130.37 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.308 1.043 . . . . 0.0 109.772 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.758 ' HA ' HG23 ' A' ' 118' ' ' VAL . 10.6 pt-20 -95.63 139.8 22.06 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.089 0.556 . . . . 0.0 111.658 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 62.4 Cg_endo -71.7 149.38 54.61 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.655 2.236 . . . . 0.0 111.734 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 9.9 p -85.68 -17.48 35.9 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.704 0.802 . . . . 0.0 111.784 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -163.24 157.85 20.83 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 120.665 0.269 . . . . 0.0 111.231 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.12 118.8 14.02 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.381 1.072 . . . . 0.0 109.535 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 135' ' ' LYS . 14.7 m-20 -102.58 110.26 22.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.387 1.475 . . . . 0.0 110.857 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.08 -48.81 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.882 0.473 . . . . 0.0 110.807 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.04 -44.58 76.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.095 0.558 . . . . 0.0 111.23 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . 72.5 mmtt -69.09 -20.86 64.08 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.008 0.523 . . . . 0.0 110.825 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 t0 66.13 59.52 0.68 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.045 1.338 . . . . 0.0 110.401 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 3.8 pp -165.21 157.14 15.19 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.76 151.34 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 125.081 1.353 . . . . 0.0 107.958 171.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -131.3 143.4 50.5 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.0 t80 -135.89 142.57 44.71 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 108.532 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.1 -5.98 64.72 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.812 0.695 . . . . 0.0 113.453 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.47 -152.67 23.94 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.13 50.18 Favored Glycine 0 C--O 1.242 0.65 0 CA-C-O 120.97 0.205 . . . . 0.0 112.909 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.401 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 3.1 t90 -54.45 134.21 45.91 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.809 1.244 . . . . 0.0 110.297 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HG3' ' HG ' ' A' ' 146' ' ' LEU . 56.7 pttt -109.82 -166.49 1.1 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.335 0.654 . . . . 0.0 111.403 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.61 ' HG ' ' HG3' ' A' ' 145' ' ' LYS . 50.2 mt 70.63 178.45 0.25 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.457 1.503 . . . . 0.0 111.501 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -143.09 -39.04 0.33 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.471 0.309 . . . . 0.0 111.587 -161.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.89 169.35 45.64 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 123.095 0.247 . . . . 0.0 113.155 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.0 153.13 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.221 0.608 . . . . 0.0 110.093 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.61 ' HA ' HG13 ' A' ' 208' ' ' VAL . 26.3 t90 -58.51 131.33 50.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.971 172.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -119.33 105.17 11.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 152.84 32.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.748 0.819 . . . . 0.0 111.507 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.01 -52.44 4.74 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.17 138.03 53.79 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.093 0.957 . . . . 0.0 110.425 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 9.6 pt-20 -76.38 141.09 41.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.539 . . . . 0.0 110.516 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.11 -177.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.307 1.043 . . . . 0.0 108.557 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.605 HE22 ' HE1' ' A' ' 16' ' ' TRP . 49.7 mt-30 -133.63 162.61 31.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.582 -0.699 . . . . 0.0 110.09 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 200' ' ' ILE . 7.4 p -137.09 136.67 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.149 0.58 . . . . 0.0 109.867 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 35.8 mt -69.52 86.94 0.46 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.79 105.23 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.6 176.8 8.36 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 163' ' ' PRO . 49.1 mp0 -28.4 155.58 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.175 0 C-N-CA 127.861 2.464 . . . . 0.0 114.326 168.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 162' ' ' GLU . 25.6 Cg_exo -1.16 137.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.638 1 C-N-CA 128.162 5.908 . . . . 0.0 118.945 -162.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.634 ' HA2' ' HB2' ' A' ' 192' ' ' SER . . . 99.69 -36.72 3.9 Favored Glycine 0 C--O 1.24 0.495 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -163.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -143.56 178.95 7.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.363 1.465 . . . . 0.0 108.42 164.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 12.3 m120 -98.35 133.74 22.57 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.045 -0.978 . . . . 0.0 108.838 167.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 25.6 Cg_endo -59.47 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.965 3.11 . . . . 0.0 113.378 -175.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 39.2 ptt180 -160.68 165.16 31.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.943 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.503 ' H ' ' HB3' ' A' ' 17' ' ' GLU . . . -88.58 102.85 15.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.5 t -86.07 133.93 28.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 109.591 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 49.1 mt-30 -79.73 139.02 37.46 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.916 0.886 . . . . 0.0 109.37 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.8 t -150.28 130.06 13.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.902 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 59.7 mttp -90.71 155.07 45.89 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.046 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.57 121.26 9.3 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.373 1.382 . . . . 0.0 111.616 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -98.12 -170.71 32.28 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.1 144.27 5.64 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.345 0.573 . . . . 0.0 110.331 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 184' ' ' ILE . 43.4 p90 -123.47 135.01 53.85 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.903 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -70.74 163.74 26.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.882 1.273 . . . . 0.0 111.99 -173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 181' ' ' ALA . 27.4 m -139.12 165.6 26.73 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.889 1.676 . . . . 0.0 108.173 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -52.91 -41.53 64.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.973 0.909 . . . . 0.0 110.213 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 179' ' ' THR . . . -76.39 -74.41 0.23 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.863 176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.17 -107.02 0.65 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.702 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t -162.8 147.16 11.57 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 0.0 109.967 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.48 HD13 ' CE2' ' A' ' 177' ' ' PHE . 4.3 mp -108.45 151.38 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.72 139.3 14.35 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.41 144.22 19.44 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.05 113.08 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 165.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.3 m -116.86 91.18 3.51 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . 62.4 tp -104.62 105.02 14.94 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.522 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.37 111.45 14.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.329 0.651 . . . . 0.0 110.121 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -164.35 -174.3 3.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.126 1.37 . . . . 0.0 109.029 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . 0.634 ' HB2' ' HA2' ' A' ' 164' ' ' GLY . 7.4 m -61.69 175.1 0.55 Allowed Pre-proline 0 CA--C 1.587 2.388 0 C-N-CA 124.787 1.235 . . . . 0.0 111.165 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 192' ' ' SER . 31.3 Cg_exo -24.57 123.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.407 3.633 1 C-N-CA 125.968 4.446 . . . . 0.0 116.925 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.46 131.55 26.93 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.006 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.1 m -81.5 97.12 7.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.912 0.485 . . . . 0.0 109.993 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 73.3 m -66.45 98.27 0.48 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -166.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 131.57 -5.05 5.52 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.631 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.9 m -47.43 124.48 9.29 Favored Pre-proline 0 N--CA 1.496 1.862 0 C-N-CA 124.275 1.03 . . . . 0.0 113.631 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.601 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 4.0 Cg_exo -72.4 121.23 7.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.738 2.292 . . . . 0.0 112.464 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 51.5 mt -84.2 110.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.46 162.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.713 0.805 . . . . 0.0 109.848 -171.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -103.04 167.48 9.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.538 0.735 . . . . 0.0 110.246 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -58.18 -40.6 81.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.565 1.546 . . . . 0.0 111.154 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -73.58 -20.84 60.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 111.77 -4.73 27.58 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.456 -0.636 . . . . 0.0 113.839 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -73.65 128.69 36.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.78 0.79 . . . . 0.0 110.183 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 146' ' ' LEU . 57.9 t -73.44 109.94 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 150' ' ' TRP . 55.1 t -64.37 -30.19 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.798 1.239 . . . . 0.0 110.576 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.87 -154.14 25.24 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.058 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 101' ' ' VAL . 75.8 mt -134.75 162.33 32.67 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.641 0.777 . . . . 0.0 109.596 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.8 OUTLIER -77.05 112.47 13.73 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 165.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.842 ' HA3' ' SD ' ' A' ' 110' ' ' MET . . . -174.26 67.31 0.1 Allowed Glycine 0 CA--C 1.496 -1.13 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 163.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.533 ' HB3' ' H ' ' A' ' 225' ' ' ALA . 11.0 t-20 -160.54 176.97 11.0 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.479 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . 61.62 -144.78 48.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 114.3 0.48 . . . . 0.0 114.3 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.437 HG22 ' N ' ' A' ' 216' ' ' VAL . 13.6 p -177.63 175.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 124.372 1.069 . . . . 0.0 108.863 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 215' ' ' VAL . 34.5 m -70.58 149.59 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 163.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.439 HG22 HD13 ' A' ' 41' ' ' ILE . 45.1 p -136.14 -165.14 1.66 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -32.4 108.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.201 1.4 . . . . 0.0 113.357 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.0 t 77.3 28.08 0.63 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.652 1.581 . . . . 0.0 111.907 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.57 15.84 80.22 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.793 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.61 116.53 6.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.497 0.719 . . . . 0.0 111.818 -171.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 189' ' ' LEU . 5.7 t80 -64.88 116.61 6.53 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.67 0.788 . . . . 0.0 109.388 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.6 t -134.16 115.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -137.09 141.98 42.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 109.25 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.533 ' H ' ' HB3' ' A' ' 213' ' ' ASN . . . -81.56 16.58 1.67 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.779 0.718 . . . . 0.0 112.49 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.9 mt 58.57 98.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.723 1.609 . . . . 0.0 111.462 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.33 130.03 40.89 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -108.8 125.86 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.411 HG21 HD12 ' A' ' 146' ' ' LEU . 38.5 p -80.72 106.26 12.59 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 110.171 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 -19.65 25.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.032 0.933 . . . . 0.0 111.456 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.7 tptm . . . . . 0 C--N 1.364 1.222 0 C-N-CA 125.46 1.504 . . . . 0.0 110.525 -172.72 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . 0.479 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 31.7 ttm180 . . . . . 0 N--CA 1.481 1.08 0 CA-C-N 118.678 0.672 . . . . 0.0 109.84 176.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.056 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.53 16.43 0.2 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.916 0.78 . . . . 0.0 112.122 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.72 44.48 0.76 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.176 0.988 . . . . 0.0 109.321 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 120' ' ' MET . 26.7 mt -86.73 95.03 9.67 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.891 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' HG2' ' HG2' ' A' ' 120' ' ' MET . 25.6 mt-10 -111.19 129.39 55.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.631 0.772 . . . . 0.0 111.982 -166.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 68' ' ' VAL . 4.3 mp -101.43 146.98 26.89 Favored 'General case' 0 N--CA 1.513 2.68 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 65' ' ' LEU . 14.1 tt0 -130.46 158.46 39.83 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.014 1.726 . . . . 0.0 109.153 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 6.3 ppt_? -90.61 148.49 22.63 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 122.95 0.5 . . . . 0.0 110.958 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.15 -37.67 3.04 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.036 0.534 . . . . 0.0 110.767 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.99 -155.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.055 1.342 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -98.25 153.65 18.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.5 1.12 . . . . 0.0 109.382 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.82 91.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -170.43 117.44 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.57 1.548 . . . . 0.0 107.484 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 21' ' ' GLU . 80.0 t90 -75.88 94.7 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -158.9 59.55 0.42 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.88 0.472 . . . . 0.0 110.542 163.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 4.1 t70 -89.72 -65.28 1.03 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.442 -0.787 . . . . 0.0 111.235 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.96 -42.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.649 ' H ' ' HB3' ' A' ' 169' ' ' ALA . . . -136.45 -170.38 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -154.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 3.3 pt-20 -166.93 90.74 0.39 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.003 1.321 . . . . 0.0 109.408 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 170' ' ' VAL . 62.9 mt -85.45 103.54 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -55.25 -24.81 29.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.476 1.11 . . . . 0.0 112.202 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.33 -94.25 0.01 OUTLIER Glycine 0 C--N 1.365 2.179 0 O-C-N 124.519 1.137 . . . . 0.0 112.462 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 173' ' ' LYS . 7.0 t 57.94 75.62 0.37 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.044 1.338 . . . . 0.0 109.564 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.7 m -64.61 147.96 97.21 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.237 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.46 168.74 3.65 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.783 2.322 . . . . 0.0 112.094 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.57 109.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.634 0.774 . . . . 0.0 110.617 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.24 159.57 14.9 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.903 0.881 . . . . 0.0 111.733 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -124.6 127.73 47.82 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.9 165.45 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -93.74 108.03 19.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.334 -0.854 . . . . 0.0 109.556 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.0 106.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -89.61 129.55 36.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.971 0.908 . . . . 0.0 110.048 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.38 8.54 5.05 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.72 1.208 . . . . 0.0 112.672 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.71 21.45 12.39 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.893 1.277 . . . . 0.0 112.745 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.86 -40.45 0.06 OUTLIER Glycine 0 N--CA 1.478 1.489 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 t -90.89 166.67 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.84 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.5 ppp? -132.72 149.42 52.29 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 p -169.2 157.18 7.49 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.955 0.902 . . . . 0.0 109.414 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' H ' HG21 ' A' ' 215' ' ' VAL . 10.3 tp -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -81.64 70.31 8.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.466 0.651 . . . . 0.0 109.978 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.462 HD22 ' HB3' ' A' ' 219' ' ' SER . 51.3 t30 176.18 126.71 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.889 1.675 . . . . 0.0 107.299 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.28 118.06 12.36 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 CA--C 1.544 0.735 0 C-N-CA 124.075 0.95 . . . . 0.0 110.559 -176.349 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.641 HG13 ' HD3' ' A' ' 87' ' ' LYS . 43.4 t . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.549 HD22 ' HB2' ' A' ' 9' ' ' GLU . 69.4 mt -156.87 134.82 11.03 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 126.364 1.866 . . . . 0.0 106.314 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.523 ' HB2' ' CG ' ' A' ' 121' ' ' HIS . 0.5 OUTLIER -158.75 70.63 0.52 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.155 0.979 . . . . 0.0 113.638 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.53 70.93 0.74 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 162.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 8' ' ' LEU . 2.1 t . . . . . 0 CA--C 1.545 0.787 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.298 -166.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.512 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 15.4 t70 . . . . . 0 CA--C 1.546 0.82 0 CA-C-O 121.017 0.437 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.15 -167.39 34.89 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.398 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.76 108.25 9.65 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.512 ' HH ' ' N ' ' A' ' 81' ' ' ASP . 4.9 m-30 -95.0 175.98 6.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 110.824 -175.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 51.1 ttt180 -144.52 143.1 30.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.575 HG22 ' HA ' ' A' ' 8' ' ' LEU . 1.1 pt -138.85 140.44 38.85 Favored 'Isoleucine or valine' 0 C--O 1.269 2.131 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HD3' HG13 ' A' ' 64' ' ' VAL . 26.2 tttm -131.2 136.57 48.39 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.434 1.494 . . . . 0.0 110.83 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.614 ' H ' HD11 ' A' ' 97' ' ' ILE . 3.5 tp60 -115.89 133.48 55.99 Favored 'General case' 0 C--O 1.26 1.642 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.74 97.21 9.01 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 163.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.42 -179.16 29.48 Favored Glycine 0 N--CA 1.462 0.374 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.298 -163.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' B' ' 253' ' ' LYS . 0.2 OUTLIER -39.79 132.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.614 166.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt 78.0 6.67 2.67 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.815 1.646 . . . . 0.0 111.976 -171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.84 -156.87 20.62 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 122.007 0.782 . . . . 0.0 114.834 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.94 69.37 7.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.285 1.434 . . . . 0.0 107.886 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 m -109.99 144.35 38.65 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -159.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -74.95 116.47 15.73 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.845 1.341 . . . . 0.0 109.162 163.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.614 HD11 ' H ' ' A' ' 88' ' ' GLN . 0.4 OUTLIER -144.38 9.08 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -152.17 170.53 31.48 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.873 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -116.4 124.64 50.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.7 155.17 22.46 Favored Glycine 0 CA--C 1.503 -0.67 0 O-C-N 123.695 0.622 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 210' ' ' LEU . 31.7 t -137.56 101.83 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -107.16 107.3 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -141.2 134.96 30.26 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.45 23.01 12.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.349 1.059 . . . . 0.0 112.349 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.23 76.74 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.088 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.2 p -127.52 133.06 49.84 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.031 0.532 . . . . 0.0 110.426 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.789 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 49.0 t80 -85.44 142.51 29.19 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB3' ' HZ3' ' A' ' 144' ' ' TRP . 94.4 m-70 -137.28 113.28 9.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.432 1.093 . . . . 0.0 110.035 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' HB ' ' A' ' 138' ' ' ILE . 9.7 t -139.81 -164.64 1.73 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.773 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' LEU . 22.2 mtp -121.6 170.47 9.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.045 0.938 . . . . 0.0 111.52 -171.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -40.44 13.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.257 0.623 . . . . 0.0 112.441 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.409 ' HE1' ' SD ' ' A' ' 110' ' ' MET . 25.2 p-80 -62.01 -20.76 64.25 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.521 0.676 . . . . 0.0 111.328 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' B' ' 253' ' ' LYS . 19.1 m -82.75 -35.1 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.934 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 116' ' ' GLY . 52.8 m -145.03 145.78 31.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.141 -1.599 . . . . 0.0 112.158 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.77 -5.52 0.95 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 126.221 1.808 . . . . 0.0 113.541 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 114' ' ' THR . . . 88.45 55.13 2.25 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.72 -175.0 3.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.918 0.487 . . . . 0.0 111.919 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.1 138.61 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.405 1.082 . . . . 0.0 112.947 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.524 ' HB2' HG13 ' A' ' 126' ' ' ILE . 7.5 mt -102.86 174.77 5.73 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.935 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.564 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -169.47 174.87 5.73 Favored 'General case' 0 C--O 1.261 1.707 0 CA-C-O 123.74 1.733 . . . . 0.0 115.208 -177.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 21.0 t60 -127.59 88.5 2.8 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.645 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 93.1 mttt 38.11 46.85 0.88 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.013 0.925 . . . . 0.0 111.798 -171.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.6 -26.57 20.92 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 11.9 mptt -73.61 109.68 7.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.214 1.507 . . . . 0.0 109.211 175.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 15.6 ttm180 -93.8 120.23 33.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.506 0.722 . . . . 0.0 112.494 -157.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 119' ' ' LEU . 17.0 pt -111.95 161.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.99 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.27 135.25 24.33 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.35 0.66 . . . . 0.0 109.725 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.84 163.5 38.24 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.395 2.063 . . . . 0.0 112.404 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 p -99.78 -30.28 12.15 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.749 0.819 . . . . 0.0 112.182 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.5 t-105 -140.84 147.82 39.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.723 0.809 . . . . 0.0 109.875 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.61 119.99 5.51 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.343 1.057 . . . . 0.0 109.047 169.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.86 114.77 11.36 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.914 0.486 . . . . 0.0 110.902 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.78 -22.19 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.788 1.235 . . . . 0.0 111.833 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.1 -50.2 69.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.471 0.708 . . . . 0.0 110.869 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -94.4 -8.14 39.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.868 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 63.88 44.1 5.01 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.156 1.382 . . . . 0.0 110.645 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 210' ' ' LEU . 77.6 mt -136.53 137.93 40.79 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.618 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.6 mt -120.63 151.96 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.788 1.635 . . . . 0.0 108.009 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 p -152.34 160.28 43.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.558 0.694 . . . . 0.0 112.014 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.789 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 27.4 t80 -129.09 135.6 49.12 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.446 1.499 . . . . 0.0 107.622 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.9 64.97 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 122.919 0.295 . . . . 0.0 113.152 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.14 -177.3 42.92 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.23 -178.21 44.59 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.538 ' HZ3' ' HB3' ' A' ' 108' ' ' HIS . 76.5 t-105 -81.84 105.01 12.62 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 122.441 -0.446 . . . . 0.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -165.7 113.84 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 107.946 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.536 HD13 HG11 ' A' ' 207' ' ' VAL . 69.5 mt -131.92 -88.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.695 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -172.52 -73.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.94 0.791 . . . . 0.0 110.716 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.07 149.73 47.95 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.64 0.588 . . . . 0.0 113.476 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.28 139.77 20.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.953 0.501 . . . . 0.0 110.009 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -68.89 122.32 18.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.699 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -105.11 116.5 32.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 166.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.35 150.09 31.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.466 0.707 . . . . 0.0 112.435 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.15 -20.75 31.59 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.499 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.46 136.4 41.37 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.726 0.811 . . . . 0.0 109.896 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 0.0 OUTLIER -73.32 140.22 46.6 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.491 0.662 . . . . 0.0 110.083 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 172' ' ' THR . 3.2 m -120.13 179.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.635 0.774 . . . . 0.0 108.96 175.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.409 HE22 ' HG3' ' A' ' 171' ' ' GLN . 69.5 mm-40 -121.66 160.7 23.89 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.091 -0.38 . . . . 0.0 110.784 -170.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.6 155.68 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.705 0.802 . . . . 0.0 110.28 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 52.5 mt -107.19 105.9 16.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 164.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.44 104.67 5.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.326 0.65 . . . . 0.0 109.474 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 167' ' ' PRO . 54.8 mt -69.65 104.64 2.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.192 0.52 . . . . 0.0 110.796 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 165' ' ' LYS . 56.7 mm-40 -76.26 141.6 70.58 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.123 -176.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 12.4 Cg_exo -71.89 116.64 4.78 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.906 3.071 . . . . 0.0 112.011 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.35 9.67 58.38 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.577 0.548 . . . . 0.0 113.894 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 162' ' ' GLU . 96.3 mttt -135.91 -177.31 4.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 0.0 110.219 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -88.26 142.96 31.99 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.848 0.859 . . . . 0.0 110.655 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.687 ' HB3' HD23 ' A' ' 161' ' ' LEU . 10.4 Cg_endo -52.86 115.65 2.39 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.515 2.81 . . . . 0.0 112.737 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -69.46 129.96 41.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.602 0.761 . . . . 0.0 109.888 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.649 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -71.73 118.79 15.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 22' ' ' ILE . 41.0 t -134.68 144.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.744 ' HB2' ' HB2' ' A' ' 21' ' ' GLU . 27.7 tt0 -84.81 163.81 18.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 156' ' ' VAL . 18.5 p -136.16 97.11 3.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 54.4 tttp -85.73 129.43 54.73 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 155' ' ' GLU . 84.0 Cg_exo -47.49 125.5 10.91 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.289 2.659 . . . . 0.0 113.714 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.36 178.41 18.13 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.928 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -139.07 128.82 24.75 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -133.75 122.06 22.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 183' ' ' THR . 5.0 ttpm? -122.39 138.83 54.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.36 1.064 . . . . 0.0 108.843 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 52.0 p -120.67 -178.68 3.78 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.026 0.931 . . . . 0.0 109.271 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -71.21 -19.63 62.36 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.36 0.664 . . . . 0.0 109.932 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.09 -48.92 8.71 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.345 1.058 . . . . 0.0 110.507 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -175.67 160.76 29.25 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.408 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 9.7 t -97.83 139.95 32.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.985 0.914 . . . . 0.0 110.145 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.49 127.73 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.93 111.51 4.0 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -163.57 -172.29 2.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.954 . . . . 0.0 109.946 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.67 100.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 121.807 0.813 . . . . 0.0 111.059 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.413 ' HA ' HG13 ' A' ' 223' ' ' VAL . 20.7 m -98.86 101.02 12.29 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 165.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.14 151.48 40.91 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.62 0.248 . . . . 0.0 110.998 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.93 159.95 32.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.818 0.847 . . . . 0.0 109.069 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.476 ' HA ' ' HD1' ' A' ' 222' ' ' TYR . 34.0 p90 -75.63 121.92 23.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.113 0.959 . . . . 0.0 111.63 -164.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.2 m -137.14 132.12 17.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.28 2.653 . . . . 0.0 113.062 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.43 100.37 0.37 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -173.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 37.3 p -73.59 140.65 46.38 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.294 0.638 . . . . 0.0 111.223 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -53.95 127.01 24.58 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.902 0.881 . . . . 0.0 112.153 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.07 -3.84 35.58 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.772 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.2 m -44.43 119.64 3.64 Favored Pre-proline 0 C--N 1.383 2.043 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.16 115.47 3.0 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.398 2.065 . . . . 0.0 111.517 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.24 106.4 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -98.38 163.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.507 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -98.85 157.65 16.16 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.245 1.418 . . . . 0.0 108.909 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -63.94 -34.27 77.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.5 1.12 . . . . 0.0 111.128 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.25 -20.36 44.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.714 0.406 . . . . 0.0 111.162 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.4 14.44 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.91 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 161.89 30.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.442 0.621 . . . . 0.0 109.843 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.536 HG11 HD13 ' A' ' 146' ' ' LEU . 2.7 p -94.02 112.12 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.38 -40.39 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 228' ' ' GLN . . . 158.23 -142.83 8.78 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 137' ' ' LEU . 70.4 mt -127.99 159.57 34.59 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.658 0.783 . . . . 0.0 110.449 -174.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . 0.481 ' O ' ' SD ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -62.98 107.87 1.09 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 170.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.07 -179.97 6.53 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 124.343 1.027 . . . . 0.0 114.837 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -69.19 86.99 0.4 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.516 1.15 . . . . 0.0 109.633 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.84 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -134.44 -151.23 6.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 113.677 -1.602 . . . . 0.0 111.661 -176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.568 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.8 p -157.28 168.63 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 111.591 -172.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.7 t -85.59 108.54 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.518 HG23 HD13 ' A' ' 41' ' ' ILE . 99.6 m -86.63 144.02 27.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.536 1.134 . . . . 0.0 110.005 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 67.79 10.3 7.69 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.613 1.165 . . . . 0.0 110.305 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.462 ' HB3' HD22 ' A' ' 43' ' ' ASN . 95.0 p 52.92 30.05 8.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.353 1.461 . . . . 0.0 111.43 -166.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.13 -70.16 0.05 OUTLIER Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.349 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.06 137.88 40.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.338 0.655 . . . . 0.0 111.164 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 191' ' ' PHE . 82.3 m-85 -86.03 102.49 13.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.141 0.496 . . . . 0.0 110.124 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 188' ' ' SER . 50.6 t -124.1 104.64 14.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.601 0.761 . . . . 0.0 108.972 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.702 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 63.4 m -132.04 162.48 30.67 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.306 1.042 . . . . 0.0 109.959 -171.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -58.65 162.72 3.71 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.006 162.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.58 103.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.343 -0.848 . . . . 0.0 109.023 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -78.91 136.58 37.31 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.459 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 8.8 pt20 -129.06 167.72 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.208 0.603 . . . . 0.0 109.494 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.532 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 1.6 p -82.72 110.69 17.99 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -72.01 -13.78 61.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.768 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.358 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 109.214 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 91' ' ' ILE . 17.2 tppt? . . . . . 0 N--CA 1.496 1.868 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 . . . . . 0 N--CA 1.48 1.064 0 C-N-CA 124.872 1.269 . . . . 0.0 108.361 -165.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -133.35 21.12 4.0 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.522 0.729 . . . . 0.0 111.143 -167.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -142.33 49.76 1.52 Allowed 'General case' 0 C--O 1.254 1.307 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 3' ' ' ALA . 34.6 mt -96.59 94.13 7.16 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.98 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' MET . 6.9 tm-20 -107.55 129.34 54.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.35 0.66 . . . . 0.0 111.095 -170.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.556 HD11 HD12 ' A' ' 119' ' ' LEU . 1.5 mp -94.78 137.16 34.22 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 34.3 tt0 -132.3 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.694 -0.629 . . . . 0.0 109.673 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.627 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 6.7 ptp180 -67.09 153.78 42.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.64 0.733 . . . . 0.0 112.454 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.31 -36.04 3.02 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.696 166.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.16 -162.39 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.52 156.81 25.08 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.647 0.779 . . . . 0.0 109.028 168.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.06 96.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.604 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 164.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -166.84 136.84 3.06 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -167.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.512 ' H ' ' HA2' ' A' ' 205' ' ' GLY . 63.7 t90 -66.69 120.16 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.748 0.655 . . . . 0.0 109.829 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -87.69 143.91 26.92 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.2 -6.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.808 1.243 . . . . 0.0 112.784 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.29 50.28 0.5 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.49 1.516 . . . . 0.0 111.709 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -65.72 100.47 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.543 0.737 . . . . 0.0 110.906 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.69 102.55 15.09 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.774 0.83 . . . . 0.0 110.246 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.59 100.91 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -153.4 144.08 22.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.54 1.536 . . . . 0.0 107.631 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 190' ' ' ASP . . . 109.46 -138.09 14.59 Favored Glycine 0 CA--C 1.503 -0.716 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.311 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m 58.82 26.79 15.22 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.413 0.685 . . . . 0.0 110.37 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 t -66.21 143.06 98.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.602 1.161 . . . . 0.0 111.039 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 175.68 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.91 2.407 . . . . 0.0 113.49 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.37 131.52 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.851 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.0 mt -109.1 160.16 16.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.852 0.861 . . . . 0.0 109.936 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 t -122.9 115.4 21.89 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 41' ' ' ILE . 30.0 mt -121.3 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.007 0.923 . . . . 0.0 109.337 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.3 p -92.96 111.9 23.68 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.34 132.45 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.935 0.894 . . . . 0.0 108.773 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -138.37 146.4 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.82 0.448 . . . . 0.0 110.341 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 52.85 32.63 12.74 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.237 1.015 . . . . 0.0 111.898 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.254 3.2 p30 52.54 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 126.975 2.11 . . . . 0.0 114.135 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.46 -10.45 66.6 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -106.55 160.55 15.34 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.186 0.993 . . . . 0.0 110.06 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -161.62 133.88 5.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.771 ' HA ' HG11 ' A' ' 215' ' ' VAL . 15.1 p -166.33 174.97 8.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.331 0.652 . . . . 0.0 110.161 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' A' ' 217' ' ' THR . 1.8 mp -89.22 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.71 73.33 1.08 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.41 0.624 . . . . 0.0 109.549 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -143.7 -179.44 6.45 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.59 1.156 . . . . 0.0 109.274 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.51 96.6 8.65 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 123.548 0.739 . . . . 0.0 110.187 175.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 1.0 OUTLIER . . . . . 0 CA--C 1.56 1.332 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.069 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 73.0 mt 74.76 -172.62 0.11 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 125.001 1.32 . . . . 0.0 111.861 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -165.24 106.21 0.78 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.627 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t70 178.66 73.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.063 0.945 . . . . 0.0 112.441 151.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER . . . . . 0 CA--C 1.561 1.374 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 165.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.64 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 27.2 t70 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 115.734 1.753 . . . . 0.0 115.734 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.34 -178.04 39.09 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.89 110.75 18.16 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 124.355 1.062 . . . . 0.0 108.786 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 6.9 m-85 -99.54 140.66 33.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -83.39 122.7 28.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.2 pt -107.63 135.44 46.23 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.62 -166.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 79.5 tttt -124.06 137.47 54.57 Favored 'General case' 0 C--N 1.379 1.851 0 O-C-N 125.041 1.463 . . . . 0.0 112.64 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -108.66 147.76 31.42 Favored 'General case' 0 C--O 1.252 1.195 0 C-N-CA 125.388 1.475 . . . . 0.0 109.001 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -59.53 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 158.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' A' ' 94' ' ' TYR . . . -59.5 154.41 30.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 124.4 1.063 . . . . 0.0 115.44 -145.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.74 -34.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.842 1.257 . . . . 0.0 110.221 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.5 mt -126.23 23.62 7.0 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.032 0.933 . . . . 0.0 111.301 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.24 -97.77 0.17 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 122.199 -0.313 . . . . 0.0 112.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 61.5 m-85 -145.06 116.21 7.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.206 1.402 . . . . 0.0 108.186 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -129.26 101.31 5.94 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -167.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.62 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 4.0 pm0 -94.24 104.19 16.2 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.579 HD13 ' HD2' ' B' ' 253' ' ' LYS . 1.4 pp -137.77 -37.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -154.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -121.56 -159.5 10.7 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.312 -1.423 . . . . 0.0 114.265 -163.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.474 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -133.36 125.29 28.83 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 174.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.13 110.82 2.36 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 108' ' ' HIS . 17.7 m -105.58 102.82 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 81' ' ' ASP . 80.2 t80 -94.06 119.95 33.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -140.06 124.53 18.01 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.891 0.876 . . . . 0.0 108.703 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 50.13 55.58 9.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.407 1.483 . . . . 0.0 112.366 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.2 15.64 79.98 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.054 -0.975 . . . . 0.0 114.219 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 m -135.62 115.39 12.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.402 0.601 . . . . 0.0 111.332 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -85.26 112.21 20.55 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.686 ' HB2' HG23 ' A' ' 101' ' ' VAL . 58.4 m80 -98.91 110.38 23.0 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.867 1.354 . . . . 0.0 110.207 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.61 HG23 ' HB ' ' A' ' 138' ' ' ILE . 15.3 t -139.97 -159.35 0.95 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.86 0.464 . . . . 0.0 110.489 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.739 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 23.2 ttm -156.55 160.73 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -157.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -80.73 -35.34 33.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 3.2 p-80 -75.6 -23.6 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 196' ' ' SER . 5.8 m -81.06 -10.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.609 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.4 m 165.58 144.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 127.113 2.165 . . . . 0.0 107.914 160.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -83.04 34.81 0.46 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.726 1.21 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.21 54.68 1.25 Allowed Glycine 0 C--N 1.347 1.173 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 3' ' ' ALA . . . -106.15 -174.48 2.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.208 0.603 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -116.14 134.68 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.43 0.634 . . . . 0.0 112.66 -163.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 mm? -90.97 179.28 5.79 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.392 1.477 . . . . 0.0 111.637 -167.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.3 ptp -175.69 163.23 2.84 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 123.088 1.423 . . . . 0.0 114.632 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.649 ' HB2' HG22 ' A' ' 68' ' ' VAL . 70.3 t60 -109.75 105.39 14.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 111.535 -2.575 . . . . 0.0 105.485 155.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.487 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 53.9 pttt -41.14 116.14 0.69 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 125.408 1.483 . . . . 0.0 113.211 -156.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.72 -7.51 55.61 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.048 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.2 tttp -138.58 113.1 8.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.319 1.448 . . . . 0.0 107.196 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -106.63 128.66 54.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.381 0.537 . . . . 0.0 111.636 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.51 129.85 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.007 1.323 . . . . 0.0 109.803 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' HA ' HG23 ' A' ' 118' ' ' VAL . 32.0 mt-10 -91.46 151.7 42.9 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.144 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.93 -178.56 3.59 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.084 2.523 . . . . 0.0 112.586 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 19.4 p -126.36 -21.53 4.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.879 0.472 . . . . 0.0 112.195 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.444 ' O ' HG23 ' A' ' 138' ' ' ILE . 21.8 t-105 -140.2 146.53 38.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.438 0.695 . . . . 0.0 110.065 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.51 120.83 3.64 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.37 1.044 . . . . 0.0 109.215 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.68 128.64 39.42 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.3 0.571 . . . . 0.0 110.039 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.96 -36.15 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.083 -166.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.35 -35.41 71.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.495 0.718 . . . . 0.0 112.376 -167.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.18 -7.39 56.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.974 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 110' ' ' MET . 22.2 t70 65.75 47.35 2.13 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.227 0.955 . . . . 0.0 109.022 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 53.5 mt -144.66 139.96 28.35 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 109' ' ' THR . 60.8 mt -132.61 142.78 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 125.506 1.522 . . . . 0.0 108.558 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.443 ' HB3' ' CE3' ' A' ' 144' ' ' TRP . 74.6 p -139.1 159.54 41.9 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 118.813 0.733 . . . . 0.0 112.259 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.42 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 20.7 t80 -129.91 146.78 51.63 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.815 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.69 4.43 54.63 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.37 -162.53 28.44 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.7 173.05 31.13 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 168.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.515 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 66.6 t-105 -63.8 129.26 39.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.7 0.75 . . . . 0.0 109.408 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -164.74 176.51 8.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.923 0.489 . . . . 0.0 111.709 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.46 HD12 ' HE1' ' A' ' 108' ' ' HIS . 3.3 tm? 67.72 97.6 0.06 Allowed 'General case' 0 C--N 1.358 0.97 0 O-C-N 125.013 1.446 . . . . 0.0 111.74 169.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.691 ' HG3' ' HA2' ' A' ' 209' ' ' GLY . 7.1 mm-40 160.1 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.105 2.562 . . . . 0.0 107.336 154.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.16 85.16 0.49 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -75.84 163.77 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -156.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.41 ' HB2' HG22 ' A' ' 208' ' ' VAL . 49.8 t90 -55.81 142.0 36.58 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 111.611 -2.54 . . . . 0.0 112.035 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -131.75 153.8 49.7 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.24 104.51 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.381 1.072 . . . . 0.0 113.374 -166.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.84 -43.56 0.64 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.485 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -78.38 167.92 20.6 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.524 0.73 . . . . 0.0 112.757 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.14 174.33 7.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.803 0.841 . . . . 0.0 110.576 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 155.87 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 0.0 109.471 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 40.3 mt-30 -126.81 128.72 47.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 200' ' ' ILE . 91.0 t -93.02 110.07 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.472 0.709 . . . . 0.0 109.718 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 199' ' ' PRO . 1.3 tm? -77.21 76.13 3.76 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.21 124.53 31.29 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.444 -171.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.02 120.59 15.12 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 123.662 0.601 . . . . 0.0 109.823 -174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.94 107.8 30.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.64 115.47 2.48 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.923 2.415 . . . . 0.0 112.686 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.57 -16.83 60.45 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.596 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -124.2 -171.69 2.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.454 0.702 . . . . 0.0 110.252 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.86 139.25 57.6 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.345 0.658 . . . . 0.0 109.893 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.73 129.14 28.85 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.814 3.01 . . . . 0.0 113.463 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -97.0 125.54 41.51 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 109.496 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -85.37 104.07 14.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.128 0.571 . . . . 0.0 109.863 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 68.5 t -87.96 109.68 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.541 1.136 . . . . 0.0 110.387 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.492 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 7.9 tt0 -80.1 125.88 30.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 109.952 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 t -151.35 151.24 31.48 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 110.676 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.88 156.45 42.52 Favored Pre-proline 0 C--O 1.244 0.778 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.443 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 172.26 13.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.9 2.4 . . . . 0.0 112.941 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.03 -174.46 28.76 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.981 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 144.76 26.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.1 0.45 . . . . 0.0 110.519 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 183' ' ' THR . 5.9 m-85 -97.4 119.39 35.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 183' ' ' THR . 62.7 tttp -99.12 98.74 9.71 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 109.424 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.523 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.0 m -95.51 -178.37 4.39 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.523 ' H ' HG22 ' A' ' 179' ' ' THR . 7.8 p30 -61.34 -25.31 67.06 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.8 -38.13 0.36 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.429 0.691 . . . . 0.0 110.719 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.45 118.7 5.28 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.587 -0.279 . . . . 0.0 112.506 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 178' ' ' LYS . 22.6 p -119.01 111.96 18.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.47 135.34 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.78 111.27 4.11 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 225' ' ' ALA . . . -143.77 -161.02 1.19 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.4 0.68 . . . . 0.0 110.424 -167.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.51 108.89 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.475 0.655 . . . . 0.0 109.454 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.625 ' HA ' HG13 ' A' ' 223' ' ' VAL . 10.0 t -80.71 112.48 18.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.837 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 191' ' ' PHE . 1.4 tt -130.22 132.34 45.95 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.899 0.38 . . . . 0.0 110.566 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 24' ' ' GLY . 10.4 m-20 -96.55 104.92 16.94 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.615 ' HB2' HD22 ' A' ' 189' ' ' LEU . 31.7 t80 -153.5 163.45 39.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.5 p -58.04 151.31 46.06 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.429 167.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 222' ' ' TYR . 84.0 Cg_exo -46.92 95.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.84 2.36 . . . . 0.0 113.691 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.61 179.25 12.92 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.556 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.461 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 71.0 p -115.19 145.93 41.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.354 0.597 . . . . 0.0 112.46 -169.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.748 ' HB3' HG12 ' A' ' 113' ' ' VAL . 62.8 m -67.91 99.1 0.8 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.296 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 132.86 3.83 3.53 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.054 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 71.4 m -55.1 122.64 43.62 Favored Pre-proline 0 C--N 1.368 1.397 0 C-N-CA 123.3 0.64 . . . . 0.0 111.3 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 210' ' ' LEU . 83.8 Cg_endo -78.43 144.66 20.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.979 2.453 . . . . 0.0 113.403 -174.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.693 HG13 ' HB ' ' A' ' 208' ' ' VAL . 8.2 pt -111.3 110.37 31.94 Favored 'Isoleucine or valine' 0 C--O 1.268 2.047 0 CA-C-O 123.105 1.431 . . . . 0.0 109.347 171.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 159' ' ' LEU . 13.7 pt -130.94 161.34 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 112.339 -2.209 . . . . 0.0 109.663 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 207' ' ' VAL . 23.6 t70 -90.82 -178.69 5.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.532 0.733 . . . . 0.0 109.585 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -58.87 -18.88 36.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . 0.455 ' HE3' ' HD2' ' A' ' 206' ' ' LYS . 62.4 tttp -71.01 -13.44 62.0 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.579 1.151 . . . . 0.0 111.365 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 16' ' ' TRP . . . 86.25 9.41 76.45 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 123.359 0.504 . . . . 0.0 112.92 -176.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.455 ' HD2' ' HE3' ' A' ' 204' ' ' LYS . 18.1 ptpt -157.81 151.89 24.35 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.255 1.022 . . . . 0.0 109.51 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.643 HG13 HG23 ' A' ' 208' ' ' VAL 0.25 7.9 p -178.11 -71.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 O-C-N 124.613 1.196 . . . . 0.0 108.489 161.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.693 ' HB ' HG13 ' A' ' 200' ' ' ILE . 2.1 t -90.6 -44.69 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 120.494 1.497 . . . . 0.0 111.253 -162.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.691 ' HA2' ' HG3' ' A' ' 147' ' ' GLU . . . 127.47 -98.17 0.49 Allowed Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 113.514 -1.676 . . . . 0.0 110.824 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 199' ' ' PRO . 2.0 pt? -146.27 172.52 13.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.281 0.562 . . . . 0.0 110.669 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . 0.737 ' HB2' ' HB3' ' A' ' 224' ' ' SER . 0.0 OUTLIER -74.88 142.28 44.09 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.739 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -82.35 -145.16 5.29 Favored Glycine 0 C--N 1.343 0.972 0 C-N-CA 123.03 0.347 . . . . 0.0 112.251 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -78.54 86.44 4.55 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.462 0.649 . . . . 0.0 109.751 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.79 -174.72 19.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.866 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 40' ' ' SER . 10.5 p -168.63 168.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.874 0.469 . . . . 0.0 110.116 -168.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.435 HG13 ' HD1' ' A' ' 222' ' ' TYR . 6.6 m -69.66 115.25 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 165.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.687 ' HA ' HD13 ' A' ' 41' ' ' ILE . 5.2 t -79.27 168.99 18.79 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.553 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -51.73 137.42 25.56 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 124.389 1.056 . . . . 0.0 110.52 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.9 m 86.07 -4.36 0.78 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.712 2.005 . . . . 0.0 111.139 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.39 29.53 36.33 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.103 0.382 . . . . 0.0 113.233 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -95.85 115.28 27.19 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 193' ' ' PRO . 23.0 t80 -74.22 101.08 3.88 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.678 0.752 . . . . 0.0 109.925 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 188' ' ' SER . 91.9 t -94.97 152.52 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.492 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 211' ' ' TYR . 69.9 m -130.1 135.03 47.78 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.521 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . . . -73.29 163.89 27.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 208' ' ' VAL . 43.5 mt -98.18 106.04 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.806 0.443 . . . . 0.0 110.536 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -99.36 108.49 21.01 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 121.794 0.807 . . . . 0.0 108.903 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 11.0 pt20 -95.25 167.39 11.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.945 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.515 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 3.9 p -117.3 126.86 53.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.01 1.98 17.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.416 1.086 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 124.374 1.07 . . . . 0.0 111.181 -167.906 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.652 ' NZ ' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.34 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 . . . . . 0 CA--C 1.561 1.381 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 155.664 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.583 0.23 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 118' ' ' VAL . . . -147.23 42.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -172.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.644 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.9 m-20 -145.75 28.11 1.17 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.351 1.06 . . . . 0.0 111.474 -171.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 5' ' ' ASP . 1.6 mp -114.92 99.8 7.74 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.925 0.784 . . . . 0.0 111.289 -167.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' MET . 36.1 mp0 -106.95 142.92 35.8 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.207 0.527 . . . . 0.0 112.056 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -116.04 166.56 11.86 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.954 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 33.3 tt0 -155.13 137.51 14.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.298 1.439 . . . . 0.0 108.892 -171.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HD1' ' A' ' 84' ' ' TYR . 35.7 ttt-85 -72.58 125.61 27.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.544 0.611 . . . . 0.0 110.711 -172.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -86.72 -56.42 3.41 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.26 -161.68 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.912 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -96.09 156.76 16.2 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.828 1.251 . . . . 0.0 107.682 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -85.69 97.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -172.61 132.92 0.59 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.572 0.749 . . . . 0.0 109.783 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.603 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 78.8 t90 -87.58 93.7 9.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.9 0.48 . . . . 0.0 110.964 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.98 58.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.035 0.534 . . . . 0.0 110.302 161.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 9.2 t70 -89.98 -55.86 3.45 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.652 0.381 . . . . 0.0 111.403 172.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.02 21.14 1.25 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.63 -168.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.24 72.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 127.137 2.175 . . . . 0.0 114.84 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.69 145.25 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.113 0.965 . . . . 0.0 110.332 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.82 143.34 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 124.08 0.952 . . . . 0.0 109.159 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -152.0 -165.56 2.26 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.251 1.02 . . . . 0.0 110.805 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.54 121.64 2.3 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -75.99 -80.22 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.983 0.513 . . . . 0.0 111.582 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.6 t -140.59 145.03 38.72 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.286 0.635 . . . . 0.0 109.887 -166.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.59 -39.57 11.87 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.731 2.287 . . . . 0.0 112.158 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.47 124.44 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.231 0.612 . . . . 0.0 109.703 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 218' ' ' ARG . 3.8 tt -143.68 119.59 10.62 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.3 p -78.03 127.96 33.12 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.19 0.996 . . . . 0.0 112.085 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 223' ' ' VAL . 54.7 mt -112.7 167.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.431 1.492 . . . . 0.0 107.277 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -99.18 126.27 44.93 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.954 1.252 . . . . 0.0 110.24 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -70.26 129.75 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.0 t -136.18 135.51 39.21 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.44 7.07 6.08 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.677 1.191 . . . . 0.0 111.782 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 57.35 27.21 13.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.834 1.254 . . . . 0.0 112.775 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.45 -29.83 0.03 OUTLIER Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.875 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -106.79 165.87 11.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.269 0.627 . . . . 0.0 110.12 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.2 ptm -140.54 130.75 24.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.402 0.681 . . . . 0.0 109.267 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 p -164.78 178.29 7.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 217' ' ' THR . 10.5 tp -86.55 152.35 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.6 126.51 27.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.5 t30 70.9 99.59 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.269 1.428 . . . . 0.0 110.476 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.71 131.37 53.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.546 0.738 . . . . 0.0 109.231 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 123.556 0.742 . . . . 0.0 110.126 178.314 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 2.3 t . . . . . 0 CA--C 1.565 1.54 0 CA-C-O 118.75 -0.643 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 42.1 mt -147.55 163.91 35.09 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 123.725 0.81 . . . . 0.0 111.9 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 122' ' ' LYS . 2.7 m0 -132.08 94.0 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 9' ' ' GLU . 0.7 OUTLIER 171.71 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 126.565 1.946 . . . . 0.0 109.645 158.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 121' ' ' HIS . 29.4 m . . . . . 0 N--CA 1.501 2.078 0 CA-C-N 119.339 0.972 . . . . 0.0 111.955 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.47 ' N ' ' HH ' ' A' ' 84' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.393 0 CA-C-O 122.311 1.053 . . . . 0.0 111.656 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.39 -153.59 24.65 Favored Glycine 0 C--O 1.254 1.381 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.281 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.99 44.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.429 1.092 . . . . 0.0 108.894 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 8.7 m-85 -122.18 138.92 54.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.352 0.261 . . . . 0.0 110.69 -171.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.682 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 43.5 mtm180 -73.34 122.67 22.4 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 165.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.774 HG13 HG23 ' A' ' 97' ' ' ILE . 24.5 pt -120.69 146.95 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.639 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 51.6 tttm -152.32 141.51 21.39 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 126.388 1.875 . . . . 0.0 110.984 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 44.8 tt0 -123.09 150.91 42.56 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.918 -0.489 . . . . 0.0 111.713 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 16.6 ttpp -101.96 84.53 2.54 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.81 176.17 44.34 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.235 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' B' ' 253' ' ' LYS . 49.0 mt 59.17 -83.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.342 1.457 . . . . 0.0 111.604 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -113.13 -30.83 6.84 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.545 0.738 . . . . 0.0 110.205 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.87 -173.82 38.29 Favored Glycine 0 C--N 1.349 1.254 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.673 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 1.8 m-30 -105.98 72.12 0.93 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HE3' ' B' ' 253' ' ' LYS . 37.1 t -135.39 155.61 50.29 Favored 'General case' 0 C--O 1.265 1.875 0 CA-C-O 121.92 0.866 . . . . 0.0 112.737 -163.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.449 ' NE2' ' HD2' ' A' ' 87' ' ' LYS . 22.8 mp0 -75.3 149.63 38.71 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.062 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 HG13 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -136.73 -43.15 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -167.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.727 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . 169.32 -124.17 1.14 Allowed Glycine 0 N--CA 1.481 1.672 0 C-N-CA 116.604 -2.712 . . . . 0.0 118.019 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -128.58 126.47 40.36 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -165.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.16 149.97 18.83 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 164.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.86 116.41 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.064 0.932 . . . . 0.0 109.93 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.561 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 50.8 t80 -133.09 138.35 46.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -161.65 151.23 16.47 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 124.008 0.818 . . . . 0.0 109.135 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 65.08 -77.66 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.462 1.505 . . . . 0.0 110.652 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.57 19.88 0.15 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t -123.48 116.73 23.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.507 0.723 . . . . 0.0 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 102' ' ' TYR . 59.9 t80 -97.53 102.91 14.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 137' ' ' LEU . 2.3 t60 -121.24 126.21 49.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.6 t -135.47 -174.26 3.58 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 108.507 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.464 ' HA ' HD23 ' A' ' 137' ' ' LEU . 82.4 mmm -79.8 160.01 26.31 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.027 0.531 . . . . 0.0 111.535 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -84.08 -46.08 12.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.019 170.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -59.29 -19.15 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.95 0.9 . . . . 0.0 113.351 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 196' ' ' SER . 24.9 m -65.02 -14.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.439 0.696 . . . . 0.0 112.107 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -151.28 -162.14 1.48 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.604 1.162 . . . . 0.0 109.365 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 -133.47 21.03 3.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 114' ' ' THR . . . 103.4 54.63 0.83 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.87 -176.71 3.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.771 0.828 . . . . 0.0 111.429 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.592 HG21 ' HE ' ' A' ' 125' ' ' ARG . 3.0 p -90.75 178.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 118' ' ' VAL . 20.9 mt -124.52 166.01 16.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.528 . . . . 0.0 111.183 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -164.82 174.84 10.2 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' HG13 ' A' ' 68' ' ' VAL . 15.8 t60 -137.54 97.53 3.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.514 1.926 . . . . 0.0 106.795 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.453 ' N ' ' HG2' ' A' ' 7' ' ' GLU . 9.0 mtmp? 8.91 75.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.282 1.833 . . . . 0.0 114.064 -159.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.32 -27.49 19.72 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 115.108 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -82.91 112.43 19.69 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.565 1.183 . . . . 0.0 109.939 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.592 ' HE ' HG21 ' A' ' 118' ' ' VAL . 75.0 ttt180 -106.4 134.44 49.53 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.514 0.725 . . . . 0.0 112.029 -164.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.62 142.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.142 1.377 . . . . 0.0 109.138 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.71 144.1 27.54 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 122.95 0.5 . . . . 0.0 112.067 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 140' ' ' TYR . 22.6 Cg_exo -68.61 138.27 41.26 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.662 2.241 . . . . 0.0 111.562 165.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 34.5 p -88.85 -7.43 56.16 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 5.1 t-105 -151.24 148.14 27.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.353 0.661 . . . . 0.0 110.151 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -146.63 124.21 11.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.923 0.889 . . . . 0.0 109.438 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.22 117.79 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.623 0.769 . . . . 0.0 110.727 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -27.73 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.78 0.832 . . . . 0.0 111.492 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -62.69 -56.66 15.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.61 0.764 . . . . 0.0 111.128 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -97.34 1.09 49.03 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.513 0.725 . . . . 0.0 109.895 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 61.41 54.34 3.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.627 1.571 . . . . 0.0 111.686 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.561 HD11 ' HB1' ' A' ' 227' ' ' ALA . 36.6 mt -144.31 145.8 32.21 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.393 0.616 . . . . 0.0 112.456 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 131' ' ' ALA . 30.8 mt -120.84 143.8 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.841 1.657 . . . . 0.0 110.253 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 2.2 m -120.32 158.19 27.62 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.228 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 3.4 t80 -151.41 135.66 16.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.846 1.258 . . . . 0.0 107.881 172.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.26 9.53 56.8 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.26 -172.6 27.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.13 -179.84 49.29 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -75.37 123.19 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.503 0.721 . . . . 0.0 110.342 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -164.01 147.22 9.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.238 1.415 . . . . 0.0 107.568 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.52 -142.06 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 O-C-N 124.314 1.009 . . . . 0.0 108.716 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 64.55 37.21 8.09 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.743 1.617 . . . . 0.0 111.353 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.84 168.08 0.96 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.786 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 150' ' ' TRP . 25.3 tt0 -143.86 129.97 19.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.236 0.614 . . . . 0.0 109.888 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.522 ' HH2' HG21 ' A' ' 226' ' ' ILE . 1.5 p90 -65.28 150.61 47.94 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.677 0.791 . . . . 0.0 110.166 164.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.69 148.82 26.2 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.765 1.226 . . . . 0.0 111.705 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 155.66 -18.7 0.5 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.494 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HB2' ' HD1' ' A' ' 150' ' ' TRP . 32.9 mt-10 -96.6 152.67 18.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.879 0.872 . . . . 0.0 109.311 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.75 114.03 25.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.2 p -97.01 164.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 120.754 0.312 . . . . 0.0 111.143 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 171' ' ' GLN . 22.3 mp0 -105.91 147.68 28.48 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.931 0.892 . . . . 0.0 109.169 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.04 143.07 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.901 0.48 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.41 93.72 8.74 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 171.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.33 100.62 10.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.89 97.79 1.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -57.66 133.04 82.51 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.239 0.616 . . . . 0.0 111.645 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.83 113.15 1.51 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.506 2.137 . . . . 0.0 112.49 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 73.08 29.43 64.69 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.056 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 166' ' ' ASN . 81.4 tttt -151.84 177.27 10.59 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 117.351 0.575 . . . . 0.0 110.045 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.415 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 1.8 p-10 -57.72 160.51 7.78 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 112.343 170.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.89 141.1 88.6 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.97 2.447 . . . . 0.0 112.378 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -112.37 116.03 29.68 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -96.37 108.14 20.62 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.182 0.593 . . . . 0.0 109.561 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.68 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.536 0.734 . . . . 0.0 110.082 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' GLN . 30.5 tt0 -87.8 149.85 23.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.864 0.866 . . . . 0.0 109.173 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.5 t -154.66 147.97 24.98 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.765 0.826 . . . . 0.0 110.744 -172.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -75.61 158.39 83.18 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.08 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.17 146.1 93.95 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.203 1.935 . . . . 0.0 112.821 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -145.7 130.87 3.93 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-O 122.114 0.841 . . . . 0.0 114.515 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.442 ' HA ' ' HA3' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -127.24 149.71 49.88 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.345 -1.091 . . . . 0.0 112.564 -171.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.11 123.25 35.32 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.682 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -89.13 106.21 18.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 182' ' ' GLY . 23.5 m -82.81 158.01 22.94 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.655 0.782 . . . . 0.0 110.756 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -82.85 57.32 3.79 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.053 0.93 . . . . 0.0 108.535 168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -175.43 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.009 1.724 . . . . 0.0 108.003 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 179' ' ' THR . . . -153.31 -131.0 1.55 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.718 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 t -162.1 131.72 4.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.583 0.753 . . . . 0.0 109.751 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.45 138.1 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.44 0.696 . . . . 0.0 109.44 175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 138.42 161.96 9.01 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.886 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -176.35 42.29 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.316 0 O-C-N 124.655 0.856 . . . . 0.0 110.382 170.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.455 ' N ' ' H ' ' A' ' 175' ' ' GLY . 9.5 p -166.46 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 120.232 -1.543 . . . . 0.0 109.73 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.7 m -129.76 106.19 8.53 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.542 0.737 . . . . 0.0 109.54 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . 0.542 HD13 ' HD2' ' A' ' 191' ' ' PHE . 3.8 pp -131.88 159.15 39.45 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.924 0.49 . . . . 0.0 111.436 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.8 103.2 15.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.459 0.704 . . . . 0.0 110.333 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.542 ' HD2' HD13 ' A' ' 189' ' ' LEU . 17.7 m-85 -157.72 -175.74 5.54 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 108.455 172.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -44.07 139.91 2.94 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.549 1.14 . . . . 0.0 110.769 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.22 116.48 2.27 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.484 2.122 . . . . 0.0 111.204 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.74 111.87 1.63 Allowed Glycine 0 C--N 1.349 1.29 0 O-C-N 124.153 0.908 . . . . 0.0 112.194 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . 0.727 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 25.2 p -50.66 124.26 10.56 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.004 1.322 . . . . 0.0 111.129 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . 0.592 ' HB3' HG12 ' A' ' 113' ' ' VAL . 36.1 m -55.65 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.563 0 O-C-N 123.901 0.751 . . . . 0.0 110.071 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 110' ' ' MET . . . 127.87 4.96 5.48 Favored Glycine 0 C--N 1.366 2.226 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.4 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 67.1 m -49.67 129.67 19.89 Favored Pre-proline 0 N--CA 1.5 2.041 0 C-N-CA 124.462 1.105 . . . . 0.0 113.456 -171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.39 133.84 6.46 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 113.223 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.426 HG21 ' CZ3' ' A' ' 150' ' ' TRP . 50.3 mt -105.81 110.97 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.801 1.241 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 208' ' ' VAL . 12.8 pt -131.8 -175.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.803 1.241 . . . . 0.0 112.432 -168.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 36.3 t70 -114.98 175.98 5.26 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.139 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . 0.603 ' HB3' ' HE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -60.54 -30.45 69.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.967 0.507 . . . . 0.0 112.053 172.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -84.98 -0.77 55.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.731 0.413 . . . . 0.0 111.963 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.56 23.85 77.52 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.921 -0.471 . . . . 0.0 111.921 -168.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 64.5 tttp -76.31 165.1 25.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.729 1.211 . . . . 0.0 109.605 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 209' ' ' GLY . 94.4 t 81.99 -89.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.959 1.304 . . . . 0.0 108.048 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 201' ' ' ILE 0.28 3.1 m 68.21 31.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 125.08 1.352 . . . . 0.0 110.187 175.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 207' ' ' VAL . . . -72.43 -174.22 23.83 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.87 168.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.3 154.53 50.06 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.349 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.0 OUTLIER -68.37 116.16 8.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 225' ' ' ALA . . . -71.61 -162.68 5.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.688 -0.292 . . . . 0.0 113.733 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -71.63 84.12 0.87 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.852 0.834 . . . . 0.0 109.523 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -127.15 -174.62 13.84 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.219 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.12 176.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.323 0.649 . . . . 0.0 109.277 -168.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.7 115.15 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.784 HG23 HD13 ' A' ' 41' ' ' ILE . 14.8 m -129.6 158.77 38.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.68 1.192 . . . . 0.0 109.783 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.77 ' HB2' HD21 ' A' ' 29' ' ' LEU . 4.1 tmm_? 63.65 76.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.647 1.179 . . . . 0.0 110.581 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 59.2 p 49.12 23.07 0.7 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.865 1.666 . . . . 0.0 114.577 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.05 0.67 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 113.794 0.278 . . . . 0.0 113.794 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.83 152.11 50.52 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.782 0.833 . . . . 0.0 109.065 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -83.36 118.84 23.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.676 0.39 . . . . 0.0 110.428 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.41 HG12 HD11 ' A' ' 31' ' ' ILE . 14.6 t -134.39 116.65 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.168 0.587 . . . . 0.0 109.577 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 45.7 t -130.88 156.76 44.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.832 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -101.8 93.26 5.22 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.171 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.522 HG21 ' HH2' ' A' ' 150' ' ' TRP . 22.9 pt -53.05 141.55 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -161.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -91.35 138.34 31.66 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.68 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.91 171.56 13.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.6 t -67.46 149.07 50.7 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.066 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -13.64 6.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.136 155.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--N 1.38 1.914 0 C-N-CA 126.03 1.732 . . . . 0.0 112.821 -176.552 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 95' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -164.543 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.12 26.62 12.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.778 1.231 . . . . 0.0 110.876 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 89' ' ' LYS . 8.5 m-20 -155.19 40.04 0.42 Allowed 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.405 1.482 . . . . 0.0 107.166 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 119' ' ' LEU . 90.2 mt -79.91 92.86 5.58 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.542 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' MET . 21.1 mt-10 -98.61 126.84 44.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.448 1.099 . . . . 0.0 110.177 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.495 HD23 ' CD2' ' A' ' 84' ' ' TYR . 0.0 OUTLIER -117.42 162.75 17.44 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.934 -1.104 . . . . 0.0 113.67 -177.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 9.3 pt-20 -148.35 161.36 41.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.443 1.097 . . . . 0.0 110.269 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.719 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 12.7 tpt180 -66.98 153.28 44.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.647 0.779 . . . . 0.0 111.43 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -125.7 -52.39 1.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.906 0.883 . . . . 0.0 109.915 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.26 -166.66 0.55 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 108.88 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 36.7 t70 -95.82 153.09 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 101' ' ' VAL . 5.1 t -73.28 99.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -162.44 149.12 13.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -168.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.62 112.05 5.16 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 166.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 0.6 OUTLIER -75.15 144.2 42.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.037 0.535 . . . . 0.0 109.827 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.28 -19.43 64.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 48.99 1.67 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.833 0.825 . . . . 0.0 109.605 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.719 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -162.03 83.57 0.58 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 165.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.58 ' HB ' ' H ' ' A' ' 171' ' ' GLN . 29.4 mm -149.69 163.28 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 p -162.79 101.63 1.02 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.297 1.439 . . . . 0.0 108.077 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.34 -107.14 1.47 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.038 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 11.6 t 63.64 41.71 6.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.958 0.903 . . . . 0.0 109.927 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.6 m -64.65 146.0 98.5 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.16 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -54.12 178.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.917 3.078 . . . . 0.0 114.992 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.69 108.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -93.0 158.37 15.83 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.757 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 118.27 36.14 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.62 -0.675 . . . . 0.0 110.574 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 223' ' ' VAL . 40.9 mt -126.21 150.94 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.895 0.878 . . . . 0.0 108.997 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.9 p -98.42 113.11 24.97 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -65.22 159.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.156 0.583 . . . . 0.0 110.346 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -135.59 120.14 18.17 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 123.525 0.73 . . . . 0.0 109.422 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 67.8 -74.56 0.07 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 125.221 1.576 . . . . 0.0 110.876 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -158.64 -57.9 0.07 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.69 0.796 . . . . 0.0 109.309 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.78 -11.3 33.02 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.232 -0.894 . . . . 0.0 114.238 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -92.24 159.9 15.41 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.482 1.141 . . . . 0.0 108.981 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.6 mtp -132.97 143.01 49.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.676 0.39 . . . . 0.0 110.454 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -143.37 153.7 42.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.433 0.693 . . . . 0.0 110.521 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.72 HG13 ' H ' ' A' ' 43' ' ' ASN . 7.3 tp -95.99 145.31 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -77.19 1.31 18.76 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-O 121.694 0.759 . . . . 0.0 111.323 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.72 ' H ' HG13 ' A' ' 41' ' ' ILE . 21.0 m120 -100.89 179.8 4.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.318 1.047 . . . . 0.0 109.5 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.3 143.28 33.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.736 0.814 . . . . 0.0 109.458 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 123.266 0.626 . . . . 0.0 109.569 179.026 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.519 ' O ' ' HD2' ' A' ' 122' ' ' LYS . 30.3 m . . . . . 0 CA--C 1.556 1.197 0 CA-C-O 121.706 0.765 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 96' ' ' GLN . 6.0 mt 85.48 87.53 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.874 1.67 . . . . 0.0 111.825 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HE1' ' HG2' ' A' ' 122' ' ' LYS . 6.4 m0 -102.06 105.39 16.12 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.719 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 28.6 t70 177.63 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.225 1.578 . . . . 0.0 109.233 155.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 8' ' ' LEU . 67.3 t . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 123.488 0.715 . . . . 0.0 110.374 -172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.578 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 147.28 -154.12 25.76 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.55 137.55 46.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CD2' HD23 ' A' ' 8' ' ' LEU . 7.7 m-85 -123.39 139.82 53.64 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.944 0.498 . . . . 0.0 111.348 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' A' ' 161' ' ' LEU . 21.9 mtp180 -92.75 126.57 37.9 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 pt -129.93 143.95 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -139.52 138.12 36.05 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.329 1.852 . . . . 0.0 112.151 -172.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.409 ' CB ' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -132.5 153.55 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 170.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 45.1 mtpt -106.97 88.97 2.86 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' B' ' 253' ' ' LYS . . . -168.64 178.11 42.24 Favored Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 mt 59.42 23.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 118.008 0.904 . . . . 0.0 111.409 166.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp 71.45 41.65 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.052 1.341 . . . . 0.0 111.538 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.07 156.09 24.92 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 121.728 -0.272 . . . . 0.0 113.57 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.63 68.94 0.83 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.564 1.146 . . . . 0.0 108.2 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 m -113.26 125.06 53.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -159.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 65' ' ' LEU . 3.4 pm0 -95.82 104.21 16.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.318 1.447 . . . . 0.0 108.893 170.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.585 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.8 pp -137.14 -37.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -120.13 -168.96 13.91 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.284 -1.436 . . . . 0.0 116.129 -154.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -125.97 138.49 53.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.879 -172.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -133.37 -176.26 14.32 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.815 HG13 ' HB2' ' A' ' 108' ' ' HIS . 0.2 OUTLIER -152.46 109.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.426 0.69 . . . . 0.0 109.323 -178.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 107' ' ' PHE . 84.2 t80 -107.09 136.21 47.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -147.99 110.83 4.78 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 109.087 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 45.38 68.5 0.56 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.587 1.555 . . . . 0.0 113.101 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 -30.08 6.18 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.555 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 9.8 m -105.41 116.34 31.79 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.555 -172.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 87.8 t80 -93.81 144.25 25.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 172.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.815 ' HB2' HG13 ' A' ' 101' ' ' VAL . 25.2 m80 -132.19 122.68 25.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.866 0.866 . . . . 0.0 109.174 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.2 t -141.98 -179.67 6.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.569 0.748 . . . . 0.0 111.462 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 210' ' ' LEU . 79.9 mmm -89.66 173.25 8.4 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.639 1.176 . . . . 0.0 109.856 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -59.45 2.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 122.091 -0.381 . . . . 0.0 111.609 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -53.72 -28.21 32.71 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 125.131 1.372 . . . . 0.0 114.16 -168.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.2 m -56.1 -25.63 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 124.531 1.132 . . . . 0.0 113.021 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.648 HG23 ' H ' ' A' ' 116' ' ' GLY . 2.9 t -142.19 -166.63 2.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -111.42 33.51 4.66 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 121.065 0.459 . . . . 0.0 111.443 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 114' ' ' THR . . . 71.73 58.57 5.25 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.965 176.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.69 -172.37 2.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.516 0.726 . . . . 0.0 111.972 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 p -100.14 148.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 124.442 1.097 . . . . 0.0 111.755 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.54 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.9 mm? -91.11 168.99 11.22 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.549 1.14 . . . . 0.0 111.211 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -172.77 163.81 5.14 Favored 'General case' 0 C--O 1.263 1.772 0 CA-C-O 123.869 1.795 . . . . 0.0 114.862 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -106.76 95.21 5.57 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.78 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.604 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 0.9 OUTLIER 48.97 48.09 21.01 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.005 0.922 . . . . 0.0 112.45 164.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.64 -8.48 56.5 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -100.25 110.55 22.8 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.997 0.899 . . . . 0.0 109.068 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 11.5 ttp180 -82.1 151.04 27.19 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -162.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 66.8 mt -142.51 121.68 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.038 1.735 . . . . 0.0 108.151 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -77.4 129.91 76.08 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.14 0.576 . . . . 0.0 111.395 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.62 170.57 19.95 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.781 2.321 . . . . 0.0 111.015 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 p -125.14 -29.69 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.575 0.75 . . . . 0.0 111.861 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TRP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 14.4 t-105 -131.22 143.74 50.8 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.762 0.825 . . . . 0.0 109.721 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.82 122.42 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.498 1.119 . . . . 0.0 108.285 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -140.98 119.81 12.61 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.276 0.631 . . . . 0.0 110.178 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -76.4 -24.39 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.291 1.037 . . . . 0.0 113.056 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -72.99 -42.41 63.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.16 0.505 . . . . 0.0 110.924 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.18 -8.89 34.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.532 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 t70 60.22 57.78 2.83 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.992 1.317 . . . . 0.0 110.644 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 144' ' ' TRP . 98.0 mt -144.87 137.07 26.03 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.412 0.685 . . . . 0.0 110.961 -174.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.2 mt -128.27 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.273 1.429 . . . . 0.0 108.864 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 130' ' ' TRP . 51.3 p -142.93 161.15 38.87 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.874 0.845 . . . . 0.0 112.99 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.663 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.9 t80 -116.52 143.64 45.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.956 1.702 . . . . 0.0 107.847 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.14 -13.45 44.59 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.53 -151.41 22.97 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 173.69 38.93 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.661 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 59.4 t-105 -69.12 108.84 3.75 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 231' ' ' LYS . 22.8 pttp -147.92 137.87 22.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.829 0.452 . . . . 0.0 110.278 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 229' ' ' THR . 15.8 tp -160.81 -90.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.497 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -172.42 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.91 0.777 . . . . 0.0 110.1 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.79 152.34 48.39 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.644 -1.162 . . . . 0.0 115.391 -161.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.13 127.26 17.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.998 0.919 . . . . 0.0 108.893 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.411 ' HZ2' ' HG3' ' A' ' 174' ' ' PRO . 47.7 t-105 -91.8 136.86 32.83 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.065 0.46 . . . . 0.0 111.35 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -134.82 127.48 30.91 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.42 125.93 25.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.965 0.906 . . . . 0.0 112.482 -170.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.36 -69.49 0.06 OUTLIER Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.84 -177.65 6.66 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.718 0.807 . . . . 0.0 109.817 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 8.1 pt-20 -104.14 147.46 27.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 110.859 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.36 171.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.586 0.754 . . . . 0.0 110.746 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.447 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -128.03 147.76 50.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 108.507 176.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 200' ' ' ILE . 29.4 m -122.86 139.59 49.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 109.449 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 90.4 mt -80.54 86.07 5.88 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.69 100.39 5.39 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 167' ' ' PRO . 62.5 mt -68.94 106.03 2.59 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' LYS . 19.4 mm-40 -67.58 133.83 92.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.21 112.43 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.476 2.117 . . . . 0.0 112.169 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.81 20.92 72.81 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.046 -0.979 . . . . 0.0 114.846 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 76.1 mmtt -138.57 -175.0 3.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.831 0.852 . . . . 0.0 109.99 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.36 152.16 70.1 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.539 0.736 . . . . 0.0 110.717 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PRO . . . . . 0.785 ' HB3' HD23 ' A' ' 161' ' ' LEU . 30.4 Cg_endo -62.98 137.59 63.18 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.868 2.379 . . . . 0.0 113.585 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -81.08 135.3 35.79 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.168 167.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -81.4 105.2 12.39 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 166.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 22' ' ' ILE . 51.3 t -112.17 116.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.441 0.696 . . . . 0.0 109.305 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . 0.58 ' H ' ' HB ' ' A' ' 22' ' ' ILE . 9.3 tt0 -108.71 137.41 46.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.834 0.349 . . . . 0.0 110.606 -165.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.4 t -153.75 147.02 24.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.82 0.848 . . . . 0.0 110.298 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 97.3 mttt -72.37 162.15 75.37 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.652 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' ALA . 50.0 Cg_exo -55.86 131.83 48.37 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.724 2.282 . . . . 0.0 111.717 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -147.66 150.75 23.03 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.254 0.919 . . . . 0.0 114.897 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 176' ' ' LEU . 1.0 OUTLIER -140.38 167.85 21.19 Favored 'General case' 0 C--O 1.239 0.55 0 O-C-N 121.101 -1.235 . . . . 0.0 111.235 -170.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.22 136.16 33.1 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.191 -1.822 . . . . 0.0 108.946 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -77.63 144.47 37.41 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.3 m -102.85 179.25 4.33 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.776 1.231 . . . . 0.0 108.932 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.43 ' H ' HG22 ' A' ' 179' ' ' THR . 20.2 m120 -68.03 -18.24 64.64 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.877 0.471 . . . . 0.0 111.893 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.38 -68.21 0.87 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.053 0.941 . . . . 0.0 110.016 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.8 -142.2 11.85 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.662 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.8 t -163.25 135.85 5.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.465 1.106 . . . . 0.0 108.842 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 165.89 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.164 0.586 . . . . 0.0 109.801 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 133.82 167.98 11.71 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-O 120.278 -0.179 . . . . 0.0 113.313 174.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -171.03 34.28 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.635 0 O-C-N 124.163 0.567 . . . . 0.0 110.812 173.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.475 ' N ' ' H ' ' A' ' 175' ' ' GLY . 2.2 t -164.87 117.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 126.565 1.946 . . . . 0.0 106.837 163.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.7 t -129.45 121.71 27.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.5 tp -144.42 151.46 39.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.86 0.864 . . . . 0.0 110.084 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.68 105.16 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 62.2 t80 -160.86 162.34 32.15 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.767 0.827 . . . . 0.0 109.121 -172.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.8 p -60.12 158.62 25.7 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.955 0.902 . . . . 0.0 111.422 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.81 107.88 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.683 2.922 . . . . 0.0 113.016 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -72.74 158.53 53.18 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.072 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.6 p -84.12 105.26 14.84 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 122.977 0.511 . . . . 0.0 109.959 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -56.75 110.06 0.73 Allowed 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.574 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 118.89 12.9 6.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.145 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.0 m -57.2 117.32 17.36 Favored Pre-proline 0 C--N 1.366 1.291 0 C-N-CA 122.899 0.48 . . . . 0.0 110.794 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 49.3 Cg_exo -58.7 112.77 1.3 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.933 2.422 . . . . 0.0 112.256 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 158' ' ' VAL . 58.9 mt -80.48 96.56 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.788 0.835 . . . . 0.0 109.304 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 208' ' ' VAL . 30.8 mt -119.57 134.18 63.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.26 -179.86 6.49 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.951 0.796 . . . . 0.0 109.456 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -63.41 -25.72 68.41 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.186 0.594 . . . . 0.0 112.527 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.43 -19.71 55.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.982 0.513 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 95.18 36.28 5.5 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.417 0.448 . . . . 0.0 112.221 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -130.22 166.79 19.57 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.215 1.006 . . . . 0.0 110.133 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 79.9 t 99.51 -60.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.14 2.176 . . . . 0.0 109.518 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 201' ' ' ILE . 33.2 m 49.74 32.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.869 1.267 . . . . 0.0 112.268 170.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.518 ' HA2' HG23 ' A' ' 229' ' ' THR . . . -76.78 -157.16 7.69 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.434 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.631 ' HB3' ' SD ' ' A' ' 110' ' ' MET . 24.4 mt -139.75 124.8 18.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.452 0.644 . . . . 0.0 112.582 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.16 124.35 26.17 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.989 164.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 176.81 66.82 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 158.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 225' ' ' ALA . 14.6 m120 -154.8 171.96 18.75 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 66.4 -118.65 11.22 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 p 179.13 168.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.257 1.476 0 CA-C-O 121.707 0.765 . . . . 0.0 110.217 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.02 113.81 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 160.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 221' ' ' ALA . 6.5 t -119.89 158.33 26.88 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.865 0.866 . . . . 0.0 111.159 -165.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 59.93 16.2 5.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.272 1.029 . . . . 0.0 111.17 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.8 t 53.6 28.54 8.01 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.561 1.544 . . . . 0.0 112.382 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 178.99 30.55 0.05 OUTLIER Glycine 0 C--N 1.358 1.794 0 C-N-CA 120.768 -0.73 . . . . 0.0 114.447 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 217' ' ' THR . . . -135.88 145.47 46.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.253 0.527 . . . . 0.0 109.596 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -105.13 101.67 11.21 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.9 1.28 . . . . 0.0 109.162 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 31' ' ' ILE . 17.9 m -122.67 141.44 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 119.103 0.865 . . . . 0.0 110.512 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.4 m -144.9 129.41 17.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.581 -166.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.791 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -81.52 -16.28 52.28 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.61 0.364 . . . . 0.0 110.648 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 17.5 pt 56.52 140.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 128.276 2.63 . . . . 0.0 116.527 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.48 27.54 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.985 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.29 143.01 51.17 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 172.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' THR . . . . . 0.661 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 62.2 p -76.03 104.4 6.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.555 0.693 . . . . 0.0 111.046 -169.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.26 107.74 19.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.424 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.56 1.343 0 C-N-CA 124.204 1.002 . . . . 0.0 111.485 172.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' A' ' 90' ' ' GLY . 2.0 tppp? . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 110.739 -0.097 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 110.941 -178.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.45 0 N-CA-C 112.307 -0.317 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 m -135.09 -163.19 1.35 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.078 0.951 . . . . 0.0 109.489 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.71 37.21 5.87 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.958 0.903 . . . . 0.0 110.772 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.18 -4.68 1.69 Allowed 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.251 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -174.84 90.73 0.06 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.344 0.592 . . . . 0.0 109.632 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' B' ' 252' ' ' NLE . 4.7 mp -133.69 95.05 3.39 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.149 1.78 . . . . 0.0 108.502 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.628 ' HB3' HG11 ' A' ' 64' ' ' VAL . 3.7 tp10 -97.53 140.67 31.62 Favored 'General case' 0 C--O 1.26 1.622 0 CA-C-O 121.76 0.79 . . . . 0.0 112.639 -170.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.419 ' HA ' HG22 ' A' ' 86' ' ' ILE . 57.0 mt -86.28 149.16 25.25 Favored 'General case' 0 CA--C 1.569 1.689 0 CA-C-N 113.376 -1.738 . . . . 0.0 112.409 175.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -147.47 111.06 4.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.621 -0.674 . . . . 0.0 109.757 170.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' ' HB3' ' A' ' 67' ' ' ASP . 55.7 ttp180 -62.78 137.17 58.2 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 119.629 1.104 . . . . 0.0 110.363 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.43 -28.8 3.58 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.281 0.632 . . . . 0.0 110.477 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.06 -169.67 2.44 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.077 0.951 . . . . 0.0 109.583 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 18.7 t70 -109.5 151.14 27.13 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.545 0.738 . . . . 0.0 109.524 173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.512 HG21 HG13 ' A' ' 101' ' ' VAL . 44.8 t -75.29 98.09 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.708 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -172.94 160.22 4.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -172.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.442 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 43.0 t90 -64.05 126.07 26.52 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 172.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 11.0 tp10 -95.62 143.96 26.46 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.523 0.729 . . . . 0.0 109.039 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.03 -3.85 11.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.971 0.908 . . . . 0.0 113.278 -177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.49 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 14.3 mm100 -82.61 36.06 0.48 Allowed 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 123.452 0.701 . . . . 0.0 110.867 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -61.69 112.59 2.32 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 125.125 1.37 . . . . 0.0 111.769 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -124.1 119.41 29.39 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.013 0.925 . . . . 0.0 110.096 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 6.4 tp -75.86 114.24 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -144.62 -24.37 0.52 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.352 0.661 . . . . 0.0 111.683 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.14 -145.39 0.06 OUTLIER Glycine 0 C--N 1.359 1.858 0 N-CA-C 114.351 0.501 . . . . 0.0 114.351 175.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 m 64.57 18.4 11.36 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.943 0.897 . . . . 0.0 111.859 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 9.9 m -65.54 120.21 66.31 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 123.386 0.674 . . . . 0.0 109.61 -175.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 26' ' ' SER . 15.3 Cg_exo -65.67 -96.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.384 2.723 . . . . 0.0 114.549 -161.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.436 ' H ' ' HB2' ' A' ' 27' ' ' PRO . 42.2 mm -113.37 119.51 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 HG21 ' A' ' 223' ' ' VAL . 7.2 mp -110.92 164.07 13.16 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.245 0.618 . . . . 0.0 110.687 172.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.4 p -115.23 110.88 20.11 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 173.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.0 mt -114.09 143.43 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.307 1.043 . . . . 0.0 108.33 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 p -90.99 108.08 19.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.69 0.757 . . . . 0.0 108.971 -175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG13 HG23 ' A' ' 179' ' ' THR . 27.2 mm -79.18 127.68 38.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.951 -175.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 38' ' ' SER . 19.7 m -100.79 95.51 6.69 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.098 0.559 . . . . 0.0 110.07 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 58.23 27.78 15.65 Favored 'General case' 0 CA--C 1.56 1.351 0 C-N-CA 125.228 1.411 . . . . 0.0 111.84 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 75.95 -42.76 0.46 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.523 1.529 . . . . 0.0 113.586 175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.06 -42.48 98.13 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 112.316 -0.313 . . . . 0.0 112.316 177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.592 ' HB2' ' HB2' ' A' ' 34' ' ' SER . 49.2 m -106.33 161.4 14.59 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 122.59 0.356 . . . . 0.0 110.732 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.479 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.3 ppp? -150.41 136.7 18.73 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.04 0.936 . . . . 0.0 108.948 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.0 p -163.52 177.27 8.96 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.968 0.414 . . . . 0.0 111.026 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.526 ' H ' HG21 ' A' ' 215' ' ' VAL . 2.8 tp -102.13 146.6 9.99 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 168.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -90.92 70.69 6.46 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 122.078 0.942 . . . . 0.0 109.729 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -155.94 114.86 3.49 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 113.335 -1.757 . . . . 0.0 106.794 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.98 103.93 1.61 Allowed 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.698 0.624 . . . . 0.0 110.276 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.513 ' HG3' ' NH2' ' B' ' 254' ' ' ARG . 2.2 pt-20 -82.91 164.28 20.56 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.378 1.071 . . . . 0.0 109.961 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -160.81 116.93 2.27 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 124.07 0.948 . . . . 0.0 108.619 173.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.84 41.03 0.16 Allowed 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 123.4 0.68 . . . . 0.0 112.255 -167.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.592 ' HG2' ' HA ' ' B' ' 254' ' ' ARG . 20.3 mt-30 -73.53 76.63 1.46 Allowed 'General case' 0 CA--C 1.571 1.76 0 C-N-CA 123.333 0.653 . . . . 0.0 111.78 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 m -155.89 121.16 4.82 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.308 0.643 . . . . 0.0 111.233 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.521 HD13 ' HA3' ' A' ' 98' ' ' GLY . 38.6 mt -160.29 -71.29 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 125.192 1.397 . . . . 0.0 110.448 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.707 ' HA2' ' HD3' ' A' ' 85' ' ' ARG . . . -63.65 152.13 48.29 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.585 177.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.12 -131.11 17.25 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 65.7 30.86 78.25 Favored Glycine 0 C--N 1.351 1.366 0 O-C-N 123.98 0.459 . . . . 0.0 112.771 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.18 160.51 8.75 Favored Glycine 0 C--N 1.344 1.002 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.5 t -82.12 78.25 8.82 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-O 121.651 0.738 . . . . 0.0 109.404 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -107.84 40.31 2.57 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.932 -175.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 -71.06 2.01 Favored Glycine 0 C--N 1.349 1.255 0 N-CA-C 111.987 -0.445 . . . . 0.0 111.987 -176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.85 125.29 22.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.204 -0.498 . . . . 0.0 112.074 174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.81 -171.71 37.81 Favored Glycine 0 C--O 1.239 0.443 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -175.0 -50.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.872 0.869 . . . . 0.0 109.593 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.0 t80 59.78 64.83 1.22 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.27 1.028 . . . . 0.0 109.671 -175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.88 -60.71 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.481 1.112 . . . . 0.0 108.12 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.79 -87.29 1.94 Allowed Glycine 0 C--N 1.345 1.057 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.39 172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.628 HG11 ' HB3' ' A' ' 7' ' ' GLU . 3.4 t -127.84 -122.15 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.247 0 CA-C-N 117.736 0.768 . . . . 0.0 109.388 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -179.68 142.41 0.17 Allowed 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.671 1.588 . . . . 0.0 107.385 -166.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.596 ' CD1' ' HE3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -147.32 178.12 8.67 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 -176.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.456 ' HB3' ' N ' ' A' ' 10' ' ' ARG . 59.1 t0 179.73 66.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 111.267 -2.697 . . . . 0.0 105.318 175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 69' ' ' PRO . 8.2 m -127.14 118.57 21.98 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.471 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 68' ' ' VAL . 22.9 Cg_endo -106.07 29.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.922 3.081 . . . . 0.0 114.661 -171.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 p -62.27 105.41 0.62 Allowed Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 117.944 0.338 . . . . 0.0 110.223 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -89.98 136.88 2.59 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 123.018 2.479 . . . . 0.0 112.865 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.57 -44.89 33.48 Favored 'Trans proline' 0 CA--C 1.566 2.076 0 C-N-CA 122.91 2.407 . . . . 0.0 114.185 170.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.98 101.39 1.46 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 CA-C-N 121.677 1.635 . . . . 0.0 111.736 170.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 37.1 t 58.37 94.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.963 1.305 . . . . 0.0 111.861 177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -155.16 -70.56 0.01 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-N 116.378 -0.374 . . . . 0.0 112.264 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm 64.68 -75.06 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.32 1.448 . . . . 0.0 112.622 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.43 171.59 13.3 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.071 0.548 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -101.25 137.1 40.04 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.158 0.583 . . . . 0.0 109.615 178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -161.99 102.38 1.14 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.613 0.72 . . . . 0.0 109.974 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . 1.3 mp0 -94.02 -23.73 17.9 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 124.202 1.001 . . . . 0.0 109.011 176.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 72.39 101.82 0.07 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 126.255 1.822 . . . . 0.0 111.955 170.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 126.47 -151.41 18.03 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.253 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.88 120.21 32.99 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 124.795 1.238 . . . . 0.0 109.295 -177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 11.3 m-85 -105.56 144.4 32.37 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 123.609 0.764 . . . . 0.0 110.473 -171.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.707 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 99.1 mtt180 -82.38 131.82 35.22 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 153.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.783 ' HB ' ' HE2' ' B' ' 252' ' ' NLE . 7.1 pt -132.58 142.84 41.44 Favored 'Isoleucine or valine' 0 C--O 1.254 1.322 0 O-C-N 121.083 -1.011 . . . . 0.0 109.283 -176.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 48.8 tttm -148.98 134.67 18.77 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.59 1.156 . . . . 0.0 110.17 -172.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -110.02 157.93 18.79 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -99.69 92.16 5.2 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 155.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.48 175.16 42.57 Favored Glycine 0 N--CA 1.472 1.078 0 CA-C-O 118.962 -0.91 . . . . 0.0 111.352 -177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.55 HD12 ' HG2' ' B' ' 253' ' ' LYS . 78.0 mt 59.07 -80.02 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 124.921 1.288 . . . . 0.0 112.052 173.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.3 tp -127.09 29.77 5.54 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.962 0.905 . . . . 0.0 109.483 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 101.02 -143.78 16.33 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-N 115.723 -0.671 . . . . 0.0 113.638 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.465 ' HB3' ' HZ1' ' A' ' 87' ' ' LYS . 11.9 m-85 -86.84 95.57 9.91 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.919 0.888 . . . . 0.0 109.234 -173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.427 ' HB2' ' HD3' ' B' ' 253' ' ' LYS . 7.8 m -140.42 146.98 39.01 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 119.854 1.206 . . . . 0.0 111.646 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.592 ' HG3' ' H ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -102.46 130.97 49.42 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.143 1.777 . . . . 0.0 113.48 -175.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.681 ' HB ' ' HA ' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -90.36 -30.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 123.626 0.77 . . . . 0.0 110.13 174.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.521 ' HA3' HD13 ' A' ' 50' ' ' LEU . . . 100.83 -86.41 0.63 Allowed Glycine 0 C--O 1.2 -2.002 0 CA-C-O 117.84 -1.533 . . . . 0.0 112.633 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -99.44 119.58 38.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 121.568 2.684 . . . . 0.0 111.127 -149.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -119.05 122.36 5.3 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 113.169 -1.832 . . . . 0.0 109.303 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.512 HG13 HG21 ' A' ' 14' ' ' VAL . 60.0 t -108.58 106.15 20.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 123.27 0.628 . . . . 0.0 110.096 -165.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 24.4 t80 -123.09 117.27 25.03 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -123.53 127.21 48.01 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 124.67 1.188 . . . . 0.0 108.646 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 65.73 -79.61 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.955 1.302 . . . . 0.0 111.391 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -142.86 -0.44 1.27 Allowed Glycine 0 N--CA 1.472 1.038 0 CA-C-O 120.052 -0.304 . . . . 0.0 113.254 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.8 t -116.57 126.84 53.86 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.279 0.632 . . . . 0.0 110.87 -173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.805 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 70.1 t80 -99.64 110.98 23.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.756 ' HE2' HD23 ' A' ' 137' ' ' LEU . 29.2 t60 -130.23 114.57 15.83 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.693 0.397 . . . . 0.0 110.752 -176.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.1 t -134.61 -171.49 2.79 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.358 1.063 . . . . 0.0 109.645 -173.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.431 ' SD ' ' O ' ' A' ' 211' ' ' TYR . 25.9 mmt -72.33 159.79 33.45 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.805 0.842 . . . . 0.0 111.936 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 40.0 t90 -85.52 -44.31 12.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.15 0.58 . . . . 0.0 110.704 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -60.37 -14.51 19.08 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.138 0.975 . . . . 0.0 113.326 -171.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 114' ' ' THR . 23.5 m -59.16 -23.64 25.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.394 172.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.589 HG23 ' H ' ' A' ' 116' ' ' GLY . 10.0 t -155.86 -166.19 2.14 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.627 1.171 . . . . 0.0 109.261 -175.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -117.64 17.97 14.3 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.162 0.585 . . . . 0.0 110.461 168.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.589 ' H ' HG23 ' A' ' 114' ' ' THR . . . 106.45 54.86 0.68 Allowed Glycine 0 C--N 1.349 1.275 0 C-N-CA 124.038 0.827 . . . . 0.0 111.574 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.03 160.01 16.56 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.2 0.524 . . . . 0.0 111.811 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.556 HG23 ' HA ' ' A' ' 127' ' ' GLU . 14.5 p -81.03 159.28 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 C-N-CA 124.678 1.191 . . . . 0.0 110.249 177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.616 HD22 ' HD2' ' B' ' 252' ' ' NLE . 10.8 mt -113.88 172.17 7.15 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.393 0.542 . . . . 0.0 111.67 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.55 ' HB3' ' HA ' ' A' ' 125' ' ' ARG . 0.0 OUTLIER -171.49 178.03 3.3 Favored 'General case' 0 C--O 1.267 2.003 0 CA-C-O 123.706 1.717 . . . . 0.0 114.793 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.538 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 43.9 t60 -114.78 100.39 8.2 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 110.615 -2.993 . . . . 0.0 108.816 164.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.596 ' HE3' ' CD1' ' A' ' 66' ' ' TRP . 8.9 mtmp? 1.98 72.75 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 127.313 2.245 . . . . 0.0 114.172 -173.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.0 19.55 16.69 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 114.828 0.691 . . . . 0.0 114.828 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.538 ' HE3' ' HB3' ' A' ' 121' ' ' HIS . 1.2 tmmt? -139.71 112.13 7.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 167.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 41.2 ttp85 -98.69 140.75 32.43 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -162.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.5 pt -134.55 130.33 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.647 0 C-N-CA 126.088 1.755 . . . . 0.0 109.438 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.556 ' HA ' HG23 ' A' ' 118' ' ' VAL . 5.2 mp0 -91.05 138.39 26.02 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.639 -0.663 . . . . 0.0 111.649 -176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 19.8 Cg_exo -68.84 156.95 63.78 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 123.032 2.488 . . . . 0.0 112.139 167.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.7 p -98.85 -17.76 18.26 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.392 0.677 . . . . 0.0 111.829 -175.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.662 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 21.6 t-105 -152.02 148.88 28.24 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.23 0.612 . . . . 0.0 110.87 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -149.25 122.28 8.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.647 1.179 . . . . 0.0 109.263 169.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -130.54 118.35 20.94 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.027 0.441 . . . . 0.0 111.29 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.0 p -75.86 -28.6 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.978 1.311 . . . . 0.0 111.805 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -65.82 -56.52 11.48 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.76 0.824 . . . . 0.0 111.951 -170.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -79.86 -23.99 41.54 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.499 0.72 . . . . 0.0 109.892 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.9 t70 79.84 44.15 0.05 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 126.077 1.751 . . . . 0.0 109.989 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.756 HD23 ' HE2' ' A' ' 108' ' ' HIS . 9.4 mp -131.65 129.43 40.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.328 -0.858 . . . . 0.0 111.327 -175.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.499 HG12 ' HA ' ' A' ' 131' ' ' ALA . 24.0 mt -114.01 144.09 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 125.548 1.539 . . . . 0.0 110.749 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.662 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 7.2 m -125.87 154.85 42.11 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.629 0.728 . . . . 0.0 111.548 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.805 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 10.9 t80 -136.68 138.47 41.1 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 125.591 1.556 . . . . 0.0 107.698 176.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.26 -45.15 1.51 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.529 -0.628 . . . . 0.0 111.529 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 175.92 -165.68 36.45 Favored Glycine 0 C--O 1.245 0.801 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.41 135.71 31.55 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 11.8 p90 -69.84 142.05 53.15 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 117.262 0.531 . . . . 0.0 110.763 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -151.33 114.24 4.71 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.5 HD23 HG21 ' A' ' 229' ' ' THR . 3.9 mm? -123.64 -91.64 0.54 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 167.8 -69.09 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 207' ' ' VAL . . . -77.12 153.86 42.13 Favored Glycine 0 N--CA 1.441 -1.006 0 CA-C-N 114.796 -1.093 . . . . 0.0 113.817 -166.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -145.3 121.96 11.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.499 -0.85 . . . . 0.0 108.784 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.499 ' HE3' HD13 ' A' ' 200' ' ' ILE . 16.3 t90 -91.12 148.47 22.35 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 174.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -153.37 160.3 42.62 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.411 ' HG3' ' HA3' ' A' ' 185' ' ' GLY . 2.0 pm0 -63.03 93.82 0.06 Allowed 'General case' 0 CA--C 1.553 1.064 0 CA-C-O 122.294 1.045 . . . . 0.0 111.047 -176.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.87 -46.97 0.07 OUTLIER Glycine 0 C--N 1.34 0.799 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.433 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -93.6 160.23 14.87 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.316 1.046 . . . . 0.0 109.218 172.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.43 ' HB2' ' HG2' ' A' ' 173' ' ' LYS . 13.6 pt-20 -93.71 145.52 24.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.964 0.506 . . . . 0.0 110.12 171.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.626 HG11 HG23 ' A' ' 200' ' ' ILE . 1.4 p -140.29 -173.97 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 122.193 -0.317 . . . . 0.0 110.275 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 38.4 mt-30 -126.35 148.07 49.63 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.964 -0.46 . . . . 0.0 110.088 166.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.84 125.82 54.65 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -92.1 88.79 6.66 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -104.17 112.51 25.54 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.235 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 167' ' ' PRO . 59.7 mt -66.99 125.73 26.91 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' A' ' 168' ' ' ARG . 45.4 mt-10 -81.22 155.57 72.04 Favored Pre-proline 0 N--CA 1.483 1.206 0 C-N-CA 123.145 0.578 . . . . 0.0 111.112 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.79 113.51 2.79 Favored 'Trans proline' 0 C--N 1.382 2.303 0 C-N-CA 122.536 2.158 . . . . 0.0 112.563 174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 69.76 5.91 53.42 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-N 115.34 -0.845 . . . . 0.0 114.302 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 88.3 mttt -129.98 -171.04 2.43 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.483 0.713 . . . . 0.0 111.666 -171.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -76.53 158.1 81.59 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.889 0.875 . . . . 0.0 112.405 -174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.539 ' HB3' HD23 ' A' ' 161' ' ' LEU . 18.3 Cg_endo -60.07 106.05 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.869 2.379 . . . . 0.0 112.113 171.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.469 ' HB2' ' HG3' ' A' ' 162' ' ' GLU . 3.3 tpt180 -75.09 97.25 3.39 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.113 176.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -76.97 104.91 7.72 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.9 t -101.74 128.22 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.425 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 9.1 tt0 -78.99 108.02 12.16 Favored 'General case' 0 C--O 1.245 0.818 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.4 p -115.64 104.72 11.98 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.394 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.43 ' HG2' ' HB2' ' A' ' 155' ' ' GLU . 90.3 mttt -83.33 164.75 44.19 Favored Pre-proline 0 CA--C 1.557 1.239 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.142 171.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.85 140.04 58.54 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 122.992 2.462 . . . . 0.0 113.934 -177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -134.88 176.86 19.71 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 173.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -163.68 156.51 18.19 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.449 0.642 . . . . 0.0 110.455 -178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -138.84 151.41 46.98 Favored 'General case' 0 C--O 1.239 0.5 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.209 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -76.46 142.42 41.01 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.583 -172.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 181' ' ' ALA . 49.6 m -137.96 162.58 33.7 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.52 1.128 . . . . 0.0 108.704 -167.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -62.16 -34.27 76.08 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.678 ' H ' HG22 ' A' ' 179' ' ' THR . . . -80.55 6.67 11.85 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.22 1.008 . . . . 0.0 112.43 174.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.14 -78.56 0.27 Allowed Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 9.4 t -157.46 142.85 17.17 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.52 0.728 . . . . 0.0 109.704 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 69.5 mt -104.93 137.46 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 169.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.411 ' HA3' ' HG3' ' A' ' 152' ' ' GLU . . . -100.32 128.95 9.74 Favored Glycine 0 C--N 1.341 0.843 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 224' ' ' SER . . . -156.53 -168.26 2.65 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.504 0.722 . . . . 0.0 110.433 -169.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.479 ' HB ' ' HZ3' ' A' ' 150' ' ' TRP . 7.6 p -93.95 105.81 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 173.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.576 ' HA ' HG22 ' A' ' 223' ' ' VAL . 21.0 t -102.88 114.21 28.29 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.461 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 19.6 tp -127.98 127.15 42.74 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.761 0.824 . . . . 0.0 111.162 -172.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.34 102.92 14.99 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 165.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -176.46 169.48 2.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.325 1.05 . . . . 0.0 108.633 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.7 m -60.9 150.44 77.51 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.913 0.885 . . . . 0.0 110.627 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -45.17 103.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.535 2.823 . . . . 0.0 113.289 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -63.23 149.35 49.98 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.21 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.442 ' OG1' ' HA3' ' A' ' 98' ' ' GLY . 2.6 t -61.86 138.48 58.35 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.441 0.696 . . . . 0.0 112.426 -173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.518 ' HA ' ' CE1' ' A' ' 211' ' ' TYR . 37.1 m -72.34 119.92 17.21 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.006 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.599 ' H ' ' HE1' ' A' ' 211' ' ' TYR . . . 107.7 -4.75 34.59 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-O 118.166 -1.352 . . . . 0.0 112.756 -170.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 39.1 m -44.62 117.74 3.13 Favored Pre-proline 0 N--CA 1.498 1.961 0 CA-C-N 117.951 0.876 . . . . 0.0 112.51 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.487 ' HG3' HG22 ' A' ' 101' ' ' VAL . 3.0 Cg_exo -76.59 135.86 16.69 Favored 'Trans proline' 0 C--N 1.369 1.617 0 C-N-CA 122.235 1.957 . . . . 0.0 112.168 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.626 HG23 HG11 ' A' ' 156' ' ' VAL . 30.3 mt -83.59 97.38 4.68 Favored 'Isoleucine or valine' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 0.0 109.1 177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 47.4 mt -117.76 134.38 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.89 -171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -80.52 164.33 23.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.353 0.661 . . . . 0.0 109.296 173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -59.19 -31.91 69.45 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 123.227 0.611 . . . . 0.0 111.421 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -89.64 13.92 12.94 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.599 0.76 . . . . 0.0 111.711 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 68.72 24.79 75.4 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 116.309 -0.405 . . . . 0.0 113.223 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 206' ' ' LYS . 33.5 ttpt -89.97 162.03 15.59 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.988 0.915 . . . . 0.0 110.011 -177.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.686 ' HA ' ' HA3' ' A' ' 148' ' ' GLY 0.365 16.4 m 68.25 -62.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 127.487 2.315 . . . . 0.0 113.385 179.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 32.9 m 55.47 33.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 C-N-CA 124.493 1.117 . . . . 0.0 111.666 166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.52 -145.11 1.73 Allowed Glycine 0 C--N 1.347 1.161 0 CA-C-N 113.74 -1.573 . . . . 0.0 112.176 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 87.2 mt -138.91 146.43 41.06 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.265 0.626 . . . . 0.0 109.785 -176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.599 ' HE1' ' H ' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -73.52 132.53 42.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 172.275 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -72.79 -154.15 2.38 Favored Glycine 0 N--CA 1.479 1.535 0 CA-C-N 118.35 0.523 . . . . 0.0 113.968 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -94.35 130.35 40.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 122.471 -0.429 . . . . 0.0 110.364 176.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.608 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -157.23 -143.67 3.72 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-O 119.245 -0.753 . . . . 0.0 112.682 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.526 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.0 p -165.15 161.5 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.259 1.593 0 CA-C-N 117.276 0.538 . . . . 0.0 110.925 -170.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.47 111.74 13.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.734 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 164.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . . . . . . . . . 2.1 t -105.61 153.55 21.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.449 1.099 . . . . 0.0 108.903 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 52.4 mmm-85 62.77 12.53 5.75 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.923 0.889 . . . . 0.0 111.605 -174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 17.7 m 55.93 23.42 6.6 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.582 1.153 . . . . 0.0 111.586 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -152.89 -50.52 0.01 OUTLIER Glycine 0 C--N 1.354 1.562 0 CA-C-N 116.299 -0.41 . . . . 0.0 112.387 -171.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -81.83 158.42 24.06 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -121.25 109.5 15.03 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.576 HG22 ' HA ' ' A' ' 188' ' ' SER . 84.1 t -121.68 134.56 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.608 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 32.0 t -146.4 159.23 43.65 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.829 0.851 . . . . 0.0 109.334 -173.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.33 167.48 4.14 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.124 0.569 . . . . 0.0 111.304 174.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 66.0 mt -99.61 122.18 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 171.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.736 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -111.22 143.59 41.73 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -148.08 166.72 26.96 Favored 'General case' 0 C--O 1.243 0.755 0 O-C-N 122.072 -0.393 . . . . 0.0 110.927 -172.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.5 HG21 HD23 ' A' ' 146' ' ' LEU . 62.4 p -91.58 110.42 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.1 -0.04 56.02 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.023 0.929 . . . . 0.0 110.616 171.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 84.8 tttt 68.01 129.79 0.02 OUTLIER 'General case' 0 C--N 1.366 1.293 0 C-N-CA 124.731 1.212 . . . . 0.0 109.449 -169.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 52.2 p -56.45 121.53 9.85 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.518 0.727 . . . . 0.0 111.142 -175.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 5.6 tt -69.26 88.41 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-O 122.013 0.911 . . . . 0.0 109.633 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -92.71 74.58 4.99 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.55 -33.88 69.5 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.131 -0.941 . . . . 0.0 109.521 175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.02 146.07 86.96 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.264 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -61.45 131.88 38.19 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.124 1.883 . . . . 0.0 111.56 170.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.462 ' HG3' HG22 ' A' ' 239' ' ' ILE . 12.3 pt-20 -63.86 -18.97 64.7 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.9 0.88 . . . . 0.0 112.703 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.462 HG22 ' HG3' ' A' ' 238' ' ' GLU . 15.4 tt -152.33 -52.51 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 122.864 0.465 . . . . 0.0 111.086 -177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 . . . . . 0 C--O 1.25 1.125 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -174.367 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.477 ' C4 ' HD21 ' A' ' 119' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.783 ' HE2' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 97' ' ' ILE . 13.4 tppt? 172.02 -85.7 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 C-N-CA 126.454 1.902 . . . . 0.0 109.992 -174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.592 ' HA ' ' HG2' ' A' ' 48' ' ' GLN . 37.4 ttt180 -102.38 -90.12 0.36 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.909 -1.12 . . . . 0.0 111.425 -171.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.659 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -150.24 156.85 42.32 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.556 0.742 . . . . 0.0 110.291 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.427 ' O ' ' HB1' ' A' ' 117' ' ' ALA . . . 56.63 26.05 10.7 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 124.296 0.997 . . . . 0.0 112.63 174.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.17 31.64 0.54 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.521 1.128 . . . . 0.0 109.006 -171.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -166.81 61.59 0.09 Allowed 'General case' 0 C--N 1.348 0.511 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 117' ' ' ALA . 52.3 mt -101.52 94.21 5.77 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.287 0.635 . . . . 0.0 110.243 177.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 120' ' ' MET . 4.5 mm-40 -95.3 130.85 41.92 Favored 'General case' 0 CA--C 1.569 1.679 0 C-N-CA 123.672 0.789 . . . . 0.0 112.27 -172.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.781 ' HB2' HG12 ' A' ' 68' ' ' VAL . 24.3 mt -97.82 143.42 28.46 Favored 'General case' 0 N--CA 1.519 3.005 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 32.0 tt0 -134.23 142.8 47.5 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 124.163 0.985 . . . . 0.0 108.953 162.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ttp180 -86.7 128.43 35.01 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 118.034 0.379 . . . . 0.0 110.732 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.825 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -85.86 -52.37 5.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.227 174.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -163.67 -164.49 0.91 Allowed 'General case' 0 C--O 1.238 0.449 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.746 -171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.561 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 27.5 t70 -108.33 146.23 33.27 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 123.484 0.714 . . . . 0.0 109.556 173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.536 ' HB ' HG21 ' A' ' 201' ' ' ILE . 2.4 m -75.34 100.12 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 121.241 0.543 . . . . 0.0 109.766 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 203' ' ' LYS . 38.1 ttmt -172.39 117.43 0.35 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.849 1.259 . . . . 0.0 107.839 -175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.495 ' CD1' ' HB1' ' A' ' 169' ' ' ALA . 84.4 t90 -87.74 91.65 8.83 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 120.622 0.249 . . . . 0.0 111.647 -172.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -158.79 65.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 156.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 1.1 t70 -85.25 -61.91 1.66 Allowed 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.459 HE21 ' NH2' ' A' ' 168' ' ' ARG . 45.6 mt-30 -150.59 33.07 0.63 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.796 1.238 . . . . 0.0 109.014 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 13.65 73.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 126.188 1.795 . . . . 0.0 113.661 -163.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' A' ' 170' ' ' VAL . 13.2 mm-40 -75.91 162.08 28.41 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.801 -1.09 . . . . 0.0 110.608 -173.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.72 117.79 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 54.8 m -146.97 -51.16 0.2 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.377 0.671 . . . . 0.0 110.791 -177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -59.45 105.58 0.76 Allowed Glycine 0 C--N 1.355 1.621 0 CA-C-O 119.416 -0.658 . . . . 0.0 113.796 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.3 p 179.88 34.25 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.923 1.289 . . . . 0.0 110.482 176.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.615 ' HB2' ' HB3' ' A' ' 188' ' ' SER . 9.1 m -64.37 137.67 97.2 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.322 0.649 . . . . 0.0 110.527 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.41 178.24 0.24 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.525 2.816 . . . . 0.0 114.542 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.6 mm -60.07 115.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.124 0.569 . . . . 0.0 110.103 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.529 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 51.7 tp -112.4 159.0 19.15 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.955 0.902 . . . . 0.0 109.839 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 48.2 p -112.45 119.56 38.64 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.483 0.713 . . . . 0.0 109.479 173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 37.0 mt -114.23 142.7 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.263 1.025 . . . . 0.0 108.694 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.6 p -88.22 110.4 20.69 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG13 ' H ' ' A' ' 180' ' ' ASN . 45.3 mm -73.41 143.62 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 115.119 -0.946 . . . . 0.0 108.697 177.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.9 t -144.84 129.36 17.99 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 -174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 56.5 20.74 5.06 Favored 'General case' 0 CA--C 1.568 1.644 0 C-N-CA 124.14 0.976 . . . . 0.0 111.472 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 72.87 -68.43 0.23 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.405 1.882 . . . . 0.0 111.523 -177.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.66 -11.27 72.76 Favored Glycine 0 C--N 1.35 1.33 0 N-CA-C 114.91 0.724 . . . . 0.0 114.91 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.421 ' HA ' HD21 ' A' ' 213' ' ' ASN . 13.6 m -105.11 156.98 17.58 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-N 118.391 1.095 . . . . 0.0 109.037 176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 19.5 ptm -158.34 138.48 12.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.427 0.691 . . . . 0.0 109.475 -178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 p -172.21 176.16 3.5 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.723 0.809 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.45 94.79 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 49.94 29.12 3.2 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 125.368 1.467 . . . . 0.0 113.12 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 53.68 33.97 17.82 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.956 1.702 . . . . 0.0 113.026 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -75.04 93.53 2.75 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.821 0.82 . . . . 0.0 108.992 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.06 157.09 20.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.324 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -158.43 136.96 11.02 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.901 0.48 . . . . 0.0 109.98 174.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.657 ' HB2' HG21 ' A' ' 97' ' ' ILE . 14.7 pt-20 -101.77 158.04 16.4 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.619 0.768 . . . . 0.0 110.646 175.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.613 ' HB3' ' NH2' ' B' ' 255' ' ' M9P . 25.9 tt0 -166.45 141.57 4.44 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.287 0.635 . . . . 0.0 110.364 -164.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 96' ' ' GLN . 65.6 p -86.42 138.88 31.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.935 0.894 . . . . 0.0 112.788 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 0.0 OUTLIER -106.78 -44.88 4.33 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.727 0.811 . . . . 0.0 110.027 -177.154 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -96.24 172.27 29.02 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.3 22.56 54.07 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.32 138.86 29.79 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.96 -158.94 15.42 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.2 t -84.4 -26.34 28.4 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.16 0.584 . . . . 0.0 110.908 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.22 -82.05 0.79 Allowed Glycine 0 C--N 1.35 1.31 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.71 -122.33 27.58 Favored Glycine 0 C--N 1.351 1.398 0 C-N-CA 123.428 0.537 . . . . 0.0 113.311 173.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.61 -78.01 0.36 Allowed Glycine 0 C--N 1.352 1.441 0 C-N-CA 123.85 0.738 . . . . 0.0 111.888 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.45 -55.67 0.08 OUTLIER Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 176.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -74.91 -43.66 53.01 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.508 0.723 . . . . 0.0 110.599 -177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.3 t80 63.55 28.77 15.29 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 124.428 1.08 . . . . 0.0 109.8 -172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.65 70.68 9.67 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.47 65.36 4.14 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.613 HG23 ' HD2' ' A' ' 87' ' ' LYS . 2.6 p -109.9 23.71 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.503 0 CA-C-O 123.248 1.499 . . . . 0.0 109.012 -175.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD11 ' HG3' ' A' ' 96' ' ' GLN . 16.7 mt 81.39 127.68 0.04 OUTLIER 'General case' 0 C--N 1.358 0.971 0 C-N-CA 126.775 2.03 . . . . 0.0 116.475 156.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.452 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 4.2 m0 -125.02 87.43 2.71 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.619 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 4.4 t70 175.23 105.15 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 124.383 1.052 . . . . 0.0 111.028 157.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.781 HG12 ' HB2' ' A' ' 8' ' ' LEU . 18.8 m -132.13 175.15 3.92 Favored Pre-proline 0 N--CA 1.493 1.681 0 C-N-CA 124.604 1.162 . . . . 0.0 111.201 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.561 ' HD2' HD13 ' A' ' 126' ' ' ILE . 74.3 Cg_endo -92.52 113.4 0.29 Allowed 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 122.439 2.092 . . . . 0.0 110.702 162.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.2 p -64.81 113.02 9.34 Favored Pre-proline 0 CA--C 1.558 1.257 0 C-N-CA 123.237 0.615 . . . . 0.0 110.771 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.4 ' HG3' HG23 ' A' ' 126' ' ' ILE . 37.1 Cg_exo -58.54 -42.19 57.12 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.769 2.313 . . . . 0.0 115.653 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -75.83 118.53 5.09 Favored 'Trans proline' 0 C--N 1.39 2.737 0 CA-C-N 121.82 1.686 . . . . 0.0 110.859 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -57.14 90.98 0.05 OUTLIER 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 123.286 2.657 . . . . 0.0 112.395 174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.0 p -109.31 -33.48 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.997 0.919 . . . . 0.0 110.508 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.88 -51.39 4.06 Favored Glycine 0 C--N 1.347 1.191 0 C-N-CA 122.968 0.318 . . . . 0.0 112.779 177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -79.63 75.76 6.28 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-O 121.666 0.746 . . . . 0.0 109.0 174.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -175.53 -174.55 0.71 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.82 1.648 . . . . 0.0 108.125 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.79 136.37 37.42 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 69' ' ' PRO . 27.4 tp -107.06 -3.0 20.47 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.67 0.788 . . . . 0.0 109.618 170.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 50.91 168.77 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 127.443 2.297 . . . . 0.0 114.135 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HD1' ' A' ' 102' ' ' TYR . 22.9 t70 -179.9 111.41 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.575 0.75 . . . . 0.0 110.409 174.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 13' ' ' ASP . . . 138.22 -132.14 5.7 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 114.873 0.709 . . . . 0.0 114.873 169.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.86 140.12 42.76 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.805 1.242 . . . . 0.0 110.096 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 62.7 m-85 -125.49 146.44 49.64 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.881 0.473 . . . . 0.0 112.095 -168.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.825 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 20.6 mtm180 -98.26 124.49 42.89 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 163.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.647 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 21.8 pt -130.98 138.8 52.66 Favored 'Isoleucine or valine' 0 C--O 1.26 1.641 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -165.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.613 ' HD2' HG23 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -125.78 151.22 47.03 Favored 'General case' 0 C--N 1.386 2.195 0 C-N-CA 124.256 1.022 . . . . 0.0 111.284 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.571 ' HB3' ' HG2' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -140.67 154.62 46.46 Favored 'General case' 0 C--O 1.251 1.153 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 166.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -104.75 91.59 3.91 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-N 114.695 -1.138 . . . . 0.0 108.057 168.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -171.17 177.0 44.33 Favored Glycine 0 C--O 1.238 0.379 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.176 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 11.3 mt 59.63 37.33 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.515 0 CA-C-O 122.212 1.006 . . . . 0.0 109.602 165.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 70.3 mt 65.16 33.84 9.05 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.691 1.596 . . . . 0.0 111.644 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.45 157.69 28.59 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 121.47 0.483 . . . . 0.0 114.241 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -130.28 87.29 2.49 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 172.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.6 m -147.77 147.17 29.59 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.59 ' O ' ' HA ' ' A' ' 49' ' ' THR . 7.3 tt0 -95.07 110.25 22.2 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 125.189 1.556 . . . . 0.0 108.397 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.657 HG21 ' HB2' ' A' ' 47' ' ' GLU . 2.5 pp -135.07 -33.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -170.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.653 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.22 176.86 29.54 Favored Glycine 0 C--O 1.258 1.612 0 C-N-CA 120.552 -0.832 . . . . 0.0 114.051 -161.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -118.49 124.49 47.7 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.772 -0.714 . . . . 0.0 109.777 173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -101.46 162.11 17.89 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.3 t -138.6 133.09 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 123.3 0.64 . . . . 0.0 109.527 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.567 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 24.9 t80 -149.67 135.28 18.48 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 174.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' NZ ' ' HB2' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -139.78 133.42 30.39 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 65.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.989 0 O-C-N 124.871 1.357 . . . . 0.0 111.985 173.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.29 19.95 0.63 Allowed Glycine 0 C--N 1.344 0.973 0 CA-C-N 116.513 -0.312 . . . . 0.0 112.399 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 p -135.74 126.73 27.78 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.518 0.727 . . . . 0.0 110.043 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.759 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 49.1 t80 -102.19 137.63 40.2 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.59 1.156 . . . . 0.0 108.72 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -132.1 122.15 24.93 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.377 0.671 . . . . 0.0 110.062 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.482 HG23 ' HB ' ' A' ' 138' ' ' ILE . 14.6 t -136.42 -155.59 0.64 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 123.848 0.859 . . . . 0.0 109.892 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.436 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 18.6 ttm -136.97 153.59 50.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 111.239 -158.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.08 -46.43 11.15 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -174.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.421 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 13.8 p-80 -65.56 -16.91 64.15 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 118.743 0.701 . . . . 0.0 112.286 -171.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.517 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 4.5 m -80.27 -38.89 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.458 0 C-N-CA 123.826 0.85 . . . . 0.0 111.769 176.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.555 HG21 HD21 ' A' ' 6' ' ' LEU . 23.1 m -156.24 151.91 27.11 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 118.937 0.789 . . . . 0.0 110.079 170.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -73.15 26.43 0.06 Allowed 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -167.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.674 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 82.79 38.2 12.16 Favored Glycine 0 N--CA 1.477 1.411 0 CA-C-N 119.031 0.832 . . . . 0.0 111.425 -178.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -87.71 -165.58 1.35 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.697 0.799 . . . . 0.0 112.383 -168.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.01 136.47 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 123.733 0.813 . . . . 0.0 111.331 -174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.644 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.8 mm? -86.79 171.61 10.76 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.933 1.293 . . . . 0.0 111.998 -176.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -172.53 173.04 4.14 Favored 'General case' 0 C--O 1.258 1.546 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 124' ' ' LYS . 41.8 t60 -132.41 97.49 4.12 Favored 'General case' 0 C--N 1.364 1.231 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.448 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.432 ' HG2' HG13 ' A' ' 64' ' ' VAL . 85.3 mttt 39.14 38.84 0.35 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 124.775 1.23 . . . . 0.0 112.149 -174.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.68 21.18 12.85 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 115.71 1.044 . . . . 0.0 115.71 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.559 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 34.2 mmtp -115.27 112.12 21.96 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-N 118.984 1.392 . . . . 0.0 110.094 172.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 25.8 ttp85 -80.54 148.95 30.16 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 124.467 1.107 . . . . 0.0 113.171 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.561 HD13 ' HD2' ' A' ' 69' ' ' PRO . 29.5 mt -140.06 125.2 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 126.208 1.803 . . . . 0.0 107.428 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.06 148.83 36.46 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 123.19 0.596 . . . . 0.0 112.356 -168.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -79.0 163.46 25.67 Favored 'Trans proline' 0 C--N 1.39 2.742 0 C-N-CA 123.597 2.865 . . . . 0.0 114.764 177.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 p -127.04 -29.45 2.79 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.781 0.833 . . . . 0.0 111.602 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.609 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 32.1 t-105 -147.91 149.03 31.49 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.165 0.586 . . . . 0.0 110.522 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -148.93 140.83 23.72 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.751 1.22 . . . . 0.0 109.279 166.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -134.73 114.56 12.79 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 123.475 0.71 . . . . 0.0 110.913 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.9 m -72.56 -27.37 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.853 1.261 . . . . 0.0 112.356 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -76.85 -59.36 2.81 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.792 0.33 . . . . 0.0 111.766 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.33 6.14 48.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.371 0.669 . . . . 0.0 110.646 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 10.4 t70 68.62 51.18 0.63 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.392 1.077 . . . . 0.0 110.989 162.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.462 HD11 ' HB1' ' A' ' 227' ' ' ALA . 52.0 mt -140.14 142.33 36.01 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.459 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.674 HD13 ' HA2' ' A' ' 116' ' ' GLY . 49.3 mt -128.74 151.37 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.537 1.135 . . . . 0.0 109.07 -176.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 23.9 t -139.1 144.04 38.53 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.082 0.468 . . . . 0.0 111.01 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.759 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 63.1 m-85 -128.95 144.18 51.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.027 1.331 . . . . 0.0 109.077 -178.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 90.66 -8.86 79.17 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.738 -178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.48 -154.76 26.14 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.45 132.01 10.93 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 168.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.734 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 2.6 p90 -79.02 130.87 35.99 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -175.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.655 ' HB3' ' HB2' ' A' ' 232' ' ' SER . 56.1 pttt -149.16 116.35 6.07 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.841 0.456 . . . . 0.0 111.021 -172.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.1 mp -137.82 -80.1 0.36 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.441 ' H ' ' H ' ' A' ' 148' ' ' GLY . 4.8 mt-10 159.35 3.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 125.699 1.6 . . . . 0.0 109.366 -163.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 207' ' ' VAL . . . -56.12 91.2 0.02 OUTLIER Glycine 0 C--N 1.345 1.082 0 C-N-CA 123.985 0.802 . . . . 0.0 114.684 -175.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -135.27 95.86 3.37 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.501 ' HE3' HD13 ' A' ' 200' ' ' ILE . 2.0 t90 -46.43 121.65 3.57 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 163.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 88.4 tttt -81.78 116.5 21.5 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.68 108.48 2.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.217 1.007 . . . . 0.0 109.623 -175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 121.34 -37.96 2.8 Favored Glycine 0 N--CA 1.469 0.897 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 151' ' ' LYS . 42.0 tt0 -95.33 148.15 22.74 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.125 0.97 . . . . 0.0 109.763 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.558 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 13.1 pt-20 -89.71 139.94 30.06 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.809 0.844 . . . . 0.0 110.679 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.419 HG21 ' HA ' ' A' ' 150' ' ' TRP . 15.3 t -131.75 159.63 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.438 ' OE1' ' HG3' ' A' ' 171' ' ' GLN . 2.2 mm-40 -93.51 160.64 14.71 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.083 0.553 . . . . 0.0 111.914 -161.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 199' ' ' PRO . 14.5 p -140.05 152.66 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.524 0.73 . . . . 0.0 111.05 176.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' A' ' 14' ' ' VAL . 88.0 mt -103.39 93.39 4.94 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 164.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.52 ' HB1' ' HB3' ' A' ' 193' ' ' PRO . . . -77.1 97.23 4.65 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 167' ' ' PRO . 91.1 mt -73.49 103.92 4.29 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -70.45 141.1 87.8 Favored Pre-proline 0 CA--C 1.554 1.125 0 O-C-N 123.625 0.578 . . . . 0.0 110.652 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 50' ' ' LEU . 32.3 Cg_endo -61.82 117.87 4.72 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 123.597 2.865 . . . . 0.0 112.511 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.29 22.8 73.05 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.419 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -141.09 -173.56 3.76 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.867 0.841 . . . . 0.0 112.02 -172.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.38 159.71 70.86 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 126.016 1.726 . . . . 0.0 113.126 173.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.425 ' HB3' HD23 ' A' ' 161' ' ' LEU . 5.0 Cg_exo -77.32 117.7 4.44 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.196 2.597 . . . . 0.0 111.433 170.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.497 ' NE ' ' HA ' ' A' ' 168' ' ' ARG . 11.4 mmp_? -75.64 99.55 4.36 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -76.1 100.66 5.04 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 169.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.542 ' HA ' ' HB2' ' A' ' 21' ' ' GLU . 28.4 t -110.02 141.65 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.857 0.863 . . . . 0.0 109.57 -173.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.438 ' HG3' ' OE1' ' A' ' 157' ' ' GLN . 28.1 tt0 -89.73 121.4 31.85 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.4 HG22 ' HA3' ' A' ' 24' ' ' GLY . 34.0 p -123.75 132.22 53.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.343 0.657 . . . . 0.0 111.226 -172.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.558 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 62.3 mttp -92.5 149.72 38.67 Favored Pre-proline 0 C--O 1.246 0.909 0 C-N-CA 125.78 1.632 . . . . 0.0 110.765 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -79.19 126.72 7.14 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.614 2.209 . . . . 0.0 111.878 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.408 ' HA3' ' OG ' ' A' ' 188' ' ' SER . . . -111.93 -173.25 19.33 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 174.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.45 140.11 19.84 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.193 0.597 . . . . 0.0 110.0 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.594 ' HE2' ' HB3' ' A' ' 186' ' ' ALA . 13.4 m-85 -128.65 150.33 50.28 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.134 0.974 . . . . 0.0 110.631 -165.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -61.23 127.97 34.11 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.83 0.852 . . . . 0.0 110.8 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.7 m -130.44 156.83 44.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.179 0.992 . . . . 0.0 109.189 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.404 ' H ' HG13 ' A' ' 33' ' ' ILE . 21.5 m120 -84.83 54.61 3.13 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 122.152 0.977 . . . . 0.0 109.122 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -173.68 -21.1 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.975 1.71 . . . . 0.0 109.038 -174.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 147.87 -106.77 0.36 Allowed Glycine 0 C--N 1.348 1.241 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.9 t -140.97 133.4 28.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.1 pt -105.05 137.09 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 123.022 0.529 . . . . 0.0 109.661 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.98 109.42 3.66 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -173.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.594 ' HB3' ' HE2' ' A' ' 177' ' ' PHE . . . -149.95 167.91 25.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.516 0.726 . . . . 0.0 109.978 -173.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.59 128.62 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.441 0.639 . . . . 0.0 111.346 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.615 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 19.1 m -103.76 80.18 1.74 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.397 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.488 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 37.9 tp -105.39 104.96 14.79 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.048 0.451 . . . . 0.0 110.017 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.79 104.51 16.23 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 169.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.427 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 27.3 t80 -178.28 168.26 1.9 Allowed 'General case' 0 C--O 1.245 0.846 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -174.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 50.6 m -117.16 74.78 7.69 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 117.953 0.342 . . . . 0.0 111.577 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.52 ' HB3' ' HB1' ' A' ' 160' ' ' ALA . 19.5 Cg_endo -88.2 -60.13 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.151 1.901 . . . . 0.0 110.016 160.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 86.93 -29.98 4.85 Favored Glycine 0 C--N 1.361 1.942 0 C-N-CA 123.731 0.682 . . . . 0.0 112.577 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.0 t -61.94 99.51 0.13 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 124.62 1.168 . . . . 0.0 113.244 -165.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.9 m -63.02 121.85 14.61 Favored 'General case' 0 C--O 1.245 0.846 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.14 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.49 6.48 33.27 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.398 -169.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 62.3 m -45.23 115.14 2.47 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 123.295 0.638 . . . . 0.0 112.227 168.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.6 Cg_endo -74.33 119.84 5.97 Favored 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 123.203 2.602 . . . . 0.0 113.96 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.501 HD13 ' HE3' ' A' ' 150' ' ' TRP . 73.3 mt -79.68 93.67 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 C-N-CA 123.955 0.902 . . . . 0.0 109.261 170.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 14' ' ' VAL . 29.2 pt -111.21 178.68 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 122.015 0.912 . . . . 0.0 111.662 -174.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.4 174.04 6.05 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 166.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 16' ' ' TRP . 84.3 tttt -59.78 -31.76 69.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.746 0.418 . . . . 0.0 111.786 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 41.9 mttp -82.43 -3.78 56.26 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.097 0.559 . . . . 0.0 111.994 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.01 26.06 54.06 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -99.54 167.1 10.81 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.032 1.333 . . . . 0.0 109.324 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.574 ' HA ' ' HA2' ' A' ' 148' ' ' GLY . 68.9 t 85.68 -69.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 125.606 1.562 . . . . 0.0 109.49 -177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 3.6 m 58.25 30.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.264 0 C-N-CA 125.131 1.372 . . . . 0.0 112.844 166.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.08 -169.65 2.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.347 171.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 83.0 mt -144.94 149.61 35.54 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.485 -1.009 . . . . 0.0 110.994 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 3.8 m-30 -74.6 107.72 6.9 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 166.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.436 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -83.87 -138.98 3.83 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 124.328 1.018 . . . . 0.0 114.046 -166.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.421 HD21 ' HA ' ' A' ' 38' ' ' SER . 43.4 t30 -70.88 87.59 0.72 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.302 0.641 . . . . 0.0 109.586 177.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -135.59 -147.67 5.5 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.189 176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.0 167.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.641 0.776 . . . . 0.0 109.589 -167.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 13.9 t -91.91 111.17 23.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 29' ' ' LEU . 91.8 m -71.57 140.06 49.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.126 0.97 . . . . 0.0 109.906 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 59.73 12.1 2.78 Favored 'General case' 0 CA--C 1.568 1.639 0 C-N-CA 123.705 0.802 . . . . 0.0 111.861 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t 62.58 18.69 10.7 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.91 1.284 . . . . 0.0 112.072 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -154.19 7.97 0.39 Allowed Glycine 0 C--N 1.354 1.54 0 CA-C-O 119.682 -0.51 . . . . 0.0 114.345 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.427 ' HA ' ' H ' ' A' ' 191' ' ' PHE . . . -140.61 92.0 2.48 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 117.759 0.78 . . . . 0.0 110.03 -178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 216' ' ' VAL . 15.4 t80 -71.04 101.32 2.19 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.242 0.544 . . . . 0.0 110.773 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.2 t -116.14 123.42 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.055 1.342 . . . . 0.0 108.841 -176.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.559 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 24.7 t -143.88 158.45 43.69 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.011 0.524 . . . . 0.0 110.888 -171.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.83 145.79 55.11 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.594 0.758 . . . . 0.0 110.795 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.427 HG13 ' HA ' ' A' ' 186' ' ' ALA . 87.9 mt -81.83 98.42 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 CA-C-O 120.964 0.411 . . . . 0.0 110.026 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.462 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -81.06 135.41 35.82 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.437 ' NE2' ' H ' ' A' ' 228' ' ' GLN . 0.6 OUTLIER -129.55 159.33 36.67 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.793 0.837 . . . . 0.0 110.398 -172.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.734 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 10.9 p -82.83 113.89 20.77 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -145.36 101.6 3.61 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.518 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -158.93 -64.03 0.08 Allowed 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.695 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.655 ' HB2' ' HB3' ' A' ' 145' ' ' LYS . 7.6 m -119.02 101.72 8.23 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.714 -176.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 23.0 pt -111.44 -30.23 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 124.175 0.99 . . . . 0.0 109.734 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.587 ' HG3' ' H ' ' A' ' 236' ' ' ASN . 11.9 tp10 -114.88 160.95 18.9 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.959 1.303 . . . . 0.0 109.055 -171.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -64.04 -18.32 64.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.365 1.066 . . . . 0.0 111.353 175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.587 ' H ' ' HG3' ' A' ' 234' ' ' GLU . 1.1 m120 -59.41 151.15 61.26 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.979 1.312 . . . . 0.0 111.006 171.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -21.18 92.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.403 3.396 1 C-N-CA 126.527 4.818 . . . . 0.0 116.481 -170.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.649 ' HG3' HG13 ' A' ' 239' ' ' ILE . 5.1 pt-20 -92.2 -39.43 11.56 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.471 -178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.649 HG13 ' HG3' ' A' ' 238' ' ' GLU . 28.7 mt -88.82 57.34 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 . . . . . 0 C--O 1.252 1.205 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -177.735 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.647 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.583 ' HE3' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.604 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 17.4 tppt? -137.26 134.78 36.54 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 161.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.446 ' O ' HG12 ' A' ' 113' ' ' VAL . 36.5 ttt180 71.43 144.2 0.06 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.953 0.901 . . . . 0.0 109.684 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . 0.613 ' NH2' ' HB3' ' A' ' 48' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.339 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.645 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 t -171.37 150.69 2.93 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-N 117.448 0.624 . . . . 0.0 110.185 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 74.86 -57.94 0.59 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 125.739 1.615 . . . . 0.0 113.261 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.79 45.46 0.96 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.171 0.989 . . . . 0.0 108.659 -170.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 6.6 m-20 -146.0 26.48 1.22 Allowed 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.117 -174.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 88' ' ' GLN . 34.9 mt -91.6 93.63 9.03 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.545 0.738 . . . . 0.0 110.14 -177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.658 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 4.8 mp0 -95.12 131.06 41.54 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.805 0.842 . . . . 0.0 111.865 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.38 130.45 56.69 Favored 'General case' 0 N--CA 1.515 2.795 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -176.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.91 129.08 51.17 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 122.886 0.474 . . . . 0.0 110.527 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.724 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 5.8 tmm_? -75.6 127.61 33.45 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.356 0.662 . . . . 0.0 110.327 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.692 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.1 -56.81 2.52 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.425 0.69 . . . . 0.0 110.577 176.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' HG3' ' A' ' 167' ' ' PRO . . . -145.49 -175.08 4.58 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.711 -171.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -93.26 146.41 23.72 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.006 0.922 . . . . 0.0 109.839 177.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.59 HG23 ' HA2' ' A' ' 82' ' ' GLY . 15.1 t -79.49 97.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 172.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' N ' HD13 ' A' ' 201' ' ' ILE . 17.6 pttp -173.58 176.36 2.78 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.581 1.152 . . . . 0.0 108.402 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.402 ' HE1' ' HB2' ' A' ' 20' ' ' ALA . 39.0 t90 -73.49 136.52 44.16 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.512 176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -112.94 144.45 42.49 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.091 0.956 . . . . 0.0 109.598 172.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.03 -6.28 8.33 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 124.301 1.04 . . . . 0.0 112.667 178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -71.15 -2.8 16.99 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.556 1.143 . . . . 0.0 111.61 174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' HB2' ' HE1' ' A' ' 16' ' ' TRP . . . -36.6 100.08 0.02 OUTLIER 'General case' 0 C--N 1.358 0.97 0 C-N-CA 126.915 2.086 . . . . 0.0 114.052 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -94.12 148.39 22.23 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.64 1.176 . . . . 0.0 109.619 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 mm -102.75 104.39 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.9 p -144.84 -20.4 0.51 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.849 0.46 . . . . 0.0 111.284 177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -71.66 -173.13 17.25 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-O 119.551 -0.583 . . . . 0.0 112.768 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m 71.82 37.9 1.01 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.545 1.138 . . . . 0.0 109.278 -173.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 m -66.86 142.73 97.62 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.692 0.797 . . . . 0.0 110.842 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.63 -176.14 0.53 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.225 2.617 . . . . 0.0 114.253 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mm -59.43 119.46 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.807 0.843 . . . . 0.0 112.142 -170.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 223' ' ' VAL . 7.0 mt -108.28 163.9 12.78 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.967 0.907 . . . . 0.0 111.075 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 37.7 t -120.14 122.51 41.18 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.285 0.634 . . . . 0.0 109.29 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.41 HG12 HD11 ' A' ' 41' ' ' ILE . 10.5 mt -127.11 149.09 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 123.98 0.912 . . . . 0.0 110.201 -175.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 89.2 m -96.99 119.46 35.5 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.096 0.958 . . . . 0.0 110.449 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.853 HG12 HG21 ' A' ' 179' ' ' THR . 35.6 mm -68.63 114.21 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 169.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.457 ' HB3' ' HB2' ' A' ' 38' ' ' SER . 23.0 t -79.84 134.51 36.33 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.24 4.56 1.24 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -76.35 -13.71 60.12 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 0.0 110.891 169.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.21 17.51 29.28 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -166.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 34' ' ' SER . 55.3 m -105.69 164.81 11.63 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.686 0.794 . . . . 0.0 109.986 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.627 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 2.4 ppp? -127.77 135.83 50.66 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.3 p -171.29 173.45 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.658 0.783 . . . . 0.0 110.536 -177.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 31' ' ' ILE . 1.6 mp -90.31 134.09 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 105.376 -2.083 . . . . 0.0 105.376 161.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -62.21 90.19 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.798 0 O-C-N 123.638 0.586 . . . . 0.0 110.371 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -157.08 157.19 34.1 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.478 1.111 . . . . 0.0 108.852 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -118.36 75.43 1.01 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -114.7 138.46 50.67 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.202 174.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -153.78 161.69 41.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -175.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 97' ' ' ILE . 36.9 tt0 85.15 137.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.622 1.569 . . . . 0.0 113.754 164.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -169.54 134.16 1.4 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.219 1.408 . . . . 0.0 109.299 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.7 m -78.07 101.92 7.2 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.081 0.952 . . . . 0.0 111.211 -174.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.43 96.46 5.15 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.713 0.805 . . . . 0.0 109.288 176.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.422 ' HA3' HE22 ' A' ' 96' ' ' GLN . . . -163.64 127.36 1.66 Allowed Glycine 0 N--CA 1.469 0.845 0 CA-C-N 115.627 -0.715 . . . . 0.0 113.092 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.23 -71.4 2.25 Favored Glycine 0 C--N 1.35 1.337 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.75 -79.96 1.73 Allowed Glycine 0 C--N 1.345 1.042 0 C-N-CA 123.13 0.395 . . . . 0.0 112.43 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.54 94.23 0.33 Allowed Glycine 0 C--N 1.342 0.878 0 O-C-N 124.055 0.503 . . . . 0.0 112.217 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.3 m 69.97 23.18 5.53 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.763 1.225 . . . . 0.0 111.179 -176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -133.82 92.05 0.25 Allowed Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -95.71 -21.84 22.77 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.658 0.229 . . . . 0.0 112.705 175.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 92.22 -77.13 1.28 Allowed Glycine 0 C--N 1.345 1.046 0 N-CA-C 112.224 -0.35 . . . . 0.0 112.224 178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.41 -63.84 4.27 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 112.371 -0.292 . . . . 0.0 112.371 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.532 ' HG3' ' H ' ' A' ' 62' ' ' ALA . 8.0 pt-20 -73.8 1.13 11.16 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.283 1.033 . . . . 0.0 112.462 176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 68.78 9.48 7.38 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.832 1.253 . . . . 0.0 111.066 -175.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.532 ' H ' ' HG3' ' A' ' 60' ' ' GLU . . . 55.41 18.83 2.78 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 125.4 1.48 . . . . 0.0 112.06 -171.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.92 -78.61 0.03 OUTLIER Glycine 0 C--N 1.354 1.565 0 C-N-CA 122.974 0.321 . . . . 0.0 112.606 -171.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.682 HG13 ' HE3' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -147.69 70.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.77 0 C-N-CA 124.601 1.16 . . . . 0.0 108.316 176.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.932 HD22 HH22 ' A' ' 85' ' ' ARG . 3.3 pp -37.45 157.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -175.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 9.2 p-90 -165.74 158.57 15.39 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 122.462 1.125 . . . . 0.0 111.779 -175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.724 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 29.5 t0 -154.81 60.39 0.67 Allowed 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 102.812 -3.033 . . . . 0.0 102.812 154.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.6 HG13 ' HB2' ' A' ' 121' ' ' HIS . 7.6 p -141.17 94.09 7.87 Favored Pre-proline 0 CA--C 1.561 1.368 0 CA-C-N 111.598 -2.546 . . . . 0.0 106.735 176.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.6 ' HD2' ' H ' ' A' ' 78' ' ' GLU . 2.1 Cg_endo -85.44 106.12 0.92 Allowed 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 123.134 2.556 . . . . 0.0 111.063 -178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.5 p -54.38 104.95 0.46 Allowed Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 123.885 0.874 . . . . 0.0 110.842 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -15.17 83.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.384 2.404 1 C-N-CA 127.169 5.246 . . . . 0.0 118.419 -158.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 76' ' ' LYS . 79.9 Cg_endo -99.69 147.82 0.47 Allowed 'Trans proline' 0 CA--C 1.564 2.02 0 C-N-CA 123.637 2.891 . . . . 0.0 112.844 172.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -83.77 38.19 0.69 Allowed 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.138 2.558 . . . . 0.0 112.488 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 14.1 p -102.42 -29.48 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.792 0.837 . . . . 0.0 110.503 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.33 -88.24 0.07 OUTLIER Glycine 0 C--N 1.347 1.167 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 72' ' ' PRO . 64.4 mttp -89.96 178.45 6.21 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.733 0.813 . . . . 0.0 111.07 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.37 75.28 0.12 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.6 ' H ' ' HD2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER 55.92 -167.45 0.1 Allowed 'General case' 0 C--O 1.251 1.161 0 C-N-CA 124.025 0.93 . . . . 0.0 110.885 -160.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.4 mp 71.87 25.4 3.15 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.011 0.924 . . . . 0.0 111.077 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -60.49 -30.76 69.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 171.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.2 t70 64.42 111.95 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 125.168 1.542 . . . . 0.0 112.215 164.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.59 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 142.77 -167.08 26.38 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.919 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.16 109.57 12.37 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 1.6 m-85 -87.32 146.28 25.99 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.932 HH22 HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -101.64 136.9 40.7 Favored 'General case' 0 C--O 1.25 1.081 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 160.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.714 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 10.8 pt -132.71 142.89 41.24 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -162.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 73.4 tttt -123.02 142.84 50.4 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.187 1.795 . . . . 0.0 111.369 -174.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.801 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 51.7 tt0 -136.1 150.37 49.08 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.568 0.223 . . . . 0.0 110.646 167.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 91.1 mttt -96.14 92.0 6.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 162.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.02 169.77 42.4 Favored Glycine 0 N--CA 1.47 0.91 0 C-N-CA 120.274 -0.965 . . . . 0.0 114.616 -173.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 33.7 mt 67.48 -77.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 125.009 1.324 . . . . 0.0 112.235 163.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.96 -15.04 1.79 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.891 0.876 . . . . 0.0 109.78 -173.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.542 ' HA3' ' HE3' ' B' ' 253' ' ' LYS . . . -144.21 -161.11 8.79 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 114.102 0.401 . . . . 0.0 114.102 -176.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 26.7 t80 -150.88 33.86 0.6 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -165.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.3 p -151.8 173.07 15.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -154.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.755 ' HB3' HD21 ' A' ' 65' ' ' LEU . 5.5 pt20 -87.31 120.04 28.19 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.791 1.637 . . . . 0.0 110.909 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 47' ' ' GLU . 2.7 pp -136.0 -37.56 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.668 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -105.76 -172.67 23.68 Favored Glycine 0 N--CA 1.48 1.594 0 C-N-CA 120.214 -0.993 . . . . 0.0 114.811 -159.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.59 125.04 33.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.101 0.56 . . . . 0.0 110.324 175.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -114.56 111.38 2.54 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.571 HG13 HG21 ' A' ' 14' ' ' VAL . 91.9 t -88.64 101.83 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 123.408 0.683 . . . . 0.0 110.829 -171.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 15.0 t80 -91.51 110.19 21.5 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HD3' ' HB ' ' A' ' 14' ' ' VAL . 23.3 tptp -144.53 143.78 31.01 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.778 0.674 . . . . 0.0 110.168 -173.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 146' ' ' LEU . 11.8 mm-40 64.92 15.58 10.01 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.927 1.291 . . . . 0.0 112.739 176.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.54 -5.22 67.15 Favored Glycine 0 C--N 1.345 1.053 0 C-N-CA 122.946 0.308 . . . . 0.0 112.981 -178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.3 p -121.66 138.19 54.44 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 110.23 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 73.5 t80 -81.08 137.55 35.99 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -134.67 119.33 18.17 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.191 0.997 . . . . 0.0 110.372 -173.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 138' ' ' ILE . 2.9 t -138.74 176.72 8.45 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 0.0 110.517 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.424 ' HE3' ' O ' ' A' ' 136' ' ' ASP . 65.9 mmm -84.62 170.73 13.06 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.595 0.758 . . . . 0.0 110.593 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -87.56 -54.84 4.06 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 174.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -57.28 -13.66 3.52 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -168.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.6 m -63.82 -45.92 95.78 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.957 0 C-N-CA 124.68 1.192 . . . . 0.0 112.983 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.489 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 20.3 m -155.12 149.54 26.19 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 124.874 1.27 . . . . 0.0 107.59 170.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.78 13.21 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 -167.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.5 62.62 0.9 Allowed Glycine 0 C--N 1.344 0.987 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.525 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -117.17 -164.76 1.01 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.269 0.628 . . . . 0.0 111.764 -171.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 6' ' ' LEU . 93.6 t -92.04 129.89 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 124.471 1.109 . . . . 0.0 112.47 -162.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.633 HD21 ' H4 ' ' B' ' 251' ' ' BEZ . 1.1 mt -91.81 157.69 16.74 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 118.497 -0.763 . . . . 0.0 109.032 -176.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.481 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 2.2 ptm -172.88 179.84 2.23 Favored 'General case' 0 C--O 1.272 2.242 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -171.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.6 ' HB2' HG13 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -147.94 111.14 4.89 Favored 'General case' 0 C--N 1.367 1.354 0 CA-C-N 112.053 -2.34 . . . . 0.0 108.874 178.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.583 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 4.5 mptp? 49.95 34.09 7.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.139 0.975 . . . . 0.0 112.624 175.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 100.3 -21.02 46.18 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-O 119.822 -0.432 . . . . 0.0 113.561 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 115.5 10.8 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.45 0.7 . . . . 0.0 109.891 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -83.18 149.21 26.98 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.883 1.273 . . . . 0.0 112.555 -164.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 49.3 mt -142.35 134.29 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 C-N-CA 125.471 1.508 . . . . 0.0 109.172 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -90.49 117.66 68.16 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.449 1.1 . . . . 0.0 110.754 -172.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.16 145.39 66.52 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.414 2.076 . . . . 0.0 111.461 171.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 72.4 p -98.78 -18.64 17.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.735 0.414 . . . . 0.0 111.945 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.453 ' CZ2' ' HB2' ' A' ' 132' ' ' ASP . 49.2 t-105 -155.91 154.26 30.94 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.701 0.4 . . . . 0.0 111.261 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -160.92 122.0 2.9 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 125.379 1.472 . . . . 0.0 109.32 170.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.453 ' HB2' ' CZ2' ' A' ' 130' ' ' TRP . 27.2 t70 -139.25 135.29 33.74 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.458 0.572 . . . . 0.0 111.998 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.9 t -75.43 -42.07 42.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.028 -172.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.55 -48.67 38.21 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 123.949 0.78 . . . . 0.0 111.543 -168.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -72.45 -16.57 61.82 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.329 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.424 ' O ' ' HE3' ' A' ' 110' ' ' MET . 35.0 t70 62.83 45.14 5.83 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 124.703 1.201 . . . . 0.0 109.584 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 80.8 mt -142.4 129.37 20.71 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.772 -171.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.682 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.4 mt -115.66 155.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.511 1.524 . . . . 0.0 108.16 173.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.0 p -156.95 151.79 25.87 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.094 0.473 . . . . 0.0 112.104 -179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.685 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.9 t80 -120.25 149.12 42.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.64 1.176 . . . . 0.0 109.133 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 109.51 -78.58 0.24 Allowed Glycine 0 C--N 1.346 1.117 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.98 85.44 0.06 OUTLIER Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.345 -0.702 . . . . 0.0 111.345 170.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.63 133.77 2.22 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 71.0 t-105 -98.52 105.7 17.88 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 166.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -166.38 124.11 1.4 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.503 ' HB3' HG11 ' A' ' 207' ' ' VAL . 6.0 mp -124.17 -63.52 1.2 Allowed 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 175.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 177.97 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.298 0.999 . . . . 0.0 110.646 167.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.27 -171.84 23.16 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 -157.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -129.65 153.66 47.9 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 123.836 0.854 . . . . 0.0 110.041 -164.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.457 ' HA ' HG13 ' A' ' 208' ' ' VAL . 31.8 t90 -67.28 106.49 2.07 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 165.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -96.25 99.68 11.37 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.07 110.57 0.37 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.628 1.171 . . . . 0.0 111.748 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.687 ' H ' ' HG2' ' A' ' 174' ' ' PRO . . . 131.02 -42.08 1.44 Allowed Glycine 0 C--N 1.342 0.879 0 N-CA-C 110.804 -0.919 . . . . 0.0 110.804 -175.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.63 121.41 11.55 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.594 1.158 . . . . 0.0 110.9 177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.87 99.47 9.06 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 208' ' ' VAL . 32.9 m -91.59 172.36 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.544 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.158 -168.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.424 ' NE2' ' HB2' ' A' ' 171' ' ' GLN . 71.8 mm-40 -108.82 154.9 21.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.438 1.095 . . . . 0.0 109.49 173.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -139.57 136.78 40.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 168.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.26 88.54 7.24 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 171.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -75.77 101.15 4.96 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.6 mt -68.11 95.6 0.57 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -60.45 113.29 7.14 Favored Pre-proline 0 C--N 1.353 0.725 0 O-C-N 124.439 1.087 . . . . 0.0 110.145 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.21 114.89 2.4 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.054 1.836 . . . . 0.0 112.087 177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.27 -14.16 56.92 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 115.326 -0.852 . . . . 0.0 113.061 178.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -129.75 -172.73 2.84 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.464 0.706 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -62.32 162.92 16.17 Favored Pre-proline 0 CA--C 1.558 1.282 0 C-N-CA 125.337 1.455 . . . . 0.0 112.602 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.525 ' HG3' ' HB2' ' A' ' 12' ' ' ALA . 21.1 Cg_endo -58.91 140.95 97.51 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.108 2.539 . . . . 0.0 111.514 169.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.451 ' HG3' ' HZ ' ' A' ' 191' ' ' PHE . 47.5 mmm-85 -116.05 100.97 8.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.212 0.605 . . . . 0.0 109.841 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.1 118.91 13.53 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 168.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.3 p -136.46 134.41 49.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 120.863 0.363 . . . . 0.0 110.282 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.554 ' NE2' ' HE3' ' A' ' 203' ' ' LYS . 59.3 tt0 -87.9 143.18 27.26 Favored 'General case' 0 C--O 1.245 0.833 0 C-N-CA 123.891 0.876 . . . . 0.0 111.122 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.635 ' HB ' HD12 ' A' ' 189' ' ' LEU . 8.1 t -146.31 133.96 21.04 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.086 1.354 . . . . 0.0 109.175 178.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -93.12 140.67 23.4 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.687 ' HG2' ' H ' ' A' ' 153' ' ' GLY . 67.0 Cg_exo -45.34 122.69 4.82 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.83 2.354 . . . . 0.0 114.195 -177.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.04 -173.1 26.39 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -156.36 132.66 10.0 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-O 121.704 0.764 . . . . 0.0 110.076 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.475 ' HE1' ' HB3' ' A' ' 186' ' ' ALA . 22.9 p90 -115.37 121.8 43.91 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.999 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -80.19 153.55 28.52 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.531 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.853 HG21 HG12 ' A' ' 33' ' ' ILE . 27.0 m -137.34 162.17 34.3 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.466 1.106 . . . . 0.0 108.358 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -59.32 -24.56 63.43 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.644 0.777 . . . . 0.0 111.546 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.466 ' H ' HG22 ' A' ' 179' ' ' THR . . . -82.03 -36.51 27.67 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.061 0.944 . . . . 0.0 112.085 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -179.85 -131.68 1.68 Allowed Glycine 0 C--N 1.35 1.35 0 CA-C-O 119.61 -0.55 . . . . 0.0 112.56 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 37.9 m -156.45 127.88 7.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.404 1.082 . . . . 0.0 108.374 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.47 133.81 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.34 116.11 5.24 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.475 ' HB3' ' HE1' ' A' ' 177' ' ' PHE . . . -162.69 -166.15 1.28 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.334 0.654 . . . . 0.0 111.152 -171.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.526 HG23 HG21 ' A' ' 172' ' ' THR . 4.6 p -74.84 100.27 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.029 0 CA-C-O 121.719 0.771 . . . . 0.0 110.641 -175.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.507 ' HA ' HG22 ' A' ' 223' ' ' VAL . 29.1 m -96.16 100.2 11.86 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 167.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.635 HD12 ' HB ' ' A' ' 172' ' ' THR . 7.6 tt -135.05 107.46 7.3 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -176.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -74.41 124.91 27.41 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-O 120.959 0.409 . . . . 0.0 110.54 176.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.451 ' HZ ' ' HG3' ' A' ' 168' ' ' ARG . 48.4 t80 -170.11 -179.53 3.18 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.672 1.189 . . . . 0.0 107.829 -175.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.2 m -58.19 159.19 11.75 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.99 0.916 . . . . 0.0 111.032 168.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.706 ' HA ' HG11 ' A' ' 216' ' ' VAL . 9.2 Cg_endo -50.13 100.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.09 2.526 . . . . 0.0 112.252 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.82 163.41 44.25 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 8.2 t -102.0 137.85 39.74 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 121.424 0.631 . . . . 0.0 111.361 -171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.3 m -70.78 105.65 3.28 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.887 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 122.75 5.14 8.46 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.027 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.3 m -49.1 116.92 5.99 Favored Pre-proline 0 N--CA 1.492 1.634 0 C-N-CA 123.399 0.679 . . . . 0.0 111.662 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.54 125.11 9.84 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.252 1.968 . . . . 0.0 112.455 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.484 HG22 ' HB ' ' A' ' 208' ' ' VAL . 40.8 mt -93.04 106.95 18.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 122.167 0.984 . . . . 0.0 108.865 177.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 202' ' ' ASP . 8.7 mt -114.05 -175.58 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 125.053 1.341 . . . . 0.0 107.616 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' HG22 ' A' ' 201' ' ' ILE . 33.7 t70 -125.04 170.11 11.48 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 118.464 0.574 . . . . 0.0 110.397 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.554 ' HE3' ' NE2' ' A' ' 171' ' ' GLN . 19.5 mttp -47.17 -50.32 20.82 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 126.667 1.987 . . . . 0.0 111.403 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.58 -19.9 64.49 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.991 0.917 . . . . 0.0 111.259 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 102.63 6.03 47.44 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -61.63 128.7 37.51 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.379 0.672 . . . . 0.0 109.203 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.503 HG11 ' HB3' ' A' ' 146' ' ' LEU . 7.6 p -80.74 109.94 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 156' ' ' VAL . 80.0 t -83.23 -30.72 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.5 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.709 ' HA2' HG23 ' A' ' 229' ' ' THR . . . 156.97 -149.88 20.8 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.455 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 101' ' ' VAL . 78.3 mt -131.54 174.0 10.55 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.355 1.062 . . . . 0.0 109.554 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -59.94 123.45 17.08 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 164.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.85 177.69 43.41 Favored Glycine 0 N--CA 1.475 1.276 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 169.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.76 97.99 0.68 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.493 0.647 . . . . 0.0 110.402 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.627 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -140.73 -152.72 5.83 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.652 176.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 6.2 p -155.25 179.81 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -169.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.706 HG11 ' HA ' ' A' ' 193' ' ' PRO . 27.2 m -98.41 125.78 51.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 162.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.426 HG21 HD13 ' A' ' 29' ' ' LEU . 10.0 t -95.46 140.58 30.11 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.685 0.394 . . . . 0.0 111.092 -174.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 58.2 ttp85 38.95 -80.65 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.871 2.068 . . . . 0.0 114.401 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.1 p -87.15 16.58 4.98 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.283 1.033 . . . . 0.0 111.892 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.98 19.34 63.24 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 122.86 0.267 . . . . 0.0 112.709 176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -77.16 123.09 25.93 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.269 0.628 . . . . 0.0 110.535 -175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -65.23 99.03 0.36 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.445 0.698 . . . . 0.0 109.718 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.552 HG21 HD13 ' A' ' 29' ' ' LEU . 63.4 t -131.42 109.74 16.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.866 0 CA-C-O 122.353 1.073 . . . . 0.0 109.264 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.616 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 15.8 m -137.2 160.16 39.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.139 -1.391 . . . . 0.0 109.997 -169.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -62.96 153.77 32.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 164.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.42 HG23 HD12 ' A' ' 200' ' ' ILE . 71.6 mt -101.38 113.15 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -78.53 147.87 33.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.4 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 9.6 pt20 -134.04 149.88 51.19 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.506 0.722 . . . . 0.0 109.363 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.709 HG23 ' HA2' ' A' ' 209' ' ' GLY . 51.1 p -105.39 108.54 20.11 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.518 0.199 . . . . 0.0 111.314 -168.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.29 141.61 13.76 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -171.0 -59.96 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.2 p -135.76 91.67 2.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.459 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.49 -18.53 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.716 167.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -62.7 101.55 0.26 Allowed 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.761 1.224 . . . . 0.0 110.849 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -122.77 -10.94 8.24 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.432 0.693 . . . . 0.0 111.619 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -76.77 153.19 83.16 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 123.296 0.638 . . . . 0.0 110.835 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.28 154.27 29.82 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 123.145 2.563 . . . . 0.0 112.537 173.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 69.48 78.83 0.2 Allowed 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.482 1.113 . . . . 0.0 109.492 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 12.1 tt -130.37 -2.28 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.11 0 C-N-CA 124.704 1.202 . . . . 0.0 109.921 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 CA--C 1.554 1.134 0 C-N-CA 123.461 0.704 . . . . 0.0 110.686 -175.914 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.714 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.506 ' HD2' ' HB ' ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 2.5 tmtt? -141.98 52.48 1.49 Allowed 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 120.23 1.377 . . . . 0.0 113.726 165.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -172.9 131.22 0.51 Allowed 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 156.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.5 p 53.36 -160.77 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.758 1.623 . . . . 0.0 112.609 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.443 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -103.74 -179.71 4.03 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.523 0.729 . . . . 0.0 110.798 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.87 15.83 0.11 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.848 0.859 . . . . 0.0 110.552 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.6 m-20 -137.67 65.14 1.49 Allowed 'General case' 0 C--O 1.246 0.902 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.547 ' HA ' ' HB2' ' A' ' 88' ' ' GLN . 5.5 mp -106.57 113.2 26.57 Favored 'General case' 0 C--N 1.357 0.902 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.117 -176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 24.2 mm-40 -112.33 127.87 56.12 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.935 0.894 . . . . 0.0 111.809 -165.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.411 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -106.46 148.83 27.69 Favored 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.951 -0.468 . . . . 0.0 112.217 -175.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.479 ' HA ' ' H ' ' A' ' 67' ' ' ASP . 31.9 tt0 -145.82 140.68 27.26 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.273 1.029 . . . . 0.0 109.24 173.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.71 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 7.1 ptm180 -60.97 143.28 55.53 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 118.677 0.672 . . . . 0.0 110.353 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.33 -39.08 3.92 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 170.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' CB ' ' HG3' ' A' ' 167' ' ' PRO . . . -169.01 -171.27 1.29 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.931 1.292 . . . . 0.0 109.296 178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -99.96 148.58 24.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.989 0.916 . . . . 0.0 110.095 174.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.62 97.71 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -157.53 157.28 33.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.914 1.286 . . . . 0.0 108.606 -172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 29.5 t90 -70.43 115.24 9.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 160.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -80.88 143.97 32.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.0 -4.81 18.29 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.865 0.466 . . . . 0.0 111.766 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -76.69 49.68 0.64 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.921 1.288 . . . . 0.0 110.723 172.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -64.6 89.98 0.07 Allowed 'General case' 0 C--N 1.355 0.845 0 C-N-CA 124.261 1.024 . . . . 0.0 110.54 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 170' ' ' VAL . 10.0 tp10 -90.75 101.92 14.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.318 1.047 . . . . 0.0 108.717 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mp -78.44 101.68 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.5 m -160.12 96.05 1.19 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.556 1.142 . . . . 0.0 109.512 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.23 -133.36 2.92 Favored Glycine 0 N--CA 1.467 0.734 0 CA-C-O 119.334 -0.704 . . . . 0.0 111.983 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.4 m 62.99 40.75 8.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.359 1.064 . . . . 0.0 109.6 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 m -62.98 116.87 27.59 Favored Pre-proline 0 CA--C 1.555 1.159 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.176 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.94 -78.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 123.418 2.745 . . . . 0.0 112.573 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.552 HD11 ' HB2' ' A' ' 178' ' ' LYS . 7.7 tp -113.52 145.59 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.022 0.529 . . . . 0.0 109.717 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 177' ' ' PHE . 52.8 tp -132.72 155.16 49.35 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.653 0.781 . . . . 0.0 109.403 172.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.1 p -97.99 122.37 41.04 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 170.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 177' ' ' PHE . 9.4 tp -117.89 152.29 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 122.73 0.412 . . . . 0.0 110.343 -173.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.412 HG21 ' HG3' ' A' ' 42' ' ' LYS . 89.9 m -105.47 107.49 18.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.695 0.798 . . . . 0.0 109.998 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.61 116.87 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.057 0.943 . . . . 0.0 108.544 174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 m -104.29 114.31 28.46 Favored 'General case' 0 C--O 1.246 0.878 0 C-N-CA 124.789 1.236 . . . . 0.0 110.534 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 60.88 19.83 10.1 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.973 1.309 . . . . 0.0 112.025 177.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 p30 51.4 8.8 0.06 Allowed 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 126.987 2.115 . . . . 0.0 114.788 -170.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -106.29 -48.64 0.98 Allowed Glycine 0 C--N 1.349 1.284 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.2 p -106.0 164.79 11.69 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.454 0.701 . . . . 0.0 109.671 177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.445 ' SD ' ' O ' ' A' ' 213' ' ' ASN . 2.5 ppp? -124.14 149.95 45.67 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 168.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 76.3 p -178.94 -175.82 0.41 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.26 1.024 . . . . 0.0 109.484 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.614 ' H ' HG11 ' A' ' 215' ' ' VAL . 3.2 mp -106.51 152.24 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 157.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.412 ' HG3' HG21 ' A' ' 32' ' ' THR . 67.1 mttm -68.73 82.99 0.29 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -121.77 152.66 39.24 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.288 1.435 . . . . 0.0 108.85 -173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -145.34 49.73 1.24 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.744 0.783 . . . . 0.0 109.899 -174.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -116.78 104.41 11.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.783 0.833 . . . . 0.0 110.825 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.05 -38.48 63.98 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.665 0.786 . . . . 0.0 110.925 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 85.71 -49.0 0.07 Allowed 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 126.374 1.869 . . . . 0.0 110.982 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 47.98 31.47 2.42 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 126.196 1.798 . . . . 0.0 113.717 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.9 m -145.73 112.0 5.75 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.845 0.858 . . . . 0.0 109.668 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD21 ' HB3' ' A' ' 161' ' ' LEU . 0.4 OUTLIER -168.63 -52.13 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.041 0.936 . . . . 0.0 108.76 174.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.705 ' HA2' ' HD3' ' A' ' 85' ' ' ARG . . . -75.04 62.32 2.54 Favored Glycine 0 N--CA 1.478 1.46 0 CA-C-N 115.451 -0.795 . . . . 0.0 114.124 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -90.93 -75.01 1.29 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.92 25.08 67.45 Favored Glycine 0 C--N 1.35 1.325 0 O-C-N 123.77 0.335 . . . . 0.0 113.406 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -177.66 -35.79 0.06 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.671 -0.572 . . . . 0.0 111.671 -174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 64.2 m 62.82 32.91 15.64 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.547 1.139 . . . . 0.0 112.172 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 171.99 -167.52 40.53 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.601 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.56 -77.78 1.55 Allowed Glycine 0 C--N 1.351 1.378 0 N-CA-C 112.402 -0.279 . . . . 0.0 112.402 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -120.2 59.96 0.53 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -82.58 48.13 3.91 Favored Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.44 0.543 . . . . 0.0 114.274 -172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -143.62 -68.68 0.33 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.024 1.33 . . . . 0.0 107.759 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -114.99 -62.53 1.59 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.26 -177.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 53.71 39.07 29.77 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.735 1.214 . . . . 0.0 110.183 -169.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.52 ' HA3' ' HD3' ' A' ' 122' ' ' LYS . . . 84.06 -103.33 2.58 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 108.581 -1.808 . . . . 0.0 108.581 -161.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 t -145.0 -88.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 87' ' ' LYS . 1.4 tp -164.69 139.25 5.32 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.029 1.331 . . . . 0.0 108.001 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.505 ' CD1' ' HE2' ' A' ' 122' ' ' LYS . 0.4 OUTLIER -164.74 67.72 0.15 Allowed 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 -177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.71 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t0 -104.76 71.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 119.566 -1.959 . . . . 0.0 107.156 163.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.488 HG13 ' ND1' ' A' ' 121' ' ' HIS . 0.3 OUTLIER -132.46 102.14 14.2 Favored Pre-proline 0 CA--C 1.563 1.457 0 CA-C-N 112.815 -1.993 . . . . 0.0 106.573 179.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HG2' ' H ' ' A' ' 79' ' ' LEU . 60.4 Cg_endo -70.4 118.12 5.51 Favored 'Trans proline' 0 C--N 1.367 1.549 0 C-N-CA 123.356 2.704 . . . . 0.0 113.517 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.4 m -74.95 139.39 73.19 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.696 173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -61.7 118.67 5.56 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 123.182 2.588 . . . . 0.0 113.085 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.88 -39.6 89.42 Favored 'Trans proline' 0 CA--C 1.57 2.301 0 C-N-CA 123.273 2.649 . . . . 0.0 114.039 175.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.6 -84.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.49 1.568 . . . . 0.0 110.752 164.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 p -174.81 -46.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.104 0.962 . . . . 0.0 110.74 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.04 78.7 1.68 Allowed Glycine 0 C--N 1.346 1.094 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.914 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -168.84 158.67 9.07 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.38 1.072 . . . . 0.0 109.216 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.01 -173.73 3.04 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 169.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -82.88 143.66 30.6 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.562 ' H ' ' HG2' ' A' ' 69' ' ' PRO . 1.8 pt? -166.69 80.95 0.24 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.61 0.719 . . . . 0.0 110.873 174.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB2' ' HD3' ' A' ' 69' ' ' PRO . 13.5 tp10 -76.05 -19.73 58.36 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 162.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.8 t70 62.83 104.18 0.03 OUTLIER 'General case' 0 C--N 1.365 1.257 0 C-N-CA 125.53 1.532 . . . . 0.0 111.937 165.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 151.81 -170.44 31.25 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.412 -0.423 . . . . 0.0 113.759 -177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.53 108.31 17.23 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 16.3 m-85 -88.64 140.01 29.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.954 0.407 . . . . 0.0 110.1 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.705 ' HD3' ' HA2' ' A' ' 51' ' ' GLY . 6.0 ptp180 -80.71 126.02 30.77 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 161.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.668 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 17.2 pt -122.14 135.45 62.23 Favored 'Isoleucine or valine' 0 C--O 1.255 1.377 0 CA-C-O 121.31 0.576 . . . . 0.0 111.251 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.528 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 86.8 tttt -135.16 138.96 44.2 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.857 1.663 . . . . 0.0 108.586 -173.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.689 ' HB3' ' HB3' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -143.43 151.8 40.79 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 177.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 27.1 tttm -97.35 93.13 6.32 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 125.857 1.973 . . . . 0.0 107.698 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.458 ' HA3' HE22 ' A' ' 88' ' ' GLN . . . -172.88 173.45 45.55 Favored Glycine 0 N--CA 1.464 0.555 0 CA-C-O 118.705 -1.053 . . . . 0.0 110.932 174.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 52.2 mt 72.42 -64.41 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 123.802 0.841 . . . . 0.0 112.049 165.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.445 HD11 ' HD2' ' B' ' 253' ' ' LYS . 1.3 pp -132.68 -9.31 3.17 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 123.946 0.898 . . . . 0.0 111.87 174.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.71 -153.74 24.8 Favored Glycine 0 N--CA 1.479 1.507 0 CA-C-O 120.136 -0.258 . . . . 0.0 112.93 -177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 6.6 m-85 -88.57 120.89 30.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.219 1.007 . . . . 0.0 109.866 177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB2' ' HE2' ' B' ' 253' ' ' LYS . 15.2 m -141.38 133.96 28.47 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 118.346 0.521 . . . . 0.0 110.912 167.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.63 ' HB2' ' H ' ' A' ' 51' ' ' GLY . 6.6 pt20 -95.5 105.15 17.1 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.03 1.332 . . . . 0.0 108.899 174.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.683 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -134.0 -41.32 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 -164.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.683 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -111.5 -177.91 20.25 Favored Glycine 0 N--CA 1.488 2.119 0 CA-C-N 119.639 1.109 . . . . 0.0 115.639 -153.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -124.17 124.11 41.75 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.398 172.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -126.94 121.02 3.8 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 175.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 33.5 m -105.71 118.69 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 117.984 0.892 . . . . 0.0 111.525 -166.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.544 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 18.5 t80 -98.56 125.5 43.82 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -138.43 149.35 45.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.073 0.949 . . . . 0.0 109.187 168.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.424 ' HG2' ' HE3' ' A' ' 145' ' ' LYS . 13.0 tp10 64.81 -82.19 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.796 1.238 . . . . 0.0 111.229 175.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -156.96 25.95 0.5 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.5 t -143.97 129.05 18.62 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.329 0.652 . . . . 0.0 110.876 -174.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.764 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 68.9 t80 -96.48 86.55 4.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.565 ' HD2' ' HB3' ' A' ' 139' ' ' SER . 28.6 t-80 -95.14 120.39 35.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.272 -173.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.456 HG21 ' C5 ' ' B' ' 251' ' ' BEZ . 9.3 t -136.15 -156.56 0.72 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.929 0.891 . . . . 0.0 109.944 -174.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.51 154.73 22.27 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.528 1.131 . . . . 0.0 110.677 -166.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 2.6 t90 -86.25 -49.96 7.31 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 174.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -60.59 -17.17 44.9 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 114' ' ' THR . 16.0 m -68.04 -57.36 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 C-N-CA 123.318 0.647 . . . . 0.0 110.81 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.573 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 23.2 m -149.43 142.93 25.36 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.0 ptp180 -75.81 18.74 0.24 Allowed 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -164.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.91 62.57 0.75 Allowed Glycine 0 C--N 1.342 0.909 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.41 168.85 9.09 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.645 0.778 . . . . 0.0 110.23 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.27 134.61 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 123.583 0.753 . . . . 0.0 113.016 -164.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.64 HD22 ' HE2' ' B' ' 252' ' ' NLE . 13.7 mt -98.14 161.06 13.9 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -173.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.506 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -172.11 175.02 3.87 Favored 'General case' 0 C--O 1.267 1.986 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -169.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 124' ' ' LYS . 21.7 t60 -121.18 95.48 4.71 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.819 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.52 ' HD3' ' HA3' ' A' ' 63' ' ' GLY . 46.1 mttm 25.77 60.32 0.07 Allowed 'General case' 0 N--CA 1.513 2.698 0 C-N-CA 125.376 1.471 . . . . 0.0 113.667 -164.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.47 -11.63 58.17 Favored Glycine 0 C--N 1.35 1.32 0 CA-C-O 119.0 -0.889 . . . . 0.0 114.777 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 121' ' ' HIS . 8.9 tmtt? -83.79 113.37 20.86 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 118.526 1.163 . . . . 0.0 108.836 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -57.65 131.48 50.37 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.444 1.498 . . . . 0.0 113.384 -170.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 44.3 mt -139.43 115.52 9.23 Favored 'Isoleucine or valine' 0 C--O 1.253 1.248 0 C-N-CA 125.137 1.375 . . . . 0.0 108.526 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -86.55 121.56 72.14 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.37 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.52 ' HG3' ' HG ' ' A' ' 119' ' ' LEU . 28.2 Cg_exo -62.73 179.03 0.79 Allowed 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 123.024 2.483 . . . . 0.0 113.595 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 31.1 t -120.39 -34.09 3.72 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.863 0.865 . . . . 0.0 111.887 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.463 ' O ' HG23 ' A' ' 138' ' ' ILE . 25.0 t-105 -156.45 151.74 26.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.38 0.272 . . . . 0.0 110.937 -170.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -151.24 124.33 8.72 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.233 1.413 . . . . 0.0 109.799 168.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.404 ' HB2' ' HE1' ' A' ' 130' ' ' TRP . 10.3 t70 -128.81 128.04 43.13 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.288 0.635 . . . . 0.0 109.621 178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 8.2 t -75.48 -46.65 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 124.644 1.178 . . . . 0.0 110.872 -172.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -75.02 -45.94 38.38 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.367 -170.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.87 -15.9 60.7 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.347 173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 28.2 t70 61.98 43.33 9.17 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.562 1.164 . . . . 0.0 110.687 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 82.0 mt -140.72 135.71 31.85 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.677 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 130' ' ' TRP . 46.3 mt -122.03 160.5 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 125.761 1.624 . . . . 0.0 108.479 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.565 ' HB3' ' HD2' ' A' ' 108' ' ' HIS . 53.9 p -153.86 155.53 35.92 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 118.185 0.448 . . . . 0.0 111.585 173.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.764 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 8.5 t80 -115.38 149.81 37.37 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.134 1.374 . . . . 0.0 108.917 170.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 114.78 -109.56 2.16 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.16 82.38 0.05 OUTLIER Glycine 0 C--O 1.239 0.452 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 169.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 146.51 136.92 2.95 Favored Glycine 0 C--O 1.239 0.425 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CH2' ' HB2' ' A' ' 146' ' ' LEU . 3.0 t-105 -105.76 106.31 16.75 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 118.536 1.168 . . . . 0.0 108.557 172.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.485 ' HA ' ' OG ' ' A' ' 232' ' ' SER . 53.4 mtmt -131.19 123.44 28.49 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 123.984 0.913 . . . . 0.0 109.816 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.427 ' HB2' ' CH2' ' A' ' 144' ' ' TRP . 23.9 tp -129.63 -85.93 0.54 Allowed 'General case' 0 C--N 1.348 0.511 0 O-C-N 123.855 0.722 . . . . 0.0 109.285 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.43 ' O ' ' HA ' ' A' ' 233' ' ' ILE . 10.5 tp10 176.98 -66.02 0.01 OUTLIER 'General case' 0 C--N 1.361 1.077 0 O-C-N 123.759 0.662 . . . . 0.0 110.868 -173.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.452 ' HA3' ' HE3' ' A' ' 206' ' ' LYS . . . -140.35 -161.94 8.91 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 114.075 0.39 . . . . 0.0 114.075 -166.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 228' ' ' GLN . 34.5 tt0 -148.32 163.86 35.79 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.046 1.339 . . . . 0.0 108.966 -167.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.558 ' HA ' HG22 ' A' ' 208' ' ' VAL . 30.8 t90 -66.84 146.88 53.95 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 176.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -144.54 132.94 21.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.558 1.143 . . . . 0.0 109.218 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.82 162.95 28.57 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.339 0.656 . . . . 0.0 110.578 174.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 88.38 -31.21 4.91 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 112.068 -0.413 . . . . 0.0 112.068 -176.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -89.28 138.66 31.23 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.921 0.888 . . . . 0.0 109.39 175.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.32 135.24 38.38 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 170.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 200' ' ' ILE . 36.0 m -106.11 140.43 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 123.434 0.694 . . . . 0.0 110.351 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -109.21 150.74 27.47 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.9 p -138.83 113.44 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 122.512 0.325 . . . . 0.0 110.77 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.652 ' HB2' ' HB2' ' A' ' 167' ' ' PRO . 2.3 pt? -67.92 87.56 0.25 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 122.475 1.131 . . . . 0.0 109.26 174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 167' ' ' PRO . . . -71.13 111.61 6.62 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.392 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.588 HD23 ' HB3' ' A' ' 167' ' ' PRO . 96.7 mt -68.78 80.34 0.29 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.34 125.33 86.94 Favored Pre-proline 0 CA--C 1.549 0.936 0 CA-C-N 114.029 -1.441 . . . . 0.0 108.791 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.81 114.27 1.42 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 123.108 2.539 . . . . 0.0 114.06 -170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 78.38 25.35 61.42 Favored Glycine 0 C--N 1.35 1.358 0 CA-C-N 115.175 -0.92 . . . . 0.0 113.401 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -151.43 163.29 39.32 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.409 0.684 . . . . 0.0 110.286 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.85 157.67 48.3 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.146 0.978 . . . . 0.0 112.233 174.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.652 ' HB2' ' HB2' ' A' ' 159' ' ' LEU . 69.3 Cg_endo -69.8 117.02 4.84 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.675 2.25 . . . . 0.0 112.292 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 35.9 mtm180 -97.84 112.74 24.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 159' ' ' LEU . . . -72.05 101.78 2.82 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.207 0.527 . . . . 0.0 110.084 -175.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.428 HG11 HD21 ' A' ' 189' ' ' LEU . 44.9 t -85.33 109.52 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.413 -174.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -84.46 105.57 15.38 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 124.095 0.872 . . . . 0.0 108.879 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.517 HG21 HD12 ' A' ' 189' ' ' LEU . 9.8 t -127.99 157.61 40.13 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.865 1.266 . . . . 0.0 109.627 -174.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -99.41 160.23 28.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -61.49 159.05 33.39 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 122.198 1.932 . . . . 0.0 113.151 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 188' ' ' SER . . . -145.95 -171.14 15.18 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -150.12 149.52 30.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.661 0.73 . . . . 0.0 111.013 -176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.72 ' HB3' ' HB3' ' A' ' 29' ' ' LEU . 1.3 p90 -131.63 127.58 37.31 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.427 1.091 . . . . 0.0 109.453 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.552 ' HB2' HD11 ' A' ' 28' ' ' ILE . 43.9 tttm -78.58 132.01 36.97 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.943 0.897 . . . . 0.0 112.237 -165.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 181' ' ' ALA . 32.7 m -90.68 162.98 14.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.783 1.233 . . . . 0.0 109.228 174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -54.34 -40.67 68.28 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.402 0.681 . . . . 0.0 111.007 170.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.507 ' H ' HG22 ' A' ' 179' ' ' THR . . . -103.97 2.34 32.24 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.957 0.903 . . . . 0.0 112.995 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.47 -126.44 1.27 Allowed Glycine 0 C--N 1.351 1.408 0 C-N-CA 121.471 -0.395 . . . . 0.0 113.11 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 10.8 t -157.38 153.93 28.07 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.157 0.983 . . . . 0.0 109.437 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 37.5 mt -116.17 127.93 73.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.17 119.96 6.66 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.79 -156.22 0.49 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 0.0 109.798 -170.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.2 p -97.42 106.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 CA-C-O 121.876 0.846 . . . . 0.0 109.296 174.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.582 ' HA ' HG13 ' A' ' 223' ' ' VAL . 23.0 t -103.8 106.07 16.47 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.517 HD12 HG21 ' A' ' 172' ' ' THR . 3.8 tt -128.54 129.63 46.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 -172.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.752 ' HA ' ' HB1' ' A' ' 221' ' ' ALA . 8.7 p-10 -107.22 120.53 42.38 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.028 0.531 . . . . 0.0 109.708 173.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -170.88 168.48 7.13 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.553 1.141 . . . . 0.0 108.793 -171.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 24.9 p -54.36 136.07 60.91 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 123.284 0.634 . . . . 0.0 110.832 175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.3 95.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 124.272 3.315 . . . . 0.0 114.932 -167.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.57 167.46 44.45 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.189 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 161' ' ' LEU . 7.7 t -103.87 143.98 32.11 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-O 121.53 0.681 . . . . 0.0 112.244 -170.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.474 ' HA ' ' OH ' ' A' ' 222' ' ' TYR . 48.2 m -68.29 116.15 8.55 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.427 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 114.02 -4.48 23.97 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.356 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 75.5 m -52.19 118.81 13.11 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 122.963 0.505 . . . . 0.0 111.922 173.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.484 ' HG2' HD21 ' A' ' 159' ' ' LEU . 85.9 Cg_endo -79.53 141.07 15.46 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.755 2.303 . . . . 0.0 113.129 -177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.476 HD12 HG23 ' A' ' 226' ' ' ILE . 14.4 mt -93.49 111.07 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.552 HD12 HD22 ' A' ' 159' ' ' LEU . 45.6 mt -119.23 155.76 21.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.112 0.965 . . . . 0.0 110.236 -173.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -97.63 164.61 12.34 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 124.665 1.186 . . . . 0.0 108.377 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.27 -24.27 64.8 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.653 1.181 . . . . 0.0 112.098 174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -71.1 -16.66 62.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.043 1.337 . . . . 0.0 111.818 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 7.86 78.18 Favored Glycine 0 C--N 1.351 1.408 0 N-CA-C 111.781 -0.528 . . . . 0.0 111.781 -170.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HE3' ' HA3' ' A' ' 148' ' ' GLY . 41.2 tttp -86.83 121.53 29.45 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.475 1.11 . . . . 0.0 108.437 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -73.42 109.31 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 150' ' ' TRP . 10.7 p -92.61 7.85 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.361 0 C-N-CA 124.192 0.997 . . . . 0.0 110.237 -173.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 155.3 -164.9 32.16 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.846 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 227' ' ' ALA . 49.5 mt -137.16 150.61 48.06 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -69.37 108.27 3.65 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 167.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -89.14 -133.78 4.93 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.833 1.333 . . . . 0.0 112.9 -171.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.445 ' O ' ' SD ' ' A' ' 39' ' ' MET . 3.3 t-20 -67.38 97.17 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -162.16 -162.46 13.34 Favored Glycine 0 C--O 1.244 0.738 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.221 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.614 HG11 ' H ' ' A' ' 41' ' ' ILE . 12.2 p -167.03 168.53 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.6 0.76 . . . . 0.0 109.625 -169.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 222' ' ' TYR . 17.3 m -68.99 114.32 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 168.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 221' ' ' ALA . 6.0 t -81.18 -178.65 7.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.382 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -36.39 117.42 0.48 Allowed 'General case' 0 C--N 1.36 1.036 0 O-C-N 125.375 1.672 . . . . 0.0 112.403 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.5 t 86.46 6.04 0.36 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.063 1.745 . . . . 0.0 112.085 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 90.8 32.28 9.3 Favored Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.596 -0.275 . . . . 0.0 113.149 174.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.752 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -98.07 105.01 17.09 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.474 ' OH ' ' HA ' ' A' ' 196' ' ' SER . 10.3 t80 -67.09 103.45 1.19 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.203 0.525 . . . . 0.0 111.792 -172.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 188' ' ' SER . 87.6 t -118.33 139.6 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 125.112 1.365 . . . . 0.0 108.694 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.507 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 44.8 t -153.4 156.58 38.51 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.025 0.44 . . . . 0.0 111.932 -174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -72.0 130.62 41.4 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.476 HG23 HD12 ' A' ' 200' ' ' ILE . 69.2 mt -70.85 111.88 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.607 0.363 . . . . 0.0 110.67 -174.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 210' ' ' LEU . . . -74.64 152.51 39.19 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 167.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 149' ' ' GLU . 11.0 pt20 -145.1 162.27 37.43 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.653 0.781 . . . . 0.0 110.439 -172.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 26.6 m -85.21 108.88 17.94 Favored 'General case' 0 C--N 1.345 0.4 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -105.24 32.87 3.96 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.956 0.902 . . . . 0.0 109.827 -178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -141.21 -70.13 0.37 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.007 0.523 . . . . 0.0 109.954 -175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 145' ' ' LYS . 19.8 p -107.31 99.16 8.71 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.795 0.838 . . . . 0.0 111.829 -170.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 147' ' ' GLU . 48.6 mt -124.68 122.82 64.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -131.21 106.92 8.64 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.828 0.347 . . . . 0.0 110.276 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -92.3 -18.34 23.51 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.586 0.754 . . . . 0.0 111.678 175.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -71.49 113.67 21.58 Favored Pre-proline 0 N--CA 1.484 1.265 0 C-N-CA 123.157 0.583 . . . . 0.0 109.946 -172.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -86.54 12.06 3.11 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.324 2.683 . . . . 0.0 114.409 -174.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.44 -32.1 67.97 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.353 0.524 . . . . 0.0 110.756 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 16.2 tt -76.7 -27.52 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.762 0.825 . . . . 0.0 110.146 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 . . . . . 0 CA--C 1.549 0.928 0 C-N-CA 123.562 0.745 . . . . 0.0 109.462 178.478 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.668 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.689 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 95' ' ' SER . 2.9 tppp? -130.24 140.51 50.7 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.612 1.165 . . . . 0.0 108.713 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 70.79 138.22 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.43 1.092 . . . . 0.0 111.396 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.279 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.6 p -165.1 134.57 3.55 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.471 1.108 . . . . 0.0 108.023 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.89 165.54 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.758 1.223 . . . . 0.0 111.756 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 81.0 21.63 0.38 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 125.116 1.367 . . . . 0.0 112.028 171.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.73 ' HA ' ' SD ' ' A' ' 120' ' ' MET . 17.2 t70 -168.07 52.47 0.06 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 174.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.677 HD23 ' HB2' ' A' ' 88' ' ' GLN . 53.2 mt -86.59 91.02 8.44 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.677 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HB3' ' NE2' ' A' ' 121' ' ' HIS . 13.0 mm-40 -87.23 124.37 33.24 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.2 1.0 . . . . 0.0 110.988 -177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD22 HD13 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -98.15 125.99 43.41 Favored 'General case' 0 N--CA 1.523 3.185 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 174.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 85' ' ' ARG . 33.2 tt0 -109.61 157.94 18.54 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 167.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 67' ' ' ASP . 21.3 ttt180 -92.96 141.7 28.12 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.822 1.192 . . . . 0.0 110.904 166.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.29 -55.71 2.86 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.44 -159.97 0.84 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.899 -170.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.47 153.44 20.52 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.185 0.594 . . . . 0.0 110.141 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.585 HG12 HG21 ' A' ' 201' ' ' ILE . 3.0 t -79.58 97.93 2.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 176.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.2 tttp -173.94 164.47 4.2 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.643 0.777 . . . . 0.0 109.19 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 20.3 t90 -64.48 126.31 27.45 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.107 0.563 . . . . 0.0 111.475 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 19' ' ' GLN . 10.8 tp10 -97.1 145.57 25.87 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.164 0.986 . . . . 0.0 109.042 172.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.17 -9.72 2.3 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 124.679 1.191 . . . . 0.0 113.49 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.499 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 28.5 mm-40 -80.81 51.78 1.59 Allowed 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 124.954 1.302 . . . . 0.0 111.161 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.72 99.29 3.66 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.286 1.034 . . . . 0.0 112.05 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HB2' HG22 ' A' ' 170' ' ' VAL . 48.5 mt-10 -94.42 91.54 6.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.003 0.921 . . . . 0.0 110.443 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 171' ' ' GLN . 17.7 mt -79.25 102.85 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.5 m -158.11 -35.99 0.07 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.114 0.566 . . . . 0.0 111.023 -171.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -53.09 99.43 0.04 OUTLIER Glycine 0 C--N 1.356 1.654 0 O-C-N 124.067 0.854 . . . . 0.0 113.979 -170.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.6 p 168.3 75.05 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.927 1.691 . . . . 0.0 108.093 -175.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 190' ' ' ASP . 77.4 p -70.13 159.79 83.11 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -60.28 175.66 1.02 Allowed 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.183 1.922 . . . . 0.0 112.931 173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.79 111.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.573 ' HB3' ' HD1' ' A' ' 177' ' ' PHE . 55.9 tp -102.93 134.88 45.63 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -164.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 31.6 t -80.55 114.3 19.35 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 172.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 HG11 ' A' ' 223' ' ' VAL . 33.1 mt -113.38 148.4 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 176.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.476 ' OG1' ' HG3' ' A' ' 42' ' ' LYS . 6.7 m -91.83 105.37 17.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 -172.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' HB ' HG23 ' A' ' 179' ' ' THR . 10.1 tp -79.85 156.5 4.58 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.015 -178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.7 m -145.34 114.24 6.9 Favored 'General case' 0 C--O 1.252 1.235 0 C-N-CA 123.224 0.61 . . . . 0.0 110.178 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 62.4 14.51 6.95 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.748 1.219 . . . . 0.0 112.142 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 37.2 t70 74.74 -20.07 0.35 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.557 1.943 . . . . 0.0 112.482 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.67 -48.23 3.49 Favored Glycine 0 C--N 1.353 1.489 0 C-N-CA 123.137 0.398 . . . . 0.0 112.675 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 85.8 p -100.56 157.52 16.6 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -145.42 135.58 23.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.137 0.575 . . . . 0.0 110.156 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 78.3 p -154.12 -178.15 6.9 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.388 1.075 . . . . 0.0 109.592 -172.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' H ' HG21 ' A' ' 215' ' ' VAL . 9.4 tp -107.05 156.16 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.476 ' HG3' ' OG1' ' A' ' 32' ' ' THR . 7.3 mtpm? -67.84 113.24 5.41 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 163.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 71.55 91.45 0.09 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.368 1.467 . . . . 0.0 110.528 -173.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -99.51 116.68 32.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.285 0.634 . . . . 0.0 109.8 173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.02 114.49 4.23 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.532 0.733 . . . . 0.0 109.275 176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.74 138.27 12.9 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 178.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -173.79 116.14 0.23 Allowed 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -156.5 136.76 12.91 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 14.7 t -77.48 -168.24 1.12 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.653 0.781 . . . . 0.0 111.525 -173.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 ' HB3' ' A' ' 161' ' ' LEU . 1.9 tt -153.14 -54.84 0.12 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.09 -19.55 60.78 Favored Glycine 0 N--CA 1.466 0.681 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.064 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.65 28.58 6.91 Favored Glycine 0 C--N 1.354 1.565 0 C-N-CA 123.051 0.358 . . . . 0.0 113.494 176.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.17 68.27 3.47 Favored Glycine 0 C--N 1.351 1.391 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 169.65 71.12 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.1 m -74.35 166.81 22.85 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.539 0.735 . . . . 0.0 112.234 -171.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 140.08 -20.72 2.83 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.232 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 131.56 -114.01 1.45 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.55 172.54 38.06 Favored Glycine 0 C--N 1.349 1.259 0 C-N-CA 122.969 0.319 . . . . 0.0 113.552 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -87.84 19.01 35.97 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.661 -0.521 . . . . 0.0 112.978 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.89 -22.36 62.25 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.889 1.276 . . . . 0.0 111.474 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -65.54 -47.17 76.8 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.248 1.019 . . . . 0.0 111.094 175.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.65 -72.34 0.63 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 122.848 0.459 . . . . 0.0 110.533 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.04 123.35 7.31 Favored Glycine 0 C--N 1.35 1.336 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HD2' ' A' ' 122' ' ' LYS . 7.0 t -91.11 171.29 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 117.714 0.757 . . . . 0.0 108.994 -165.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -93.34 140.42 29.57 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.419 0.688 . . . . 0.0 112.105 173.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.532 ' HB3' ' CE1' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -152.79 -176.38 5.72 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 173.232 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 10' ' ' ARG . 27.4 t70 -177.98 68.8 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 168.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.618 HG12 ' HE2' ' A' ' 84' ' ' TYR . 15.4 m -134.73 164.31 44.93 Favored Pre-proline 0 N--CA 1.491 1.592 0 CA-C-N 114.406 -1.27 . . . . 0.0 112.958 -162.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.645 ' HB3' HD22 ' A' ' 79' ' ' LEU . 29.3 Cg_endo -60.76 124.57 15.25 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 122.893 2.395 . . . . 0.0 112.892 176.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.7 m -100.72 -179.33 0.8 Allowed Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.389 1.076 . . . . 0.0 109.312 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -38.22 137.71 0.48 Allowed 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 123.864 3.042 . . . . 0.0 114.805 169.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.13 -36.12 54.18 Favored 'Trans proline' 0 C--N 1.39 2.749 0 C-N-CA 124.342 3.361 . . . . 0.0 116.023 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.54 -141.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.393 2.879 0 C-N-CA 122.096 1.864 . . . . 0.0 110.989 165.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.9 p 57.56 16.81 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 C-N-CA 125.571 1.548 . . . . 0.0 113.135 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.83 -31.56 5.12 Favored Glycine 0 C--N 1.348 1.226 0 CA-C-O 119.828 -0.429 . . . . 0.0 112.462 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm 76.29 -45.76 0.52 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 126.042 1.737 . . . . 0.0 113.401 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.94 85.07 0.08 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.542 0.737 . . . . 0.0 110.123 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -173.73 93.61 0.09 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.571 1.148 . . . . 0.0 108.263 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.645 HD22 ' HB3' ' A' ' 69' ' ' PRO . 0.8 OUTLIER -146.54 -59.6 0.3 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.44 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 0.4 OUTLIER 60.4 41.58 15.88 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.851 0.861 . . . . 0.0 112.524 168.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 103' ' ' LYS . 7.8 p-10 -70.48 129.32 38.92 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 120.774 0.321 . . . . 0.0 110.483 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' H ' ' HE1' ' A' ' 84' ' ' TYR . . . 172.82 -146.86 9.34 Favored Glycine 0 C--O 1.249 1.044 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.019 -175.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.14 108.87 17.9 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.618 ' HE2' HG12 ' A' ' 68' ' ' VAL . 14.0 m-85 -89.44 158.42 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.642 0.777 . . . . 0.0 112.064 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 9' ' ' GLU . 83.4 mtt180 -93.43 156.85 16.52 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 125.089 1.356 . . . . 0.0 110.136 163.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.81 HG12 ' HD2' ' B' ' 252' ' ' NLE . 0.6 OUTLIER -126.36 106.32 15.61 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.641 -166.099 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 96' ' ' GLN . 80.7 tttt -124.4 131.91 53.51 Favored 'General case' 0 C--N 1.406 3.045 0 C-N-CA 124.725 1.21 . . . . 0.0 113.048 177.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.677 ' HB2' HD23 ' A' ' 6' ' ' LEU . 6.9 tp60 -134.27 151.2 51.15 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -87.48 85.58 7.14 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -166.71 169.85 40.91 Favored Glycine 0 C--N 1.337 0.633 0 CA-C-N 115.984 -0.553 . . . . 0.0 114.032 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.801 HG12 ' HD2' ' B' ' 253' ' ' LYS 0.254 0.1 OUTLIER 30.2 39.72 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.3 2.24 . . . . 0.0 114.323 178.708 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 62.9 tp 158.13 -57.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 128.261 2.624 . . . . 0.0 106.177 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 152.0 -152.43 24.17 Favored Glycine 0 C--N 1.346 1.127 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.573 -177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -58.96 96.19 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.727 0.811 . . . . 0.0 110.227 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.4 m -143.54 123.79 13.78 Favored 'General case' 0 C--O 1.256 1.418 0 CA-C-N 118.471 0.578 . . . . 0.0 111.171 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 0.7 OUTLIER -92.53 119.61 32.17 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 166.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.576 HD12 HG22 ' A' ' 86' ' ' ILE . 1.9 pp -124.84 -42.06 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.134 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.568 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -115.79 -163.9 13.88 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.761 -1.209 . . . . 0.0 115.01 -156.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -125.17 122.33 36.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 122.912 0.485 . . . . 0.0 110.101 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -99.97 174.87 26.95 Favored Glycine 0 C--N 1.348 1.221 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 171.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 14' ' ' VAL . 54.9 t -137.24 135.25 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.529 ' HB2' ' CD2' ' A' ' 107' ' ' PHE . 34.9 t80 -151.27 122.57 7.8 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 5.9 mtmp? -135.92 136.46 40.48 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 61.95 -81.67 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.948 1.405 . . . . 0.0 111.989 170.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.05 28.98 1.12 Allowed Glycine 0 C--N 1.345 1.06 0 CA-C-O 120.188 -0.229 . . . . 0.0 112.666 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.4 t -144.47 125.27 14.24 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.386 0.674 . . . . 0.0 110.139 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.721 ' HB3' ' HB2' ' A' ' 140' ' ' TYR . 5.7 t80 -97.91 121.22 39.56 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 173.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -110.14 108.25 18.35 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.069 0.948 . . . . 0.0 109.41 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.608 HG23 ' HB ' ' A' ' 138' ' ' ILE . 10.1 t -136.46 -156.37 0.7 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.366 0.666 . . . . 0.0 110.261 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.515 ' SD ' ' CE1' ' A' ' 112' ' ' HIS . 31.6 ttm -149.37 152.44 35.79 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -154.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 -43.25 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.438 1.095 . . . . 0.0 113.019 -176.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 4.3 p-80 -64.86 -22.44 66.99 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 118.144 0.429 . . . . 0.0 111.31 -175.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.0 m -78.72 -44.23 25.51 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.513 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.184 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.699 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 96.8 m -148.89 147.61 28.88 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 119.242 0.928 . . . . 0.0 109.214 166.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -71.52 32.73 0.05 Allowed 'General case' 0 CA--C 1.568 1.656 0 C-N-CA 126.275 1.83 . . . . 0.0 115.857 -168.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.446 ' HA2' HD13 ' A' ' 138' ' ' ILE . . . 87.41 45.77 5.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-N 118.68 0.673 . . . . 0.0 113.264 171.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.642 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -97.46 -169.73 1.89 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.115 0.566 . . . . 0.0 112.296 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 127' ' ' GLU . 8.9 p -100.45 139.75 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 C-N-CA 124.642 1.177 . . . . 0.0 111.986 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' HG ' ' CZ ' ' A' ' 140' ' ' TYR . 16.0 mt -85.27 171.4 11.95 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 118.078 0.399 . . . . 0.0 111.271 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.73 ' SD ' ' HA ' ' A' ' 5' ' ' ASP . 21.9 ptp -178.5 177.3 0.94 Allowed 'General case' 0 C--O 1.283 2.845 0 CA-C-O 122.17 0.986 . . . . 0.0 112.37 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.532 ' CE1' ' HB3' ' A' ' 66' ' ' TRP . 0.7 OUTLIER -166.33 120.87 1.14 Allowed 'General case' 0 C--N 1.365 1.26 0 CA-C-N 113.384 -1.735 . . . . 0.0 114.173 167.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.508 ' HD2' ' HB ' ' A' ' 64' ' ' VAL . 19.1 mtpp 48.48 40.62 15.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 124.82 1.325 . . . . 0.0 113.34 158.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.28 19.25 14.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 115.905 -0.589 . . . . 0.0 113.742 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 120' ' ' MET . 13.0 tppt? -137.11 158.83 43.56 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.353 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -143.58 124.95 14.68 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 119.859 1.209 . . . . 0.0 112.795 -176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.462 HD12 HD21 ' A' ' 8' ' ' LEU . 60.3 mt -103.74 118.09 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.264 1.425 . . . . 0.0 109.592 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HA ' HG23 ' A' ' 118' ' ' VAL . 33.8 mt-10 -87.92 138.42 31.13 Favored Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 123.642 0.777 . . . . 0.0 112.096 -171.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 73.9 Cg_endo -71.86 156.37 56.75 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.312 2.674 . . . . 0.0 113.69 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.2 p -124.06 -20.68 5.26 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.554 0.742 . . . . 0.0 110.975 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 139' ' ' SER . 17.5 t-105 -148.77 146.02 27.86 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.544 0.737 . . . . 0.0 110.076 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.49 125.75 8.0 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.205 1.402 . . . . 0.0 108.573 167.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -138.47 128.21 25.08 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 118.506 0.593 . . . . 0.0 111.114 -178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.34 -32.18 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 C-N-CA 123.913 0.885 . . . . 0.0 111.341 -175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 134' ' ' LYS . 3.4 mptp? -73.37 -38.1 65.81 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.065 0.946 . . . . 0.0 110.051 -171.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -85.51 -17.07 37.47 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.727 0.811 . . . . 0.0 109.461 173.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.2 t70 59.53 36.39 22.88 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 125.025 1.33 . . . . 0.0 109.482 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 1.5 mp -137.84 140.67 40.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.671 0.748 . . . . 0.0 110.563 -169.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 109' ' ' THR . 73.1 mt -124.09 148.03 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.765 1.626 . . . . 0.0 108.251 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.475 ' HB3' ' HB3' ' A' ' 130' ' ' TRP . 32.9 t -141.91 143.7 33.42 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-O 121.256 0.55 . . . . 0.0 111.265 -177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.721 ' HB2' ' HB3' ' A' ' 107' ' ' PHE . 3.5 m-85 -119.88 146.26 45.93 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.888 -1.051 . . . . 0.0 108.998 176.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 95.93 -23.08 35.97 Favored Glycine 0 N--CA 1.473 1.138 0 O-C-N 123.499 0.499 . . . . 0.0 112.2 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 159.3 -161.39 32.05 Favored Glycine 0 C--O 1.242 0.613 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.9 132.7 11.35 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 166.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.695 ' NE1' ' HA ' ' A' ' 229' ' ' THR . 4.9 p90 -75.7 107.68 8.03 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.193 0.997 . . . . 0.0 111.169 -169.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -116.33 116.37 27.61 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.525 ' HB2' HG21 ' A' ' 229' ' ' THR . 5.7 mp -131.62 -66.51 0.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 172.11 -41.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.708 0.803 . . . . 0.0 109.407 -175.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 207' ' ' VAL . . . -47.31 109.64 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 118.065 1.986 . . . . 0.0 118.065 -162.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -142.59 94.23 2.62 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.574 ' HE3' HD13 ' A' ' 200' ' ' ILE . 7.8 t90 -56.75 109.91 0.71 Allowed 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 172.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -87.25 123.64 32.47 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.407 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -52.82 135.86 35.06 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.984 0.914 . . . . 0.0 111.663 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.429 ' H ' ' HG3' ' A' ' 174' ' ' PRO . . . 110.48 -59.22 0.36 Allowed Glycine 0 C--N 1.34 0.766 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -81.0 111.28 17.34 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.622 0.769 . . . . 0.0 110.304 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.46 152.39 40.75 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.194 0.598 . . . . 0.0 111.736 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.782 HG21 HG23 ' A' ' 200' ' ' ILE . 34.6 m -124.8 -169.13 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.532 1.133 . . . . 0.0 109.89 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.683 ' HG2' ' HG3' ' A' ' 171' ' ' GLN . 9.9 mt-30 -126.04 167.12 15.77 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.965 1.306 . . . . 0.0 109.065 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 13.5 p -140.26 148.92 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 122.985 0.514 . . . . 0.0 110.51 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 58.9 mt -97.54 95.21 7.47 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.98 0.809 . . . . 0.0 109.907 170.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 168' ' ' ARG . . . -76.48 99.97 5.1 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 168.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.513 ' HB3' HD21 ' A' ' 50' ' ' LEU . 88.0 mt -86.66 106.02 17.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.544 0.738 . . . . 0.0 109.494 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.27 159.63 29.04 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 123.551 0.74 . . . . 0.0 111.135 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -51.37 113.61 1.2 Allowed 'Trans proline' 0 C--N 1.393 2.892 0 C-N-CA 124.123 3.216 . . . . 0.0 115.165 -176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 65.45 8.81 40.44 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.634 -0.712 . . . . 0.0 114.016 176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -106.2 158.91 16.5 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 123.982 0.913 . . . . 0.0 110.636 -173.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.47 157.62 63.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.539 174.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.55 103.19 0.21 Allowed 'Trans proline' 0 C--N 1.372 1.772 0 C-N-CA 122.544 2.163 . . . . 0.0 111.134 175.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.437 ' HB2' ' HB3' ' A' ' 160' ' ' ALA . 80.2 mtp180 -72.99 96.71 2.18 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.02 99.84 7.86 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 21' ' ' GLU . 94.9 t -102.72 122.38 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.362 0.665 . . . . 0.0 109.751 -176.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.683 ' HG3' ' HG2' ' A' ' 157' ' ' GLN . 2.1 mp0 -82.15 119.35 23.94 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.0 t -127.67 141.29 51.65 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.142 0.977 . . . . 0.0 111.368 -173.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -98.27 160.14 28.95 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 125.539 1.536 . . . . 0.0 109.481 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.429 ' HG3' ' H ' ' A' ' 153' ' ' GLY . 64.3 Cg_endo -73.52 124.1 9.1 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 121.696 1.597 . . . . 0.0 111.216 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -103.06 -172.79 26.34 Favored Glycine 0 C--N 1.342 0.872 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.291 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.1 133.58 9.9 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.573 ' HD1' ' HB3' ' A' ' 29' ' ' LEU . 29.0 m-85 -121.79 126.5 48.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.818 0.847 . . . . 0.0 109.298 -165.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -73.06 117.92 15.38 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.604 0.716 . . . . 0.0 109.215 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.473 HG23 ' HB ' ' A' ' 33' ' ' ILE . 91.0 m -120.65 147.82 44.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.927 1.291 . . . . 0.0 109.479 -170.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -78.98 65.57 4.2 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 178.46 -43.16 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.832 1.653 . . . . 0.0 108.214 -170.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 178.28 -127.33 1.15 Allowed Glycine 0 C--N 1.349 1.285 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.131 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 m -144.18 128.58 17.93 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.647 0.779 . . . . 0.0 109.026 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 77.2 mt -104.1 122.88 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.877 0.871 . . . . 0.0 109.245 -175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.31 106.61 3.17 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 -175.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -159.32 178.55 9.84 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.971 0.909 . . . . 0.0 109.975 -170.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.05 131.83 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -170.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 20.3 p -111.0 89.67 3.11 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 124.168 0.987 . . . . 0.0 109.385 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.518 ' HB3' ' O ' ' A' ' 222' ' ' TYR . 3.4 tm? -106.78 124.81 50.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.541 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 30.5 t70 -125.49 105.18 8.86 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 108.678 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -163.86 -173.5 3.25 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 125.075 1.35 . . . . 0.0 109.043 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 77.6 p -51.9 149.41 9.02 Favored Pre-proline 0 CA--C 1.556 1.185 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.759 159.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.416 ' HB2' ' NH1' ' B' ' 255' ' ' M9P . 9.4 Cg_endo -47.71 114.42 1.07 Allowed 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 123.139 2.56 . . . . 0.0 112.834 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . 0.57 ' H ' ' HB2' ' A' ' 222' ' ' TYR . . . -72.67 163.02 54.82 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.898 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -85.9 120.72 27.61 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 122.979 0.512 . . . . 0.0 110.025 -172.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 15.0 m -59.88 115.1 3.16 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.639 0.776 . . . . 0.0 110.343 173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 96.93 17.18 33.36 Favored Glycine 0 C--N 1.341 0.836 0 O-C-N 124.107 0.879 . . . . 0.0 112.426 -174.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . 0.414 ' HB3' HG22 ' A' ' 158' ' ' VAL . 56.5 m -64.61 127.65 92.63 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 117.113 0.457 . . . . 0.0 111.059 172.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -80.79 138.45 11.78 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.085 2.524 . . . . 0.0 114.483 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.782 HG23 HG21 ' A' ' 156' ' ' VAL . 62.3 mt -85.25 99.72 7.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 125.039 1.336 . . . . 0.0 109.121 176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.585 HG21 HG12 ' A' ' 14' ' ' VAL . 20.8 pt -124.25 156.6 31.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.058 0 CA-C-O 121.368 0.604 . . . . 0.0 111.895 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.546 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 15.5 t70 -90.84 176.01 6.79 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.643 1.177 . . . . 0.0 108.975 174.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.441 ' HA ' HE22 ' A' ' 157' ' ' GLN . 38.0 mtpt -56.61 -27.19 57.67 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.695 1.198 . . . . 0.0 112.681 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -95.54 -6.58 40.12 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.68 0.792 . . . . 0.0 111.941 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 85.81 46.64 5.34 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 -175.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 57.9 tttm -115.25 162.49 17.01 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.278 1.431 . . . . 0.0 108.932 -174.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.583 ' O ' ' HA3' ' A' ' 148' ' ' GLY . 59.4 t 79.99 -58.51 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 C-N-CA 125.191 1.396 . . . . 0.0 110.731 -175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 146' ' ' LEU . 10.9 m 57.09 26.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 124.278 1.031 . . . . 0.0 112.521 167.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -72.18 -153.96 1.97 Allowed Glycine 0 C--N 1.361 1.969 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.7 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 56.0 mt -150.04 155.85 40.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 117.969 0.884 . . . . 0.0 111.27 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -82.12 104.12 12.23 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 165.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -83.75 -137.12 3.2 Favored Glycine 0 N--CA 1.476 1.361 0 C-N-CA 123.469 0.557 . . . . 0.0 114.202 -169.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -71.22 103.64 2.86 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.746 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -141.27 -136.69 3.32 Favored Glycine 0 CA--C 1.505 -0.588 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.407 172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.7 p -165.95 156.61 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.825 0 CA-C-O 121.121 0.486 . . . . 0.0 111.15 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.405 HG22 ' CD1' ' A' ' 222' ' ' TYR . 22.2 t -84.61 110.26 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 173.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.447 HG21 HD21 ' A' ' 29' ' ' LEU . 95.0 m -85.97 148.24 25.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.283 1.033 . . . . 0.0 109.407 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 49.52 30.38 3.44 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 125.476 1.51 . . . . 0.0 112.846 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 93.4 p 56.45 27.45 12.18 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 126.289 1.836 . . . . 0.0 112.733 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -162.34 -53.83 0.02 OUTLIER Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.125 -0.489 . . . . 0.0 113.202 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -68.36 95.18 0.59 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.119 0.567 . . . . 0.0 110.478 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.57 ' HB2' ' H ' ' A' ' 194' ' ' GLY . 30.9 t80 -74.41 98.62 3.32 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -173.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.524 HG11 HD11 ' A' ' 31' ' ' ILE . 78.0 t -98.78 146.02 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.746 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 23.1 t -159.21 158.93 33.61 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -73.43 142.12 46.9 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.572 167.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 70.8 mt -73.28 102.5 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.62 0.768 . . . . 0.0 109.786 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -91.03 143.29 26.86 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 122.788 0.435 . . . . 0.0 110.037 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -137.58 172.43 12.98 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.411 1.084 . . . . 0.0 111.44 -167.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.695 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 65.8 p -74.2 133.17 42.71 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 123.255 0.622 . . . . 0.0 111.668 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -61.34 -29.31 69.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.762 0.825 . . . . 0.0 110.588 -178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 63.5 tttp 60.65 35.04 19.96 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 122.372 1.082 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 11.6 p -71.7 100.36 2.31 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.355 -1.293 . . . . 0.0 110.649 -174.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.567 HG23 ' HG3' ' A' ' 238' ' ' GLU . 7.6 tp -137.82 10.25 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 C-N-CA 124.101 0.96 . . . . 0.0 110.392 -172.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -60.77 -26.14 67.03 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.617 0.767 . . . . 0.0 113.009 -172.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.3 -33.23 75.36 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.102 0.561 . . . . 0.0 111.751 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.443 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.8 OUTLIER -108.52 159.61 30.18 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.244 1.017 . . . . 0.0 108.877 178.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -56.31 131.32 45.05 Favored 'Trans proline' 0 C--N 1.369 1.646 0 C-N-CA 121.443 1.429 . . . . 0.0 110.688 165.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . 0.567 ' HG3' HG23 ' A' ' 233' ' ' ILE . 1.9 mp0 -68.51 79.96 0.27 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.796 0.838 . . . . 0.0 111.527 -172.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 50.8 mt -121.15 82.64 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.549 0.931 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.414 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.699 ' H2 ' ' HB ' ' A' ' 114' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.81 ' HD2' HG12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.801 ' HD2' HG12 ' A' ' 91' ' ' ILE . 8.3 tmtt? -147.23 138.18 23.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 108.718 172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.451 ' H ' ' HD3' ' B' ' 253' ' ' LYS . 16.5 tpt180 97.37 111.8 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 127.726 2.41 . . . . 0.0 107.9 -163.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . 0.416 ' NH1' ' HB2' ' A' ' 193' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 CA-C-O 119.981 -0.344 . . . . 0.0 112.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m 65.88 22.18 11.38 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.811 1.244 . . . . 0.0 113.229 172.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.421 ' HB2' ' NH2' ' A' ' 115' ' ' ARG . . . -167.55 16.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -165.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -161.56 -24.47 0.05 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 123.212 0.605 . . . . 0.0 111.367 176.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.416 ' N ' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -87.82 36.59 0.77 Allowed 'General case' 0 C--O 1.249 1.044 0 C-N-CA 126.713 2.005 . . . . 0.0 110.579 -159.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.703 ' HG ' ' HG3' ' A' ' 88' ' ' GLN . 4.3 mp -118.84 103.46 9.65 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.09 0.956 . . . . 0.0 109.737 -165.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.498 ' O ' HD12 ' A' ' 65' ' ' LEU . 62.2 tt0 -109.13 153.02 24.31 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.188 0.811 . . . . 0.0 113.188 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.556 ' HB2' HG22 ' A' ' 68' ' ' VAL . 3.7 mp -91.8 148.95 21.85 Favored 'General case' 0 N--CA 1.515 2.791 0 CA-C-N 114.419 -1.264 . . . . 0.0 113.532 175.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.852 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 25.2 tt0 -140.63 133.5 29.08 Favored 'General case' 0 N--CA 1.524 3.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.264 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.2 ttm180 -73.88 127.27 32.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.221 0.919 . . . . 0.0 111.857 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -96.56 -42.38 8.09 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.038 0.935 . . . . 0.0 109.569 174.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.53 -162.53 0.19 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.147 1.379 . . . . 0.0 108.927 -172.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -107.16 158.45 17.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.467 0.707 . . . . 0.0 109.814 170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 103' ' ' LYS . 2.3 t -74.78 97.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.023 0 N-CA-C 105.064 -2.198 . . . . 0.0 105.064 169.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 47.9 tptt -168.39 151.74 5.63 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -164.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.605 ' HE1' HE22 ' A' ' 157' ' ' GLN . 28.8 t90 -71.87 137.49 47.52 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 172.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.503 ' HB3' ' H ' ' A' ' 169' ' ' ALA . 11.2 tp10 -106.77 133.77 50.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.095 0.958 . . . . 0.0 109.512 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.7 -8.21 52.73 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.789 0.836 . . . . 0.0 113.076 -175.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 17' ' ' GLU . 1.4 mp0 -84.69 50.78 1.97 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.651 0.78 . . . . 0.0 109.815 176.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.54 118.83 23.07 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.42 -174.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -132.48 138.41 47.57 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.636 0.774 . . . . 0.0 109.4 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.47 126.69 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -145.06 -41.8 0.23 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.294 0.638 . . . . 0.0 109.851 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' A' ' 189' ' ' LEU . . . -66.56 97.35 0.33 Allowed Glycine 0 C--N 1.356 1.66 0 O-C-N 123.455 0.472 . . . . 0.0 113.807 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 p -171.92 90.45 0.12 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.599 1.16 . . . . 0.0 109.055 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.7 m -115.13 151.53 45.79 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.394 0.677 . . . . 0.0 109.767 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -74.23 -163.71 0.19 Allowed 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.95 2.433 . . . . 0.0 113.055 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.5 mm -61.57 110.83 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 174.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.2 tp -101.83 143.04 32.23 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.04 0.448 . . . . 0.0 111.499 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.0 p -91.61 112.24 24.08 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.258 0.623 . . . . 0.0 109.722 172.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.8 mt -118.27 157.48 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 124.705 1.202 . . . . 0.0 108.139 172.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.46 HG21 ' HE3' ' A' ' 42' ' ' LYS . 53.6 p -93.97 107.42 19.33 Favored 'General case' 0 C--N 1.362 1.147 0 CA-C-N 118.954 0.797 . . . . 0.0 109.353 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.518 HG13 ' HB3' ' A' ' 39' ' ' MET . 1.8 mp -83.13 123.68 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.783 0.833 . . . . 0.0 109.138 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -102.95 138.67 39.52 Favored 'General case' 0 C--O 1.264 1.819 0 C-N-CA 123.896 0.878 . . . . 0.0 112.479 -172.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 55.69 -86.59 0.02 OUTLIER 'General case' 0 C--N 1.356 0.871 0 CA-C-N 112.989 -1.914 . . . . 0.0 113.056 168.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -156.56 100.8 1.97 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.66 -0.83 87.62 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 118.933 -0.926 . . . . 0.0 114.172 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.9 m -95.61 160.46 14.49 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 118.835 1.318 . . . . 0.0 108.527 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.518 ' HB3' HG13 ' A' ' 33' ' ' ILE . 2.8 ppp? -160.42 144.32 13.95 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.903 0.481 . . . . 0.0 110.203 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.5 p -165.73 174.33 9.82 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.462 0.705 . . . . 0.0 110.265 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 217' ' ' THR . 10.3 tp -104.89 155.87 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.46 ' HE3' HG21 ' A' ' 32' ' ' THR . 99.6 mttt -81.57 123.34 28.58 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 169.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.3 m120 71.99 114.45 0.05 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 125.668 1.587 . . . . 0.0 110.451 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -161.12 93.22 0.95 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.677 0.791 . . . . 0.0 110.847 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -99.29 -77.33 0.52 Allowed 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 63.84 120.47 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.858 1.663 . . . . 0.0 113.121 174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -155.38 177.71 11.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.166 0.586 . . . . 0.0 111.403 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.545 HE21 ' HA ' ' A' ' 48' ' ' GLN . 0.0 OUTLIER 55.48 -137.76 1.11 Allowed 'General case' 0 C--N 1.363 1.19 0 C-N-CA 124.959 1.304 . . . . 0.0 110.745 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 163' ' ' PRO . 49.1 p 55.41 41.69 30.76 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 124.92 1.288 . . . . 0.0 113.164 169.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -169.43 118.72 0.65 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 126.056 1.743 . . . . 0.0 107.682 170.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.65 -72.15 1.04 Allowed Glycine 0 CA--C 1.539 1.545 0 O-C-N 123.807 0.692 . . . . 0.0 112.957 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -178.69 -96.64 0.1 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 154.85 -62.18 0.36 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.61 57.23 0.03 OUTLIER Glycine 0 C--N 1.34 0.78 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.6 t -71.32 100.35 2.13 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 123.784 0.833 . . . . 0.0 109.729 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 167.83 117.28 0.4 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.45 85.44 0.34 Allowed Glycine 0 C--N 1.352 1.433 0 CA-C-N 117.086 0.443 . . . . 0.0 112.097 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.64 170.72 38.98 Favored Glycine 0 C--N 1.343 0.963 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 -172.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 121.38 -167.35 14.23 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 122.545 0.117 . . . . 0.0 112.949 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.52 35.75 2.21 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.765 0.826 . . . . 0.0 111.018 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -72.57 9.0 1.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 123.099 0.56 . . . . 0.0 112.149 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.84 -22.2 61.93 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.922 1.289 . . . . 0.0 111.148 160.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.65 119.9 12.44 Favored Glycine 0 C--N 1.36 1.88 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 163.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 7' ' ' GLU . 4.5 t -87.21 -86.82 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -161.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.852 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 88.6 mt -143.11 -155.15 0.57 Allowed 'General case' 0 C--O 1.201 -1.469 0 C-N-CA 124.35 1.06 . . . . 0.0 109.854 -170.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 6.0 m0 -166.98 87.47 0.3 Allowed 'General case' 0 N--CA 1.507 2.379 0 C-N-CA 124.036 0.934 . . . . 0.0 112.881 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 66' ' ' TRP . 5.6 t0 174.65 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 124.757 1.223 . . . . 0.0 109.729 159.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.556 HG22 ' HB2' ' A' ' 8' ' ' LEU . 74.5 t -133.87 150.99 76.07 Favored Pre-proline 0 N--CA 1.506 2.342 0 CA-C-O 118.406 -0.807 . . . . 0.0 112.295 -168.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -60.26 80.52 0.07 OUTLIER 'Trans proline' 0 C--N 1.405 3.535 0 C-N-CA 123.32 2.68 . . . . 0.0 112.579 172.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.3 t -130.45 85.73 55.5 Favored Pre-proline 0 N--CA 1.449 -0.521 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 73.0 Cg_endo -92.1 105.27 0.22 Allowed 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.495 2.13 . . . . 0.0 114.197 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -88.66 -177.69 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.984 2.456 . . . . 0.0 110.393 165.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -84.44 19.19 1.42 Allowed 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 121.857 1.704 . . . . 0.0 112.694 166.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.5 t -123.17 137.69 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 124.283 1.033 . . . . 0.0 110.377 -170.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.14 57.53 13.33 Favored Glycine 0 C--N 1.359 1.818 0 O-C-N 123.686 0.616 . . . . 0.0 113.522 173.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 61.83 15.18 6.86 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 124.946 1.298 . . . . 0.0 112.444 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 68.83 0.38 2.69 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.322 1.449 . . . . 0.0 112.938 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 55.14 -75.96 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.143 0.977 . . . . 0.0 110.631 -168.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 80.33 -48.99 0.33 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 127.008 2.123 . . . . 0.0 110.374 174.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 77.78 133.88 0.06 Allowed 'General case' 0 C--N 1.362 1.144 0 C-N-CA 125.579 1.551 . . . . 0.0 109.122 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -168.45 114.98 0.66 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 152.51 -155.81 26.35 Favored Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 170.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.19 129.82 50.22 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.994 1.318 . . . . 0.0 109.066 177.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 12.6 m-85 -123.92 146.69 48.28 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -162.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.662 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 30.4 mtt85 -86.8 126.92 34.94 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 106.39 -1.708 . . . . 0.0 106.39 161.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.647 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 9.2 pt -126.88 134.45 66.18 Favored 'Isoleucine or valine' 0 C--O 1.267 2.016 0 O-C-N 122.032 -0.417 . . . . 0.0 110.971 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.814 ' HB2' ' HB3' ' A' ' 96' ' ' GLN . 80.7 tttt -125.66 142.82 51.32 Favored 'General case' 0 C--N 1.387 2.2 0 C-N-CA 125.681 1.592 . . . . 0.0 111.795 -169.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.703 ' HG3' ' HG ' ' A' ' 6' ' ' LEU . 48.1 tt0 -121.88 152.71 39.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.588 167.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.8 pttm -105.0 90.9 3.59 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-O 123.05 1.405 . . . . 0.0 107.883 155.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.8 172.59 43.78 Favored Glycine 0 C--O 1.24 0.482 0 CA-C-N 114.721 -1.127 . . . . 0.0 112.292 -176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.606 ' HB ' ' HG2' ' B' ' 253' ' ' LYS . 48.0 mt 60.91 -81.52 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 125.097 1.359 . . . . 0.0 111.021 166.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.489 ' HB3' ' HD2' ' B' ' 253' ' ' LYS . 50.6 tp -93.69 -46.12 7.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.3 1.04 . . . . 0.0 110.535 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 174.46 -150.08 11.16 Favored Glycine 0 C--N 1.353 1.517 0 CA-C-N 116.386 -0.37 . . . . 0.0 113.513 -173.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -104.41 88.11 2.88 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.621 1.168 . . . . 0.0 107.899 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.9 t -141.55 132.93 26.68 Favored 'General case' 0 C--O 1.257 1.48 0 CA-C-N 118.514 0.597 . . . . 0.0 112.521 -170.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.814 ' HB3' ' HB2' ' A' ' 87' ' ' LYS . 2.2 pt20 -94.09 114.87 27.11 Favored 'General case' 0 C--N 1.366 1.291 0 C-N-CA 125.36 1.464 . . . . 0.0 109.077 168.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 98' ' ' GLY . 2.7 pp -133.67 -35.66 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.13 -166.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -99.78 168.95 21.78 Favored Glycine 0 N--CA 1.48 1.625 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.249 -162.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.543 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -110.15 123.21 49.32 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 172.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.44 129.56 9.52 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' A' ' 199' ' ' PRO . 27.8 t -110.83 103.76 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.692 ' HD2' ' HB2' ' A' ' 107' ' ' PHE . 21.2 t80 -116.36 140.11 49.69 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 170.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 79.5 tttt -169.34 152.88 5.05 Favored 'General case' 0 C--O 1.245 0.841 0 O-C-N 123.955 0.785 . . . . 0.0 109.358 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 69.97 -69.58 0.17 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.785 1.634 . . . . 0.0 110.119 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -166.43 10.85 0.07 OUTLIER Glycine 0 C--N 1.343 0.964 0 CA-C-O 119.627 -0.54 . . . . 0.0 113.25 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -133.64 150.13 51.58 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 117.802 0.801 . . . . 0.0 111.371 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.705 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 90.7 t80 -109.96 122.55 47.82 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.543 1.137 . . . . 0.0 108.435 175.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.504 ' HE1' HD22 ' A' ' 137' ' ' LEU . 54.3 t-80 -132.2 111.76 11.69 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -175.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.588 HG21 ' H5 ' ' B' ' 251' ' ' BEZ . 15.1 t -134.69 -165.22 1.63 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.089 1.356 . . . . 0.0 108.388 -170.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.842 ' SD ' ' HA3' ' A' ' 212' ' ' GLY . 31.5 mmt -99.65 162.19 13.16 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.828 1.195 . . . . 0.0 113.722 -173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.402 ' HB2' ' N ' ' A' ' 137' ' ' LEU . 1.5 t90 -86.24 -52.99 5.3 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 110.6 175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.8 p-80 -57.34 -24.33 54.48 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 124.872 1.269 . . . . 0.0 113.09 -170.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 254' ' ' ARG . 22.6 m -62.51 -12.63 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.381 0 C-N-CA 124.432 1.093 . . . . 0.0 113.038 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.83 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -160.72 -157.24 0.52 Allowed 'General case' 0 CA--C 1.563 1.471 0 C-N-CA 124.727 1.211 . . . . 0.0 109.535 -173.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.421 ' NH2' ' HB2' ' A' ' 3' ' ' ALA . 27.8 ptt180 -119.65 14.85 12.71 Favored 'General case' 0 CA--C 1.566 1.578 0 C-N-CA 124.252 1.021 . . . . 0.0 111.021 175.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.83 ' H ' HG23 ' A' ' 114' ' ' THR . . . 94.28 58.54 1.21 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 124.152 0.882 . . . . 0.0 111.437 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -97.6 165.1 12.14 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -169.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.758 HG23 ' HA ' ' A' ' 127' ' ' GLU . 2.2 p -98.58 144.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.326 1.05 . . . . 0.0 109.844 -177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.713 HD22 ' HE2' ' B' ' 252' ' ' NLE . 29.1 mt -103.46 179.22 4.33 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.403 0.681 . . . . 0.0 111.965 -166.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.4 ptp -168.96 178.44 4.51 Favored 'General case' 0 C--O 1.282 2.805 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 13.7 t60 -127.23 95.0 4.15 Favored 'General case' 0 C--N 1.369 1.42 0 CA-C-N 110.214 -3.175 . . . . 0.0 107.946 164.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 35.2 mttt 34.81 64.29 0.42 Allowed 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 125.234 1.414 . . . . 0.0 113.778 174.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.23 -26.42 24.67 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.246 178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -88.33 111.66 21.98 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 117.532 0.666 . . . . 0.0 109.624 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -105.08 130.37 53.29 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.289 -0.257 . . . . 0.0 111.1 -163.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.8 pt -119.53 130.37 74.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.308 1.043 . . . . 0.0 109.772 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.758 ' HA ' HG23 ' A' ' 118' ' ' VAL . 10.6 pt-20 -95.63 139.8 22.06 Favored Pre-proline 0 N--CA 1.479 1.024 0 C-N-CA 123.089 0.556 . . . . 0.0 111.658 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 118' ' ' VAL . 62.4 Cg_endo -71.7 149.38 54.61 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.655 2.236 . . . . 0.0 111.734 175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 9.9 p -85.68 -17.48 35.9 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.704 0.802 . . . . 0.0 111.784 -177.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 49.0 t-105 -163.24 157.85 20.83 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 120.665 0.269 . . . . 0.0 111.231 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -138.12 118.8 14.02 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 124.381 1.072 . . . . 0.0 109.535 170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 135' ' ' LYS . 14.7 m-20 -102.58 110.26 22.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 125.387 1.475 . . . . 0.0 110.857 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 39.7 t -73.08 -48.81 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 122.882 0.473 . . . . 0.0 110.807 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -68.04 -44.58 76.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.095 0.558 . . . . 0.0 111.23 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 132' ' ' ASP . 72.5 mmtt -69.09 -20.86 64.08 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.008 0.523 . . . . 0.0 110.825 177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.6 t0 66.13 59.52 0.68 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 125.045 1.338 . . . . 0.0 110.401 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 3.8 pp -165.21 157.14 15.19 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.76 151.34 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 125.081 1.353 . . . . 0.0 107.958 171.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.9 t -131.3 143.4 50.5 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.0 t80 -135.89 142.57 44.71 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.17 1.388 . . . . 0.0 108.532 -175.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 81.1 -5.98 64.72 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.812 0.695 . . . . 0.0 113.453 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.47 -152.67 23.94 Favored Glycine 0 C--N 1.343 0.923 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.38 -174.13 50.18 Favored Glycine 0 C--O 1.242 0.65 0 CA-C-O 120.97 0.205 . . . . 0.0 112.909 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.401 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 3.1 t90 -54.45 134.21 45.91 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 124.809 1.244 . . . . 0.0 110.297 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HG3' ' HG ' ' A' ' 146' ' ' LEU . 56.7 pttt -109.82 -166.49 1.1 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.335 0.654 . . . . 0.0 111.403 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.61 ' HG ' ' HG3' ' A' ' 145' ' ' LYS . 50.2 mt 70.63 178.45 0.25 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.457 1.503 . . . . 0.0 111.501 174.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -143.09 -39.04 0.33 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.471 0.309 . . . . 0.0 111.587 -161.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.89 169.35 45.64 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 123.095 0.247 . . . . 0.0 113.155 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -151.0 153.13 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.221 0.608 . . . . 0.0 110.093 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.61 ' HA ' HG13 ' A' ' 208' ' ' VAL . 26.3 t90 -58.51 131.33 50.43 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.971 172.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -119.33 105.17 11.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 152.84 32.34 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.748 0.819 . . . . 0.0 111.507 -174.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 83.01 -52.44 4.74 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 -177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.17 138.03 53.79 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.093 0.957 . . . . 0.0 110.425 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 9.6 pt-20 -76.38 141.09 41.59 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.231 0.539 . . . . 0.0 110.516 176.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.0 m -117.11 -177.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 124.307 1.043 . . . . 0.0 108.557 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.605 HE22 ' HE1' ' A' ' 16' ' ' TRP . 49.7 mt-30 -133.63 162.61 31.45 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.582 -0.699 . . . . 0.0 110.09 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 200' ' ' ILE . 7.4 p -137.09 136.67 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.149 0.58 . . . . 0.0 109.867 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.601 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 35.8 mt -69.52 86.94 0.46 Allowed 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 170.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -80.79 105.23 11.87 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 78.0 mt -84.6 176.8 8.36 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.539 ' HB3' ' HD2' ' A' ' 163' ' ' PRO . 49.1 mp0 -28.4 155.58 0.01 OUTLIER Pre-proline 0 N--CA 1.502 2.175 0 C-N-CA 127.861 2.464 . . . . 0.0 114.326 168.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 162' ' ' GLU . 25.6 Cg_exo -1.16 137.36 0.0 OUTLIER 'Trans proline' 0 C--N 1.407 3.638 1 C-N-CA 128.162 5.908 . . . . 0.0 118.945 -162.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.634 ' HA2' ' HB2' ' A' ' 192' ' ' SER . . . 99.69 -36.72 3.9 Favored Glycine 0 C--O 1.24 0.495 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -163.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -143.56 178.95 7.42 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.363 1.465 . . . . 0.0 108.42 164.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 168' ' ' ARG . 12.3 m120 -98.35 133.74 22.57 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.045 -0.978 . . . . 0.0 108.838 167.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.52 ' HD3' ' HA ' ' A' ' 162' ' ' GLU . 25.6 Cg_endo -59.47 93.1 0.08 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.965 3.11 . . . . 0.0 113.378 -175.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 166' ' ' ASN . 39.2 ptt180 -160.68 165.16 31.01 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.943 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.503 ' H ' ' HB3' ' A' ' 17' ' ' GLU . . . -88.58 102.85 15.34 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.5 t -86.07 133.93 28.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 123.973 0.909 . . . . 0.0 109.591 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.513 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 49.1 mt-30 -79.73 139.02 37.46 Favored 'General case' 0 C--O 1.243 0.712 0 C-N-CA 123.916 0.886 . . . . 0.0 109.37 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.8 t -150.28 130.06 13.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.902 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 155' ' ' GLU . 59.7 mttp -90.71 155.07 45.89 Favored Pre-proline 0 C--O 1.243 0.713 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.046 173.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -61.57 121.26 9.3 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 121.373 1.382 . . . . 0.0 111.616 176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -98.12 -170.71 32.28 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 171.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -166.1 144.27 5.64 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 117.345 0.573 . . . . 0.0 110.331 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.48 ' CE2' HD13 ' A' ' 184' ' ' ILE . 43.4 p90 -123.47 135.01 53.85 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.903 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -70.74 163.74 26.56 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.882 1.273 . . . . 0.0 111.99 -173.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 181' ' ' ALA . 27.4 m -139.12 165.6 26.73 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.889 1.676 . . . . 0.0 108.173 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -52.91 -41.53 64.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.973 0.909 . . . . 0.0 110.213 167.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.451 ' H ' HG22 ' A' ' 179' ' ' THR . . . -76.39 -74.41 0.23 Allowed 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.863 176.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -141.17 -107.02 0.65 Allowed Glycine 0 C--N 1.353 1.515 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.702 -174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 14.4 t -162.8 147.16 11.57 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.06 0.944 . . . . 0.0 109.967 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.48 HD13 ' CE2' ' A' ' 177' ' ' PHE . 4.3 mp -108.45 151.38 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -99.72 139.3 14.35 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.41 144.22 19.44 Favored 'General case' 0 C--N 1.35 0.597 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -164.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.9 p -68.05 113.08 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 165.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.3 m -116.86 91.18 3.51 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -173.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 222' ' ' TYR . 62.4 tp -104.62 105.02 14.94 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.522 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -78.37 111.45 14.38 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.329 0.651 . . . . 0.0 110.121 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -164.35 -174.3 3.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.126 1.37 . . . . 0.0 109.029 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.634 ' HB2' ' HA2' ' A' ' 164' ' ' GLY . 7.4 m -61.69 175.1 0.55 Allowed Pre-proline 0 CA--C 1.587 2.388 0 C-N-CA 124.787 1.235 . . . . 0.0 111.165 169.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 192' ' ' SER . 31.3 Cg_exo -24.57 123.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.407 3.633 1 C-N-CA 125.968 4.446 . . . . 0.0 116.925 177.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -68.46 131.55 26.93 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.006 177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 43.1 m -81.5 97.12 7.65 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.912 0.485 . . . . 0.0 109.993 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 211' ' ' TYR . 73.3 m -66.45 98.27 0.48 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -166.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 131.57 -5.05 5.52 Favored Glycine 0 C--N 1.358 1.797 0 CA-C-N 114.748 -1.114 . . . . 0.0 112.631 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.9 m -47.43 124.48 9.29 Favored Pre-proline 0 N--CA 1.496 1.862 0 C-N-CA 124.275 1.03 . . . . 0.0 113.631 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.601 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 4.0 Cg_exo -72.4 121.23 7.29 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 122.738 2.292 . . . . 0.0 112.464 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 51.5 mt -84.2 110.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.46 162.96 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.713 0.805 . . . . 0.0 109.848 -171.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -103.04 167.48 9.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.538 0.735 . . . . 0.0 110.246 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -58.18 -40.6 81.91 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.565 1.546 . . . . 0.0 111.154 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -73.58 -20.84 60.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.53 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 111.77 -4.73 27.58 Favored Glycine 0 C--N 1.349 1.291 0 CA-C-O 119.456 -0.636 . . . . 0.0 113.839 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -73.65 128.69 36.19 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.78 0.79 . . . . 0.0 110.183 175.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 146' ' ' LEU . 57.9 t -73.44 109.94 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 150' ' ' TRP . 55.1 t -64.37 -30.19 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.798 1.239 . . . . 0.0 110.576 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 158.87 -154.14 25.24 Favored Glycine 0 N--CA 1.44 -1.057 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.058 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.471 HD22 HG21 ' A' ' 101' ' ' VAL . 75.8 mt -134.75 162.33 32.67 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 123.641 0.777 . . . . 0.0 109.596 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.8 OUTLIER -77.05 112.47 13.73 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 165.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.842 ' HA3' ' SD ' ' A' ' 110' ' ' MET . . . -174.26 67.31 0.1 Allowed Glycine 0 CA--C 1.496 -1.13 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 163.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.533 ' HB3' ' H ' ' A' ' 225' ' ' ALA . 11.0 t-20 -160.54 176.97 11.0 Favored 'General case' 0 C--O 1.245 0.85 0 N-CA-C 105.477 -2.046 . . . . 0.0 105.477 162.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.479 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . 61.62 -144.78 48.94 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 114.3 0.48 . . . . 0.0 114.3 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.437 HG22 ' N ' ' A' ' 216' ' ' VAL . 13.6 p -177.63 175.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 C-N-CA 124.372 1.069 . . . . 0.0 108.863 -171.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.437 ' N ' HG22 ' A' ' 215' ' ' VAL . 34.5 m -70.58 149.59 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 163.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.439 HG22 HD13 ' A' ' 41' ' ' ILE . 45.1 p -136.14 -165.14 1.66 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -32.4 108.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.201 1.4 . . . . 0.0 113.357 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 14.0 t 77.3 28.08 0.63 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.652 1.581 . . . . 0.0 111.907 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 78.57 15.84 80.22 Favored Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.793 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.61 116.53 6.3 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.497 0.719 . . . . 0.0 111.818 -171.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 189' ' ' LEU . 5.7 t80 -64.88 116.61 6.53 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.67 0.788 . . . . 0.0 109.388 178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 84.6 t -134.16 115.62 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 15.3 m -137.09 141.98 42.36 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.898 0.879 . . . . 0.0 109.25 -175.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.533 ' H ' ' HB3' ' A' ' 213' ' ' ASN . . . -81.56 16.58 1.67 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 118.779 0.718 . . . . 0.0 112.49 -172.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.9 mt 58.57 98.42 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.93 0 C-N-CA 125.723 1.609 . . . . 0.0 111.462 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.33 130.03 40.89 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 173.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -108.8 125.86 52.41 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.411 HG21 HD12 ' A' ' 146' ' ' LEU . 38.5 p -80.72 106.26 12.59 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.035 0.445 . . . . 0.0 110.171 -175.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.9 -19.65 25.56 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.032 0.933 . . . . 0.0 111.456 -172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 23.7 tptm 74.45 147.73 0.09 Allowed 'General case' 0 C--N 1.364 1.222 0 C-N-CA 125.46 1.504 . . . . 0.0 110.525 -172.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 12.4 p -63.54 118.18 7.81 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.15 0.98 . . . . 0.0 111.134 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 14.9 tt -77.39 89.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 CA-C-O 122.367 1.08 . . . . 0.0 109.012 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.11 -15.26 63.61 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.81 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.11 -32.21 63.98 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.59 1.156 . . . . 0.0 113.256 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.429 HD22 ' N ' ' A' ' 236' ' ' ASN . 0.9 OUTLIER -74.75 107.63 4.11 Favored Pre-proline 0 CA--C 1.548 0.902 0 O-C-N 123.661 0.601 . . . . 0.0 109.941 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -98.49 134.06 0.29 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.57 2.847 . . . . 0.0 112.462 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.09 -52.43 62.69 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.896 0.478 . . . . 0.0 109.988 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 16.8 tt -172.76 -46.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.349 1.059 . . . . 0.0 110.513 176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 123.196 0.599 . . . . 0.0 110.046 -177.81 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.647 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.713 ' HE2' HD22 ' A' ' 119' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.606 ' HG2' ' HB ' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -141.58 -27.54 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 173.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.479 ' HB3' ' HA ' ' A' ' 113' ' ' VAL . 31.7 ttm180 -106.79 145.42 32.12 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 118.678 0.672 . . . . 0.0 109.84 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 CA-C-O 119.194 -0.781 . . . . 0.0 113.442 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t 68.8 177.08 0.26 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.625 1.17 . . . . 0.0 111.87 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.466 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . 61.0 9.92 2.57 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 125.46 1.504 . . . . 0.0 114.863 177.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.53 16.43 0.2 Allowed 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 118.916 0.78 . . . . 0.0 112.122 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -151.72 44.48 0.76 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.176 0.988 . . . . 0.0 109.321 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.556 ' N ' ' SD ' ' A' ' 120' ' ' MET . 26.7 mt -86.73 95.03 9.67 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 113.414 -1.721 . . . . 0.0 109.891 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' HG2' ' HG2' ' A' ' 120' ' ' MET . 25.6 mt-10 -111.19 129.39 55.97 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.631 0.772 . . . . 0.0 111.982 -166.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.738 ' HB2' HG22 ' A' ' 68' ' ' VAL . 4.3 mp -101.43 146.98 26.89 Favored 'General case' 0 N--CA 1.513 2.68 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -169.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.549 ' HB2' HD22 ' A' ' 65' ' ' LEU . 14.1 tt0 -130.46 158.46 39.83 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 126.014 1.726 . . . . 0.0 109.153 177.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.412 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 6.3 ppt_? -90.61 148.49 22.63 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 122.95 0.5 . . . . 0.0 110.958 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.15 -37.67 3.04 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.036 0.534 . . . . 0.0 110.767 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.99 -155.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.055 1.342 . . . . 0.0 109.53 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -98.25 153.65 18.35 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.5 1.12 . . . . 0.0 109.382 172.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -82.82 91.51 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -170.43 117.44 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.57 1.548 . . . . 0.0 107.484 -174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 21' ' ' GLU . 80.0 t90 -75.88 94.7 3.39 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 174.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -158.9 59.55 0.42 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 122.88 0.472 . . . . 0.0 110.542 163.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.594 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 4.1 t70 -89.72 -65.28 1.03 Allowed 'General case' 0 N--CA 1.479 1.012 0 O-C-N 121.442 -0.787 . . . . 0.0 111.235 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -152.96 -42.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.649 ' H ' ' HB3' ' A' ' 169' ' ' ALA . . . -136.45 -170.38 2.66 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -154.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.744 ' HB2' ' HB2' ' A' ' 171' ' ' GLN . 3.3 pt-20 -166.93 90.74 0.39 Allowed 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.003 1.321 . . . . 0.0 109.408 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.576 ' HB ' HG13 ' A' ' 170' ' ' VAL . 62.9 mt -85.45 103.54 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -55.25 -24.81 29.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.476 1.11 . . . . 0.0 112.202 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 51.33 -94.25 0.01 OUTLIER Glycine 0 C--N 1.365 2.179 0 O-C-N 124.519 1.137 . . . . 0.0 112.462 -176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.444 ' HB2' ' HB3' ' A' ' 173' ' ' LYS . 7.0 t 57.94 75.62 0.37 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.044 1.338 . . . . 0.0 109.564 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.7 m -64.61 147.96 97.21 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.237 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -58.46 168.74 3.65 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.783 2.322 . . . . 0.0 112.094 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 41.1 mm -56.57 109.19 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 123.634 0.774 . . . . 0.0 110.617 -173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.24 159.57 14.9 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.903 0.881 . . . . 0.0 111.733 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.1 p -124.6 127.73 47.82 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 170.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.9 165.45 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.9 m -93.74 108.03 19.83 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.334 -0.854 . . . . 0.0 109.556 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.3 mm -71.0 106.83 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 p -89.61 129.55 36.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.971 0.908 . . . . 0.0 110.048 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 65.38 8.54 5.05 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.72 1.208 . . . . 0.0 112.672 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 64.71 21.45 12.39 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.893 1.277 . . . . 0.0 112.745 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.86 -40.45 0.06 OUTLIER Glycine 0 N--CA 1.478 1.489 0 N-CA-C 111.768 -0.533 . . . . 0.0 111.768 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 41.1 t -90.89 166.67 12.94 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.84 ' SD ' ' HA2' ' A' ' 214' ' ' GLY . 4.5 ppp? -132.72 149.42 52.29 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 173.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.5 p -169.2 157.18 7.49 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.955 0.902 . . . . 0.0 109.414 -174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' H ' HG21 ' A' ' 215' ' ' VAL . 10.3 tp -82.27 148.19 5.48 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 169.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -81.64 70.31 8.5 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.466 0.651 . . . . 0.0 109.978 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.462 HD22 ' HB3' ' A' ' 219' ' ' SER . 51.3 t30 176.18 126.71 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.889 1.675 . . . . 0.0 107.299 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -139.28 118.06 12.36 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -113.77 -174.64 2.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.075 0.95 . . . . 0.0 110.559 -176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -75.9 161.92 28.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.108 0.963 . . . . 0.0 110.709 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -119.24 -149.2 0.43 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.386 1.075 . . . . 0.0 110.139 -167.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 71.38 114.78 0.05 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.774 1.23 . . . . 0.0 113.733 168.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.669 ' HB ' ' HB3' ' A' ' 163' ' ' PRO . 13.9 p -140.44 -67.21 0.43 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.328 1.051 . . . . 0.0 109.13 167.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 65' ' ' LEU . 8.6 tp 84.85 140.26 0.06 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 125.564 1.546 . . . . 0.0 111.998 168.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -78.84 -91.96 0.35 Allowed Glycine 0 C--N 1.343 0.93 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.684 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.43 -35.82 90.67 Favored Glycine 0 CA--C 1.535 1.291 0 O-C-N 123.637 0.257 . . . . 0.0 113.045 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.87 16.58 59.08 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.197 0.427 . . . . 0.0 112.725 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -82.97 53.76 4.9 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.131 0.396 . . . . 0.0 113.018 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.3 p -86.96 -32.41 20.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.067 0.947 . . . . 0.0 110.586 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.23 115.69 0.79 Allowed Glycine 0 C--N 1.35 1.306 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.246 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.02 -46.34 3.27 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 116.725 0.263 . . . . 0.0 113.072 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.31 -42.71 0.27 Allowed Glycine 0 C--N 1.341 0.857 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.87 -125.18 18.97 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.271 -0.465 . . . . 0.0 113.831 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -84.36 55.05 3.2 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.527 0.731 . . . . 0.0 109.91 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 46.03 43.44 10.64 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 125.124 1.37 . . . . 0.0 111.302 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.35 -24.56 67.9 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 114.235 -1.348 . . . . 0.0 111.075 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.02 -89.06 0.19 Allowed Glycine 0 C--N 1.349 1.262 0 O-C-N 124.03 0.831 . . . . 0.0 111.855 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.641 HG13 ' HD3' ' A' ' 87' ' ' LYS . 43.4 t -138.98 -107.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.723 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.706 HD21 HD21 ' A' ' 50' ' ' LEU . 69.4 mt -156.87 134.82 11.03 Favored 'General case' 0 C--O 1.251 1.152 0 C-N-CA 126.364 1.866 . . . . 0.0 106.314 -166.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.523 ' HB2' ' CG ' ' A' ' 121' ' ' HIS . 0.5 OUTLIER -158.75 70.63 0.52 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.155 0.979 . . . . 0.0 113.638 179.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -114.53 70.93 0.74 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 162.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.738 HG22 ' HB2' ' A' ' 8' ' ' LEU . 2.1 t -131.74 132.97 23.64 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-N 114.127 -1.397 . . . . 0.0 109.298 -166.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.88 83.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.261 0 C-N-CA 123.461 2.774 . . . . 0.0 112.511 169.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.411 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 49.8 m -70.06 154.42 94.62 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 124.449 1.1 . . . . 0.0 112.171 -172.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.71 -38.78 91.35 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 123.466 2.777 . . . . 0.0 116.46 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 49.0 Cg_exo -44.01 136.36 7.57 Favored 'Trans proline' 0 C--N 1.408 3.702 0 C-N-CA 123.053 2.502 . . . . 0.0 115.471 178.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.01 144.48 36.71 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.464 2.776 . . . . 0.0 113.638 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.7 t 64.49 66.01 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.34 0 C-N-CA 124.538 1.135 . . . . 0.0 110.012 -174.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -96.3 24.52 29.95 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.121 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -74.18 -27.52 60.85 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.453 0.701 . . . . 0.0 109.877 174.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.71 -1.64 32.21 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 124.19 0.996 . . . . 0.0 111.768 175.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -102.11 6.3 40.84 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.038 0.935 . . . . 0.0 111.096 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.0 tp -110.32 86.53 2.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.834 0.854 . . . . 0.0 110.307 -171.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.71 -45.41 29.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 170.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.4 t70 61.87 94.62 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.82 0 O-C-N 124.619 1.199 . . . . 0.0 110.175 176.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.15 -167.39 34.89 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.398 -172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.76 108.25 9.65 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -95.0 175.98 6.43 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.012 0.925 . . . . 0.0 110.824 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 9' ' ' GLU . 51.1 ttt180 -144.52 143.1 30.67 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.668 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 1.1 pt -138.85 140.44 38.85 Favored 'Isoleucine or valine' 0 C--O 1.269 2.131 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -160.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.641 ' HD3' HG13 ' A' ' 64' ' ' VAL . 26.2 tttm -131.2 136.57 48.39 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.434 1.494 . . . . 0.0 110.83 -172.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.614 ' H ' HD11 ' A' ' 97' ' ' ILE . 3.5 tp60 -115.89 133.48 55.99 Favored 'General case' 0 C--O 1.26 1.642 0 C-N-CA 124.589 1.156 . . . . 0.0 109.39 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -83.74 97.21 9.01 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 163.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.42 -179.16 29.48 Favored Glycine 0 N--CA 1.462 0.374 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.298 -163.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.746 HD11 ' HG2' ' B' ' 253' ' ' LYS . 0.2 OUTLIER -39.79 132.79 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.322 0 C-N-CA 123.941 0.896 . . . . 0.0 111.614 166.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.8 mt 78.0 6.67 2.67 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.815 1.646 . . . . 0.0 111.976 -171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.84 -156.87 20.62 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 122.007 0.782 . . . . 0.0 114.834 173.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -89.94 69.37 7.44 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.285 1.434 . . . . 0.0 107.886 -172.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.0 m -109.99 144.35 38.65 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -159.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.636 HE21 HD13 ' A' ' 50' ' ' LEU . 2.1 tp-100 -74.95 116.47 15.73 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.845 1.341 . . . . 0.0 109.162 163.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.648 HD13 ' C ' ' B' ' 252' ' ' NLE . 0.4 OUTLIER -144.38 9.08 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.813 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -169.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -152.17 170.53 31.48 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.873 171.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -116.4 124.64 50.54 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 171.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -92.7 155.17 22.46 Favored Glycine 0 CA--C 1.503 -0.67 0 O-C-N 123.695 0.622 . . . . 0.0 111.71 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 210' ' ' LEU . 31.7 t -137.56 101.83 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -107.16 107.3 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -141.2 134.96 30.26 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.45 23.01 12.86 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.349 1.059 . . . . 0.0 112.349 177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.81 8.23 76.74 Favored Glycine 0 C--N 1.342 0.914 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.088 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.2 p -127.52 133.06 49.84 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.031 0.532 . . . . 0.0 110.426 -178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.789 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 49.0 t80 -85.44 142.51 29.19 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB3' ' HZ3' ' A' ' 144' ' ' TRP . 94.4 m-70 -137.28 113.28 9.77 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.432 1.093 . . . . 0.0 110.035 -173.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.523 HG23 ' HB ' ' A' ' 138' ' ' ILE . 9.7 t -139.81 -164.64 1.73 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.597 1.159 . . . . 0.0 109.773 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' LEU . 22.2 mtp -121.6 170.47 9.67 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.045 0.938 . . . . 0.0 111.52 -171.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -88.52 -40.44 13.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.257 0.623 . . . . 0.0 112.441 175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.409 ' HE1' ' SD ' ' A' ' 110' ' ' MET . 25.2 p-80 -62.01 -20.76 64.25 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.521 0.676 . . . . 0.0 111.328 -174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.5 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 19.1 m -82.75 -35.1 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.934 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.61 HG22 ' H ' ' A' ' 116' ' ' GLY . 52.8 m -145.03 145.78 31.62 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.141 -1.599 . . . . 0.0 112.158 -178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -59.77 -5.52 0.95 Allowed 'General case' 0 CA--C 1.568 1.641 0 C-N-CA 126.221 1.808 . . . . 0.0 113.541 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.61 ' H ' HG22 ' A' ' 114' ' ' THR . . . 88.45 55.13 2.25 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.72 -175.0 3.11 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.918 0.487 . . . . 0.0 111.919 -168.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.1 138.61 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 C-N-CA 124.405 1.082 . . . . 0.0 112.947 -167.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.646 HD21 ' H4 ' ' B' ' 251' ' ' BEZ . 7.5 mt -102.86 174.77 5.73 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 123.694 0.798 . . . . 0.0 110.935 -171.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.564 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -169.47 174.87 5.73 Favored 'General case' 0 C--O 1.261 1.707 0 CA-C-O 123.74 1.733 . . . . 0.0 115.208 -177.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 68' ' ' VAL . 21.0 t60 -127.59 88.5 2.8 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.645 -175.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.529 ' HG2' ' HB ' ' A' ' 64' ' ' VAL . 93.1 mttt 38.11 46.85 0.88 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 124.013 0.925 . . . . 0.0 111.798 -171.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.6 -26.57 20.92 Favored Glycine 0 C--N 1.355 1.589 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.522 ' HB2' ' HB3' ' A' ' 121' ' ' HIS . 11.9 mptt -73.61 109.68 7.32 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.214 1.507 . . . . 0.0 109.211 175.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.422 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 15.6 ttm180 -93.8 120.23 33.79 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.506 0.722 . . . . 0.0 112.494 -157.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.524 HG13 ' HB2' ' A' ' 119' ' ' LEU . 17.0 pt -111.95 161.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.845 0.858 . . . . 0.0 108.99 171.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.27 135.25 24.33 Favored Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 123.35 0.66 . . . . 0.0 109.725 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.84 163.5 38.24 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.395 2.063 . . . . 0.0 112.404 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 18.0 p -99.78 -30.28 12.15 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.749 0.819 . . . . 0.0 112.182 -177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 138' ' ' ILE . 20.5 t-105 -140.84 147.82 39.57 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.723 0.809 . . . . 0.0 109.875 -172.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -153.61 119.99 5.51 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.343 1.057 . . . . 0.0 109.047 169.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -136.86 114.77 11.36 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.914 0.486 . . . . 0.0 110.902 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.1 p -76.78 -22.19 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 124.788 1.235 . . . . 0.0 111.833 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -64.1 -50.2 69.25 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.471 0.708 . . . . 0.0 110.869 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.3 tptp -94.4 -8.14 39.55 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.868 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 63.88 44.1 5.01 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 125.156 1.382 . . . . 0.0 110.645 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.591 HD22 HD12 ' A' ' 210' ' ' LEU . 77.6 mt -136.53 137.93 40.79 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.399 0.618 . . . . 0.0 111.338 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.523 ' HB ' HG23 ' A' ' 109' ' ' THR . 64.6 mt -120.63 151.96 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.788 1.635 . . . . 0.0 108.009 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.9 p -152.34 160.28 43.34 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.558 0.694 . . . . 0.0 112.014 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.789 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 27.4 t80 -129.09 135.6 49.12 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.446 1.499 . . . . 0.0 107.622 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.9 64.97 Favored Glycine 0 N--CA 1.475 1.282 0 C-N-CA 122.919 0.295 . . . . 0.0 113.152 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.14 -177.3 42.92 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -76.23 -178.21 44.59 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.538 ' HZ3' ' HB3' ' A' ' 108' ' ' HIS . 76.5 t-105 -81.84 105.01 12.62 Favored 'General case' 0 CA--C 1.548 0.895 0 O-C-N 122.441 -0.446 . . . . 0.0 109.894 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -165.7 113.84 0.97 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.583 1.153 . . . . 0.0 107.946 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.536 HD13 HG11 ' A' ' 207' ' ' VAL . 69.5 mt -131.92 -88.71 0.45 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.695 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -172.52 -73.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 118.94 0.791 . . . . 0.0 110.716 -175.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.07 149.73 47.95 Favored Glycine 0 C--N 1.355 1.584 0 O-C-N 123.64 0.588 . . . . 0.0 113.476 -171.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.28 139.77 20.53 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 122.953 0.501 . . . . 0.0 110.009 -171.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -68.89 122.32 18.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.699 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -105.11 116.5 32.05 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 166.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.35 150.09 31.72 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.466 0.707 . . . . 0.0 112.435 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 89.15 -20.75 31.59 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.499 -172.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -101.46 136.4 41.37 Favored 'General case' 0 C--O 1.244 0.806 0 C-N-CA 123.726 0.811 . . . . 0.0 109.896 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 174' ' ' PRO . 0.0 OUTLIER -73.32 140.22 46.6 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-O 121.491 0.662 . . . . 0.0 110.083 177.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 172' ' ' THR . 3.2 m -120.13 179.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.635 0.774 . . . . 0.0 108.96 175.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.409 HE22 ' HG3' ' A' ' 171' ' ' GLN . 69.5 mm-40 -121.66 160.7 23.89 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.091 -0.38 . . . . 0.0 110.784 -170.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.6 155.68 18.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 C-N-CA 123.705 0.802 . . . . 0.0 110.28 173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 52.5 mt -107.19 105.9 16.12 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 164.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -74.44 104.67 5.26 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.326 0.65 . . . . 0.0 109.474 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.687 HD23 ' HB3' ' A' ' 167' ' ' PRO . 54.8 mt -69.65 104.64 2.45 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.192 0.52 . . . . 0.0 110.796 -175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 165' ' ' LYS . 56.7 mm-40 -76.26 141.6 70.58 Favored Pre-proline 0 CA--C 1.556 1.18 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.123 -176.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.669 ' HB3' ' HB ' ' A' ' 49' ' ' THR . 12.4 Cg_exo -71.89 116.64 4.78 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.906 3.071 . . . . 0.0 112.011 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 68.35 9.67 58.38 Favored Glycine 0 C--N 1.349 1.266 0 O-C-N 123.577 0.548 . . . . 0.0 113.894 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.603 ' HB2' ' HB3' ' A' ' 162' ' ' GLU . 96.3 mttt -135.91 -177.31 4.63 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.495 1.118 . . . . 0.0 110.219 -172.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -88.26 142.96 31.99 Favored Pre-proline 0 N--CA 1.473 0.684 0 C-N-CA 123.848 0.859 . . . . 0.0 110.655 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.687 ' HB3' HD23 ' A' ' 161' ' ' LEU . 10.4 Cg_endo -52.86 115.65 2.39 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 123.515 2.81 . . . . 0.0 112.737 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -69.46 129.96 41.17 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.602 0.761 . . . . 0.0 109.888 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.649 ' HB3' ' H ' ' A' ' 20' ' ' ALA . . . -71.73 118.79 15.01 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.576 HG13 ' HB ' ' A' ' 22' ' ' ILE . 41.0 t -134.68 144.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.744 ' HB2' ' HB2' ' A' ' 21' ' ' GLU . 27.7 tt0 -84.81 163.81 18.86 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 173.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 156' ' ' VAL . 18.5 p -136.16 97.11 3.52 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 25' ' ' SER . 54.4 tttp -85.73 129.43 54.73 Favored Pre-proline 0 C--O 1.245 0.821 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 155' ' ' GLU . 84.0 Cg_exo -47.49 125.5 10.91 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 123.289 2.659 . . . . 0.0 113.714 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -114.36 178.41 18.13 Favored Glycine 0 C--O 1.247 0.914 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.928 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -139.07 128.82 24.75 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -133.75 122.06 22.78 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 183' ' ' THR . 5.0 ttpm? -122.39 138.83 54.4 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.36 1.064 . . . . 0.0 108.843 -171.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 52.0 p -120.67 -178.68 3.78 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.026 0.931 . . . . 0.0 109.271 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -71.21 -19.63 62.36 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.36 0.664 . . . . 0.0 109.932 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.09 -48.92 8.71 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.345 1.058 . . . . 0.0 110.507 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -175.67 160.76 29.25 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 116.078 -0.51 . . . . 0.0 113.408 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 9.7 t -97.83 139.95 32.93 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.985 0.914 . . . . 0.0 110.145 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.0 mp -130.49 127.73 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -102.93 111.51 4.0 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -163.57 -172.29 2.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.086 0.954 . . . . 0.0 109.946 -171.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.5 p -70.67 100.13 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 121.807 0.813 . . . . 0.0 111.059 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.413 ' HA ' HG13 ' A' ' 223' ' ' VAL . 20.7 m -98.86 101.02 12.29 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 165.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.3 tp -122.14 151.48 40.91 Favored 'General case' 0 N--CA 1.482 1.163 0 CA-C-O 120.62 0.248 . . . . 0.0 110.998 -174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -69.93 159.95 32.77 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.818 0.847 . . . . 0.0 109.069 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.476 ' HA ' ' HD1' ' A' ' 222' ' ' TYR . 34.0 p90 -75.63 121.92 23.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.113 0.959 . . . . 0.0 111.63 -164.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 35.2 m -137.14 132.12 17.97 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 173.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -53.93 89.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.28 2.653 . . . . 0.0 113.062 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -134.43 100.37 0.37 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -173.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 37.3 p -73.59 140.65 46.38 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 123.294 0.638 . . . . 0.0 111.223 -176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 44.8 m -53.95 127.01 24.58 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.902 0.881 . . . . 0.0 112.153 -173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . 107.07 -3.84 35.58 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 118.73 -1.039 . . . . 0.0 111.772 -168.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.2 m -44.43 119.64 3.64 Favored Pre-proline 0 C--N 1.383 2.043 0 C-N-CA 124.079 0.952 . . . . 0.0 112.012 174.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.16 115.47 3.0 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.398 2.065 . . . . 0.0 111.517 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 41.5 mt -79.24 106.4 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 41.2 mt -98.38 163.51 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.507 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -98.85 157.65 16.16 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.245 1.418 . . . . 0.0 108.909 176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -63.94 -34.27 77.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.5 1.12 . . . . 0.0 111.128 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -80.25 -20.36 44.69 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.714 0.406 . . . . 0.0 111.162 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 116.27 7.4 14.44 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.835 -0.425 . . . . 0.0 113.91 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -71.55 161.89 30.31 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 117.442 0.621 . . . . 0.0 109.843 170.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.536 HG11 HD13 ' A' ' 146' ' ' LEU . 2.7 p -94.02 112.12 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 171.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 26.3 t -70.38 -40.39 77.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 228' ' ' GLN . . . 158.23 -142.83 8.78 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.9 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.591 HD12 HD22 ' A' ' 137' ' ' LEU . 70.4 mt -127.99 159.57 34.59 Favored 'General case' 0 C--O 1.247 0.951 0 C-N-CA 123.658 0.783 . . . . 0.0 110.449 -174.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.481 ' O ' ' SD ' ' A' ' 110' ' ' MET . 0.2 OUTLIER -62.98 107.87 1.09 Allowed 'General case' 0 C--N 1.35 0.59 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 170.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.07 -179.97 6.53 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 124.343 1.027 . . . . 0.0 114.837 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -69.19 86.99 0.4 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.516 1.15 . . . . 0.0 109.633 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.84 ' HA2' ' SD ' ' A' ' 39' ' ' MET . . . -134.44 -151.23 6.33 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 113.677 -1.602 . . . . 0.0 111.661 -176.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.568 HG21 ' H ' ' A' ' 41' ' ' ILE . 8.8 p -157.28 168.63 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.486 0.66 . . . . 0.0 111.591 -172.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 41.7 t -85.59 108.54 17.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 166.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.518 HG23 HD13 ' A' ' 41' ' ' ILE . 99.6 m -86.63 144.02 27.35 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.536 1.134 . . . . 0.0 110.005 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 36.1 ttm180 67.79 10.3 7.69 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.613 1.165 . . . . 0.0 110.305 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.462 ' HB3' HD22 ' A' ' 43' ' ' ASN . 95.0 p 52.92 30.05 8.68 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 125.353 1.461 . . . . 0.0 111.43 -166.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -139.13 -70.16 0.05 OUTLIER Glycine 0 C--N 1.346 1.117 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.349 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -76.06 137.88 40.47 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.338 0.655 . . . . 0.0 111.164 -170.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.476 ' HD1' ' HA ' ' A' ' 191' ' ' PHE . 82.3 m-85 -86.03 102.49 13.86 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.141 0.496 . . . . 0.0 110.124 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.413 HG13 ' HA ' ' A' ' 188' ' ' SER . 50.6 t -124.1 104.64 14.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 123.601 0.761 . . . . 0.0 108.972 -175.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.702 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 63.4 m -132.04 162.48 30.67 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.306 1.042 . . . . 0.0 109.959 -171.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -58.65 162.72 3.71 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.006 162.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 81.9 mt -107.58 103.69 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 O-C-N 121.343 -0.848 . . . . 0.0 109.023 170.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.419 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -78.91 136.58 37.31 Favored 'General case' 0 C--N 1.346 0.448 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 173.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.459 ' HA ' ' HA3' ' A' ' 209' ' ' GLY . 8.8 pt20 -129.06 167.72 17.11 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.208 0.603 . . . . 0.0 109.494 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.532 ' HA ' ' NE1' ' A' ' 144' ' ' TRP . 1.6 p -82.72 110.69 17.99 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 175.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -72.01 -13.78 61.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.768 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.6 37.66 22.49 Favored 'General case' 0 C--N 1.358 0.955 0 C-N-CA 124.988 1.315 . . . . 0.0 109.214 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.3 m -58.85 96.31 0.03 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.532 1.133 . . . . 0.0 111.077 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . 0.438 HG12 ' ND2' ' A' ' 236' ' ' ASN . 14.7 tt -97.43 27.03 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-O 122.576 1.179 . . . . 0.0 108.986 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -74.17 -8.11 55.01 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.531 -171.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -65.34 -11.72 44.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.384 1.074 . . . . 0.0 111.849 174.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.438 ' ND2' HG12 ' A' ' 233' ' ' ILE . 34.6 m-80 -56.87 117.43 17.45 Favored Pre-proline 0 CA--C 1.554 1.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.92 129.91 29.14 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.878 2.385 . . . . 0.0 111.516 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.44 -39.48 77.77 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.227 0.611 . . . . 0.0 111.275 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.84 -49.42 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.134 0.574 . . . . 0.0 109.582 -176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--O 1.248 1.0 0 C-N-CA 123.219 0.608 . . . . 0.0 110.021 -175.797 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.668 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.648 ' C ' HD13 ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.746 ' HG2' HD11 ' A' ' 91' ' ' ILE . 17.2 tppt? 164.43 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 126.521 1.928 . . . . 0.0 109.473 161.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 69.28 115.95 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.872 1.269 . . . . 0.0 108.361 -165.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 CA-C-O 119.195 -0.781 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m 72.63 167.75 0.31 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 125.392 1.477 . . . . 0.0 111.607 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 6' ' ' LEU . . . -68.62 120.49 14.71 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.189 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HA ' HG13 ' A' ' 118' ' ' VAL . . . -133.35 21.12 4.0 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.522 0.729 . . . . 0.0 111.143 -167.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -142.33 49.76 1.52 Allowed 'General case' 0 C--O 1.254 1.307 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.85 HD22 ' HG3' ' B' ' 252' ' ' NLE . 34.6 mt -96.59 94.13 7.16 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.864 -1.971 . . . . 0.0 109.98 -175.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 120' ' ' MET . 6.9 tm-20 -107.55 129.34 54.99 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.35 0.66 . . . . 0.0 111.095 -170.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.556 HD11 HD12 ' A' ' 119' ' ' LEU . 1.5 mp -94.78 137.16 34.22 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.565 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 34.3 tt0 -132.3 136.72 47.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.694 -0.629 . . . . 0.0 109.673 171.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.627 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 6.7 ptp180 -67.09 153.78 42.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.64 0.733 . . . . 0.0 112.454 -176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.31 -36.04 3.02 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.296 -1.32 . . . . 0.0 108.696 166.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -177.16 -162.39 0.07 Allowed 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.52 156.81 25.08 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.647 0.779 . . . . 0.0 109.028 168.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.06 96.44 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.604 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 164.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -166.84 136.84 3.06 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -167.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.512 ' H ' ' HA2' ' A' ' 205' ' ' GLY . 63.7 t90 -66.69 120.16 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.748 0.655 . . . . 0.0 109.829 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -87.69 143.91 26.92 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 168.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -58.2 -6.96 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.808 1.243 . . . . 0.0 112.784 176.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -75.29 50.28 0.5 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 125.49 1.516 . . . . 0.0 111.709 172.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -65.72 100.47 0.54 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.543 0.737 . . . . 0.0 110.906 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -88.69 102.55 15.09 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.774 0.83 . . . . 0.0 110.246 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.59 100.91 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.8 m -153.4 144.08 22.64 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.54 1.536 . . . . 0.0 107.631 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.719 ' HA2' ' H ' ' A' ' 190' ' ' ASP . . . 109.46 -138.09 14.59 Favored Glycine 0 CA--C 1.503 -0.716 0 CA-C-O 118.869 -0.962 . . . . 0.0 111.311 -174.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.6 m 58.82 26.79 15.22 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.413 0.685 . . . . 0.0 110.37 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.8 t -66.21 143.06 98.18 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.602 1.161 . . . . 0.0 111.039 -168.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.02 175.68 0.6 Allowed 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 122.91 2.407 . . . . 0.0 113.49 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 43.8 mm -57.37 131.52 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.851 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.0 mt -109.1 160.16 16.29 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.852 0.861 . . . . 0.0 109.936 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.0 t -122.9 115.4 21.89 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.416 HG12 HD11 ' A' ' 41' ' ' ILE . 30.0 mt -121.3 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.007 0.923 . . . . 0.0 109.337 -172.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.3 p -92.96 111.9 23.68 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.34 132.45 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.935 0.894 . . . . 0.0 108.773 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -138.37 146.4 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.82 0.448 . . . . 0.0 110.341 -174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 52.85 32.63 12.74 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.237 1.015 . . . . 0.0 111.898 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.254 3.2 p30 52.54 -66.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 126.975 2.11 . . . . 0.0 114.135 -170.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.46 -10.45 66.6 Favored Glycine 0 N--CA 1.474 1.185 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 -177.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.7 t -106.55 160.55 15.34 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 118.186 0.993 . . . . 0.0 110.06 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 ppp? -161.62 133.88 5.83 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.771 ' HA ' HG11 ' A' ' 215' ' ' VAL . 15.1 p -166.33 174.97 8.59 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.331 0.652 . . . . 0.0 110.161 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.687 HD13 ' HA ' ' A' ' 217' ' ' THR . 1.8 mp -89.22 150.21 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 165.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -72.71 73.33 1.08 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.41 0.624 . . . . 0.0 109.549 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -143.7 -179.44 6.45 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.59 1.156 . . . . 0.0 109.274 -174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -83.51 96.6 8.65 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.63 119.41 10.47 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.548 0.739 . . . . 0.0 110.187 175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -148.6 141.74 24.98 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.217 0.607 . . . . 0.0 109.595 172.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 193' ' ' PRO . 1.4 mp0 -125.05 -123.29 0.25 Allowed 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 117.614 -1.184 . . . . 0.0 111.315 -165.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -156.17 150.2 25.27 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 120.852 1.66 . . . . 0.0 113.121 -169.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 94.1 m -116.98 123.8 47.81 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.55 1.14 . . . . 0.0 109.009 -172.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HB3' ' HG3' ' A' ' 163' ' ' PRO . 0.4 OUTLIER -140.26 119.71 13.1 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 122.669 1.223 . . . . 0.0 111.579 -178.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -160.35 -37.82 0.02 OUTLIER Glycine 0 N--CA 1.466 0.681 0 CA-C-N 113.045 -1.889 . . . . 0.0 110.042 174.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 86.58 -76.03 2.16 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.46 -0.37 . . . . 0.0 113.085 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 77.57 -63.68 3.36 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -153.23 171.63 32.16 Favored Glycine 0 C--O 1.243 0.683 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 168.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.2 t -70.45 105.15 2.96 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.77 32.38 21.62 Favored Glycine 0 C--N 1.348 1.21 0 N-CA-C 111.499 -0.641 . . . . 0.0 111.499 -171.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.28 96.48 0.72 Allowed Glycine 0 C--N 1.351 1.38 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.98 -110.01 0.22 Allowed Glycine 0 C--N 1.349 1.253 0 N-CA-C 113.93 0.332 . . . . 0.0 113.93 -172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -97.57 51.0 1.38 Allowed Glycine 0 C--N 1.342 0.905 0 C-N-CA 123.092 0.377 . . . . 0.0 112.204 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.97 -54.63 4.23 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 61.29 95.96 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.312 1.445 . . . . 0.0 110.523 -174.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -79.86 63.37 4.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.312 0.645 . . . . 0.0 109.775 175.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.93 -121.74 22.9 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-N 115.39 -0.823 . . . . 0.0 113.085 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 7' ' ' GLU . 1.0 OUTLIER -109.29 28.51 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.332 0 C-N-CA 123.853 0.861 . . . . 0.0 110.069 177.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 73.0 mt 74.76 -172.62 0.11 Allowed 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 125.001 1.32 . . . . 0.0 111.861 -174.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -165.24 106.21 0.78 Allowed 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.627 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 16.7 t70 178.66 73.09 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 124.063 0.945 . . . . 0.0 112.441 151.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.649 HG22 ' HB2' ' A' ' 121' ' ' HIS . 0.2 OUTLIER -134.33 158.76 74.49 Favored Pre-proline 0 CA--C 1.561 1.374 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 165.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.401 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 52.4 Cg_exo -23.93 138.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.395 2.999 1 C-N-CA 125.766 4.311 . . . . 0.0 116.258 175.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -61.8 148.47 87.39 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.417 1.087 . . . . 0.0 112.157 -171.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.431 ' HD3' ' HD2' ' A' ' 121' ' ' HIS . 5.0 Cg_endo -45.61 -38.5 16.77 Favored 'Trans proline' 0 C--N 1.389 2.658 0 C-N-CA 124.303 3.335 . . . . 0.0 117.345 -178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.45 166.71 1.09 Allowed 'Trans proline' 0 C--N 1.391 2.765 0 C-N-CA 122.484 2.123 . . . . 0.0 115.133 172.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -69.54 -163.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.929 2.419 . . . . 0.0 112.415 172.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.3 t 74.66 -61.63 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 C-N-CA 125.049 1.34 . . . . 0.0 110.004 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.43 67.37 3.72 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 112.195 -0.362 . . . . 0.0 112.195 172.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -89.58 -31.1 17.74 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.102 0.561 . . . . 0.0 109.713 176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 146.09 47.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.333 174.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -62.9 137.56 58.3 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 123.984 0.802 . . . . 0.0 109.719 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 94.4 mt -149.14 -164.4 2.02 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.043 1.337 . . . . 0.0 107.92 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 71.57 25.06 3.42 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.181 1.392 . . . . 0.0 109.982 -171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.64 ' HA ' ' HD2' ' A' ' 102' ' ' TYR . 27.2 t70 -17.96 113.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.323 2.649 . . . . 0.0 115.734 -170.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 163.34 -178.04 39.09 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.89 110.75 18.16 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 124.355 1.062 . . . . 0.0 108.786 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 10' ' ' ARG . 6.9 m-85 -99.54 140.66 33.41 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.432 ' HB2' HD13 ' A' ' 50' ' ' LEU . 12.5 ptt180 -83.39 122.7 28.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 162.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.666 ' HB ' ' HE2' ' B' ' 252' ' ' NLE . 18.2 pt -107.63 135.44 46.23 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.62 -166.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.62 ' HD2' ' HB3' ' A' ' 96' ' ' GLN . 79.5 tttt -124.06 137.47 54.57 Favored 'General case' 0 C--N 1.379 1.851 0 O-C-N 125.041 1.463 . . . . 0.0 112.64 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -108.66 147.76 31.42 Favored 'General case' 0 C--O 1.252 1.195 0 C-N-CA 125.388 1.475 . . . . 0.0 109.001 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -59.53 95.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 158.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.611 ' H ' ' HA ' ' A' ' 94' ' ' TYR . . . -59.5 154.41 30.58 Favored Glycine 0 N--CA 1.465 0.625 0 O-C-N 124.4 1.063 . . . . 0.0 115.44 -145.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.4 mp -54.74 -34.41 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 124.842 1.257 . . . . 0.0 110.221 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.5 mt -126.23 23.62 7.0 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.032 0.933 . . . . 0.0 111.301 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.24 -97.77 0.17 Allowed Glycine 0 N--CA 1.482 1.708 0 O-C-N 122.199 -0.313 . . . . 0.0 112.997 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.611 ' HA ' ' H ' ' A' ' 90' ' ' GLY . 61.5 m-85 -145.06 116.21 7.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 125.206 1.402 . . . . 0.0 108.186 177.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -129.26 101.31 5.94 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -167.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.62 ' HB3' ' HD2' ' A' ' 87' ' ' LYS . 4.0 pm0 -94.24 104.19 16.2 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 168.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.579 HD13 ' HD2' ' B' ' 253' ' ' LYS . 1.4 pp -137.77 -37.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 116.556 2.058 . . . . 0.0 116.556 -154.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -121.56 -159.5 10.7 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.312 -1.423 . . . . 0.0 114.265 -163.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.474 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -133.36 125.29 28.83 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-O 121.045 0.45 . . . . 0.0 110.495 174.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.13 110.82 2.36 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 171.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.686 HG23 ' HB2' ' A' ' 108' ' ' HIS . 17.7 m -105.58 102.82 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.64 ' HD2' ' HA ' ' A' ' 81' ' ' ASP . 80.2 t80 -94.06 119.95 33.64 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -140.06 124.53 18.01 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 123.891 0.876 . . . . 0.0 108.703 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 50.13 55.58 9.22 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 125.407 1.483 . . . . 0.0 112.366 170.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.2 15.64 79.98 Favored Glycine 0 C--N 1.341 0.845 0 CA-C-N 115.054 -0.975 . . . . 0.0 114.219 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 m -135.62 115.39 12.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.402 0.601 . . . . 0.0 111.332 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -85.26 112.21 20.55 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.686 ' HB2' HG23 ' A' ' 101' ' ' VAL . 58.4 m80 -98.91 110.38 23.0 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 124.867 1.354 . . . . 0.0 110.207 -174.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.61 HG23 ' HB ' ' A' ' 138' ' ' ILE . 15.3 t -139.97 -159.35 0.95 Allowed 'General case' 0 CA--C 1.566 1.574 0 C-N-CA 122.86 0.464 . . . . 0.0 110.489 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.739 ' HE1' ' HA2' ' A' ' 212' ' ' GLY . 23.2 ttm -156.55 160.73 39.75 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -157.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -80.73 -35.34 33.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CE1' ' SD ' ' A' ' 110' ' ' MET . 3.2 p-80 -75.6 -23.6 56.45 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 196' ' ' SER . 5.8 m -81.06 -10.94 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.609 175.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.849 ' HB ' ' H2 ' ' B' ' 251' ' ' BEZ . 8.4 m 165.58 144.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 C-N-CA 127.113 2.165 . . . . 0.0 107.914 160.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 mtm-85 -83.04 34.81 0.46 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.726 1.21 . . . . 0.0 113.83 -166.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.21 54.68 1.25 Allowed Glycine 0 C--N 1.347 1.173 0 N-CA-C 112.654 -0.178 . . . . 0.0 112.654 172.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 3' ' ' ALA . . . -106.15 -174.48 2.55 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.208 0.603 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 127' ' ' GLU . 3.1 p -116.14 134.68 58.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 121.43 0.634 . . . . 0.0 112.66 -163.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.703 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 mm? -90.97 179.28 5.79 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.392 1.477 . . . . 0.0 111.637 -167.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.559 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 11.3 ptp -175.69 163.23 2.84 Favored 'General case' 0 C--O 1.258 1.551 0 CA-C-O 123.088 1.423 . . . . 0.0 114.632 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.649 ' HB2' HG22 ' A' ' 68' ' ' VAL . 70.3 t60 -109.75 105.39 14.61 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 111.535 -2.575 . . . . 0.0 105.485 155.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.487 ' H ' ' HG2' ' A' ' 7' ' ' GLU . 53.9 pttt -41.14 116.14 0.69 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 125.408 1.483 . . . . 0.0 113.211 -156.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.72 -7.51 55.61 Favored Glycine 0 CA--C 1.54 1.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 113.048 -170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 69' ' ' PRO . 10.2 tttp -138.58 113.1 8.89 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.319 1.448 . . . . 0.0 107.196 175.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -106.63 128.66 54.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 118.381 0.537 . . . . 0.0 111.636 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.51 129.85 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 125.007 1.323 . . . . 0.0 109.803 -176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' HA ' HG23 ' A' ' 118' ' ' VAL . 32.0 mt-10 -91.46 151.7 42.9 Favored Pre-proline 0 N--CA 1.485 1.276 0 CA-C-O 119.235 -0.412 . . . . 0.0 111.144 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.93 -178.56 3.59 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 123.084 2.523 . . . . 0.0 112.586 173.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 140' ' ' TYR . 19.4 p -126.36 -21.53 4.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.879 0.472 . . . . 0.0 112.195 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.444 ' O ' HG23 ' A' ' 138' ' ' ILE . 21.8 t-105 -140.2 146.53 38.83 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.438 0.695 . . . . 0.0 110.065 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -158.51 120.83 3.64 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 124.37 1.044 . . . . 0.0 109.215 170.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.68 128.64 39.42 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.3 0.571 . . . . 0.0 110.039 174.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.7 t -77.96 -36.15 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.083 -166.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 20.5 ttmm -71.35 -35.41 71.16 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.495 0.718 . . . . 0.0 112.376 -167.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.18 -7.39 56.95 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 119.181 -0.438 . . . . 0.0 110.974 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 110' ' ' MET . 22.2 t70 65.75 47.35 2.13 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.227 0.955 . . . . 0.0 109.022 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 110' ' ' MET . 53.5 mt -144.66 139.96 28.35 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.61 ' HB ' HG23 ' A' ' 109' ' ' THR . 60.8 mt -132.61 142.78 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 125.506 1.522 . . . . 0.0 108.558 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.443 ' HB3' ' CE3' ' A' ' 144' ' ' TRP . 74.6 p -139.1 159.54 41.9 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-N 118.813 0.733 . . . . 0.0 112.259 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.42 ' HA ' ' OG ' ' A' ' 129' ' ' SER . 20.7 t80 -129.91 146.78 51.63 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.815 169.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 100.69 4.43 54.63 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.37 -162.53 28.44 Favored Glycine 0 C--N 1.344 0.983 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.7 173.05 31.13 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 168.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.515 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 66.6 t-105 -63.8 129.26 39.36 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 117.7 0.75 . . . . 0.0 109.408 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -164.74 176.51 8.74 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.923 0.489 . . . . 0.0 111.709 -174.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.46 HD12 ' HE1' ' A' ' 108' ' ' HIS . 3.3 tm? 67.72 97.6 0.06 Allowed 'General case' 0 C--N 1.358 0.97 0 O-C-N 125.013 1.446 . . . . 0.0 111.74 169.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.691 ' HG3' ' HA2' ' A' ' 209' ' ' GLY . 7.1 mm-40 160.1 110.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 128.105 2.562 . . . . 0.0 107.336 154.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.16 85.16 0.49 Allowed Glycine 0 N--CA 1.478 1.459 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.659 ' HG2' ' HB2' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -75.84 163.77 26.89 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 117.742 2.497 . . . . 0.0 117.742 -156.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.41 ' HB2' HG22 ' A' ' 208' ' ' VAL . 49.8 t90 -55.81 142.0 36.58 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 111.611 -2.54 . . . . 0.0 112.035 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -131.75 153.8 49.7 Favored 'General case' 0 C--O 1.247 0.942 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -55.24 104.51 0.12 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.381 1.072 . . . . 0.0 113.374 -166.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 152.84 -43.56 0.64 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.485 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -78.38 167.92 20.6 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.524 0.73 . . . . 0.0 112.757 -177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -93.14 174.33 7.28 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.803 0.841 . . . . 0.0 110.576 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 155.87 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.549 0.74 . . . . 0.0 109.471 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.492 ' HG2' ' HA ' ' A' ' 171' ' ' GLN . 40.3 mt-30 -126.81 128.72 47.02 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 175.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.457 HG22 HG22 ' A' ' 200' ' ' ILE . 91.0 t -93.02 110.07 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 123.472 0.709 . . . . 0.0 109.718 -175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.616 ' HB3' ' HG2' ' A' ' 199' ' ' PRO . 1.3 tm? -77.21 76.13 3.76 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -84.21 124.53 31.29 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 114.257 -1.338 . . . . 0.0 109.444 -171.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.473 ' HB2' HD22 ' A' ' 50' ' ' LEU . 18.1 mt -69.02 120.59 15.12 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 123.662 0.601 . . . . 0.0 109.823 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -93.94 107.8 30.6 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.65 ' HG3' ' HB3' ' A' ' 50' ' ' LEU . 47.0 Cg_exo -55.64 115.47 2.48 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.923 2.415 . . . . 0.0 112.686 -178.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.57 -16.83 60.45 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-O 119.663 -0.521 . . . . 0.0 113.596 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -124.2 -171.69 2.39 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.454 0.702 . . . . 0.0 110.252 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.86 139.25 57.6 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.345 0.658 . . . . 0.0 109.893 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_exo -51.73 129.14 28.85 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.814 3.01 . . . . 0.0 113.463 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -97.0 125.54 41.51 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.057 0.943 . . . . 0.0 109.496 -176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -85.37 104.07 14.86 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.128 0.571 . . . . 0.0 109.863 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 68.5 t -87.96 109.68 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.541 1.136 . . . . 0.0 110.387 -172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.492 ' HA ' ' HG2' ' A' ' 157' ' ' GLN . 7.9 tt0 -80.1 125.88 30.37 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.552 0.741 . . . . 0.0 109.952 -177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 3.4 t -151.35 151.24 31.48 Favored 'General case' 0 C--O 1.243 0.759 0 C-N-CA 123.731 0.812 . . . . 0.0 110.676 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -91.88 156.45 42.52 Favored Pre-proline 0 C--O 1.244 0.778 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.443 174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.0 172.26 13.2 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.9 2.4 . . . . 0.0 112.941 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -159.03 -174.46 28.76 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.981 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.05 144.76 26.91 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 117.1 0.45 . . . . 0.0 110.519 176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 183' ' ' THR . 5.9 m-85 -97.4 119.39 35.86 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.624 ' HA ' HG22 ' A' ' 183' ' ' THR . 62.7 tttp -99.12 98.74 9.71 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.014 0.926 . . . . 0.0 109.424 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.523 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.0 m -95.51 -178.37 4.39 Favored 'General case' 0 CA--C 1.555 1.169 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.523 ' H ' HG22 ' A' ' 179' ' ' THR . 7.8 p30 -61.34 -25.31 67.06 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.8 -38.13 0.36 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.429 0.691 . . . . 0.0 110.719 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -89.45 118.7 5.28 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.587 -0.279 . . . . 0.0 112.506 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.624 HG22 ' HA ' ' A' ' 178' ' ' LYS . 22.6 p -119.01 111.96 18.97 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.47 135.34 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -100.78 111.27 4.11 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 225' ' ' ALA . . . -143.77 -161.02 1.19 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.4 0.68 . . . . 0.0 110.424 -167.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.51 108.89 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.475 0.655 . . . . 0.0 109.454 172.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.625 ' HA ' HG13 ' A' ' 223' ' ' VAL . 10.0 t -80.71 112.48 18.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.837 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 191' ' ' PHE . 1.4 tt -130.22 132.34 45.95 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 120.899 0.38 . . . . 0.0 110.566 -169.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.719 ' H ' ' HA2' ' A' ' 24' ' ' GLY . 10.4 m-20 -96.55 104.92 16.94 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.615 ' HB2' HD22 ' A' ' 189' ' ' LEU . 31.7 t80 -153.5 163.45 39.93 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 36.5 p -58.04 151.31 46.06 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.718 -0.658 . . . . 0.0 109.429 167.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.638 ' HB3' ' HA ' ' A' ' 47' ' ' GLU . 84.0 Cg_exo -46.92 95.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.84 2.36 . . . . 0.0 113.691 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -66.61 179.25 12.92 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.556 172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.461 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 71.0 p -115.19 145.93 41.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.354 0.597 . . . . 0.0 112.46 -169.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.748 ' HB3' HG12 ' A' ' 113' ' ' VAL . 62.8 m -67.91 99.1 0.8 Allowed 'General case' 0 C--O 1.244 0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.296 -172.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 132.86 3.83 3.53 Favored Glycine 0 C--N 1.346 1.115 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.054 178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 71.4 m -55.1 122.64 43.62 Favored Pre-proline 0 C--N 1.368 1.397 0 C-N-CA 123.3 0.64 . . . . 0.0 111.3 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 210' ' ' LEU . 83.8 Cg_endo -78.43 144.66 20.44 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.979 2.453 . . . . 0.0 113.403 -174.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.693 HG13 ' HB ' ' A' ' 208' ' ' VAL . 8.2 pt -111.3 110.37 31.94 Favored 'Isoleucine or valine' 0 C--O 1.268 2.047 0 CA-C-O 123.105 1.431 . . . . 0.0 109.347 171.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 159' ' ' LEU . 13.7 pt -130.94 161.34 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 112.339 -2.209 . . . . 0.0 109.663 -174.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 207' ' ' VAL . 23.6 t70 -90.82 -178.69 5.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.532 0.733 . . . . 0.0 109.585 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -58.87 -18.88 36.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . 0.455 ' HE3' ' HD2' ' A' ' 206' ' ' LYS . 62.4 tttp -71.01 -13.44 62.0 Favored 'General case' 0 CA--C 1.563 1.462 0 C-N-CA 124.579 1.151 . . . . 0.0 111.365 173.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 16' ' ' TRP . . . 86.25 9.41 76.45 Favored Glycine 0 C--N 1.353 1.496 0 C-N-CA 123.359 0.504 . . . . 0.0 112.92 -176.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.455 ' HD2' ' HE3' ' A' ' 204' ' ' LYS . 18.1 ptpt -157.81 151.89 24.35 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.255 1.022 . . . . 0.0 109.51 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.643 HG13 HG23 ' A' ' 208' ' ' VAL 0.25 7.9 p -178.11 -71.27 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.205 -1.26 0 O-C-N 124.613 1.196 . . . . 0.0 108.489 161.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.693 ' HB ' HG13 ' A' ' 200' ' ' ILE . 2.1 t -90.6 -44.69 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 120.494 1.497 . . . . 0.0 111.253 -162.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.691 ' HA2' ' HG3' ' A' ' 147' ' ' GLU . . . 127.47 -98.17 0.49 Allowed Glycine 0 CA--C 1.505 -0.542 0 CA-C-N 113.514 -1.676 . . . . 0.0 110.824 -169.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 199' ' ' PRO . 2.0 pt? -146.27 172.52 13.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.281 0.562 . . . . 0.0 110.669 -171.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.737 ' HB2' ' HB3' ' A' ' 224' ' ' SER . 0.0 OUTLIER -74.88 142.28 44.09 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 176.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.739 ' HA2' ' HE1' ' A' ' 110' ' ' MET . . . -82.35 -145.16 5.29 Favored Glycine 0 C--N 1.343 0.972 0 C-N-CA 123.03 0.347 . . . . 0.0 112.251 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -78.54 86.44 4.55 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.462 0.649 . . . . 0.0 109.751 171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . -112.79 -174.72 19.32 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.866 170.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . 0.771 HG11 ' HA ' ' A' ' 40' ' ' SER . 10.5 p -168.63 168.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 122.874 0.469 . . . . 0.0 110.116 -168.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.435 HG13 ' HD1' ' A' ' 222' ' ' TYR . 6.6 m -69.66 115.25 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 165.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.687 ' HA ' HD13 ' A' ' 41' ' ' ILE . 5.2 t -79.27 168.99 18.79 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.553 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -51.73 137.42 25.56 Favored 'General case' 0 CA--C 1.552 1.046 0 O-C-N 124.389 1.056 . . . . 0.0 110.52 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.9 m 86.07 -4.36 0.78 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.712 2.005 . . . . 0.0 111.139 -165.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 82.39 29.53 36.33 Favored Glycine 0 C--N 1.354 1.537 0 C-N-CA 123.103 0.382 . . . . 0.0 113.233 174.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 190' ' ' ASP . . . -95.85 115.28 27.19 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . 0.505 ' HB2' ' HA ' ' A' ' 193' ' ' PRO . 23.0 t80 -74.22 101.08 3.88 Favored 'General case' 0 C--N 1.348 0.54 0 CA-C-O 121.678 0.752 . . . . 0.0 109.925 -172.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.625 HG13 ' HA ' ' A' ' 188' ' ' SER . 91.9 t -94.97 152.52 3.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.492 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.737 ' HB3' ' HB2' ' A' ' 211' ' ' TYR . 69.9 m -130.1 135.03 47.78 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -168.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.521 ' HA ' ' HB1' ' A' ' 186' ' ' ALA . . . -73.29 163.89 27.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 165.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.63 HG23 HG11 ' A' ' 208' ' ' VAL . 43.5 mt -98.18 106.04 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 122.806 0.443 . . . . 0.0 110.536 175.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -99.36 108.49 21.01 Favored 'General case' 0 C--N 1.362 1.132 0 CA-C-O 121.794 0.807 . . . . 0.0 108.903 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.659 ' HB2' ' HG2' ' A' ' 149' ' ' GLU . 11.0 pt20 -95.25 167.39 11.38 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.945 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.515 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 3.9 p -117.3 126.86 53.41 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 169.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.01 1.98 17.74 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.416 1.086 . . . . 0.0 110.869 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 54.51 92.62 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.374 1.07 . . . . 0.0 111.181 -167.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 22.3 m -61.99 91.14 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.229 1.012 . . . . 0.0 111.393 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.3 pt -86.31 -31.21 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 124.506 1.122 . . . . 0.0 109.966 176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -161.56 154.62 20.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.383 -174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -111.08 -50.06 2.97 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.03 0.932 . . . . 0.0 109.211 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -73.23 124.72 90.86 Favored Pre-proline 0 N--CA 1.477 0.902 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.076 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -62.92 112.32 1.62 Allowed 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.456 2.104 . . . . 0.0 110.409 169.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.05 -39.76 79.25 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.159 0.912 . . . . 0.0 111.915 -175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -163.69 -42.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 171.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 CA--C 1.549 0.926 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 170.384 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.849 ' H2 ' ' HB ' ' A' ' 114' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.85 ' HG3' HD22 ' A' ' 6' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.697 ' HZ2' ' HB ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -166.29 -148.4 0.1 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.062 -148.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 81.6 mtt85 -68.96 -110.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.381 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 155.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . 0.536 ' NE ' ' HB2' ' A' ' 47' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 120.81 0.117 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 117' ' ' ALA . 35.6 t -72.03 -31.98 66.69 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.601 1.16 . . . . 0.0 112.117 -176.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.413 ' HB3' HD11 ' A' ' 6' ' ' LEU . . . -163.49 176.08 10.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.389 0.676 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 118' ' ' VAL . . . -147.23 42.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -172.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.644 ' H ' HD12 ' A' ' 6' ' ' LEU . 5.9 m-20 -145.75 28.11 1.17 Allowed 'General case' 0 CA--C 1.56 1.342 0 C-N-CA 124.351 1.06 . . . . 0.0 111.474 -171.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.644 HD12 ' H ' ' A' ' 5' ' ' ASP . 1.6 mp -114.92 99.8 7.74 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.925 0.784 . . . . 0.0 111.289 -167.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' MET . 36.1 mp0 -106.95 142.92 35.8 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.207 0.527 . . . . 0.0 112.056 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HG22 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -116.04 166.56 11.86 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.954 176.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.688 ' HB2' ' HB3' ' A' ' 65' ' ' LEU . 33.3 tt0 -155.13 137.51 14.94 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.298 1.439 . . . . 0.0 108.892 -171.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HA ' ' HD1' ' A' ' 84' ' ' TYR . 35.7 ttt-85 -72.58 125.61 27.88 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 118.544 0.611 . . . . 0.0 110.711 -172.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.682 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -86.72 -56.42 3.41 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -171.26 -161.68 0.22 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.424 -1.262 . . . . 0.0 109.912 -173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -96.09 156.76 16.2 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.828 1.251 . . . . 0.0 107.682 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 HG21 ' A' ' 201' ' ' ILE . 0.0 OUTLIER -85.69 97.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -172.61 132.92 0.59 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.572 0.749 . . . . 0.0 109.783 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.603 ' HE3' ' HB3' ' A' ' 203' ' ' LYS . 78.8 t90 -87.58 93.7 9.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.9 0.48 . . . . 0.0 110.964 -177.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -155.98 58.09 0.59 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.035 0.534 . . . . 0.0 110.302 161.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 9.2 t70 -89.98 -55.86 3.45 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.652 0.381 . . . . 0.0 111.403 172.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -147.02 21.14 1.25 Allowed 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.63 -168.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 8.24 72.14 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 127.137 2.175 . . . . 0.0 114.84 -169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -121.69 145.25 48.2 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.113 0.965 . . . . 0.0 110.332 -172.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.82 143.34 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 124.08 0.952 . . . . 0.0 109.159 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.3 m -152.0 -165.56 2.26 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.251 1.02 . . . . 0.0 110.805 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.54 121.64 2.3 Favored Glycine 0 C--N 1.356 1.691 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -75.99 -80.22 0.09 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 122.983 0.513 . . . . 0.0 111.582 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.6 t -140.59 145.03 38.72 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 123.286 0.635 . . . . 0.0 109.887 -166.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.59 -39.57 11.87 Favored 'Trans proline' 0 C--N 1.377 2.071 0 C-N-CA 122.731 2.287 . . . . 0.0 112.158 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.47 124.44 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.231 0.612 . . . . 0.0 109.703 174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.77 HD21 ' HB2' ' A' ' 218' ' ' ARG . 3.8 tt -143.68 119.59 10.62 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 33.3 p -78.03 127.96 33.12 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.19 0.996 . . . . 0.0 112.085 -173.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.41 HD11 HG12 ' A' ' 223' ' ' VAL . 54.7 mt -112.7 167.71 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.431 1.492 . . . . 0.0 107.277 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -99.18 126.27 44.93 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 119.954 1.252 . . . . 0.0 110.24 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 43.9 mm -70.26 129.75 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.0 t -136.18 135.51 39.21 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 70.44 7.07 6.08 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.677 1.191 . . . . 0.0 111.782 175.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 57.35 27.21 13.45 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.834 1.254 . . . . 0.0 112.775 -177.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -156.45 -29.83 0.03 OUTLIER Glycine 0 N--CA 1.465 0.632 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.875 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.2 t -106.79 165.87 11.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.269 0.627 . . . . 0.0 110.12 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 20.2 ptm -140.54 130.75 24.99 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.402 0.681 . . . . 0.0 109.267 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.6 p -164.78 178.29 7.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.019 0.928 . . . . 0.0 109.411 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 217' ' ' THR . 10.5 tp -86.55 152.35 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -60.6 126.51 27.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 170.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 36.5 t30 70.9 99.59 0.06 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.269 1.428 . . . . 0.0 110.476 -169.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -106.71 131.37 53.92 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.546 0.738 . . . . 0.0 109.231 174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -122.26 106.23 10.93 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.556 0.742 . . . . 0.0 110.126 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -82.81 -168.7 2.15 Favored 'General case' 0 CA--C 1.559 1.299 0 C-N-CA 124.232 1.013 . . . . 0.0 109.732 169.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 73.42 100.16 0.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 124.571 1.149 . . . . 0.0 109.932 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 49' ' ' THR . 6.0 tt0 -131.01 164.78 24.64 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.189 0.996 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 96' ' ' GLN . 9.5 t -128.84 134.51 48.35 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 164.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.749 ' HA ' ' H ' ' A' ' 164' ' ' GLY . 1.4 pt? -137.53 -17.44 1.3 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 119.554 -0.26 . . . . 0.0 111.342 177.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.32 -55.81 27.11 Favored Glycine 0 C--N 1.36 1.864 0 O-C-N 123.637 0.586 . . . . 0.0 111.892 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.97 -83.37 0.09 OUTLIER Glycine 0 C--N 1.356 1.651 0 O-C-N 123.918 0.422 . . . . 0.0 113.19 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.73 -44.02 16.63 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.782 -0.527 . . . . 0.0 111.782 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.1 -175.37 39.7 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 113.357 0.103 . . . . 0.0 113.357 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.51 ' HB2' ' HG3' ' A' ' 9' ' ' GLU . 32.2 t -90.01 108.37 19.68 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.845 0.858 . . . . 0.0 109.152 177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.67 -86.32 0.09 OUTLIER Glycine 0 C--N 1.355 1.639 0 O-C-N 124.012 0.82 . . . . 0.0 112.498 -178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.19 11.96 0.03 OUTLIER Glycine 0 C--N 1.34 0.771 0 CA-C-O 119.923 -0.376 . . . . 0.0 113.212 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.09 10.63 73.4 Favored Glycine 0 C--N 1.349 1.283 0 CA-C-O 119.633 -0.537 . . . . 0.0 113.806 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.736 ' HA2' ' HE2' ' A' ' 122' ' ' LYS . . . -75.43 -64.98 2.16 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 111.579 -0.609 . . . . 0.0 111.579 174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 66.99 4.21 3.46 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 125.662 1.585 . . . . 0.0 113.94 169.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 66.9 t80 68.06 -0.13 2.2 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.724 1.21 . . . . 0.0 111.326 -167.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.45 11.62 3.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.793 0.837 . . . . 0.0 111.04 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.45 -127.23 0.92 Allowed Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.54 ' HA ' ' HZ2' ' A' ' 87' ' ' LYS . 2.3 t -126.35 -95.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 C-N-CA 124.181 0.992 . . . . 0.0 109.877 -174.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.688 ' HB3' ' HB2' ' A' ' 9' ' ' GLU . 42.1 mt -147.55 163.91 35.09 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 123.725 0.81 . . . . 0.0 111.9 -173.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.413 ' HE1' ' HB2' ' A' ' 122' ' ' LYS . 2.7 m0 -132.08 94.0 3.39 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -174.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.566 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 0.7 OUTLIER 171.71 117.22 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.399 0 C-N-CA 126.565 1.946 . . . . 0.0 109.645 158.714 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.487 HG13 ' HB2' ' A' ' 121' ' ' HIS . 29.4 m -132.19 157.34 78.51 Favored Pre-proline 0 N--CA 1.501 2.078 0 CA-C-N 119.339 0.972 . . . . 0.0 111.955 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -86.18 79.32 1.97 Allowed 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.414 2.076 . . . . 0.0 111.099 171.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.1 t -66.99 126.03 91.84 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.088 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_exo -51.08 -43.73 46.49 Favored 'Trans proline' 0 CA--C 1.575 2.54 0 C-N-CA 122.984 2.456 . . . . 0.0 115.576 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -99.29 108.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 122.254 1.969 . . . . 0.0 113.45 171.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.91 83.83 2.13 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.286 1.991 . . . . 0.0 111.315 174.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.6 p -63.69 -30.5 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 124.208 1.003 . . . . 0.0 112.627 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.6 28.68 3.23 Favored Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.564 -0.615 . . . . 0.0 111.564 175.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 63.7 8.22 3.6 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.917 1.287 . . . . 0.0 112.725 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.28 169.07 11.42 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.003 0.921 . . . . 0.0 108.557 173.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.549 ' HG2' ' HE2' ' A' ' 124' ' ' LYS . 3.9 tp10 60.5 35.16 20.29 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 122.07 0.938 . . . . 0.0 110.492 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.71 86.64 1.81 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 104.285 -2.487 . . . . 0.0 104.285 173.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -83.37 -52.95 6.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.76 -164.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 57.22 100.91 0.02 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 126.074 1.75 . . . . 0.0 111.656 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 159.39 -153.59 24.65 Favored Glycine 0 C--O 1.254 1.381 0 CA-C-N 115.272 -0.877 . . . . 0.0 113.281 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.85 132.99 44.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.429 1.092 . . . . 0.0 108.894 173.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.59 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 8.7 m-85 -122.18 138.92 54.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.352 0.261 . . . . 0.0 110.69 -171.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.682 ' HG3' ' HB2' ' A' ' 11' ' ' ALA . 43.5 mtm180 -73.34 122.67 22.4 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 165.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.774 HG13 HG23 ' A' ' 97' ' ' ILE . 24.5 pt -120.69 146.95 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.639 -173.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.54 ' HZ2' ' HA ' ' A' ' 64' ' ' VAL . 51.6 tttm -152.32 141.51 21.39 Favored 'General case' 0 N--CA 1.507 2.392 0 C-N-CA 126.388 1.875 . . . . 0.0 110.984 -172.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' B' ' 253' ' ' LYS . 44.8 tt0 -123.09 150.91 42.56 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.918 -0.489 . . . . 0.0 111.713 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 94' ' ' TYR . 16.6 ttpp -101.96 84.53 2.54 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 164.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.81 176.17 44.34 Favored Glycine 0 C--N 1.346 1.133 0 CA-C-N 115.553 -0.749 . . . . 0.0 114.235 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' B' ' 253' ' ' LYS . 49.0 mt 59.17 -83.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.342 1.457 . . . . 0.0 111.604 172.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.8 tt -113.13 -30.83 6.84 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.545 0.738 . . . . 0.0 110.205 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -170.87 -173.82 38.29 Favored Glycine 0 C--N 1.349 1.254 0 C-N-CA 121.151 -0.547 . . . . 0.0 113.673 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 89' ' ' LYS . 1.8 m-30 -105.98 72.12 0.93 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.771 ' HB3' ' HE3' ' B' ' 253' ' ' LYS . 37.1 t -135.39 155.61 50.29 Favored 'General case' 0 C--O 1.265 1.875 0 CA-C-O 121.92 0.866 . . . . 0.0 112.737 -163.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.509 ' HB3' HD22 ' A' ' 50' ' ' LEU . 22.8 mp0 -75.3 149.63 38.71 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.062 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.774 HG23 HG13 ' A' ' 86' ' ' ILE . 1.0 OUTLIER -136.73 -43.15 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -167.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.727 ' HA2' ' HB ' ' A' ' 195' ' ' THR . . . 169.32 -124.17 1.14 Allowed Glycine 0 N--CA 1.481 1.672 0 C-N-CA 116.604 -2.712 . . . . 0.0 118.019 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' TYR . . . -128.58 126.47 40.36 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -165.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -100.16 149.97 18.83 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 164.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -135.86 116.41 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.064 0.932 . . . . 0.0 109.93 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.561 ' HB2' ' HD2' ' A' ' 107' ' ' PHE . 50.8 t80 -133.09 138.35 46.67 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 173.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -161.65 151.23 16.47 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 124.008 0.818 . . . . 0.0 109.135 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 67.2 mt-10 65.08 -77.66 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.462 1.505 . . . . 0.0 110.652 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.57 19.88 0.15 Allowed Glycine 0 C--N 1.338 0.694 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 174.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.9 t -123.48 116.73 23.69 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.507 0.723 . . . . 0.0 109.667 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.561 ' HD2' ' HB2' ' A' ' 102' ' ' TYR . 59.9 t80 -97.53 102.91 14.78 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 167.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.53 ' NE2' ' HB3' ' A' ' 137' ' ' LEU . 2.3 t60 -121.24 126.21 49.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.411 HG21 ' C4 ' ' B' ' 251' ' ' BEZ . 9.6 t -135.47 -174.26 3.58 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 108.507 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.464 ' HA ' HD23 ' A' ' 137' ' ' LEU . 82.4 mmm -79.8 160.01 26.31 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.027 0.531 . . . . 0.0 111.535 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 9.0 t90 -84.08 -46.08 12.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.019 170.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 -59.29 -19.15 43.85 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.95 0.9 . . . . 0.0 113.351 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 196' ' ' SER . 24.9 m -65.02 -14.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.439 0.696 . . . . 0.0 112.107 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.549 HG23 ' H ' ' A' ' 116' ' ' GLY . 14.7 t -151.28 -162.14 1.48 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.604 1.162 . . . . 0.0 109.365 -177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 19.3 mtm180 -133.47 21.03 3.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.084 0.954 . . . . 0.0 110.353 171.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 114' ' ' THR . . . 103.4 54.63 0.83 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 2' ' ' SER . . . -101.87 -176.71 3.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.771 0.828 . . . . 0.0 111.429 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.592 HG21 ' HE ' ' A' ' 125' ' ' ARG . 3.0 p -90.75 178.57 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.532 HD23 ' O ' ' A' ' 118' ' ' VAL . 20.9 mt -124.52 166.01 16.8 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.019 0.528 . . . . 0.0 111.183 167.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -164.82 174.84 10.2 Favored 'General case' 0 C--O 1.257 1.488 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -176.414 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.487 ' HB2' HG13 ' A' ' 68' ' ' VAL . 15.8 t60 -137.54 97.53 3.48 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 126.514 1.926 . . . . 0.0 106.795 -177.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.736 ' HE2' ' HA2' ' A' ' 59' ' ' GLY . 9.0 mtmp? 8.91 75.19 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 126.282 1.833 . . . . 0.0 114.064 -159.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.32 -27.49 19.72 Favored Glycine 0 CA--C 1.54 1.64 0 CA-C-N 115.382 -0.826 . . . . 0.0 115.108 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.549 ' HE2' ' HG2' ' A' ' 78' ' ' GLU . 63.7 tttp -82.91 112.43 19.69 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 118.565 1.183 . . . . 0.0 109.939 177.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.592 ' HE ' HG21 ' A' ' 118' ' ' VAL . 75.0 ttt180 -106.4 134.44 49.53 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.514 0.725 . . . . 0.0 112.029 -164.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.62 142.83 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 125.142 1.377 . . . . 0.0 109.138 176.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -98.71 144.1 27.54 Favored Pre-proline 0 N--CA 1.489 1.477 0 C-N-CA 122.95 0.5 . . . . 0.0 112.067 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HA ' ' HB2' ' A' ' 140' ' ' TYR . 22.6 Cg_exo -68.61 138.27 41.26 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.662 2.241 . . . . 0.0 111.562 165.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.442 ' H ' ' HA ' ' A' ' 140' ' ' TYR . 34.5 p -88.85 -7.43 56.16 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -173.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 139' ' ' SER . 5.1 t-105 -151.24 148.14 27.84 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.353 0.661 . . . . 0.0 110.151 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 138' ' ' ILE . . . -146.63 124.21 11.77 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.923 0.889 . . . . 0.0 109.438 171.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -130.22 117.79 20.4 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.623 0.769 . . . . 0.0 110.727 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.23 -27.73 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 123.78 0.832 . . . . 0.0 111.492 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -62.69 -56.66 15.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.61 0.764 . . . . 0.0 111.128 -170.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -97.34 1.09 49.03 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.513 0.725 . . . . 0.0 109.895 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.7 t70 61.41 54.34 3.16 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.627 1.571 . . . . 0.0 111.686 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.561 HD11 ' HB1' ' A' ' 227' ' ' ALA . 36.6 mt -144.31 145.8 32.21 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.393 0.616 . . . . 0.0 112.456 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 131' ' ' ALA . 30.8 mt -120.84 143.8 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 125.841 1.657 . . . . 0.0 110.253 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' A' ' 130' ' ' TRP . 2.2 m -120.32 158.19 27.62 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.202 0.525 . . . . 0.0 110.228 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 3.4 t80 -151.41 135.66 16.78 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.846 1.258 . . . . 0.0 107.881 172.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 96.26 9.53 56.8 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 147.26 -172.6 27.65 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -77.13 -179.84 49.29 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 3.4 t90 -75.37 123.19 24.94 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.503 0.721 . . . . 0.0 110.342 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -164.01 147.22 9.63 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.238 1.415 . . . . 0.0 107.568 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 74.52 -142.06 0.03 OUTLIER 'General case' 0 CA--C 1.568 1.655 0 O-C-N 124.314 1.009 . . . . 0.0 108.716 -171.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 64.55 37.21 8.09 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.743 1.617 . . . . 0.0 111.353 -175.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -52.84 168.08 0.96 Allowed Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.303 -0.862 . . . . 0.0 114.786 -175.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 150' ' ' TRP . 25.3 tt0 -143.86 129.97 19.65 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.236 0.614 . . . . 0.0 109.888 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.522 ' HH2' HG21 ' A' ' 226' ' ' ILE . 1.5 p90 -65.28 150.61 47.94 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.677 0.791 . . . . 0.0 110.166 164.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -84.69 148.82 26.2 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.52 92.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.765 1.226 . . . . 0.0 111.705 178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 155.66 -18.7 0.5 Allowed Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.494 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.402 ' HB2' ' HD1' ' A' ' 150' ' ' TRP . 32.9 mt-10 -96.6 152.67 18.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.879 0.872 . . . . 0.0 109.311 175.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -94.75 114.03 25.88 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 4.2 p -97.01 164.17 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 120.754 0.312 . . . . 0.0 111.143 -175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 171' ' ' GLN . 22.3 mp0 -105.91 147.68 28.48 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.931 0.892 . . . . 0.0 109.169 -176.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.9 p -139.04 143.07 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 122.901 0.48 . . . . 0.0 110.965 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 96.6 mt -92.41 93.72 8.74 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 171.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -82.33 100.62 10.06 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.89 97.79 1.17 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -57.66 133.04 82.51 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.239 0.616 . . . . 0.0 111.645 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.83 113.15 1.51 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.506 2.137 . . . . 0.0 112.49 -176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.749 ' H ' ' HA ' ' A' ' 50' ' ' LEU . . . 73.08 29.43 64.69 Favored Glycine 0 C--N 1.345 1.032 0 CA-C-N 115.403 -0.817 . . . . 0.0 113.056 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 166' ' ' ASN . 81.4 tttt -151.84 177.27 10.59 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 117.351 0.575 . . . . 0.0 110.045 -174.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.415 ' H ' ' HG2' ' A' ' 165' ' ' LYS . 1.8 p-10 -57.72 160.51 7.78 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 124.307 1.043 . . . . 0.0 112.343 170.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.89 141.1 88.6 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.97 2.447 . . . . 0.0 112.378 169.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 22.6 ttt180 -112.37 116.03 29.68 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 172.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -96.37 108.14 20.62 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.182 0.593 . . . . 0.0 109.561 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.68 136.06 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.536 0.734 . . . . 0.0 110.082 -177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 157' ' ' GLN . 30.5 tt0 -87.8 149.85 23.91 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.864 0.866 . . . . 0.0 109.173 173.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.5 t -154.66 147.97 24.98 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 123.765 0.826 . . . . 0.0 110.744 -172.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -75.61 158.39 83.18 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.08 172.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.17 146.1 93.95 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.203 1.935 . . . . 0.0 112.821 174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -145.7 130.87 3.93 Favored Glycine 0 N--CA 1.494 2.526 0 CA-C-O 122.114 0.841 . . . . 0.0 114.515 177.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.442 ' HA ' ' HA3' ' A' ' 185' ' ' GLY . 0.2 OUTLIER -127.24 149.71 49.88 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 121.345 -1.091 . . . . 0.0 112.564 -171.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.11 123.25 35.32 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.682 174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -89.13 106.21 18.29 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 182' ' ' GLY . 23.5 m -82.81 158.01 22.94 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 123.655 0.782 . . . . 0.0 110.756 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -82.85 57.32 3.79 Favored 'General case' 0 CA--C 1.555 1.144 0 CA-C-O 122.053 0.93 . . . . 0.0 108.535 168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -175.43 -53.1 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.009 1.724 . . . . 0.0 108.003 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 179' ' ' THR . . . -153.31 -131.0 1.55 Allowed Glycine 0 C--N 1.35 1.32 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.718 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 8.1 t -162.1 131.72 4.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.583 0.753 . . . . 0.0 109.751 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.45 138.1 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.44 0.696 . . . . 0.0 109.44 175.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.832 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 138.42 161.96 9.01 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 119.43 -0.65 . . . . 0.0 112.886 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -176.35 42.29 0.01 OUTLIER 'General case' 0 C--O 1.204 -1.316 0 O-C-N 124.655 0.856 . . . . 0.0 110.382 170.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.455 ' N ' ' H ' ' A' ' 175' ' ' GLY . 9.5 p -166.46 104.84 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.517 0 O-C-N 120.232 -1.543 . . . . 0.0 109.73 166.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.7 m -129.76 106.19 8.53 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.542 0.737 . . . . 0.0 109.54 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.542 HD13 ' HD2' ' A' ' 191' ' ' PHE . 3.8 pp -131.88 159.15 39.45 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 122.924 0.49 . . . . 0.0 111.436 174.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -96.8 103.2 15.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.459 0.704 . . . . 0.0 110.333 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.542 ' HD2' HD13 ' A' ' 189' ' ' LEU . 17.7 m-85 -157.72 -175.74 5.54 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.491 1.516 . . . . 0.0 108.455 172.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.1 m -44.07 139.91 2.94 Favored Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 124.549 1.14 . . . . 0.0 110.769 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -49.22 116.48 2.27 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.484 2.122 . . . . 0.0 111.204 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -51.74 111.87 1.63 Allowed Glycine 0 C--N 1.349 1.29 0 O-C-N 124.153 0.908 . . . . 0.0 112.194 -175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . 0.727 ' HB ' ' HA2' ' A' ' 98' ' ' GLY . 25.2 p -50.66 124.26 10.56 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 125.004 1.322 . . . . 0.0 111.129 -174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.592 ' HB3' HG12 ' A' ' 113' ' ' VAL . 36.1 m -55.65 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.563 0 O-C-N 123.901 0.751 . . . . 0.0 110.071 -171.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 110' ' ' MET . . . 127.87 4.96 5.48 Favored Glycine 0 C--N 1.366 2.226 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.4 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 67.1 m -49.67 129.67 19.89 Favored Pre-proline 0 N--CA 1.5 2.041 0 C-N-CA 124.462 1.105 . . . . 0.0 113.456 -171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -83.39 133.84 6.46 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.752 2.302 . . . . 0.0 113.223 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.426 HG21 ' CZ3' ' A' ' 150' ' ' TRP . 50.3 mt -105.81 110.97 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.801 1.241 . . . . 0.0 109.588 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 208' ' ' VAL . 12.8 pt -131.8 -175.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.803 1.241 . . . . 0.0 112.432 -168.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 206' ' ' LYS . 36.3 t70 -114.98 175.98 5.26 Favored 'General case' 0 CA--C 1.551 1.001 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.139 169.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . 0.603 ' HB3' ' HE3' ' A' ' 16' ' ' TRP . 0.0 OUTLIER -60.54 -30.45 69.77 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.967 0.507 . . . . 0.0 112.053 172.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -84.98 -0.77 55.47 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.731 0.413 . . . . 0.0 111.963 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 71.56 23.85 77.52 Favored Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.921 -0.471 . . . . 0.0 111.921 -168.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 202' ' ' ASP . 64.5 tttp -76.31 165.1 25.34 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.729 1.211 . . . . 0.0 109.605 169.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.491 HG12 ' H ' ' A' ' 209' ' ' GLY . 94.4 t 81.99 -89.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.959 1.304 . . . . 0.0 108.048 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 201' ' ' ILE 0.28 3.1 m 68.21 31.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 125.08 1.352 . . . . 0.0 110.187 175.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.491 ' H ' HG12 ' A' ' 207' ' ' VAL . . . -72.43 -174.22 23.83 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 113.529 -1.669 . . . . 0.0 109.87 168.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 80.6 mt -137.3 154.53 50.06 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.349 -172.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . 0.568 ' CE2' ' HA ' ' A' ' 196' ' ' SER . 0.0 OUTLIER -68.37 116.16 8.63 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 175.644 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 225' ' ' ALA . . . -71.61 -162.68 5.47 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.688 -0.292 . . . . 0.0 113.733 -176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -71.63 84.12 0.87 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.852 0.834 . . . . 0.0 109.523 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 224' ' ' SER . . . -127.15 -174.62 13.84 Favored Glycine 0 C--N 1.344 0.99 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.219 177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 7.2 p -160.12 176.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 C-N-CA 123.323 0.649 . . . . 0.0 109.277 -168.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.7 115.15 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 169.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.784 HG23 HD13 ' A' ' 41' ' ' ILE . 14.8 m -129.6 158.77 38.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.68 1.192 . . . . 0.0 109.783 -177.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.77 ' HB2' HD21 ' A' ' 29' ' ' LEU . 4.1 tmm_? 63.65 76.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 124.647 1.179 . . . . 0.0 110.581 177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 59.2 p 49.12 23.07 0.7 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.865 1.666 . . . . 0.0 114.577 175.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 104.64 60.05 0.67 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 113.794 0.278 . . . . 0.0 113.794 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.83 152.11 50.52 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.782 0.833 . . . . 0.0 109.065 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -83.36 118.84 23.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.676 0.39 . . . . 0.0 110.428 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.41 HG12 HD11 ' A' ' 31' ' ' ILE . 14.6 t -134.39 116.65 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.168 0.587 . . . . 0.0 109.577 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.404 ' HA ' ' HA3' ' A' ' 214' ' ' GLY . 45.7 t -130.88 156.76 44.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.832 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -101.8 93.26 5.22 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.171 173.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.522 HG21 ' HH2' ' A' ' 150' ' ' TRP . 22.9 pt -53.05 141.55 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 -161.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.561 ' HB1' HD11 ' A' ' 137' ' ' LEU . . . -91.35 138.34 31.66 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.68 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.91 171.56 13.04 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.028 0.931 . . . . 0.0 111.975 -166.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . . . . . . . . . 5.6 t -67.46 149.07 50.7 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.066 168.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.95 -13.64 6.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.136 155.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt 33.2 87.77 0.01 OUTLIER 'General case' 0 C--N 1.38 1.914 0 C-N-CA 126.03 1.732 . . . . 0.0 112.821 -176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.5 m -52.66 99.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.742 0.817 . . . . 0.0 111.552 -174.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 42.4 mm 68.91 146.47 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 125.623 1.569 . . . . 0.0 111.665 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.12 61.55 6.94 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 121.915 0.864 . . . . 0.0 111.438 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -76.21 -29.65 57.68 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.047 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.459 HD22 ' HA ' ' A' ' 239' ' ' ILE . 5.7 t30 -55.65 114.71 7.84 Favored Pre-proline 0 CA--C 1.549 0.915 0 O-C-N 124.527 1.142 . . . . 0.0 110.874 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.03 120.14 7.26 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.161 1.908 . . . . 0.0 110.102 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 62.99 67.07 0.7 Allowed 'General case' 0 CA--C 1.543 0.704 0 O-C-N 124.39 1.056 . . . . 0.0 108.718 -170.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.459 ' HA ' HD22 ' A' ' 236' ' ' ASN . 10.0 tt -70.8 -30.58 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-N 114.002 -1.454 . . . . 0.0 110.93 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.927 0.891 . . . . 0.0 109.272 178.588 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.521 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.701 ' HA ' HD13 ' A' ' 97' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.771 ' HE3' ' HB3' ' A' ' 95' ' ' SER . 0.1 OUTLIER 69.95 -63.13 0.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 127.597 2.359 . . . . 0.0 114.219 -172.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 49.8 tpt85 -43.87 -44.28 6.87 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -164.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.469 ' H ' ' HB3' ' A' ' 115' ' ' ARG . 15.2 m -107.26 91.59 3.72 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -177.6 -78.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.194 1.398 . . . . 0.0 108.384 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.12 26.62 12.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.778 1.231 . . . . 0.0 110.876 175.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 89' ' ' LYS . 8.5 m-20 -155.19 40.04 0.42 Allowed 'General case' 0 C--O 1.242 0.668 0 C-N-CA 125.405 1.482 . . . . 0.0 107.166 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.54 ' HB2' ' HA ' ' A' ' 119' ' ' LEU . 90.2 mt -79.91 92.86 5.58 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.542 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 120' ' ' MET . 21.1 mt-10 -98.61 126.84 44.33 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 124.448 1.099 . . . . 0.0 110.177 -174.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -117.42 162.75 17.44 Favored 'General case' 0 N--CA 1.515 2.824 0 O-C-N 120.934 -1.104 . . . . 0.0 113.67 -177.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' LEU . 9.3 pt-20 -148.35 161.36 41.71 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.443 1.097 . . . . 0.0 110.269 175.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.719 ' H ' ' HB3' ' A' ' 67' ' ' ASP . 12.7 tpt180 -66.98 153.28 44.02 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.647 0.779 . . . . 0.0 111.43 175.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 85' ' ' ARG . . . -125.7 -52.39 1.58 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.906 0.883 . . . . 0.0 109.915 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.26 -166.66 0.55 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.784 1.234 . . . . 0.0 108.88 -176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.445 ' HA ' ' HA3' ' A' ' 82' ' ' GLY . 36.7 t70 -95.82 153.09 17.93 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.628 HG21 HG23 ' A' ' 101' ' ' VAL . 5.1 t -73.28 99.57 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 106.147 -1.798 . . . . 0.0 106.147 172.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -162.44 149.12 13.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -168.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.62 112.05 5.16 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 166.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 169' ' ' ALA . 0.6 OUTLIER -75.15 144.2 42.9 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.037 0.535 . . . . 0.0 109.827 -178.151 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.28 -19.43 64.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.61 48.99 1.67 Allowed 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.833 0.825 . . . . 0.0 109.605 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 169' ' ' ALA . . . -92.04 115.15 27.82 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.719 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -162.03 83.57 0.58 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 165.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.58 ' HB ' ' H ' ' A' ' 171' ' ' GLN . 29.4 mm -149.69 163.28 4.01 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.469 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 173.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 p -162.79 101.63 1.02 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.297 1.439 . . . . 0.0 108.077 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.34 -107.14 1.47 Allowed Glycine 0 C--N 1.344 1.01 0 CA-C-N 116.202 -0.453 . . . . 0.0 113.038 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 173' ' ' LYS . 11.6 t 63.64 41.71 6.94 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.958 0.903 . . . . 0.0 109.927 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.6 m -64.65 146.0 98.5 Favored Pre-proline 0 CA--C 1.554 1.134 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.16 177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -54.12 178.19 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.917 3.078 . . . . 0.0 114.992 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 mm -65.69 108.57 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.6 tt -93.0 158.37 15.83 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.757 -169.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -105.4 118.27 36.14 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 121.62 -0.675 . . . . 0.0 110.574 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.561 HD11 HG21 ' A' ' 223' ' ' VAL . 40.9 mt -126.21 150.94 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.895 0.878 . . . . 0.0 108.997 177.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.9 p -98.42 113.11 24.97 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.1 tp -65.22 159.37 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.007 0 C-N-CA 123.156 0.583 . . . . 0.0 110.346 -178.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -135.59 120.14 18.17 Favored 'General case' 0 C--O 1.257 1.464 0 C-N-CA 123.525 0.73 . . . . 0.0 109.422 -176.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 67.8 -74.56 0.07 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 125.221 1.576 . . . . 0.0 110.876 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -158.64 -57.9 0.07 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.69 0.796 . . . . 0.0 109.309 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -103.78 -11.3 33.02 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.232 -0.894 . . . . 0.0 114.238 -174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 49.0 m -92.24 159.9 15.41 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.482 1.141 . . . . 0.0 108.981 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 68.6 mtp -132.97 143.01 49.17 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 122.676 0.39 . . . . 0.0 110.454 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.1 m -143.37 153.7 42.98 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.433 0.693 . . . . 0.0 110.521 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.72 HG13 ' H ' ' A' ' 43' ' ' ASN . 7.3 tp -95.99 145.31 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 172.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -77.19 1.31 18.76 Favored 'General case' 0 CA--C 1.564 1.506 0 CA-C-O 121.694 0.759 . . . . 0.0 111.323 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.72 ' H ' HG13 ' A' ' 41' ' ' ILE . 21.0 m120 -100.89 179.8 4.28 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.318 1.047 . . . . 0.0 109.5 171.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.3 143.28 33.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.736 0.814 . . . . 0.0 109.458 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -162.0 141.77 9.96 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.266 0.626 . . . . 0.0 109.569 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -81.13 108.49 14.83 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.57 -107.55 0.0 OUTLIER 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.717 0.807 . . . . 0.0 111.155 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.727 ' HA ' HG22 ' A' ' 97' ' ' ILE . 49.7 mt-30 64.74 -176.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 172.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 49.9 p 64.45 112.42 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 126.711 2.004 . . . . 0.0 113.82 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 161' ' ' LEU . 0.3 OUTLIER -156.4 -77.17 0.09 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 167.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.39 -26.37 73.57 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 115.636 -0.711 . . . . 0.0 114.46 -168.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.57 56.84 5.03 Favored Glycine 0 C--N 1.345 1.048 0 C-N-CA 122.84 0.257 . . . . 0.0 113.322 -176.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.08 4.36 4.57 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 170.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.88 175.31 16.61 Favored Glycine 0 C--N 1.356 1.661 0 N-CA-C 111.72 -0.552 . . . . 0.0 111.72 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 46.9 t -130.73 137.56 49.56 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.305 0.642 . . . . 0.0 110.441 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.69 -29.34 35.77 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.59 -82.2 1.13 Allowed Glycine 0 C--N 1.35 1.319 0 C-N-CA 122.909 0.29 . . . . 0.0 113.158 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -141.78 127.82 3.41 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -173.07 -124.37 0.77 Allowed Glycine 0 C--N 1.342 0.883 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -94.58 -63.48 1.17 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -113.24 -66.08 1.12 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.539 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -176.32 -41.54 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.167 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.87 113.79 0.94 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.943 -174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.519 ' O ' ' HD2' ' A' ' 122' ' ' LYS . 30.3 m -82.49 76.14 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.197 0 CA-C-O 121.706 0.765 . . . . 0.0 111.595 -176.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 96' ' ' GLN . 6.0 mt 85.48 87.53 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.874 1.67 . . . . 0.0 111.825 176.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TRP . . . . . 0.604 ' HE1' ' HG2' ' A' ' 122' ' ' LYS . 6.4 m0 -102.06 105.39 16.12 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.719 ' HB3' ' H ' ' A' ' 10' ' ' ARG . 28.6 t70 177.63 100.0 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 125.225 1.578 . . . . 0.0 109.233 155.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.412 HG22 HD22 ' A' ' 8' ' ' LEU . 67.3 t -128.36 146.73 60.91 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.488 0.715 . . . . 0.0 110.374 -172.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.575 ' HD2' HD21 ' A' ' 8' ' ' LEU . 10.7 Cg_endo -54.89 79.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.421 2.081 . . . . 0.0 110.645 157.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.8 p -65.32 128.49 93.84 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.833 -169.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' HG3' HG12 ' A' ' 126' ' ' ILE . 72.4 Cg_exo -49.39 -47.3 22.91 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.369 2.713 . . . . 0.0 115.422 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -59.43 124.2 15.01 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 121.927 1.751 . . . . 0.0 113.06 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -86.03 49.83 2.36 Favored 'Trans proline' 0 C--N 1.376 2.004 0 C-N-CA 123.408 2.739 . . . . 0.0 112.245 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.8 m -74.55 2.46 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.738 0.815 . . . . 0.0 112.793 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.34 -58.28 2.71 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 112.369 -0.292 . . . . 0.0 112.369 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.99 -83.77 0.15 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.102 0.561 . . . . 0.0 109.489 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 57.02 -158.93 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.999 0.92 . . . . 0.0 112.894 173.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -79.37 -85.64 0.08 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 tm? 40.59 86.63 0.02 OUTLIER 'General case' 0 C--N 1.361 1.074 0 C-N-CA 126.197 1.799 . . . . 0.0 112.797 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -118.78 -169.18 1.68 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.4 142.23 20.05 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.08 0.552 . . . . 0.0 109.736 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.578 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 147.28 -154.12 25.76 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 178.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.55 137.55 46.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 171.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.495 ' CD2' HD23 ' A' ' 8' ' ' LEU . 7.7 m-85 -123.39 139.82 53.64 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.944 0.498 . . . . 0.0 111.348 -173.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG3' HD13 ' A' ' 161' ' ' LEU . 21.9 mtp180 -92.75 126.57 37.9 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 172.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.765 HD12 ' H6 ' ' B' ' 251' ' ' BEZ . 15.1 pt -129.93 143.95 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.551 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -166.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -139.52 138.12 36.05 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 126.329 1.852 . . . . 0.0 112.151 -172.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.654 ' HB3' ' HG2' ' B' ' 252' ' ' NLE . 0.0 OUTLIER -132.5 153.55 50.8 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 170.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 45.1 mtpt -106.97 88.97 2.86 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' B' ' 253' ' ' LYS . . . -168.64 178.11 42.24 Favored Glycine 0 C--O 1.221 -0.692 0 N-CA-C 110.616 -0.993 . . . . 0.0 110.616 -174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.7 mt 59.42 23.15 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-N 118.008 0.904 . . . . 0.0 111.409 166.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.1 mp 71.45 41.65 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 125.052 1.341 . . . . 0.0 111.538 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -172.07 156.09 24.92 Favored Glycine 0 C--N 1.355 1.602 0 C-N-CA 121.728 -0.272 . . . . 0.0 113.57 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -119.63 68.94 0.83 Allowed 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.564 1.146 . . . . 0.0 108.2 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.0 m -113.26 125.06 53.89 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -159.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.471 ' HB2' HD11 ' A' ' 65' ' ' LEU . 3.4 pm0 -95.82 104.21 16.13 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.318 1.447 . . . . 0.0 108.893 170.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.727 HG22 ' HA ' ' A' ' 48' ' ' GLN . 2.8 pp -137.14 -37.75 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -161.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 97' ' ' ILE . . . -120.13 -168.96 13.91 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.284 -1.436 . . . . 0.0 116.129 -154.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.458 ' O ' ' HA3' ' A' ' 197' ' ' GLY . . . -125.97 138.49 53.76 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.565 -0.817 . . . . 0.0 110.879 -172.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -133.37 -176.26 14.32 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.834 -0.907 . . . . 0.0 110.834 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.815 HG13 ' HB2' ' A' ' 108' ' ' HIS . 0.2 OUTLIER -152.46 109.84 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.426 0.69 . . . . 0.0 109.323 -178.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.497 ' HB2' ' HD1' ' A' ' 107' ' ' PHE . 84.2 t80 -107.09 136.21 47.33 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 174.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -147.99 110.83 4.78 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 124.645 1.178 . . . . 0.0 109.087 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 45.38 68.5 0.56 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.587 1.555 . . . . 0.0 113.101 168.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 -30.08 6.18 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.555 178.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 140' ' ' TYR . 9.8 m -105.41 116.34 31.79 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 117.548 0.674 . . . . 0.0 111.555 -172.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.663 ' HB3' ' HB3' ' A' ' 140' ' ' TYR . 87.8 t80 -93.81 144.25 25.59 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 172.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.815 ' HB2' HG13 ' A' ' 101' ' ' VAL . 25.2 m80 -132.19 122.68 25.66 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.866 0.866 . . . . 0.0 109.174 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.41 HG21 ' C4 ' ' B' ' 251' ' ' BEZ . 15.2 t -141.98 -179.67 6.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 123.569 0.748 . . . . 0.0 111.462 175.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.631 ' SD ' ' HB3' ' A' ' 210' ' ' LEU . 79.9 mmm -89.66 173.25 8.4 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.639 1.176 . . . . 0.0 109.856 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.08 -59.45 2.29 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 122.091 -0.381 . . . . 0.0 111.609 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -53.72 -28.21 32.71 Favored 'General case' 0 N--CA 1.504 2.271 0 C-N-CA 125.131 1.372 . . . . 0.0 114.16 -168.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.427 HG23 ' H2 ' ' B' ' 251' ' ' BEZ . 4.2 m -56.1 -25.63 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.239 0 C-N-CA 124.531 1.132 . . . . 0.0 113.021 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.648 HG23 ' H ' ' A' ' 116' ' ' GLY . 2.9 t -142.19 -166.63 2.29 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 170.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.469 ' HB3' ' H ' ' A' ' 2' ' ' SER . 17.3 tpt180 -111.42 33.51 4.66 Favored 'General case' 0 CA--C 1.556 1.21 0 CA-C-O 121.065 0.459 . . . . 0.0 111.443 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 114' ' ' THR . . . 71.73 58.57 5.25 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.965 176.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.69 -172.37 2.07 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.516 0.726 . . . . 0.0 111.972 -170.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.9 p -100.14 148.67 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 C-N-CA 124.442 1.097 . . . . 0.0 111.755 -173.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.665 HD21 ' H4 ' ' B' ' 251' ' ' BEZ . 2.9 mm? -91.11 168.99 11.22 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.549 1.14 . . . . 0.0 111.211 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' MET . . . . . 0.49 ' SD ' ' N ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -172.77 163.81 5.14 Favored 'General case' 0 C--O 1.263 1.772 0 CA-C-O 123.869 1.795 . . . . 0.0 114.862 -179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 35.0 t60 -106.76 95.21 5.57 Favored 'General case' 0 C--N 1.348 0.518 0 CA-C-N 111.979 -2.373 . . . . 0.0 107.78 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.604 ' HG2' ' HE1' ' A' ' 66' ' ' TRP . 0.9 OUTLIER 48.97 48.09 21.01 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.005 0.922 . . . . 0.0 112.45 164.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 101.64 -8.48 56.5 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 114.735 0.654 . . . . 0.0 114.735 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -100.25 110.55 22.8 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 117.997 0.899 . . . . 0.0 109.068 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.46 ' HA ' ' HB3' ' A' ' 120' ' ' MET . 11.5 ttp180 -82.1 151.04 27.19 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -162.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.452 HG12 ' HG3' ' A' ' 71' ' ' PRO . 66.8 mt -142.51 121.68 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.038 1.735 . . . . 0.0 108.151 -178.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -77.4 129.91 76.08 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 123.14 0.576 . . . . 0.0 111.395 -176.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.62 170.57 19.95 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.781 2.321 . . . . 0.0 111.015 167.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.6 p -125.14 -29.69 3.27 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.575 0.75 . . . . 0.0 111.861 -172.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.435 ' HB3' ' OG ' ' A' ' 139' ' ' SER . 14.4 t-105 -131.22 143.74 50.8 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.762 0.825 . . . . 0.0 109.721 -176.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.82 122.42 4.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.498 1.119 . . . . 0.0 108.285 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -140.98 119.81 12.61 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.276 0.631 . . . . 0.0 110.178 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 29.7 m -76.4 -24.39 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 124.291 1.037 . . . . 0.0 113.056 -176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -72.99 -42.41 63.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.16 0.505 . . . . 0.0 110.924 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -95.18 -8.89 34.98 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.532 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 t70 60.22 57.78 2.83 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.992 1.317 . . . . 0.0 110.644 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.405 HD13 ' CE2' ' A' ' 144' ' ' TRP . 98.0 mt -144.87 137.07 26.03 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.412 0.685 . . . . 0.0 110.961 -174.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 75.2 mt -128.27 140.64 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 125.273 1.429 . . . . 0.0 108.864 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.435 ' OG ' ' HB3' ' A' ' 130' ' ' TRP . 51.3 p -142.93 161.15 38.87 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.874 0.845 . . . . 0.0 112.99 178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.663 ' HB3' ' HB3' ' A' ' 107' ' ' PHE . 23.9 t80 -116.52 143.64 45.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.956 1.702 . . . . 0.0 107.847 174.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 106.14 -13.45 44.59 Favored Glycine 0 N--CA 1.479 1.529 0 O-C-N 123.393 0.433 . . . . 0.0 113.269 175.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 155.53 -151.41 22.97 Favored Glycine 0 C--N 1.341 0.833 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.2 173.69 38.93 Favored Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.661 ' HE1' ' HA ' ' A' ' 229' ' ' THR . 59.4 t-105 -69.12 108.84 3.75 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 231' ' ' LYS . 22.8 pttp -147.92 137.87 22.67 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.829 0.452 . . . . 0.0 110.278 -177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.484 HD23 HG21 ' A' ' 229' ' ' THR . 15.8 tp -160.81 -90.74 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.497 175.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -172.42 -68.1 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 118.91 0.777 . . . . 0.0 110.1 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.79 152.34 48.39 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 114.644 -1.162 . . . . 0.0 115.391 -161.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.13 127.26 17.5 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.998 0.919 . . . . 0.0 108.893 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.411 ' HZ2' ' HG3' ' A' ' 174' ' ' PRO . 47.7 t-105 -91.8 136.86 32.83 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.065 0.46 . . . . 0.0 111.35 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -134.82 127.48 30.91 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 168.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.42 125.93 25.55 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.965 0.906 . . . . 0.0 112.482 -170.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -178.36 -69.49 0.06 OUTLIER Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.84 -177.65 6.66 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.718 0.807 . . . . 0.0 109.817 173.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 173' ' ' LYS . 8.1 pt-20 -104.14 147.46 27.41 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.927 0.491 . . . . 0.0 110.859 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 m -109.36 171.21 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.586 0.754 . . . . 0.0 110.746 -177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.447 ' HG3' ' HB1' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -128.03 147.76 50.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.512 1.125 . . . . 0.0 108.507 176.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.459 HG12 HG12 ' A' ' 200' ' ' ILE . 29.4 m -122.86 139.59 49.21 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 C-N-CA 123.562 0.745 . . . . 0.0 109.449 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.677 ' HB2' ' HD2' ' A' ' 199' ' ' PRO . 90.4 mt -80.54 86.07 5.88 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -76.69 100.39 5.39 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.785 HD23 ' HB3' ' A' ' 167' ' ' PRO . 62.5 mt -68.94 106.03 2.59 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -175.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' LYS . 19.4 mm-40 -67.58 133.83 92.7 Favored Pre-proline 0 CA--C 1.546 0.815 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.636 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.21 112.43 1.08 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.476 2.117 . . . . 0.0 112.169 178.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 67.81 20.92 72.81 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-N 115.046 -0.979 . . . . 0.0 114.846 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 162' ' ' GLU . 76.1 mmtt -138.57 -175.0 3.98 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.831 0.852 . . . . 0.0 109.99 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -81.36 152.16 70.1 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.539 0.736 . . . . 0.0 110.717 173.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . 0.785 ' HB3' HD23 ' A' ' 161' ' ' LEU . 30.4 Cg_endo -62.98 137.59 63.18 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.868 2.379 . . . . 0.0 113.585 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 53.2 mtt180 -81.08 135.3 35.79 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.168 167.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 20' ' ' ALA . . . -81.4 105.2 12.39 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 166.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.513 HG13 HG13 ' A' ' 22' ' ' ILE . 51.3 t -112.17 116.13 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.441 0.696 . . . . 0.0 109.305 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . 0.58 ' H ' ' HB ' ' A' ' 22' ' ' ILE . 9.3 tt0 -108.71 137.41 46.69 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.834 0.349 . . . . 0.0 110.606 -165.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 4.4 t -153.75 147.02 24.76 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.82 0.848 . . . . 0.0 110.298 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 97.3 mttt -72.37 162.15 75.37 Favored Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.652 172.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 186' ' ' ALA . 50.0 Cg_exo -55.86 131.83 48.37 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.724 2.282 . . . . 0.0 111.717 175.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ALA . . . -147.66 150.75 23.03 Favored Glycine 0 N--CA 1.482 1.726 0 CA-C-O 122.254 0.919 . . . . 0.0 114.897 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 176' ' ' LEU . 1.0 OUTLIER -140.38 167.85 21.19 Favored 'General case' 0 C--O 1.239 0.55 0 O-C-N 121.101 -1.235 . . . . 0.0 111.235 -170.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.22 136.16 33.1 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 113.191 -1.822 . . . . 0.0 108.946 -171.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -77.63 144.47 37.41 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.859 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 180' ' ' ASN . 2.3 m -102.85 179.25 4.33 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.776 1.231 . . . . 0.0 108.932 -176.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.43 ' H ' HG22 ' A' ' 179' ' ' THR . 20.2 m120 -68.03 -18.24 64.64 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 122.877 0.471 . . . . 0.0 111.893 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.38 -68.21 0.87 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.053 0.941 . . . . 0.0 110.016 172.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -93.8 -142.2 11.85 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.662 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 4.8 t -163.25 135.85 5.38 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.465 1.106 . . . . 0.0 108.842 174.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.36 165.89 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.164 0.586 . . . . 0.0 109.801 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.791 ' HA2' ' HA ' ' A' ' 225' ' ' ALA . . . 133.82 167.98 11.71 Favored Glycine 0 N--CA 1.471 0.994 0 CA-C-O 120.278 -0.179 . . . . 0.0 113.313 174.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 175' ' ' GLY . . . -171.03 34.28 0.02 OUTLIER 'General case' 0 C--O 1.198 -1.635 0 O-C-N 124.163 0.567 . . . . 0.0 110.812 173.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.475 ' N ' ' H ' ' A' ' 175' ' ' GLY . 2.2 t -164.87 117.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 126.565 1.946 . . . . 0.0 106.837 163.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.7 t -129.45 121.71 27.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 30.5 tp -144.42 151.46 39.27 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.86 0.864 . . . . 0.0 110.084 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -102.68 105.16 15.57 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 170.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.458 ' H ' ' HA ' ' A' ' 221' ' ' ALA . 62.2 t80 -160.86 162.34 32.15 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.767 0.827 . . . . 0.0 109.121 -172.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 22.8 p -60.12 158.62 25.7 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 123.955 0.902 . . . . 0.0 111.422 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -43.81 107.88 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.683 2.922 . . . . 0.0 113.016 176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . -72.74 158.53 53.18 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.072 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' THR . . . . . . . . . . . . . 47.6 p -84.12 105.26 14.84 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 122.977 0.511 . . . . 0.0 109.959 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -56.75 110.06 0.73 Allowed 'General case' 0 C--N 1.35 0.613 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.574 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 99' ' ' ALA . . . 118.89 12.9 6.84 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 113.231 -1.804 . . . . 0.0 111.145 -176.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 69.0 m -57.2 117.32 17.36 Favored Pre-proline 0 C--N 1.366 1.291 0 C-N-CA 122.899 0.48 . . . . 0.0 110.794 173.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PRO . . . . . 0.677 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 49.3 Cg_exo -58.7 112.77 1.3 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 122.933 2.422 . . . . 0.0 112.256 175.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.459 HG12 HG12 ' A' ' 158' ' ' VAL . 58.9 mt -80.48 96.56 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.788 0.835 . . . . 0.0 109.304 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 208' ' ' VAL . 30.8 mt -119.57 134.18 63.97 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -87.26 -179.86 6.49 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 118.951 0.796 . . . . 0.0 109.456 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -63.41 -25.72 68.41 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.186 0.594 . . . . 0.0 112.527 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -77.43 -19.71 55.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.982 0.513 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 95.18 36.28 5.5 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.417 0.448 . . . . 0.0 112.221 178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -130.22 166.79 19.57 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.215 1.006 . . . . 0.0 110.133 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 79.9 t 99.51 -60.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 127.14 2.176 . . . . 0.0 109.518 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.435 HG12 HG12 ' A' ' 201' ' ' ILE . 33.2 m 49.74 32.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 C-N-CA 124.869 1.267 . . . . 0.0 112.268 170.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.518 ' HA2' HG23 ' A' ' 229' ' ' THR . . . -76.78 -157.16 7.69 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.434 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.631 ' HB3' ' SD ' ' A' ' 110' ' ' MET . 24.4 mt -139.75 124.8 18.68 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.452 0.644 . . . . 0.0 112.582 -174.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -74.16 124.35 26.17 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.989 164.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 176.81 66.82 0.06 OUTLIER Glycine 0 CA--C 1.493 -1.336 0 N-CA-C 108.414 -1.874 . . . . 0.0 108.414 158.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 225' ' ' ALA . 14.6 m120 -154.8 171.96 18.75 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -173.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLY . . . . . . . . . . . . . . . 66.4 -118.65 11.22 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' VAL . . . . . . . . . . . . . 9.5 p 179.13 168.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.257 1.476 0 CA-C-O 121.707 0.765 . . . . 0.0 110.217 176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.02 113.81 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 160.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 221' ' ' ALA . 6.5 t -119.89 158.33 26.88 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.865 0.866 . . . . 0.0 111.159 -165.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 59.93 16.2 5.57 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.272 1.029 . . . . 0.0 111.17 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.8 t 53.6 28.54 8.01 Favored 'General case' 0 CA--C 1.56 1.33 0 C-N-CA 125.561 1.544 . . . . 0.0 112.382 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 178.99 30.55 0.05 OUTLIER Glycine 0 C--N 1.358 1.794 0 C-N-CA 120.768 -0.73 . . . . 0.0 114.447 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 217' ' ' THR . . . -135.88 145.47 46.38 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.253 0.527 . . . . 0.0 109.596 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -105.13 101.67 11.21 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.9 1.28 . . . . 0.0 109.162 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 31' ' ' ILE . 17.9 m -122.67 141.44 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-N 119.103 0.865 . . . . 0.0 110.512 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.4 m -144.9 129.41 17.97 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.581 -166.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.791 ' HA ' ' HA2' ' A' ' 185' ' ' GLY . . . -81.52 -16.28 52.28 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 122.61 0.364 . . . . 0.0 110.648 172.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 17.5 pt 56.52 140.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 128.276 2.63 . . . . 0.0 116.527 171.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.05 149.48 27.54 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.985 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.29 143.01 51.17 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 172.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' THR . . . . . 0.661 ' HA ' ' HE1' ' A' ' 144' ' ' TRP . 62.2 p -76.03 104.4 6.54 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.555 0.693 . . . . 0.0 111.046 -169.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.26 107.74 19.87 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.424 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.636 ' HD3' ' H ' ' A' ' 231' ' ' LYS . 0.0 OUTLIER -56.98 80.57 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.343 0 C-N-CA 124.204 1.002 . . . . 0.0 111.485 172.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 52.3 p -70.27 93.49 0.85 Allowed 'General case' 0 C--N 1.349 0.566 0 C-N-CA 123.854 0.861 . . . . 0.0 109.877 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ILE . . . . . . . . . . . . . 10.8 tp -97.36 14.53 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.568 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -65.16 92.3 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.894 0.878 . . . . 0.0 110.375 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.71 -39.56 94.62 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 172.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -55.32 132.54 69.83 Favored Pre-proline 0 CA--C 1.558 1.284 0 CA-C-N 114.166 -1.379 . . . . 0.0 111.04 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.01 -52.2 8.51 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.838 2.359 . . . . 0.0 113.259 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -134.24 -77.8 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.132 0.573 . . . . 0.0 110.002 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 42.6 mm 49.91 82.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 124.928 1.291 . . . . 0.0 112.245 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 124.235 1.014 . . . . 0.0 110.487 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' BEZ . . . . . 0.765 ' H6 ' HD12 ' A' ' 86' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' NLE . . . . . 0.654 ' HG2' ' HB3' ' A' ' 88' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' A' ' 90' ' ' GLY . 2.0 tppp? -121.71 -49.45 2.11 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.331 0.653 . . . . 0.0 110.739 167.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -104.32 158.58 16.36 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.917 0.389 . . . . 0.0 110.941 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' M9P . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_